
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-11101-11400*
  '(".48+7C" ".7806-2A" "8-OHdG" "A+B" "A-associated" "A-containing"
    "A-independent" "A-specific" "A-type" "A1" "A130-G147" "A138P" "A138S"
    "A146T" "A146V" "A1634C" "A1708E" "A18C" "A2" "A20-G44" "A219–U228" "A298T"
    "A3-2K3A" "A373T" "A39S" "A3B" "A3C" "A3DE" "A3F-CTD" "A3F-CTDs" "A3F-NTD"
    "A3F-Vif" "A3F-null" "A3F-ssDNA" "A3G" "A3G's" "A3G-2K3A" "A3G-CTD" "A3H"
    "A4" "A53T" "A592T" "A664S" "A7" "AA+AG" "AAK" "AATT" "AAV2" "AAV8"
    "AB042199" "ABMRs" "ABO" "AC-430" "ACAGGTAA" "ACB" "ACGT" "ACIS-III" "AD"
    "AD#17" "AD#17+ATM" "AD#17+TM" "ADAMTS" "ADP-ATP" "AE" "AE9a" "AFU" "AG+GG"
    "AG13145" "AGC" "AGCCT" "AGGGG" "AGJ" "AGLCL" "AIDF193A" "AIDL196A"
    "AIDR190A" "AIDS-defining" "AIDS-like" "AIDS38A" "AIPI" "AIPIpTPT" "AKT-P"
    "ALI" "ALK+TCL" "ALK-TCL-derived" "ALK-and" "ALK-dependent"
    "ALK-expressing" "ALK-induced" "ALK-mediated" "ALK-transformed"
    "ALL-Berlin-Frankfurt-Münster" "AMAGs" "AML1-ETO9a" "AMP-to-ATP" "AMPK1α"
    "AMPKα2" "AMR" "ANC" "ANCOVA" "ANRIL" "ANT1–4" "AP-1-dependent" "AP-1-like"
    "API-59CJ-Ome" "APL" "APOBEC" "APOBEC3DE" "APOBEC3H" "AP‐1" "AQ5" "AR-ARE"
    "AR-NTD" "AR-NTD-Gal4DBD" "AR-V" "AR-V567es" "AR-Vs" "AR-Vs."
    "AR-dependence" "AR-null" "AR-positive" "ARA70α" "ARBS" "ARE-luciferase"
    "ARE–DNA" "ARE–luciferase" "ARGH5" "ARGS" "ARHG5" "ARMC8" "ARN509"
    "ARNT-mediated" "ARQ" "ARQ-197" "AR~55%" "ASD-relevant" "AT1OS" "ATCC"
    "ATM-defective" "ATM-proficient" "ATMRi2" "ATMRi4" "ATP-competitive"
    "ATP-synthase" "ATP-γ-S" "ATP5α" "ATP–competitive" "ATTG" "AU-Rich"
    "AU-rich" "AU1-tagged" "AUC=0.707" "AUG1" "AUG2" "AVN" "AWD" "AXINs"
    "AZD2281was" "Abelson" "Abraham" "Ac" "Ac-H3K16" "Ac-H4" "Ac-K382"
    "Acetyl-H3" "Acetyl-H4" "Achille" "Activated" "Acyl" "Ad-FGF21" "Ad-GFP"
    "Adichie" "Ado+Hcy" "Adv" "Adv-GFP-Bcl-xl" "Ad‐Ex" "Ad‐GFP" "Affymetrix"
    "Afghani" "Africa" "African" "African-American" "African-Americans"
    "African-Ecuadorian" "Africans" "Ag" "Ags" "Agua" "AhRs" "Ahnen" "Aims"
    "Akt-mediated" "Akt1" "Akt2" "Akti-1" "Alano" "Aldrich" "Alexa" "Algeria"
    "Allen" "AluJ" "AluJO" "AluJb" "AluSc" "AluSg" "AluSp" "AluSq" "AluSx"
    "AluY" "Alzheimer" "Alzheimer’s" "AmNogo" "AmNogo-B" "America" "American"
    "Americans" "Amgen" "Amin" "Amino-terminal" "Ampelopsin" "AmpliSeq"
    "Anatomia" "Angiopoietin‐1" "Anglia" "Ang‐1" "Ang‐1‐induced"
    "Ang‐1‐treated" "Ang‐2" "Antitumour" "Anton" "Apak" "Apulia" "Aquitaine"
    "Arab" "Araki" "Areb6" "Artemisia" "Asako" "Asef-b" "Ashkenazi" "Asian"
    "Asians" "Asp538Gly" "Asp87Arg" "Asp87–89" "Asp87–89Arg" "Asp88Arg"
    "Asp89Arg" "Asperger" "Asperger’s" "Astler" "Astler-Coller" "AstraZeneca"
    "Atiprimod" "Australia" "AutoDock" "Autosomal-dominant" "Avanzate" "Avery"
    "AxxA" "Azadirachta" "Aβ" "A–5D" "A–E" "A–U" "B-Cdk1" "B-G" "B-clade"
    "B-cyclin" "B-factors" "B-lymphocytic" "B1" "B1-EGFP" "B2" "B2-EGFP" "B3"
    "B6" "B9" "BA" "BALB" "BAPTA-AM" "BAT-1" "BAs" "BCAAs" "BCAR" "BCP1"
    "BCR-ABL-kinase-dependent" "BCRT101" "BCRT102" "BCRT104" "BD" "BDs"
    "BGJ398" "BGR1" "BH3-only" "BHP" "BHP2-7" "BIBW" "BIBW-2992" "BIMAS"
    "BIRB0796" "BIRC8" "BIU" "BIU-87" "BJ" "BLM-F2" "BLM-TOPOIIIα-RMI1" "BMDMs"
    "BOLERO-2" "BOX" "BPD-like" "BPV-1" "BPV1" "BR293" "BRAC" "BRAF-35"
    "BRAF-positive" "BRAFi" "BRAFi+AKTi" "BRAFi+MEKi" "BRAFi+MEKi+AKTi"
    "BRAFmutant" "BRCA1-and" "BRCA1-mutated" "BRCA1-responsive"
    "BRCA2-defective" "BRCC5" "BRCT7+8" "BRIM7" "BV" "BW" "BYL719-alone"
    "Background" "Bahamas" "Balta" "BamHI" "Banck" "Bandres" "Banff"
    "Bangladesh" "Bangladeshi" "Barosi" "Barr" "Barrington" "Barrington’s"
    "Barts" "Basal" "Basal-like" "Basal-type" "BasalA" "BasalB" "Basilico"
    "Baugé" "Baur" "Bax" "Bax-to-Bcl-2" "Bcl" "Bcl-2" "Bcl-xl" "Bedford" "Begg"
    "Begg's" "Begg’s" "Belarus" "Beltran" "Beneke" "Bennett" "Berardinelli"
    "Berardinelli-Seip" "Berger" "Beta-integrins" "BigDye" "BilIN" "BilINs"
    "Bim" "BindingDB" "Bio" "Bio-Rad" "BioB" "BioGrid" "Biocarta" "Biomediche"
    "Bioproducts" "Biotage" "Bivariate" "Blangero" "Boc-Lys" "Bonferroni"
    "Boston" "Boyden" "Brainstem" "Braoudaki" "Bratislava" "Brazil" "Brian"
    "British" "Brodmann" "Brownell" "Browser" "Burlingame" "Buss" "BvD" "Bzp"
    "B·GTP" "C-index" "C-isoform" "C-lobe" "C-residues" "C-statistic"
    "C-terminally" "C-to-G" "C-to-U" "C124-C71" "C124R" "C13" "C1–212" "C1–391"
    "C2" "C28I2" "C3" "C3HC4" "C4D" "C4d" "C4d-negative" "C4d-positive"
    "C50-A68" "C57" "C57BL6" "C8-PA" "CA19-9" "CAAAAA" "CAAT" "CAAX" "CACCTG"
    "CAGGTA" "CAGGTG" "CARDIoGRAM" "CARDIoGRAMplusC4D" "CATT" "CATb" "CAY10593"
    "CB11130" "CB11171" "CB660" "CBF-β" "CBR3" "CBRK" "CC-chemokines" "CCAAT"
    "CCAGGTGC" "CCAT" "CCCGG" "CCG1423" "CCLE" "CCNEI" "CCP-positive" "CCR10"
    "CCT" "CCU" "CCZ" "CD" "CD117-positive" "CD133-positive" "CD135"
    "CD15s-positive" "CD44+" "CD44-dependent" "CD44-high" "CD44-positive"
    "CD44s" "CD44v2–10" "CD62Lhi" "CD8β" "CDDP-GA" "CDDP–GA" "CDK6NFG" "CDK6WT"
    "CEM-T4" "CEN" "CENP" "CEP-33779" "CEP8" "CEU" "CGD" "CGs" "CH12F3"
    "CHECK2" "CHR" "CID-independence" "CIMP-positive" "CK666" "CKIδ"
    "CKIδ-mediated" "CL" "CNKI" "CNNM2" "CNVs" "COL14A1is" "COLO" "COLO-320"
    "CORM" "COS-1" "CPA-7" "CPDHC" "CPSF6ΔNLS" "CPT-1α" "CPT-treatment" "CPT1α"
    "CPTC" "CR+PR" "CRE-level" "CSA" "CSL-2" "CSNK1A1L" "CT+TT" "CTAs" "CTCAE"
    "CTCs" "CU" "CWR" "CWR-22RV1" "CWR-22Rv1" "CXCL14" "CXCR4-positive"
    "CYP17A1-CNNM2-NT5C2" "CaMKKβ" "CaMKKβ-AMPK" "Caenorhabditis"
    "Cajal–Retzius" "Cal" "Cal-62" "Calm-dependent" "CalmodulinIP" "Cambridge"
    "Campbell" "Canada" "Cancer" "Cap-dependent" "Caraglia" "Caribbean" "Carlo"
    "Carlsbad" "Case-control" "Catarino" "Catechol-O-Methyl" "Caucasian"
    "Caucasians" "Cbl-dependent" "CcO" "Cdc37" "Cdk-substrate" "Cdk1-Clb5"
    "Cdk1-specific" "Cdk2" "Celgene" "Cell-permeable" "CellProfiler" "CellROX"
    "CellTiter" "Cercopithecus" "CeuI" "ChIP" "ChIP-qPCR" "ChIP-qPCRs"
    "ChIP-reChIP" "ChIP–qPCR" "Chacko" "Chaft" "Chagas" "Chang" "Chappe"
    "Chemi" "Cheong" "Cheung" "Chi-square" "Chien" "Chile" "Chilean" "ChinaPCa"
    "Chipuk" "Chirurgia" "Chmielecki" "Chr10∶123298158" "Chr10∶123310871"
    "Chr7p12" "Chu" "Chuang" "Cish" "Cks-substrate" "Cks1-consensus"
    "Cks1-phosCdc6" "Clark" "Claros" "CldU" "CldU-positive" "Clinical"
    "ClinicalTrials" "Clock-partner" "Coller" "Collette" "Collins"
    "Colony-forming" "Colorado" "Comprida" "Conclusions" "ConsensusPathDB"
    "Consite" "Control+Veh" "Coomassie" "Corbo" "Coregulators" "Cosmo"
    "Costello" "Cowden" "Cox-regression" "Cox7a1" "CpGplot" "Cq" "Cr" "CreP"
    "Cross-analysis" "Cross-reactivity" "Cruciferae" "Cruz" "Cs" "CsCl"
    "Csk-reversible" "Ct" "Cullin-RING" "Cullin4A" "Cunningham"
    "Cyclin-dependant" "Cyclooxygenase-1" "Cyclopia" "Cylopia" "Cypriot" "Cyr"
    "Cys3HisCys4" "Cyto" "Czech" "Czyzyk-Krzeska" "Cα" "Cα2" "Cι" "Cμ"
    "D-Cyclin-activated" "D-beta-hydroxybutyrate" "D-loop" "D-loops" "D-scores"
    "D128K-A3G" "D2" "D3" "D49H" "D835" "DAP-1Baf" "DATATOP" "DAVID" "DBrD"
    "DDB-Cul4A" "DDB1-Cul4A-Roc1" "DDB2-proficient" "DDFS" "DDR8" "DED1" "DED2"
    "DETA" "DEXA" "DFMO+diclofenac" "DFMO+sulindac" "DFN" "DG" "DHL-41" "DHM"
    "DIRT" "DJ" "DJ-1alpha" "DJ-1beta" "DK" "DKL" "DKO" "DLB" "DLC27-14" "DLE"
    "DLEKHGAITS" "DLPl" "DMBA-DHD" "DMBA-DHD-induced" "DMBA-DHD-stimulated"
    "DMBADHD" "DME" "DMEM" "DMEs" "DNAJB" "DNA–protein" "DNMTB3" "DNR" "DOI"
    "DPP3" "DQBS" "DR-GFP" "DRB1" "DRE-dependent" "DRE-like" "DSBR" "DSBs"
    "DSMO" "DTPP" "DTPPs" "DTPs" "DU14" "DUSP22" "DUSP4‐induced"
    "DUSP4‐knockdown" "DUSP5‐knockdown" "DWN" "DXM1200" "DZA" "DZAari" "Dahiya"
    "Dakhova" "Daniels" "Danish" "Danlos" "Darby" "Datoga" "Davis"
    "Davit-Spraul" "Dbl-like" "Ddi1" "Debidda" "Deletion" "Delta-like"
    "Demographic" "Deng" "Denmark" "Deoxytetrangomycin" "Derzbach" "Descemet"
    "Dexibuprofen" "Diaminobenzidine" "Dictyostelium" "Diego" "Diet-induced"
    "Dihydromyricetin" "Dinsdale" "Dipartimento" "DisProt" "Discoidin"
    "Disease-Free-Survival" "Dojindo" "Dominant-negative" "Dominguez" "Dong"
    "Double-Knockdown" "Dougherty" "Dox" "DpnI" "Draviam" "Drf" "Drf1-null"
    "Drosha" "Dual-target" "Duan" "Dulbecco" "Dumont" "Dutch" "Duval"
    "Dynabeads" "Döhner" "D–E" "E-Cad" "E-GBM" "E-GBMs" "E-TABM-158"
    "E-TABM-276" "E-TABM-66" "E-box" "E-box-binding" "E-boxes" "E-plate"
    "E-twenty-six" "E189-T198" "E2-treatment" "E2F-dependent" "E2F-regulated"
    "E2F-regulation" "E2F-regulatory" "E2F-target" "E2F1-dependent"
    "E2F1-induced" "E2F1-mediated" "E2F1-regulated" "E2f1-dependent"
    "E2f1-induced" "E3-ligase" "E5" "E6*I" "E6*II" "E6I28T" "E6SAT" "E6STOP"
    "E6WT" "E746-A750" "E746-A750+T790M" "E8.5" "EAhy926" "EBPa–miR-122–IGF-1R"
    "EBPβ-2" "EBPγ" "EBPδ" "EBPε" "EC1-5" "EC3" "EC4" "ECGG" "ECM-components"
    "ECOG" "EDEME1" "EDIL3" "EFGP" "EFLARH" "EFN" "EGF-like" "EGFP-C1"
    "EGFP-positive" "EGFP-positivity" "EGFR-T790M-derived"
    "EGFR-T790M-negative" "EGFR-positive" "EGFRI" "EGFRTKI" "EGFRvIII-driven"
    "EGFRwt" "EGTs" "EHO" "EIA" "EIF3n" "EKR1" "ELISPOT" "ELL-DOPA"
    "ELM4-ALK-driven" "ELY" "EMR" "EMT-like" "EMT-marker" "EMT-regulatory"
    "ENSG00000259001" "EORTC" "ER-antagonist" "ER-modulator" "ER-negative"
    "ER-negativity" "ER-positive" "ER-status" "ER-stress-relieving"
    "ER-tracker" "ER46" "ER66" "ERAD-L" "ERB-041" "ERBB2-positive"
    "ERE-luciferase" "EREs" "ERFFI" "ERIC" "ERIC’s" "ERK-RSK-mediated"
    "ERK-fission" "ERK-mediated" "ERK1,2" "ERK1,2-dependent" "ERKi" "ERM"
    "ERRa" "ERRβ" "ERα+E2" "ERα-E2" "ERα-E2-induction" "ERα-bioactivity"
    "ERα-genomic" "ERα-positive" "ERα-regulatory" "ERβ-positive" "ERβ-to-ERα"
    "ER–agonist" "ES-like" "ESCRT" "ESCRT-0" "ESCRT-1" "ESCRT-I"
    "ESI-035-BCL-XL" "ESSC" "ET-1-mediated" "ET-LA" "ETGE" "ETLS" "EVVKHHSPVS"
    "EWT" "EYFP" "EYFP155–238" "EYFP1–154" "Earle" "Earle’s" "EcoRV"
    "Editor-in-Chief" "Egger" "Egger's" "Egger’s" "Egr‐1" "Ehlers"
    "Ehlers-Danlos" "El" "Ellis" "Elsevier" "Elston" "Emx1-IRES-cre" "EndMT"
    "Endo+Exo" "Endocrinology" "Endoh" "England" "English" "Ensembl"
    "EpCAM-positive" "EpCAM-positivity" "EpRE" "Epithelial-to-mesenchymal"
    "Eps15S" "Epstein" "Epstein-Barr" "ErbB" "ErbB2-induced" "ErbB2-negative"
    "Erithacus" "Escara" "Escara-Wilke" "Estaquier" "Estonia" "EtOH-soluble"
    "Europe" "European" "European-American" "Europeans" "ExoI" "Ex " "F-SNP"
    "F-fluorodeoxyglucose" "F1" "F11" "F2" "F4" "F45Y" "F47Y" "F807Qfsx41"
    "F807fsx41" "FACSCalibur" "FACScanto" "FBJ" "FCD1" "FCD2" "FCD3" "FCD4"
    "FERM" "FFB" "FGF" "FGFR2a" "FGFR2b" "FGFR4-negative" "FGFR4-positive"
    "FIGO" "FIPI" "FISH-positive" "FIr-B" "FK2" "FKBP12-rapamycin" "FL3"
    "FL34R" "FLAG" "FLAG-Synpo-T" "FLAG-Synpo-long" "FLAG-Synpo-short"
    "FLAG-tag" "FLT3-LM" "FNC" "FNCs" "FOLFIRI" "FOLFIRI-aflibercept" "FOLFOX4"
    "FOLFOX4-BEV" "FOLFOX6" "FOLFOXIRI" "FOPflash" "FOX" "FOX01" "FOX03" "FOX3"
    "FOx" "FPD" "FPV" "FRB" "FTY720-phosphate" "FTY720P" "FUT11" "FV"
    "Fabaceae" "Fackler" "Falini" "False-positive" "Fattahi" "Fc-epsilon" "Fcγ"
    "FcγR" "FcγRI" "FcγRII" "FcγRIII" "FcγRs" "FcεR" "FcεRI" "FcεRI-bound"
    "FcεRI-mediated" "Fe" "Federico" "Feinberg" "Feldmann" "Fenton" "Fernebro"
    "FiO2" "Fifty-four" "Fifty-seven" "Fill-and-trim" "Fine-needle" "Finland"
    "Finnish" "Fischer" "Five-year" "FlAsH-reactive" "Flag" "Flag-β-TRCP1"
    "Flag–14-3-3ζ–EYFP1–154" "Flag–AIDF193A–EYFP1–154"
    "Flag–AIDL196A–EYFP1–154" "Flag–AIDR190A–EYFP1–154"
    "Flag–AIDS38A–EYFP1–154" "Flag–AID–EYFP1–154" "Flag–PKA-Cα–EYFP1–154"
    "Flag–PKA-RIα–EYFP1–154" "Flag–RPA1–EYFP1–154" "Flag–Ung"
    "Flag–Ung–EYFP1–154" "FlnA–KO" "FlnA–WT-reconstituted" "FlnB" "Fluidigm"
    "Fluor-de-Lys" "Fms-like" "FoldX" "Folfiri-bevacizumab" "Folfox"
    "Follow-Up" "Foo" "Forkhead-box" "Forty-three" "Foti" "FoxO1-positive"
    "FoxO3-positive" "Framingham" "Francisco" "Fraumeni" "French"
    "French-Canadian" "Fricker" "Fristrup" "Friuli" "Fuchs" "Fujii" "FunSimPD"
    "FunSimPD_ND1" "FunSimPDsub" "Fura-2" "FxFG" "Förster" "F " "G-C" "G-actin"
    "G-band" "G-quadruplex" "G-to-A" "G0" "G0-G1" "G0-phase" "G0-state" "G1"
    "G1-S" "G160-G167" "G161-G168" "G1–S" "G2" "G2+M" "G2-M" "G217-G226"
    "G23-C34" "G2M" "G3" "G56-C169" "G56–C169" "G7" "GA+AA" "GA-induced"
    "GA-to-AA" "GAC" "GAD1-positive" "GADD45α" "GAGAGA" "GAL4-AD" "GAP-ploidy"
    "GAP-relevant" "GATA3≤1" "GATOR" "GC-Relatives" "GCAGGTAG" "GCAGGTGG"
    "GCTGC" "GDS1699" "GEF-mediated" "GEF-relevant" "GEMM" "GEMMs" "GEP-NENs"
    "GFAP-immunopositive" "GFP-NLSTBLR1" "GFP-RhoAN19" "GFP-RhoAV14E40L"
    "GFP-Synpo-T" "GFP-Synpo-long" "GFP-mDia1" "GFP-positive" "GFP-sui"
    "GFP-transgenic" "GG-AT" "GG4-like" "GGGAA" "GL" "GM7166+NBS1" "GNCT3"
    "GOComp" "GOLDN" "GOSlimPD" "GPX-1" "GPX-2" "GR5" "GRAFIT"
    "GRAFIT-Erithacus" "GRCh37" "GRO-seq" "GS" "GSE10797" "GSE11121" "GSE11965"
    "GSE12093" "GSE12306" "GSE12763" "GSE12917" "GSE13671" "GSE1456" "GSE1561"
    "GSE22050" "GSE3494" "GSE47011" "GSE4922" "GSE5460" "GSE5462" "GSE5764"
    "GSE5847" "GSE6532" "GSE6596" "GSE6883" "GSE7390" "GSE7904" "GSE8193"
    "GSE8977" "GSE9195" "GSE9574" "GSHLKSKKGQSTSRHK" "GSHLKSKKGQSTSRHK-K"
    "GSK-3b–C" "GSK-3βled" "GSK-3βresistant" "GSK-3βwas" "GSK464361"
    "GST-KIBRA-M" "GST-KIBRA-N" "GST-MIB1-D3" "GST-SH3-A" "GST-SH3-B"
    "GST-SH3-C" "GST-fusion" "GST-pull" "GST–14-3-3γ"
    "GST–14-3-3γ–precipitated" "GST–Crib" "GST–Rothekin" "GTG" "GTPase-like"
    "GTPases" "GW843682" "GW843682-induced" "GWAF" "Gago" "Gago-Dominguez"
    "Gaithersburg" "Gal4DBD" "Gal4UAS-TATA-luciferase" "Gallen" "Garcia"
    "Garcinia" "Gateway-based" "Gemignani" "GenBank" "GenCord" "Genbank"
    "GeneChip" "Generale" "Geneva" "Genomatix" "Genome-Wide" "Genome-wide"
    "Genotypes" "Gerais" "German" "German-Austrian" "Germany" "Gi" "Giam"
    "Gibco" "Gillum" "Giralt" "Gleason" "Gln+Arg" "Gln+Gln" "GlobPlot"
    "Glutathione-Sepharose" "Gly538" "Gly538–Asp351" "Goh" "Goias" "Goosecoid"
    "Goossens" "Gouédard" "Goven" "GpppN" "Grade" "GraphPad" "Grb2" "Grecco"
    "Greco" "Greek" "Griner" "Grose" "Gsα" "Guajarati" "Gudlaugsson" "Guilford"
    "Gujarati" "GxE" "Gy" "Gynecologie" "Gö6976" "Gα12" "Gαs" "G–U" "H&E"
    "H-RasV12" "H-Rasv12" "H-STS" "H-Scores" "H-Score " "H-bond" "H-score" "H1"
    "H1-CNV" "H1-mediated" "H109–393" "H121R" "H1975" "H3" "H3-positive"
    "H3K18" "H3K18Ac" "H3K27" "H3K56" "H3K9acS10ph" "H3K9me2" "H4" "H4K20"
    "H4K5" "H5N1" "H7N7" "H9" "HA-ER" "HA-TSG101" "HA-tag" "HAK-1B"
    "HA–14-3-3β–EYFP155–238" "HA–14-3-3γ–EYFP155–238" "HA–14-3-3ε–EYFP155–238"
    "HA–14-3-3ζ–EYFP155–238" "HA–14-3-3η–EYFP155–238" "HA–14-3-3σ–EYFP155–238"
    "HA–14-3-3τ–EYFP155–238" "HA–14-3-3–EYFP155–238" "HA–Vpr–EYFP155–238"
    "HBEC3KT53" "HBEC3KTR" "HBECs" "HBII-239" "HBOC" "HCAECs" "HCC-2998"
    "HCC-366" "HCC-366-DR" "HCC-origin" "HCC827-GR5" "HCLc" "HCT116Dicer"
    "HDAC3-FL" "HDAC3-NLS" "HDAC3-△C1" "HDAC3-△C2" "HDAC3A" "HDV" "HECTD3m"
    "HECTD3sh" "HEK-STAT3-YF-YFP" "HEK-STAT3-YF-YFP-NLS" "HEK292" "HEKgp80"
    "HER-family" "HER2-negative" "HER2-positive" "HER2-positivity"
    "HER2-status" "HER2→PUMA" "HES3-BCL-XL-overexpressing" "HFKs"
    "HGF-mediated" "HHL-17" "HHR" "HIF-activity" "HIF-α" "HIFα" "HIFβ"
    "HIV-1Vpr" "HIV-1ΔVpr" "HJ" "HJH" "HJs" "HKG" "HKGs" "HLA-A*0201"
    "HLA-A1-B8-DR3" "HLA-A2" "HLA-A2-positive" "HLA-I" "HLD-DR" "HMEC50"
    "HMG-I" "HMG-Y" "HNOKs" "HNRNPA1" "HNSCCs" "HNSSC" "HOMA-B" "HOMA-IR"
    "HOMA-β-cell-function" "HOpic" "HPCs" "HPMEC" "HPRD" "HPRT" "HPV-positive"
    "HPV31WT" "HPV6b" "HR-positive" "HR=0.22" "HR=0.23" "HR=0.26" "HR=0.27"
    "HR=11" "HR=2.02" "HR=2.112" "HR=2.20" "HR=2.26" "HR=2.4" "HR=2.7" "HR=3.3"
    "HR=3.8" "HR=4.13" "HR=4.2" "HR=5.0" "HR=5.9" "HR=7.0" "HR=7.2" "HRASV12"
    "HRECs" "HR = 2.26" "HS90A" "HS90B" "HSPH" "HT1080" "HT2-19" "HT29FU"
    "HT29OXA" "HTM" "HU-exposure" "HV" "HX" "Habashy" "Haber" "Haber-Weiss"
    "Hadza" "Hairy-cell" "Half-life" "Haller" "Hamid" "Hanahan" "HapMap"
    "HapMapIII" "Haplotter" "Hardy-Weinberg" "Hardy-Zuc-kermann"
    "Hardy–Weinberg" "Harijith" "Hartwig" "Hartwig’s" "Harvey" "Hashimoto"
    "Hashimoto's" "Hayes" "Hazarika" "Hck" "Hck-YEEI" "Hematology" "Henan"
    "Hepa1c1c7" "Hepatocyte-specific" "Hercules" "Hg-days" "Hgf" "HiSeq"
    "Hialeah" "High-coverage" "High-dose" "High-grade" "High-molecular-weight"
    "High-resolution" "High-sensitivity" "Himisha" "Hindorff" "Hippo"
    "Hippo-YAP" "His-FHA" "His-tBRCT" "His-tag" "His-ubiquitin" "Hispanic"
    "Hispanics" "Hochberg" "Hodgkin" "Hodgkin's" "Hodgkins" "Hoechst" "Hofland"
    "Hofmann" "Hokkaido" "Holliday" "Homeodomain" "Honeybush" "Hong" "Honma"
    "Houtkooper" "How-ever" "Hpe3B" "HpeG2" "Hrecka" "HsCks2" "Hsieh" "Hsp90"
    "Hsu" "Httex1-Cerulean" "Httex1-Emerald" "Huang" "Hui" "Huntington"
    "Huntington’s" "Hurd" "Hutchinson" "Hörnberg" "I+II" "I-CeuI" "I-DIRT"
    "I-II" "I-III" "I-IV" "I-MIBG" "I-PpoI" "I-PpoI–induced" "I-kB"
    "I-metaiodobenzylguanidine" "I1954" "I6" "IACUC" "IC50" "IC50s" "IC50 "
    "ICH" "ID17" "ID8" "ID9" "IENS" "IFN-γused" "IGF-1Rβ" "IGFBP2-null" "IGHV"
    "IGR-1R" "II-1" "II-4" "II-5" "II-6" "II-III" "III+IV" "III-4" "III-5"
    "III-IV" "IIIa" "III–IV" "IIa" "II–III" "IKBα" "IKK-γ" "IL-10R–deficient"
    "IL-17+" "IL-2Rα" "IL-2Rγ" "IL-6Rα" "IL21R" "ILV" "IMC" "IMC-A12"
    "IMQLMPFGCLL" "IPIpTPTK" "IPNBs" "IQGAP1and" "IRAB" "IRACARP" "IRES"
    "IRIFs" "IS" "ISG" "ISGs" "ISRE" "ISRE-luc" "ITC" "ITD" "ITGβ" "IU" "IVDWB"
    "IVF" "IVIS" "IVKA" "IVR" "IVS" "IVS1" "IVS1-20" "IVS1-8" "IVS11" "IVS12"
    "IVS14-1ArG" "IVS16-14T" "IVS16-2A" "IVS17-53C" "IVS2" "IVS2+24"
    "IVS2+24(AG)" "IVS2+9" "IVS20+48" "IVS4" "IVS5-8" "IVS6-70-T" "IVS7+83"
    "IVS7-34T" "IVS8-70" "Iacovazzi" "IdU-positive" "IgA" "Igoctamer"
    "Illumina" "ImageJ" "Immuno-Precipitation" "ImmunoCAP"
    "Immunocytochemistry" "In-vitro" "Inc" "Indians" "InhibitorSelect" "Innes"
    "Inos" "Insulin" "Intent-to-treat" "Inter-individual" "Interlukin"
    "Interlukin-6" "Internationale" "Intra-tumoral" "Inv-mut-AA2" "Invitrogen"
    "Iorns" "Iran" "Iraq" "Iraqi" "Irf-4" "Irie" "Irie-Sasaki" "Irino" "Irish"
    "Ischemia-reperfusion" "Isoleucin" "Israel" "Iwaki" "Iα-Cα" "Iγ-Cγ"
    "Iγ-Cγ1" "Iγ2a-Cγ2a" "Iγ2b-Cγ2b" "Iδ" "Iε-Cε" "Iκ-kinase" "Iκ-kinase-RelA"
    "IκK" "Iμ" "Iμ-Cα" "Iμ-Cγ" "Iμ-Cε" "Iμ-Cμ" "I–III" "J04431.1" "J101" "J82"
    "JAJ2V617F" "JAK-STAT3" "JAK2V617F" "JAK2WT" "JAK3-deficient" "JAR" "JCT"
    "JFZ" "JLF" "JMC" "JNJ" "JNJ-10198402" "JNJ-10198409" "JOCK" "JOCK1" "JPP"
    "JPT" "JVG" "JW" "JYL" "JZ" "Jacinto" "Jackman" "Jadad" "Janex-1"
    "Janus-activated" "Japanese" "Jeong" "Jerez" "Jewish" "Jews" "Jiang" "Jin"
    "Jing-kang" "Johnsen" "Johnstone" "Jonathan" "Joseph" "Josephin" "Juan"
    "Juan-Miguel" "Judson" "Jun-chao" "Juxta" "K-Ras-transformation"
    "K-RasG12+AGF" "K-RasG12+p38AGF" "K-RasG12V" "K-RasWT" "K-means" "K0" "K13"
    "K266A" "K36" "K382Ac" "K38A" "K39A" "K3A" "K40A" "K48-linked" "K48-only"
    "K5A" "K5D" "K63-only" "K63A" "K63R" "K9" "KAN-1" "KB101471" "KDL" "KEGG"
    "KELCH" "KG" "KIBRA-C" "KIBRA-M" "KIFs" "KIT-positive" "KPS" "KRASwt" "KRJ"
    "KRJ-1" "KRJ-I" "KSR2_921" "KSR2_950" "KVL" "KYSE" "KZ" "Kae" "Kae’s"
    "Kaminchik" "Kanters" "Kaplan" "Kaplan-Meier" "Kaplan-Meyer" "Kaplan-meier"
    "Kaplan–Meier" "Kaptein" "Kapteins" "Karnofsky" "Karolinska" "Katayama"
    "Kazanietz" "Kd" "Kekkon" "Kekkon-1" "Kelsey" "Kepes" "Ki-67" "Ki67"
    "Ki67-positive" "Kim" "KinasePhos" "Kinexus" "Kirsten" "Kit-8" "Kiyono"
    "Klenow" "Knock-down" "Knudson" "Koelsche" "Kong" "Korea" "Korean"
    "Koreans" "Koskela" "Kotha" "Kouso" "Kras" "Krasteva" "Kriegl" "Krisko"
    "Kruppel-like" "Kruskal-Wallis" "Krzeska" "Ku" "Ku-0059436" "Kubota"
    "Kufor" "Kufor-Rakeb" "Kumamoto" "Kurasawa" "L-DOPA" "L-L" "L-VDCC"
    "L-dopa" "L-type" "L1" "L1-RNP" "L1-RNPs" "L1-UPF1" "L1-host" "L1RP"
    "L1–L2" "L2" "L822Pfsx26" "LA-versus-ET" "LAINef" "LAINefP72A" "LAIs"
    "LAP2α" "LC3-I" "LC3-phosphatidylethanolamine" "LDL-cholesterol" "LEAP"
    "LGR" "LGRs" "LIGIII" "LIMQLMPFGCL" "LINE-1" "LINE-1s" "LINE1" "LIRG1"
    "LKO" "LKPS" "LKR13" "LMFK" "LNCaP-Stat3C" "LNCaP-pBabe" "LNM" "LNMs"
    "LOF-p53" "LOX-PP-P111A" "LOX-PP-R116A" "LOX-PP-WT" "LOX-PP-interacting"
    "LP-2" "LP-4" "LPAAT-α" "LPAAT-β" "LSCC" "LSL-K-RasG12" "LSL-Trp53R172H"
    "LU" "LVI" "LW" "LX" "LXCXE" "LXXLL" "LXXS" "LY29400" "Lack" "Langerhans"
    "Lanka" "LapR" "Latin" "Latina" "Latinas" "Latino" "Lats1" "Latvia"
    "Lauren" "Lavoie" "Leber" "Leber's" "Lepik" "Leslie" "Leu1418X" "Leu3X"
    "Leung" "Levit" "Lewy" "Leygue" "Li" "Li-Fraumeni" "Li6c" "Ligand-receptor"
    "Lipofectamine" "Lipopolysaccharide" "Lippert" "Litzenberger" "Liu"
    "Liverpool" "Lk" "Lo" "Loci-genes" "Log-rank" "Long-lived" "Lopez"
    "Lopez-Pajares" "Loss-of-Function" "Loss-of-function" "Lotan" "Louise"
    "Ltd" "LuCaP" "LuciRi" "Lui" "Lumio" "Lund" "Ly5.1" "Ly5.2" "Lys-X" "Lys33"
    "Lys33Glu" "Lys581X" "LysMCre" "M-expressing" "M-group" "M-stage"
    "M-tropic" "M0" "M1-like" "M134del" "M2-like" "M5" "M6" "M7" "M9-BSA"
    "MA1-80087" "MAGIC" "MAGIC-5B" "MAPK-redundant" "MAPKAK-2" "MAPKAP"
    "MAPKAP-2" "MAPK‐independent" "MBC" "MC-7" "MCF-7-14" "MCF-7BUS"
    "MCF7-ATMi" "MCF7-ERβ-expressing" "MCF7-shBeta" "MCF7ras" "MCM2–7"
    "MDA-MD-231" "MDA-PCA2b" "MDC1-tBRCT" "MDDC" "MDR" "MEIS1D"
    "MEK-ERK-dependent" "MEKK-JNK-dependent" "MEKi" "MEKi+AKTi" "MEM" "MEPCE"
    "MET-like" "MET-targeting" "METASTROKE" "MF101" "MFP" "MFS" "MHC-I" "MHCII"
    "MHS2" "MIBC-group" "MINDACT" "MIR" "MK-8745" "MK12" "MKK6A"
    "MLN4924-treatment" "MM" "MMP-9-activity" "MO_1031" "MO_1051" "MO_1069"
    "MO_1129" "MQLMPFGCLL" "MRPs" "MS" "MSA-C" "MSGM" "MSI-H" "MSKCC" "MT-PCR"
    "MTS-STAT3" "MTS-STAT3-S" "MTS-STAT3-S727D" "MTS-STAT3S" "MTS-STAT3S727D"
    "MUC5C" "MUS81-dependent" "MUS81-depleted" "MUS81-null" "MVM" "MW13.7"
    "MY-I" "MYB-miR-200" "MYB-transfected-MDA-MB-231" "MYC-Nicks" "MYR-AKT"
    "MYR-AKT1" "Mac-3" "Mac3" "Machado" "Madin" "Madin-Darby" "Maggiolini"
    "Mahul" "Malay" "Malonyl-CoA-Decarboxylase" "Malvern" "Mander" "Mansfield"
    "Maori" "Marche" "Massie" "Matikainen" "Mb" "McCarthy" "McDougall" "Meier"
    "Melnick" "Melnick–Needles" "Mendelian" "Meng" "Menten" "Merker" "Merker’s"
    "Mesenchymal-to-epithelial" "Meta-regression" "Metazoa" "MethPrimer"
    "Methodology" "Mexican" "Meyer" "Meyskens" "Mfenyana" "MiR-122" "MiR-142"
    "MiR-195" "MiR-200" "MiR-223" "Michaelis" "Michaelis–Menten" "Michigan"
    "MicroRNA-124-3p" "Micron-scale" "Miguel" "Mihaylova" "Millikan"
    "Millipore" "Milone" "Minas" "Minckwitz" "Mitotracker" "MnSOD2" "Model-1"
    "Model-2" "Monocyte-derived" "MonogenicPD" "MonogenicPDIP" "Monte" "Montes"
    "Morrison" "Morrison’s" "Mosquera" "Mounir" "Mst" "MuTHER" "MuTect"
    "Muhajir" "Muller" "Multi-dimensionality" "Multi-liter" "Munro" "Murdoch"
    "MurineTIPE2" "Murraya" "Mut-1" "Mut-2" "Mut-Luc" "MutS-homologue"
    "Mutation" "Mx-1Cre" "Myc-tag" "MycER" "N-Acyl" "N-RasG12V" "N-WASP-Arp2"
    "N-acetyl" "N-glycosyl" "N-glycosylation" "N-isoform" "N-isoforms" "N-lobe"
    "N-truncated" "N-type" "N0" "N1a" "N1b" "N3ICD-CSL" "N3ICD-HA" "N469fs"
    "N=11" "N=6" "NA7" "NAML" "NAML-6" "NCB" "NCBI" "NCI-60" "NCI-H1703"
    "NCI-H2023" "NCI-H2286" "NCI-H2286-DR" "NCI-H322" "NCI-H522" "NCI-adr-Res"
    "NCOA" "NCOs" "NCXmito" "NEBD" "NED" "NEDD8-AMP" "NEK" "NET-PD" "NF-κB1"
    "NF639" "NF639-EV" "NF639-LOX-PP-P111A" "NF639-LOX-PP-R116A"
    "NF639-LOX-PP-WT" "NFAT-driven" "NFAT3-positive" "NFATl" "NFP" "NFkBIL-1"
    "NH2-end" "NHRs" "NHW" "NIEHS" "NKCD-motif" "NL" "NL4-3" "NLS-AXIN2"
    "NLSTBRL1" "NLSs" "NME" "NMIBC" "NMSCs" "NO" "NOD-SCID-IL2Rγ" "NOQ1"
    "NOTCH1~4" "NOTCH3-Asef-mediated" "NP13" "NP14" "NP6" "NPADG"
    "NPM-ALK-transformed" "NQO1-ARE-dependent" "NRG1-positive" "NRG1–ERBB2"
    "NS+E2∶1.733±0.037×10" "NS+E2∶12.733±0.521×10" "NS+E2∶2.333±0.023×10"
    "NSLCLC" "NT102" "NT70" "NU1025" "NVP" "NVP-AEW54" "NVP-AFW541" "Nagi"
    "Nakajima" "Nakanishi" "Nakashima" "Nanosizer" "Naples" "Naïve" "NdeI"
    "Nef-defective" "Neh6" "Nencioni" "Net" "NetMHC" "NetPhosK" "NeuT-PEC"
    "Neuregulin1-ErbB2" "Neuron" "Newcastle" "Newcastle–Ottawa"
    "Next-Generation" "Next-generation" "Nf2flox" "Nick-End" "Nicolaides"
    "Nielsen" "Nikon" "Nil-2-a" "Ninety-seven" "Nisman" "Nmut" "Nogo-A"
    "Nogo-C" "NogoB" "Nonsense-mediated" "Noonan" "Normal-like" "Norman"
    "North-East" "Northway" "Norway" "Novartis" "Nrf2" "Nrf2-activator" "NtAI"
    "Nu" "NuRD–CHD4" "Nup" "Nups" "Nups358" "N = 12" "O-glycosylation"
    "O-methyl" "O-stained" "O1" "O2" "O8" "OA-like" "OCT3" "ODC+COX"
    "ODC+COX-2" "OH" "OHdG" "OLT" "OLYMPUS" "OMIM" "ONCOSEQ" "ONM" "ONOO"
    "OR=0.8" "OR=0.93" "OR=0.96" "OR=1.01" "OR=1.06" "OR=1.08" "OR=1.09"
    "OR=7.97" "ORC1–6" "ORF1p+ORF2p" "ORF1p-Flag" "ORF2p-3xFLAG" "ORF2p-3xFlag"
    "ORF2p-L1" "ORF2s" "ORF2–3xFlag" "ORFS" "ORFeus" "ORFeus-Hs" "ORR" "ORs"
    "OR = 1.09" "OTF" "OVCA" "OVCA429-shRPS7" "OVCA433-shRPS7" "Objective"
    "Obstetrique" "Occurrence" "OdDHL" "OdHL" "Off-label" "Okayama" "OligoWalk"
    "Oligomycin" "Oncomine" "Oncopanel" "One-way" "OnlyAP2M1" "Onuf" "Origene"
    "Ottawa" "Otx" "Otx2" "Oxford" "Ozaki" "P&P" "P0" "P0-Cre" "P1" "P1+P2"
    "P102" "P102C" "P104A" "P107A" "P113A" "P2" "P318fs" "P55G" "P5K" "P5Ks"
    "P5Y" "P6" "P7" "P70S6kinase" "P72A" "P72Q73V74P75L76R77" "P75A" "P85A"
    "P85B" "P8A" "P8K" "P9" "P9A" "P=0.01" "P=0.024" "P=0.49" "P=0.66" "P=0.97"
    "PAGE4was" "PAI-1-PMO" "PAK2-Nef" "PANDA" "PARP-1zf"
    "PARP-inhibitor-sensitive" "PARP1i" "PARPi" "PAVSMC" "PBECs" "PBLs" "PC1-3"
    "PC9GR" "PCID" "PCR-RFLP" "PCa-relevant" "PD0332991" "PD98095" "PDA"
    "PDGFRβ-positive" "PDGFs" "PDGene" "PF-3450074" "PF562271" "PF74" "PFT-α"
    "PGHEC" "PGTS2" "PHA" "PHD-like" "PHGEC" "PI-3-P" "PI-4,5-P" "PI-4-P"
    "PI-5-P" "PI3K-PTEN-AKT-upregulating" "PI3K-Pdk1" "PI4P5Ks" "PI5K" "PI5Ks"
    "PI5P4K" "PI5P4Ks" "PI5P4Kα" "PI5P4Kβ" "PIASxa" "PIASxb" "PIK3A" "PINK1IP"
    "PINK1TAP" "PIP-box" "PIP4KB" "PIPK1γi5" "PI‐3" "PK3CA" "PK3CB" "PKA-001"
    "PKA-Cα" "PKA-Cβ" "PKA-RIIα" "PKA-RIα" "PKBβ" "PKC-8" "PKC-ζ" "PKC-θ"
    "PKCβI" "PKCε" "PKCθ" "PKKKRKV" "PKR-like" "PLC-β" "PLCε" "PLINK" "PLTs"
    "PLX5622" "PMA+ionomycin" "PMA-ionomycin" "PMC42-ET" "PMSP" "PNS" "POC"
    "PP2B" "PR-negative" "PR-positive" "PRCA" "PROMO" "PRSSLSS" "PSQ" "PTAP"
    "PTEN-non-expressing" "PTEN-null" "PTEN-positive" "PTENP1" "PTP1E" "PVH"
    "PVs" "PX-866" "PXA-AT" "PXA-As" "PXA-EGTs" "PXA-GG" "PXA-gangliogliomas"
    "Paclitaxel" "Pajares" "Pak" "Pakistan" "Pakistani" "Pam3CSK4"
    "Pam3CSK4-induced" "Pam3csk4" "PanNET" "PanNETs" "Panc0403" "PancT4"
    "PancT6" "Paracoccidioides" "Parkin-dependent" "Parkin-mediated" "ParkinGS"
    "ParkinIP" "ParkinTAP" "Parkinson" "Parkinson-like" "Paso" "Pathaan"
    "Patologica" "Patricia" "Patrick" "Pearson" "Peddigari" "Peng"
    "Pericyte-like" "Pertel" "Peterson" "Petri" "PhePP" "Philadelphia"
    "PhosphoGRID" "PhosphoMotif" "Phosphorylated" "Phytohemagglutin" "Pi"
    "Picetannol" "Pifithrin-α" "Pineda" "Pink1GS" "Pink1TAP" "Plk1" "Poisson"
    "Poland" "PolyPhen-2" "Polyphen2" "Popanda" "Portuguese" "Post-endocytic"
    "Post-hoc" "Post-transcription" "Post-translational" "Povegliano" "Powell"
    "PpI" "PrSc" "PredPhospho" "Prescrire" "Principal" "Pro-Cat"
    "Pro-inflammatory" "Pro72Arg" "Pro871Lue" "ProSpec" "Promo3"
    "Promoter-reporter" "Proof-of-principle" "Propargylglycine" "Propidium"
    "PubChem" "PulSA" "Punjabi" "PvuII" "PxPxxR" "PxpxxRh" "PxxA" "PxxP"
    "PxxPxR" "PxxxPR" "P = 0.004" "P = 0.007" "P = 0.008" "P = 0.009"
    "P = 0.013" "P = 0.03" "P = 0.038" "P≤0.05" "P≤10" "Q455" "Q455V" "Q563X"
    "QQ" "QQ-plots" "QRS" "QS" "QT" "QTL" "QW" "QZ" "Qi" "Qiu" "Qxx" "R-Taxol"
    "R-V5" "R-VBL" "R-positive" "R0" "R1" "R105" "R106" "R10T" "R2" "R5"
    "R5-tropic" "R8S" "RAD51-ssDNA" "RAD52-depleted" "RAS-ERK-stimulated"
    "RAS-family" "RASSF1C" "RBS811E" "RC-165" "RC-170" "RCHACV" "RE-containing"
    "RE-transactivation" "RECQ5-proficient" "REDS" "REDS-II" "RFC1-5" "RFI"
    "RFLP" "RIA" "RII" "RIME" "RIP-Tag" "RIP1-Tag2" "RJ" "RLW" "RLYYFWD" "RMCE"
    "RMSSD" "RNA" "RNA-DNA" "RNAStructure" "RNAiMAX" "RNU26" "RNaseP" "ROKβ"
    "ROS-source" "ROSA26" "RPMI-1640" "RPPH1.1" "RPS6K" "RR-AA" "RR=2.03"
    "RR=2.59" "RR=4.97" "RRRCWWGYYY" "RSCU" "RSG3" "RSP7" "RT--PCR" "RTK"
    "RTK-driven" "RTN4-A" "RTX" "RUNX" "RWPE" "RWPE-3" "RXRXXS" "RXXS"
    "Rab11-positive" "Rabet" "Rac1GTPase" "Rac1GTPases" "RacGTPases"
    "Rad23-like" "Rad3" "Rad3-related" "Rad51-made" "Raf-1" "Raf1-MEK-ERK"
    "Rakeb" "RalA-GTP" "RalB-GTP" "Rallison" "Ramachandran" "Randolph"
    "Random-effects" "Ras-association" "Ras-mediated" "Ras-superfamily"
    "Ras-transformation" "RasGTPases" "RasWT" "Raschella" "Ras•GTP" "Rausei"
    "Rausei-Mills" "Rb-E2F" "Re-challenge" "Re-localization" "RefSNP" "Refseq"
    "Reison" "RelA" "RelatedPD" "Remak" "Rembrandt" "Ren-SV40TAg" "Ren-SV40Tag"
    "RenCre" "Renkema" "Results" "Retzius" "Reuter" "RfBP" "Rheb·GTP"
    "Rheumatology" "Rho0" "Rho1·GDP" "Rho1·GTPγS" "RhoA-GTP" "RhoA-Rac1"
    "RhoA-like" "RhoAV14" "RhoA·GTP" "RhoC-p38MAPK" "RhoC-structure" "RhoGDIα"
    "RhoGDP" "RhoGTPases" "Richardson" "Riemann" "Right-sided" "Robinson"
    "Robles" "Roche" "Rockford" "Rockville" "Rojo" "Roswell" "Roszak"
    "Rothekin" "Rowley" "Rse" "Rubin" "Rudolph" "Ruijin" "Russell" "Russia"
    "RvD" "RvE" "S-G2M" "S-glutathionylated" "S-nitosylated"
    "S-protein-agarose" "S1" "S1-S5" "S10a" "S134P" "S1366" "S194" "S1975"
    "S1981" "S199" "S199A" "S1C" "S1D" "S235" "S2481-mTOR" "S2A" "S2A-C" "S2B"
    "S2D" "S3" "S3C" "S3D" "S3c" "S4281-mTOR" "S473-Akt" "S4A" "S4B" "S4C"
    "S535A" "S542A" "S544A" "S548A" "S6" "S7" "S727" "S727A" "S807" "S947A"
    "S9A-GSK-3β" "SA-GFP" "SAHA" "SAIPI" "SAK-motif" "SAKK" "SAR" "SATB1-decoy"
    "SAhRMs" "SB203580-p38" "SB649146" "SC514" "SCEs" "SCNAs" "SCRsh"
    "SCRsh-ET" "SCneo" "SDF-1α" "SDF1α" "SDS-gel" "SDS-polyacrylamide" "SDSD"
    "SDS–polyacrylamide" "SE5-OH" "SEMQ" "SERPINA15P" "SERPINE4P" "SERQ"
    "SERSMs" "SFMCs" "SGC" "SH2-domain" "SH2-domain-containing" "SH3-2" "SH3-A"
    "SH3-B" "SH3-C" "SH3-N" "SHBM1009" "SHIVs" "SI-NEN" "SIFT" "SIR=0.82"
    "SIR=0.89" "SIR=0.92" "SIR=3.81" "SIRT" "SIRT1promoted"
    "SIRT6-associations" "SIRTi" "SIVE" "SIVagm" "SIVblu" "SIVcpz" "SIVmac239"
    "SIVsmm" "SJ-172550" "SKOV" "SKOV3-c-FOS#1" "SKOV3-shRPS7" "SLQYLA" "SM"
    "SM-like" "SM6Met" "SMA-positive" "SMAD3-positive" "SMIFH2" "SNF-family"
    "SNORD29" "SNORD33" "SNORD34" "SNORD68" "SNORD71" "SNP" "SNP-level"
    "SNP309T" "SNP6" "SNP6.0" "SNPs" "SNPstats" "SNV" "SNVs" "SOX" "SPSS"
    "SRF-MRTF" "SRPGKTC" "SSEA-3" "SSNV" "SSNVs" "SSc" "STAGA"
    "STAT3-DNA-binding" "STAT3-R609Q-YFP" "STAT3-S" "STAT3-YF"
    "STAT3-YF-YFP-NLS" "STAT3-YF-ΔN-YFP" "STAT3-null" "STAT3-ΔN-YFP" "STAT3C"
    "STAT3β" "STAT5Ptyr" "STAT5Ptyr’s" "STAT5Pytr" "STAT6Ptyr" "STATA" "STP-A"
    "STRING" "SU3" "SU3-pEGFP-N1-SATB1" "SUMO-conjugation" "SV40Tag" "SWItch"
    "SWK" "SYBR" "SYPRO" "SYTOX" "SZ" "Sabatini" "Saimiri" "Sakakibara"
    "Salt-bridge" "Samani" "Sampson" "Sanger" "Santagata" "Saos-2-2"
    "Sarbassov" "Sardinia" "Sasaki" "Sca1" "Scaber" "Scandinavia" "Scansite"
    "Scar" "Scarff-Bloom-Richardson" "Sce3" "Schessl" "Schindler"
    "Schizosaccharomyces" "Schlemm" "Schlemm’s" "Schrager" "Schuylerville"
    "Schwann" "ScienCell" "Scienze" "Score" "Scottish" "Scr" "Seattle" "Sebat"
    "Second-generation" "Second-line" "Seip" "Semi-quantification" "Sen"
    "Sen-Adichie" "Sendai" "Sengupta" "Sephacryl" "Sepharose–binding" "Seq"
    "Ser-Ser-X-Ser" "Ser1333" "Ser1981" "Ser217" "Ser235" "Ser463Pro" "Ser473"
    "Ser537" "Ser780RB1" "Serine" "Sharma" "Shea" "Shen" "Shibata" "Shih"
    "Short-hairpin" "Short-term" "Shulman" "Si" "Sic1ΔC" "Siewert" "Siewert's"
    "Sigma-Aldrich" "Significance" "Silva" "Silva-Grecco" "Silveira"
    "Silverman" "Single-molecule" "Single-strand" "SinoGenoMax" "SirBACO"
    "Sircol" "Sirt4-AMPK-mediated" "Sirt4KD" "Sirt4KO" "Sirtuins" "Six-hour"
    "Sixty-three" "Size-fractionation" "Skoulidis" "Skp1-Cullin1-F-box"
    "Skp2-Skp1-Cullin" "Smad2" "Smads" "Small-molecule" "Small-molecules"
    "Smithgall" "Sokal" "Somoza" "Soond" "Sox9" "Sp" "SpNet" "Spain" "Spanish"
    "Spano" "Spearman's" "Spearman–Rho" "Spiegelman" "Spraul" "Sq" "SqCC"
    "SqCCs" "Src-family" "Sri" "Stanley" "State-of-the-art" "Steward-Tharp"
    "Stiff-Person" "Stouffer" "Strautnieks" "Strep-HA-tagged" "Stress-induced"
    "Study-II" "Sub-groups" "SubG1" "Sudhl-1" "Suv39" "Suzuki" "Sweden"
    "Swedish" "Swiss-3T3" "Sx" "Syngene" "Synpo-S" "Synpo-T" "Synpo-long"
    "Synpo-short" "Syria" "Sγ1" "Sμ" "S→D" "T-LGLL" "T-MS" "T-bet" "T-cell"
    "T-helper" "T-independent" "T-lymphoma" "T-tropic" "T1" "T1972"
    "T1972-dependent" "T1972A" "T1972D" "T1D" "T2" "T2-T3" "T2-T4" "T203"
    "T203A" "T204" "T204A" "T24" "T2D" "T2DM" "T2c-T3b" "T3" "T3a" "T3b" "T3–4"
    "T4" "T5" "T56-Bcl2" "T7" "T7-T39swap" "T790M" "T790M-7" "T790M-7-specific"
    "T790M-7-stimulated" "T790M-8" "T7A" "T877A-mutant" "T929A" "T98G-ATMRi2"
    "T98G–ATMRi2" "T9K" "T9P" "TA-p63α" "TA-p63β" "TA-p73α" "TA-p73β" "TAA"
    "TAATCC" "TAFD3" "TALL#9" "TAM" "TAP-LC-MS" "TAP-MS" "TAR" "TAT-STAT5a"
    "TATA" "TATA-less" "TAp63α" "TBST" "TC9" "TCAGGGCCAAAAATTTAATCA3" "TCDD"
    "TCF-dependent" "TCF4-DN" "TCFs" "TCID50" "TCIU" "TCONS" "TCRζ" "TCTG"
    "TCVPTC" "TD-performed" "TE-9" "TEAD-interaction" "TEAE" "TEAEs" "TECP"
    "TFSEARCH" "TGACNNNGC" "TGCTTGCTCTGATAGGAAAAT3" "TGF-β-nonresponsive"
    "TGF-β1-negative" "TGF-β1-positive" "TGF-β1PMO" "TGF-βRII" "TGFBRII"
    "TGFβ-RII" "THY3" "THY4" "TIM-deficient" "TIPE1" "TIR-domain-containing"
    "TJG" "TL" "TL3" "TLE" "TMRM" "TMRSS" "TMRSS2-ERG" "TNBCs" "TNFA-308"
    "TOPflash" "TRA-1-60" "TRA-1-81" "TRA-2-54" "TRAIL-2" "TRAIL-R2-positive"
    "TRAIL-receptor" "TRAIL-receptor-specific" "TS234t" "TS510t" "TSC2A-FLAG"
    "TSG01" "TSG101-co-repressor" "TS–since" "TTAGGG" "TTCCTATGAT" "TTGGTGTTGG"
    "TUBB7P" "TUNEL-positive" "TUNEL-positively-stained" "TURP" "TY" "Table1"
    "TailorX" "Taiwan" "Takahashi" "Tamara" "Tanabe" "Tanaka" "Tanzania"
    "TaqMan" "Targetscan" "Tat-mediated" "Teixeira" "Tek" "Teleangiectasia"
    "Testis" "Tet-Off" "Tet-On" "Tfh-like" "Tg" "Th17" "Th2" "Thailand"
    "Thames" "Thapsigargin-treatment" "Tharp" "Therapeutically-targetable"
    "Thermo" "Thirty-nine" "Thirty-six" "Thomas" "Thoreen" "Thoulouze" "Thp1"
    "Thr180" "Thr183" "Thr202" "Thr55-phosphorylation-enriched"
    "Three-dimensional" "Threonine-specific" "Tie‐2" "Time-course" "Time-lapse"
    "Tip60-H3F" "Tip60-p400-dependent" "Tip60-p400-interacting" "Tis" "Tm"
    "Tokyo" "Toll-like" "Tomascovic-Crook" "TopBP1-BRCT5" "TopoIIB" "Tr"
    "Trans-activator" "Transcription" "Treacher–Collins" "Treatment-emergent"
    "Tri-m-H3K9" "TriC" "Trialists" "Trichrome" "Trogatizalone" "Troncoso"
    "Turkson" "Tuscany" "Tuveson" "Tweedie" "Tween" "Tween-20" "Twenty-eight"
    "Twenty-four" "Twenty-one" "Twenty-six" "Twenty-three" "Tyr182" "Tyr185"
    "Tyr204" "Tyr537Ser" "Tyr537Ser–Asp351" "Tyr694" "Tyr978X" "Tyr→Phe"
    "TβR-1" "TβR-2" "TβR-3" "TβRs" "U133" "U133A" "U180" "U180-A218"
    "U180–A218" "U251" "U251-SATB1-shRNA" "U266-B1" "U33" "U353MG"
    "U87EGFRvIII" "UAB" "UBS3B" "UHFR1" "UNG2-defective" "URL" "USA" "USP13-RE"
    "USP2A" "USP2a" "UTRA" "UTRs" "UV-C" "UV-light" "UVB-induced" "UbKO" "Ubi"
    "Ubi-Cat" "Ullenhag" "Under-expression" "UniProtKB" "Units" "Università"
    "UoCB6" "Uppsala" "Urology" "Utah" "UvrD" "V-FITC" "V-ets" "V2" "V5"
    "V5-tagged" "V511Cfsx29" "V600-W604" "VBL" "VCA" "VCO" "VDCCs" "VDL" "VDS"
    "VDV" "VE1" "VEGF‐induced" "VHCSXGXGR" "VLBW" "VLDL-TG" "VNR"
    "VP16-Gal4DBD" "VP1u" "VP1u-exposure" "VP2" "VPC03090" "VSV-G"
    "VSV-G-pseudotyped" "VSX1" "Vaillancourt" "Vanderbilt" "Vannini"
    "Vannucchi" "Vater" "Vavl" "Vectibix" "Veek" "Vehicle-treated" "Venn"
    "Verhaak" "Verhoog" "Viemann" "Vietnamese" "Vif-APOBEC3" "Vina"
    "Vinkemeier" "Viridiplantae" "Vogelsang" "Vogelstein" "Vpr-CUL4-E3" "Vs"
    "W6" "W741C-AR" "WBC" "WBCs" "WD-fed" "WJ" "WM2664" "WNT16B" "WO" "WRE"
    "WREs" "WST" "WST-1" "WST-8" "WT-3" "WT-5" "WT-5-specific"
    "WT-5-stimulated" "WT-7" "WT-AR" "WT-ARs" "WT-Luc" "WT-MTSS1" "WT-PUMA"
    "WT-PUMA-induced" "WT-STAT3" "WT-STAT3-CFP" "WT-STAT3-YFP"
    "WT-STAT3-induced" "WWP2-C" "WY" "WZ" "WZ-4002" "WZW" "Waals" "Wallis"
    "Wanglong" "Warburg" "Washington" "Weibull" "Weidler" "Weil" "Weinberg"
    "Weinhouse" "Weiss" "Well-conserved" "Well-differentiated" "Wellcome"
    "Wennuan" "Werner" "Western-blot" "Western-blotting" "Western-type"
    "WhereBRAF" "Whitney" "Whole-exome" "Wicha" "Wiemer" "Wilcoxon" "Wilke"
    "Williams" "Williams-Blangero" "Withaferin" "Witte" "Wnt-gene" "Wolcott"
    "Wolcott-Rallison" "Wong" "Wt" "Wu" "X-Ray" "X-independent" "X-inhibitor"
    "X-linked" "X-positive" "X-ray" "X-ray-irradiated" "X-rays" "X-α-gal"
    "X1016" "X1046" "X1066" "X4-dependent" "X4-tropic" "XBP" "XC" "XFZ" "XH"
    "XL" "XLOC" "XPC-normal" "XPCB" "XRCC" "XTP" "XTT" "XW" "XXI" "XZ" "XbaI"
    "XiaX" "Xie" "XinX" "Xinarianos" "Xu" "Y-box" "Y221R" "Y224-I235" "Y317"
    "Y569X" "Y569X " "Y701F" "YAP-TEAD2" "YASARA" "YB-1-IP" "YB-1-sncRNA" "YC"
    "YE" "YE-S" "YHS" "YJW" "YM" "YM-21" "YQ" "YRHHY" "YRI" "YS" "YURY" "YXXL"
    "YYH" "YZ" "Ya5" "Yamamoto-Sugitani" "Yang" "Yasuda" "Yemen" "Yemenites"
    "Yen1" "Yes" "Yes-associated" "Yoon" "Yorkie" "Yorkshire" "Yu" "Z-box"
    "Z-boxes" "Z-disk" "Z-disks" "Z-score" "ZD" "ZEB1-miR200" "ZEB1sh-ET"
    "ZFNs" "ZH" "ZKX" "ZL" "ZR-75" "ZR-ATMi" "ZR-ctr" "ZYQ" "Zap-70"
    "Zarnestra" "Zeb-1" "Zeng" "Zfhep" "Zhang" "Zhao" "Zheng" "Zheng-hong"
    "Zhi-8-induced" "Zhou" "Zigoneanu" "Zitzmann" "Zn" "Zou" "Zsgreen"
    "a-helical" "a5β1" "a6b4" "aBRAF" "aCGH" "aIqgap2" "aa1-147" "aberaterone"
    "aberrancies" "absorbance" "absorptiometry" "accelerometer" "acetoxymethyl"
    "acetyl-lysine" "acetyllysines" "acid-binding" "acid-induced"
    "acid-initiated" "acid-mediated" "acid-sensing" "acid-treated"
    "acid–stimulated" "acid–treated" "actin-remodeling" "activatemTORC1"
    "activation-domain" "activators" "activity-activity" "add-back" "adducts"
    "adeno" "adenocarcinoma-like" "adenoid" "adenoma-to-carcinoma" "adenomas"
    "adrenal-derived" "adrenal-gland" "adult-onset" "adults"
    "affinity-purification" "agar" "age-associated" "age-dependent"
    "age-driven" "agent-Pirfenidone" "agent-pirfenidone" "aglycone" "aglycones"
    "agmA3G" "agonism" "air-liquid" "albicans" "algorithm" "algorithms"
    "alkoxyl" "alkyl" "alkyl-transferase" "alleles" "allograft" "allografts"
    "allotypes" "alpha-subunit" "alpha-synucleiln" "althoughthis" "alveoles"
    "alveoli" "amacrine" "amines" "amino-N-terminal" "amino-acid"
    "amino-terminal" "amino-terminus" "aminobenzamide" "aminochrome"
    "aminophenoxy" "ammonium" "amoeboid" "amplicon" "amplicons"
    "amplifications" "ampulla" "amyloid-like" "analyser" "anaplasia" "and-18"
    "andDicer" "andIqgap2" "andMet" "andRAC1" "andShp" "andautophagy"
    "andcyclin" "androgen-deprivation" "androgen-independence"
    "androgen-insensitivity" "androstanedione" "androsterone" "andshort"
    "aneuploid" "aneuploidy" "angio" "angiogeness" "angiographic-restenosis"
    "angiotenginogen" "angolensin" "anions" "anisotropy" "annexinAnnexin"
    "annulus" "anoxia" "antagonise" "anthracene-3,4-dihydrodiol" "antibodies"
    "antibody–receptor" "antihormone" "antihuman" "antioxidant-defense"
    "antiparkinson" "antiplatelet" "antistripes" "antitetanus" "apical-basal"
    "aplasia" "apnea" "apo-PARPzf" "apo-peptide" "apocrine" "apoptotic-related"
    "apparato" "appropriateness" "aptamers" "apurinic-apyrimidinic" "arcuate"
    "argenine" "arisen" "arm-level" "arrhythmia" "arsenite-bond" "asA20"
    "asgalactosamine" "aspartyl" "at-risk" "athero" "athero-relevant"
    "atheromata" "atheroprone" "athy" "ation" "atrophy1" "autacoids"
    "auto-dephosphorylation" "auto-down-regulated" "auto-immunity"
    "auto-inhibitory" "auto-modified" "auto-oxidation" "auto-reactive"
    "autoinhibit" "autophage" "autoregulate" "autoregulates"
    "autosomal-dominant" "avidin-biotin" "axon" "axon-intrinsic"
    "axonally-derived" "axonopathy" "azaspirane" "a–c" "back-titration"
    "backcross" "backcrosses" "baldder" "baroreflex" "basal-like" "base-level"
    "base-line" "base-pair" "basic-helix-loop" "bead-binding" "bead-bound"
    "beadchip" "begun" "benzenesulfonamide" "benzo" "beta-alkenal"
    "beta-glucoronidase" "beta-oxidation" "between-studies" "between-study"
    "between1996" "betweenDicer" "betweencyclin" "bi" "bi-allelic" "bilayer"
    "bilayers" "biliverdin" "bio-behaviours" "bio-informatics" "bioassays"
    "bioenergy" "biomarker-breast" "biomass" "bipyridinium" "bisphosphate"
    "bisulfate" "bleb-like" "blocker" "blockers" "blood-brain" "blood-samples"
    "blood–brain" "blue-native" "bocks" "bolus" "bona" "bona-fide" "bonafide"
    "boney" "botrocetin" "box-O" "bp" "bp-promoters" "bpV" "bradykinesia"
    "break-induced" "breakpoint" "breakpoints" "breast-like" "breast-ovary"
    "brethren" "broad-spectrum" "broader" "bronchioid" "brown-fat-like"
    "brown-staining" "buffy" "buffy-coat" "buthionine" "butylhydroperoxide"
    "butylhydroquinone" "by-pass" "by-product" "byMet" "b–d"
    "c-Cbl-co-depleted" "c-FOS#1" "c-FOS#5" "c-FOS#6" "c-FOS#7"
    "c-Met-positive" "c-Myc-PEC" "c-MycER" "c-Src-dependent" "c-myc-promoter"
    "cCR" "cGAMP" "cIMT" "cMYCmRNA" "cPARP" "cPPT" "cRhoC" "caRags" "caRheb"
    "caRhoA" "callosum" "calorimetry" "cancer-relevant" "cancer-spectrum"
    "cancer-stem-cell-like" "candidate-gene" "cap-dependent" "capillaris"
    "capillaritis" "capsase-3" "capsid" "capsid-saturation" "carbazole"
    "carbobenzoxyl-leucyl-leucyl-leucinal" "carbonyl" "carbonylcyanide"
    "carbonyls" "carboxyl" "carboxyl-terminal" "carboxyl-terminus" "cardia"
    "cardio" "cardio-facio-cutaneous" "cardio-thrombotic" "cardiomyopathies"
    "cardiovascular-related" "cargos" "carnitine" "carotid" "carrageenin"
    "carriers" "case-control" "case-controlled" "case–control"
    "caspase-dependent" "caspsase-8" "castration-resistance" "catalyse"
    "cathespins" "cation-pi" "caudate" "cdh1" "ceRNA" "ceRNAs" "cel-miR-39"
    "cell-autonomous" "cell-chamber" "cell-cluster-based" "cell-cycle-arrest"
    "cell-directional" "cell-extrinsic" "cell-intrinsic" "cell-like"
    "cell-lineage" "cell-permeable" "cell-substratum" "cell-to-cell"
    "cell-type-dependent" "cells" "center-like" "centrally-located"
    "centromere" "centrosomal-like" "cerebella" "cerebellum" "cerebroid"
    "cerevisiae" "challengingIqgap1" "chao" "charcoal-stripped" "charge-swap"
    "checkpoint-deficient" "checkpoint-regulated" "chemically-induced" "chemo"
    "chemo-attract" "chemo-preventative" "chemo-sensitivity" "chemo-therapy"
    "chemoattractant" "chemodrug" "chemoradiotherapy" "chemoresistance"
    "chemoresistant" "chemotherapeutic-induced" "chi-square" "chi-squared"
    "chiasm" "chirurgica" "chloromethylketone" "chlorophelyhydrazone"
    "chlorophenylhydrazone" "cholecystectomy" "cholesterol-containing"
    "cholestyramine" "choline" "chondria" "chondrocyte-like" "choroid" "chosen"
    "chr12q24" "chromatid" "chromatin-remodeling" "chromatographs"
    "chromosome-negative" "chromosome–positive" "chromostatin"
    "chrondrocyte-like" "cingulate" "cip1" "circuit-selective" "circuitry"
    "cis-eQTL" "cis-elements" "cis-regulatory" "cisplatin‐induced" "clade"
    "clades" "clamp-loaders" "classically-defined" "classifier" "clear-cut"
    "clinically-annotated" "clinically-proven" "clinically-relevant"
    "clinical–biologic" "clinicians" "clinico" "clinico-pathologic"
    "clinico-pathological" "clinico-pathologically" "clinicopathology"
    "clone-selective" "clorgyline" "clumpy" "cluster-like" "coactivator-bound"
    "coagulant" "cobblestone-like" "codonG12V" "coil-like" "coiled-coil"
    "cold-shock" "coli" "collagen-1A1" "collagens" "colonise" "colonoscopy"
    "colony-forming" "colorectum" "combination-induced" "combination-treated"
    "combined-modality" "commissure" "commonest" "comorbid" "compacta"
    "competitive-binding" "concentration-response" "condyle" "confirme"
    "confounder" "confounders" "confrm" "conjugases" "connectivity-based"
    "consensus-binding" "continuum" "contiuum"
    "contractile-mechanotransduction" "control-siRNA-transfected" "cooccur"
    "copy-neutral" "copy-number" "core-tail" "correlationswith"
    "corticopontine" "corticosteroid" "corticosteroids" "cosegregate" "cosmid"
    "cosmosiin" "coumestan" "counter-regulation" "counter-regulatory"
    "country-specific" "covariate" "covariates" "coverglass" "cowa" "coworkers"
    "craniotomy" "cribriform" "cross-activation" "cross-complementary"
    "cross-platform" "cross-react" "cross-reactivity" "cross-regulation"
    "cross-sectional" "cross-sections" "cross-table" "crossing-over"
    "crossover" "crossovers" "crossreact" "crush-induced" "crystallographic
B-factors"
    "ctDNA" "cup-of-tea" "currentstudy" "cut-off" "cut-offs" "cut-point"
    "cut-points" "cutpoint" "cyan" "cybrid" "cybrids" "cycB2" "cyclin-EGFPs"
    "cyclo" "cyclohexamide" "cyclolignan" "cyclooxygenase-3" "cystectomy"
    "cysteinyl" "cytoDeath" "cytohesin" "cytohesins" "cytology" "cytometer"
    "cytoplasma" "c‐Jun" "dC-to-dU" "dHJ" "dHJs" "dL" "dMMR" "dU" "dUs"
    "damage-associated" "damage-binding" "damage-induced" "damage-mediated"
    "damage–induced" "dataset" "datasets" "day-treatment" "dbSNP"
    "de-differentiate" "de-differentiated" "de-differentiating"
    "de-differentiation-like" "de-novo" "de-regulated" "de-regulation"
    "de-repressed" "de-repression" "de-silenced" "de-ubiquitinase"
    "deactylase-3" "deaminase-independent" "death-1" "deazaadenosine" "decamer"
    "decile" "deconvolute" "dedifferentiate" "deeper" "defatty"
    "defatty-acylation" "definitiveBRAF" "degraders" "degron" "dehydrogenases"
    "del2352ins12" "del3835" "del4" "delE746-A750" "delV" "delV600-W604"
    "delayed-start" "deletions" "dense-core" "deoxycytidines" "deoxynucleotide"
    "deoxynucleotidyl" "deoxyuracils" "deoxyuridines" "dependo"
    "dependo-viruses" "depolarizaton" "depolymerise" "depressant"
    "deprivation‐induced" "deprivation–induced" "der" "derepresses"
    "desensitise" "desferrioxamine" "desmoplasia" "destabilises"
    "detergent-insoluble" "detergent-soluble" "determineBRAF" "deubiquitylases"
    "developmentally-regulated" "di-ubiquitinated" "diabetes-induced" "diacyl"
    "diaminoquinoxaline" "diaphanous-related" "diastereomers" "dichloride"
    "dichroism" "diclofenac+DFMO" "diet-fed" "diet-fedLdlr" "diet-induced"
    "diet-induced-obesity" "diethylstibesterol" "difficile" "difluoride"
    "digerente" "digestiva" "dihydrobenzo-1,4-dioxin-substituted"
    "dihydrochalcone" "dihydrochalcones" "dihydrochloride" "dileucine"
    "diluent-treated" "dimethoxycoumarin" "dimethylbenz" "dimethylbiguanide"
    "dimorphism" "dinucelotide" "dinucleotides" "dioctanoyl" "diphenylformazan"
    "diphenylpyrazolo" "diphenylpyrazolodiazene" "diphosphate"
    "diphosphate–ribose" "diphosphatidylglycerol" "diploid" "dipyrimidine"
    "dirigente" "discrepant" "disease-relevant" "disomy" "disorder-to-order"
    "disrupters" "disruptingmTORC2" "dissolvasome" "distant-stage" "dney" "doi"
    "domains" "dominant-negative" "dominant‐negative" "donovani" "dormancy"
    "dose-and" "dose-dependency" "dose-dependently" "dose-intensive"
    "dose-limiting" "dose-response" "dose–response" "dot-like" "double-blind"
    "double-helix" "double-knockdown" "double-knockout" "double-minute"
    "double-strand" "double-transgenic" "doublings" "down-modulate"
    "down-modulation" "down-regulator" "down-stream" "downmodulate" "downstage"
    "doxycycline-repressible" "drawn" "driven-signaling" "droplets" "drug-like"
    "drug-therapy" "drug-tolerant" "drug-treatment" "drug-withdrawal" "ds"
    "dsDNA" "ductules" "dulxanthone" "dupl" "duplexes" "dura" "dye-binding"
    "dye-independent" "dyn " "dyslipidemia" "dysphagia" "dysplasia" "dyspnea"
    "dystopohy" "d–f" "e-IF2α" "e-QTL" "eLife" "early-morning" "early-onset"
    "early-phase" "early-stage" "ectodomain" "ectopically-expressed" "ed"
    "edema" "eeyarestatin" "efect" "eight-week" "electrophoregrams"
    "electrospray" "ellipsoid" "elrotinib" "eluate" "embolus" "embryoid"
    "enantiomers" "end-stage" "end-to-end" "endarterectomy" "endo-exocytic"
    "endocrine-therapy" "endocytosis-independent" "endog" "endometrioid"
    "endometrium" "endoscopia" "endoscopy" "endothelial-like"
    "endothelial-targeted" "endothelial-to-mesenchymal" "endplates" "endpoint"
    "endpoints" "energy-depleted" "energy-expensive" "energy-minimization"
    "energy-restrictive" "energy-triggered" "enhancer" "enhancer-binding"
    "enin" "enterochromaffin" "enterocyte-like" "entropy" "environment-gene"
    "eosin" "eosinophilia" "eosinophils" "epidermoid" "epididymis"
    "epigallocatechin" "epigenome" "epimers" "epiphenomenon" "epithelia"
    "epithelia-like" "epithelial-associated" "epithelial-derived"
    "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelin" "epithelioid" "epithelium"
    "equivocalBRAF" "ericotrin" "eriocitin" "eriocitrin" "erlotinib-pemetrexed"
    "erosions" "erythema" "erythro" "erythroblastopenia" "erythrocytes" "esBAF"
    "esponse" "establishedcyclin" "estradiol-like" "estradiol-stimulatory"
    "estrogen-independence" "estrogen-independently" "et" "ethane-N"
    "ethanol-soluble" "ethmoid" "ethnicity-specific" "etiopathology"
    "ever-growing" "ex" "ex-vivo" "exact-test" "execution-phase" "exocrine"
    "exog" "exogenously-produced" "exome" "exomes" "exon5" "exons" "exposer"
    "expressNF" "expressNFκB-dependent" "expressionp38TM" "expressors"
    "extra-articular" "extra-cerebellar" "extra-hepatic" "extra-renal"
    "extradomain" "extrauterine" "extravasate" "exudates" "fMRI" "factor-2"
    "factor-4" "factor-Y" "factor-β" "factors" "fapy" "farnesyl" "fascicles"
    "faster-migrating" "fat-fed" "fat-like" "fecal" "fedLdlr"
    "feeding-fasting-refeeding" "female-specific" "feng" "ferrousiron"
    "fetal-placental" "fibrillations" "fibro" "fibro-proliferative"
    "fibrobalsts" "fibroblast-like" "fibroblastoid" "fibrocartilage"
    "fibrosis-the" "fibrosus" "fibroxanthomas" "fide" "figitumuab"
    "filopodia-like" "finalBRAF" "fine-needle" "fine-tune" "fine-tunes"
    "fine-tuning" "finger-like" "fingolimod" "first-degree" "first-generation"
    "first-hit" "first-line" "first-pass" "fission-fusion" "five-year"
    "flash-frozen" "flavo" "flavo-enzymes" "flavonoid" "flavonoids" "flexure"
    "flourephores" "flow-cytometric" "flow-through" "flowchart" "flowcytometry"
    "fluorodeoxyglucose" "fluoronucleotides" "fluorophore" "fluorophores"
    "flurouracil" "follicle" "follicles" "follow-on" "follow-up" "followup"
    "forBRAF" "forebrain" "forkhead-box" "formamido" "formamido-pyrimidine"
    "forty-eight" "fossa" "four-base" "four-gene" "four-stranded" "fraktalkine"
    "frame-shift" "frameshift" "frameshifts" "free-cancer" "free-survival"
    "freeze-and-thaw" "fresh-frozen" "frozen" "fs" "full-serum" "full-site"
    "full-term" "full-thickness" "fulminant" "function-1" "function-2"
    "fungoides" "fusiform" "fusion-negative" "fx" "fynbos" "g" "g-ratio" "gDNA"
    "gad8" "gain-of-function" "gallate" "gallbladder" "gamma-irradiation"
    "gapmers" "gas-exchange" "gas-phase" "gastro" "gastro-esophageal"
    "gastroenterology" "gastrojejunostomy" "gastroscopy" "gatekeeper"
    "gelatinases" "gemicitabine" "gene-duplication" "gene-environment"
    "gene-gene" "gene-level" "gene-only" "gene-regulatory" "genes"
    "genetic-interaction" "gene–environment" "gene–gene" "geno" "genome-wide"
    "genome-wild" "genotoxic-stress" "genotype-phenotype" "genotype–phenotype"
    "germ-line" "germline" "gingipains" "gingiva" "gingivalis" "gland-to-gland"
    "glia" "glial-neuronal" "globus" "glomeruli" "glomerulitis" "glomerulus"
    "glucorticoid" "glutamylcysteine" "glutathione-S-transferase-P1" "glycan"
    "glycine-proline-rich" "glycosyl" "goitrogen" "gondii" "gone"
    "goodness-of-fit" "gp130-receptor" "gp130-receptor-peptide"
    "gradient-separated" "granin" "granulin-epithelin" "greater" "greatest"
    "grossedentata" "groupsofPTMC" "growth-regulatory" "growth-suppressive"
    "guanine-nucleotide-release" "guanyl" "guanylyl" "guttae" "hAPBTs" "hECC"
    "hECCs" "hESC" "hESCs" "hIPSC" "hMDMs" "hTERT-promoter" "haematology"
    "hairy-cell" "half-dosing" "half-life" "half-lives" "half-maximal"
    "half-site" "half-sites" "hanburyi" "haplo" "haplo-insufficiency"
    "haplotype" "haplotypes" "harborBRAF" "harboringBRAF" "hard-line"
    "has-let-7g" "head-to-head" "head-to-tail" "heap-1c1c7" "heart-specific"
    "heat-mediated" "heat-shock" "heatmap" "helices" "helix" "helix-12"
    "helix-A" "helix-bulge" "helix-loop-helix" "helixes" "hemaglutinin" "hemi"
    "hemocytometer" "hemoxigenase-1" "hepatectomy" "hepatoctyes"
    "hepatocyte-derived" "hepatocyte-specific" "hepatokine" "herbal-derived"
    "hereconfirm" "hesperitin" "hetero" "hetero-chromatic" "hetero-dimer"
    "hetero-multimerize" "heterocomplex" "heterocycles" "heteroduplex"
    "heteroduplexes" "heterotopy" "heterotrimer" "heterozygote" "hiPSCs"
    "hidden" "high-affinity" "high-allelic-ratio" "high-caloric" "high-calorie"
    "high-confidence" "high-content" "high-density" "high-dose" "high-end"
    "high-expression" "high-frequency" "high-grade" "high-incidence"
    "high-level" "high-mobility" "high-molecular-weight" "high-penetrance"
    "high-performance" "high-proliferative" "high-quality" "high-resolution"
    "high-risk" "high-sensitivity" "higher-grade" "higher-order" "hind-brain"
    "histoarrays" "histologies" "histology" "histopathology" "histoscore"
    "histoscores" "histotype" "hoc" "homeo" "homogenates" "homolog"
    "homologies" "homologs" "homology-2" "homozygote" "homozygotes" "hormone-1"
    "hormone-like" "hormone-naïve" "hormone-poor" "hormone-receptor-mediated"
    "hormone-therapy" "host-interaction" "host-pathogen" "host-virus" "hotspot"
    "hotspots" "hr" "hsCks1" "hsCks1-Q52" "hsCks2" "hsa-let-7g"
    "hsa-let-7gcluster" "hsa-miR-377" "hsa-mir-377" "hsp40·hsp70"
    "hunter–gatherers" "hybrid-capture" "hydatidiform" "hydrogen-to-acceptor"
    "hydroxybutyrate" "hydroxydeoxyguanosine" "hydroxyethyl" "hydroxyl"
    "hydroxylysine" "hydroxyphloretin" "hyper-IgE" "hyper-chromatic"
    "hyper-myelination" "hyper-permissive" "hyper-proliferative"
    "hyper-reactive" "hyper-variable" "hyperbilirubinemia" "hypercytokinemia"
    "hyperinduces" "hyperinsulinemia" "hyperoxia" "hyperphagia" "hyperploidy"
    "hypodiploid" "hypogastrium" "hypoglycinemia" "hypomorphicMET" "hypomorphs"
    "hypopharynx" "hypopnea" "hyposideremia" "hypoxemia"
    "hypoxemia-reoxygenation" "hypoxemia–reoxygenation"
    "hypoxia-inducible-factor-1-alpha" "hypoxia-inducible-factors" "hyroxyl"
    "i2" "i5" "iBAQ" "iLRP5" "iMonogenicPD" "ice-cold" "identifiedBRAF"
    "identifiedas" "identifiers" "ie" "ii" "iii" "ill-defined" "imidazole"
    "immediate-early" "immune-compromised" "immune-deficient" "immune-mediated"
    "immune-precipitates" "immune-related" "immune-responsive" "immune-system"
    "immuno-precipitation" "immuno-protein" "immunocomplex" "immunoelectron"
    "immunoglobulin" "immunoglobulin-like" "immunohistochemistry"
    "immunohistology" "immunopathology" "immunophenotype" "immunophenotypes"
    "immunoprecipitations" "immunoprecipitation–quantitative" "immunosignals"
    "immunosuppressors" "immunotherapies" "immunotherapy" "impedance"
    "imperfecta" "importin-α5" "importin-β" "in-cell" "in-depth" "in-frame"
    "in-gel" "in-house" "in-situ" "in-vitro" "in-vivo" "inDicer" "inIqgap1"
    "inIqgap2" "inMet" "inPten" "inasmuch" "incyclin" "indels" "indenopyrazole"
    "indica" "indirubin-3" "individual-specific" "individuate"
    "inducible-expression" "inducing-ligand" "infants" "infected-cell"
    "inflammation-associated" "inflammation-mediated"
    "infratentorially-located" "inhibitedNF" "inhibitedNFκB"
    "inhibitedNFκB-mediated" "inhibitedNFκB-mediatedgene" "inhibitor-AG490"
    "inhibitor-C3" "inhibitor-Y27632" "inhibitor-tractable"
    "iniparib-treatment" "inocula" "inoculum" "inositol-3-kinase" "insTGATG"
    "insensitivity-susceptibility" "insertions" "inside-out"
    "insulin-expressing" "insulin-independent" "insulin-induced"
    "insulin-raising" "insulin-stimulated" "int" "integrin-b4" "inter-ORF"
    "inter-cellular" "inter-group" "inter-individual" "inter-laboratory"
    "inter-membrane" "inter-neurons" "inter-observer" "interORF" "interactions"
    "intercell" "interconvert" "intermediate-grade"
    "internal-ribosome-entry-site" "intra" "intra-abdominal" "intra-chain"
    "intra-epithelial" "intra-group" "intra-metastatic" "intra-tumor"
    "intra-tumoral" "intra-tumoural" "intrachain" "intracrine" "intragraft"
    "intron" "intronless" "introns" "invariant" "invasion-promoting"
    "ion-channel" "iriflophenone" "irradiation-induced" "irregular-shaped"
    "ischemia-reperfusion" "ischemia–reperfusion" "iso" "isoenzymes"
    "isoforms-A" "isopeptide" "isotype" "isotypes" "isozymes" "iv" "juxtacrine"
    "kDa-band" "kJ" "kang" "karyoplasm" "karyotype" "kbp" "kcal"
    "keratin-positive" "keratoplasty" "ketocholesterol" "kg" "ki-67"
    "kilo-base" "kilobases" "kin-cohort" "kinas" "kit-8" "knock-down"
    "knock-in" "knocked-down" "knockin" "koenigii" "laboratory-generated"
    "lactone" "lactones" "laevis" "lambda" "lamellipodia-like" "lamina"
    "laparotomy" "large-cell" "large-scale" "larger-scale" "laser-capture"
    "laser-induced" "lasoxifene" "late-apoptosis" "late-onset" "late-phase"
    "late-stage" "later-onset" "lead-in" "leaner" "lectin-like" "left-hand"
    "left-right" "left-sided" "leiomodin" "lens-specific" "lenti"
    "lentiviral-delivered" "lentiviral-mediated" "leptin-melanocortin"
    "let-7-a1" "let-7a" "let-7b" "let-7e" "let-7g" "letiviruses"
    "leucovorin-based" "levels" "libitum" "life-time" "lifecycle" "lifecycles"
    "lifespan" "lifespans" "ligand-independently" "ligand-like"
    "ligand-receptor" "ligand-selectivity" "ligand-specificity"
    "ligand–receptor" "lignin" "like-like" "limiting-dilution" "limma"
    "limonoid" "lineages" "lipid-permeable" "lipid-soluble"
    "lipopolysaccharides" "lipoprotein-bound" "liposome" "liqueritigenin"
    "littermate" "littermates" "live-birth" "live-cell" "live-cell-imaging"
    "liver-only" "lnHR" "lncRNA-p21" "lobectomy" "loco-regional" "locu"
    "locus-dose" "locus-level" "locu–locu" "log2" "long-chain" "long-distance"
    "long-lasting" "long-lived" "long-loop" "long-projecting" "long-range"
    "long-standing" "long-terminal" "long-time" "longer-range" "longer-term"
    "loss-of" "loss-of-function" "loss-of-function-dependent"
    "loss-of-heterozygosity" "low-abundance" "low-attachment" "low-cost"
    "low-dose" "low-estrogen" "low-expression" "low-frequency" "low-grade"
    "low-level" "low-lying" "low-molecular-weight" "low-pass" "low-penetrant"
    "low-risk" "low-toxicity" "lower-grade" "loxP" "lucifer"
    "luciferase-reporter" "lymph-node" "lymphadenopathy" "lymphoblastoid"
    "lymphoma-2" "lymphoma-extra" "lysine-less" "lysis" "lα"
    "m-chlorophelyhydrazone" "m-chlorophenylhydrazone" "mBRCA" "mCAT-positive"
    "mCherry-GFP-LC3B" "mCherry-HA-Rb-expressing" "mDab1" "mESCs" "mIL-4"
    "mKate" "mKate2" "mKate2-F" "mNeuNT" "mRNA" "mTOR-rictor" "mTORC1-S6"
    "mTORC1-associatedmTOR" "mTORC2-multikinase" "macro-dissection"
    "macro-vascular" "macrophage-mCAT-expressing" "macrophage-mitoOS"
    "macrophage-tropic" "magnoid" "main-chain" "malignacy" "malignances"
    "malony" "malony-CoA" "malonyl-CoA-decarboxylase" "mammosphere"
    "mammospheres" "matchedcyclin" "materials" "maternal-placental" "mcg"
    "mdivi-1" "mean±SEM" "mean±s" "mechano" "mechano-sensitivity"
    "medium-throughput" "mega-syndromes" "melanocortin" "melanogaster"
    "melatonin" "mellitus" "membrane-associated" "membrane-permeable"
    "membrane-soluble" "meniscus" "merlin-iso1-deficient" "merlin-iso2"
    "mesenchymal-like" "mesenchymal-type" "mesenchymal–epithelial" "mesenchyme"
    "mesentery" "meshwork" "meso" "meso-hypogastric" "meso-hypogastrium"
    "mesocolon" "mesoderm" "mesothelium" "mesylate" "meta-regression"
    "metabolic-targeted" "metallopeptidases" "metastasectomies"
    "metastasis-initiation" "metastasis-suppressor" "methothrexate"
    "methyl-binding" "methyl-piperidino-pyrazole" "methylcoumarin"
    "methylphenyl-4-carboxylic" "methylransferases" "mevalonate" "mfps"
    "miR-1-2" "miR-101" "miR-107" "miR-1204" "miR-1204-1208" "miR-1206"
    "miR-122" "miR-122exp" "miR-124" "miR-124-3p-Rho" "miR-124-overexpressing"
    "miR-1285" "miR-129-5p" "miR-1308" "miR-130b" "miR-137" "miR-140"
    "miR-140-3p" "miR-140-5p" "miR-142" "miR-142-3p" "miR-142-5p"
    "miR-142-expressing" "miR-142-overexpressing" "miR-142-regulated" "miR-143"
    "miR-143exp" "miR-144" "miR-145" "miR-146" "miR-146a" "miR-149" "miR-15"
    "miR-151" "miR-151a" "miR-153" "miR-155" "miR-17" "miR-17-5p" "miR-182"
    "miR-183" "miR-19" "miR-192" "miR-195" "miR-195exp" "miR-1973" "miR-19a"
    "miR-19b" "miR-20" "miR-200" "miR-200b" "miR-202" "miR-203" "miR-205"
    "miR-206" "miR-20a" "miR-20b" "miR-211" "miR-216a" "miR-22" "miR-222"
    "miR-223" "miR-223-inhibitor" "miR-223-targeted" "miR-23b"
    "miR-23b-associated" "miR-25" "miR-29a" "miR-30c" "miR-30d" "miR-30e-3p"
    "miR-31" "miR-320" "miR-320a" "miR-326" "miR-33" "miR-33a" "miR-34"
    "miR-34a-c" "miR-375" "miR-377" "miR-380" "miR-424" "miR-4284" "miR-449a"
    "miR-449b" "miR-452" "miR-486" "miR-486-3p" "miR-499" "miR-504"
    "miR-590-5p" "miR-638" "miR-768-5p" "miR-886" "miR-923" "miR-98"
    "miR-control" "miR-null" "miR-null-expressing" "miR10b" "miR200" "miR30"
    "miR34a" "miR34a-positive" "miRNA-326" "miRNA-recognition" "miRNA21"
    "miRNA29" "miRNA29a" "miRNA29b" "miRStart" "miRanda" "micro-environment"
    "micro-environmental" "microRNA-1" "microRNA-375" "microaneurysms"
    "microangiopathy" "microcircuit" "microcircuits" "microclusters"
    "microdomains" "micrographs" "micrometastases" "micropthalmia"
    "microsatellite" "microsections" "microtubule-dis-rupting" "mid-S"
    "midbrain" "middle-high" "middle-income" "middle-late" "midsections"
    "milk-specific" "millisecond" "miltenyi" "mini-CMV" "minichromosome"
    "minimise" "minireview" "miniscule" "minus-end" "minus-strand" "mir-151a"
    "mir-196a" "mir221" "mismatches" "missense" "mitis" "mito-chondria"
    "mito-chondrial" "mitoOS-atherosclerosis" "mitochondria-only"
    "mitochondrial-associated" "mitochondrial-derived"
    "mitochondrially-restricted" "mitochondrially-targeted" "mitofusins"
    "mitoses" "mitosis-like" "mitotically-enriched" "mix-up" "mixed-cell" "ml "
    "mm-Hg" "mmLDL" "mock-depleted" "mock-infected" "mock-inhibited"
    "mock-treated" "moderately-responsive" "moderate–risk" "molten"
    "mono-ADP-ribosylase" "mono-ADP-ribosylation" "mono-functional"
    "mono-regimens" "mono-therapies" "mono-therapy" "mono-transgenic"
    "mono-ubiquitin" "monoamine" "monocyte-derived" "monolayer" "monophosphate"
    "monosomes" "monosomy" "monotherapy" "monoxime" "morbidities" "morpholino"
    "morpholinos" "mortem" "motif-containing" "motif-dependent"
    "motif-positive" "motifs" "motile" "motogen" "moyamoya" "mt" "mtPUMA"
    "mucosa" "multi-cellular" "multi-center" "multi-copy" "multi-drug"
    "multi-factorial" "multi-genic" "multi-kinase" "multi-layer" "multi-organ"
    "multi-polar" "multi-protein" "multi-racial" "multi-step" "multi-well"
    "multicenter" "multicentre" "multicohort" "multilineage" "multilocus"
    "multimers" "multiorgan" "multiple-round" "multiprotein" "multisite"
    "multistage" "multisubstrate" "multisubunit" "multivariate"
    "muscle-invasive" "muscle-specific" "muscularis" "mutant-FlnA"
    "mutant-to-normal" "mutant-to-wild-type" "mutants" "mutated-SKNAS"
    "mutation-positive" "mutations" "myc-His-tagged" "mycS1P" "myocytes"
    "myofibroblast-like" "myristate" "myxoid" "n=12" "n=13" "n=131" "n=14"
    "n=17" "n=2" "n=212" "n=28" "n=3" "n=31" "n=4" "n=6" "n=76" "n=8" "n=9"
    "nAChR" "nCounter" "nDCT" "nEV" "nPARP" "nPARP-1" "nRhoC" "nab-paclitaxel"
    "nano" "nano-LC-MS" "nanofiber" "nanotechnology" "nasopharynx"
    "native-state" "natural-like" "nc" "nc886" "near-complete" "near-gross"
    "near-normal" "near-null" "near-physiological" "near-term" "nearly-absent"
    "necropsies" "necropsy" "negativeBRAF" "negatively-charged" "neo-adjuvant"
    "neo-antigens" "neoadjuvant" "neocortex" "neoepitope" "neoplasias"
    "nephrectomy" "nephropathy" "nestin-positive" "neural-inducing" "neurite"
    "neuro" "neurobiology" "neuroectoderm" "neuroendocrine" "neuroin"
    "neuroin-flammatory" "neuromelanin" "neuropathology" "neuropil"
    "neurosphere" "neurospheres" "neutropenia" "never-smoker" "never-smokers"
    "neverthesless" "newer" "newest" "newly-derived" "next-generation" "ni"
    "nick-end" "nicotinamide-adenine-dinucleotide-phosphate" "nidus" "niduses"
    "nifedipine" "nigra" "nigricans" "nimbolide’s" "ninety-seven" "no-donor"
    "node-negative" "node-positive" "noise-driven" "nonconsensus" "nonexercise"
    "nonfat" "nongreen" "nonlymphoid" "nonmalignant" "nonmuscle" "nonmutant"
    "nonobese" "nonrandom" "nonsense-mediated" "nonsignificant" "nonsmall"
    "nonsolid" "nonstress" "nontransmembrane" "normal-karyotype" "normal-sized"
    "normal-to-elevated" "not-significantly" "notaby" "notochord" "nt"
    "nucleate" "nucleophosphmin" "nutraceuticals" "nutrients" "n = 8" "n = 2"
    "n = 3" "n = 6" "n = 9" "ob" "obsessive–compulsive" "octamers" "oestrogen"
    "oestrogens" "ofBRAF" "ofcyclin" "off-label" "off-target" "off-targets"
    "off-treatment" "offs" "olaparib-treatment" "oligo" "oligoduplex" "oligos"
    "olycomb" "omega-3" "omplex" "on-line" "on-target" "on-time" "on-times"
    "on-treatment" "oncologists" "oncology" "oncosphere" "oncospheres"
    "one-covariate" "one-sided" "one-step" "one-tenth" "one-third" "one-to-one"
    "one-way" "ontogeny" "oocytes" "open-angle" "open-label" "ordinario"
    "organelle" "organelles" "organochlorine" "organoid" "ori" "ormCAT"
    "oropharynx" "ortholog" "orthologues" "osteoblast-like" "osteoblasts"
    "osteophyte" "osteophytes" "osterpontin" "out-competes" "out-of-frame"
    "outs" "ovariectomy" "over-activation" "over-all" "over-night"
    "over-production" "over-representation" "over-sized" "over-stimulation"
    "over-transmission" "overstretches" "overview" "oxLDL-macrophage" "oxPAPC"
    "oxPL" "oxPLs" "oxidative-induced" "oxidative-stress-induced" "oxodGuo"
    "oxyethylenenitrilo" "oxygenase-1" "p015-1" "p21-promoter-binding" "p38AGF"
    "p38TM" "p38WT" "p38β" "p3XFLAG-CMV9-LRIG1" "p50α" "p53-RE" "p53-S10a"
    "p53-TAF1" "p53-binding" "p53-bound" "p53-deficient" "p53-dependant"
    "p53-dependency" "p53-dependent" "p53-family" "p53-independent"
    "p53-induced" "p53-insufficient" "p53-mediated"
    "p53-mediated-transcriptional" "p53-miR-34a" "p53-mutated" "p53-null"
    "p53-occupancy" "p53-proficient" "p53-profieient" "p53-response" "p53-the"
    "p53-wildtype" "p53DD" "p53WT" "p53–MDM2" "p55α" "p58β" "p85α" "p85γ"
    "p=0.0001" "p=0.001" "p=0.003" "p=0.004" "p=0.006" "p=0.007" "p=0.008"
    "p=0.0088" "p=0.009" "p=0.013" "p=0.016" "p=0.02" "p=0.022" "p=0.0231"
    "p=0.025" "p=0.028" "p=0.03" "p=0.030" "p=0.031" "p=0.035" "p=0.038"
    "p=0.039" "p=0.04" "p=0.0433" "p=0.049" "p=0.0492" "p=0.05" "p=0.056"
    "p=0.071" "p=0.08" "p=0.084" "p=0.09" "p=0.092" "p=0.1" "p=0.13" "p=0.27"
    "p=0.678" "p=2.2×10" "p=2.9E" "p=2x10" "p=3.4" "p=3.8×10" "p=4.8×10"
    "p=5.6×10" "p=7" "pAMPK" "pAdenoX" "pAdxsi-GFP" "pCMV" "pEBG" "pEC" "pEGFR"
    "pEct2" "pGEM-T" "pGSK-3β" "pH" "pH2A" "pH2AX" "pHH3" "pJAK1" "pJAK2"
    "pJak2" "pKRAS" "pL" "pLAINef" "pLD288" "pLD401" "pLD561" "pLXSN"
    "pLXSNp53DD" "pM" "pMSCV-IRES-GFP" "pMT302" "pMek" "pNL-A1" "pNL4-3"
    "pPAK1" "pPAK2" "pPON" "pPON1000-FL" "pS1333" "pS194" "pS392" "pS6K1"
    "pS727" "pSTAT3" "pSTAT5" "pSer1333" "pSer1366" "pSer9-GSK-3βwas"
    "pShuttle-GFP-CMV" "pT-ROCK1" "pT288" "pT7pS" "pT7pY" "pTAC" "pTIREX"
    "pTNM" "pTRE" "pTarget" "pY1173" "pY416" "pY505" "pack-years" "pair-end"
    "pair-wise" "paired-end" "pairwise" "paler" "pallial-specific" "pallidus"
    "pallium" "palmitoyl" "pan-HDACIs" "pan-kinase" "pan-nuclear"
    "pancreaticoduodenectomy" "panel-reactive" "pannus" "papillae" "paracrine"
    "paralog" "paramaters" "parenchyma" "parent-of-origin" "parent-sensitive"
    "parieto" "parieto-occipital" "parkinsonism" "partby" "particulate"
    "patho-physiology" "pathobiology" "pathogen-associated" "pathogen-derived"
    "pathologist-verified" "pathophysiology" "pathways" "patients"
    "pattern-recognition" "pcDNA-SRα" "pcDNA3-NLS-AXIN2" "pcDNA3.1-ZEB1"
    "peak-to-peak" "peanut-specific" "penetrance" "penetrant" "pentanucleotide"
    "pentostatin" "peptide-precipitation" "peptide-pull" "peptides"
    "peptidyl-prolyl" "peptidyl-α-aminoadipic-δ-semialdehyde" "perforant"
    "perhaps" "peri-nuclear" "peri-tumoral" "peri-tumour" "peritonectomies"
    "peritoneum" "persisters" "person–years" "ph-p53" "phalloidin-Alexa"
    "phalloindin" "pharmacophore" "phase-3" "phenethyl" "pheochromocytomas"
    "phloretin-3,5-di-C-glucoside" "phos27" "phosCdc" "phosSic1" "phosSic1ΔC"
    "phosp27" "phosp27-hsCks1" "phosp27-hsCks1-ligase" "phosphate-binding"
    "phosphatidylinositol-3-phosphate"
    "phosphatidylinositol-4,5-bisphosphonate"
    "phosphatidylinositol-5-phosphate" "phospho-c-Jun" "phosphoAkt"
    "phosphoAkt1" "phosphoERK1" "phosphoHDAC3" "phosphoLimK" "phosphoRac1"
    "phosphoThr172" "phosphodegron" "phosphodegrons" "phosphodiester"
    "phosphohistone" "phosphoinositide-dependant" "phosphoinositol"
    "phosphoinositol-3-kinase" "phosphopeptide-Cks" "phosphorodiamidate"
    "phosphorothioates" "phosphorylatesI" "phosphorylatesIκB-αin"
    "phosphorylation-defective" "phosphosites" "phosphothreonines"
    "phosphotidylinositol-4,5-biphosphate" "phosphotyrosines" "photometry"
    "photomicrographs" "photomicrography" "photophobia" "photoproduct"
    "photoreceptors" "phyto" "phyto-chemicals" "phytomedicine" "piecewise"
    "piloid" "pilomyxoid" "pin-point" "placebo-controlled" "placenta-specific"
    "planum" "plasmacytoid" "plasmonigen" "platin" "platinum-based"
    "pleomorphism" "plus-end" "plus-strand" "pmaxGFP" "pmirGLO" "pml"
    "pneumophila" "point-mutant" "point-mutants" "point-mutations"
    "polarity-impaired" "poly-L-lysine" "poly-glutamine" "polyQ" "polymerase-1"
    "polymerase-I" "polymerase-II" "polymerase-delta-associated" "polymorphism"
    "polymorphisms" "polynucleotide" "polyphenol" "polyphenols" "polyploid"
    "polypurine" "polysome-to-monosome" "polyubiquitinaton" "polyvinylidene"
    "pombe" "pons" "poor-prognosis" "poorer" "poorest" "poorly-differentiated"
    "positive-feedback" "positively-charged" "post-Oligomycin" "post-cancer"
    "post-cystectomy" "post-doxycycline" "post-endocytic" "post-extraction"
    "post-fixation" "post-induction" "post-infection" "post-injection"
    "post-irradiation" "post-lysis" "post-menopausal" "post-mitotic"
    "post-mortem" "post-natal" "post-progression" "post-recombination"
    "post-replicative" "post-resection" "post-stimulation" "post-surgery"
    "post-synaptic" "post-test" "post-transcriptional" "post-transcriptionally"
    "post-transfection" "post-translation" "post-translational"
    "post-translationally" "post-transplantation" "post-treatment"
    "post-washout" "postdamage" "posthatch" "posthoc" "postmortem" "poststress"
    "posttransplant" "pp" "pp70S6K" "ppRb" "ppxx" "precision-cut"
    "precursor-induced" "preligand" "preselect" "preselects" "preterm"
    "pri-miR" "pri-miR-202" "primograft" "prion-like" "priori" "pro-CASP3"
    "pro-ERα" "pro-adhesive" "pro-angiogenic" "pro-apoptosis" "pro-atherogenic"
    "pro-cancer" "pro-caspase-8" "pro-death" "pro-differentiation" "pro-drug"
    "pro-drugs" "pro-enzyme" "pro-fibrotic" "pro-growth" "pro-hormone"
    "pro-inductive" "pro-inflammatory" "pro-invasive" "pro-mitotic"
    "pro-neoplastic" "pro-proliferation" "pro-proliferative" "pro-proteins"
    "pro-survival" "pro-tumoral" "proCASP3" "proband" "probands" "procaspase-3"
    "procoagulant" "procollagen" "product-derived" "professore"
    "progenitor-and-derivative" "progenitors" "progeny" "progestin"
    "progressors" "prokaryote" "proliferator-activated" "promoter-inherent"
    "promoter-intron" "promoter-less" "promoter-p53-TAF1" "promoter-proximal"
    "promoter-reporter" "promots" "proof-of-concept" "proof-of-principle"
    "propeptide" "propeptides" "propidine" "propria" "prostaglandinD"
    "prostaglandinE" "prostaglandins" "prostatectomy" "prostatosphere"
    "prostatospheres" "protein-5" "protein-6-oxidase" "protein-DNA"
    "protein-interaction" "protein-level" "protein-ligand" "protein-tyrosine"
    "proteinase-K-resistant" "proteins" "proteome" "proteosome" "proteosomes"
    "protofibrils" "protomers" "protooncogene" "proven" "pseudogene"
    "pseudogenes" "pseudoinclusions" "pull-down" "pull-downs" "pulled-down"
    "pulposus" "pulse-chase" "pump-resistance" "putamen" "pvalue"
    "pvalue-0.025" "p " "p = 0.001" "p = 0.004" "p = 0.025" "p = 0.04"
    "p = 0.05" "p = 0.001" "p = 0.006" "p = 0.02" "p = 0.025" "p = 0.05" "q3w"
    "quadruplex" "quadruplexes" "quencher" "quintile" "quintuple" "rac1on"
    "radiation-induced" "radiatum" "radio-resistance" "radio-sensitivity"
    "radioimmunoassay" "radioresistance" "radiotherapy-induced"
    "random-effects" "rapalogs" "rapalogues" "rapamycin-derivative"
    "rapamycin-derivatives" "rapamycin-downstream-targets" "raphe"
    "rapidly-activated" "rapidly-progressing" "rarer" "ratio=8.1" "ratio=8.5"
    "ratio=8.81" "re-analysed" "re-analyzed" "re-associates" "re-biopsy"
    "re-challenge" "re-challenged" "re-challenging" "re-circularized"
    "re-cycling" "re-differentiate" "re-differentiated" "re-differentiation"
    "re-direct" "re-emerged" "re-endothelization" "re-engage" "re-enter"
    "re-entering" "re-equilibration" "re-established" "re-evaluate"
    "re-evaluated" "re-evaluating" "re-evaluation" "re-examined" "re-exposed"
    "re-exposure" "re-expressed" "re-expressing" "re-expression" "re-forming"
    "re-grew" "re-grow" "re-growth" "re-hospitalization" "re-identified"
    "re-introduction" "re-localization" "re-localized" "re-location"
    "re-oriented" "re-phosphorylated" "re-programming" "re-purchased"
    "re-purifying" "re-replicated" "re-replication" "re-review" "re-reviewed"
    "re-screened" "re-sensitized" "re-sequencing" "re-stimulated"
    "re-stimulation" "re-synthesis" "re-synthesized" "re-transplantation"
    "re-treatment" "re1741981" "reChIP" "reacquire" "reaction-restriction"
    "read-depth" "read-out" "read-outs" "readout" "readouts" "real-time-PCR"
    "realtime" "reassociates" "receptor-ligand" "receptor-like"
    "receptor-peptide" "receptor-positive" "receptor-subtype" "rechallenge"
    "recirculate" "red-fluorescent" "reddish-brown" "reduced-intensity"
    "reduviid" "reenter" "reestablish" "reexposure" "reexpress" "refractile"
    "reg" "regions" "regrowth" "regulators" "related-1" "related-2"
    "relatedness" "relavant" "renilla" "reoccur" "repair-defective"
    "repair-deficient" "repair-impaired" "replication-checkpoint"
    "replication-competent" "replication-independent" "replicon" "replicons"
    "reporter-gene" "representativeness" "repressors" "residues1–200"
    "resitance" "resolvases" "resolvin-D1-induced" "resolvin-D1-treated"
    "resolving-D1-treated" "resp" "responder" "responders" "respose"
    "reticulum" "retinectomies" "retransplant" "retro" "retro-elements"
    "retroperitoneum" "retrotransposition-competent" "retrotransposon"
    "retrotransposons" "retroviral-mediated" "retrovirus" "reuglates"
    "reuptake" "reverse-transcription" "revertant" "rewarms" "rhabdoid"
    "rhabdomyosarcomas" "rho=0.88" "rho=0.91" "rho=0.93" "rhodamine-phalloidin"
    "rhomboid-like" "ribose" "rictor-induced" "right-hand" "right-sided"
    "risk-allele" "risk-associated" "rod-like" "rpm" "rs1042522" "rs1047100"
    "rs10796856" "rs11203042" "rs11238349" "rs1126643" "rs1126643-T"
    "rs1147098" "rs1147098C" "rs115597780" "rs11773818" "rs12311754"
    "rs12311754C" "rs12582717" "rs149917140" "rs17172432" "rs17172438"
    "rs17228212" "rs1741981" "rs17878362" "rs17883323" "rs1799889" "rs1800371"
    "rs1800449" "rs1800629" "rs1801516" "rs1815009" "rs1820453" "rs1858830"
    "rs1966265" "rs20118426" "rs201184269" "rs20417" "rs20544" "rs2088126"
    "rs2233406" "rs2234693" "rs2279744" "rs2517959" "rs2517960" "rs25487"
    "rs2643194" "rs2643195" "rs2664352" "rs2736098" "rs28720239" "rs2981578"
    "rs3217992" "rs344781" "rs35117667" "rs35550267" "rs3743249" "rs3743250"
    "rs3842787" "rs38841" "rs38845" "rs4149018" "rs4316697" "rs4331978"
    "rs58677352" "rs603965" "rs652438" "rs6533014" "rs6533015" "rs6581580"
    "rs6581580G" "rs6581580T" "rs696" "rs7313765" "rs7313765A" "rs7313765G"
    "rs755793" "rs780094" "rs903506" "rs9340799" "rs984654" "rs999460" "rsmiR"
    "rsmiR-140" "ruffels" "runtime" "s00277-013-1920-0" "s00401-013-1198-2"
    "sGCα1" "sIL-6R" "sIL-6Rα" "saccules" "salt-bridge" "salt-bridges"
    "same-sex" "sample-size" "sapiens" "sarcomatoid" "sc-23556" "scale-up"
    "sdRNAs" "second-generation" "second-line" "second-messenger" "second-site"
    "secre" "secre-tagogue" "secretome" "self-assembling" "self-assembly"
    "self-benefit" "self-cleavage" "self-complementary" "self-limiting"
    "self-regulatory" "self-renew" "self-renewal" "self-reported"
    "self-tolerance" "self-ubiquitination" "semi" "semi-mature"
    "semi-quantitative" "semi-random" "senescence-like" "sensitisers"
    "sensitizer" "septae" "seq1" "seq2" "seq3" "seq4" "sequelae"
    "sequence-dependent" "sequence-independent" "sequence-specific"
    "sequencing-by-synthesis" "serine-2" "serine-327-phosphorylated" "serine-5"
    "serotype" "serum-deprivation" "serum-replete" "servivin" "set-point"
    "sex-determining" "sex-specific" "sh-MYB-knocked-down" "sh-Rb-expressing"
    "shATM" "shCD44–2E" "shCD44–3E" "shEcad" "shGAD1" "shGFP" "shGal-3"
    "shLACZ" "shMDM" "shMDM4" "shMDM4-negative" "shNC" "shPAI-1" "shPI5P4Kα"
    "shRNA3" "shRNA7" "shRNA8" "shRNAi" "shRPS" "shRPS7" "shRPS7-treated"
    "shRb" "shRb-1" "shRb-2" "shSRF" "shaken" "sheath-like" "sheet-like"
    "short-chain" "short-term" "short-time" "siATXN3" "siATXN3_3" "siControl"
    "siCtrl" "siERα" "siFOXA1" "siK469" "siK655" "siNgBR"
    "siNgBR+E2∶1.447±0.068×10" "siNgBR+E2∶1.800±0.0405×10"
    "siNgBR+E2∶9.777±0.665×10" "siNgBR1" "siNgBR2" "siR5" "siRNA+Dox"
    "siRNA-scramble" "siRNA7" "siRNA8" "siROCK1" "siSTAT3" "siScr" "siUNG2"
    "siYB-1" "sialyl" "side-chain" "side-chains" "sidechain-Cks1" "sigmoid"
    "sigmoidoscopy" "signaling-incompetent" "signficant" "silico" "simpler"
    "simplest" "single-base" "single-cell" "single-chain" "single-gene"
    "single-molecule" "single-nucleotide" "single-round" "single-site"
    "single-strand" "single-target" "singleFxr" "sinusoids" "sip50" "sip65"
    "sirtuin" "sister-chromatid" "sites" "situ" "size-fractionation"
    "slip-bound" "slow-cycling" "slow-down" "slower-migrating" "slowly-cycling"
    "smFRET" "small-cell" "small-hairpin" "small-molecule" "small-scale"
    "smokers" "snc" "snoRNA" "social-economic-status" "solute" "solution-phase"
    "sought-after" "soy-rich" "spacer" "spatio" "spatio-temporal" "specialista"
    "specializzando" "species-appropriate" "specises" "sphere-forming"
    "spike-in" "spindle-like" "splice-variant" "split-read" "squamoid" "srs2"
    "ss" "ssDNA-translocase" "stably-expressing" "stainings" "starvation-like"
    "staurosporine-induced" "steady-state" "stellate" "stem-associated"
    "stem-cell" "stem-cell-like" "stem-like" "stem-loop-stem" "stemness"
    "stem–loop" "step-wise" "stepwise" "stereoisomer" "stereotypy"
    "steric-blocker" "steroid-deplete" "still-poorly" "stop-codon" "storiform"
    "strand-invasion" "strand-specific" "streptavidinsepharose"
    "stress-activated" "stress-associated" "stress-granule" "stress-induced"
    "stress-inducible" "stress-inducing" "stress-mediated" "stress-response"
    "stressful" "stressors" "structure-functional" "structure-specific"
    "study-level" "study-wide" "sub-G1" "sub-Mendelian" "sub-bisulfate"
    "sub-cellular" "sub-clonal" "sub-clone" "sub-clones" "sub-complex"
    "sub-divided" "sub-divisions" "sub-family" "sub-group" "sub-groups"
    "sub-line" "sub-lines" "sub-network" "sub-optimal" "sub-pathway"
    "sub-pathways" "sub-population" "sub-populations" "sub-synaptic"
    "sub-tissue" "sub-type" "sub-unit" "subG1" "subarachnoid" "subclass"
    "subclasses" "subcomplex" "subculture" "subfamilies" "subgroup-specific"
    "sublines" "submicron" "submicron-scale" "subnetwork" "subnetworks"
    "subpathway" "subpathways" "subscales" "subset" "subsets" "substrate-like"
    "substrates" "subtelomere" "subtelomeres" "subtype" "suc1" "suceeds"
    "sugroups" "sulfhydryl" "sulforodamine" "sulphotransferases" "sulphoximine"
    "super-binder" "super-shift" "super-transactivating" "superbinder"
    "superbinders" "supernatant" "supernatants" "supershift" "supershifts"
    "supertype" "supra-physiological" "supraclinoid" "sural" "surgey"
    "surgey+EGFR-TKIs" "surgey+chemotherapy" "surgey+radiation"
    "survival-curves" "survivorship" "suvivin" "switch-like" "switching-on"
    "synapse" "synapses" "synculein" "syndrome-relevant" "synergism" "synovia"
    "synpatophysin" "synpo-long" "synpo-short" "synthesis-dependent"
    "synucleinopathy" "systems-wide" "t-NEPC" "t-NEPCs" "tRNA-Gly"
    "tachycardia" "tachypnea" "tacrolimus" "tagogue" "tail-DNA" "tail-vein"
    "tamoxifen-liganded" "tamoxifen-treatment" "tandem-purified" "targetings"
    "taxane-treated" "teleost" "teleosts" "telomerase-deficient"
    "temperature-sensitive" "ten-year" "tenovin" "tenovin-1" "tenovin-1's"
    "tenovin-1-mediated" "tenovins" "teratoid" "tert" "testings"
    "tetracysteine" "tetramethylrhodaminemethylester" "tetranortriterpenoid"
    "tetranucleotide" "tetraploid" "tetrasaccharides" "thatBRAF" "thatcyclin"
    "thatdetermine" "theBRAF" "theFxr" "thecyclin" "therapy-induced"
    "therapy–which" "therse" "thiol-disulfide" "third-generation" "third-line"
    "thirty-six" "three-covariate" "three-dimensional" "three-gene"
    "three-group" "three-hit" "three-step" "three-stranded" "three-way"
    "threonine-183" "threonine-specific" "threonine-to-alanine"
    "thrombocythemia" "thrombus" "thymidine-nocodazole" "thyroxine" "tiRNAs"
    "tibialis" "time-course" "time-dependant" "time-frame" "time-lapse"
    "time-point" "time-points" "time-to-cancer" "timeframe" "timeline"
    "timelines" "timepoint" "timepoints" "tissue-resident" "tissue-specificity"
    "titer" "titers" "toTNF" "toTrx1" "tocopherol" "toll-like" "tolllike"
    "toolkit" "toolkits" "topoisomerases" "tor1" "tor2" "traffic-related"
    "trans-dominant" "trans-membrane" "trans-neuronal" "transcription-PCR"
    "transcriptome" "transcriptome-wide" "transcriptomes" "transdifferentiate"
    "transducer" "transducin-like" "transferase-mediated" "transferases"
    "transformants" "transgenes" "translationally-silent" "translocalizes"
    "transmenbrane" "transposons" "transwell" "treatedcyclin" "treatment-naive"
    "treatment-naïve" "treatments" "trend=0.001" "trend=0.016" "trend=0.05"
    "trend=0.74" "treshhold" "tri-carbon" "tri-m-H3K9" "triage"
    "tricarbonyldichlororuthenium" "trihydroxystilbene" "trim-H3K9" "trimester"
    "trinucleotide" "trinucleotides" "triphosphate" "triple-epitope"
    "triple-negative" "triple-negative-breast-cancer" "trisphosphate"
    "trypsinogen" "tubastatin" "tubule" "tumor-normal" "tumor-suppressive"
    "tumour-associated" "tumour-initiating" "tumour-promoting"
    "tumour-propagating" "tumour-site" "tumour-specific" "tumour-suppressive"
    "tumour-suppressor" "tumour-supressor" "tumour-type" "turn-off" "turn-over"
    "twenty-seven" "two-color" "two-covariate" "two-day" "two-factor"
    "two-gene" "two-hit" "two-hybrid" "two-kinase" "two-log" "two-pronged"
    "two-sided" "two-stage" "two-step" "two-tailed" "two-thirds" "two-way"
    "type-1" "type-I" "type-II" "ubiquinol" "ubiquitin-recognition"
    "ubiquitin-specific" "ug" "ultrasonography" "ultrastructure" "un"
    "un-degradable" "uncoordinated-51-like" "uncoupler" "uncouplers"
    "under-expressed" "under-expression" "under-sampled" "under-surveyed"
    "underexpressed-tumors" "undergoes" "undergone" "underpinnings"
    "undertaken" "units" "univariate" "universally-conserved" "unkown"
    "unmature" "unmet" "untreated-SY5Y" "up-expression" "up-modulating"
    "up-regulators" "up-stream" "up-to-date" "upshift" "uracil-N-glycosylase2"
    "uracils" "uracil–DNA" "urothelium" "usingCcr2" "usual-type" "uteri"
    "utero" "utr-variant-3-prime" "v-Ki-ras2" "v-akt" "vacuoles" "value=0.02"
    "value=0.04" "values" "vasorelaxant" "vasospasms" "vasostatin" "vector-V5"
    "vehicle-treated" "vemurfenib" "venules" "vera" "vesicle-like" "vicenin-2"
    "vimentin-positive" "viremia" "virus-supportive" "vitrectomy" "vitro" "viv"
    "vivo" "viz" "vs.17.1±2.8" "vs.4.8%" "vs.GG" "water-soluble" "weakest"
    "website" "websites" "well-annotated" "well-characterised" "well-conserved"
    "well-correlated" "well-defined" "well-delimitated" "well-delimited"
    "well-designed" "well-developed" "well-differentiated" "well-documented"
    "well-ordered" "well-organized" "well-powered" "well-recognized"
    "well-standardized" "well-studied" "well-suited" "well-tolerated"
    "well-translated" "well-water" "wheal" "whites" "whole-body" "whole-cell"
    "whole-chromosome" "whole-exome" "whole-genome" "whole-genomes"
    "whole-grain" "whole-transcriptome" "wide-ranging" "wildtype"
    "wing-posture" "withBRAF" "withcyclin" "withdrawn" "withthe" "wk" "wks"
    "workers" "workflow" "working-class" "world-class" "world-wide"
    "wound-like" "written" "wrote" "wt" "wtBRCA" "wtBRCA1" "wtRhoA" "x-axis"
    "x10" "x2.4" "xanthoastrocytoma-epithelioid" "xeno" "xeno-graft"
    "xerodermapigmentosum" "xxP" "yAHAYc6" "yclin" "year-old" "yeast-based"
    "yin" "young-elderly" "yr" "z-transform" "zinc-bond" "zinc-dependent"
    "zone-specific" "zymography" "×10" "×2" "×2.2" "× 10" "× 10 " "× 10" "·GTP"
    "·Met·tRNA" "Δ1-511" "Δ140–151" "Δ145–151" "Δ146–151" "Δ1–215" "Δ21-35"
    "Δ213–233" "Δ216–393" "Δ394–511" "Δ512–861" "Δ652" "Δ749" "ΔAD" "ΔBRCT5"
    "ΔC" "ΔCC" "ΔCC1" "ΔCC2" "ΔCq" "ΔCt" "ΔDAD" "ΔDAD-expressing" "ΔG" "ΔGBD"
    "ΔLXCXE" "ΔN" "ΔN-PINK1" "ΔN-YFP" "ΔN-specific" "ΔN17" "ΔNLS" "ΔNef"
    "ΔNp53" "ΔNp53utr-Luc" "ΔNp63" "ΔPEST" "ΔRHD" "ΔRb" "ΔSB" "ΔSLQ" "ΔUEV"
    "ΔVP1" "ΔVP2" "ΔVpr" "Δexon" "ΔmΨm" "Δvpr" "ΔΔCq" "Δψm" "α-1-antitrypsin"
    "α-5" "α-CSF1R" "α-CTLA-4" "α-KG" "α-Nef" "α-PAK2" "α-cell" "α-crystallin"
    "α-gp130" "α-helical" "α-helices" "α-helix" "α-stimulating" "α-subunit"
    "α-synculein" "α-synucleinopathy" "α0" "α2β1" "α3" "α4" "α4β1" "α6β4" "αB"
    "αB-crystallin" "αG" "αORF1p" "αv" "αvβ8" "β-Galacotosidase" "β-TRCP"
    "β-TRCP-mediated" "β-TRCP1-R474A" "β-catenin-driven" "β-catenin-mediated"
    "β-catenin-responsive" "β-chemokine" "β-glucosidases" "β-hydroxybutyrate"
    "β-klotho" "β-oestradiol" "β-oxidation" "β-propeller" "β-sheet" "β-sheets"
    "β-strand" "β-subunit" "β-subunits" "β1" "β1-β2" "β2-MG" "β3-strand" "β4"
    "βI" "β–hydroxybutyrate" "γ-H2Ax" "γ-IR" "γ-aminobutyric" "γ-carboxyl"
    "γ-factor" "γ-glutamylcysteine" "γ-hydroxyl" "γ-irradiation" "γ-lyase"
    "γ-methyl" "γH2A" "γc" "δ-lactonic" "ζ–EYFP155–238" "κB" "λ-phosphatase"
    "λPPase" "μ1" "μ2" "μg" "μl" "μm3" "μmol" "μs" "π-electrons" "π-stack"
    "ψεRACK" "ω-CTX" "ω-conotoxin" " 0.05" " S1A" " S1B" " hr" " hrs" " kD"
    " ng" " μM" " μg" " contributed" " risk" "‒2HA" "‘neurospheres’" "‘spacer’"
    "‘superbinders’" "‘superbinder’" "”-like" "∆-1" "∆-13" "∆153" "∆183" "−2.9"
    "√6" "∧E4" "＞70%"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-11101-11400*
  '("etiopathology" "Ruijin" "p= 0.031" "p= 0.022" "mir" "BRAC"
    "factors/pathways" "sexual dimorphism" "dimorphism" "Riemann" "nasopharynx"
    "HLA-A1-B8-DR3" "Guajarati" "0-4" "ESSC" "GA +AA" "GA+AA" "CT+TT" "+TT"
    "1+2" "dysphagia" "Hapmap" "Gujarati" "KYSE" "p50/105" "ins/del"
    "Haplotypes" "UTRA" "ATTG" "trend = 0.001" "= 0.008" "=0.011" "P = 0.028"
    "= 0.41" "P = 0.025" "= 1.08" "= 57" "6p21" "LU" "Lund" "Gudlaugsson"
    "high-proliferative ER-positive luminal subtypes" "TailorX" "MINDACT"
    "HR=4.2" "HR=7.2" "HR=7.0" "DDFS" "10-year" "Phosphohistone"
    "the biological intrinsic subtypes" "Gallen" "HR=2.7" "decile"
    "phosphohistone" "p =0.035" "a 10-year" "3–5" "Draviam"
    "complete re-location" "EGFPs" "cycB2" "kd" "et al. first" "re-analyzed"
    "N = 12" "p = 0.025" "IC50s" "non-linear" "PHH3" "APC/C" "Krzeska"
    "a particularly aggressive and drug-resistant subset" "RII" "CD44-positive"
    "S807/811" "EGFP-positive" "shRb-2" "shRb-1" "shRb" "CD44s"
    "normal mammary epithelium" "basal mammary epithelium" "8/18" "5/6"
    "MCF7ras" "mouse mammary epithelium" "The most aggressive subset"
    "mammary epithelium" "filopodia-like"
    "both cardiovascular-related and immune-related gene polymorphisms"
    "NFkBIL-1" "Teixeira" "baroreflex" "mechanoreceptor/baroreceptor"
    "transports organic anions" "methothrexate" "rs12582717" "rs4149018"
    "PLINK" "Retrovirus" "Comprida" "Agua" "Grecco" "Goias" "Blangero"
    "Williams" "auto-immunity" "cardiomyopathies" "arrhythmia"
    "infection/disease" "haematophagous reduviid" "reduviid" "resitance"
    "suggestive SNPs" "EIA" "QT" "QRS" "genic" "12p12.2" "between1996" "REDS"
    "NHLBI" "Chagas" "angiogeness" "TβRs" "FGFR4-positive" "TGF-β1-positive"
    "paramaters" "= 0.000" "p = 0.003" "p = 0.001" "≥ 30"
    "Transforming growth factor-β1" "insertion/duplication" "Gemignani"
    "An intronic polymorphism" "these intronic polymorphisms"
    "Both intronic polymorphisms" "scientific websites" "websites"
    "the intronic polymorphism" "Popanda" "The intronic polymorphism"
    "3 intronic TP53 polymorphisms" "Pro72Arg" "72Arg" "rs1801516" "rs2279744"
    "The remaining intronic polymorphisms" "rs17878362" "rs1800371" "rs1042522"
    "intronic TP53 polymorphisms" "The intronic TP53 polymorphism" "rs17883323"
    "rs35117667" "RTOG" "10 ng/mL" "= 0.032" "P = 0.003" "ImageJ" "TopoIIB"
    "ECGG" "homeo" "gallate" "epigallocatechin" "Fristrup" "Scaber" "p =0.678"
    "cyclin D1-positive" "urothelium" "=131" "=212" "p =0.003" "n=28" "=14"
    "cystectomy" "non-muscle invasive bladder cancer NMIBC" "MIBC" "NMIBC"
    "the most frequent histological subtype" "muscle-invasive UCB" "UCB"
    "p =0.016" "=strong" "=weak" "p=0.016" "=0.003" "=28" "preselects"
    "receptor/non-receptor tyrosine kinases" "survive re-challenge" "Folfiri"
    "Folfox" "preselect" "36h" "5F7-" "HT29OXA" "CXCR4-positive" "HT29FU" "5F7"
    "the Yes-associated protein (YAP) transcription co-activator"
    "angiogenic dormancy" "mammosphere" "5F31" "Yes/YAP" "Lats 1/2" "=0.022"
    "p=0.025" "re-exposed" "re-treatment" "4h" "1h" "CD24 +" "CD133-positive"
    "5/7" "HotSpot" "LuCaP" "only 1.6% or 2/125" "or 2/125" "Wennuan" "TURP"
    "FFPE" "NEPCs" "aberaterone" "NEPC" "_696TC" "6/10" "Ampliseq" "AmpliSeq"
    "Hotspot" "11/13" "nCounter" "4/6" "14/25" "17/27" "5/13" "2/13"
    "non-focal" "clumpy" "Jonathan" "Troncoso" "Patricia" "Robinson" "Brian"
    "Reuter" "Mosquera" "Miguel" "Juan" "Lotan" "Tamara" "Beltran" "Himisha"
    "Rubin" "Amin" "Mahul" "10/150" "3/7" "26/29" "RWPE" "PrSc"
    "this aggressive subtype" "an unusual and aggressive subtype" "=13"
    "cell-like" "1/4" "5/5" "n=2" "=31" "0+" "metallopeptidases" "just 1 wk"
    "lo" "PLX5622" "int" "monocyte/macrophage" "MHCII" "reg" "yr" "M2-like"
    "1H" "Anti–mouse" "U133A" "Non-adherent" "200 mg/kg" "n = 4" "anti-tumoral"
    "M1-like" "KELCH" "IVR" "eluate" "‘superbinder’" "‘superbinders’"
    "superbinders" "DPP3" "P318fs" "co-occur" "ETGE" "SQCC" "hypomorphs"
    "superbinder" "N469fs" "mesothelium" "ITGα 2" "sulphotransferases"
    "O-glycosylation" "FUT11" "HPMEC" "the mesothelial monolayer" "x/a"
    "sialyl" "tetrasaccharides" "glycan" "dyn " "Pulmonary micrometastases"
    "micrometastases" "CTCs" "polyploid" "Necropsy" "cytoDeath"
    "activating protein-1" "platin" "OvCa" "=0.07" "β 4" "P =0.030" "P =0.056"
    "1.3 × 10" "n =9" "CA19-9" "#5" "#6" "ovariectomy" "quintile" "bioassays"
    "ERα -positive" "kg/m2" "non-pathogenic" "Estaquier" "non-catalytic" "JMC"
    "FFB" "Nisman" "non-BRCA1-mutated" "EGFR-positive" "Cyr" "Norman"
    "Hutchinson" "Litzenberger" "Allen" "Chacko" "co-associated" "Santagata"
    "EGTs" "choroid" "pilomyxoid" "synpatophysin"
    "similar fibrovascular septae" "Iwaki" "Kepes" "anaplasia"
    "the predominant histology" "fascicles" "subarachnoid" "parieto" "planum"
    "dura" "supraclinoid"
    "the patient underwent left frontotemporal craniotomy" "papillae"
    "A left frontotemporal craniotomy" "craniotomy" "moyamoya"
    "the vascular septae" "NFP" "fibrillary neuropil" "refractile"
    "Eosinophilic fibrillary neuropil" "pseudoinclusions"
    "the anterior cranial fossa" "the optic chiasm" "chiasm" "ethmoid" "boney"
    "cribriform" "the right anterior cranial fossa" "photophobia"
    "predominantly low-grade histology" "adenoid" "rhabdoid" "year-old"
    "nutraceuticals" "aminobenzamide" "Beneke" "Alano" "quadruplexes"
    "G-quadruplex" "quadruplex" "Sengupta" "Spearman's" "subtelomere" "2p"
    "approximately 1490 bp" "doublings" "subtelomeres" "dinucleotides"
    "senescence-like" "chromosome–positive" "disomy" "EcoRV" "nonmalignant"
    "Hematology" "FLT3/TKD" "–positive" "~ 7%" "SCneo" "srs2" "dissolvasome"
    "dHJs" "SCEs" "+1172" "oligoduplex" "Rad51-made" "UvrD" "NCOs"
    "non-crossover" "dHJ" "efficiently repair DNA DSBs" "crossover" "2–3"
    "2–3 µ" "the fibrogenic activity perhaps" "mesoderm" "endothelial-like"
    "SMAD2/3" "miRNA29a" "miRNA21" "miRNA29b" "miRNA29" "10ng/ml" "shSRF"
    "10 ng/ml" "epididymis" "n=4" "RhoAV14" "HTM" "transdifferentiate" "MRTF"
    "EndMT" "myofibroblast-like" "Schlemm’s" "Schlemm" "JCT" "pathobiology"
    "collagen-1A1" "generation/activation" "Sircol"
    "the trabecular meshwork (TM)" "≥ 2" "alpha-smooth muscle" "aberrancies"
    "signficant" "CKIδ" "TRCP1" "β-TRCP1" "phosphodegron" "non-degradable"
    "dorsal ruffels" "ruffels" "VCA" "Iδ" "TRCP" "degron" "DSGXXS"
    "non-migrated" "8 μg/ml" "60-mm" "Cullin 4A" "non-metastatic" "RASSF1C"
    "oestrogens" "co-ordinately" "confrm"
    "the well-characterised suppressive efect" "efect" "TSC2A" "malignances"
    "GAC" "Okayama" "III-4" "II-4" "lobectomy" "Gα12" "disruptingmTORC2"
    "Jacinto" "Rheb·GTP" "caRhoA" "wtRhoA" "GATOR" "caRags" "RhoA·GTP"
    "Anti-HA" "·GTP" "MIR" "ectodomain" "nonsignificant" "MFI" "synovia"
    "germinal center-like" "the postcapillary venules" "nonlymphoid"
    "Langerhans" "plasmacytoid" "pannus" "Flt3L/CD135" "CD135" "SFMCs"
    "rheumatoid arthritis (RA) immunopathology" "/CD135" "S3C" "50 ng/ml" "4H"
    "≤10 " "QZ" "WY" "TY" "baldder" "LIRG1" "Kekkon" "p3XFLAG-CMV9-LRIG1" "BIU"
    "3p14.3" "transmenbrane" "P-values" "4 h" "Arab" "Yemen" "Iraq" "Syria"
    "Russia" "Denmark" "Scandinavia" "4803delCC" "_799delTT" "Algeria"
    "non-Jewish" "Israel" "Afghani" "Iraqi" "_1995" "IVS2+24(AG)" "IVS8-70"
    "IVS2+9" "IVS5-8" "IVS2" "TTCCTATGAT" "-CATT" "CATT" "Fattahi"
    "381-389del9ins29" "IVS17-53C" "_6034insGT" "4418delAGAA" "Weibull"
    "piecewise" "4153delA" "3889delAG" "AATT" "3972delTGAG" "_4676-1465del"
    "only one LGR" "LGR" "northern and eastern Pakistan" "Punjabi" "Pathaan"
    "Muhajir" "del4" "Caribbean" "Bahamas" "Chile" "Belarus" "Latvia" "Mexican"
    "AluSc" "AluSq" "AluSp" "AluSg" "AluJO" "AluJ" "AluSx/Sp" "AluSx/Sx"
    "_3952delTAGinsAT" "8765delAG" "Sardinia" "185delAG" "_850dupTCATTAC"
    "HBOC" ".7806-2A" "_3978dupTGCT" "AluJb" "AluY" "AluSx" "Yorkshire"
    "Oxford" "Thames" "5382 insC" "185 delAG" "Irish" "Scottish" "Anglia"
    "Canada" "Yemenites" "Sp/Sq" "Ya5" "bps" "Portuguese"
    "duplication/deletion" "Colorado" "185AGdel" "_8991del14" "_9030delATCAT"
    "_68delAG" "OC" "_3493insT" "_9258delATCAT" "_22733del14637" "Apulia"
    "6174delT" "_5064delTGT" "Estonia" "2804delAA" "1411insT" "Dutch" "999del5"
    "1675delA" "3829delT" "2594delC" "Swedish" "4088insA"
    "deletion/duplication" "Jewish" "5382insC" "argenine"
    "a nonpathogenic polymorphism" "Chilean" "Danish" "western European" "El"
    "Spain" "Czech" "Cypriot" "Lanka" "Sri" "Malay" "Greek"
    "the most important polymorphisms" "pseudogene" "LGRs" "multisubunit"
    "OCCR" "PhePP" "an Iranian proband" "proband" "19p" "usually younger"
    "Iran" "insertions/deletions" "exon 5" "1/3" "Gö6976" "-3β" "GSK-3βwas"
    "S9A" "GSK-3α and 3β" "GSK-3αand 3β" "GSK-3β was" "9hrs" "and 3β" "1μg/ml"
    "units/mL" "anti-glioma" "Gs" "gallbladder"
    "10 perihilar IPNB (45.5%) and 2 distal IPNBs"
    "12 perihilar IPNBs (50%) and 3 distal IPNBs" "BilINs" "BilIN"
    "colorectal villous adenomas" "distal IPNBs" "perihilar IPNBs" "&13" "M/F "
    "IPNBs" "IPNB" "v-Ki-ras2" "PDA" "LSL-Trp53R172H" "a5β1" "8μg/ml"
    "Co-localization" "αvβ8" "Panc0403" "Lumio" "nEV" "expressors" "cRhoC"
    "nDCT" "nRhoC" "RhoGDP" "CAAX" "re-cycling" "P=0.02" "MTS-STAT3-S/D"
    "MTS-STAT3-S" "farnesyl" "H-RasV12:MTS-STAT3" "H-RasV12: STAT3"
    "H-RasV12:MTS-STAT3S" "MTS-STAT3S/D" "MTS-STAT3 S/D" "MTS-STAT3S727D"
    "MTS-STAT3 S" "RasV12/35S" "2-5" "pS727" "phosphoinositol" "PMSP"
    "RasGTPases" "0.5-1µ" "anti-Mouse" "mTORC1/2" "Fischer"
    "subcutaneous HAK-1B" "HAK-1B" "approximately 10% EpCAM-positive"
    "EpCAM-positive" "HAK-1B cells" "caRheb" "BCAAs" "NOD/SCID"
    "the chondrocytic hsa-miR-377" "hsa-miR-377" "epithelin" "HCS-2/8"
    "neoepitope" "βI" "SOX" "ARGS" "ADAMTS" "stellate" "NP6"
    "all tested chondrocytic lineages" "notochord" "flexure"
    "the external annulus fibrosus (AF)" "fibrosus (AF)" "endplates"
    "fibrocartilage" "fibrosus" "annulus" "ψεRACK" "pulposus" "I2" "7 P" "9 P"
    "8 P" "/µL" "2-3" "PKCβI" "confirme" "Liposome" "rhabdomyosarcomas" "Y-box"
    "IU/mL" "serine-5" "meier" "cMYCmRNA" "MCF7:2A" "anti-hormone"
    "survivorship" "MCF7:5C" "serine-2"
    "suggested transcriptional de-regulation" "ERα+" "-5" "growth factor-like"
    "8-week-old" "a severe chronic axonopathy" "axonopathy" "sural"
    "NRG1-positive" "merlin-iso2-" "Δ/fl" "Nf2flox" "merlin-iso2"
    "both irregular-shaped PNS axons" "PNS" "22q" "Remak" "ERBB2/3"
    "juxtacrine" "Axons" "co-ordinated" "Schwann" "P = 0.004" "non-tumorigenic"
    "‐knockdown" "‐deprivation" "Ang‐1‐Induced" "‐independent" "c‐Jun"
    "dominant‐negative" "deprivation‐induced" "Egr‐1" "‐Jun" "‐negative" "AP‐1"
    "Activating protein‐1" "Ad‐Ex" "Ad‐GFP" "Tek" "‐Ex" "‐GFP" "Ex"
    "retroviruses (MSCV)" "MSCV" "PI‐3" "‐3" "‐treated" "Ang‐2" "‐dependent"
    "Ang‐1/Tie‐2" "‐specificity" "‐activated protein kinase" "Angiopoietin‐1"
    "Tie‐2" "Ang‐1‐induced" "‐induced" "Ang‐1" "‐2" "‐1" "caspase 3/7"
    "Caspase 3/7" "neutral SNPs" "re1741981" "TFSearch" "bronchial biopsies"
    "Corticosteroids" "Stouffer" "rs58677352" "Rs1741981"
    "exogenous corticosteroids" "rs1741981" "corticosteroids" "p = 0.006" "× 2"
    "AREIII" "LNCaP-IL6+" "co-targeting" "≤0.001" "–5" "RSG3" "TGF-βRII"
    "a dysplastic epithelium" "JOCK" "Dakhova"
    "separate pre-cancerous (hyperplasia and mPIN) epithelia" "Trichrome"
    "inductive rat urogenital sinus mesenchyme" "intra-" "sarcomatoid" "enin"
    "CID" "JOCK1" "Ubi" "co-activated" "= 0.112" "~ 50%" "BJ" "FV" "WO"
    "Berger" "non-inhibiting" "pY1173" "Hazarika" "GenBank" "5 × 10"
    "100 ng/ml" "Smad2/3" "the avian lens-specific d1-crystallin enhancer"
    "Zfhep" "Bzp" "heterocomplex" "curative hepatectomy" "p = 0.04" "= 0.024"
    "p = 0.05" "= 0.023" "= 44" "~ 10%" "= 12" "p = 0.025" "= 0.027"
    "the mouse mammary epithelium" "C/EBPβ-2" "p160/NCOA" "JAR" "Jackman"
    "NCOA" "≤ 0.05" "P -values " "non-classical" "Cheong" "pGSK-3β" "shGal-3"
    "Iacovazzi" "Greco" "Povegliano" "multistage" "anti-acetyl-lysine" "Endoh"
    "embryoid" "tubastatin" "re-localized" "HPCs" "H3F"
    "amino acid 6-histidine-3-FLAG" "omplex" "olycomb" "esBAF"
    "de-differentiated" "/ +" "non-cell" "_4" "co-precipitates" "de-repressed"
    "co-purifies" "leiomodin" "ΔGBD/ΔDAD" "ΔDAD" "ΔGBD/" "Z-disk" "tibialis"
    "GBD" "Δexon" "hemaglutinin (HA)" "hemaglutinin" "Z-disks" "EPS" "LAP2α"
    "Lamina" "LXCXE" "DOI" "Araki" "faulty Rb" "eLife"
    "many oxidative and chemical stressors" "Biliverdin" "biliverdin"
    "synergises" "servivin" "viv" "hanburyi" "-diphenylformazan (MTT)"
    "-diphenylformazan" "diphenylformazan" "4 h" "±1.0" "±3.1" "IC 50 s" "n =6"
    "G 0 /G 1" "phospho-ERK1/2" "Lui" "AXINs" "paralog" "subcomplex" "WRE"
    "FOPflash" "TOPflash" "NLSs" "both normal colonic mucosa"
    "uninvolved colonic mucosa" "pCMV-" "TCFs" "TLE" "WREs" "casein kinase 1α"
    "Tag 2" "co-occupies" "LKPS" "CGD" "fraktalkine" "Bennett" "cellROX"
    "Goossens" "Kanters" "Mitotracker" "ATP5α" "YURY" "mmLDL" "ketocholesterol"
    "oxPL" "oxPAPC" "oxPLs" "ormCAT" "Inos" "Randolph" "→Ldlr" "→ Ldlr"
    "mCAT-positive" "WD-fed" "BMDMs" "-fed" "wks" "anti-Mac3" "wk"
    "here again 8-OHdG-mitochondrial co-localization"
    "8-OHdG-mitochondrial co-localization" "athero"
    "no 8-OHdG-mitochondrial co-localization" "CellROX" "non-nuclear" "LysMCre"
    "atheroprone" "atheromata" "fedLdlr" "mitoOS" "fat-fed" "CD3+" "non-tissue"
    "shLACZ" "A664S" "Mutect" "the previously described Oncopanel" "Hiseq"
    "Oncopanel" "The previously reported GI" "GI" "SqCCs" "Discoidin" "SqCC"
    "cytoplasm/nucleus (AMPK)" "ADP/Pi" "ERRa" "malony" "pAMPK" "AMP/ADP"
    "Sirt4 KD" "Oligomycin" "KG" "chondria" "Sirt4 KO" "ADP/ATP" "1μg/mL"
    "the stress-inducible p38 MAPK" "non-RTK" "PIPK1γi5" "i5" "ILVs"
    "subsequent ESCRT" "ILV" "Hrs" "Goh" "AP2 β2" "dileucine" "cytohesin"
    "cytohesins" "Overview" "overexpression/mutation" "rs7313765 G"
    "rs12311754 C" "rs7313765 A" "rs6581580 G" "SNP309T"
    "the other RASSF3 intronic (rs7313765) SNP" "some intronic SNPs"
    "rs6581580 T-to-G" "testings" "non-oropharyngeal" "rs7313765A" "rs6581580G"
    "rs6581580 T" "GG/ TG" "oropharynx" "0–4" "locus" "non-oropharynx" "GG/TG"
    "hypopharynx" "locu" "rs1147098" "rs12311754" "Utah" "SARAH" "rs7313765"
    "rs6581580" "= 0.696" "= 0.013" "= 0.031" "= 0.006" "= 0.009" "= 0.004"
    "= 1.40" "= 1.09" "= 1.18" "= 1.27" "= 0.048" "= 0.001" "= 0.66" "= 0.04"
    "= 0.70" "AA/GA" "P = 0.006" "P = 0.024" "±11.0" "P = 0.038" "95% CI = 0"
    "= 0.68" "non-Hispanic" "AR+" "Sharma" "Trogatizalone" "≤4.0" "p=0.028"
    "co-occupy" "RIME" "the unique ARBS" "siFOXA1" "apocrine" "ARBS"
    "AR-positive" "=76" "=0.039" "proteosomes" "K266A" "K5D" "K5A" "CBRK"
    "CBR3" "C124R/S" "transformants" "Cα2" "Dictyostelium" "-bisphosphate"
    "flourephores" "Leung" "Ren-SV40TAg" "RenCre/p53/Rb" "Zsgreen" "sinusoids"
    "the newly developed pancreatic tumor model ten RenCre x"
    "approximately 1/3" "healthy age-matched littermates" "skin/fur"
    "necropsies" "p53/Rb" "3–4" "Ren-SV40Tag" "RenCre" "Hanahan" "targetings"
    "PanNETs" "angiotenginogen" "aspartyl" "PanNET" "~12%" "_3" "siATXN3"
    "re-equilibration" "PTEN/PTENP1" "ceRNA" "deconvolute" "Joseph" "Machado"
    "Deubiquitylases" "Foti" "Leslie" "ceRNAs" "PTENP1" "deubiquitylases"
    "p65/RelA" "20 h" "_5" "colonoscopy" "sigmoidoscopy" "USPSTF" "Jews"
    "Ashkenazi" "Poland" "colorectum" "approximately four times greater"
    "P =0.05" "=21" "95% CI=0" "P =0.03" "–4" "Twenty-one"
    "loss-of-function-dependent" "-butylhydroperoxide" "butylhydroperoxide"
    "tert" "expression/phosphorylation" "loss/downregulation" "K9/6" "K +/+"
    "Deeper" "re-expressing" "48 h" "E8.5" "non-deleted" "/+" "ROSA26"
    "glucorticoid" "primograft" "RXXS" "131RSTS134" "-pulldown" "f/f" "#9"
    "synaptic microcircuits" "microcircuits" "excitatory/inhibitory"
    "corticopontine" "LSPS" "inMet" "neurobiology"
    "reduced fractional anisotropy" "byMet" "andMet" "lucifer" "radial glia"
    "Retzius" "fx/fx" "Judson" "microcircuit" "relatively mature synapses"
    "fMRI" "neurite" "7q31" "Campbell" "OMIM" "the glutamatergic synapses"
    "radiatum" "cingulate" "perforant" "commissure" "Brodmann" "Barrington’s"
    "the dorsal raphe" "Barrington" "raphe" "dorsal pallium" "pallium"
    "cortical projecting axons" "neocortex" "callosum" "neuropil"
    "glutamatergic synapses" "immunoelectron" "excitatory synapses"
    "an axonal chemoattractant" "cranial motor axons" "axons" "andRAC1/p38"
    "motogen" "hypomorphicMET" "Cerebellum" "homology-2" "multisubstrate" "Hgf"
    "timeline" "the glutamatergic synapse" "submicron" "effects/interactions"
    "Asperger’s" "PDD" "Asperger" "underpinnings" "available nutrients/ATP"
    "LGALS7/PIG1" "p53-bound" "p53-binding"
    "8-hydroxy-2-methylquinazolin-4-one" "4-amino-1,8-naphthalimide" "pL"
    "Dynabeads" "p53-mediated" "acetyllysines" "DBrD"
    "all currently known cyclin-dependent protein kinases" "SubG1" "α3"
    "Transcription/exportation" "hand/split" "alkyl" "BCSS"
    "which causes severe hyperploidy" "hyperploidy" "PCID" "7q21.3–q22.1"
    "CCNEI" "transcription/RNA" "/S" "NCB" "Phytohemagglutin"
    "Radioimmunoassay" "miR-129-5p" "anti-fibrotic" "1/2" "fibrobalsts"
    "Nakashima" "procollagen" "Kurasawa" "CCR10"
    "fibro-proliferative microangiopathy" "microangiopathy" "fibro" "RIA"
    "radioimmunoassay" "CCR" "SSc" "μg/ml " "Th17"
    "a functionally significant polymorphism" "-4" "Hyperoxia"
    "secondary septae" "septae" "Isoleucin" "propeptides" "rs2664352"
    "tachypnea" "alveoles" "gelatinases" "mostly allelic polymorphisms" "Levit"
    "Lavoie" "rs999460" "rs4316697" "rs10796856" "rs652438" "rs20544"
    "no BPD-associated polymorphism" "bronchopulmonary dysplasia"
    "transcription factor-1" "mesenchyme" "hyperoxia" "Harijith"
    "larger alveoli" "alveoli" "the primitive saccules" "saccules" "Northway"
    "bronchopulmonary dysplasia (BPD)" "VLBW" "dysplasia" "rs1966265"
    "Transcription Factor-1" "SIRPA" "preterm" "= 0.033" "= 0.003" "Schessl"
    "Rausei" "a unique immunophenotype" "Braoudaki" "Döhner" "Falini" "Hsu"
    "AML/ETO" "significantly higher median WBC" "significantly higher WBC" "/L"
    "ITD" "FLT3/D835" "tetranucleotide" "TCTG" "Lymphadenopathy" "HSM" "M0/M1"
    "835/836" "13q12" "tyrosine kinase-3" "FLT3/ITD" "= 0.21" "= 1.0"
    "P -value" "P = 0.04" "P = 0.01" "P = 0.05" "P = 0.02" "Yu" "184B5" "184A1"
    "HECTD3m" "the catalytic inactive HECTD3m" "Δ213–233" "C1–212" "C-residues"
    "K63R" "DEDs" "Δ1-511" "subfamilies" "isopeptide" "BCRT102" "mDab1" "SH3-2"
    "99.7±" "SMIFH2" "CK666" "co-depleted" "glomeruli" "sui" "Nck1/2" "8 h"
    "/Ca 2+" "±0.8" "n = 3" "TAR" "geno-" "geno" "Suv39" "tri-m-H3K9"
    "HCT116Dicer" "mature let-7a" "pre-miR-20a" "ofCyclin" "inDicer" "miR-20a"
    "exon5" "betweenDicer" "andDicer" "Incyclin" "establishedcyclin"
    "breakpoint" "micropthalmia" "thatcyclin" "yclin" "cells / well" "N=3"
    "△C2" "△C1" "Ac-H3 K16" "VBL" "deactylase-3" "H3K 9" "H3 K9"
    "co-introduction" "letiviruses" "miRanda" "MBC" "4 h" "angio" "cerebella"
    "Anti-Flag" "hIPSC" "BCL" "hECC" "routinely split hESCs" "intercell"
    "actively cycling hESCs" "G0/1" "shRNAi" "cells/cm 2" "ESI-035"
    "a minimal amplicon" "hiPSCs" "the minimal amplicons" "hECCs" "nonmutant"
    "karyotype" "Avery" "the minimal amplicon" "20q11.21" "nonrandom" "Biopsy"
    "p53-dependency" "shMDM4" "shNC" "shMDM" "p53-wildtype" "immunosignals"
    "NL/PT" "NL" "activated/phosphorylated" "de-ubiquitinase" "USP2a" "RPS6K"
    "at least 48 h" "at least 24 h" "SJ-172550" "Pajares" "Lopez"
    "Teleangiectasia" "homolog/mammalian target of Rapamycin" "p53-deficient"
    "nmol/L" "Invitrogen" "RNAiMAX" "duplexes" "DXM1200" "Tokyo" "OLYMPUS"
    "Cambridge" "Syngene" "Chemi" "procaspase-3" "/Tween" "TBS" "Bedford"
    "FACSCalibur" "Kumamoto" "Dojindo" "Urology" "Schuylerville" "Aldrich"
    "nanotechnology" "phyto" "Garcia" "a dietary flavonoid" "Kae’s" "DSMO"
    "propidine" "inositol-3-kinase" "-trisphosphate" "trisphosphate" "Kae"
    "stage/grade" "the separate histologies" "mutation/deletion/methylation"
    "Liverpool" "The bronchial epithelium" "normal bronchial epithelium"
    "squamous histology" "reduction/loss" "co-occurrence" "= 43" "= 32" "= 21"
    "≥2" "Murdoch" "athy" "Australia" "NPADG" "EWT" "DFN" "BvD" "ETLS" "TJG"
    "HJH" "Roswell" "-diaminobenzidine" "diaminobenzidine" "Raschella"
    "miR34a-positive" "autoregulates" "dormancy" "reexpress" "autoregulate"
    "CATb" "encompassed nt position +687" "+687" "GCAGGTAG"
    "encompassed nt position +550" "+550" "CCAGGTGC"
    "encompassed nt position +294" "+294" "GCAGGTGG"
    "encompassed nt position +219" "+219" "ACAGGTAA" "Z-box" "E-box" "9-day"
    "BasalB" "BasalA" "sulforodamine" "ZEB1sh-ET" "SCRsh"
    "mesenchymal/invasive" "Z-boxes (CAGGTA)" "E-boxes" "CAGGTA" "CAGGTG"
    "CACCTG"
    "lentiviral small-hairpin RNA (shRNA)-mediated knockdown/overexpression"
    "fibroblast-like" "2 +  " "n  = 3" "1.6 × 10" "A β" "S1C" "JYL" "JFZ" "YJW"
    "CQ" "LW" "ZYQ" "Pure red blood cell aplasia" "Koskela" "Jerez" "and β2-MG"
    "β2-MG" "neutropenia" "pure red cell aplasia (PRCA)" "aplasia (PRCA)"
    "PRCA" "aplasia" "cooccur" "P  = 0.030" "P  = 0.008" "P  = 0.001" "= 0.018"
    "Exons" "circuitry" "18q21.3" "let- 7f" "miR-17-5p" "miR-19b" "covariate"
    "miR-590-5p" "miR-19 a" "95%CI: 0.06-0.77" "HR=0.22" "95%CI: 0.07-0.84"
    "III/IV" "surgey" "miR-19a" "95%CI=0" "1.0×10" "-ΔΔCq" "ΔΔCq" "ΔCq" "Cq"
    "HR=0.23" "chromosome 17p" "let- 7a" "A+B" "Non-smoking" "non-smoking"
    "=0.23" "=0.010" "=0.018" "Sγ1" "ExoI" "to 14-3-3" "Sμ" "Iγ-Cγ" "Iμ-Cγ"
    "pTAC" "2E2" "ss" "AIDR190A" "‘spacer’" "EYFP155–238" "EYFP1–154"
    "AIDL196A" "AIDF193A" "EYFP" "H3K9acS10ph" "14-3-3ζ" "14-3-3τ" "14-3-3σ"
    "14-3-3η" "14-3-3γ" "14-3-3ε" "14-3-3β" "Iγ2a-Cγ2a" "lipopolysaccharides"
    "-Cα" "DJ" "Iμ" "deoxyuracils" "dUs" "Cμ" "nucleate" "PKA-Cα" "PKA-RIα"
    "2H" "anti–Flag" "anti–mouse" "+ 2" "Cα" "anti-correlated" "xeno"
    "ofcyclin" "vs.cyclin D1" "VDL" "/CD45f" "Trop2 +" "P-value" "K-means"
    "shEcad" "goosecoid" "vs. cyclin D1" "AR~55%" "PEC" "NeuT" "withcyclin"
    "treatedcyclin" "incyclin" "matchedcyclin" "Thecyclin" "thecyclin"
    "andcyclin" "betweencyclin" "prostatosphere" "prostatospheres"
    "non-canonical" "inPten" "re-grow" "TMRSS" "Goosecoid" "Co-transfection"
    "Stem/progenitor" "P = 0.007" "P = 0.03" "= 0.07" "= 1.01" "= 9" "= 8"
    "Log2" "destabilises" "antitumour" "tenovins" "synergise" "sensitisers"
    "outs" "p53-independent" "Tenovin-1" "tenovin-1's" "p53-dependent"
    "Antitumour" "tenovin-1" "SIRTi" "isozymes" "tenovin" "p53–" "Δ Ct"
    "Δ ψ  m" "Δ ψ m" "1 h" "μ g " "p53−" "non-histone" "co-silencing"
    "re-replicated" "Akti-1" "co-inhibition" "ATMRi4" "LuciRi" "GM7166+NBS1"
    "HFF2/T" "AD#17" "#17" "AT1OS/T cells" "ATMRi2" "A/Cdk2" "re-replication"
    "minichromosome" "Ser1981" "N-acetyl" "~90%" "important protein kinases"
    "chemodrug" "anti-cell growth" "Sttatic co-treatment" "Semi"
    "kinases (JAK)" "the latter subtype" "ordinario" "professore" "Patologica"
    "Anatomia" "dirigente" "chirurgica" "digestiva" "endoscopia" "ed"
    "digerente" "apparato" "specialista" "Università" "Avanzate" "Biomediche"
    "Scienze" "Dipartimento" "Generale" "Chirurgia" "specializzando" "RTX"
    "NED" "AWD" "propria" "muscularis" "storiform" "cholecystectomy"
    "gastrojejunostomy" "hyposideremia" "59-year-old" "mesocolon" "sigmoid"
    "cerebroid" "laparotomy" "mesentery" "hypogastrium" "meso" "Federico"
    "retroperitoneum" "myxoid" "000/year" "non-epithelial" "Biopsies" "respose"
    "S3c" "gemicitabine" "VNR" "p=2x10" "approximately 1.2-1.4" "Poisson"
    "RERs" "RER" "runtime" "ctDNA" "non-invasive" "LINE-1" "+/p53-" "B2 +"
    "representativeness" "Munro" "Histoscores" "+/p53+" "downstage"
    "the best prognostic immunophenotype" "fluoronucleotides" "Wong"
    "neverthesless" "P&P/TS+" "TS +" "p53+" "histoscores" "histoscore"
    "Immunohistochemical nuclear stainings" "stainings" "prognostic/predictive"
    "sugroups" "flurouracil" "P&P" "TS+" "&P" "Coller" "Astler" "≥50 %"
    "= 0.82" "= 0.07" "= 0.41" "P  = 0.004" "= 4" "= 0.003" "P  = 0.007"
    "P  = 0.05" "= 0.85" "P  = 0.01" "= 2" "P  = 0.009" "= 0.36" "= 0.23"
    "= 0.099" "= 0.66" "95 % CI" "HR = 2.26" "P  = 0.038" "P  = 0.04"
    "P  = 0.02" "P  = 0.03" "= strong" "= weak" "= 20 " "= 5 " "≥1 " "4 Gy"
    "5-day" "= 0.005" "P  = 0.006" "RfBP" "Hartwig’s" "Hartwig" "PARP-1zf"
    "the observed optical absorbance" "Optical absorbance" "absorbance" "TECP"
    "PARPzf" "non-cytotoxic" "a functional interaction/competition" "imidazole"
    "fapy" "formamido" "xerodermapigmentosum" "OHdG" "polymerase-1" "ZL" "XW"
    "YS" "RacGTPases" "TIPE1" "Rac1GTPases" "-κB" "DED"
    "Tumor necrosis factor (TNF)-alpha-induced protein 8-like" "8-like"
    "Co-Immunoprecipitation" "= 5" "= 3" "1 h" "S4C" "S4A" "= 0" "Rembrandt"
    "eeyarestatin" "Tm" "HRASV12" "Tg" "the senescence-associated secretome"
    "secretome" "specises (ROS)" "specises" "streptavidinsepharose" "Cowden"
    "PTEN-positive" "predominantly IPAH PAVSMC" "Rapalogs"
    "proliferative apoptosis-resistant distal IPAH PAVSMC" "and 2α"
    "SMA-positive" "DG" "Distal PAVSMC" "P-S473-Akt" "P-S2481-mTOR" "mTOR" "SM"
    "distal PAVSMC" "PAVSMC" "non-physiological" "n=6" "non-diseased"
    "Insulin/IGF-1" "non-weight" "fibrillations" "osteophytes" "non-covered"
    "FoxO3-positive" "meniscus" "24-month-old" "4-month-old"
    "nuclear/cytoplasmic" "the entire femoral condyle" "condyle"
    "non-fibrillated" "# 5" "n = 6" "1 μg/ml" "= 7" "invasion/metastasis"
    "T929A/S947A" "upshift" "PRSSLSS" "subsequent ERK1/2 kinases"
    "shift/phosphorylation" "cell motility/invasiveness" "non-neuronal cells"
    "dney" "RSK1/2" "Thr 202 /Tyr 204" "posthoc" "pAdenoX" "Rockville" "Roche"
    "deoxynucleotidyl" "Strautnieks" "Silveira" "Spraul" "Takahashi" "andShp"
    "singleFxr" "theFxr" "IQGAP1 And" "IQGAP1 and" "ductules" "Adeno"
    "andIqgap2" "inIqgap1" "pathological BA"
    "3,5-diethoxycarbonyl-1,4-dihydroxychollidine (DDC)" "cholestyramine"
    "progenitor/oval" "well-developed adenomas" "Lats1/2" "Mst1/2" "BA" "BAs"
    "stereotypy" "GEMM" "AstraZeneca" "histopathology"
    "high-grade prostatic intraepithelial neoplasias" "neoplasias" "parenchyma"
    "999Del5" "Wt" "Skoulidis" "Feldmann" "Rowley" "loxP" "Tuveson"
    "the classical Knudson" "Knudson" "GEMMs" "co-regulation" "embolus" " kD"
    " μg/ml" "EGFRI" "elrotinib" " hr" " S1B" " μM" "24 hrs" "SHBM1009" " 0.05"
    "100 ng/ml" "6 hrs" " ng/ml" " hrs" "factors/receptors"
    "89 inflammatory factors/receptors" "chemokine receptor-2" "CXCL" "ΔCt"
    "Endocrinology" "Naples" "papillary/follicular" "goitrogen"
    "16 inconclusive FNC" "FNCs" "Cervical lymphadenopathy" "lymphadenopathy"
    "Diego" "GraphPad" "Sweden" "Uppsala" "Biotage" "PSQ" "BigDye" "Cytology"
    "British" "eosin" "ellipsoid" "disrupters" "Hashimoto's" "inconclusive FNC"
    "cytology (FNC)" "FNC" "DNA replication/repair" "Lifecycle" "MEPCE"
    "non-LTR" "retrotransposon" "co-purification" "transposons" "ORF1p+ORF2p"
    "lifecycle" "ORF2s" "F/Y" "Qxx" "interORF" "intronless" "L1/" "-Hs-" "iBAQ"
    "approximately 6:1–9:1" "Sypro" "3xFlag" "∼3:1" "LEAP"
    "an exogenous homopolymeric template/primer" "electrospray" "pMT302"
    "ORF2p-3xFlag" "ORF2p-3xFLAG" "and 3xFlag" "L1RP" "CBB" "Coomassie"
    "pLD401" "pLD288" "pTRE" "ORFeus" "DIRT" "co-purifying" "ORF1p" "Peddigari"
    "Long INterspersed Element-1s" "autonomous retrotransposons"
    "retrotransposons" "LINE-1s" "polymerase-delta-associated" "lifecycles"
    "#3" "=0" "∼30%" "re-enter" "Intermittent hypoxemia"
    "untreated obstructive apnea" "AHI" "cardiovascular pathophysiology"
    "nocturnal hypoxemia" "consequent myocardial and systemic hypoxemia"
    "Apnea" "the intermittent hypoxemia/reperfusion"
    "overnight intermittent hypoxemia" "intermittent hypoxemia" "hypoxemia"
    "HCAEC" "apnea" "anti-aging" "trinucleotides" "trinucleotide"
    "photoproduct" "The epigenetic co-inactivation" "mBRCA-" "NtAI" "FLOH"
    "exocrine" "haplo" "a significantly higher tumor Nmut" "wtBRCA"
    "non-carriers" "mBRCA" "Nmut" "re-expressed" "n = 8" "= 31" "P = 0.056"
    "= 0.83" "= 0.82" "the trabecular meshwork" "meshwork" "JNK2/3"
    "Morrison’s" "amacrine" "Promo3" "six retired breeder Brown Norway"
    "Hg-days" "bp-" "Promo 3" "the Morrison’s" "Morrison" "Brown Norway"
    "Norway" "IOP" "non-pigmented" "HNPE" "C/EBPs" "severity/efficiency"
    "colonise" "/Sca-1" "K-RasG12+AGF" "K-RasG12+p38AGF" "p38AGF"
    "Progenitor/Stem Cells" "progenitor/stem cells"
    "a bronchioalveolar epithelium" "RasWT" "K-RasG12"
    "mouse bronchioalveolar epithelium" "Stem Cell-like" "co-infected"
    "the optimal ZFN" "Pakistan" "Bangladesh" "Innes" "non-modified"
    "Vietnamese" "Pakistani" "Bangladeshi" "Louise" "Barts" "Chr10∶123310871"
    "rs755793" "GRCh37" "Chr10∶123298158" "a synonymous SNP" "rs1047100"
    "website" "Browser" "additional heterozygous marker SNPs" "Anti-Ki67"
    "FGFR2 intronic SNPs" "Grose" "pmaxGFP" "heteroduplex" "non-disease" "CCLE"
    "Rs2981578" "study functional intronic SNPs" "ZFNs" "ZFN" "ENSEMBL" "ASE"
    "rs2981578" "= 0" "6-diamidino-2-phenylindole" "Non-specific" "100 ng/ml"
    "FOXO1/3" "mucosal epithelium" "FOX3" "effectively knockdown FOX01" "FOX01"
    "well-differentiated PGHEC" "PGHEC" "gingivalis" "gingipains" "PHGEC"
    "gingival epithelium" "DTPP" "the evolutionary temporal contiuum" "DTPPs"
    "DTPs" "contiuum" "drug-tolerant persisters" "persisters"
    "the allosteric MEKi’s" "1 h" "target/pathway" "non-expressing"
    "BRAFi+AKTi" "AKT1/3" "vemurfenib" "weakest" "WM2664" "ERKi" "BRAFmutant"
    "BRAFi+MEKi" "re-growth" "the dynamic evolutionary continuum"
    "crosstalk/feedback" "MEKi" "niduses" "kown" "nidus" "BRAFi" "≤ 0.05"
    "n = 9" "nonsolid" "cS" "glycogen synthase kinase-3β" "PhosphoMotif"
    "Scansite" "PredPhospho" "NetPhosK" "KinasePhos" "Cish" "SDSD" "Mx-1Cre"
    "fl/fl" "p185+" "Δ749" "p160+" "Abelson" "Annexin V-positive" "5 × 10"
    "miR-221/222" "mir221/222" "liposomes" "Zigoneanu" "stressful" "+0.27" "QY"
    "anisotropy" "ProSpec" "vector/control" "Huang" "/R" "P102C/63C" "P102C"
    "P102/63C" "A18C/63C" "liposome" "A18C" "millisecond" "Ia/" "6His" "Thermo"
    "bilayers" "donor/acceptor" "fluorophores" "coil-like" "molten" "Nanosizer"
    "Malvern" "0.357log(MW)" "smFRET" "toxicity/pathology" "CTAs" "Zeng"
    "Cancer/Testis" "diphosphatidylglycerol" "Förster" "~10%" "= 1.06" "= 0"
    "= 0.56" "3 +" "Zitzmann" "p=0.04" "=N" "phase-3"
    "an alternate MEK inhibitor PD98095" "PD98095" "pp70S6K" "Novartis"
    "hydroxyethyl" "LY29400" "p=0.02" "=0.0001" "VPC03090" "/ERK1,2" "chemo-"
    "receptor-positive" "Kazanietz" "Griner" "SB649146" "at least 24 h"
    "=10.52±0.32" "pEC" "Giam" "Chipuk" "fingolimod" "erythro" "FTY720P"
    "1  μ g/ml" "Non-targeting" "1P" "sub-G 1" "n =3" "Washington" "SAKK"
    "=100%" "optimise" "Prescrire" "pKRAS" "∼14%" "P =0.01" "=0.04"
    "appropriate analytic algorithms" "algorithms" "vascular endpoints"
    "CARDIoGRAM/C4D" "17p11.2" "comorbid" "the combined vascular endpoint"
    "=0.85" "=0.83" "=0.68" "LAS/CAD" "5×10" "=1.62×10" "CAD/LAS"
    "the broader vascular endpoint" "only two SNPs" "CES" "chr12q24/SH2B3"
    "9p21" "CYP17A1-CNNM2-NT5C2" "ABO"
    "the ischemic large artery stroke (LAS) subtype" "METASTROKE" "=0.46" "=5"
    "=0.78" "=0.82" "N=6" "12q" "C4D" "YE" "GAD1-positive" "shGAD1" "HNOKs"
    "Chuang" "collagens" "adenomatous polyposis coli" "endometrioid" "= 0.011"
    "1 × 10" "+ 3 " "+ 2 " "+ 1 " "Written" "synchronous LNMs" "ICH" "gastro"
    "23/102" "LNM" "LNMs" "P  = 0.013" "≥3" "3+" "~50%" "CgA/peptide" "CgA/"
    "chloromethylketone" "PC1-3" "subculture" "KRJ-1" "Vasostatin" "Units/µ"
    "168.6±53" "KRJ" "prohormone convertase 1-3" "pheochromocytomas" "granin"
    "chromostatin" "vasostatin" "small intestinal NENs" "NENs" "SI"
    "ELISA/western" "enterochromaffin" "NEN" "p =0.03" "x 10" "~30%" "~70%"
    "x10" "negative/basal-like" "bio" "Fluidigm" "-UTRs" "UTRs" "re-expression"
    "this aggressive tumor subtype" "de-differentiation/stem cell"
    "hypoxia-inducible-factor-1-alpha" "shBeta" "survival/proliferation" "T-MS"
    "mammospheres (MS)" "mammospheres" "stem/basal-like" "stem/progenitor"
    "maintenance/acquisition" "Basal-like" "Non-enzymatic" "100ng/ml" "CO-IP"
    "Δ C" "stem cell-like" "mmol/L" "anti-coagulant" "STAT3C" "ppRb" "WST"
    "vasorelaxant" "yin" "dimethoxycoumarin" "capillaris" "Artemisia" "n=8"
    "1 μg/mL" "pSTAT3 S" "pJAK2" "ΔN-" "non-receptor tyrosine kinases"
    "the described functionally relevant hotspots" "dipyrimidine"
    "histologic subtype" "LVI" "Clark" "atypical fibroxanthomas"
    "fibroxanthomas" "n = 6" "= 11" "n = 2" "= 4" "tiRNAs" "YB-1:RNA" "H/ACA"
    "sdRNAs" "C/D" "stem-cell-like" "miR-30c" "U33" "let-7b" "BioB" "limma"
    "siYB-1" "snc" "miR-216a" "co-localisation" "nt" "sncRNA" "sncRNAs"
    "let-7a" "non-protein" "DFMO+sulindac" "preventing colorectal adenomas"
    "diclofenac+DFMO" "p = 0.007" "p = 0.004" "MAPKAP-2" "p = 0.05"
    "DFMO+Diclofenac" "DFMO/diclofenac" "=  0.04" "= 0.04" "p = 0.008" "= 0.01"
    "TUNEL-positive" "p = 0.02" "p = 0.03" "epidermoid" "DFMO+diclofenac"
    "all colorectal adenomas" "Meyskens" "ODC+COX-2" "NMSCs" "NMSC" "g/ ml"
    "Non-melanoma" "Dumont" "neither Begg’s" "=1.07" "OR=0.93"
    "histological subtype" "non-melanoma" "=0.96" "=1.08"
    "pure S- (-)equol diastereomers" "diastereomers" "EpRE" "phenethyl" "TUNEL"
    "Nrf2/ARE" "nicotinamide-adenine-dinucleotide-phosphate" "g/d"
    "enantiomers" "PHTPP" "a synonymous single nucleotide polymorphism" "NHW"
    "at 5p15.33" " risk" " contributed" "a synonymous polymorphism" "Begg's"
    "Dominguez" "Gago" "vs.GG:P" "*GG+AG" "*AA+AG" "vs. GG" "1.04–1.35"
    "1.02–1.18" "= 1.06–1.41" "1.07–1.46" "AA+AG" "AG+GG" "1.12–2.50"
    "1.05–1.57" "1.05–2.09" "1.02–1.43" "TTAGGG" "1-like" "nAChR" "rs2736098"
    "= 32" "= 30" "95%CI " "= 0.010" "= 1.19" "= 0.82" "= 0.003" "5p15.33"
    "Non-small-cell" "P  = 0.013" "P  = 0.025" "cyclohexamide (CHX)"
    "cyclohexamide" "Gal4DBD" "function-1" "intracrine" "reoccur" "koenigii"
    "Murraya" "carbazole" "de-repression" "co-knockdown" "non-cancer cells"
    "transcriptional co-activation" "non-cancer cell" "P -values" "≥ 3"
    "poststress" "CSA" "non-NER" "hypoglycinemia" "S4B" "p53-S10a" "S10a"
    "nonstress" "AG13145" "postdamage" "XPCB" "JPP" "dihydrochloride"
    "Rheumatology" "Immunoglobulin" "Baugé" "osteophyte"
    "competition/cooperation" "N-isoforms" "C-isoform" "Soond" "miRStart"
    "Yang" "expression/regulation" "90-minute" "≤0.0001" "≤0.003" "≤0.01"
    "TTGGTGTTGG" "GGAAA" "GAGAGA" "CAAAAA" "miR-33a" "TAA" "miR-140-3p"
    "miR-140-5p" "OA-like" "rsmiR" "OA" "1 μg/ml" "A/G" "1/5" "n = 8" "P ≤0.05"
    "VDV" "VDS" "YC" "AGJ" "generation/development" "miR10b/10b" "miR-151a"
    "miR-23b" "LOF" "IARC" "A138S" "spacer" "miR-30d" "d" "Jin" "RRRCWWGYYY"
    "p73β" "p63β" "2 h" "the optimal cutpoint" "Germany" "8p11-12"
    "slightly greater median pack-years" "non-whites" "pack-years (PY)"
    "pack-years" "BGJ398" "cutpoint" "pvalue" "≥ 10" "p = 0.025"
    "non-overlapping" "life-time" "N = 3" "N = 6" "N = 2" "8p21.3" "C/Kras"
    "C /EGFR" "C/EGFR" "transgenes" "phosphotyrosines" "PXXP" "subclass" "= 12"
    "= 29" "2  +" "= 4" "2 +" "~15%" "Let-7g" "Hsa-let-7g" "Hsa-Let-7g"
    "EAhy926" "anti-atherosclerotic" "anti-atherosclerosis" "hsa-let-7g"
    "HCAECs" "let-7g" "has-let-7g" "g" "FL3" "= 0.023" "= 0.20" "tocopherol"
    "DATATOP" "symptomatic antiparkinson" "antiparkinson" "L-dopa" "ontogeny"
    "commonest" "neuroin" "toTrx1" "vesicular monoamine transporter-2"
    "erythrocytes" "DJ-1alpha" "DJ-1beta" "homologs" "forebrain" "carbonyls"
    "the progressive neuropathology" "neuropathology" "CMA" "oxygenase-1"
    "primary mesencephalic neuron-glia co-cultures" "tolllike"
    "cytotoxic soluble protofibrils" "protofibrils" "organochlorine"
    "osterpontin" "lipopolysaccharide (LPS)" "lipopolysaccharide" "nigra"
    "alpha-subunit" "mitochondrial fusion/fission"
    "1-methyl-4-phenylpyridinuim" "ubiquinol" "catalyses" "dehydrogenases"
    "sulfhydryl" "4-Hydroxyl-2-nonenal" "alkoxyl"
    "Instead VTA neurons use HCN/Na +" "HCN/Na +" "midbrain" "desferrioxamine"
    "hyroxyl" "putamen" "pallidus" "globus" "L-DOPA" "VTA" "Neuromelanin"
    "reuptake" "cysteinyl" "Postmortem" "neuromelanin" "Aminochrome"
    "aminochrome" "ammonium" "auto-oxidation" "flavo" "ferrousiron" "OH"
    "Weiss" "Haber" "Fenton" "dichloride" "-bipyridinium" "bipyridinium"
    "co-cultures" "Huntington’s" "Aβ-" "ultrastructure" "bleb-like"
    "these human neuronal cybrids" "DLPl" "Cybrids" "~1.5–1.6"
    "vehicle-treated AD cybrids" "production/accumulation"
    "tetramethylrhodaminemethylester"
    "potential, and bioenergy in newly created cybrid neuronal cells containing"
    "bioenergy" "Cybrid" "cybrids" "non-AD" "Aβ" "Parkinson" "optic atrophy1"
    "CcO" "mdivi-1" "cybrid" "Fission/fusion" "Fission/Fusion" "mean ± SEM"
    "HRECs" "~14%" "ONOO" "DETA" "retinal glia" "nitric oxide synthase-2"
    "adhesion molecule-1" "sacular microaneurysms" "microaneurysms"
    "macular edema" "HREC" "non-transfected" "7B" "= 20" "+ 10" "VS" "MSGM"
    "cancer 1/2" "hypodiploid" "XTT" "Ku" "Jiang" "ATMi" "shATM"
    "mutation/inactivation" "an Achille’s" "Achille" "expression/activity"
    "BRCA 1/2" "BRCA1 / 2" "SDF1α" "m/min" "m/minute" "PKCθ−/−" "anti-Ly5.2"
    "venules (HEV)" "venules" "PKCθ S" "PMA+ionomycin" "IIA" "PKCθ" "= 17 µ"
    "= 3" "= 3 µ" "# 10" "2 /5" "TargetScan" "G 0 /G 1 phase" "mfps" "gDNA"
    "non-amplified" "p110β siRNA #2’s" "LapR" "= 0.015" "vitro" "Duan" "DHL-41"
    "phosphodiester" "pentanucleotide" "AGCCT" "BCP1" "proteome" "biomass"
    "chemoresistant" "STAGA" "CAAT" "a TATA-less" "TATA-less" "TATA"
    "Chemoresistance" "H3K27" "ANTI-FLAG" "the homologous residue S1975"
    "S1975" "I1816T cells" "the active tor1" "gad8" "T1972D" "T1972A" "tor1"
    "RMCEtor1 +" "RMCE" "pombe" "Schizosaccharomyces" "T1972" "AGC" "1.5 × 10"
    "1 +" "secondary metastasectomies" "5-FU/OXP" "1–32+" "Metastasectomies"
    "cCR" "rechallenge" "Secondary metastasectomies" "peritonectomies" "dupl"
    "O/MM" "10/11" "5/12" "male/female" "significantly higher ORR" "BSC"
    "FOLFOXIRI" "BEV" "OXP" "FOLFOX4" "FOLFIRI" "re-challenged"
    "metastasectomies" "ORR" "pts" "MCRC" "p=0.007" "8/9" "RJ" "hMDMs" "pNL4-3"
    "VSV-G-pseudotyped" "‒2HA" "exog" "IE" "endog" "Stanley" "HIV-2/SIV" "j"
    "Hrecka" "Brownell" "Pertel" "deoxynucleotide" "Retroviruses"
    "uracil-N-glycosylase2" "miR-1-2" "Transwell" "CSL-2" "GCTGC" "GGGAA"
    "N3ICD" "kbp" "intestinal adenomas" "Min/+" "NOTCH1~4" "XXI (GSI)" "XXI"
    "-c" "Refseq" "-b" "Genbank" "Delta-like" "microRNA-1"
    "The tumor suppressor adenomatous polyposis coli (APC)" "Tumor/Normal"
    "= 0.88" "homeodomain" "TS234t" "aneuploid" "MEIS1D" "hemi" "*10" "= 228"
    "CIMP" "our previous dataset" "= 3" "= 2" "= 6" "= 0.0001" "= 5" "= 13"
    "log 2" "PROMO" "TFSEARCH" "ΔSB" "ΔCC" "ΔUEV" "-1518" "-1727" "Saos-2-2"
    "ESCRT-1" "PTAP" "conjugases" "ESCRT" "mortem" "dietary amines" "amines"
    "melatonin" "miR-142-5p" "miR-142-overexpressing" "clorgyline"
    "miR-142-expressing" "miR-142-" "miR-142-3p" "neuronal pathophysiology"
    "aryl hydrocarbon receptor nuclear translocator-like" "caudate" "SIVE"
    "HIVE" "monoamine" "n = 3" "fecal" "Chien" "cip/kip" "RSP7" "Thr180/Tyr182"
    "Thr183/Tyr185" "Thr202/Tyr204" "Ser217/221" "shRPS7" "sub-G1" "OVCA"
    "SKOV" "the pro-apoptotic proteins p21 waf1/cip1" "waf1/cip1" "shRPS"
    "realtime" "shGFP" "1 × 10" "P85α" "/sr" "DNR-" "co-administration" "DNR"
    "co-treatments" "= 37" "= 44" "= 0.0001" "= 9" "×2" "7 p" "S/G2-phase"
    "non-small" "aptamers" "blocker" "heteroduplexes" "G161-G168" "G217-G226"
    "gapmers" "7b" "A20-G44" "AUG2" "AUG1" "RNAStructure" "OligoWalk" "Codons"
    "Pb 2+" "RRL" "helixes" "U180" "ΔNp53utr-Luc" "HDV" "Renilla" "ΔNp53"
    "non-standard" "ΔG" "p21 WAF1" "Transducer" "Picetannol" "±6.3" "Scr"
    "C/EBPγ" "vs" "κB" "Kinases" "Gi" "Alzheimer’s" "synapses"
    "Human immunodeficiency virus-1" "Janex-1" "and 3B" "Anti-mouse" "adducts"
    "gene/pathway" "Pairwise" "non-transcribed" "non-synonymous" "RPPH1.1"
    "the bronchial epithelium" "non-zero" "RPKM" "nc" "dinucelotide" "Wilcoxon"
    "ds" "61x" "55x" "AGLCL"
    "two cancer-associated BRCA1 germline polymorphisms" "= 0.93"
    "a probable classical genetic subtype" "UAB" "Tanabe" "IKKα/β" "Withaferin"
    "Dox" "JAK1/2" "U251-TR/" "X1016"
    "receptor-associated JAK1 and JAK2 protein tyrosine kinases" "p65/"
    "comprehensive interaction datasets" "the shortest path network SpNet"
    "TAP/MS" "Parkin -linked parkinsonism" "1×10" "≤5" "PDGene" "ParkinGS"
    "orthologues" "1.5×10" "FunSimPD" "≤0.05" "_ND1" "≥0.7" "FunSimPDsub"
    "GOSlimPD" "GOComp" "P≤10" "1.2×10" "1.1×10" "1.6×10" "1.9×10"
    "processing/splicing" "Intron" "ConsensusPathDB"
    "particular Parkin -linked parkinsonism" "CalmodulinIP" "iMonogenicPD"
    "SpNet" "Rakeb" "Kufor" "subnetwork" "identifiers"
    "The previously reported Pink1TAP dataset" "Pink1TAP" "RelatedPD"
    "MonogenicPDIP" "ParkinIP" "MonogenicPD" "Cyto" "ParkinTAP"
    "fission/fusion" "melanogaster" "compacta" "monogenic parkinsonism"
    "depolarizaton" "7P" "1 of" "= 7" "= 6" "the Antithrombotic Trialists"
    "antiplatelet" "Trialists" "available study-level continuous covariates"
    "1.07–3.6" "categorical confounders" "1.44–3.89" "cases/controls"
    "rs20118426" "209/676" "588/878" "344/698" "353/595" "written" "English"
    "alpha 2b" "rs201184269" "relatedness" "cardio" "STATA" "rs1126643"
    "rs20417" "rs3842787" "P = 0.013" "= 5" "= 2" "epimers" "Hamid" "Hofland"
    "androsterone" "Chang" "androstanedione" "Hörnberg" "15/25" "AR-V567es"
    "es" "HN" "Vs" "= 8" "= 43" "P = 0.009" "P = 0.001" "= 0.49" "P = 0.008"
    "P = 0.007" "P = 0.03" "= 0.70" "= 0.011" "P = 0.004" "= 13" "= 51–75%"
    "= moderate" "= weak" "Conclusions/Significance" "Non-malignant" "n = 9"
    "Methodology/Principal" "H/H" "heterozygotes" "allotypes" "FcγRI" "FcγRII"
    "FcγRIII" "FcγR" "FISH-positive" "IIIA" "the secondary efficacy endpoints"
    "/week" "mg/m 2" "dyspnea" "a serious AE (SAE)" "hyperbilirubinemia" "AEs"
    "AE" "CTCAE" "TEAEs" "erythema" "at least 1 TEAE" "TEAE" "ECOG" "POC"
    "Lysis" "Celgene" "Fcγ" "Amgen" "v" "Clinicaltrials" "mg/day" "IIa"
    "multicenter" "F/F" "V/V" "28-day" "Daniels" "ARA70α" "Subset" "pBabe"
    "PKKKRKV" "immunohistochemistry (IHC)" "benign RC-165" "RC-170" "RC-165"
    "wildtype" "NLSTBLR1" "renilla" "NHRs" "NHR" "suppression/differentiation"
    "48 h" "Anti-FLAG" "co-repressor" "Hsieh" "rapalogs" "subpathway" "p-S6K1"
    "immunophenotype" "/day" "and 3D" "nephrectomy" "subpathways" "≤6"
    "p = 0.02" "p = 0.009" "= 0.005" "= 0.002" "p = 0.03" "mg/kg/day"
    "auto-inhibitory" "pairwise" "IGHV4-34-" "IGHV" "46x" "HiSeq" "Illumina"
    "IGHV4-34+" "pentostatin" "immunophenotypes" "HCLc" "non-silent" "=2" "n=3"
    "WU" "chao" "hong" "Zheng" "ZHOU" "feng" "XIE" "kang" "CpGplot"
    "Vogelstein" "Feinberg" "IIIa" "Hercules" "Bio" "6.42%±2.36%" "8.52%±2.55%"
    "3.84%±2.08%" "10.45%±5.51%" "6.00%±2.80%" "Francisco" "MethPrimer" "Qiu"
    "Wanglong" "Peng" "Liu" "Tanaka" "A1634C" "3/76" "Henan" "bisulfate"
    "P =0.013" "=0.015" "PI5Ks" "adenomatous polyposis coli (APC)" "coli (APC)"
    "coli" "HBECs" "HBEC3KT53" "Earle’s" "Earle" "HBEC3KTR" "HBEC" "KIFs"
    "1.5 x10" "CG/GG" "IQ" "had both the CG/GG genotypes" "re-sequencing"
    "particulate" "rs1858830" "=0.09" "=0.03" "SYBR" "CCTGTGGGC" "Consite"
    "E/R -positive" "E/R" "=11" "=12" "mean±s" "2 h" "48 h" "clinicaltrials"
    "=0.01" "endpoint" "proteosome" "fide" "bona" "co-immunoprecipitaion" "4/5"
    "Anti-Mouse" "K3A" "NEK" "LXXS" "lambda" "Zou" "BRCT5" "aBRAF"
    "deletion/mutation" "non-brainstem (45%) pediatric GGs" "pediatric GG"
    "Dahiya" "Schindler" "withBRAF" "nodular/aggregate" "=4" "piloid" "=3"
    "a 2+" "equivocalBRAF" "negativeBRAF" "7/7" "2+" "1+" "thatBRAF" "non-BRAF"
    "=6" "harboringBRAF" "7/13" "determineBRAF" "WhereBRAF" "delV" "insTGATG"
    "two further brainstem GGs" "chromatographs" "theBRAF" "Non-brainstem"
    "ratio=8.81" "ratio=8.1" "=0.0021" "=9" "pediatric non-brainstem GG"
    "forBRAF" "pediatric brainstem GG" "Younger" "14/31 pediatric GGs"
    "Koelsche" "Chappe" "47 pediatric GG" "ofBRAF" "Dougherty" "identifiedBRAF"
    "normal pediatric autopsy brainstem" "pediatric GGs"
    "The equivocal brainstem GGs" "finalBRAF" "harborBRAF" "VE1" "5/11"
    "non-brainstem" "13 (38%) pediatric GG" "definitiveBRAF"
    "Pediatric brainstem GGs" "pediatric brainstem GGs" "brainstem"
    "collective GGs" "Therapeutically-targetable BRAF c" "Brainstem" "GGs"
    "4/12" "p=0.038" "9/9" "=8" "Propargylglycine"
    "Hypoxia inducible factor 1α"
    "the chemotherapeutic agent buthionine sulphoximine" "sulphoximine"
    "buthionine" "-like-2" "2008/C13" "GPX-1" "GPX-2"
    "hypoxia inducible factor 1α" "Lo" "AFU" "ets" "repopulate" "Sx" "BV" "OTF"
    "KVL" "HV" "IVDWB" "AVN" "Nonobese" "re-localization" "P104A/P107A" "/F195"
    "its closest simian counterpart SIVsmm/SIVmac" "SIVsmm/SIVmac"
    "its simian precursor SIVcpz" "mitis" "Cercopithecus" "∆183" "∆153" "Ii"
    "P107A" "AxxA" "PxxA" "SIVmac239" "iso" "PBLs" "EHO" "non-transduced"
    "CD8β" "NA7" "SIVblu" "non-progressors" "PASM" "SIVsmm" "1 μg/mL" "A/P"
    "grade/stage" "colorectal adenomas" "GSE22050"
    "the relevant microarray datasets" "pTNM" "ONCOMINE"
    "only one independent mRNA dataset" "Siewert's" "Siewert" "GEJ"
    "P  = 0.031" "H-score  " "P  = 0.006" "= 113" "hypoxia-treated hESCs"
    "MycER" "c" "48h" "embryonal carcinoma cells 2102Ep" "2102Ep"
    "Transcriptome" "2h" "2 h" "mESCs" "HIFα" "SSEA-3" "hESC" "hESCs"
    "Non-essential" "Fricker" "mtPUMA" "approximately 7 hrs" "MCF-7/HER2"
    "IP/WB" "NME" "non-mitochondrial" "caspases 3/9" "H-Score" "H-Score "
    "H-Scores" "ug/mL" "Zymography" "photomicrographs" "= 0.005" "H&E"
    "P = 0.038" "Apak" "1-kb" "shRNA8/siRNA8" "CWR" "siRNA8" "siRNA7" "shRNA7"
    "shRNA8" "SGC" "-monophosphate" "monophosphate" "guanylyl" "suvivin"
    "sGCα1" "ZNF" "-G" "glomerulus" "capillaritis" "≤1" "tacrolimus"
    "retransplant" "Banff" "bolus" "allografts" "ABMRs" "C4d-positive"
    "antihuman" "allograft" "C4d-negative" "C4d" "resp" "glomerulitis" "AMR"
    "intragraft" "TCMR" "ABMR" "P = 0.013" "TGACNNNGC" "supershifts"
    "supershift" "CHR" "esponse" "∼3-fold" "hemoxigenase-1" "8-oxo-dGuo"
    "butylhydroquinone" "tricarbonyldichlororuthenium (CORM)" "CORM"
    "tricarbonyldichlororuthenium" "TPA" "μ g/ml" "0.5–1" "DLC27-14"
    "diphenylpyrazolodiazene" "Thomas" "Smithgall" "pharmacophore" "SYPRO"
    "diphenylpyrazolo" "Vina" "AutoDock" "M-group"
    "-4-chlorobenzenesulfonamide" "dihydrobenzo-1,4-dioxin-substituted"
    "Nef:Hck" "xxP" "Co-expression" "benzenesulfonamide" "diaminoquinoxaline"
    "heterocycles" "AIDS-like" "DQBS" "= 8" "= 7" "anti-Nef"
    "Co-immunoprecipitation" "W6/32" "= 0.05" "non-polar" "1–3" "NL4-3" "FS"
    "133/289" "HR+/ERBB2-" "a significantly better MFS" "MFS" "15/54" "10/43"
    "16/68" "ERBB2+" "HR+/ERBB2+" "ERBB2-" "174/454" "_330del" "_307del"
    "Cheung" "= 0.018" "p = 0.013" "1/50" "= 290" "ER +" "HR +" "= 0.014" "SWK"
    "KDL" "DKL" "andshort" "withthe" "althoughthis" "Xu" "≥ 45" "thatdetermine"
    "Koreans" "groupsofPTMC" "currentstudy"
    "no statistically significant correlationswith" "correlationswith" "N1a"
    "N1b" "combined Hashimoto’s" "non-progressive" "Hashimoto" "PTMC"
    "identifiedas" "postmortem" "an intronic polymorphism" "Silva" "follicles"
    "the maternal TA haplotype" "Pineda" "Rabet" "Derzbach" "Corbo"
    "extrauterine" "Xx" "xx" "XX" "Pp" "PpI" "pp" "IVF" "trimester" "ppxx"
    "rs9340799" "rs2234693" "XbaI" "PvuII" "= 0.09" "timeframe"
    "intraocular tissue rewarms" "rewarms" "vitrectomy" "TAATCC" "posthatch"
    "dedifferentiate" "glia" "Muller" "teleost" "teleosts" "Photoreceptors"
    "Otx" "the retinal pigment epithelium" "photoreceptors" "neuroectoderm"
    "Homeodomain" "non-PDGFs" "individuate" "photometry" "retinectomies" "μ g"
    "downmodulate" "FcεR" "TCR/CD4" "the membrane-associated Csk co-localized"
    "PF562271" "Wiemer" "3-to-10-fold" "TCRζ" "lysis" "timepoint" "anti-mouse"
    "2-to-3-fold" "soluble anti-TCR" "anti-TCR" "miR30" "TIRF" "hAPBTs"
    "re-phosphorylated" "re-associates" "microdomains (PAG)" "= 0.93" "= 0.025"
    "=0.025" "mean ± s" "U/mL" "Anti-human" "co-stimulatory" "C/EBP" "2–3 "
    "HPRT" "pre-treated 1 h" "SC514" "un" "FACScanto" "Si" "HAART" "MCMD"
    "nmol/mg" "hereconfirm" "methylransferases" "DZAari" "deazaadenosine (DZA)"
    "DZA" "deazaadenosine" "Jeong" "inhibitedNFκB" "phosphorylatesI"
    "re-synthesis" "inhibitedNFκB-mediated" "Ado+Hcy" "asA20" "expressNF"
    "asgalactosamine" "inhibitedNF" "protein A20" "toTNF" "partby" "―reflects"
    "SOS/10" "miniscule" "k  +8" "k  +7" "k  +4" "k  +3" "GEF-relevant"
    "GEF-mediated" "A146V" "A146T" "k  +6" "Ras•GTP" "•GTP" "guanyl" "Harvey"
    "Costello" "~20%" "ZKX" "WZW" "XFZ" "newest" "EORTC" "the Begg’s" "Jadad"
    "Ottawa" "Newcastle" "CD117-positive" "KIT-positive" "1-3"
    "Hardy-Zuc-kermann" "p=0.001" "p =0.001" "dihydrochalcone" "Eriocitrin"
    "ericotrin" "hydroxyphloretin" "hesperitin" "eriocitrin" "aglycones"
    "aglycone" "co-regulator" "Cylopia" "Powell" "angolensin" "cosmosiin"
    "ERα/β" "co-regulators" "displayed only weak agonism" "SERSMs" "lasoxifene"
    "BW" "uteri" "COS-1" "MCF-7BUS" "9.8 μg/ml" "μg/ml" "x"
    "an estrogenic polyphenol" "coumestan" "lignin" "Agonism" "re-evaluating"
    "polyphenols" "vicenin-2" "-β-glucoside" "phloretin-3,5-di-C-glucoside"
    "DME" "iriflophenone" "dihydrochalcones" "eriocitin" "antagonise"
    "Mfenyana" "Verhoog" "DMEs" "honeybush" "Fabaceae"
    "methyl-piperidino-pyrazole (MPP)" "MF101" "liqueritigenin" "SERSM"
    "organ/tissue" "HRT" "progestins" "SM6Met" "agonism" "Honeybush" "fynbos"
    "Cyclopia" "non-genomic" "co-repressors" "non-essential" "SIRT1 promoted"
    "sirtuins" "ug/ml" "markedly shorter PFS" "Sirtuin" "NSLCLC" "PFS" "=7"
    "non-responder" "the Egger’s" "Mansfield" "DK" "Nagi" "Cosmo" "co-dominant"
    "the modified Begg’s" "diabetic nephropathy (DN)" "mellitus (DM)"
    "insertion/deletion" "4G/5G" "1.152-2.102" "Hofmann" "≥1" "lnHR"
    "1.622–2.748" "=2.112" "analyser" "≥5%" "H-score" "=none" "dichotomise"
    "SISH" "situ" "flowchart" "HRs" "=0.007" "0–3" "95%CIs" "I 2" "miR-146a"
    "miltenyi" "co-localizing" "SDF-1α" "only 24 hrs" "hrs" "re-introduction"
    "lenti" "TGF-β1 PMO" "TGF-β1PMO" "survival/stress" "plasmonigen"
    "oligo (PMO)" "morpholino" "phosphorodiamidate" "non-diabetic" "cells/ml"
    "cells/ well" "co-localization" "~19%" "p=0.05" "Genotype" "ER+/PR+"
    "ER-PR-" "=1.27" "=1.03-1.57" "QTL" "rs1820453" "= 0.024" "P =0.004"
    "=1.19" "P = 0.009" "95 % CI" "RSCU" "Aquitaine" "TKD" "haematology"
    "SNPstats" "C/T" "C/C" "heterozygous C/T genotype"
    "homozygous T/T genotype" "homozygous C/C genotype" "electrophoregrams"
    "This synonymous SNP" "polymorphism (SNP)" "mesylate" "Sokal" "French"
    "= 0.002" "p = 0.006" "= 0.024" "difficile" "Drf" "mevalonate" "RhoGTPases"
    "photomicrography" "flowcytometry" "FIGO" "Obstetrique" "Gynecologie"
    "Internationale" "+++" "around 100-times" "presence/occurrence" "Sampson"
    "the mutated epitope T790M-5" "*0207" "*0206" "*0205" "*0204" "*0203"
    "*0202" "supertype" "crossreact" "*1101" "T790M − cell" "PC9/ZD" "Cr"
    "ELISPOT" "IMQLMPFGCLL" "BIMAS" "NetMHC" "HLA-A*0201" "immunotherapies"
    "delE746-A750" "HLA-A2" "T790M-5-" "T790M-5" "*0201" "LIMQLMPFGCL"
    "MQLMPFGCLL" "Hong" "Dong" "|iHS" "Wilke" "Escara" "brethren" "rs11773818"
    "rs984654" "rs17172438" "rs11238349" "GenCord" "Geneva" "MuTHER"
    "HapMapIII" "JPT" "rs17172432" "|iHs" "YRI" "CEU" "Haplotter" "eQTL" "GWA"
    "Milone" "Zarnestra" "Caraglia" "eQTLs" "HapMap" "ChinaPCa" "17q12"
    "lobular histology" "NS+E2∶12.733±0.521×10" "NS+E2∶2.333±0.023×10"
    "NS+E2∶1.733±0.037×10" "siNgBR" "Origene" "ISV" "morpholinos" "NogoB"
    "AmNogo" "microdomains" "axon" "IDC" "the ductal subtype"
    "The ductal and lobular subtype" "PR-positive" "re-evaluated" "A/B"
    "ER-positive" "Dulxanthone" "dulxanthone" "cowa" "Garcinia" "PFT-α"
    "Erithacus" "GRAFIT" "hydatidiform" "anti-hypertension" "grossedentata"
    "Ampelopsin" "co-treatment" "DHM" "Dihydromyricetin" "flavonoids"
    "cells/mL" "U/ml" "T/T" "Polymorphisms" "chromatid" "genotypes/alleles"
    "G/T" "KC/FECD" "keratoplasty" "2.5–3 " "solute" "called corneal guttae"
    "guttae" "Descemet" "Fuchs" "VSX1" "Leber's" "imperfecta" "Danlos" "Ehlers"
    "Leber" "G/G" "3p" "relapsed or refractory indolent non-Hodgkin’s"
    "relapsed or refractory indolent non-Hodgkin" "PX-866" "p85α" "endometrium"
    "botrocetin" "vasospasms" "αB-crystallin" "HSPH" "HSPB" "five-year" "Deng"
    "Egger's" "GA" "heterozygote" "GG" "homozygote" "Catarino" "Taiwan" "DHPLC"
    "RFLP" "Barr" "Epstein" "= 0.497" "= 0.538" "P = 0.001" "= 0.968" "= 0.011"
    "= 0.007" "mg/kg (MTD)" "Ki67-positive" "PancT6" "PancT4" "non-responsive"
    "A-independent" "pS194" "HPNE" "pT288" "thymidine/nocodazole" "desmoplasia"
    "kinas (AAK)" "AAK" "kinases" "kinas" "non-Hodgkin" "non-transformed"
    "DDR8/Drosha" "Suzuki" "miR-130b" "ΔNp63" "enhancers" "pri" "motile"
    "organelles" "phalloindin" "MAPKAP" "midsections" "broader" "and β 1"
    "Alexa"
    "Arachidonic acid-treated cells generated dramatically increased impedance"
    "electric cell-substrate impedance" "co-staining" "cells / ml" "anti-human"
    "β 1" "α 2 β 1" "γ-H2Ax" "topoisomerases" "SNVs" "SNV" "BRCA1/2"
    "X-ray irradiation-induced DNA DSBs"
    "Sustained X-ray irradiation-induced DSBs" "AZD2281 was" "tetraploid"
    "Chemoradiotherapy" "EMR" "FERM" "leukemia/lymphoma" "notaby" "IL-2Rγ"
    "neural cells suceeds" "suceeds" "IL-2Rα" "re-programming" "treshhold"
    "Sudhl-1" "non-neural" "ALK+TCL" "nucleophosphmin" "posttransplant"
    "the memory B cell subset" "γc/JAK3" "inasmuch" "the memory cell subset"
    "∼20%" "Co-incident" "the residual subset" "antitetanus"
    "∼5,000 sorted B cells/well" "Ig-switched memory B cell subsets"
    "Approximately ∼90%" "IL21R" "isotypes" "reexposure"
    "memory B cells recirculate" "recirculate" "Ags" "Ag" "IgA" "antigens"
    "anti–human" "∼25%" "∼95%" "9/10" "IRIFs" "H4K20" "X-independent"
    "typically 1–4 h" "FUCCI" "antistripes" "H4K5" "I-PpoI–induced DSBs" "pH2A"
    "crossovers" "NuRD" "IRIF" "γH2A" "MRN" "#2" "Rad3" "H3K9" "H3K56" "S/G2"
    "SPSS" "Nikon" "-Diaminobenzidine (DAB)" "-Diaminobenzidine"
    "Diaminobenzidine" "Burlingame" "Robles" "Paso" "shaken" "Inc" "Cruz"
    "nonfat" "TBST" "Tween" "difluoride" "polyvinylidene" "Rockford" "BCA"
    "Bioproducts" "Boston" "RIPA" "Hialeah" "Ltd" "annexinAnnexin" "μg/mL"
    "Petri" "titer" "SinoGenoMax" "pAdxsi" "CeuI" "cosmid" "pShuttle-GFP-CMV-"
    "pGEM-T-" "medium Dulbecco’s" "mg/L" "Carlsbad" "ScienCell" "ECGS"
    "Gaithersburg" "Gibco" "DMEM" "Dulbecco" "nanofiber" "Adv-GFP- Bcl-xl"
    "Shibata" "anti-oxidative" "re-endothelization" "chemoattractants"
    "chemoattractant" "Adv" "exposer" "Kit-8" "Adv-GFP-" "Annexin V/propidium"
    "fusiform" "pAdxsi-GFP-" "procoagulant" "endarterectomy" "xl" "p38TM"
    "expressionp38TM" "p38WT" "retro" "pEGFR" "HNSCCs" "Nu/Nu" "p38 MAPKs"
    "MHS2" "Meyer" "Kaplan" "bivariate" "No clinicopathologic covariates"
    "2p22" "Wallis" "Bivariate" "Brazil" "Gerais" "Minas" "Claros" "HNSSC"
    "Montes" "=0.002" "=0.024" "=17" "shorter on-times" "longer SMAD4 on-times"
    "on-times" "on-time" "TIRFM" "TGFBRII" "AAV8" "e" "co-occupancy" "H3K18Ac"
    "reestablish" "monosomes" "polysome-to-monosome" "ACGT" "VLDL" "leaner"
    "paler" "Sirtuins" "Houtkooper" "Gillum" "NAFLD" "Co-immunoprecipitations"
    "/NADH" "C57BL6" "AMPKα2" "Ex " "arcuate" "nonexercise" "penetrant"
    "dimethylbiguanide" "A373T" "within/close to" "nigricans" "priori"
    "thyroxine" "RMSSD" "a portable digital accelerometer" "accelerometer"
    "melanocortin" "BMR" "libitum" "dual energy X-ray absorptiometry (DEXA)"
    "absorptiometry (DEXA)" "DEXA" "absorptiometry" "kg/m 2" "probands"
    "L822Pfsx26" "Y569X " "Y569X" "V511Cfsx29" "_950" "_921" "cosegregate"
    "45/2,101" "overweight/obese" "ELY" "GOOS" "hyperphagia" "C57BL/6J"
    "anti-FLAG" "insertion/deletions" "ob/ob" "= 44" "wider ERBB2 amplicons"
    "lifespans" "Germline" "Fraumeni" "a separate amplicon" "backcrosses"
    "backcross" "NdeI" "oxodGuo" "hydroxydeoxyguanosine" "heatmap" "PI5P4Kα/β"
    "PI5P4K α/β" "gain/amplification" "mutation/deletion" "amplicons"
    "nonsmall" "Mutation/Deletion" "PI-4,5-P" "PI5P4Kβ" "PI5P 4-kinase
activity"
    "PI5P4K" "PI4P5Ks" "protooncogene" "PI5P4Ks" "PI5P4Kα" "p38MAPK" "g/ml"
    "p38 MAPK" "-Positive" "P5Ks" "histoarrays" "Preligand" "Kriegl" "TRAIL-2"
    "G1/2" "≥2.8" "OLT" "lymphoma-2" "non-apoptotic" "Ullenhag" "PLAD"
    "preligand" "hepatectomy" "= 0.078" "≥7" "≥10" "p = 0.001" "= 0.002"
    "p = 0.004" "pCDNA3.1" "re-stimulation" "GW843682" "Pam3CSK4-"
    "Pam3CSK4-Induced" "Pam3CSK4" "Pam3CSK4-induced" "12 h" "non-small-cell"
    "Toll-like" "FIPI" "type Iα" "SOS" "length/width" "Sabatini" "Peterson"
    "dioctanoyl" "LP-2" "Seip" "Berardinelli" "LPLAT" "choline" "diacyl"
    "non-targeting" "non-bronchioid" "multicohort" "5q34-q35.3" "classifier"
    "centroid" "≥II" "ploidy" "8p12" "12q14-q15" "p=0.004" "Hochberg" "21q"
    "6q16.3-q21" "12p12.1" "7p11.2" "1p34.2" "9p" "8p" "7q11.21" "1p" "16p"
    "7p" "aCGH" "squamoid" "magnoid" "Bronchioid" "Hayes" "bronchioid"
    "EGFRwt/KRASwt" "a comprehensive overview" "overview" "~60%" "≤10" "=0.05"
    "=0.02" "=0.004" "=62" "Shih" "Kouso" "Vogelsang" "Xinarianos" "=0.013"
    "=0.006" "=0.030" "p=0.031" "=0.008" "=0.056" "=0.009" "=0.031" "Xie"
    "Zhang" "1.50–2.84" "= 1.09–3.47" "1.31–2.04" "SSBR" "Tweedie" "Duval"
    "Roszak" "Kelsey" "cardia" "1.02–2.33" "1.02–2.00" "Africans" "= 1.06–1.84"
    "Polymorphism" "non-smokers" "h  " "1.04–1.14" "1.03–1.13" "= 1.01–1.07"
    "XRCC" "DSBR" "the covariates responsible" "Indians" "G0/G1 phases"
    "= 0.008" "= 0.86" "= 0.97" "= 62" "= 21" "= 0.78" "= 57" "I  2  " "I  2"
    "95% CIs" "= 1.09" "= 1.06" "OR = 1.09" "95% CI " "= 1.08" "= 1.01" "=0.49"
    "0.85-1.40" "=1.09" "Ahnen" "=0.66" "0.82-1.36" "=1.06" "=0.97" "0.73-1.38"
    "=1.01" "2-year" "Kirsten" "Clinicians" "3-year" "dbSNP" "rs25487"
    "19q13.2–13.3" "Egger’s" "Begg’s" "Begg" "Egger" "ORs" "≥0.05"
    "Gln/Gln+Arg/Gln" "Shen" "LIGIII" "CNKI" "Elsevier"
    "X-ray repair cross-complementary group 1 ( XRCC1 ) Arg399Gln polymorphisms"
    "HNSCC" "HPV-positive" "95% CI" "= 0.36" "Samani" "erosions" "serotype"
    "anti-CCP-positive" "=0.014" "confounder" "Framingham" "ANCOVA" "=0.0094"
    "the other CV events subtypes" "=0.038" "=0.36" "anti-cyclic" "=0.27"
    "=0.93" "=0.56" "=0.88" "=0.31" "95%CI" "dyslipidemia" "mellitus" "HWE"
    "Weinberg" "ultrasonography (US)" "Spanish" "ultrasonography"
    "cardiovascular sequelae" "sequelae" "proinflammatory Th17" "Smads"
    "Wellcome" "rs17228212" "cIMT" "carotid" "CV" "anti-rheumatic"
    "co-activators" "diabetic nephropathy" "nephropathy" "p-ERK1/2" "p- ERK1/2"
    "pcDNA" "EMT-like" "related-1" "related-2" "Bonferroni" "GOLDN" "Greater"
    "rs780094" "GRS" "Qi" "only two significant SNPs"
    "the most significant GxE" "1.0E-5" "the QQ-plots" "QQ-plots" "QQ" "GWAF"
    "HOMA" "covariates" "BMI" "confounders" "polymorphisms (SNP)" "Hindorff"
    "T2D" "more significant SNPs" "HOMA-β-cell-function" "GxE" "= 0.001"
    "= 0.112" "non-significant" "Kim" "droplets" "Thoreen" "Sarbassov" "Mounir"
    "cerevisiae" "Kubota" "non-phosphorylatable" "Gy" "FRB"
    "stress-induced transcriptome" "Rallison" "Wolcott" "CReP" "A/A" "S/S"
    "CreP" "·tRNA" "the inactive eIF2·GDP" "·GDP" "Rapalogues" "stents"
    "rapalogues" "non-irradiated" "CD 44+" "non-enzymatic" "non-homologous"
    "GSK464361" "IENS" "sensitises" "CB11171" "PBECs" "PBEC" "BBB"
    "immunocytochemistry" "Kinexus" "CENP" "a cell-permeable indenopyrazole"
    "indenopyrazole" "PubChem" "neural/mesenchymal" "Johnstone" "CB660" "pHH3"
    "undergone" "Immunocytochemistry" "cells/debris" "PCA" "CellProfiler"
    "endpoints" "Millipore" "InhibitorSelect" "Verhaak" "‘neurospheres’"
    "neurospheres" "at least three major subclasses" "subclasses"
    "focal amplifications/deletions" "J101" "JNJ-10198409" "JNJ" "co-culture"
    "IC50 " "Friuli" "non-missense" "Marche" "Tuscany" "histotype" "ID17"
    "ID 17" ".48+7C" "IVS1" "German" "England" "41-year-old" "intronic IVS4"
    "a healthy 41-year-old Japanese" "Finnish" "endoscopy" "Maori" "FoldX"
    "Guilford" "BD" "EC4" "EC3" "extradomain" "protomers" "PolyPhen-2" "SIFT"
    "Seattle" "NIEHS" "RefSNP" "intestinal metaplasia/dysplasia" "gastroscopy"
    "gastroenterology" "IGCLC" "AMAG" "the intestinal subtype" "Lauren" "EOGC"
    "A592T" "1937-13T" "intronic IVS12" "IVS12" "protein 3D" "A298T"
    "the intronic IVS12" "IVS" "BDs" "AMAGs" "= 20" "non-functional" "ID 8"
    "transducers" "glutamylcysteine" "hypoxia inducible factor 1a" "Goven"
    "donovani" "factor-2" "Kong" "activity/lifespan" "gondii" "albicans"
    "pneumophila" "eosinophils" "buccal mucosa" "gingiva" "epithelioid" "Latin"
    "Paracoccidioides" "acetylation/deacetylation" "auto-reactive" "cell/DNA"
    "Whitney" "STAT5Ptyr/CD14+" "hr" "Intra" "Non-autoimmune" "non-autoimmune"
    "anti-STAT5Ptyr" "dimerized phosphorylated STAT5A/B" "nonobese"
    "immunopathology" "STAT6Ptyr" "STAT5Ptyr’s" "STAT5Ptyr" "T1D" "STAT5A/B"
    "Ålgars" "Ozaki" "Yasuda" "Fernebro" "biopsies-" "Spano" "Giralt" "TATI−"
    "TATI+" "EGFR+" "cytoplasma" "ErbB" "Finland" "EGFR+/TATI+" "trypsinogen"
    "p = 0.001" "Five-year" "= 0.009" "node-positive" "HJ" "Yen1" "resolvases"
    "MUS81 specifically targets D-loops" "almost all the DSBs"
    "a diagnostic readout" "CldU" "CldU/IdU" "RFI" "D-loops" "co-depletion"
    "oligo" "HU" "siCtrl" "D-loop" "Werner" "nicked Holliday's" "HJs"
    "Holliday" "anti-His" "+4" "Lepik" "Sakakibara" "Reison" "16 E6"
    "an extrachromosomal replicon" "HFKS" "Nicolaides" "Δ140–151" "Kiyono"
    "HFKs" "extrachromosomal replicons" "replicons" "parental NIKS" "16E6's"
    "p53DD" "E6 SAT" "Adichie" "Sen" "E6 WT" "Δ146–151" "E6I128T" "16E6WT"
    "E6SAT" "E6*II" "E6*I" "*II" "*I" "DpnI" "BamHI" "E6WT" "E6STOP" "31 E6"
    "p53WT" "NIKS" "16E6" "YYH" "∧ E4" "BPV1" "∧E4" "ori"
    "a multi-copy extrachromosomal replicon" "replicon"
    "the stratified squamous epithelia" "epithelia" "extrachromosomal genomes"
    "co-localizes" "non-enveloped" "homologies" "co-injected" "mitotic NEBD"
    "∼50%" "significantly accelerated PV-mediated NEBD" "cdk-1/2" "rarer"
    "5 fold" "ΔVP2" "ΔVP1" "AAV2-" "and β" "co-precipitation" "FXFG" "Nup"
    "the characteristic pH" "PVs" "AAV2" "5fold" "CsCl" "co-sedimenting"
    "non-infected" "depolymerise" "laevis" "MVM" "capsids" "at least AAV2"
    "VP1u" "AAV" "dependo" "isoenzymes" "hyper" "increased perinuclear Ca ++"
    "NEBD" "disassembles" "ONM" "bilayer" "karyoplasm" "FxFG" "Nups" "cargos"
    "amphipathic helices" "lamina" "non-dividing" "++" "oocytes" "kilobases"
    "nonconsensus" "C57Bl/6" "Genomatix" "pPON" "AhR-" "AhR" "3MC-"
    "transcriptional activator/cofactor" "Gouédard" "DMBA-DHD-" "Matikainen"
    "C57BL/6" "DMBADHD" "and 3MC" "3MC" "invariant" "co-workers"
    "anthracene-3,4-dihydrodiol" "SAhRMs" "2,3,7,8-tetrachlorodibenzo-p-dioxin"
    "benzo" "DRE-like" "unique DRE-like" "AhRs" "DRE" "DREs" "non-denaturing"
    "structure/function" "spatio" "Cunningham" "FlnAs" "FlnB" "dCI/d" "dCI/dt"
    "CI/min" "E-plate" "impedance" "Rothekin" "coverslips" "HT1080" "XMVD"
    "myxomatous valvular dystopohy" "periventricular heterotopy (PVH)"
    "dystopohy" "OPD" "Melnick" "PVH" "heterotopy" "mechano"
    "immunoglobulin-like" "RhoA/ROCK" "mesenchymal-like" "atiprimod"
    "azaspirane" "Atiprimod" "fungoides" "Nielsen" "Hodgkins" "Ni" "-monoxime"
    "monoxime" "OdHL" "OdDHL" "Acyl" "lactones" "CPDHC" "Weidler" "NCI"
    "Deoxytetrangomycin" "Cruciferae" "flavonoid" "Kotha" "-trihydroxystilbene"
    "trihydroxystilbene" "Hodgkin's" "Hodgkin" "immunosuppressors" "Debidda"
    "Saimiri" "Turkson" "extravasate" "LXXLL" "PIASxb" "PIASxa"
    "protein phosphatase 2A" "Irie" "phosphatase 1B" "nontransmembrane"
    "VHCSXGXGR" "UV" "catalyse" "carboxyl" "Lk" "T-helper" "intrachain"
    "aggregation/dysfunction" "·Htt" "DNAJB" "Htt TC9 -Cerulean revealed ∼0.5%"
    "∼0.5%" "triage" "rpm" "Sephacryl" "hsp40·hsp70" "IRES" "·hsp70" "25Gln"
    "ni" "SYTOX−" "SYTOX" "mKate" "46Gln" "C-terminally"
    "a second membrane-associated red fluorescent protein mKate2" "mKate2"
    "pTIREX" "workflow" "cytometer" "PulSA" "readouts" "cyan" "TC9"
    "tetracysteine (TC)" "tetracysteine" "PolyQ" "polyQ" "Huntington"
    "toolkits" "Juxta" "soluble Httex1" "overstretches" "Httex1" "toolkit"
    "characterises" "=20" "#7" "head/neck" "#1" "mutation-positive" "∼6–30%"
    "MDDC" "-SAR" "SAR" "Cs" "phenocopy" "non-immunosuppressive" "Sendai"
    "cGAMP" "hypothesise" "P90A" "CPSF6ΔNLS" "ΔNLS" "PF74" "PF-3450074"
    "type-1" "type -1" "higher dose viral inocula" "inocula" "capsid (CA)"
    "capsid" "an essential responder" "responder" "ΔCC2" "ΔRb" "domains/motifs"
    "Rb" "transcriptional repression/activation" "G 1 /S" "Carlo" "Monte"
    "APC/cdh1" "pCMV" "UbKO" "timepoints" "Patrick" "CDK6NFG" "CDK6D224Y"
    "CDK6WT" "osteoblasts" "20 h" "co-transfected" "non-redundant" "Nakanishi"
    "circular dichroism (CD)" "pS392" "Ac-K382" "undergoes" "tBRCT" "ation"
    "Habashy" "Univariate" "Korea" "= 0.007" "non-tumorous"
    "three dopaminergic gene polymorphisms" "multilocus" "genes/polymorphisms"
    "minimise" "Dinsdale" "Vaillancourt" "Hurd" "+10" "subscales" "Buss"
    "racial/ethnic" "homozygotes" "A1/A1" "A1/A2" "10/10" "Tanzania" "Hadza"
    "2D:4D" "microsatellite" "utero" "Datoga" "Kapteins" "Vinkemeier"
    "coworkers" "Kaptein" "Nakajima" "non-induced" "STAT3-YF-ΔN -YFP"
    "STAT3-ΔN-YFP" "STAT3-YF-ΔN-YFP" "ΔN" "non-stimulated" "HEKgp80" "sIL-6Rα"
    "STAT3-YF-YFP" "Dominant-negative STAT3-YF-YFP" "STAT3-YF-" "eosinophilia"
    "STAT3β" "ΔN-YFP" "ERα/ERβ-positive" "Honma" "ERβ-positive" "reChIP"
    "AP-1-like" "EREs" "co-regulated" "Leygue" "KB101471" "seq" "NFY"
    "co-localize" "hetero-" "hetero" "aneuploidy" "ERα-positive" "poorer" "XH"
    "CCZ" "JZ" "XC" "β1" "HOpic" "bpV" "AE9a" "pml" "deeper" "shRNA3" "NAML"
    "RCHACV" "h" "αv" "α5" "AML1-ETO9a" "anti-apoptotic" "CD3 +" "WJ" "Ellis"
    "Elston" "Richardson" "ImmunoHistoChemistry" "Non-homologous" "non-mutated"
    "PARPi" "135 Bulgarian HR-positive" "Krasteva" "Veek" "nPARP-1" "Rojo"
    "neoadjuvant" "nPARP" "cPARP" "Minckwitz" "53BP1/" "offs" "N1+" "non-TN"
    "U/mg" "pg/mgP" "HER2-positive" "HR-positive" "mitoses" "pleomorphism"
    "tubule" "-positive" "monotherapy" "DSBs" "DSB" "clinico" "ribose"
    "diphosphate" "auto-" "= 0.009" "= 0.048" "= 0.022" "= 0.007" "+ 3" "μg"
    "= 57" "basal-like" "myocytes" "Stat3C" "Luc" "Interlukin-6" "Interlukin"
    "mNeuNT" "PTP1E" "μ L " "mg/mL" "IU/" "Fe" "Cu" "Zn" "Weinhouse"
    "epiphenomenon" "Warburg" "Non-radiolabeled" "carbonylcyanide" "stemness"
    "poorest" "I-metaiodobenzylguanidine (MIBG)" "EFN" "MIBG"
    "recent re-emerged" "synergism" "E746-A750+T790M" "BIBW" "Davis" "Kd"
    "unmet" "BindingDB" "ARHG5" "MK12" "PC9GR" "co-chaperone" "P55G" "P85B"
    "PK3CA" "CellTiter" "DAVID" "ERFFI" "a coherent interactome" "HPRD"
    "BioGrid" "the Pearson's" "nano" "TAP-MS" "a larger interactome" "UBS3B"
    "AALE" "LC-MS/MS" "HS90B" "HS90A" "pulldown" "pulldowns" "Strep-HA-tagged"
    "retroviruses" "subnetworks" "Interactomes" "interactomes" "gatekeeper"
    "non-phosphorylated" "anti-phosphotyrosine" "co-purified" "H7N7-"
    "the colonic mucosa" "immune/inflammatory response" "I:C" "BALB/c"
    "a human pathogenic H5N1" "Y701F/S727A" "luc" "ISRE" "Supernatants"
    "-triphosphate" "p38β" "ISG" "ISGs" "viral titers" "Darby" "Madin"
    "Nencioni" "Viemann" "FPV-" "H7N7 (FPV)" "FPV" "KAN-1" "H7N7" "Alzheimer"
    "Hui" "neuro-" "neuro" "multiorgan" "H5N1" "reduced viral titers" "titers"
    "This cell-intrinsic hypercytokinemia" "hypercytokinemia" "HPAIV" "∼70%"
    "Krisko" "DKO" "SIVcpz" "SHIVs" "SIVmac" "Haplotype" "-GA-to-AA"
    "multimers" "McDougall" "A3G's" "the transfected cells expressed A3G" "dU"
    "Non-editing" "reassociates" "Perhaps" "cPPT" "GA-to-AA" "-CU" "CU" "-CCU"
    "CCU" "retrovirus" "A3B" "anti-HIV-1" "dsDNA" "RUNX" "non-viral" "YXXL"
    "haplotype" "YRHHY" "Russell" "SIVagm" "SEMQ" "SERQ" "HX" "SLQYLA" "A3H"
    "co-crystal" "iii" "ii" "A3G-2K3A" "α4" "quintuple" "EVVKHHSPVS" "RLYYFWD"
    "EFLARH" "A3DE" "β3-strand" "polynucleotide" "A3F" "A3C" "A3G"
    "non-editing" "codons" "deoxyuridines" "deoxycytidines" "ssDNA"
    "the viral genome" "haplotypes" "APOBEC3" "Anti-HIV" "YQ" "QS" "SZ"
    "the Spearman's" "Spearman" "radioresistance" "non-responders" "responders"
    "Multivariate" "chemoradiotherapy" "coverglass" "Fackler" "Kaminchik"
    "Baur" "Fujii" "cocultures" "lα" "CD3/TCR" "Vavl" "multiprotein"
    "R105/R106" "Renkema" "Haller" "microclusters" "Abraham" "Rudolph"
    "Bandres" "TCR/CD3C chain" "Schrager" "Yoon" "Collette" "Witte"
    "hyperinduces" "NFATl" "Thoulouze" "myristate" "latent proviral genomes"
    "synapse" "begun" "proviral genomes" "viral progeny" "semi" "Antigen"
    "progeny" "viremia" "cell growth/survival" "Bruce Spiegelman's"
    "Spiegelman" "1-β-D-ribo-furanoside (AICAR)" "F-fluorodeoxyglucose"
    "fluorodeoxyglucose" "Oncomine" "growth/survival" "CRPC" "stepwise" "pM"
    "OXPHOS" "at least ∼1.5" "succinate" "Massie" "ECAR" "Gleason"
    "prostatectomy" "0-3"
    "subsequent threonine-172 (refers to threonine-183/172 of the AMPKα 1/AMPKα2 isoforms, respectively) phosphorylation/activation"
    "phosphorylation/activation" "cells/well" "orthologs" "hsCks2" "suc1"
    "ortholog" "Skp2-Skp1-Cullin" "phosp27" "hsCks1" "a smaller subset"
    "phosphosites" "PhosphoGRID" "ORFS" "XTP" "CEN" "°C" "P5K" "T7A" "Sic1ΔC"
    "phosphodegrons" "circular dichroism" "+3" "hydroxyl" "Waals" "der"
    "phosSic1ΔC" "ΔC" "PhosSic1" "phosSic1" "sidechain" "+1" "+2" "SAIPI"
    "AIPI" "IPIpTPTK" "AIPIpTPT" "entropy" "phosphothreonines" "phosCdc"
    "phosCdc6" "isothermal titration calorimetry (ITC)" "calorimetry (ITC)"
    "ITC" "immuno" "anions" "switch-like" "Multisite" "multisite" "S/T"
    "SERMs/SERDs" "newer" "LBDs" "co-activator" "co-occurred" "5/44" "9/36"
    "exomes" "RMSD" "agonist/antagonist" "mg/ml" "sublines" "coregulators"
    "Coregulators" "XBP" "HA" "BOLERO-2" "function-2" "~500X" "WBCs" "MSKCC"
    "ER+" "degraders (SERD)" "degraders" "tumor/normal" "pcDNA 3.1" "datasets"
    "SNPs" "~95%" "diploid" "log2" "~78%" "bi" "frameshifts" "Banck" "=0.048"
    "0.77/Mb" "SSNV" "algorithm" "MuTect" "SSNVs" "Neuroendocrine"
    "neuroendocrine" "diethylstibesterol"
    "80 triple-negative breast carcinoma transcriptomes" "transcriptomes"
    "MO_1051" "timelines" "_1185" "_1167" "_1129" "_1069" "MO_1031" "_1051"
    "_1031" "frameshift" "indels" "biopsy" "Michigan" "ONCOSEQ" "IRB"
    "histologies" "Oncology" "oncology" "Shulman" "hyperinsulinemia" "SirBACO"
    "BAT" "indirect calorimetry" "calorimetry" "VCO" "ΔN17"
    "autocrine/paracrine" "CPT1α" "readout" "hepatoctyes" "+117"
    "the sterol regulatory element binding protein-1c" "hydroxybutyrate"
    "palmitoyl" "carnitine" "~40%" "genotypes" "~2-fold" "fat-like"
    "hepatokine" "polyphenol" "a brown fat-like" "LKO" "littermates" "SIRT"
    "presenilin-associated rhomboid-like" "rhomboid-like" "/Ca 2 +" "Hoechst"
    "trifluoromethoxyphenylhydrazone" "oxyethylenenitrilo"
    "chlorophenylhydrazone" "FBJ murine osteosarcoma viral oncogene homolog"
    "acetoxymethyl" "aminophenoxy" "at least 24 h" "Lipofectamine" "L-type"
    "blockers" "nifedipine" "the ratiometric indicator Fura-2" "Fura-2"
    "autophagosome/lysosome" "andautophagy" "co-localized" "Mander" "uncoupler"
    "intensity/cell" "TMRM" "VDCCs" "N-type" "NCXmito" "FBJ" "mitofusins"
    "organelle" "uncouplers" "Δψm" "vacuoles"
    "carbobenzoxyl-leucyl-leucyl-leucinal" "1-methyl-4-phenyl-1" "ΔN-PINK1"
    "bradykinesia" "chlorophelyhydrazone" "carbonyl" "± 1.0 " "12 h" "± 3.1"
    "× 10" "FcεRI" "48/80" "peritoneum" "tagogue" "secre" "Shea" "Tharp" "ex"
    "wheal" "antigen" "Fc" "ImmunoCAP" "anti-progestin" "progestin" "PRE" "ERE"
    "withdrawn" "MCF-7:2A" "re-grew" "cobblestone-like"
    "an important transducer" "transducer" "re-transplantation" "antihormone"
    "MCF-7:PF" "IGF-1Rβ" "MCF-7:5C" "TL" "GL" "ACB" "KZ" "CL" "QW" "Karolinska"
    "non-small cell lung carcinoma" "I/II" "IMC" "NVP" "nu/nu" "necropsy"
    "bocks" "figitumuab" "mt" "COLO-320" "COLO" "IGR-1R" "paracrine" "IGF-I/II"
    "cyclolignan" "YHS" "Ser235/236" "β4" "MDA-MB-435/β4"
    "non-receptor tyrosine kinase" "GpppN" "α6β4" "YZ" "JW" "YM" "XinX" "LX"
    "XZ" "ZH" "XiaX" "promots" "co-transfection" "MicroRNA-124-3p" "ie"
    "reuglates" "pTarget" "siROCK1" "pmirGLO" "oligos" "Targetscan" "-UTR"
    "the representative micrographs" "micrographs" "sapiens" "Caenorhabditis"
    "nonmuscle" "J82" "RT--PCR" "transwell" "quantitative RT--PCR" "miR-124-3p"
    "Non-tumor" "non-cancerous" "24 h" "non-malignant" "bp" "adeno" "HIV-1 Vpr"
    "biotin" "MOI" "HIV-1Vpr" "∼40%" "HIV-1ΔVpr" "ΔVpr" "UI" "siScr" "siUNG2"
    "MAGIC-5B cells" "isotype" "MAGIC" "-quencher" "-fluorophore" "quencher"
    "lymphoblastoid" "undertaken" "uracils" "Weil" "LTR" "UGI"
    "the retroviral genome" "viral genome" "Ung" "immunoglobulin" "U:A" "U:G"
    "AP" "glycosyl" "mismatches" "∼60%" "∼80%" "pg/ml"
    "the respective mono-therapies" "mono-therapies" "multi" "Wicha" "IL-6Rα"
    "de-differentiation/pluripotency" "XL" "Bcl" "homogenates" "microsections"
    "pSTAT3" "α2β1" "malignacy" "/CD44 +" "/pSTAT3" "HRPC" "multilineage"
    "non-silencing" "CD44 +" "Iorns" "Chu" "Asako" "SU3-pEGFP-N1-SATB1" "U251"
    "KPS" "Karnofsky" "SU3" "Pearson" "72 h" "12 h" "μ l" "non-tumor"
    "supernatants" "exudates" "carrageenin" "omega-3" "tachycardia"
    "multicentre" "ALI/ARDS" "edema" "Lipopolysaccharide" "or/and" "pg/mL"
    "supernatant" "g/mL" "RvD" "RvE" "DHA" "prostaglandinD" "ProstaglandinE"
    "Prostaglandins" "cyclooxygenase-3" "autacoids" "prostaglandinE"
    "prostaglandins" "anti-inflammatory" "Wu" "polyubiquitinaton" "UTR"
    "Collins" "drawn" "cell lines/types" "FACS" "anti-HA" "anti-Flag" "CHX"
    "Co-IP" "Noonan" "knockin" "congenital erythroblastopenia"
    "erythroblastopenia" "translocalizes" "~80%" "LSCC" "3q26"
    "readily form oncospheres" "soft agar" "pMek" "pEct2" "therse" "amplicon"
    "TCGA" "dataset" "non-adherent" "the murine ovarian tumor cell line ID8"
    "ID8" "human ovarian cancer TICs" "parental ES2 or ES2 TICs" "IVIS"
    "inoculum" "re-differentiate" "oncosphere" "Ovarian cancer oncospheres"
    "oncospheres" "Pak" "the intestinal epithelium" "epithelium"
    "the heterogeneous cancer cell lineages" "lineages"
    "highly tumorigenic ovarian cancer stem-like" "regrowth" "stem-like" "TICs"
    "TIC" "Cι" "IC 50" "+ 4" "reacquire" "hotspot" "frozen" "SCNAs" "10q" "1/6"
    "monosomy" "M-stage" "Non-infant" "non-infants" "non-infant" "5-year"
    "desmoplastic histology" "classic histology" "histology"
    "the available matched germline" "p  " "both mutational hotspots" "AGGGG"
    "CCCGG" "hotspots" "Taqman" "Sanger" "CNS" "fossa" "= 0.024" "Kaplan–Meier"
    "× 10 " "non-treated" "the active stereoisomer" "stereoisomer"
    "Dexibuprofen" "U133" "-ibuprofen-treated" "Johnsen" "the favorable subset"
    "NCBI/GEO" "GDS1699" "NCBI" "ELISA" "PC3/AR" "Li" "relavant" "72 h"
    "Barosi" "Irino" "Lippert" "discrepant" "simpler" "Merker’s" "Merker" "Ct"
    "JAJ2V617F" "appropriateness" "WBC" "presence/absence" "22/22" "CGs" "HKGs"
    "MRD" "HKG" "buffy" "Vannucchi" "JAK2V617F/JAK2WT" "Zhao"
    "a biological continuum" "continuum" "essential thrombocythemia (ET)"
    "Philadelphia" "PLTs" "JAK2WT" "p  " "5/9" "29/38"
    "38 essential thrombocythemia (ET)" "vera (PV)" "thrombocythemia" "vera"
    "JAK2V617F" "p  = 0.001" "JVG" "JLF" "WZ" "RLW" "codon (CCT)" "codon (GCT)"
    "the human thymic organoid" "organoid" "LXSN" "LAINefP72A/P75A"
    "replication competent LAINefP72A/P75A" "naïve" "LAIs" "p " "Naïve"
    "pLAINef" "IVKA" "pcDNA3.1" "MHCI" "pLXSN" "revertant" "SRPGKTC"
    "DLEKHGAITS" "missense" "DLE" "TCIU" "iv" "polypurine" "Klenow"
    "PVRPQVPLRP" "vivo" "∆-13" "∆-1" "LAI (LAI)" "fs" "LAINef" "LAI" "CD8 +"
    "DWN" "GS" "gene/protein" "Ensembl" "pseudogenes" "the ancestral homolog"
    "prokaryote" "homolog" "Viridiplantae" "Clade" "arisen" "intron" "introns"
    "an excellent minireview" "Silverman" "minireview" "secondary helices"
    "helices" "clade" "corticosteroid" "cathespins" "Clades" "clades" "viz"
    "Pre" "unkown" "region/gene" "unmature" "non-glycosylated"
    "preoperative colorectal tumor biopsies" "biopsies" "hidden" "BIOMOL"
    "Menten" "Michaelis" "-LMFK" "LMFK" "GSHLKSKKGQSTSRHK" "natural-like"
    "the crystal structure 2V5W" "2V5W" "fluorophore" "methylcoumarin"
    "-7-amino-4-methylcoumarin
(MAL)"
    "Ac" "chosen" "i2" "crystallographic
B-factors"
    "HDAC8:SAHA" "L1:L2" "interconvert" "μs" "Anton" "1T64" "Somoza"
    "B-factors" "substrate-like" "Vannini" "24 h" "μL" "Z -score" "∼10%" "C α"
    "HHR" "dsb" "Meng" "| 0.5" "oncologists" "Biocarta" "KEGG" "Venn" "pH"
    "Mihaylova" "p53-" "p" "anoxia" "24 h" "immunotherapy" "TIL/TAM" "Balta"
    "Genotypes" "genotype" "IHC" "TCVPTC" "CPTC" "followup" "cytology" "CD8+"
    "subsets" "= 0.05" "μ L" "μ mol/L" "Rse" "Katayama" "Basilico" "non-MET"
    "the peri-tumoral normal follicle" "follicle" "_10" "tissue/carcinoma"
    "BHP2-7" "Cal" "TL3" "BHP" "fulminant" "anti-tumor" "ARQ"
    "non-MET-targeting" "mg/kg" "μg/g" "greatest" "4μg/μl"
    "Immunohistochemistry" "&E" "μl" "IACUC" "bonafide" "2μg/μl" "μg/μl"
    "Azt/nimbolide’s" "DMSO-treated RBS811E" "RBS811E" "monolayers" "perhaps"
    "24h" "12h" "G2M" "U87EGFRvIII" "U87 EGFRvIII" "neurosphere" "20h" "hoc"
    "lactone" "dimethylbenz" "anti-cancer" "anti-malarial" "anti-HIV"
    "limonoid" "tetranortriterpenoid" "IRACARP" "Africa" "IRAB" "Indica"
    "Azt/nimbolide" "indica" "Azadirachta" "phytomedicine" "IC50" "72h" "G0/G1"
    "70/30" "phosphoRac1/cdc42" "phosphoAkt" "phosphoLimK"
    "approximately 70/30" "the radial monolayer" "monolayer" "seq4" "seq2"
    "seq3" "seq1" "immunohistology" "86HG39" "amoeboid" "GTP-bound RhoA" "72 h"
    "× 10" "RNaseP" "America" "Europe" "proven" "Korean" "16p12.1"
    "disease-associated CNVs" "breakpoints" "simplest" "exome" "GWAS"
    "penetrance" "Hokkaido" "Sebat" "even de novo CNVs"
    "presumably benign polymorphisms" "CNVs" "genomes" "Vanderbilt"
    "clinicians" "10/31" "beadchip" "polymorphisms" "pathophysiology"
    "synculein" "synucleinopathy" "DLB" "Lewy" "Onuf" "pons" "cerebellum"
    "parkinsonism" "TaqMan" "CNV" "Sasaki" "MSA" "co-IP" "EIF3n" "littermate"
    "stressors" "co-fractionate" "KO" "NurD" "STRING" "metabolism/repair" "80+"
    "mono-ADP-ribosylation" "defatty" "lifespan" "sirtuin" "interactome"
    "induction/inhibition" "octamers" "transferases" "ClinicalTrials"
    "reticulum" "SWItch/Sucrose" "Ser780RB1" "desensitise" "BCAR" "enhancer"
    "chemoresistance" "Affymetrix" "ICI" "Oestrogen" "GeneChip" "FUL"
    "oestrogen" "× 10" "non-steroidal" "ROCKI/II" "GFP-RhoAV14E40L"
    "anti-pSer1333" "phosphopeptide" "immunocomplex" "thrombus" "autoinhibit"
    "RhoA" "non-specific" "pancreaticobiliary subtype" "intestinal subtype"
    "Foo" "recurrence/metastasis" "± 11.0" "the histologic subtype"
    "benign ampullary/duodenal mucosa" "mucosa" "univariate" "bisphosphate"
    "triphosphate" "10q23.31" "adenomas" "McCarthy" "Vater" "ampulla" "pT"
    "AJCC" "underwent pancreaticoduodenectomy" "pancreaticoduodenectomy"
    "Kaplan-Meier" "chemo" "E2F1-dependent" "ANRIL" "derepresses" "b" "G1/S"
    "reenter" "Δ21-35" "wt" "OHT" "exons" "8q24.3" "Seq" "PANDA" "epigenome"
    "transcriptome" "Genome" "non-coding" "ERIC’s" "ERIC" "XLOC" "genome" "GR5"
    "transforming growth factor-β1" "STAT5a/b" "agar" "zymography" "Chmielecki"
    "EGFRTKI" "H1975" "re-challenge" "Chaft" "fibroblastoid" "non-androgenic"
    "0.1nmol/L" "sensitizer" "Zhou" "anti-proliferative" "≤ 10" "Maggiolini"
    "μmol/L" "≤ 10µ" "subset" "greater" "1nmol/L" "kcal/mol" "silico"
    "G0/G1 phase" "Hemocytometer" "1 nmol/L" "hemocytometer" "MTS" "codon"
    "LBD" "Japanese" "Europeans" "mol/L" "Asians" "USA" "Asian" "germline"
    "Caucasians" "et" "Millikan" "Model-2" "gone" "multivariate" "=0.001"
    "younger" "TNBCs" "Latinas" "HR+/HER2+" "HR+" "Latina" "clinicopathology"
    "low/negative" "European" "HER2+" "subtypes" "CD24+" "CD44+" "Americans"
    "the Hormonal Receptor (HR) positive subtype" "subtype" "TNBC" "DFS"
    "Meier" "immunohistochemistry" "Hispanic/Latina" "SNP" "American" "African"
    "polymorphism" "CD" "dichroism" "DisProt" "GlobPlot" "intra"
    "hydroxylysine" "peptidyl" "heterotrimer" "NF639-LOX-PP-R116A"
    "NF639-LOX-PP-P111A" "NF639-LOX-PP-WT" "Boyden" "±19.7" "EV" "55.8%±6.2"
    "WB" "siControl" "helix" "Z-score" "kJ/mol" "Ramachandran" "YASARA" "×10"
    "RPRPAARHW" "P113A" "PxxPxR" "PxPxxR" "∼36%" "co-precipitated" "ZR-75"
    "UniProtKB" "ZR" "pEBG" "PxxP" "CC" "co-affinity-purification" "pre"
    "NF639" "PxpxxRh" "PxxxPR" "propeptide"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-11101-11400*
  '(("HR and 95% CI" . SPARSER::COLLECTION)
    ("Androgens and AR" . SPARSER::COLLECTION)
    ("ER, PR, HER2 and Ki67" . SPARSER::COLLECTION)
    ("a complex and heterogenetic disease" . SPARSER::COLLECTION)
    ("ER, PR, HER2, and Ki67" . SPARSER::COLLECTION)
    ("TNFA and NFKBIA" . SPARSER::COLLECTION)
    ("multi-genic" . SPARSER::PROTEIN-PAIR)
    ("larger cohort" . SPARSER::MOLECULE) ("TNFA-" . SPARSER::PROTEIN)
    ("angiogenic mediators" . SPARSER::PROTEIN)
    ("premalignant chemokines" . SPARSER::PROTEIN)
    ("TNFA -308 GA genotype and A allele" . SPARSER::COLLECTION)
    ("GIH" . SPARSER::PROTEIN) ("immune-responsive genes" . SPARSER::GENE)
    ("TNFA -308 GA genotype" . SPARSER::PROTEIN)
    ("TNFA , NFKB1 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKB1 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKB1 (1900 SNPs) and NFKBIA (158 SNPs)" . SPARSER::COLLECTION)
    ("common polymorphic variants" . SPARSER::VARIANT)
    ("classical form" . SPARSER::FORM) ("The dimeric form" . SPARSER::FORM)
    ("p50/RelA" . SPARSER::COLLECTION) ("p52/p100" . SPARSER::COLLECTION)
    ("a pro-inflammatory pleiotropic cytokine" . SPARSER::PROTEIN)
    ("gene ( TNFA )" . SPARSER::GENE)
    ("TNFA  -308GA genotype" . SPARSER::PROTEIN)
    ("TNFA, NFkB1 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN)
    ("NF-κB and its inhibitor IκB genes" . SPARSER::COLLECTION)
    ("TNF-α, NF-κB and its inhibitor IκB genes" . SPARSER::COLLECTION)
    ("DR3" . SPARSER::PROTEIN) ("MDR 3" . SPARSER::PROTEIN)
    ("IκBs" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("NFkB1" . SPARSER::PROTEIN) ("Tumour necrosis factor" . SPARSER::PROTEIN)
    ("PPH3, and cyclin" . SPARSER::COLLECTION)
    ("MAI, PPH3, and cyclin" . SPARSER::COLLECTION)
    ("antibody, cut-offs, and tissue" . SPARSER::COLLECTION)
    ("MAI or PPH3" . SPARSER::COLLECTION)
    ("MAI and PPH3" . SPARSER::COLLECTION)
    ("MAI, PPH3 and Ki67" . SPARSER::COLLECTION)
    ("late G2-phase specific proliferation marker PPH3" . SPARSER::PROTEIN)
    ("Cyclin B1 and PPH3" . SPARSER::COLLECTION)
    ("Ki67, and cyclin" . SPARSER::COLLECTION)
    ("cyclin B1, PPH3, and Ki67" . SPARSER::COLLECTION)
    ("PPH3, cyclin B1 or Ki67" . SPARSER::COLLECTION)
    ("univariable analysis MAI" . SPARSER::PROTEIN)
    ("MAI, PPH3, cyclin B1, Ki67, and cyclin" . SPARSER::COLLECTION)
    ("the clear and contrast-rich PPH3" . SPARSER::PROTEIN)
    ("MAI and cyclin" . SPARSER::COLLECTION)
    ("MAI and/or cyclin" . SPARSER::COLLECTION)
    ("Ki67, and cyclin B1" . SPARSER::COLLECTION) ("MAI" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN) ("PPH3" . SPARSER::PROTEIN)
    ("enough residual cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("residual cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("cyclin B2/Cdk1" . SPARSER::COLLECTION)
    ("at least one critical substrate" . SPARSER::SUBSTRATE)
    ("cyclin/Cdk1" . SPARSER::COLLECTION) ("acetone" . SPARSER::MOLECULE)
    ("NEB" . SPARSER::PROTEIN)
    ("several cyclins and several Cdks (e.g., mammals) or one Cdk"
     . SPARSER::COLLECTION)
    ("several Cdks (e.g., mammals) or one Cdk" . SPARSER::COLLECTION)
    ("cyclins and Cdks" . SPARSER::COLLECTION)
    ("a single mitotic cyclin and a single Cdk" . SPARSER::COLLECTION)
    ("a single mitotic cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plus exogenous cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the exogenous B cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a single exogenous B cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("siRNAs and Dox" . SPARSER::COLLECTION)
    ("either exogenous B cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a mitotic cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a slightly elevated G2 fraction and a reduced fraction"
     . SPARSER::COLLECTION)
    ("RPE" . SPARSER::PROTEIN) ("cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("exogenous B-cyclin EGFP" . SPARSER::PROTEIN)
    ("exogenous cyclin B1-EGFP" . SPARSER::COLLECTION)
    ("Exo" . SPARSER::PROTEIN) ("Endo" . SPARSER::PROTEIN)
    ("cyclin A2 and Cdk1" . SPARSER::COLLECTION)
    ("cyclin B1 and B2 co-depletion" . SPARSER::COLLECTION)
    ("siRNA and Dox" . SPARSER::COLLECTION)
    ("cyclin-EGFPs" . SPARSER::PROTEIN-PAIR)
    ("exogenous B cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone H2b-GFP" . SPARSER::COLLECTION)
    ("siRNA or siRNA+Dox" . SPARSER::COLLECTION)
    ("exogenous B cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin B2-EGFP" . SPARSER::COLLECTION)
    ("Cyclin B2-EGFP" . SPARSER::COLLECTION)
    ("Cyclin B1-EGFP" . SPARSER::COLLECTION)
    ("exogenous proteins" . SPARSER::PROTEIN)
    ("exogenous cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ectopic EGFP or B cyclin-EGFP proteins" . SPARSER::COLLECTION)
    ("cyclin B1 and B2 siRNAs" . SPARSER::COLLECTION)
    ("cyclin B2–EGFP" . SPARSER::COLLECTION)
    ("cyclin B1-EGFP" . SPARSER::COLLECTION)
    ("these exogenous proteins" . SPARSER::PROTEIN)
    ("cyclin B1 and cyclin B2" . SPARSER::COLLECTION)
    ("aster" . SPARSER::BIO-COMPLEX)
    ("the principal activators" . SPARSER::ACTIVATOR)
    ("mutant or immunodepletion" . SPARSER::COLLECTION)
    ("Cdc2 or cyclin-dependent kinase 1" . SPARSER::COLLECTION)
    ("cyclin/Cdk" . SPARSER::COLLECTION)
    ("the dispensible cyclin B2" . SPARSER::PROTEIN)
    ("cyclin B1 or cyclin B2" . SPARSER::COLLECTION)
    ("cycB1 and cycB2" . SPARSER::COLLECTION)
    ("the respective endogenous cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-EGFP" . SPARSER::COLLECTION)
    ("doxycycline (Dox) and bromodeoxyuridine" . SPARSER::COLLECTION)
    ("cyclin B1- or B2-EGFP" . SPARSER::COLLECTION)
    ("cyclin B1-" . SPARSER::PROTEIN)
    ("cyclin B1 (cycB1) or cyclin B2 (cycB2)" . SPARSER::COLLECTION)
    ("cycB" . SPARSER::PROTEIN) ("cyclinB1" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN)
    ("histone H2b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pBcl2" . SPARSER::MOLECULE) ("Age1" . SPARSER::PROTEIN)
    ("Cyclin B2" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("cyclin B2" . SPARSER::PROTEIN) ("cycB1" . SPARSER::PROTEIN)
    ("Rb or p53" . SPARSER::COLLECTION)
    ("essential tight junction proteins ZO-1 and claudin-1"
     . SPARSER::COLLECTION)
    ("ZO-1 and claudin-1" . SPARSER::COLLECTION)
    ("66 active genes" . SPARSER::GENE)
    ("essential regulator" . SPARSER::REGULATOR)
    ("macrometastatic fraction" . SPARSER::COMPONENT)
    ("shCD" . SPARSER::PROTEIN) ("Rb and CD44" . SPARSER::COLLECTION)
    ("an essential effector" . SPARSER::EFFECTOR)
    ("cytokeratins and CD44" . SPARSER::COLLECTION)
    ("Slug (Snail-2) and Twist-1" . SPARSER::COLLECTION)
    ("mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("Rb or its homologue (p107 or p130)" . SPARSER::COLLECTION)
    ("p107 or p130" . SPARSER::COLLECTION)
    ("E7, Ki-67, CD44 and cytokeratins" . SPARSER::COLLECTION)
    ("Rb, p107 and p130" . SPARSER::COLLECTION)
    ("p63 and cytokeratins" . SPARSER::COLLECTION)
    ("E-cadherin and luminal" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("claudin-1 and ZO-1" . SPARSER::COLLECTION)
    ("the epithelial marker E-cadherin and the mesenchymal marker vimentin"
     . SPARSER::COLLECTION)
    ("functional Rb" . SPARSER::PROTEIN) ("MFP" . SPARSER::PROTEIN)
    ("LV" . SPARSER::MOLECULE) ("mouse mammary fat" . SPARSER::PROTEIN)
    ("MFPs" . SPARSER::PROTEIN)
    ("either enhanced green fluorescent protein (EGFP) or antibiotic resistance gene, and shRNAs"
     . SPARSER::COLLECTION)
    ("enhanced green fluorescent protein (EGFP)" . SPARSER::PROTEIN)
    ("gene, and shRNAs" . SPARSER::COLLECTION)
    ("hyaluronan" . SPARSER::PROTEIN) ("BLC" . SPARSER::PROTEIN)
    ("SCM" . SPARSER::PROTEIN-FAMILY) ("Rb/CD44" . SPARSER::COLLECTION)
    ("Rb-1" . SPARSER::PROTEIN) ("Snail-2" . SPARSER::PROTEIN)
    ("ZO-3" . SPARSER::PROTEIN) ("claudin-7" . SPARSER::PROTEIN)
    ("keratin 14" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("claudin-1" . SPARSER::PROTEIN)
    ("ACCN1, and alpha-2" . SPARSER::COLLECTION) ("alpha-2" . SPARSER::PROTEIN)
    ("IP10/CXCL10" . SPARSER::COLLECTION) ("MIG/CXCL9" . SPARSER::COLLECTION)
    ("chemokines and chemokine" . SPARSER::COLLECTION)
    ("MCP1/CCL2" . SPARSER::COLLECTION) ("MAL/TIRAP" . SPARSER::COLLECTION)
    ("NFkBIL" . SPARSER::PROTEIN) ("LTA" . SPARSER::PROTEIN)
    ("TNFA" . SPARSER::PROTEIN) ("DRB" . SPARSER::PROTEIN)
    ("the hypothesis-driven candidate genes" . SPARSER::GENE)
    ("a nucleolar protein" . SPARSER::PROTEIN)
    ("ACCN1/ASIC2" . SPARSER::COLLECTION)
    ("HSPB8/Hsp22/H11" . SPARSER::COLLECTION)
    ("ABCB5, COL1A2, HSPB8, ACCN1, LEPREL4, and LPIN2" . SPARSER::COLLECTION)
    ("a fibril-associated collagen" . SPARSER::PROTEIN)
    ("statin" . SPARSER::MOLECULE) ("digoxin" . SPARSER::DRUG)
    ("MEX" . SPARSER::PROTEIN) ("ASW" . SPARSER::PROTEIN)
    ("PR, QRS and QT" . SPARSER::COLLECTION) ("mega" . SPARSER::MOLECULE)
    ("ECG and X" . SPARSER::COLLECTION) ("ECG" . SPARSER::DRUG)
    ("Fraction" . SPARSER::COMPONENT) ("CXCL10" . SPARSER::PROTEIN)
    ("UAP56" . SPARSER::PROTEIN) ("IL12B" . SPARSER::PROTEIN)
    ("IL1RN" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("DQB1" . SPARSER::PROTEIN) ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("ASIC2" . SPARSER::PROTEIN)
    ("Hsp22" . SPARSER::PROTEIN) ("LPIN2" . SPARSER::PROTEIN)
    ("LEPREL4" . SPARSER::PROTEIN) ("ACCN1" . SPARSER::PROTEIN)
    ("HSPB8" . SPARSER::PROTEIN) ("ABCB5" . SPARSER::PROTEIN)
    ("COL14A1" . SPARSER::PROTEIN) ("LAT 1" . SPARSER::PROTEIN)
    ("solute carrier family" . SPARSER::PROTEIN) ("SLCO1B1" . SPARSER::PROTEIN)
    ("FGFR4 and TGF-β1" . SPARSER::COLLECTION)
    ("FGFRs and co-receptor" . SPARSER::COLLECTION)
    ("FGFR4 and KLB" . SPARSER::COLLECTION) ("KLB" . SPARSER::PROTEIN)
    ("FGF19/FGFR4" . SPARSER::COLLECTION)
    ("TGF-β and its receptor" . SPARSER::COLLECTION)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("intratumoral FGFR4" . SPARSER::PROTEIN)
    ("TGF-β1 ( p = 0.002) and FGFR4 ( p = 0.001)" . SPARSER::COLLECTION)
    ("anti-TGF-β1 and anti-FGFR4" . SPARSER::COLLECTION)
    ("oncoproteins, TGF-β1 and FGFR4" . SPARSER::COLLECTION)
    ("the predominant FGFR isoform" . SPARSER::ISOFORM)
    ("a prototypical multifunctional cytokine" . SPARSER::PROTEIN)
    ("FGFR4 or TGF-β1" . SPARSER::COLLECTION)
    ("TGF-β1 and FGFR4" . SPARSER::COLLECTION)
    ("α-fetoprotein" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("Smad 7" . SPARSER::PROTEIN) ("R-2" . SPARSER::PROTEIN)
    ("FGF19" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 4" . SPARSER::PROTEIN)
    ("Codon" . SPARSER::PROTEIN) ("ATM-P53" . SPARSER::COLLECTION)
    ("ATM and MDM2" . SPARSER::COLLECTION)
    ("ATM, TP53, and MDM2" . SPARSER::COLLECTION)
    ("antigen (PSA)" . SPARSER::PROTEIN) ("ATM and TP53" . SPARSER::COLLECTION)
    ("the stimulatory protein" . SPARSER::PROTEIN)
    ("a pivotal negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("Group (RTOG)" . SPARSER::MOLECULE)
    ("ATM , TP 53 and MDM 2" . SPARSER::COLLECTION) ("PIN3" . SPARSER::PROTEIN)
    ("XRCC3" . SPARSER::PROTEIN)
    ("X-ray repair cross-complementing protein 3" . SPARSER::PROTEIN)
    ("X-ray repair cross-complementing protein 1" . SPARSER::PROTEIN)
    ("TGFB1" . SPARSER::PROTEIN)
    ("transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("MDM 2" . SPARSER::PROTEIN) ("TP 53" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("these two separate types" . TYPE)
    ("HDAC3 and DNMT3A" . SPARSER::COLLECTION)
    ("the classic protein synthesis inhibitor" . SPARSER::INHIBITOR)
    ("HDAC2 and -3" . SPARSER::COLLECTION)
    ("EGCG and DNMTs" . SPARSER::COLLECTION)
    ("HDACs and DNMTs" . SPARSER::COLLECTION)
    ("UHRF1 and HDAC3" . SPARSER::COLLECTION)
    ("UHRF1 and DNMT3" . SPARSER::COLLECTION)
    ("DNMT3A, HDAC3A and UHRF1" . SPARSER::COLLECTION)
    ("sepharose" . SPARSER::MOLECULE)
    ("ubiquitin ligase, UHRF1, and DNMT3A" . SPARSER::COLLECTION)
    ("UHRF1, DNMT3A and HDAC3" . SPARSER::COLLECTION)
    ("DMSO and EGCG" . SPARSER::COLLECTION)
    ("DNMT3A and HDAC3 and drug" . SPARSER::COLLECTION)
    ("HDAC3 and drug" . SPARSER::COLLECTION)
    ("each western blot" . SPARSER::PROTEIN)
    ("HDAC2 and HDAC3" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, and HDAC3" . SPARSER::COLLECTION)
    ("The western blot" . SPARSER::PROTEIN)
    ("DNMT3A and TopoIIB" . SPARSER::COLLECTION)
    ("DNMTs and HDACs" . SPARSER::COLLECTION) ("MutL" . SPARSER::PROTEIN)
    ("DNMT and HDAC" . SPARSER::COLLECTION)
    ("DNMT3A and HDAC3" . SPARSER::COLLECTION)
    ("HDAC and DNMT" . SPARSER::COLLECTION) ("EGCG" . SPARSER::DRUG)
    ("DNMT3" . SPARSER::PROTEIN) ("HDAC 1" . SPARSER::PROTEIN)
    ("herpesvirus-associated ubiquitin specific protease" . SPARSER::PROTEIN)
    ("epigallocatechin gallate" . SPARSER::DRUG)
    ("tea polyphenol" . SPARSER::MOLECULE)
    ("the aggressive MIBC group" . SPARSER::MOLECULE)
    ("pTis/pTa/pT1" . SPARSER::COLLECTION) ("pTa" . SPARSER::PROTEIN)
    ("pTis" . SPARSER::PROTEIN) ("Ta" . SPARSER::PROTEIN)
    ("HTB3" . SPARSER::PROTEIN) ("HTB5" . SPARSER::PROTEIN)
    ("HTB1" . SPARSER::PROTEIN) ("cyclin D1b" . SPARSER::PROTEIN)
    ("c-Yes/cdc42" . SPARSER::COLLECTION)
    ("receptors and tyrosine" . SPARSER::COLLECTION) ("src" . SPARSER::PROTEIN)
    ("c-Yes and c-Abl" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("Yes/YAP-TEAD2" . SPARSER::PROTEIN-PAIR)
    ("the c-Yes/YAP complex and depletion of nuclear YAP"
     . SPARSER::COLLECTION)
    ("ATM/Chk-2" . SPARSER::COLLECTION)
    ("irinotecan and bevacizumab" . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("Chk-2 and c-Yes" . SPARSER::COLLECTION) ("5FU-" . SPARSER::DRUG)
    ("-FU" . SPARSER::COLLECTION) ("ALDH" . SPARSER::PROTEIN)
    ("CD133− and CXCR4-positive" . SPARSER::COLLECTION)
    ("CD133−" . SPARSER::PROTEIN)
    ("CD24, CD44, CD133 and CXCR4-positive" . SPARSER::COLLECTION)
    ("OXA" . SPARSER::MOLECULE) ("/CXCR4" . SPARSER::COLLECTION)
    ("/CD133" . SPARSER::COLLECTION)
    ("CD24, CD44, CD133 and CXCR4" . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN)
    ("CD133 (16- to 30-fold) and CD44 (2-fold)" . SPARSER::COLLECTION)
    ("5FU or oxaliplatin" . SPARSER::COLLECTION)
    ("5FU and oxaliplatin" . SPARSER::COLLECTION)
    ("two monoclonal antibodies" . SPARSER::ANTIBODY)
    ("a classical anticancer drug" . SPARSER::DRUG) ("CK1" . SPARSER::PROTEIN)
    ("TEAD2" . SPARSER::PROTEIN) ("c-yes" . SPARSER::PROTEIN)
    ("SU6656" . SPARSER::PROTEIN) ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("Chk-2" . SPARSER::PROTEIN) ("ALDH1A3" . SPARSER::PROTEIN)
    ("CD166" . SPARSER::PROTEIN) ("c-Yes" . SPARSER::PROTEIN)
    ("Rb and p53" . SPARSER::COLLECTION)
    ("CDK4/6 or cyclin D1" . SPARSER::COLLECTION)
    ("kinase and UBE2C" . SPARSER::COLLECTION)
    ("AR or neuroendocrine" . SPARSER::COLLECTION)
    ("proteins and p53" . SPARSER::COLLECTION) ("t-NEPC" . SPARSER::COLLECTION)
    ("NEPC" . SPARSER::PROTEIN)
    ("synaptophysin, chromogranin and CD56" . SPARSER::COLLECTION)
    ("t-NEPCs" . SPARSER::PROTEIN-PAIR) ("TAK" . SPARSER::PROTEIN)
    ("available DNA" . SPARSER::DNA) ("adequate DNA" . SPARSER::DNA)
    ("TP53 , PTEN and RB1" . SPARSER::COLLECTION)
    ("Rb and PTEN" . SPARSER::COLLECTION)
    ("RB1 and PTEN" . SPARSER::COLLECTION)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("chromogranin and synaptophysin" . SPARSER::COLLECTION)
    ("chromogranin and/or synaptophysin" . SPARSER::COLLECTION)
    ("prostatic/AR" . SPARSER::COLLECTION)
    ("chromogranin or synaptophysin" . SPARSER::COLLECTION)
    ("Rb protein and the small cell carcinoma component" . SPARSER::COLLECTION)
    ("the acinar component" . SPARSER::COMPONENT)
    ("the acinar carcinoma component" . SPARSER::COMPONENT)
    ("acinar carcinoma components" . SPARSER::COMPONENT)
    ("RB1 , PTEN and TP53" . SPARSER::COLLECTION)
    ("RB1 and TP53" . SPARSER::COLLECTION)
    ("this currently uniformly lethal tumor type" . TYPE)
    ("both androgen receptor and downstream targets" . SPARSER::COLLECTION)
    ("a useful diagnostic and potential therapeutic target"
     . SPARSER::TARGET-PROTEIN)
    ("RB1 , TP53 and PTEN" . SPARSER::COLLECTION)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("UBE2C" . SPARSER::PROTEIN)
    ("PCA2" . SPARSER::PROTEIN) ("anti-CSF1R or PLX5622" . SPARSER::COLLECTION)
    ("CD14, COX-2, IL-1β, IL-6, IL-8, IL-12, CSF1R, iNOS, and TNF"
     . SPARSER::COLLECTION)
    ("chemokines/chemokine" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("chitinase" . SPARSER::PROTEIN)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("VEGF and CCL2" . SPARSER::COLLECTION)
    ("an antibody or molecular inhibitor" . SPARSER::COLLECTION)
    ("C/EBPα , C/EBPδ , and C/EBPε" . SPARSER::COLLECTION)
    ("TNF, IL-1β, and IL-6" . SPARSER::COLLECTION)
    ("CD11c, HLA-DR, CD86, and CD64" . SPARSER::COLLECTION)
    ("CD3, CD19, and CD56" . SPARSER::COLLECTION)
    ("C/EBPβ and the LAP isoform" . SPARSER::COLLECTION)
    ("TNF and IL-6" . SPARSER::COLLECTION)
    ("a short repressive isoform liver-enriched inhibitory protein"
     . SPARSER::PROTEIN)
    ("the predominant C/EBPβ isoform" . SPARSER::ISOFORM)
    ("LIP" . SPARSER::PROTEIN)
    ("regulator of both Il10 and Msr1 ( xref ) and tumor-induced immunosuppression ( xref )"
     . SPARSER::COLLECTION)
    ("Il10 and Msr1" . SPARSER::COLLECTION)
    ("Il10 , Chi3l3 , Pla2g7 , CXCR4 , and Msr1" . SPARSER::COLLECTION)
    ("Msr1" . SPARSER::PROTEIN) ("Pla2g7" . SPARSER::PROTEIN)
    ("Il10" . SPARSER::PROTEIN) ("CD80, and CD86" . SPARSER::COLLECTION)
    ("significantly less intracellular IFN-γ" . SPARSER::PROTEIN)
    ("macrophages, monocytes, and neutrophils" . SPARSER::COLLECTION)
    ("PLX" . SPARSER::PROTEIN)
    ("cytometry and immunohistochemistry" . SPARSER::COLLECTION)
    ("CX3CR1-GFP" . SPARSER::COLLECTION)
    ("tissue-resident monocytes" . SPARSER::PROTEIN)
    ("CCR2-GFP" . SPARSER::COLLECTION)
    ("several monocyte/macrophage developmental genes" . SPARSER::GENE)
    ("Csf1r" . SPARSER::PROTEIN) ("Ccr2" . SPARSER::PROTEIN)
    ("Csf" . SPARSER::PROTEIN) ("CCR2 or CX3CR1" . SPARSER::COLLECTION)
    ("the high inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF, IL-6, and IL-1β" . SPARSER::COLLECTION)
    ("CD14, and Fc" . SPARSER::COLLECTION)
    ("iNOS and CD40" . SPARSER::COLLECTION)
    ("CD11c and MHC" . SPARSER::COLLECTION)
    ("Ly6C and Ly6G" . SPARSER::COLLECTION)
    ("KIT and CD34" . SPARSER::COLLECTION) ("arginase" . SPARSER::PROTEIN)
    ("TNF, IL-6, IL-1β, and IL-12" . SPARSER::COLLECTION)
    ("LPS or IFN-γ" . SPARSER::COLLECTION)
    ("IL-4 or IL-13" . SPARSER::COLLECTION) ("that imatinib’s" . SPARSER::DRUG)
    ("KIT and PDGFRA" . SPARSER::COLLECTION) ("Gleevec" . SPARSER::DRUG)
    ("either KIT ( xref ) or PDGFRA ( xref )" . SPARSER::COLLECTION)
    ("Tumor-associated macrophages" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("Brefeldin A" . SPARSER::MOLECULE) ("FUN-1" . SPARSER::MOLECULE)
    ("MRC1" . SPARSER::PROTEIN) ("I-E" . SPARSER::PROTEIN)
    ("Ly-6G" . SPARSER::PROTEIN) ("Ly-6C" . SPARSER::PROTEIN)
    ("NK1.1" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("NKp30" . SPARSER::PROTEIN) ("MSR1" . SPARSER::PROTEIN)
    ("phospholipase A2 group VII" . SPARSER::PROTEIN)
    ("ATF1" . SPARSER::PROTEIN)
    ("liver-enriched inhibitory protein" . SPARSER::PROTEIN)
    ("Chi3l3" . SPARSER::PROTEIN) ("CSF1" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("CSF1R" . SPARSER::PROTEIN)
    ("IRF5" . SPARSER::PROTEIN) ("Ly6G" . SPARSER::PROTEIN)
    ("Ly6C" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("CCL22" . SPARSER::PROTEIN) ("CTLA-4" . SPARSER::PROTEIN)
    ("pKa" . SPARSER::PROTEIN) ("multifunctional proteins" . SPARSER::PROTEIN)
    ("active and inactive" . SPARSER::COLLECTION)
    ("the ETGE-containing competitive binding protein" . SPARSER::PROTEIN)
    ("hypomorphic KEAP1 mutants" . SPARSER::MUTANT)
    ("SMARCA4 and STK11" . SPARSER::COLLECTION)
    ("the hypomorphic mutants" . SPARSER::MUTANT)
    ("near-null alleles" . SPARSER::ALLELE)
    ("wild-type KEAP1 or the R320Q superbinder" . SPARSER::COLLECTION)
    ("KEAP1-associated NRF2" . SPARSER::PROTEIN)
    ("no exogenous KEAP1" . SPARSER::PROTEIN)
    ("NRF2 and HMOX1" . SPARSER::COLLECTION)
    ("wild-type KEAP1 or the superbinder mutants" . SPARSER::COLLECTION)
    ("NRF2 and the NRF2 target gene HMOX1" . SPARSER::COLLECTION)
    ("an artificial reporter gene" . SPARSER::GENE)
    ("associated NRF2" . SPARSER::PROTEIN)
    ("wild-type KEAP1 and two superbinder mutants (R320Q and R470C)"
     . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN)
    ("wild-type KEAP1 and the following mutants" . SPARSER::COLLECTION)
    ("shotgun" . SPARSER::PROTEIN)
    ("SLK, MCM3, and DPP3" . SPARSER::COLLECTION)
    ("MCM3, DPP3, and IKBKB" . SPARSER::COLLECTION)
    ("IKBKB" . SPARSER::PROTEIN) ("DPP" . SPARSER::MOLECULE)
    ("WTX" . SPARSER::PROTEIN) ("SLK" . SPARSER::PROTEIN)
    ("KEAP1 and mutant" . SPARSER::COLLECTION)
    ("KEAP1-CUL3" . SPARSER::COLLECTION)
    ("ROS and xenobiotic" . SPARSER::COLLECTION)
    ("KEAP1 and each KEAP1 mutant" . SPARSER::COLLECTION)
    ("protein or mRNA" . SPARSER::COLLECTION)
    ("NRF2 as well as wild-type KEAP1" . SPARSER::COLLECTION)
    ("KEAP1-NRF2" . SPARSER::COLLECTION) ("xenobiotic" . SPARSER::MOLECULE)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION) ("DLG" . SPARSER::PROTEIN)
    ("genotypes and protein" . SPARSER::COLLECTION)
    ("KEAP1 and NRF2" . SPARSER::COLLECTION)
    ("NRF2 and CUL3" . SPARSER::COLLECTION) ("AMER1" . SPARSER::PROTEIN)
    ("LSM5" . SPARSER::PROTEIN) ("Neh2" . SPARSER::PROTEIN)
    ("NEH2" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("UB1" . SPARSER::PROTEIN)
    ("hNQO1" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("MCM3" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("vitronectin or fibronectin" . SPARSER::COLLECTION)
    ("vitronectin and laminin" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN) ("laminins" . SPARSER::PROTEIN-FAMILY)
    ("selectins" . SPARSER::PROTEIN)
    ("GCNT3 , ST3GAL6 and ST6GAL1" . SPARSER::COLLECTION)
    ("a type II transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("glycolipids" . SPARSER::MOLECULE)
    ("glycosaminoglycans, versican and perlecan" . SPARSER::COLLECTION)
    ("perlecan" . SPARSER::PROTEIN) ("versican" . SPARSER::PROTEIN)
    ("sulphate" . SPARSER::MOLECULE)
    ("CHST11 and CHST15" . SPARSER::COLLECTION)
    ("fucosidase" . SPARSER::PROTEIN) ("Selectin" . SPARSER::PROTEIN-FAMILY)
    ("ITGB3 and ITGB8" . SPARSER::COLLECTION)
    ("ITGB5 and ITGB6" . SPARSER::COLLECTION)
    ("B3GALTl, FUCA1, MAN1A1, GANAB and NEU1" . SPARSER::COLLECTION)
    ("CHST11, CHST15, FUT11, GALNT12, GALNT14, GCNT3 and ST6GAL1"
     . SPARSER::COLLECTION)
    ("GANAB" . SPARSER::PROTEIN)
    ("AMIGO2 , CDH11 , FN1 , TNC , VCAN and NPNT" . SPARSER::COLLECTION)
    ("NPNT" . SPARSER::PROTEIN) ("VCAN" . SPARSER::PROTEIN)
    ("MES" . SPARSER::MOLECULE) ("selectin" . SPARSER::PROTEIN-FAMILY)
    ("Selectins" . SPARSER::PROTEIN)
    ("vitronectin and fibronectin" . SPARSER::COLLECTION)
    ("monomers and dimers" . SPARSER::COLLECTION)
    ("laminin and vitronectin" . SPARSER::COLLECTION)
    ("the stromal ECM proteins, type I collagen, fibronectin and vitronectin, and the basement membrane proteins, type IV collagen and laminin"
     . SPARSER::COLLECTION)
    ("collagen, fibronectin and vitronectin" . SPARSER::COLLECTION)
    ("proteins, type IV collagen and laminin" . SPARSER::COLLECTION)
    ("Spearman–Rho" . SPARSER::PROTEIN-PAIR)
    ("immunohistochemical M30 cytoDeath antibody" . SPARSER::ANTIBODY)
    ("murine mammary carcinoma cells c-FOS" . SPARSER::PROTEIN)
    ("Fra-1 and Fra-2" . SPARSER::COLLECTION)
    ("the retroviral oncogene v-fos" . SPARSER::PROTEIN)
    ("adhesion proteins and glycosylation enzymes" . SPARSER::COLLECTION)
    ("β 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("L1-CAM" . SPARSER::PROTEIN)
    ("immunoglobulin superfamily" . SPARSER::PROTEIN)
    ("ST3GAL6" . SPARSER::PROTEIN) ("C-6" . SPARSER::PROTEIN)
    ("O-glycan" . SPARSER::MOLECULE) ("ITGB6" . SPARSER::PROTEIN)
    ("ITGB5" . SPARSER::PROTEIN) ("ITGB8" . SPARSER::PROTEIN)
    ("ITGB3" . SPARSER::PROTEIN) ("ST6GAL1" . SPARSER::PROTEIN)
    ("GCNT3" . SPARSER::PROTEIN) ("GALNT14" . SPARSER::PROTEIN)
    ("GALNT12" . SPARSER::PROTEIN) ("CHST15" . SPARSER::PROTEIN)
    ("NEU1" . SPARSER::PROTEIN) ("MAN1A1" . SPARSER::PROTEIN)
    ("FUCA1" . SPARSER::PROTEIN) ("B3GALTl" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("CDH11" . SPARSER::PROTEIN)
    ("AMIGO2" . SPARSER::PROTEIN) ("CD15S" . SPARSER::DRUG)
    ("α V β 5" . SPARSER::PROTEIN) ("α V β 3" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α v β 3" . SPARSER::PROTEIN)
    ("CD104" . SPARSER::PROTEIN) ("CD29" . SPARSER::PROTEIN)
    ("CD15s" . SPARSER::DRUG) ("ml –1" . SPARSER::PROTEIN)
    ("Urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("CHST11" . SPARSER::PROTEIN) ("Fra-2" . SPARSER::PROTEIN)
    ("Fra-1" . SPARSER::PROTEIN) ("v-fos" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("C-Fos" . SPARSER::PROTEIN)
    ("intact ERα" . SPARSER::PROTEIN)
    ("additive estrogenic mixture" . SPARSER::MOLECULE)
    ("endosulfan, toxaphene, and dieldrin" . SPARSER::COLLECTION)
    ("dieldrin" . SPARSER::MOLECULE) ("toxaphene" . SPARSER::MOLECULE)
    ("endosulfan" . SPARSER::MOLECULE) ("biphenyls" . SPARSER::DRUG)
    ("dioxins" . SPARSER::MOLECULE) ("EDCs" . SPARSER::MOLECULE)
    ("estradiol and estrone" . SPARSER::COLLECTION)
    ("estrone and BMI" . SPARSER::COLLECTION)
    ("estradiol, estrone and ERα" . SPARSER::COLLECTION)
    ("estrogens and ERα- and ERβ-" . SPARSER::COLLECTION)
    ("ERα- and ERβ-" . SPARSER::COLLECTION) ("ERβ-" . SPARSER::PROTEIN)
    ("SHBG and ERβ" . SPARSER::COLLECTION)
    ("estradiol, SHBG and ERβ" . SPARSER::COLLECTION)
    ("estradiol, SHBG, and ERα-" . SPARSER::COLLECTION)
    ("SHBG" . SPARSER::PROTEIN) ("estrone and estradiol" . SPARSER::COLLECTION)
    ("estrogens and estrogen receptor-mediated bioactivity and breast cancer risk"
     . SPARSER::COLLECTION)
    ("estradiol and testosterone" . SPARSER::COLLECTION)
    ("E2 and estrone" . SPARSER::COLLECTION) ("estrone" . SPARSER::DRUG)
    ("estrogens and estrogen receptor" . SPARSER::COLLECTION)
    ("a population-based prospective cohort" . SPARSER::MOLECULE)
    ("sex hormone binding globulin" . SPARSER::PROTEIN)
    ("the antiretroviral drugs and not" . SPARSER::COLLECTION)
    ("the antiretroviral drugs" . SPARSER::DRUG)
    ("raltegravir" . SPARSER::DRUG)
    ("the relevant HIV-1 cell target" . SPARSER::TARGET-PROTEIN)
    ("DNAPK-p53" . SPARSER::COLLECTION)
    ("cellular proteases" . SPARSER::PROTEIN)
    ("CC and CYL" . SPARSER::COLLECTION) ("CYL" . SPARSER::MOLECULE)
    ("DL" . SPARSER::MOLECULE)
    ("a physiologically relevant downstream target" . SPARSER::TARGET-PROTEIN)
    ("soluble EGFR" . SPARSER::PROTEIN) ("BRCA and EGFR" . SPARSER::COLLECTION)
    ("EGFR and BRCA1" . SPARSER::COLLECTION)
    ("complex, and convergence" . SPARSER::COLLECTION)
    ("BRCA1 and EGFR" . SPARSER::COLLECTION)
    ("BRCA1 and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("composite or divergent morphological components" . SPARSER::COMPONENT)
    ("an under-sampled GG" . SPARSER::PROTEIN)
    ("PXA or GG" . SPARSER::COLLECTION)
    ("non-mutated pediatric GGs" . SPARSER::PROTEIN)
    ("their larger tumor cohort" . SPARSER::MOLECULE)
    ("18 pure pediatric GGs" . SPARSER::PROTEIN)
    ("PXAs (64: 38 adult, 26 pediatric) and PXA-As (23: 13 adult; 10 pediatric)"
     . SPARSER::COLLECTION)
    ("pure PXA" . SPARSER::PROTEIN-FAMILY) ("PXA-GGs" . SPARSER::COLLECTION)
    ("DNT" . SPARSER::PROTEIN) ("focal synaptophysin" . SPARSER::PROTEIN)
    ("Focal synaptophysin ( xref D) and fascicles" . SPARSER::COLLECTION)
    ("Focal synaptophysin" . SPARSER::PROTEIN)
    ("a large cystic component and contrast-enhancing solid portion"
     . SPARSER::COLLECTION)
    ("a large cystic component" . SPARSER::COMPONENT)
    ("migraine" . SPARSER::PROTEIN)
    ("the surrounding frontal lobe" . SPARSER::PROTEIN)
    ("the left mesial anterior basal frontal lobe" . SPARSER::PROTEIN)
    ("synaptophysin ( xref E) as well as focal GFAP" . SPARSER::COLLECTION)
    ("focal GFAP" . SPARSER::PROTEIN) ("two separate tumor DNA" . SPARSER::DNA)
    ("hydrated" . SPARSER::MOLECULE) ("xylene" . SPARSER::MOLECULE)
    ("MyoD1, desmin, and smooth muscle" . SPARSER::COLLECTION)
    ("desmin" . SPARSER::PROTEIN)
    ("S100, CD56, and synaptophysin" . SPARSER::COLLECTION)
    ("NeuN" . SPARSER::PROTEIN) ("equivocal focal EMA" . SPARSER::PROTEIN)
    ("Glial" . SPARSER::PROTEIN) ("reticulin" . SPARSER::MOLECULE)
    ("MRIs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a newly recognized biphasic type" . TYPE)
    ("INI-1, and polymerase" . SPARSER::COLLECTION)
    ("PXA and EGT" . SPARSER::COLLECTION)
    ("pure PXAs" . SPARSER::PROTEIN-FAMILY) ("PXAs" . SPARSER::PROTEIN-FAMILY)
    ("PXA-GG" . SPARSER::COLLECTION) ("PXA-EGT" . SPARSER::COLLECTION)
    ("EGT" . SPARSER::PROTEIN) ("PXA" . SPARSER::PROTEIN-FAMILY)
    ("MyoD1" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("INI-1" . SPARSER::PROTEIN) ("DNMT-" . SPARSER::PROTEIN)
    ("strong PARP-1" . SPARSER::PROTEIN)
    ("ALS, Parkinson and Huntington" . SPARSER::COLLECTION)
    ("ALS" . SPARSER::PROTEIN) ("tetracyclines" . SPARSER::DRUG)
    ("Minocycline" . SPARSER::DRUG)
    ("fisetin and t -BHP" . SPARSER::COLLECTION)
    ("Fisetin and minocycline" . SPARSER::COLLECTION)
    ("Fisetin" . SPARSER::DRUG)
    ("a nonhomologous chromosome arm or extrachromosomal telomeric DNA [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("extrachromosomal telomeric DNA" . SPARSER::DNA)
    ("a nonhomologous chromosome arm" . SPARSER::PROTEIN)
    ("a short-chain organic hydroperoxide" . SPARSER::MOLECULE)
    ("hydroperoxide" . SPARSER::MOLECULE) ("was run" . SPARSER::PROTEIN-FAMILY)
    ("t -BHP or minocycline" . SPARSER::COLLECTION)
    ("t -BHP, t -BHP and fisetin, and minocycline" . SPARSER::COLLECTION)
    ("fisetin, and minocycline" . SPARSER::COLLECTION)
    ("t -BHP, minocycline and t -BHP, and fisetin" . SPARSER::COLLECTION)
    ("t -BHP, and fisetin" . SPARSER::COLLECTION)
    ("minocycline or fisetin" . SPARSER::COLLECTION)
    ("t -BHP, fisetin, and minocycline" . SPARSER::COLLECTION)
    ("1 μ M fisetin or 100 nM minocycline" . SPARSER::COLLECTION)
    ("a lone guanine" . SPARSER::PROTEIN) ("GGG" . SPARSER::MOLECULE)
    ("fisetin and minocycline" . SPARSER::COLLECTION)
    ("minocycline" . SPARSER::DRUG) ("fisetin" . SPARSER::DRUG)
    ("b and AP-1" . SPARSER::COLLECTION) ("sirtuin 1" . SPARSER::PROTEIN)
    ("minocycline hydrochloride" . SPARSER::MOLECULE)
    ("arm 2" . SPARSER::PROTEIN-FAMILY)
    ("Telomerase activity" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("TRF2" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("sunitinib, sorafenib, and ponatinib" . SPARSER::COLLECTION)
    ("Philadelphia chromosome–positive acute lymphoblastic leukemia"
     . SPARSER::PROTEIN)
    ("quizartinib" . SPARSER::DRUG)
    ("lestaurtinib and midostaurin" . SPARSER::COLLECTION)
    ("TKIs or TKIs" . SPARSER::COLLECTION) ("azacitidine" . SPARSER::DRUG)
    ("the German-Austrian Acute Myeloid Leukemia Study Group"
     . SPARSER::MOLECULE)
    ("at least a 20" . SPARSER::PROTEIN)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("ITD-mutated alleles" . SPARSER::ALLELE)
    ("a pure 1:1 mixture" . SPARSER::MOLECULE)
    ("the 330-bp wild-type fragment and the longer mutant fragment"
     . SPARSER::COLLECTION)
    ("the longer mutant fragment" . SPARSER::FRAGMENT)
    ("sample DNA and the number of PCR" . SPARSER::COLLECTION)
    ("AML-ETO or BCR-ABL" . SPARSER::COLLECTION)
    ("fluorochrome" . SPARSER::MOLECULE) ("DNMT3a" . SPARSER::PROTEIN)
    ("c-KIT" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("Neo" . SPARSER::PROTEIN) ("RECQ5 and BRCA2" . SPARSER::COLLECTION)
    ("Rad51-ssDNA" . SPARSER::COLLECTION)
    ("the legitimate RAD51 filaments" . SPARSER::PROTEIN-FAMILY)
    ("sgs1" . SPARSER::PROTEIN) ("interchromosomal COs" . SPARSER::MOLECULE)
    ("mitotic COs" . SPARSER::MOLECULE) ("RECQ5 and BLM" . SPARSER::COLLECTION)
    ("the two complementary oligonucleotides" . SPARSER::MOLECULE)
    ("a homologous DNA" . SPARSER::DNA)
    ("RECQ5 (RECQ5 K58R ) or a RECQ5 mutant" . SPARSER::COLLECTION)
    ("-ssDNA" . SPARSER::COLLECTION) ("ssDNA-RPA" . SPARSER::COLLECTION)
    ("two complementary oligonucleotides" . SPARSER::MOLECULE)
    ("ATPase and helicase" . SPARSER::COLLECTION)
    ("RECQ5-RAD51" . SPARSER::COLLECTION) ("DNA-end" . SPARSER::DNA)
    ("RECQ5 and RAD51" . SPARSER::COLLECTION)
    ("RAD51 (HEK293/SA-GFP cells) and BRCA2 (HEK293/SA-GFP and U2OS/SA-GFP cells)"
     . SPARSER::COLLECTION)
    ("RAD51 or its loader BRCA2" . SPARSER::COLLECTION)
    ("the distal GFP fragment" . SPARSER::FRAGMENT)
    ("GFP and Sce3" . SPARSER::COLLECTION) ("SSA" . SPARSER::PROTEIN)
    ("the RAD51 recombinase or its loader BRCA2 ( xref C and D)"
     . SPARSER::COLLECTION)
    ("the I-SceI endonuclease and an internal GFP fragment"
     . SPARSER::COLLECTION)
    ("the proximal GFP allele" . SPARSER::ALLELE)
    ("an internal GFP fragment" . SPARSER::FRAGMENT)
    ("two mutated GFP alleles" . SPARSER::ALLELE)
    ("FBH1 and RECQ5" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("RAD51-ssDNA" . SPARSER::COLLECTION)
    ("the anti-recombinase activity" . SPARSER::ANTIBODY)
    ("COs" . SPARSER::MOLECULE) ("BTR" . SPARSER::PROTEIN)
    ("NCO" . SPARSER::MOLECULE) ("the most dangerous type" . TYPE)
    ("DNA double-strand break-induced HR" . SPARSER::PROTEIN)
    ("RTEL1" . SPARSER::PROTEIN) ("FBH1" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("Srs2" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN) ("RECQ5" . SPARSER::PROTEIN)
    ("Rho GTPase and TGF-β2" . SPARSER::COLLECTION)
    ("αSMA, fibronectin and vimentin" . SPARSER::COLLECTION)
    ("RhoA and MRTF-A" . SPARSER::COLLECTION)
    ("Snail, Slug and Twist-1" . SPARSER::COLLECTION)
    ("SRF/MRTF" . SPARSER::COLLECTION)
    ("cell-cell junctional proteins" . SPARSER::PROTEIN)
    ("SRF and MRTF" . SPARSER::COLLECTION)
    ("actin-SRF-MRTF" . SPARSER::COLLECTION) ("LPA-" . SPARSER::LPA)
    ("MRTF-A and SRF" . SPARSER::COLLECTION)
    ("TGF-β2 and LPA" . SPARSER::COLLECTION)
    ("transcription factor (MRTF)" . SPARSER::PROTEIN)
    ("various immediate-early genes" . SPARSER::GENE)
    ("LPA and TGF-β2" . SPARSER::COLLECTION)
    ("total secretory collagen" . SPARSER::PROTEIN)
    ("IL-1 and various ECM proteins" . SPARSER::COLLECTION)
    ("Rho GTPase/Rho kinase" . SPARSER::COLLECTION)
    ("constitutively active Rho GTPase and physiological activators"
     . SPARSER::COLLECTION)
    ("Y-27632 and Pirfenidone" . SPARSER::COLLECTION)
    ("Y-27632 or Pirfenidone" . SPARSER::COLLECTION)
    ("Pirfenidone" . SPARSER::DRUG)
    ("the SMAD2/3 inhibitor SIS3 (10 μM for 6 h) and RhoA inhibitor (C3 toxin; 1μg/ml for 6 h)"
     . SPARSER::COLLECTION)
    ("SMADs and RhoA" . SPARSER::COLLECTION)
    ("RhoA and SMAD3" . SPARSER::COLLECTION)
    ("RhoA, MRTF-A and TGF-β2" . SPARSER::COLLECTION)
    ("RhoA and TGF-β2" . SPARSER::COLLECTION)
    ("αSMA and fibronectin" . SPARSER::COLLECTION)
    ("Slug and GFP" . SPARSER::COLLECTION)
    ("Myc and GFP" . SPARSER::COLLECTION) ("Myc-Slug" . SPARSER::COLLECTION)
    ("Slug-Myc" . SPARSER::COLLECTION) ("EMT or EndMT" . SPARSER::COLLECTION)
    ("Slug, Snail and Twist-1" . SPARSER::COLLECTION)
    ("RhoA and MRTF" . SPARSER::COLLECTION)
    ("αSMA, collagen-1A1 and FSP-1" . SPARSER::COLLECTION)
    ("SRF (shSRF) significantly knocked down SRF protein" . SPARSER::PROTEIN)
    ("αSMA and FSP-1" . SPARSER::COLLECTION) ("MRTF" . SPARSER::PROTEIN)
    ("profibrotic genes FSP-1, collagen-1A1 and αSMA" . SPARSER::COLLECTION)
    ("FSP-1, collagen-1A1 and αSMA" . SPARSER::COLLECTION)
    ("EGFP-MRTF-A" . SPARSER::COLLECTION) ("SRF-MRTF" . SPARSER::COLLECTION)
    ("MRTF-A and MRTF-B" . SPARSER::COLLECTION)
    ("MAL and MKL1/2" . SPARSER::COLLECTION)
    ("serum response factor (SRF)" . SPARSER::PROTEIN)
    ("SRF-MRTF-A" . SPARSER::COLLECTION)
    ("TGF-β2 or CTGF" . SPARSER::COLLECTION)
    ("TGF-β2 (10 ng/ml) and CTGF (40 ng/ml)" . SPARSER::COLLECTION)
    ("secretory collagen" . SPARSER::PROTEIN)
    ("respective GFP" . SPARSER::PROTEIN)
    ("hydroxyproline" . SPARSER::MOLECULE)
    ("FSP-1 and αSMA" . SPARSER::COLLECTION)
    ("both αSMA ( xref ) and collagen-1A1 ( xref )" . SPARSER::COLLECTION)
    ("FSP-1, αSMA and collagen-1A1" . SPARSER::COLLECTION)
    ("rhodamine" . SPARSER::PROTEIN)
    ("three well-recognized biomarkers" . SPARSER::MOLECULE)
    ("αSMA and collagen-1A1" . SPARSER::COLLECTION)
    ("a constitutively active RhoA (RhoAV14 mutant) and GFP or GFP"
     . SPARSER::COLLECTION)
    ("GFP or GFP" . SPARSER::COLLECTION)
    ("TGF-β2 and CTGF" . SPARSER::COLLECTION)
    ("αSMA, FSP-1 and collagen-1" . SPARSER::COLLECTION)
    ("LPA and CTGF" . SPARSER::COLLECTION)
    ("fibrogenic biomarkers" . SPARSER::MOLECULE)
    ("TGF-β and Rho GTPase" . SPARSER::COLLECTION)
    ("Snail, Slug, MRTF and Twist" . SPARSER::COLLECTION)
    ("EMT and EndMT" . SPARSER::COLLECTION)
    ("Rho GTPase and Rho kinase" . SPARSER::COLLECTION)
    ("Endothelin-1 and CTGF" . SPARSER::COLLECTION)
    ("matrix and αSMA" . SPARSER::COLLECTION)
    ("endothelin-1, autotaxin, CTGF and TGF-β2" . SPARSER::COLLECTION)
    ("autotaxin" . SPARSER::PROTEIN) ("Rho/Rho kinase" . SPARSER::COLLECTION)
    ("characteristic optic disc" . SPARSER::BIO-COMPLEX)
    ("RhoA/Rho kinase" . SPARSER::COLLECTION)
    ("αSMA, FSP-1 and collagen-1A1" . SPARSER::COLLECTION)
    ("pirfenidone" . SPARSER::DRUG)
    ("Serum Response Factor (SRF)" . SPARSER::PROTEIN)
    ("Slug and Twist-1" . SPARSER::COLLECTION) ("myocardin" . SPARSER::PROTEIN)
    ("SRF" . SPARSER::PROTEIN) ("secretory total collagen" . SPARSER::PROTEIN)
    ("TGF-β and connective tissue growth factor" . SPARSER::COLLECTION)
    ("AH" . SPARSER::MOLECULE) ("small nucleolar RNA" . SPARSER::RNA)
    ("U26" . SPARSER::PROTEIN) ("MKL1" . SPARSER::PROTEIN)
    ("MRTF-B" . SPARSER::PROTEIN) ("Iba-1" . SPARSER::PROTEIN)
    ("protein-4" . SPARSER::PROTEIN) ("α–Tubulin" . SPARSER::PROTEIN)
    ("FSP1" . SPARSER::PROTEIN) ("mir29b" . SPARSER::RNA)
    ("Col1A1" . SPARSER::PROTEIN) ("Lysophosphatidic acid" . SPARSER::LPA)
    ("Endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Twist-1" . SPARSER::PROTEIN) ("MRTF-A" . SPARSER::PROTEIN)
    ("Serum Response Factor" . SPARSER::PROTEIN)
    ("collagen-1" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("FSP-1" . SPARSER::PROTEIN) ("Protein-1" . SPARSER::PROTEIN)
    ("TGF-β2" . SPARSER::PROTEIN)
    ("β-TRCP inhibitors or CKI inhibitors" . SPARSER::COLLECTION)
    ("GTPase and actin" . SPARSER::COLLECTION)
    ("MTSS1 (S322A-MTSS1) or wild-type MTSS1 (as a control)"
     . SPARSER::COLLECTION)
    ("either Cullin 1 or both β-TRCP isoforms" . SPARSER::COLLECTION)
    ("Cullin 1 or β-TRCP" . SPARSER::COLLECTION)
    ("β-TRCP1 and CKIδ" . SPARSER::COLLECTION)
    ("previously identified β-TRCP substrates" . SPARSER::SUBSTRATE)
    ("CKIα or CKIε" . SPARSER::COLLECTION) ("GST-MTSS1" . SPARSER::COLLECTION)
    ("β-TRCP1" . SPARSER::PROTEIN) ("and β-TRCP1" . SPARSER::PROTEIN-PAIR)
    ("Flag-β-TRCP1" . SPARSER::PROTEIN-PAIR) ("HA-MTSS1" . SPARSER::COLLECTION)
    ("TRCP" . SPARSER::PROTEIN) ("and β-TRCP" . SPARSER::COLLECTION)
    ("MTSS1 and Rbx1" . SPARSER::COLLECTION)
    ("MTSS1 and Skp1" . SPARSER::COLLECTION) ("XX" . SPARSER::DRUG)
    ("DSG" . SPARSER::DRUG) ("other essential components" . SPARSER::COMPONENT)
    ("protein and Rbx1" . SPARSER::COLLECTION)
    ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("CKI or β-TRCP" . SPARSER::COLLECTION)
    ("possible tumor suppressors" . SPARSER::SUPPRESSOR)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("the ubiquitin-conjugating enzyme (E2) and the ubiquitin ligase (E3)"
     . SPARSER::COLLECTION)
    ("GTPase, Cortactin and RPTPδ" . SPARSER::COLLECTION)
    ("Cortactin" . SPARSER::PROTEIN)
    ("N-WASP and G-actin" . SPARSER::COLLECTION)
    ("the WH2 domain-containing neuronal Wiskott—Aldrich Syndrome protein (N-WASP) VCA protein"
     . SPARSER::PROTEIN)
    ("a cytoskeletal scaffold protein" . SPARSER::PROTEIN)
    ("Rac, actin and actin" . SPARSER::COLLECTION)
    ("wild-type MTSS1 or a non-degradable MTSS1 (S322A)" . SPARSER::COLLECTION)
    ("trigger MTSS1's" . SPARSER::PROTEIN) ("CKI" . SPARSER::PROTEIN)
    ("Casein" . SPARSER::PROTEIN) ("Cullin 1 or β-TRCP1" . SPARSER::COLLECTION)
    ("more aggressive forms" . SPARSER::FORM) ("Hema-3" . SPARSER::PROTEIN)
    ("1—2" . SPARSER::PROTEIN) ("anti—β" . SPARSER::PROTEIN)
    ("α-HA" . SPARSER::MOLECULE) ("Cullin 5" . SPARSER::PROTEIN)
    ("Cullin 3" . SPARSER::PROTEIN) ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("CKIε" . SPARSER::PROTEIN) ("CKIα" . SPARSER::PROTEIN)
    ("Cullin1" . SPARSER::PROTEIN) ("Cullin 2" . SPARSER::PROTEIN)
    ("Cullin family" . SPARSER::PROTEIN-FAMILY) ("Rbx1" . SPARSER::PROTEIN)
    ("RPTPδ" . SPARSER::PROTEIN)
    ("Wiskott—Aldrich Syndrome protein" . SPARSER::PROTEIN)
    ("WH2" . SPARSER::PROTEIN-FAMILY) ("Cullin 1" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("MTSS1" . SPARSER::PROTEIN)
    ("TSC2 and TSC2" . SPARSER::COLLECTION)
    ("a well-characterised tumour suppressor protein" . SPARSER::PROTEIN)
    ("RASSF1A and RASSF1C" . SPARSER::COLLECTION)
    ("a tumour suppressor and an alternative isoform functioning as an oncogene"
     . SPARSER::COLLECTION)
    ("the shorter TSC2A protein" . SPARSER::PROTEIN)
    ("promoters (AP)" . SPARSER::PROMOTER)
    ("the shorter TSC2A isoform" . SPARSER::ISOFORM)
    ("TSC2A" . SPARSER::PROTEIN) ("TSC2A-FLAG" . SPARSER::PROTEIN-PAIR)
    ("antisera" . SPARSER::PROTEIN)
    ("a shorter protein isoform" . SPARSER::ISOFORM)
    ("RACE" . SPARSER::PROTEIN)
    ("a heterodimeric tumour suppressor complex" . SPARSER::BIO-COMPLEX)
    ("previously uncharacterised mRNA isoform" . SPARSER::ISOFORM)
    ("Edu" . SPARSER::DRUG) ("androgens and full-length" . SPARSER::COLLECTION)
    ("an internal androgen-regulated alternative promoter" . SPARSER::PROMOTER)
    ("DNA 2" . SPARSER::PROTEIN) ("β–tubulin" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("A15" . SPARSER::PROTEIN)
    ("Sam68" . SPARSER::PROTEIN) ("p70-S6K" . SPARSER::PROTEIN)
    ("N-term" . SPARSER::PROTEIN) ("family 1" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("CAMKK2" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Akt and p38" . SPARSER::COLLECTION)
    ("phospho-Akt and phospho-p38" . SPARSER::COLLECTION)
    ("Akt and p38α" . SPARSER::COLLECTION) ("GAA" . SPARSER::PROTEIN)
    ("HER2/neu" . SPARSER::COLLECTION) ("GGC" . SPARSER::PROTEIN)
    ("mitogen–activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the hyperactive mTORC1" . SPARSER::PROTEIN)
    ("RhoA and mTORC1/2" . SPARSER::COLLECTION)
    ("GTP loading of RhoA and the subsequent metastasis [ xref ]"
     . SPARSER::COLLECTION)
    ("fully activatemTORC1 kinase" . SPARSER::KINASE)
    ("mTORC1 and Rheb·GTP" . SPARSER::COLLECTION)
    ("RhoA and RAPTOR" . SPARSER::COLLECTION)
    ("Rho2, Cdc42, or Ras1" . SPARSER::COLLECTION)
    ("PRAS40 (Thr246) and TSC2 (Ser939)" . SPARSER::COLLECTION)
    ("p70S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("p70S6K1, 4E-BP1, and ULK1" . SPARSER::COLLECTION)
    ("Rheb and Rag" . SPARSER::COLLECTION)
    ("TSC1 (hamartin) and TSC2 (tuberin)" . SPARSER::COLLECTION)
    ("Complex (TSC)" . SPARSER::BIO-COMPLEX) ("hamartin" . SPARSER::PROTEIN)
    ("proteins, RagA, RagB, RagC, and RagD" . SPARSER::COLLECTION)
    ("RagD" . SPARSER::PROTEIN) ("RagC" . SPARSER::PROTEIN)
    ("RagB" . SPARSER::PROTEIN) ("RagA" . SPARSER::PROTEIN)
    ("aka" . SPARSER::PROTEIN) ("RAPTOR and RICTOR" . SPARSER::COLLECTION)
    ("RAPTOR (regulatory-associated protein of mTOR, complex 1) and PRAS40 (proline-rich Akt/PKB substrate 40 kDa)"
     . SPARSER::COLLECTION)
    ("mTORC1 and RICTOR" . SPARSER::COLLECTION)
    ("Akt and mTORC2" . SPARSER::COLLECTION)
    ("mTORC2-associated mTOR" . SPARSER::PROTEIN)
    ("4E-BP1 (Ser65) and ULK1 (Ser757)" . SPARSER::COLLECTION)
    ("Rheb and Rags" . SPARSER::COLLECTION) ("Rags" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("Gα13" . SPARSER::PROTEIN) ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("Ras1" . SPARSER::PROTEIN) ("Rho2" . SPARSER::PROTEIN)
    ("Kog1" . SPARSER::PROTEIN) ("Rag B" . SPARSER::PROTEIN)
    ("pRK5" . SPARSER::PROTEIN) ("Rag A" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("stress-activated map kinase-interacting protein 1" . SPARSER::PROTEIN)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("p70S6K1" . SPARSER::PROTEIN)
    ("Rho1" . SPARSER::PROTEIN) ("KAR" . SPARSER::PROTEIN)
    ("DMG" . SPARSER::PROTEIN)
    ("Tumor necrosis factor-converting enzyme" . SPARSER::COLLECTION)
    ("Interferon" . SPARSER::PROTEIN)
    ("preclinical biomarkers" . SPARSER::MOLECULE)
    ("a reliable biomarker" . SPARSER::MOLECULE)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("Macrophages" . SPARSER::PROTEIN)
    ("IL-6 and IL-8 and macrophages" . SPARSER::COLLECTION)
    ("IL-8 and macrophages" . SPARSER::COLLECTION)
    ("its soluble form" . SPARSER::FORM)
    ("a membrane-bound protein [ xref ] and soluble Flt3L"
     . SPARSER::COLLECTION)
    ("soluble Flt3L" . SPARSER::PROTEIN)
    ("Flt3L and its receptor" . SPARSER::COLLECTION)
    ("colony-stimulating factor and granulocyte–macrophage colony-stimulating factor"
     . SPARSER::COLLECTION)
    ("Flt3L, CD135 and TACE" . SPARSER::COLLECTION) ("vWF" . SPARSER::PROTEIN)
    ("These included CD68 + intimal macrophages" . SPARSER::PROTEIN)
    ("RA and gout ST" . SPARSER::COLLECTION)
    ("PB and SF" . SPARSER::COLLECTION)
    ("higher extracellular Flt3L" . SPARSER::PROTEIN)
    ("Flt3L (MFI)" . SPARSER::PROTEIN)
    ("expressed extracellular Flt3L" . SPARSER::PROTEIN)
    ("extracellular Flt3L" . SPARSER::PROTEIN)
    ("mDCs and CD304" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("receptor and ligand" . SPARSER::COLLECTION)
    ("tumor necrosis factor-converting enzyme (TACE)" . SPARSER::COLLECTION)
    ("transmembrane metalloproteases" . SPARSER::PROTEIN)
    ("disintegrin and metalloprotease" . SPARSER::COLLECTION)
    ("tumor necrosis factor-converting enzyme" . SPARSER::COLLECTION)
    ("a soluble growth factor" . SPARSER::GROWTH-FACTOR)
    ("pDC" . SPARSER::PROTEIN)
    ("RA and systemic lupus erythematosus" . SPARSER::COLLECTION)
    ("CD80 and CD83" . SPARSER::COLLECTION)
    ("costimulatory molecules" . SPARSER::MOLECULE)
    ("abundant immature mDCs and pDCs" . SPARSER::COLLECTION)
    ("mDCs and pDCs" . SPARSER::COLLECTION)
    ("IL-15, IL-18, and IL-23" . SPARSER::COLLECTION)
    ("CD86 and nuclear RelB" . SPARSER::COLLECTION)
    ("type 1 and T-helper" . SPARSER::COLLECTION)
    ("lymphoid and nonlymphoid" . SPARSER::COLLECTION)
    ("pDCs" . SPARSER::PROTEIN) ("mDCs" . SPARSER::PROTEIN)
    ("prednisolone and adalimumab" . SPARSER::COLLECTION)
    ("monocytes and CD19" . SPARSER::COLLECTION) ("FLS" . SPARSER::PROTEIN)
    ("SF and ST" . SPARSER::COLLECTION)
    ("prednisolone or adalimumab" . SPARSER::COLLECTION)
    ("adalimumab" . SPARSER::DRUG)
    ("TNF-Converting Enzyme (TACE)" . SPARSER::COLLECTION)
    ("TNF-Converting Enzyme" . SPARSER::COLLECTION)
    ("Flt3L and CD135" . SPARSER::COLLECTION) ("SF" . SPARSER::PROTEIN)
    ("FMS-related tyrosine kinase 3 Ligand" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("CD304" . SPARSER::PROTEIN)
    ("CD1c" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("granulocyte–macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("CD55" . SPARSER::PROTEIN)
    ("CD163" . SPARSER::PROTEIN) ("Converting Enzyme" . SPARSER::PROTEIN)
    ("Flt3L" . SPARSER::PROTEIN)
    ("FMS-related tyrosine kinase 3 ligand" . SPARSER::PROTEIN)
    ("YG" . SPARSER::MOLECULE)
    ("mammalian decorin and the Drosophila Kekkon-1 gene"
     . SPARSER::COLLECTION)
    ("decorin" . SPARSER::PROTEIN) ("LRRs" . SPARSER::PROTEIN)
    ("EGFR (p-EGFR) and EGFR" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION) ("aad" . SPARSER::MOLECULE)
    ("p-MAPK" . SPARSER::COLLECTION)
    ("leucine-rich repeat and immunoglobulin" . SPARSER::COLLECTION)
    ("LRIG2 [ xref ] and LRIG3 [ xref ]" . SPARSER::COLLECTION)
    ("three paralogous genes" . SPARSER::GENE)
    ("LRIG" . SPARSER::PROTEIN-FAMILY) ("EGFR/LRIG1" . SPARSER::COLLECTION)
    ("LRIG1 and EGFR" . SPARSER::COLLECTION)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("LRIG3" . SPARSER::PROTEIN)
    ("LRIG2" . SPARSER::PROTEIN) ("LIG1" . SPARSER::PROTEIN)
    ("LRIG1" . SPARSER::PROTEIN)
    ("Danish population around 200 AC" . SPARSER::PROTEIN)
    ("contralateral form" . SPARSER::FORM) ("HPF" . SPARSER::PROTEIN)
    ("gene and degree" . SPARSER::COLLECTION)
    ("ethnics and population especially Asian BC families"
     . SPARSER::PROTEIN-FAMILY)
    ("-BRCA2" . SPARSER::COLLECTION)
    ("histological and pathological state" . SPARSER::BIO-STATE)
    ("gene, 185AGdel and 5382insC" . SPARSER::COLLECTION)
    ("the 352 participants Nigerian BRCA" . SPARSER::PROTEIN-FAMILY)
    ("Ins" . SPARSER::PROTEIN) ("-AG" . SPARSER::COLLECTION)
    ("-GC" . SPARSER::COLLECTION)
    ("Iranian breast cancer families" . SPARSER::PROTEIN-FAMILY)
    ("kin" . SPARSER::PROTEIN) ("only BRCA1 gene" . SPARSER::GENE)
    ("ArG" . SPARSER::AMINO-ACID) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA damage-associated kinas BACH1" . SPARSER::PROTEIN)
    ("Sq" . SPARSER::MOLECULE)
    ("ovarian cancer (OC) families" . SPARSER::PROTEIN-FAMILY)
    ("gene and c" . SPARSER::COLLECTION)
    ("an inefficient truncated form" . SPARSER::FORM)
    ("drug resistance especially PARP inhibitors" . SPARSER::INHIBITOR)
    ("Italian high risk families" . SPARSER::PROTEIN-FAMILY)
    ("delG" . SPARSER::PROTEIN) ("delC" . SPARSER::PROTEIN)
    ("ins" . SPARSER::PROTEIN) ("insA" . SPARSER::PROTEIN)
    ("BRCA1 , and 6174delT" . SPARSER::COLLECTION)
    ("this nonsynonymous variant" . SPARSER::VARIANT)
    ("the two basic amino acids" . SPARSER::AMINO-ACID)
    ("Hispanic BC families" . SPARSER::PROTEIN-FAMILY)
    ("Salvador" . SPARSER::PROTEIN) ("BRCA1 and c" . SPARSER::COLLECTION)
    ("a pathogenic variant" . SPARSER::VARIANT)
    ("premature stop codon" . SPARSER::PROTEIN)
    ("entire nonfunctional BRCA proteins" . SPARSER::PROTEIN)
    ("complex (BASC)" . SPARSER::BIO-COMPLEX) ("OB1-3" . SPARSER::COLLECTION)
    ("proteins as well as BRCA2" . SPARSER::COLLECTION)
    ("BRC" . SPARSER::PROTEIN) ("The largest exon" . SPARSER::PROTEIN)
    ("Myb" . SPARSER::PROTEIN) ("BRCA2 and colon cancer" . SPARSER::COLLECTION)
    ("triple negative forms" . SPARSER::FORM)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("ATM, CHECK2, BRIP1, and PALB2" . SPARSER::COLLECTION)
    ("STK11/LKB1" . SPARSER::COLLECTION) ("P-cadherin" . SPARSER::PROTEIN)
    ("A-G" . SPARSER::PROTEIN) ("Rad-51" . SPARSER::PROTEIN)
    ("OB1" . SPARSER::PROTEIN) ("DMC1" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("STK11" . SPARSER::PROTEIN)
    ("EGF and its receptor" . SPARSER::COLLECTION)
    ("atypical PKC" . SPARSER::PROTEIN)
    ("atypical PKC and GSK-3β" . SPARSER::COLLECTION)
    ("PKC and GSK-3β" . SPARSER::COLLECTION)
    ("U0126 and Gö6983" . SPARSER::COLLECTION)
    ("anti-GSK-3β or -PKCζ antibodies ( xref )" . SPARSER::COLLECTION)
    ("PKCζ or GSK-3β" . SPARSER::COLLECTION) ("-PKCζ" . SPARSER::COLLECTION)
    ("aPKC" . SPARSER::PROTEIN) ("only MEK-1 inhibitor" . SPARSER::INHIBITOR)
    ("typical PKC" . SPARSER::PROTEIN)
    ("LY294002 and wortmannin" . SPARSER::COLLECTION)
    ("Gö6983 or U0126" . SPARSER::COLLECTION)
    ("pan-PKC or mitogen-activated protein kinase kinase"
     . SPARSER::COLLECTION)
    ("MAPKK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKC and MAPK" . SPARSER::COLLECTION)
    ("GSK-3α and -3β" . SPARSER::COLLECTION)
    ("S9A-GSK-3β" . SPARSER::PROTEIN-PAIR) ("axin" . SPARSER::PROTEIN)
    ("NaCl and DMSO" . SPARSER::COLLECTION)
    ("LiCl or SB216763" . SPARSER::COLLECTION)
    ("LiCl and SB216763" . SPARSER::COLLECTION) ("LiCl" . SPARSER::DRUG)
    ("GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("pSer21-GSK-3α and pSer9-GSK-3β" . SPARSER::COLLECTION)
    ("PCP" . SPARSER::PROTEIN) ("A 37" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("Gö6983" . SPARSER::DRUG)
    ("GID5" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("MUC2 and MUC5C" . SPARSER::COLLECTION)
    ("physiological biliary mucin" . SPARSER::PROTEIN)
    ("mucins, MUC5AC, MUC5B, and MUC6" . SPARSER::COLLECTION)
    ("MUC2-rich polymeric mucin and these trimers" . SPARSER::COLLECTION)
    ("MUC2-rich polymeric mucin" . SPARSER::PROTEIN)
    ("pyloric gland type mucins" . SPARSER::PROTEIN)
    ("MUC2, MUC5AC and MUC6" . SPARSER::COLLECTION)
    ("mucins" . SPARSER::PROTEIN) ("viscous mucin" . SPARSER::PROTEIN)
    ("KRAS and GNAS" . SPARSER::COLLECTION)
    ("GNAS or KRAS" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("CCs" . SPARSER::PROTEIN) ("fluke" . SPARSER::PROTEIN)
    ("Mucin" . SPARSER::PROTEIN) ("GAT and GGT" . SPARSER::COLLECTION)
    ("GAT" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("MUC1, MUC2, MUC5AC, MUC5B and MUC6" . SPARSER::COLLECTION)
    ("the stimulatory G-protein" . SPARSER::PROTEIN)
    ("polypeptide (GNAS)" . SPARSER::PROTEIN) ("Guanine" . SPARSER::PROTEIN)
    ("MUC2 and MUC5AC" . SPARSER::COLLECTION) ("MUC" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("GNAS and KRAS" . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN) ("MUC5" . SPARSER::PROTEIN)
    ("MUC3" . SPARSER::PROTEIN) ("gastric type" . SPARSER::PROTEIN)
    ("MUC6" . SPARSER::PROTEIN) ("MUC5B" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN)
    ("adenylate cyclase activity" . SPARSER::PROTEIN)
    ("MUC5AC" . SPARSER::PROTEIN) ("MUC2" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::PROTEIN)
    ("integrin and caveolin1" . SPARSER::COLLECTION)
    ("RhoC-p38MAPK" . SPARSER::PROTEIN-PAIR)
    ("peri-tumoral fibronectin" . SPARSER::PROTEIN)
    ("RhoA or RhoB" . SPARSER::COLLECTION)
    ("integrins, the Src-family and small GTPases" . SPARSER::COLLECTION)
    ("Biotin" . SPARSER::PROTEIN)
    ("protein and integrin" . SPARSER::COLLECTION)
    ("anti-RhoC or anti-integrin" . SPARSER::COLLECTION)
    ("α5β1 or anti-integrin" . SPARSER::COLLECTION)
    ("collagen and laminin" . SPARSER::COLLECTION)
    ("α5β1 and αvβ3" . SPARSER::COLLECTION)
    ("GTPases and ROCK" . SPARSER::COLLECTION) ("endo" . SPARSER::PROTEIN)
    ("Nocodazole" . SPARSER::DRUG) ("Paxillin" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::PROTEIN) ("DEC-hTERT" . SPARSER::COLLECTION)
    ("DEC" . SPARSER::PROTEIN) ("mir10b" . SPARSER::PROTEIN)
    ("small GTPases (RhoA, RhoB and RhoC) share nearly 84% amino acid sequence homology"
     . SPARSER::PROTEIN)
    ("RhoA, RhoB and RhoC" . SPARSER::COLLECTION)
    ("α5β1 and RhoC" . SPARSER::COLLECTION) ("Pdx-1-Cre" . SPARSER::COLLECTION)
    ("KrasG" . SPARSER::PROTEIN) ("RhoC and integrin" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Trop-2" . SPARSER::PROTEIN)
    ("caveolin1" . SPARSER::PROTEIN) ("FMNL1" . SPARSER::PROTEIN)
    ("Transferrin receptor" . SPARSER::PROTEIN) ("α5" . SPARSER::PROTEIN)
    ("αvβ6" . SPARSER::PROTEIN) ("αvβ5" . SPARSER::PROTEIN)
    ("αvβ3" . SPARSER::PROTEIN) ("secretory granule" . SPARSER::PROTEIN)
    ("Notch-1" . SPARSER::PROTEIN) ("FMNL3" . SPARSER::PROTEIN)
    ("FMNL2" . SPARSER::PROTEIN) ("Pdx-1" . SPARSER::PROTEIN)
    ("activated mitochondrial STAT3" . SPARSER::PROTEIN)
    ("the transformed state" . SPARSER::BIO-STATE)
    ("S727 phosphorylated mitochondrial STAT3" . SPARSER::PROTEIN)
    ("ERK2 and STAT3" . SPARSER::COLLECTION)
    ("those expressing wild type mitochondrial STAT3" . SPARSER::PROTEIN)
    ("ERK, JNK, p38, mTOR, SEC1, PKCδ, and Rac-" . SPARSER::COLLECTION)
    ("Rac-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrially-targeted S727D mutant STAT3" . SPARSER::PROTEIN)
    ("K-Ras and p" . SPARSER::COLLECTION)
    ("mitochondrially-targeted STAT3 or the mitochondrially-targeted S727D substitution mutant"
     . SPARSER::COLLECTION)
    ("the mitochondrially-targeted S727D substitution mutant"
     . SPARSER::MUTANT)
    ("mitochondrially-targeted STAT3" . SPARSER::PROTEIN)
    ("phospho-mimetic mitochondrial STAT3" . SPARSER::PROTEIN)
    ("a mitochondrially-restricted phospho-mimetic STAT3" . SPARSER::PROTEIN)
    ("only mitochondrial STAT3" . SPARSER::PROTEIN)
    ("mitochondrially-restricted MTS-STAT3" . SPARSER::COLLECTION)
    ("a mitochondrially-targeted STAT3" . SPARSER::PROTEIN)
    ("MTS" . SPARSER::PROTEIN) ("MTS-STAT3" . SPARSER::COLLECTION)
    ("Ras-transformed MEFs" . SPARSER::PROTEIN)
    ("rapamycin or inhibition of the PI3K-AKT pathway with LY294002"
     . SPARSER::COLLECTION)
    ("S6K and AKT" . SPARSER::COLLECTION)
    ("ERK, S6K, and AKT" . SPARSER::COLLECTION)
    ("genetic mutants and pharmacological inhibitors" . SPARSER::COLLECTION)
    ("Mitochondrial STAT3" . SPARSER::PROTEIN)
    ("p38, JNK, PKCδ, SEK1, mTOR, or Rac1-" . SPARSER::COLLECTION)
    ("VAV" . SPARSER::PROTEIN) ("PXS/TP" . SPARSER::COLLECTION)
    ("PI3K and Ral" . SPARSER::COLLECTION)
    ("FLT3, EGFR, Src and JAK2" . SPARSER::COLLECTION)
    ("mitochondrial STAT3" . SPARSER::PROTEIN) ("SEC1" . SPARSER::PROTEIN)
    ("bar 1" . SPARSER::PROTEIN) ("Rasv12" . SPARSER::DRUG)
    ("cytochrome c oxidase subunit VIII" . SPARSER::PROTEIN)
    ("RasV12" . SPARSER::DRUG) ("SEK1" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN)
    ("EpCAM, c-myc, and FOXO3a" . SPARSER::COLLECTION)
    ("GSK3β and protein" . SPARSER::COLLECTION)
    ("EpCAM and c-myc" . SPARSER::COLLECTION)
    ("c-myc, EpCAM, and Bmi1" . SPARSER::COLLECTION)
    ("mTOR and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("c-myc and FOXO3a" . SPARSER::COLLECTION)
    ("mTORC1 or mTORC2" . SPARSER::COLLECTION)
    ("which signals Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCAA and 5-FU" . SPARSER::COLLECTION) ("a 2:1:1.2" . SPARSER::COLLECTION)
    ("CD133 and EpCAM" . SPARSER::COLLECTION) ("cscs" . SPARSER::PROTEIN)
    ("5-FU and BCAA" . SPARSER::COLLECTION)
    ("rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCAA and/or 5-fluorouracil (FU)" . SPARSER::COLLECTION)
    ("FU" . SPARSER::PROTEIN) ("BCAA" . SPARSER::PROTEIN)
    ("P70S6" . SPARSER::PROTEIN) ("a  2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRF-1" . SPARSER::PROTEIN) ("p-70" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("CYP3A4" . SPARSER::PROTEIN)
    ("sh-RNA" . SPARSER::RNA) ("1-B" . SPARSER::PROTEIN)
    ("oncostatin M" . SPARSER::PROTEIN) ("Oncostatin M" . SPARSER::PROTEIN)
    ("branched chain" . SPARSER::PROTEIN)
    ("PKCε and hsa-miR-377" . SPARSER::COLLECTION)
    ("ACAN and hsa-miR-377, and dowregulation" . SPARSER::COLLECTION)
    ("AP-1 and CREB1" . SPARSER::COLLECTION) ("GlcAT-1" . SPARSER::COLLECTION)
    ("granulin" . SPARSER::PROTEIN) ("PD98059 and U0126" . SPARSER::COLLECTION)
    ("ATF and Fos" . SPARSER::COLLECTION) ("CTGF/CCN2" . SPARSER::COLLECTION)
    ("antirheumatic drugs" . SPARSER::DRUG)
    ("the adult bovine caudal disc" . SPARSER::BIO-COMPLEX)
    ("Indeed LPA receptors" . SPARSER::RECEPTOR)
    ("normoxia and serum growth factors" . SPARSER::COLLECTION)
    ("aggrecan and type II" . SPARSER::COLLECTION)
    ("chondrocytic differentiation transcription factor" . SPARSER::PROTEIN)
    ("ACAN and ADAMTS5" . SPARSER::COLLECTION) ("ACAN" . SPARSER::PROTEIN)
    ("CREB1 and AP-1" . SPARSER::COLLECTION)
    ("MEK1/2-ERK1/2" . SPARSER::COLLECTION)
    ("transcription factor (ATF) and Fos ( xref )" . SPARSER::COLLECTION)
    ("PKCε/ERK" . SPARSER::COLLECTION) ("JNK or p38" . SPARSER::COLLECTION)
    ("MARCKS" . SPARSER::PROTEIN) ("PKCε and ERK" . SPARSER::COLLECTION)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("biglycan, fibromodulin, and lumican" . SPARSER::COLLECTION)
    ("the chondrogenic Hedgehog proteins" . SPARSER::PROTEIN)
    ("proteoglycan" . SPARSER::PROTEIN) ("chondroitin" . SPARSER::MOLECULE)
    ("chitosan" . SPARSER::MOLECULE)
    ("a chondrocytic phenotype regulator" . SPARSER::REGULATOR)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("particular aggrecan" . SPARSER::PROTEIN) ("ADAM" . SPARSER::PROTEIN)
    ("aggrecan, and type II" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN)
    ("the intervertebral disc (IVD)" . SPARSER::BIO-COMPLEX)
    ("IVD" . SPARSER::PROTEIN)
    ("both chondrogenic genes and microRNAs" . SPARSER::COLLECTION)
    ("genes and microRNAs" . SPARSER::COLLECTION)
    ("ATF, CREB1, and Fos" . SPARSER::COLLECTION)
    ("aggrecan, biglycan, fibromodulin, and lumican" . SPARSER::COLLECTION)
    ("SOX-trio" . SPARSER::COLLECTION) ("lumican" . SPARSER::PROTEIN)
    ("fibromodulin" . SPARSER::PROTEIN) ("biglycan" . SPARSER::PROTEIN)
    ("aggrecan" . SPARSER::PROTEIN) ("NP" . SPARSER::PROTEIN)
    ("BMP-2" . SPARSER::PROTEIN) ("HCS-2" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("Col2A1" . SPARSER::PROTEIN)
    ("P13" . SPARSER::PROTEIN) ("P23" . SPARSER::PROTEIN)
    ("NP10" . SPARSER::PROTEIN) ("NP2" . SPARSER::PROTEIN)
    ("NP1" . SPARSER::PROTEIN) ("P10" . SPARSER::PROTEIN)
    ("P28" . SPARSER::PROTEIN) ("P17" . SPARSER::PROTEIN)
    ("ki67" . SPARSER::PROTEIN) ("SOX6" . SPARSER::PROTEIN)
    ("SOX5" . SPARSER::PROTEIN) ("1µL" . SPARSER::PROTEIN)
    ("cAMP responsive element binding protein 1" . SPARSER::PROTEIN)
    ("C-kinase" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("ADAMTS5" . SPARSER::PROTEIN) ("CREB1" . SPARSER::PROTEIN)
    ("Patched-1" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("miRNA and its target genes" . SPARSER::COLLECTION)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRS-1 or IRS-2" . SPARSER::COLLECTION)
    ("metastasis-associated gene" . SPARSER::GENE)
    ("under-expressed miRNAs" . SPARSER::PROTEIN)
    ("genes or oncogenes" . SPARSER::COLLECTION)
    ("miR-126 inhibitor or NC inhibitor" . SPARSER::COLLECTION)
    ("MiR-126 and IRS-1" . SPARSER::COLLECTION)
    ("typical cytosolic adaptor proteins" . SPARSER::PROTEIN)
    ("growth factor/phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("p53 pathway-associated regulatory proteins" . SPARSER::PROTEIN)
    ("MDM2, Bcl-2, Bcl-xL and Bax" . SPARSER::COLLECTION)
    ("colon cancer-1" . SPARSER::COLLECTION) ("MiRNAs" . SPARSER::PROTEIN)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("IRS-1, AKT, and ERK1/2" . SPARSER::COLLECTION)
    ("p58" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAK4" . SPARSER::PROTEIN)
    ("UBF-1" . SPARSER::PROTEIN)
    ("upstream binding factor-1" . SPARSER::PROTEIN)
    ("IRS-2" . SPARSER::PROTEIN) ("programmed cell death 4" . SPARSER::PROTEIN)
    ("insulin-like growth factor I" . SPARSER::PROTEIN)
    ("insulin-like growth factor I receptor" . SPARSER::PROTEIN)
    ("Insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MACC1" . SPARSER::PROTEIN) ("MiR-126" . SPARSER::PROTEIN)
    ("CDK9 or cMYC" . SPARSER::COLLECTION)
    ("CDK9 and cyclin T1" . SPARSER::COLLECTION)
    ("PTEF-b" . SPARSER::COLLECTION)
    ("elongation factor-b" . SPARSER::COLLECTION)
    ("the higher transcriptional elongation" . SPARSER::PROTEIN)
    ("a well-defined estrogen-regulated gene [ xref ] and the estrogen-induced growth"
     . SPARSER::COLLECTION)
    ("a well-defined estrogen-regulated gene" . SPARSER::GENE)
    ("its natural proximal promoter" . SPARSER::PROMOTER)
    ("the transcriptional elongation" . SPARSER::PROTEIN)
    ("AIs [ xref ] and antiestrogens [ xref , xref ]" . SPARSER::COLLECTION)
    ("subsequent genes" . SPARSER::GENE)
    ("cMYC RNA and levels of cMYC protein in MCF7:5C cells"
     . SPARSER::COLLECTION)
    ("competitive inhibitor" . SPARSER::INHIBITOR)
    ("serine-2 RNA polymerase II [ xref , xref ] and the elongation"
     . SPARSER::COLLECTION)
    ("poor RFS" . SPARSER::PROTEIN) ("Tamoxifen or AIs" . SPARSER::COLLECTION)
    ("AIs" . SPARSER::PROTEIN)
    ("The top 25% percent highest cMYC" . SPARSER::PROTEIN)
    ("MCF7 and MCF7:5C" . SPARSER::COLLECTION)
    ("4OHT and fulvestrant" . SPARSER::COLLECTION)
    ("the cMYC oncogene and the genes regulated by cMYC" . SPARSER::COLLECTION)
    ("tamoxifen and aromatase" . SPARSER::COLLECTION)
    ("cMYC" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("cyclin T1" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("FCP1" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 9" . SPARSER::PROTEIN) ("S’" . SPARSER::PROTEIN)
    ("CTDP1" . SPARSER::PROTEIN) ("4-hydroxy - tamoxifen" . SPARSER::DRUG)
    ("Neuronal merlin" . SPARSER::PROTEIN)
    ("ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("type III–ERBB2" . SPARSER::COLLECTION)
    ("NRG1/ERBB2" . SPARSER::COLLECTION)
    ("laminin/integrin" . SPARSER::COLLECTION)
    ("neuregulin" . SPARSER::PROTEIN)
    ("EGFR, ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("axonal NRG1 type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BACE1 ( xref ) or TACE ( xref )" . SPARSER::COLLECTION)
    ("TACE" . SPARSER::PROTEIN) ("neuregulins" . SPARSER::PROTEIN)
    ("the hereditary tumour syndrome NF2" . SPARSER::PROTEIN)
    ("receptors—PI-3K/Akt" . SPARSER::COLLECTION)
    ("an axonal surface molecule" . SPARSER::MOLECULE)
    ("the axonal surface protein NRG1 type III"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one functional merlin allele" . SPARSER::ALLELE)
    ("Nefh-Cre" . SPARSER::COLLECTION) ("Nefh" . SPARSER::PROTEIN)
    ("axonal NRG1" . SPARSER::PROTEIN)
    ("the respective axonal surface proteins" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN)
    ("Another prominent axonal surface protein" . SPARSER::PROTEIN)
    ("PI-3K/Akt" . SPARSER::COLLECTION) ("ERBB2/3" . SPARSER::PROTEIN)
    ("merlin-iso1" . SPARSER::COLLECTION)
    ("proteins as well as NOTCH1" . SPARSER::COLLECTION)
    ("obvious axonal membrane molecules" . SPARSER::MOLECULE)
    ("axonal surface proteins" . SPARSER::PROTEIN)
    ("this axonal membrane-associated growth factor" . SPARSER::GROWTH-FACTOR)
    ("NRG1–ERBB2/3" . SPARSER::COLLECTION)
    ("namely merlin isoform 2" . SPARSER::PROTEIN)
    ("axonal merlin" . SPARSER::PROTEIN)
    ("the axonal surface protein neuregulin 1" . SPARSER::PROTEIN)
    ("neuronal merlin" . SPARSER::PROTEIN)
    ("the hereditary tumour syndrome neurofibromatosis type 2"
     . SPARSER::PROTEIN)
    ("heterogeneous molecules" . SPARSER::MOLECULE)
    ("Axonal surface proteins" . SPARSER::PROTEIN)
    ("merlin" . SPARSER::PROTEIN) ("GPR126" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("BACE1" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN)
    ("neuregulin family" . SPARSER::PROTEIN)
    ("Neuregulin 1" . SPARSER::PROTEIN) ("TRS 1" . SPARSER::PROTEIN)
    ("anti-ErbB2" . SPARSER::DRUG) ("Nrg1" . SPARSER::PROTEIN)
    ("I-19" . SPARSER::PROTEIN) ("myelin protein zero" . SPARSER::PROTEIN)
    ("CD79a" . SPARSER::PROTEIN)
    ("leukocyte common antigen" . SPARSER::PROTEIN)
    ("S-100" . SPARSER::HUMAN-PROTEIN-FAMILY) ("iso1" . SPARSER::PROTEIN)
    ("Nf2" . SPARSER::PROTEIN) ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P19" . SPARSER::PROTEIN) ("Neuregulin1" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a strong inhibitor" . SPARSER::INHIBITOR) ("Smac" . SPARSER::PROTEIN)
    ("ShcA" . SPARSER::PROTEIN) ("CCL" . SPARSER::DRUG)
    ("MAPK and MAPK‐independent" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("DUSP5 and DUSP1" . SPARSER::COLLECTION)
    ("ERK1/2, p38, and SAPK" . SPARSER::COLLECTION)
    ("VEGF and thrombin" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("DUSP4 and DUSP5" . SPARSER::COLLECTION)
    ("DUSP4 or DUSP5" . SPARSER::COLLECTION)
    ("a recombinant soluble Tie‐2 receptor" . SPARSER::RECEPTOR)
    ("the ERK1/2, p38, SAPK/JNK, and PI‐3 kinase pathways"
     . SPARSER::COLLECTION)
    ("p38 and PI‐3" . SPARSER::COLLECTION)
    ("ERK1/2 and PI‐3" . SPARSER::COLLECTION)
    ("DUSP1 ( xref A) and DUSP5 ( xref C)" . SPARSER::COLLECTION)
    ("APF" . SPARSER::PROTEIN) ("ERK1/2 or PI‐3" . SPARSER::COLLECTION)
    ("p38 or PI‐3" . SPARSER::COLLECTION) ("kinase/AKT" . SPARSER::COLLECTION)
    ("DUSP1, DUSP4, or DUSP5" . SPARSER::COLLECTION)
    ("DUSP1 and DUSP4" . SPARSER::COLLECTION)
    ("DUSP1 or DUSP5" . SPARSER::COLLECTION)
    ("DUSP1, DUSP3, DUSP4, DUSP5, DUSP6, DUSP7, DUSP11, DUSP12, DUSP14, and DUSP22"
     . SPARSER::COLLECTION)
    ("DUSP1 and DUSP5" . SPARSER::COLLECTION)
    ("phosphothreonine and phosphotyrosine" . SPARSER::COLLECTION)
    ("ERK1/2 and SAPK" . SPARSER::COLLECTION)
    ("DUSP1, DUSP4, and DUSP5" . SPARSER::COLLECTION)
    ("SAPK/JNK" . SPARSER::COLLECTION) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphotyrosine and phosphoserine/phosphothreonine residues on target MAPKs"
     . SPARSER::COLLECTION)
    ("Dual‐specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ang" . SPARSER::PROTEIN)
    ("Angiopoietin" . SPARSER::PROTEIN)
    ("Sphingosine kinase" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Activating protein" . SPARSER::PROTEIN) ("PD184352" . SPARSER::DRUG)
    ("DUSP7" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("DUSP3" . SPARSER::PROTEIN) ("DUSP2" . SPARSER::PROTEIN)
    ("CDC25" . SPARSER::PROTEIN) ("CH2" . SPARSER::PROTEIN)
    ("early growth response" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN)
    ("HDAC1 and rs58677352" . SPARSER::COLLECTION) ("FEV" . SPARSER::PROTEIN)
    ("histone deacetylase 1 ( HDAC1 ) and HDAC2" . SPARSER::COLLECTION)
    ("Aims" . SPARSER::PROTEIN) ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("IL-6/Stat3" . SPARSER::COLLECTION) ("CCL2-STAT3" . SPARSER::COLLECTION)
    ("Jak2-stat3" . SPARSER::COLLECTION) ("Jak2-Stat3" . SPARSER::COLLECTION)
    ("p-Stat3" . SPARSER::COLLECTION) ("Stat3 and AR" . SPARSER::COLLECTION)
    ("Stat3C" . SPARSER::PROTEIN) ("LNCaP-Stat3C" . SPARSER::COLLECTION)
    ("c-Myc and survivin" . SPARSER::COLLECTION)
    ("AR, c-Myc, survivin, and Bcl-2" . SPARSER::COLLECTION)
    ("c-Myc, survivin, and Bcl-2" . SPARSER::COLLECTION)
    ("complete FBS" . SPARSER::PROTEIN) ("LNCaP-neo" . SPARSER::COLLECTION)
    ("LNCaP-s17" . SPARSER::COLLECTION) ("IL-6-Stat3" . SPARSER::COLLECTION)
    ("Stat3 siRNA or a Stat3 inhibitor-AG490" . SPARSER::COLLECTION)
    ("Autocrine IL-6" . SPARSER::PROTEIN) ("JAK-Stat" . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN)
    ("an IL6-specific receptor subunit and a signal transducer"
     . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("IL6-Stat3" . SPARSER::COLLECTION)
    ("enzalutamide and AG490" . SPARSER::COLLECTION)
    ("Stat3 and its target genes" . SPARSER::COLLECTION)
    ("autocrine IL-6" . SPARSER::PROTEIN)
    ("IL-6, c-Myc, survivin and AR" . SPARSER::COLLECTION)
    ("Janus kinase 2" . SPARSER::PROTEIN) ("stat3" . SPARSER::PROTEIN)
    ("AR-C" . SPARSER::PROTEIN) ("s17" . SPARSER::PROTEIN)
    ("TGF-β, FGFs, and WNTs" . SPARSER::COLLECTION) ("WNTs" . SPARSER::PROTEIN)
    ("CAFs" . SPARSER::PROTEIN) ("collagen and vimentin" . SPARSER::COLLECTION)
    ("tenascin" . SPARSER::PROTEIN)
    ("known prostate-associated oncogenes" . SPARSER::ONCOGENE)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt7a , Wnt3 and Wnt6" . SPARSER::COLLECTION)
    ("Wnt7a" . SPARSER::PROTEIN)
    ("tumor-associated stromal p-Smad2" . SPARSER::COLLECTION)
    ("p-Smad2" . SPARSER::COLLECTION)
    ("various metastasis-associated genes" . SPARSER::GENE)
    ("Snail2, Twist1, and R-Ras" . SPARSER::COLLECTION)
    ("the FGF axis receptors ( i.e ., FGFR1 , 2 , 3 , and 4 ) and ligands ( i.e ., FGF s 3 , 7 and 8 )"
     . SPARSER::COLLECTION)
    ("an all-inclusive stromal promoter" . SPARSER::PROMOTER)
    ("FGFR1 and WNT" . SPARSER::COLLECTION) ("Tenascin" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN) ("FGFR1/WNT" . SPARSER::COLLECTION)
    ("a lipid-permeable chemical inducer" . SPARSER::MOLECULE)
    ("composite probasin promoter" . SPARSER::PROMOTER)
    ("probasin" . SPARSER::PROTEIN) ("WNT and TGF-β" . SPARSER::COLLECTION)
    ("MAPK/pERK" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("RAF/MEK/MAPK-ERK1/2" . SPARSER::COLLECTION)
    ("FGFR1-WNT-TGF-β" . SPARSER::COLLECTION) ("mPIN" . SPARSER::PROTEIN)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("the cellular components and signaling control mechanisms"
     . SPARSER::COLLECTION)
    ("Wnt3a" . SPARSER::PROTEIN) ("WNT16" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN) ("Wnt6" . SPARSER::PROTEIN)
    ("Wnt3" . SPARSER::PROTEIN) ("H-2K" . SPARSER::PROTEIN)
    ("LRP5" . SPARSER::PROTEIN) ("AP20187" . SPARSER::DRUG)
    ("ARR 2" . SPARSER::PROTEIN) ("Wnt-1" . SPARSER::PROTEIN)
    ("lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("EGFR and Ras" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("ErbB2 or ErbB3" . SPARSER::COLLECTION)
    ("the flotillin-1 [ xref ] and flotillin-2 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("protein kinase B/AKT" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("the respective flotillin" . SPARSER::PROTEIN)
    ("flotillin-1-EGFP" . SPARSER::COLLECTION)
    ("flotillin-2-EGFP" . SPARSER::COLLECTION)
    ("stably re-expressing EGFP-tagged flotillins" . SPARSER::PROTEIN-FAMILY)
    ("EGFP" . SPARSER::PROTEIN) ("EGF, and EGFR" . SPARSER::COLLECTION)
    ("LAMP3/CD63" . SPARSER::COLLECTION)
    ("neither ErbB2 (Figure  xref C) nor ErbB3 (Figure  xref D)"
     . SPARSER::COLLECTION)
    ("EGFR, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("the respective flotillin protein" . SPARSER::PROTEIN)
    ("flotillin-1 or flotillin-2" . SPARSER::COLLECTION)
    ("Flotillins" . SPARSER::PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION) ("flotillin" . SPARSER::PROTEIN)
    ("Flotillin-1 and flotillin-2" . SPARSER::COLLECTION)
    ("Foxo3" . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("Flotillin-2" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("PD153035" . SPARSER::DRUG) ("AG9" . SPARSER::PROTEIN)
    ("LAMP3" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("flotillin-1" . SPARSER::PROTEIN)
    ("flotillin-2" . SPARSER::PROTEIN) ("Flotillin-1" . SPARSER::PROTEIN)
    ("KH" . SPARSER::MOLECULE) ("MH, SU and SN" . SPARSER::COLLECTION)
    ("MH and SU" . SPARSER::COLLECTION)
    ("ZEB1 and E-cadherin" . SPARSER::COLLECTION)
    ("transcriptional activators and repressors" . SPARSER::COLLECTION)
    ("Again using western blot" . SPARSER::PROTEIN)
    ("dEF1, Nil-2-a, Tcf8, Bzp, Areb6, Meb1, Zfhx1a and Zfhep"
     . SPARSER::COLLECTION)
    ("Tcf8" . SPARSER::PROTEIN) ("Snail, Slug and SIP" . SPARSER::COLLECTION)
    ("SIP" . SPARSER::PROTEIN) ("ZEB-1, and ZEB2" . SPARSER::COLLECTION)
    ("Snail2/Slug" . SPARSER::COLLECTION)
    ("fibronectin and/or N-cadherin" . SPARSER::COLLECTION)
    ("mesenchymal molecules" . SPARSER::MOLECULE)
    ("both operable and advanced HCC" . SPARSER::PROTEIN)
    ("ZEB-1 and E-cadherin" . SPARSER::COLLECTION)
    ("Zfhx1a" . SPARSER::PROTEIN) ("Meb1" . SPARSER::PROTEIN)
    ("dEF1" . SPARSER::PROTEIN) ("hepatitis B surface antigen" . SPARSER::DRUG)
    ("Smad4" . SPARSER::PROTEIN) ("smad4" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN) ("ZEB-1" . SPARSER::PROTEIN)
    ("PPARs" . SPARSER::PROTEIN) ("NCOA2 and NCOA3" . SPARSER::COLLECTION)
    ("RXRα and LXR" . SPARSER::COLLECTION)
    ("TP53, RB and NCOA2" . SPARSER::COLLECTION)
    ("estrogen receptor- and progesterone receptor-positive and ErbB2-negative"
     . SPARSER::COLLECTION)
    ("estrogen receptor-" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor (PPAR) isoforms"
     . SPARSER::ISOFORM)
    ("PPAR" . SPARSER::PROTEIN) ("peroxisome" . SPARSER::PROTEIN)
    ("LXR" . SPARSER::PROTEIN)
    ("a possible downstream effector" . SPARSER::EFFECTOR)
    ("ERα and other hormone receptors
[ xref , xref ]"
     . SPARSER::COLLECTION)
    ("E2F-1, RAR, NFκB, and STAT6" . SPARSER::COLLECTION)
    ("E2F-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLAC1 and NCOA3" . SPARSER::COLLECTION)
    ("SP1 and C/EBPβ-2" . SPARSER::COLLECTION)
    ("general transcription factor IIB (TFIIB) and RNA polymerase II (Pol II)"
     . SPARSER::COLLECTION)
    ("p300 and pCAF" . SPARSER::COLLECTION) ("pCAF" . SPARSER::PROTEIN)
    ("/ERα" . SPARSER::COLLECTION) ("ICI 182,780 (ICI)" . SPARSER::DRUG)
    ("NCOA1 and NCOA2" . SPARSER::COLLECTION)
    ("NCOA2
[ xref ] and NCOA3
[ xref ]"
     . SPARSER::COLLECTION)
    ("directly tethering activated ERα" . SPARSER::PROTEIN)
    ("tethering activated ERα" . SPARSER::PROTEIN)
    ("C/EBPβ-2" . SPARSER::COLLECTION)
    ("SP1 and isoform 2" . SPARSER::COLLECTION) ("Plac1" . SPARSER::PROTEIN)
    ("cancer-associated placental genes" . SPARSER::GENE)
    ("NCOA1 or NCOA2" . SPARSER::COLLECTION)
    ("NCOA3 and PLAC1" . SPARSER::COLLECTION)
    ("NCOA1, NCOA2 and NCOA3" . SPARSER::COLLECTION)
    ("a membrane-associated protein" . SPARSER::PROTEIN)
    ("The placenta-specific 1 ( PLAC1) gene" . SPARSER::GENE)
    ("PPARδ" . SPARSER::PROTEIN) ("RXRα" . SPARSER::PROTEIN)
    ("retinoid X receptor alpha" . SPARSER::PROTEIN) ("F-1" . SPARSER::PROTEIN)
    ("general transcription factor IIB" . SPARSER::PROTEIN)
    ("RNA-Polymerase" . SPARSER::PROTEIN) ("ATG-3" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("SRC-3" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("NCOA3" . SPARSER::PROTEIN)
    ("NCOA2" . SPARSER::PROTEIN) ("NCOA1" . SPARSER::PROTEIN)
    ("PLAC1" . SPARSER::PROTEIN) ("proteins and complex" . SPARSER::COLLECTION)
    ("caspase-3 and caspase -7" . SPARSER::COLLECTION)
    ("caspase -7" . SPARSER::PROTEIN) ("Caspase-9" . SPARSER::PROTEIN)
    ("survivin and cyclin D1" . SPARSER::COLLECTION)
    ("P-gp, MRP1, and MRP2" . SPARSER::COLLECTION)
    ("β-catenin, cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("GSK-3β and GSK-3α" . SPARSER::COLLECTION) ("GSK-3α" . SPARSER::PROTEIN)
    ("chemoresistance-associated proteins" . SPARSER::PROTEIN)
    ("MDR1 and MRP" . SPARSER::COLLECTION)
    ("c-myc and P-gp" . SPARSER::COLLECTION)
    ("β-catenin, c-myc, and cyclin D1" . SPARSER::COLLECTION)
    ("TCF4/β-catenin" . SPARSER::COLLECTION)
    ("MRP1 and MRP2" . SPARSER::COLLECTION) ("GSK-3" . SPARSER::PROTEIN)
    ("glucosylceramide synthase" . SPARSER::PROTEIN)
    ("cyclin D1 and the downstream product P-gp ( xref )"
     . SPARSER::COLLECTION)
    ("cyclin-D1" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bcl-2" . SPARSER::PROTEIN)
    ("c Myc" . SPARSER::PROTEIN)
    ("apoptosis-associated pathway components" . SPARSER::COMPONENT)
    ("Bax, caspase-3, and caspase-9" . SPARSER::COLLECTION)
    ("Bax, Bcl-2, and caspases" . SPARSER::COLLECTION)
    ("MDR1 and MRP1" . SPARSER::COLLECTION)
    ("MDR1, MRP1, and MRP2" . SPARSER::COLLECTION)
    ("galectin-3 and GSK-3β" . SPARSER::COLLECTION) ("MRP1" . SPARSER::PROTEIN)
    ("galectin-3 and P-gp" . SPARSER::COLLECTION)
    ("apoptosis-associated proteins" . SPARSER::PROTEIN)
    ("Bcl-2, Bax, and caspases" . SPARSER::COLLECTION)
    ("GSK-3β, β-catenin, c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("β-catenin and T-cell factor 4" . SPARSER::COLLECTION)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("cyclin D1 and Akt" . SPARSER::COLLECTION)
    ("T-cell factor 4" . SPARSER::PROTEIN)
    ("Protein Kinase B" . SPARSER::PROTEIN)
    ("galectin-3 and its ligand 90K" . SPARSER::COLLECTION)
    ("Epirubicin" . SPARSER::DRUG)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("GSK-3β, Bax, caspase-3, and caspase-9" . SPARSER::COLLECTION)
    ("GSK-3β and Bax" . SPARSER::COLLECTION)
    ("MDR-associated protein (MRP)" . SPARSER::PROTEIN)
    ("P-gp, cyclin D1, galectin-3, β-catenin, c-Myc, and Bcl-2"
     . SPARSER::COLLECTION)
    ("MRP" . SPARSER::PROTEIN) ("β-catenin/GSK-3β" . SPARSER::COLLECTION)
    ("epirubicin" . SPARSER::DRUG) ("Multidrug" . SPARSER::PROTEIN)
    ("90K" . SPARSER::PROTEIN)
    ("galactoside-binding protein" . SPARSER::PROTEIN)
    ("MRP2" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("Galectin-3" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("KD/Tip60-H3F" . SPARSER::COLLECTION)
    ("at least one protein" . SPARSER::PROTEIN)
    ("Western blotted complex" . SPARSER::BIO-COMPLEX)
    ("mg132" . SPARSER::PROTEIN)
    ("a regulator of cellular motility and clearance" . SPARSER::COLLECTION)
    ("KD and loss-of-function" . SPARSER::COLLECTION)
    ("Tip60 or p400" . SPARSER::COLLECTION)
    ("Tip60 , p400 , or Dmap1" . SPARSER::COLLECTION)
    ("Dmap1" . SPARSER::PROTEIN) ("KD and Tip60" . SPARSER::COLLECTION)
    ("KO or KD" . SPARSER::COLLECTION) ("EBs" . SPARSER::PROTEIN-FAMILY)
    ("KD and Hdac6" . SPARSER::COLLECTION)
    ("histones or Tip60-p400 subunits" . SPARSER::COLLECTION)
    ("Tip60 and p400" . SPARSER::COLLECTION)
    ("histones or other proteins" . SPARSER::COLLECTION)
    ("bead-bound Tip60-p400 complex" . SPARSER::BIO-COMPLEX)
    ("Tip60- and p400-target genes" . SPARSER::COLLECTION)
    ("Western blotting Tip60-p400 complex" . SPARSER::BIO-COMPLEX)
    ("H2A acetylation at most shared targets" . SPARSER::TARGET-PROTEIN)
    ("KD, and Hdac6" . SPARSER::COLLECTION)
    ("KD or Tip60" . SPARSER::COLLECTION)
    ("Hdac6 or Tip60" . SPARSER::COLLECTION) ("bivalent genes" . SPARSER::GENE)
    ("p400- ( xref ) and Tip60-target genes ( xref )" . SPARSER::COLLECTION)
    ("p400-" . SPARSER::PROTEIN) ("developmental genes" . SPARSER::GENE)
    ("Tip60/Hdac6" . SPARSER::COLLECTION)
    ("a hypomorphic allele" . SPARSER::ALLELE)
    ("Tip60 or Hdac6" . SPARSER::COLLECTION)
    ("Hdac6 or genes" . SPARSER::COLLECTION)
    ("Tip60 and Hdac6" . SPARSER::COLLECTION)
    ("Hdac6 and Tip60" . SPARSER::COLLECTION)
    ("Hdac6-Tip60" . SPARSER::COLLECTION)
    ("a bona fide Tip60-p400-interacting protein" . SPARSER::PROTEIN)
    ("Tip60-Hdac6" . SPARSER::COLLECTION) ("H3F" . SPARSER::PROTEIN)
    ("Tip60-H3F" . SPARSER::COLLECTION)
    ("novel Tip60-p400-interacting proteins" . SPARSER::PROTEIN)
    ("a unique form" . SPARSER::FORM)
    ("Tip60- and Hdac6" . SPARSER::COLLECTION) ("Tip60-" . SPARSER::PROTEIN)
    ("particularly differentiation genes" . SPARSER::GENE)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("unique interacting proteins" . SPARSER::PROTEIN)
    ("H2AZ–H2B" . SPARSER::COLLECTION) ("H2A–H2B" . SPARSER::COLLECTION)
    ("Kat5" . SPARSER::PROTEIN) ("accessory proteins" . SPARSER::PROTEIN)
    ("Ring1a/b" . SPARSER::COLLECTION)
    ("two paralogous subunits" . SPARSER::PROTEIN)
    ("rg1/Brahma" . SPARSER::COLLECTION) ("Brahma" . SPARSER::PROTEIN)
    ("BAF" . SPARSER::PROTEIN) ("Regulators" . SPARSER::REGULATOR)
    ("Tip60-p400" . SPARSER::COLLECTION) ("Hdac6" . SPARSER::PROTEIN)
    ("M 1" . SPARSER::MOLECULE) ("Histone H4" . SPARSER::PROTEIN)
    ("HD1" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("brain)" . SPARSER::PROTEIN) ("H2AZ" . SPARSER::PROTEIN)
    ("Ring1a" . SPARSER::PROTEIN) ("rg1" . SPARSER::PROTEIN)
    ("p400" . SPARSER::PROTEIN) ("TNF-α and IFN-γused" . SPARSER::COLLECTION)
    ("sh-Rb" . SPARSER::COLLECTION) ("NES-fused" . SPARSER::COLLECTION)
    ("these exogenous Rb proteins" . SPARSER::PROTEIN)
    ("the exogenous Rb proteins" . SPARSER::PROTEIN)
    ("mCherry-HA-Rb" . SPARSER::COLLECTION) ("letter" . SPARSER::MOLECULE)
    ("these inflammatory cytokines" . SPARSER::PROTEIN)
    ("Monocytes/macrophages" . SPARSER::COLLECTION)
    ("TNF-α and IFN-γ" . SPARSER::COLLECTION)
    ("thick and thin filaments" . SPARSER::PROTEIN-FAMILY)
    ("Ppargc1a and Tfam" . SPARSER::COLLECTION) ("Ppargc1a" . SPARSER::PROTEIN)
    ("Tfam" . SPARSER::PROTEIN) ("Tk1 and Dhfr" . SPARSER::COLLECTION)
    ("Tk1" . SPARSER::PROTEIN) ("Dhfr" . SPARSER::PROTEIN)
    ("Fhod3 and leiomodin" . SPARSER::COLLECTION) ("DAD" . SPARSER::PROTEIN)
    ("constitutively active mDia1" . SPARSER::PROTEIN)
    ("both normal and atrophied skeletal muscles"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mDia1 and TNF-α-induced cytoplasmic Rb" . SPARSER::COLLECTION)
    ("Rb" . SPARSER::PROTEIN) ("cyclin D/CDK4" . SPARSER::COLLECTION)
    ("monomeric red fluorescent protein mCherry and influenza hemaglutinin (HA)"
     . SPARSER::COLLECTION)
    ("monomeric red fluorescent protein mCherry" . SPARSER::PROTEIN)
    ("a heterologous nuclear exporting signal (NES)-fused form"
     . SPARSER::FORM)
    ("mCherry-HA-NES" . SPARSER::COLLECTION) ("myogenic" . SPARSER::PROTEIN)
    ("mitotic myoblasts or prematurely differentiated myoblasts"
     . SPARSER::COLLECTION)
    ("mitotic myoblasts" . SPARSER::PROTEIN)
    ("nucleoplasmic A-type lamins" . SPARSER::PROTEIN-FAMILY)
    ("myoblasts" . SPARSER::PROTEIN) ("actin and myosin" . SPARSER::COLLECTION)
    ("polymerized actin monomers" . SPARSER::MONOMER)
    ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("cyclin D/cyclin-dependent kinase 4" . SPARSER::COLLECTION)
    ("Skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mammalian diaphanous-related formin" . SPARSER::PROTEIN)
    ("mDia1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mDia" . SPARSER::PROTEIN)
    ("Pro-inflammatory cytokine TNF-α" . SPARSER::PROTEIN)
    ("Skeletal muscle" . SPARSER::PROTEIN) ("DIAPH1" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("Cytochalasin D" . SPARSER::DRUG)
    ("Fhod3" . SPARSER::PROTEIN) ("cytochalasin D" . SPARSER::DRUG)
    ("LAP2" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("Nrf2-HO-1" . SPARSER::COLLECTION) ("GA sensitises CDDP" . SPARSER::DRUG)
    ("X-IAP, survivin and Bcl-2" . SPARSER::COLLECTION)
    ("X-IAP and survivin" . SPARSER::COLLECTION)
    ("p65–p50" . SPARSER::COLLECTION)
    ("proinflammatory cytokines, cellular stress, and growth factors"
     . SPARSER::COLLECTION)
    ("caspase-3, caspase-8, caspase-9, and PARP" . SPARSER::COLLECTION)
    ("NF- κ B and HO-1" . SPARSER::COLLECTION)
    ("proteins and HO-1" . SPARSER::COLLECTION)
    ("GA group or CDDP group" . SPARSER::MOLECULE)
    ("group or CDDP" . SPARSER::COLLECTION)
    ("GA synergises CDDP" . SPARSER::DRUG) ("MAPK/p38" . SPARSER::COLLECTION)
    ("PDTC" . SPARSER::DRUG) ("MAPK and NF- κ B" . SPARSER::COLLECTION)
    ("MAPK/JNK" . SPARSER::COLLECTION)
    ("the classical target genes" . SPARSER::GENE)
    ("IL-8 and servivin" . SPARSER::COLLECTION)
    ("Bcl-2 , survivin and X-IAP" . SPARSER::COLLECTION)
    ("ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("family, and IAPs" . SPARSER::COLLECTION)
    ("survivin and X-IAP" . SPARSER::COLLECTION)
    ("Fas, Bax, Bcl-2, Bcl-XL, survivin and X-IAP" . SPARSER::COLLECTION)
    ("CDDP-" . SPARSER::DRUG) ("sequential treatment CDDP" . SPARSER::DRUG)
    ("MAPK/HO-1" . SPARSER::COLLECTION)
    ("NF- κ B and MAPK" . SPARSER::COLLECTION)
    ("NF- κ B and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("/heme" . SPARSER::COLLECTION) ("Fas and Bax" . SPARSER::COLLECTION)
    ("Bcl-2, survivin and X-inhibitor" . SPARSER::COLLECTION)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("factor- κ B" . SPARSER::PROTEIN) ("procaspase-8" . SPARSER::PROTEIN)
    ("per 2" . SPARSER::PROTEIN) ("l −1" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("X-IAP" . SPARSER::PROTEIN)
    ("MYC and AXIN2" . SPARSER::COLLECTION)
    ("AXIN2 and AXIN1" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("AXIN2/β-catenin/TCF4" . SPARSER::COLLECTION)
    ("transcriptionally active genes" . SPARSER::GENE)
    ("β-catenin and TCF4" . SPARSER::COLLECTION)
    ("exogenous AXIN2" . SPARSER::PROTEIN)
    ("β-catenin, TCF4 and NLS-AXIN2" . SPARSER::COLLECTION)
    ("exogenous β-catenin" . SPARSER::PROTEIN)
    ("AXIN2 and TCF" . SPARSER::COLLECTION)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("β-catenin and AXIN2" . SPARSER::COLLECTION)
    ("a ternary AXIN2/β-catenin/TCF complex" . SPARSER::BIO-COMPLEX)
    ("AXIN2/β-catenin/TCF" . SPARSER::COLLECTION)
    ("a commercially available anti-AXIN2 antibody" . SPARSER::ANTIBODY)
    ("transducin" . SPARSER::PROTEIN) ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("β-catenin and TCF" . SPARSER::COLLECTION)
    ("c - MYC ( MYC ) and Axis inhibition protein 2 ( AXIN2 )"
     . SPARSER::COLLECTION)
    ("XAV939" . SPARSER::DRUG) ("co-repressor" . SPARSER::PROTEIN)
    ("large T-antigen" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 5" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN)
    ("Axis inhibition protein 2" . SPARSER::PROTEIN)
    ("c - MYC" . SPARSER::PROTEIN) ("TRAF6 and ECSIT" . SPARSER::COLLECTION)
    ("ECSIT" . SPARSER::PROTEIN) ("-phosphatase 1" . SPARSER::COLLECTION)
    ("increased inflammatory cytokines" . SPARSER::PROTEIN)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("gp91 phox and p22 phox" . SPARSER::COLLECTION) ("MitoQ" . SPARSER::DRUG)
    ("Mitoquinone" . SPARSER::DRUG) ("macrophage-mCAT" . SPARSER::COLLECTION)
    ("other potentially atherogenic chemokines and their receptors"
     . SPARSER::COLLECTION)
    ("other potentially atherogenic chemokines" . SPARSER::PROTEIN)
    ("CXCL1/CXCR2" . SPARSER::COLLECTION)
    ("CX3CR1/CX3CL1" . SPARSER::COLLECTION) ("CCR5/CCL5" . SPARSER::COLLECTION)
    ("lesional macrophage mitoOS" . SPARSER::PROTEIN)
    ("NF-κB—MCP1" . SPARSER::COLLECTION)
    ("inflammatory macrophages" . SPARSER::PROTEIN)
    ("IKK/RelA" . SPARSER::COLLECTION) ("RelA-MCP-1" . SPARSER::COLLECTION)
    ("cCAT" . SPARSER::PROTEIN) ("LPS-macrophage" . SPARSER::COLLECTION)
    ("LPS-treated cultured macrophages" . SPARSER::PROTEIN)
    ("Mcp1 , and Tnfa" . SPARSER::COLLECTION) ("p-IKK" . SPARSER::COLLECTION)
    ("LPS or oxLDL" . SPARSER::COLLECTION) ("OxLDL" . SPARSER::MOLECULE)
    ("p38 and c-Jun" . SPARSER::COLLECTION) ("LPS-TLR" . SPARSER::COLLECTION)
    ("mmLDL-treated macrophages" . SPARSER::PROTEIN)
    ("Mcp1 and Tnfa" . SPARSER::COLLECTION)
    ("cytokines and chemokines and RelA" . SPARSER::COLLECTION)
    ("chemokines and RelA" . SPARSER::COLLECTION)
    ("LPS and oxLDL" . SPARSER::COLLECTION)
    ("inducers, oxLDL and LPS" . SPARSER::COLLECTION)
    ("two inflammatory cytokines, TNF-α and interleukin-1β"
     . SPARSER::COLLECTION)
    ("cytokines, TNF-α and interleukin-1β" . SPARSER::COLLECTION)
    ("REF" . SPARSER::PROTEIN)
    ("a highly atherogenic lipoprotein" . SPARSER::PROTEIN)
    ("-2-" . SPARSER::PROTEIN) ("KodiA-PC" . SPARSER::COLLECTION)
    ("oxysterol" . SPARSER::MOLECULE)
    ("tested molecules or other factors that are" . SPARSER::COLLECTION)
    ("mitoOS, NF-κB, and MCP-1" . SPARSER::COLLECTION)
    ("IKK-RelA" . SPARSER::COLLECTION)
    ("NF-κB and MCP-1" . SPARSER::COLLECTION) ("p-RelA" . SPARSER::COLLECTION)
    ("DAPI and p" . SPARSER::COLLECTION)
    ("Tnfa and Inos" . SPARSER::COLLECTION) ("Tnfa" . SPARSER::PROTEIN)
    ("plasma MCP-1 and lesional mRNAs" . SPARSER::COLLECTION)
    ("other chemokines and their receptors" . SPARSER::COLLECTION)
    ("lesional mRNAs" . SPARSER::PROTEIN) ("Cx3cr1" . SPARSER::PROTEIN)
    ("Ccr5" . SPARSER::PROTEIN) ("Cxcl1" . SPARSER::PROTEIN)
    ("Cx3cl1" . SPARSER::PROTEIN) ("Ccl5" . SPARSER::PROTEIN)
    ("Cx" . SPARSER::PROTEIN-FAMILY) ("Ccl" . SPARSER::DRUG)
    ("Mcp1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1)"
     . SPARSER::COLLECTION)
    ("vascular cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("netirn-1" . SPARSER::COLLECTION)
    ("Ki67-positive lesional macrophages" . SPARSER::PROTEIN)
    ("cre-lox" . SPARSER::COLLECTION)
    ("lipids and lipoprotein" . SPARSER::COLLECTION)
    ("lesional murine catalase mRNA" . SPARSER::PROTEIN)
    ("lesional mitoOS" . SPARSER::PROTEIN)
    ("the respective isotype-matched IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("atherosclerotic lesional macrophages" . SPARSER::PROTEIN)
    ("an athero-relevant inducer" . SPARSER::PROTEIN)
    ("oxLDL" . SPARSER::MOLECULE) ("MitoSOX" . SPARSER::DRUG)
    ("-RelA" . SPARSER::COLLECTION) ("Ldlr" . SPARSER::PROTEIN)
    ("Catalase" . SPARSER::PROTEIN)
    ("lesional endothelial mitoOS" . SPARSER::PROTEIN)
    ("lowered ROS" . SPARSER::PROTEIN) ("Apoe" . SPARSER::PROTEIN)
    ("Mn-SOD or uncoupling protein-2" . SPARSER::COLLECTION)
    ("mitoOS" . SPARSER::PROTEIN) ("lesional MCP-1" . SPARSER::PROTEIN)
    ("the monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("MitoOS" . SPARSER::PROTEIN) ("macrophage-mitoOS" . SPARSER::PROTEIN-PAIR)
    ("mCAT" . SPARSER::PROTEIN) ("lesional macrophages" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 6" . SPARSER::PROTEIN)
    ("SHIP-1" . SPARSER::PROTEIN) ("p22 phox" . SPARSER::PROTEIN)
    ("gp91 phox" . SPARSER::PROTEIN) ("CX3CL1" . SPARSER::PROTEIN)
    ("thioredoxin-2" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("interleukin 10" . SPARSER::PROTEIN) ("Lp(a)" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("netrin-1" . SPARSER::PROTEIN) ("ATP5" . SPARSER::PROTEIN)
    ("concanavalin A" . SPARSER::DRUG) ("mitochondrial)" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("p-S" . SPARSER::PROTEIN)
    ("thioredoxin 2" . SPARSER::PROTEIN) ("Mn-SOD" . SPARSER::PROTEIN)
    ("Ly6c" . SPARSER::PROTEIN) ("EGFR and BRAF" . SPARSER::COLLECTION)
    ("BRAF and EGFR" . SPARSER::COLLECTION) ("NF1-ERK" . SPARSER::COLLECTION)
    ("DDR2-ERK" . SPARSER::COLLECTION) ("p-MEK" . SPARSER::COLLECTION)
    ("EPHA7 or IL6ST" . SPARSER::COLLECTION)
    ("IL6ST, EPHA7 and NF1" . SPARSER::COLLECTION)
    ("NF1 and missense" . SPARSER::COLLECTION)
    ("our group and others ( xref )" . SPARSER::COLLECTION)
    ("only one variant" . SPARSER::VARIANT)
    ("dasatinib, nilotinib, imatinib and ponatinib" . SPARSER::COLLECTION)
    ("ponatinib" . SPARSER::DRUG) ("nilotinib" . SPARSER::DRUG)
    ("a cellular collagen receptor" . SPARSER::PROTEIN)
    ("EGFR T790M ( xref , xref ) and ALK L1196M ( xref , xref )"
     . SPARSER::COLLECTION)
    ("therapeutic biomarkers" . SPARSER::MOLECULE)
    ("BRAF, PIK3CA and DDR2" . SPARSER::COLLECTION)
    ("EGFR ( xref – xref ) and ALK ( xref , xref )" . SPARSER::COLLECTION)
    ("ROS1 ( xref , xref ) and RET ( xref – xref )" . SPARSER::COLLECTION)
    ("EGFR and ALK" . SPARSER::COLLECTION) ("CO-1686" . SPARSER::DRUG)
    ("IL6ST" . SPARSER::PROTEIN) ("EPHA7" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN) ("shNF1" . SPARSER::PROTEIN)
    ("collagen receptor" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor" . SPARSER::PROTEIN-FAMILY)
    ("instructive cues" . SPARSER::PROTEIN-FAMILY)
    ("ATP and calcium" . SPARSER::COLLECTION)
    ("an instructive cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("Sirt4-AMPK-PGC1α" . SPARSER::COLLECTION)
    ("AMPK-ACC" . SPARSER::COLLECTION)
    ("PGC1α, MCAD, CPT1b and ERRα" . SPARSER::COLLECTION)
    ("PGC1α and its downstream FAO genes" . SPARSER::COLLECTION)
    ("Decarboxylase" . SPARSER::PROTEIN) ("Malonyl" . SPARSER::PROTEIN)
    ("pACC" . SPARSER::PROTEIN) ("ANT2 and Sirt4" . SPARSER::COLLECTION)
    ("ADP and ATP" . SPARSER::COLLECTION) ("antiporters" . SPARSER::PROTEIN)
    ("AMPK and PGC1α" . SPARSER::COLLECTION)
    ("mitochondrial Sirt4" . SPARSER::PROTEIN)
    ("ANT2-AMPK-PGC1α" . SPARSER::COLLECTION) ("Porin" . SPARSER::PROTEIN)
    ("TFAM and cytochrome C" . SPARSER::COLLECTION)
    ("nuclear-encoded mito-chondrial genes" . SPARSER::GENE)
    ("PGC1α, ERRα, TFAM, NRF1 , and Cyt" . SPARSER::COLLECTION)
    ("PGC1α, ERRα, TFAM, NRF1 and Cyt" . SPARSER::COLLECTION)
    ("Cyt" . SPARSER::MOLECULE) ("TFAM" . SPARSER::PROTEIN)
    ("AMPK-PGC1α" . SPARSER::COLLECTION)
    ("ANT2/AMPK/PGC1α" . SPARSER::COLLECTION)
    ("PGC1α and its downstream FAO genes (such as ERRa, CPT1b and MCAD )"
     . SPARSER::COLLECTION)
    ("CPT1b" . SPARSER::PROTEIN) ("ANT2 and AMPK" . SPARSER::COLLECTION)
    ("Sirt4-AMPK" . SPARSER::COLLECTION)
    ("ACC and PGC1α" . SPARSER::COLLECTION)
    ("Sirt4 and AMPK" . SPARSER::COLLECTION)
    ("ANT2/AMPK" . SPARSER::COLLECTION) ("ANT1 and ANT2" . SPARSER::COLLECTION)
    ("ANT" . SPARSER::PROTEIN) ("Sirt4-ANT2" . SPARSER::COLLECTION)
    ("succinate and ADP/Pi" . SPARSER::COLLECTION)
    ("succinate" . SPARSER::PROTEIN) ("Rotenone" . SPARSER::PROTEIN)
    ("proteins (UCPs) and adenine nucleotide translocator proteins (ANTs)"
     . SPARSER::COLLECTION)
    ("ANTs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UCPs" . SPARSER::PROTEIN)
    ("pyruvate" . SPARSER::PROTEIN) ("ETC" . SPARSER::PROTEIN)
    ("mito" . SPARSER::DRUG) ("HHL" . SPARSER::PROTEIN)
    ("SIrt4 and the Adenine nucleotide translocator 2 (ANT2)"
     . SPARSER::COLLECTION)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("carbohydrate and fat" . SPARSER::COLLECTION) ("MCD" . SPARSER::PROTEIN)
    ("malonyl" . SPARSER::PROTEIN) ("GDH" . SPARSER::PROTEIN)
    ("ADP-ribosylase" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("sirtuins, Sirt3, Sirt4 and Sirt5" . SPARSER::COLLECTION)
    ("robust deacetylase activity, and Sirt5" . SPARSER::COLLECTION)
    ("deacetylase activity, and Sirt5" . SPARSER::COLLECTION)
    ("Cytochrome b" . SPARSER::PROTEIN) ("pCDNA3.1" . SPARSER::PROTEIN)
    ("ERRα" . SPARSER::PROTEIN) ("ANT1" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("Complex-I" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN)
    ("Adenine nucleotide translocator 2" . SPARSER::PROTEIN)
    ("SIrt4" . SPARSER::PROTEIN) ("Sirt3" . SPARSER::PROTEIN)
    ("Sirt5" . SPARSER::PROTEIN) ("Acetyl-CoA" . SPARSER::MOLECULE)
    ("ANT2" . SPARSER::PROTEIN)
    ("adenine nucleotide translocator 2" . SPARSER::PROTEIN)
    ("Sirt4" . SPARSER::PROTEIN) ("stress-activated EGFR" . SPARSER::PROTEIN)
    ("Atypical EGFR" . SPARSER::PROTEIN) ("PKB/Akt" . SPARSER::COLLECTION)
    ("clathrin-" . SPARSER::PROTEIN) ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinase and phosphatase" . SPARSER::COLLECTION)
    ("monoclonal antibodies (mAbs; e.g., cetuximab) and low molecular weight tyrosine kinase inhibitors (TKIs; e.g., gefitinib)"
     . SPARSER::COLLECTION)
    ("rays" . SPARSER::PROTEIN)
    ("EGFR and its downstream effectors" . SPARSER::COLLECTION)
    ("the tumor suppressors PTEN (phosphatase and tensin homolog) and SPRY2 (sprouty homolog 2)"
     . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN)
    ("activated Cdc42-associated Kinase ACK1" . SPARSER::PROTEIN)
    ("Cdc42 and EGFR" . SPARSER::COLLECTION)
    ("EGFR, ERK, and Akt" . SPARSER::COLLECTION)
    ("the NSCLC-associated EGFR mutants" . SPARSER::MUTANT)
    ("Src and EGFR" . SPARSER::COLLECTION)
    ("mitochondrial EGFR" . SPARSER::PROTEIN)
    ("Mitochondrial EGFR" . SPARSER::PROTEIN) ("CoxII" . SPARSER::PROTEIN)
    ("EGFR/ERBB2" . SPARSER::COLLECTION) ("Odin" . SPARSER::PROTEIN)
    ("cyclophilin ligand (CAML)" . SPARSER::PROTEIN)
    ("CAML" . SPARSER::PROTEIN) ("Rab4-" . SPARSER::PROTEIN)
    ("Hrs–EGFR" . SPARSER::COLLECTION) ("Cezanne-1" . SPARSER::COLLECTION)
    ("Cezanne" . SPARSER::PROTEIN) ("isopeptidase" . SPARSER::PROTEIN)
    ("UBPY" . SPARSER::PROTEIN) ("STAM" . SPARSER::PROTEIN)
    ("AMSH" . SPARSER::PROTEIN)
    ("Hrs and efficient lysosomal" . SPARSER::COLLECTION)
    ("efficient lysosomal" . SPARSER::PROTEIN)
    ("Tsg" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ILVs" . SPARSER::PROTEIN)
    ("LAMTOR-1, -2, and -3" . SPARSER::COLLECTION)
    ("MEK1/ERK1" . SPARSER::COLLECTION) ("Regulator" . SPARSER::REGULATOR)
    ("Post-endocytic EGFR" . SPARSER::PROTEIN)
    ("type or concentration" . SPARSER::COLLECTION)
    ("residual clathrin" . SPARSER::PROTEIN)
    ("heparin-binding EGF-like growth factor (HB-EGF) and betacellulin (BTC)"
     . SPARSER::COLLECTION)
    ("EGF or transforming growth factor" . SPARSER::COLLECTION)
    ("BTC" . SPARSER::PROTEIN) ("Clathrin" . SPARSER::PROTEIN)
    ("AP-2 and Grb2" . SPARSER::COLLECTION)
    ("epsin and Eps15" . SPARSER::COLLECTION) ("epsin" . SPARSER::PROTEIN)
    ("epsin1 or Eps15" . SPARSER::COLLECTION)
    ("epsin1 and Eps15" . SPARSER::COLLECTION)
    ("which targets Gab1" . SPARSER::PROTEIN)
    ("Gab1–EGFR" . SPARSER::COLLECTION)
    ("Cdc42 and PI3K" . SPARSER::COLLECTION)
    ("Grb2 and EGFR" . SPARSER::COLLECTION)
    ("EGFR and the μ2 subunit" . SPARSER::COLLECTION)
    ("EGFRs" . SPARSER::PROTEIN) ("Active EGFR dimers" . SPARSER::DIMER)
    ("flotillins" . SPARSER::PROTEIN-FAMILY)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("the prototypic receptor tyrosine kinase (RTK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sprouty homolog 2" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("ACK1" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("cyclophilin ligand" . SPARSER::PROTEIN) ("Rab35" . SPARSER::PROTEIN)
    ("Rab4" . SPARSER::PROTEIN) ("sorting nexin 5" . SPARSER::PROTEIN)
    ("SNX5" . SPARSER::PROTEIN) ("PIPK1" . SPARSER::PROTEIN)
    ("ESCRT-III" . SPARSER::PROTEIN-FAMILY)
    ("hepatocyte growth-factor" . SPARSER::PROTEIN)
    ("Rabex-5" . SPARSER::PROTEIN) ("LAMTOR-1" . SPARSER::PROTEIN)
    ("APPL1" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("dynamin2" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("TGF-α" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("Dynamin2" . SPARSER::PROTEIN) ("eps15" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("Eps15" . SPARSER::PROTEIN)
    ("epsin1" . SPARSER::PROTEIN)
    ("neural precursor cell expressed" . SPARSER::PROTEIN)
    ("son of sevenless" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("AP2 β" . SPARSER::PROTEIN) ("RASSF3 and MDM2" . SPARSER::COLLECTION)
    ("mRNA and MDM2 protein" . SPARSER::COLLECTION)
    ("promoter and some intronic SNPs" . SPARSER::COLLECTION)
    ("a RAS effector or a tumour suppressor gene" . SPARSER::COLLECTION)
    ("both variant rs6581580G allele (GG/GT) and rs7313765A allele (AA/GA)"
     . SPARSER::COLLECTION)
    ("gene and risk" . SPARSER::COLLECTION)
    ("mRNA and rs7313765" . SPARSER::COLLECTION)
    ("the TG genotype (16.38 ± 0.79) and the GG/TG genotypes (16.44 ± 0.78)"
     . SPARSER::COLLECTION)
    ("FPRP" . SPARSER::PROTEIN) ("TG, GG and GG/TG" . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("MMTV/neu" . SPARSER::COLLECTION)
    ("MMTV/RASSF3-neu" . SPARSER::COLLECTION) ("Hpo" . SPARSER::PROTEIN)
    ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("Tobacco and alcohol" . SPARSER::COLLECTION) ("SNP309" . SPARSER::PROTEIN)
    ("RASSF7" . SPARSER::PROTEIN) ("RASSF6" . SPARSER::PROTEIN)
    ("RASSF10" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("RASSF3" . SPARSER::PROTEIN)
    ("the genes expressed in CRPC" . SPARSER::GENE)
    ("targets and TNC" . SPARSER::COLLECTION) ("TNC" . SPARSER::PROTEIN)
    ("CPRC" . SPARSER::PROTEIN) ("remodelling complex" . SPARSER::BIO-COMPLEX)
    ("LARC" . SPARSER::PROTEIN) ("139 AR and 236 FOXA1" . SPARSER::COLLECTION)
    ("AR-FOXA1" . SPARSER::COLLECTION)
    ("ER ( xref ) and PR ( xref )" . SPARSER::COLLECTION)
    ("AR ( xref ), ER ( xref ) and PR ( xref )" . SPARSER::COLLECTION)
    ("key transcriptional cofactors" . SPARSER::PROTEIN)
    ("Enzalutamide" . SPARSER::DRUG) ("Abiraterone" . SPARSER::DRUG)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("new AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN and target PTEN" . SPARSER::COLLECTION)
    ("phosphatidylinositols" . SPARSER::PROTEIN) ("clock" . SPARSER::PROTEIN)
    ("cAMP and PTEN-null" . SPARSER::COLLECTION)
    ("a soluble form" . SPARSER::FORM)
    ("PTEN CBR(K5A) and PTEN CBR(K5D)" . SPARSER::COLLECTION)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("PTEN N262Y, D381V and PTEN K269E" . SPARSER::COLLECTION)
    ("PHcrac-GFP" . SPARSER::COLLECTION)
    ("PTEN C124S and PTEN C124S" . SPARSER::COLLECTION)
    ("arginine or serine" . SPARSER::COLLECTION)
    ("geneticin" . SPARSER::MOLECULE) ("PTEN-GFP" . SPARSER::COLLECTION)
    ("a flexible fragment" . SPARSER::FRAGMENT)
    ("PTEN or the PIP3-regualted serine/threonine kinase AKT"
     . SPARSER::COLLECTION)
    ("PI3K, PTEN or the PIP3-regualted serine/threonine kinase AKT"
     . SPARSER::COLLECTION)
    ("CBR" . SPARSER::PROTEIN) ("CR3" . SPARSER::PROTEIN)
    ("diC8" . SPARSER::DRUG) ("266A" . SPARSER::PROTEIN)
    ("Men1 and Vhl" . SPARSER::COLLECTION)
    ("particular renin and the precursor substrate" . SPARSER::COLLECTION)
    ("particular renin" . SPARSER::PROTEIN)
    ("angiotensinogen" . SPARSER::PROTEIN)
    ("INK4c and p27 KIP1" . SPARSER::COLLECTION)
    ("PTEN and TSC2" . SPARSER::COLLECTION)
    ("WIP1, and CDK4" . SPARSER::COLLECTION) ("RADIL" . SPARSER::PROTEIN)
    ("Cre−" . SPARSER::PROTEIN) ("the vascular marker CD31" . SPARSER::PROTEIN)
    ("the RenCre transgene and the floxed p53/Rb alleles"
     . SPARSER::COLLECTION)
    ("synaptophysin and chromogranin" . SPARSER::COLLECTION)
    ("synaptophysin" . SPARSER::PROTEIN)
    ("many separate metastatic foci" . SPARSER::PROTEIN)
    ("Renin" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("Vhl" . SPARSER::PROTEIN) ("Endocrine" . SPARSER::PROTEIN)
    ("glucagon-" . SPARSER::PROTEIN) ("somatostatin" . SPARSER::PROTEIN)
    ("Glucagon" . SPARSER::PROTEIN)
    ("renin and its substrate" . SPARSER::COLLECTION)
    ("renin and RAS" . SPARSER::COLLECTION)
    ("the developing renal vasculature" . SPARSER::PROTEIN)
    ("JG" . SPARSER::PROTEIN) ("angiotensin" . SPARSER::PROTEIN)
    ("glucagon" . SPARSER::PROTEIN) ("p53 and Rb" . SPARSER::COLLECTION)
    ("Cre-recombinase" . SPARSER::COLLECTION) ("renin" . SPARSER::PROTEIN)
    ("CD 31" . SPARSER::PROTEIN) ("RP23" . SPARSER::PROTEIN)
    ("p27 KIP1" . SPARSER::PROTEIN) ("INK4c" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("− 3" . SPARSER::PROTEIN)
    ("p16 Ink4a" . SPARSER::PROTEIN) ("WIP1" . SPARSER::PROTEIN)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("Men1" . SPARSER::PROTEIN)
    ("pancreatic polypeptide" . SPARSER::PROTEIN) ("Ngn3" . SPARSER::PROTEIN)
    ("Neurogenin3" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("a global transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("SL1" . SPARSER::PROTEIN) ("threefold increased PTEN" . SPARSER::PROTEIN)
    ("REST" . SPARSER::PROTEIN) ("at least 6 h" . SPARSER::PROTEIN)
    ("ATXN3, ATXN3L or JOSD1" . SPARSER::COLLECTION)
    ("only four cysteine proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the most efficacious ATXN3 siRNAs" . SPARSER::PROTEIN)
    ("cellular ATXN3" . SPARSER::PROTEIN)
    ("virtually all cellular ATXN3" . SPARSER::PROTEIN)
    ("the three Josephin DUBs led to robust induction of PTEN"
     . SPARSER::PROTEIN)
    ("STAMBPL1 and other DUBs" . SPARSER::COLLECTION)
    ("ATXN3, ATXN3L and JOSD1" . SPARSER::COLLECTION)
    ("approximately 90 enzymes" . SPARSER::ENZYME)
    ("competitive endogenous RNAs" . SPARSER::RNA)
    ("PtdIns" . SPARSER::PROTEIN) ("Vorinostat (SAHA)" . SPARSER::DRUG)
    ("PTEN and PTENP1" . SPARSER::COLLECTION) ("DUB" . SPARSER::PROTEIN)
    ("ataxin 3-like (ATXN3L) and Josephin domain containing 1 (JOSD1)"
     . SPARSER::COLLECTION)
    ("ataxin 3 (ATXN3), ataxin 3-like (ATXN3L) and Josephin domain containing 1 (JOSD1)"
     . SPARSER::COLLECTION)
    ("Josephin" . SPARSER::PROTEIN-FAMILY)
    ("a tumor suppressor and major antagonist" . SPARSER::COLLECTION)
    ("major antagonist" . SPARSER::MOLECULE)
    ("Machado-Joseph Disease" . SPARSER::PROTEIN) ("JOSD3" . SPARSER::PROTEIN)
    ("SCG3" . SPARSER::PROTEIN) ("STAMBPL1" . SPARSER::PROTEIN)
    ("P  3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JOSD1" . SPARSER::PROTEIN)
    ("Josephin domain containing 1" . SPARSER::PROTEIN)
    ("ATXN3L" . SPARSER::PROTEIN) ("ataxin 3-like" . SPARSER::PROTEIN)
    ("ATXN3" . SPARSER::PROTEIN) ("ataxin 3" . SPARSER::PROTEIN)
    ("a historical cohort" . SPARSER::MOLECULE) ("vs" . SPARSER::PROTEIN)
    ("SIR" . SPARSER::PROTEIN) ("SIR 3" . SPARSER::MOLECULE)
    ("C20" . SPARSER::PROTEIN) ("fasudil and statins" . SPARSER::COLLECTION)
    ("ROS and the redox-sensitive transcription factor c-Jun"
     . SPARSER::COLLECTION)
    ("cyclin D1 and MMP-2" . SPARSER::COLLECTION)
    ("lipoxygenase, and protein" . SPARSER::COLLECTION)
    ("kinases and tyrosine" . SPARSER::COLLECTION)
    ("H 2 O 2 and tert -butyl hydroperoxide" . SPARSER::COLLECTION)
    ("c-Jun and its target genes" . SPARSER::COLLECTION)
    ("cyclin D1 and COX2" . SPARSER::COLLECTION)
    ("a major oxidative stress biomarker and inflammatory mediator"
     . SPARSER::COLLECTION)
    ("a major oxidative stress biomarker" . SPARSER::MOLECULE)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("c-Jun and phospho-c-Jun" . SPARSER::COLLECTION)
    ("either inorganic or organic oxidants" . SPARSER::MOLECULE)
    ("either exogenous oxidants" . SPARSER::MOLECULE)
    ("KRIT1 and c-Jun" . SPARSER::COLLECTION)
    ("gene-regulatory proteins" . SPARSER::PROTEIN)
    ("KRIT1 and ROS" . SPARSER::COLLECTION) ("oxidants" . SPARSER::MOLECULE)
    ("statins and fasudil" . SPARSER::COLLECTION) ("fasudil" . SPARSER::DRUG)
    ("statins" . SPARSER::DRUG) ("CCM3" . SPARSER::PROTEIN)
    ("cerebral MRI" . SPARSER::PROTEIN)
    ("intractable seizures" . SPARSER::PROTEIN) ("seizures" . SPARSER::PROTEIN)
    ("our findings shed new light" . SPARSER::PROTEIN)
    ("malformations (CCM)" . SPARSER::PROTEIN)
    ("cerebral cavernous malformations (CCM)" . SPARSER::PROTEIN)
    ("phospholipase A2" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("K2" . SPARSER::PROTEIN) ("Activator Protein 1" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("PDCD10" . SPARSER::PROTEIN)
    ("CCM2" . SPARSER::PROTEIN) ("MGC4607" . SPARSER::PROTEIN)
    ("CCM1" . SPARSER::PROTEIN) ("KRIT1" . SPARSER::PROTEIN)
    ("MK2206 and glucocorticoids" . SPARSER::COLLECTION)
    ("Cre-ERT2" . SPARSER::COLLECTION)
    ("MK2206 and dexamethasone" . SPARSER::COLLECTION)
    ("GILZ" . SPARSER::PROTEIN) ("MK2206 and MK2206" . SPARSER::COLLECTION)
    ("rag" . SPARSER::PROTEIN) ("Delta" . SPARSER::PROTEIN)
    ("dexamethasone or MK2206" . SPARSER::COLLECTION)
    ("MK2206, dexamethasone or MK2206" . SPARSER::COLLECTION)
    ("MK2206 and glucocorticoid" . SPARSER::COLLECTION)
    ("glucocorticoids and AKT" . SPARSER::COLLECTION)
    ("dexamethasone and MK2206" . SPARSER::COLLECTION)
    ("decreased AKT phosphorylated NR3C1" . SPARSER::PROTEIN)
    ("HA-tagged wild type NR3C1 (HA-NR3C1) or an HA-tagged form"
     . SPARSER::COLLECTION)
    ("MYR" . SPARSER::MOLECULE) ("GST-NR3C1" . SPARSER::COLLECTION)
    ("NR3C1 and AKT1" . SPARSER::COLLECTION) ("HA-NR3C1" . SPARSER::COLLECTION)
    ("Flag-AKT1" . SPARSER::COLLECTION)
    ("Flag-tagged AKT1 and HA-tagged NR3C1" . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG)
    ("childhood acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("a natural adrenal hormone" . SPARSER::MOLECULE)
    ("cortisol" . SPARSER::PROTEIN) ("Glucocorticoids" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN) ("Glucocorticoid" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("4-Hydroxytamoxifen" . SPARSER::DRUG)
    ("ERT2" . SPARSER::PROTEIN) ("TSC22D3" . SPARSER::PROTEIN)
    ("BCL2L11" . SPARSER::PROTEIN) ("MK2206 S" . SPARSER::DRUG)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("NR3C1" . SPARSER::PROTEIN)
    ("GTPase/Ras" . SPARSER::COLLECTION) ("idiopathic forms" . SPARSER::FORM)
    ("the principal substrates" . SPARSER::SUBSTRATE)
    ("neuroanatomical and functional mapping" . SPARSER::PROTEIN)
    ("tracer" . SPARSER::MOLECULE) ("/Emx1" . SPARSER::COLLECTION)
    ("conditional gene" . SPARSER::GENE)
    ("NR2B, GluR1, and CaMKII" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN)
    ("postsynaptic density proteins" . SPARSER::PROTEIN)
    ("temporoparietal lobes" . SPARSER::PROTEIN)
    ("MET and ASD" . SPARSER::COLLECTION) ("trio" . SPARSER::PROTEIN)
    ("allele variants and autism" . SPARSER::COLLECTION)
    ("MET and PLAUR" . SPARSER::COLLECTION)
    ("PLAUR and SERPINE1" . SPARSER::COLLECTION)
    ("HGF , and PLAUR" . SPARSER::COLLECTION) ("PLAUR" . SPARSER::PROTEIN)
    ("both pre- and postsynaptic mechanisms" . SPARSER::COLLECTION)
    ("PLA" . SPARSER::PROTEIN)
    ("the inactivated monomeric form" . SPARSER::FORM) ("soma" . SPARSER::DRUG)
    ("the activated multimeric form" . SPARSER::FORM)
    ("the postsynaptic signaling complex" . SPARSER::BIO-COMPLEX)
    ("the temporal and occipital lobes" . SPARSER::PROTEIN)
    ("protein and mRNAs" . SPARSER::COLLECTION)
    ("Met and Hgf" . SPARSER::COLLECTION) ("CA1" . SPARSER::PROTEIN)
    ("MET/HGF" . SPARSER::COLLECTION)
    ("the postsynaptic density fraction" . SPARSER::COMPONENT)
    ("AMPA" . SPARSER::MOLECULE) ("NR2B and PSD-95" . SPARSER::COLLECTION)
    ("NMDA" . SPARSER::MOLECULE)
    ("a MET dominant-negative mutant receptor" . SPARSER::RECEPTOR)
    ("exogenous HGF" . SPARSER::PROTEIN) ("MET–Grb2" . SPARSER::COLLECTION)
    ("MET and the AXL receptor tyrosine kinase ( xref )" . SPARSER::COLLECTION)
    ("gonadotropin" . SPARSER::PROTEIN) ("uPAR" . SPARSER::PROTEIN)
    ("HGF and MET" . SPARSER::COLLECTION) ("HGF/MET" . SPARSER::COLLECTION)
    ("a dominant-negative form" . SPARSER::FORM)
    ("small GTPase Rac1- and p21-activated kinase" . SPARSER::COLLECTION)
    ("Rac1-" . SPARSER::PROTEIN) ("MET–HGF" . SPARSER::COLLECTION)
    ("phosphatase, and Src" . SPARSER::COLLECTION)
    ("JNK/SAP" . SPARSER::COLLECTION) ("Ras/MAP kinase" . SPARSER::COLLECTION)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("Grb2 and Gab1" . SPARSER::COLLECTION) ("ERK/MAPKs" . SPARSER::COLLECTION)
    ("Grb2, Src, SHC, and PI3K" . SPARSER::COLLECTION)
    ("PI3K, SHP2, and PLC-γ" . SPARSER::COLLECTION)
    ("and β-subunits" . SPARSER::COLLECTION)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("Met or Hgf" . SPARSER::COLLECTION)
    ("The MET RTK and its sole polypeptide growth factor ligand"
     . SPARSER::COLLECTION)
    ("MET and HGF" . SPARSER::COLLECTION)
    ("growth factors and their receptors" . SPARSER::COLLECTION)
    ("the previously mentioned ASD genes" . SPARSER::GENE)
    ("CNTNAP2 , SYNGAP1 , and FMR1" . SPARSER::COLLECTION)
    ("autistic traits" . SPARSER::PROTEIN) ("causative genes" . SPARSER::GENE)
    ("synaptic proteins" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN) ("Emx1" . SPARSER::PROTEIN)
    ("GluN1" . SPARSER::PROTEIN) ("GluR1" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN) ("FOXP2" . SPARSER::PROTEIN)
    ("SUB1" . SPARSER::PROTEIN) ("P14" . SPARSER::PROTEIN)
    ("P35)" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("GluA1" . SPARSER::PROTEIN)
    ("calmodulin-dependent protein kinase" . SPARSER::PROTEIN)
    ("PSD-95" . SPARSER::PROTEIN) ("NR2B" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3 beta" . SPARSER::PROTEIN)
    ("AXL receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN)
    ("PLC-γ" . SPARSER::PROTEIN-FAMILY) ("Gab1" . SPARSER::PROTEIN)
    ("Sema domain" . SPARSER::PROTEIN) ("50 kD" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("a polypeptide" . SPARSER::PROTEIN)
    ("FMR1" . SPARSER::PROTEIN) ("SYNGAP1" . SPARSER::PROTEIN)
    ("CNTNAP2" . SPARSER::PROTEIN) ("NLGN3" . SPARSER::PROTEIN)
    ("UBE3a" . SPARSER::PROTEIN) ("SHANK3" . SPARSER::PROTEIN)
    ("NRXN1" . SPARSER::PROTEIN) ("cellular metabolites" . SPARSER::PROTEIN)
    ("apoptosis genes (such as PIG1) and metabolism genes (such as TIGAR, xref )"
     . SPARSER::COLLECTION)
    ("p21 and SESN2" . SPARSER::COLLECTION)
    ("PARP-1, AMPK or TAF1" . SPARSER::COLLECTION) ("hnRNA" . SPARSER::RNA)
    ("LGALS7, TRIAP1, PLXNB2, SESN2, GPC1 and MDM4" . SPARSER::COLLECTION)
    ("PIDD" . SPARSER::PROTEIN) ("p53 and TFIID" . SPARSER::COLLECTION)
    ("Compound C or apigenin" . SPARSER::COLLECTION)
    ("p53 and TAFs" . SPARSER::COLLECTION)
    ("TAF1, TAF4 and TAF5" . SPARSER::COLLECTION)
    ("TAF1 or kinase" . SPARSER::COLLECTION)
    ("kinase and affinity-purified p53" . SPARSER::COLLECTION)
    ("p53 or TAF1" . SPARSER::COLLECTION)
    ("PARP-1 and AMPK" . SPARSER::COLLECTION)
    ("purified Thr55-phosphorylation-enriched p53"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and TAF1" . SPARSER::COLLECTION)
    ("either ATP or a non-hydrolyzable ATP analog" . SPARSER::COLLECTION)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION) ("PARPs" . SPARSER::MOLECULE)
    ("protein (TBP)" . SPARSER::PROTEIN)
    ("the largest subunit" . SPARSER::FRAGMENT) ("TAFs" . SPARSER::PROTEIN)
    ("TBP" . SPARSER::PROTEIN) ("TFIID" . SPARSER::PROTEIN)
    ("serine or threonine" . SPARSER::COLLECTION) ("TAF9" . SPARSER::PROTEIN)
    ("SI-1" . SPARSER::PROTEIN) ("m2" . SPARSER::MOLECULE)
    ("GPC1" . SPARSER::PROTEIN) ("SESN2" . SPARSER::PROTEIN)
    ("PLXNB2" . SPARSER::PROTEIN) ("TRIAP1" . SPARSER::PROTEIN)
    ("LGALS7" . SPARSER::PROTEIN) ("TAF5" . SPARSER::PROTEIN)
    ("TAF4" . SPARSER::PROTEIN) ("RAP74" . SPARSER::PROTEIN)
    ("Compound C" . SPARSER::MOLECULE) ("PARP-2" . SPARSER::PROTEIN)
    ("TAF1" . SPARSER::PROTEIN) ("YY" . SPARSER::MOLECULE)
    ("cisplatin and melphalan" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG)
    ("DSS1 and p53-mutated" . SPARSER::COLLECTION)
    ("CPT and ETP" . SPARSER::COLLECTION)
    ("GANP/PCID2/ENY2/centrin/DSS1" . SPARSER::COLLECTION)
    ("centrin" . SPARSER::PROTEIN) ("Sac3" . SPARSER::PROTEIN)
    ("The cellular genome" . SPARSER::PROTEIN)
    ("the allelic genes" . SPARSER::GENE)
    ("RAD51 and BRCA1" . SPARSER::COLLECTION)
    ("a cervical cancer cohort" . SPARSER::MOLECULE)
    ("BRCA1:BRCA2" . SPARSER::BIO-COMPLEX) ("CPT or ETP" . SPARSER::COLLECTION)
    ("XII and propidium" . SPARSER::COLLECTION) ("XII" . SPARSER::PROTEIN)
    ("Annexin" . SPARSER::PROTEIN) ("si" . SPARSER::PROTEIN)
    ("wild-type p53 or insufficient p53" . SPARSER::COLLECTION)
    ("insufficient p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the DNA-damage inducing agents CPT and etoposide (ETP)" . SPARSER::DNA)
    ("CPT and etoposide (ETP)" . SPARSER::COLLECTION)
    ("CPT and etoposide" . SPARSER::COLLECTION) ("ETP" . SPARSER::PROTEIN)
    ("CPT" . SPARSER::PROTEIN) ("PgR" . SPARSER::PROTEIN)
    ("Mad2" . SPARSER::PROTEIN) ("Mad" . SPARSER::PROTEIN)
    ("a principal component" . SPARSER::COMPONENT)
    ("GANP, PCID2, and DSS1" . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN) ("GANP" . SPARSER::PROTEIN)
    ("a BRCA2-associated protein" . SPARSER::PROTEIN)
    ("BRCA2, DNMTB3, and CCNEI" . SPARSER::COLLECTION)
    ("camptothecin and etoposide" . SPARSER::COLLECTION)
    ("MCF7 and p53-insufficient" . SPARSER::COLLECTION)
    ("mRNA and p53" . SPARSER::COLLECTION)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("ENY2" . SPARSER::PROTEIN) ("RPN3" . SPARSER::PROTEIN)
    ("PCID2" . SPARSER::PROTEIN) ("TREX2" . SPARSER::PROTEIN)
    ("DSS1" . SPARSER::PROTEIN) ("PLM" . SPARSER::PROTEIN)
    ("Interleukin" . SPARSER::PROTEIN) ("Enzyme" . SPARSER::ENZYME)
    ("IL-17, TNF and IFN-γ" . SPARSER::COLLECTION)
    ("IL-17 or TNF" . SPARSER::COLLECTION)
    ("IL-17 and IFN-γ" . SPARSER::COLLECTION)
    ("CCR6 and CCR4" . SPARSER::COLLECTION)
    ("AP1 and NF-κB" . SPARSER::COLLECTION)
    ("c-Fos/c-Jun" . SPARSER::COLLECTION) ("NF-κB/MAPK" . SPARSER::COLLECTION)
    ("NF-κB/Akt" . SPARSER::COLLECTION) ("IL-6/IL-8" . SPARSER::COLLECTION)
    ("NF-κB and p38" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-2" . SPARSER::COLLECTION)
    ("IL-1, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("IL-17 and TNF" . SPARSER::COLLECTION)
    ("pro-inflammatory mediators and MMP-1" . SPARSER::COLLECTION)
    ("mediators and MMP-1" . SPARSER::COLLECTION) ("iloprost" . SPARSER::DRUG)
    ("connective tissue growth factor and type I" . SPARSER::COLLECTION)
    ("IL-17A and TNF or IL-17A, TNF and IFN-γ" . SPARSER::COLLECTION)
    ("TNF or IL-17A, TNF and IFN-γ" . SPARSER::COLLECTION)
    ("IL-17A or TNF" . SPARSER::COLLECTION)
    ("slightly decreased MCP-1 and strongly increased MMP-1"
     . SPARSER::COLLECTION)
    ("IL-17A and TNF" . SPARSER::COLLECTION)
    ("IL-8 and MMP-1" . SPARSER::COLLECTION)
    ("MCP-1 and MMP-1" . SPARSER::COLLECTION)
    ("IL-22 and IFN-γ" . SPARSER::COLLECTION) ("CD45RA-" . SPARSER::PROTEIN)
    ("pro-inflammatory chemokines (p38 and NF-κB dependent) and MMP-1 (JNK dependent)"
     . SPARSER::COLLECTION)
    ("p38 and NF-κB" . SPARSER::COLLECTION)
    ("the pro-inflammatory chemokines MCP-1 and IL-8" . SPARSER::COLLECTION)
    ("TPCK" . SPARSER::MOLECULE)
    ("the specific MAP Kinase Kinase (MEK)1/2 (upstream of ERK1/2) inhibitor U0126 and PI3K (upstream of AKT) inhibitor LY294002"
     . SPARSER::MOLECULE)
    ("U0126 and PI3K" . SPARSER::COLLECTION)
    ("ERK 1/2, p38 and protein kinase B" . SPARSER::COLLECTION)
    ("c-Jun/JNK" . SPARSER::COLLECTION)
    ("a heterodimeric IL-17 receptor" . SPARSER::PROTEIN)
    ("IL-17RA and IL-17RC" . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines (MCP-1, IL-8) and MMP-1"
     . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines" . SPARSER::PROTEIN)
    ("COL1A1 and COL1A2" . SPARSER::COLLECTION)
    ("MCP-1, MMP-1, IL-8 and type I" . SPARSER::COLLECTION)
    ("cytokines and ECM" . SPARSER::COLLECTION)
    ("connective tissue growth factor and α1(I) collagen [ xref ]"
     . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines (MCP-1, IL-6 and IL-8) and matrix metalloproteinases (MMP-1 and MMP-3)"
     . SPARSER::COLLECTION)
    ("MCP-1, IL-6 and IL-8" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("IL-17 F, IL-21 and IL-22" . SPARSER::COLLECTION)
    ("CCR4 and CCR6" . SPARSER::COLLECTION) ("CCR" . SPARSER::PROTEIN)
    ("bleomycin" . SPARSER::DRUG)
    ("-1 and interleukin (IL)" . SPARSER::COLLECTION)
    ("fibroblasts release several pro-inflammatory chemokines"
     . SPARSER::PROTEIN)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-1 and interleukin" . SPARSER::COLLECTION)
    ("especially type I collagen" . SPARSER::PROTEIN)
    ("IL-17A, TNF and IFN-γ" . SPARSER::COLLECTION)
    ("MCP-1, IL-8 and MMP-1" . SPARSER::COLLECTION)
    ("HD and SSc" . SPARSER::COLLECTION)
    ("tumor necrosis factor (TNF) and interferon-gamma (IFN-γ)"
     . SPARSER::COLLECTION)
    ("IL-17A, tumor necrosis factor (TNF) and interferon-gamma (IFN-γ)"
     . SPARSER::COLLECTION)
    ("-1, MMP-2 and type-I" . SPARSER::COLLECTION) ("MCP" . SPARSER::PROTEIN)
    ("Monoclonal antibody" . SPARSER::DRUG)
    ("Interferon gamma" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFN-γ " . SPARSER::PROTEIN) ("PGI 2" . SPARSER::PROTEIN)
    ("MAP Kinase Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-17 receptor" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("IL-17RC" . SPARSER::PROTEIN) ("IL-17RA" . SPARSER::PROTEIN)
    ("COL1A2" . SPARSER::PROTEIN)
    ("eukaryotic translation elongation factor 1 alpha 1" . SPARSER::PROTEIN)
    ("EEF1A1" . SPARSER::PROTEIN) ("CCR4 " . SPARSER::PROTEIN)
    ("CCR6 " . SPARSER::PROTEIN) ("SP-600125" . SPARSER::DRUG)
    ("U-0126" . SPARSER::MOLECULE) ("brefeldin A" . SPARSER::MOLECULE)
    ("IL-23" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("IL-17A " . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("CCR4" . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("IL-17 F" . SPARSER::PROTEIN)
    ("interferon-gamma" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("CD161" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("the correspondent gene" . SPARSER::GENE)
    ("FGFR-3 and -4" . SPARSER::COLLECTION)
    ("MMP-2 and -9 propeptides" . SPARSER::COLLECTION)
    ("fgf3/int2" . SPARSER::COLLECTION)
    ("extracellular components and play" . SPARSER::COLLECTION)
    ("angiogenic growth factors" . SPARSER::GROWTH-FACTOR)
    ("mostly genes encoding components" . SPARSER::COMPONENT)
    ("growth factors or enzymes" . SPARSER::COLLECTION)
    ("SP-A1, SP-A2, and SP-B" . SPARSER::COLLECTION)
    ("FGF-3 and rs4316697" . SPARSER::COLLECTION)
    ("Valine" . SPARSER::AMINO-ACID) ("Isoleucine" . SPARSER::AMINO-ACID)
    ("MMP-" . SPARSER::PROTEIN)
    ("the G/G homozygous genotype" . SPARSER::PROTEIN)
    ("FGFRs" . SPARSER::PROTEIN)
    ("further potential biomarkers" . SPARSER::MOLECULE)
    ("lower tracheal MMP-2" . SPARSER::PROTEIN)
    ("glucocorticoids" . SPARSER::PROTEIN)
    ("supplemental oxygen" . SPARSER::MOLECULE)
    ("MMP-9, MMP-12, FGFR-4, FGF-3, and FGF-7" . SPARSER::COLLECTION)
    (":MMP-1" . SPARSER::BIO-COMPLEX)
    ("matrix metalloproteinases (MMPs) and fibroblast growth factors (FGFs) and their receptors (FGFR)"
     . SPARSER::COLLECTION)
    ("fibroblast growth factors (FGFs) and their receptors (FGFR)"
     . SPARSER::COLLECTION)
    ("receptors (FGFR)" . SPARSER::RECEPTOR) ("FGFs" . SPARSER::PROTEIN)
    ("FGFR-1" . SPARSER::PROTEIN) ("int2" . SPARSER::PROTEIN)
    ("fgf3" . SPARSER::PROTEIN) ("FGF3" . SPARSER::PROTEIN)
    ("MBL2" . SPARSER::PROTEIN) ("mannose-binding lectin" . SPARSER::PROTEIN)
    ("SP-B" . SPARSER::PROTEIN) ("SP-A2" . SPARSER::PROTEIN)
    ("SP-A1" . SPARSER::PROTEIN) ("MMP16" . SPARSER::PROTEIN)
    ("MMP12" . SPARSER::PROTEIN)
    ("signal-regulatory protein" . SPARSER::PROTEIN)
    ("FGFR-3" . SPARSER::PROTEIN) ("FGFR 1" . SPARSER::PROTEIN)
    ("IFN γ" . SPARSER::PROTEIN) ("MMP-16" . SPARSER::PROTEIN)
    ("FGF-7" . SPARSER::PROTEIN) ("FGF-3" . SPARSER::PROTEIN)
    ("FGFR-4" . SPARSER::PROTEIN) ("Transcription Factor" . SPARSER::PROTEIN)
    ("Signal-Regulatory Protein" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("inducing acute leukemia" . SPARSER::PROTEIN)
    ("FLT3 and NPM1" . SPARSER::COLLECTION) ("PML/RAR" . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("PML/RAR α" . SPARSER::COLLECTION)
    ("CD3, CD5, CD10, CD19, CD14, CD13, CD33, TdT, HLA-DR, and MPO"
     . SPARSER::COLLECTION)
    ("MPO" . SPARSER::PROTEIN) ("FLT" . SPARSER::PROTEIN)
    ("yrs" . SPARSER::PROTEIN) ("LAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("biphenotypic acute leukemia (BAL)" . SPARSER::PROTEIN)
    ("BAL" . SPARSER::PROTEIN) ("FAB" . SPARSER::PROTEIN)
    ("ARF-P53" . SPARSER::COLLECTION) ("CEBPA" . SPARSER::PROTEIN)
    ("FLT3, KIT, and RAS" . SPARSER::COLLECTION)
    ("CEBP/alpha)" . SPARSER::COLLECTION) ("CEBP" . SPARSER::PROTEIN)
    ("recurrent fusion genes" . SPARSER::GENE) ("HLD" . SPARSER::PROTEIN)
    ("NPM1 and FLT3/ITD" . SPARSER::COLLECTION)
    ("NPM1 and FLT3" . SPARSER::COLLECTION) ("RAR α" . SPARSER::PROTEIN)
    ("cytosine arabinoside" . SPARSER::DRUG) ("G-CSF" . SPARSER::PROTEIN)
    ("CD33" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("TRAIL and cisplatin" . SPARSER::COLLECTION)
    ("MALT1 and caspase-8" . SPARSER::COLLECTION)
    ("MALT1 and Caspase-8" . SPARSER::COLLECTION) ("his" . SPARSER::AMINO-ACID)
    ("drICE" . SPARSER::PROTEIN)
    ("FLIP, FADD, PEA-15, and DEDD" . SPARSER::COLLECTION)
    ("DEDD" . SPARSER::PROTEIN)
    ("APC10, CUL7, PARC, and HERC2" . SPARSER::COLLECTION)
    ("TRAIL, TNF α , and Fas" . SPARSER::COLLECTION)
    ("Mdm2 and IAPs" . SPARSER::COLLECTION)
    ("northern blot" . SPARSER::PROTEIN)
    ("antibody and TNF α" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-8" . SPARSER::COLLECTION)
    ("caspase-8 and HECTD3" . SPARSER::COLLECTION)
    ("catalytic cysteine" . SPARSER::AMINO-ACID)
    ("Almost all HECT-type E3 ligases" . SPARSER::LIGASE)
    ("FN" . SPARSER::PROTEIN) ("p18 and p10" . SPARSER::COLLECTION)
    ("DEDs" . SPARSER::PROTEIN) ("Flag-HECTD3" . SPARSER::COLLECTION)
    ("HECTD3-caspase-8" . SPARSER::COLLECTION)
    ("HECTD3 and caspase-8" . SPARSER::COLLECTION)
    ("PARC, CUL7, and HERC2" . SPARSER::COLLECTION)
    ("APC10/DOC1" . SPARSER::COLLECTION) ("Tara" . SPARSER::PROTEIN)
    ("PARC" . SPARSER::PROTEIN)
    ("the RING finger domain-containing E3s and the HECT (homologous to E6-AP COOH terminus) domain-containing E3s"
     . SPARSER::COLLECTION)
    ("DOC" . SPARSER::DRUG) ("COOH" . SPARSER::MOLECULE)
    ("HECT" . SPARSER::PROTEIN) ("the substrate's" . SPARSER::SUBSTRATE)
    ("ligases, XIAP and cIAP1/2" . SPARSER::COLLECTION)
    ("SIAH2 and POSH" . SPARSER::COLLECTION) ("POSH" . SPARSER::PROTEIN)
    ("the oligomeric membrane-associated death-inducing signaling complex (DISC)"
     . SPARSER::BIO-COMPLEX)
    ("polyubiquitin" . SPARSER::PROTEIN) ("UbcH5b" . SPARSER::PROTEIN)
    ("p-1" . SPARSER::PROTEIN)
    ("vesicle trafficking protein" . SPARSER::PROTEIN)
    ("TRIM13" . SPARSER::PROTEIN) ("DIAP1" . SPARSER::PROTEIN)
    ("PEA-15" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("p10" . SPARSER::PROTEIN) ("MALT1" . SPARSER::PROTEIN)
    ("Syntaxin-8" . SPARSER::PROTEIN)
    ("Trio-associated repeat on actin" . SPARSER::PROTEIN)
    ("HERC2" . SPARSER::PROTEIN) ("CUL7" . SPARSER::PROTEIN)
    ("DOC1" . SPARSER::PROTEIN) ("APC10" . SPARSER::PROTEIN)
    ("anaphase-promoting complex subunit 10" . SPARSER::PROTEIN)
    ("E6-AP" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("SIAH2" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("HECTD3" . SPARSER::PROTEIN)
    ("RhoGDI" . SPARSER::PROTEIN) ("proteins or guanine" . SPARSER::COLLECTION)
    ("Nck1/Nck2" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor and platelet-derived growth factor"
     . SPARSER::COLLECTION)
    ("stabilizer" . SPARSER::MOLECULE) ("Nck2/Nck1" . SPARSER::COLLECTION)
    ("the highly homologous Nck2" . SPARSER::PROTEIN)
    ("(K178R) but not GFP-Nck2" . SPARSER::PROTEIN)
    ("GFP-RhoA" . SPARSER::COLLECTION)
    ("Rho kinase and formins" . SPARSER::COLLECTION)
    ("N-WASP/Arp2/3" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("formins" . SPARSER::PROTEIN)
    ("Rho kinase and formin" . SPARSER::COLLECTION)
    ("formin" . SPARSER::PROTEIN) ("c-Cbl-co-depleted" . SPARSER::PROTEIN-PAIR)
    ("synaptopodin/c-Cbl" . SPARSER::COLLECTION)
    ("c-Cbl shRNA or a scrambled control shRNA" . SPARSER::COLLECTION)
    ("FLAG-c-Cbl" . SPARSER::COLLECTION)
    ("c-Cbl and synaptopodin" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION) ("Myc-c-Cbl" . SPARSER::COLLECTION)
    ("FLAG-Nck1" . SPARSER::COLLECTION) ("sui" . SPARSER::PROTEIN)
    ("Nck1 and cyclin D1" . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG)
    ("synaptopodin and Nck1" . SPARSER::COLLECTION)
    ("GFP-sui" . SPARSER::COLLECTION) ("Nck2 or c-Cbl" . SPARSER::COLLECTION)
    ("Nck2 and c-Cbl" . SPARSER::COLLECTION) ("GST-Nck2" . SPARSER::COLLECTION)
    ("GST-Nck1" . SPARSER::COLLECTION)
    ("synaptopodin and co-precipitated" . SPARSER::COLLECTION)
    ("anti-Nck1 or anti-Nck2" . SPARSER::COLLECTION)
    ("synaptopodin and Nck" . SPARSER::COLLECTION)
    ("synaptopodin or N-WASP" . SPARSER::COLLECTION)
    ("FLAG-N-WASP" . SPARSER::COLLECTION) ("GFP-Nck1" . SPARSER::COLLECTION)
    ("GFP-Nck2" . SPARSER::COLLECTION) ("-Nck1" . SPARSER::COLLECTION)
    ("Synpo" . SPARSER::PROTEIN) ("synpo" . SPARSER::PROTEIN)
    ("proteins and actin" . SPARSER::COLLECTION)
    ("Nck and synaptopodin" . SPARSER::COLLECTION)
    ("RhoA and a negative regulator" . SPARSER::COLLECTION)
    ("Synaptopodin" . SPARSER::PROTEIN) ("nephrin" . SPARSER::PROTEIN)
    ("Nck1 and Nck2" . SPARSER::COLLECTION)
    ("Nck1 (Nckα) and Nck2 (Nckβ)" . SPARSER::COLLECTION)
    ("c-Cbl-resistant Nck1(K178R) or Nck2" . SPARSER::COLLECTION)
    ("Nck2" . SPARSER::PROTEIN) ("Nck1" . SPARSER::PROTEIN)
    ("Nck" . SPARSER::PROTEIN) ("bis-tris" . SPARSER::MOLECULE)
    ("DR8" . SPARSER::PROTEIN) ("ARP2" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("γ-interferon" . SPARSER::DRUG)
    ("pcDNA 3.1" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("WAVE2" . SPARSER::PROTEIN) ("TRPC5" . SPARSER::PROTEIN)
    ("ARP3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Myc-c" . SPARSER::PROTEIN)
    ("green-fluorescent protein" . SPARSER::PROTEIN)
    ("IRSp53" . SPARSER::PROTEIN) ("Pak1" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("Nckβ" . SPARSER::PROTEIN)
    ("Nckα" . SPARSER::PROTEIN) ("Smurf1" . SPARSER::PROTEIN)
    ("myc , E2F and cyclin D1" . SPARSER::COLLECTION)
    ("The cyclin D1 a isoform’s" . SPARSER::ISOFORM)
    ("a labile growth factor and oncogene-inducible protein"
     . SPARSER::COLLECTION)
    ("KSRP" . SPARSER::PROTEIN) ("PACT" . SPARSER::PROTEIN)
    ("KD or cyclin D1" . SPARSER::COLLECTION) ("Suv" . SPARSER::PROTEIN)
    ("MafB" . SPARSER::PROTEIN)
    ("an active kinase complex" . SPARSER::BIO-COMPLEX)
    ("LKR" . SPARSER::PROTEIN) ("Dicer1" . SPARSER::PROTEIN)
    ("H3K9" . SPARSER::PROTEIN) ("trim-H3K9" . SPARSER::PROTEIN-PAIR)
    ("mature form" . SPARSER::FORM) ("mature miR-16" . SPARSER::PROTEIN)
    ("Dicer or cyclin D1" . SPARSER::COLLECTION)
    ("Dicer and cyclin D1" . SPARSER::COLLECTION)
    ("pre-miR-16, pre-let-7a, pre-miR-17 and pre-miR-20a"
     . SPARSER::COLLECTION)
    ("cyclin D1 −/− and cyclin D1" . SPARSER::COLLECTION)
    ("the cyclin D1-associated chromatin" . SPARSER::PROTEIN)
    ("Top2a" . SPARSER::PROTEIN)
    ("cyclin D1a or cyclin D1" . SPARSER::COLLECTION)
    ("KE" . SPARSER::MOLECULE) ("MMTV-" . SPARSER::PROTEIN)
    ("two essential components" . SPARSER::COMPONENT)
    ("Drosha and DGCR8" . SPARSER::COLLECTION)
    ("siRNA/miRNA" . SPARSER::COLLECTION)
    ("the holoenzyme that phosphorylates and inactivates both the pRb tumor suppressor and the key inducer of mitochondrial biogenesis NRF-1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the key inducer" . SPARSER::PROTEIN) ("MITF" . SPARSER::PROTEIN)
    ("long double-stranded RNA (dsRNA) or stem-loop-stem"
     . SPARSER::COLLECTION)
    ("endoribonuclease" . SPARSER::PROTEIN)
    ("Complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("Mature miRNAs" . SPARSER::PROTEIN)
    ("the 20–22 nucleotide mature miRNAs" . SPARSER::PROTEIN)
    ("TRBP" . SPARSER::PROTEIN)
    ("the endonuclease Drosha and its partner DGCR8" . SPARSER::COLLECTION)
    ("Tri" . SPARSER::PROTEIN) ("Cyclin D1 and Dicer" . SPARSER::COLLECTION)
    ("double strand RNA or stem-loop-stem RNA" . SPARSER::COLLECTION)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Anti-Histone" . SPARSER::PROTEIN)
    ("Argonaute 2" . SPARSER::PROTEIN) ("cyclin D1 a" . SPARSER::PROTEIN)
    ("KH type splicing regulatory protein" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("ELF5" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("ZNF354C" . SPARSER::PROTEIN) ("FOXD3" . SPARSER::PROTEIN)
    ("SOX10" . SPARSER::PROTEIN) ("Exportin 5" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("NRF-1" . SPARSER::PROTEIN)
    ("RNase III" . SPARSER::PROTEIN) ("Exportin-5" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("cyclin D1a" . SPARSER::PROTEIN)
    ("HDAC3-△C1 and HDAC3-△C2" . SPARSER::COLLECTION)
    ("HDAC3-△C2" . SPARSER::PROTEIN-PAIR) ("HDAC3-△C1" . SPARSER::PROTEIN-PAIR)
    ("HDAC3 or HDAC3" . SPARSER::COLLECTION)
    ("HDAC3-NES" . SPARSER::COLLECTION) ("HDAC3-" . SPARSER::PROTEIN)
    ("HDAC3 and MDR1" . SPARSER::COLLECTION)
    ("HDAC3 and p53" . SPARSER::COLLECTION) ("PP4c" . SPARSER::PROTEIN)
    ("the MDR1 gene proximal promoter" . SPARSER::PROMOTER)
    ("adriamycin" . SPARSER::DRUG) ("/HDAC3-Flag" . SPARSER::COLLECTION)
    ("p53, ETS, and AP1" . SPARSER::COLLECTION)
    ("taxol (SNU387 R-Taxol and Malme3M R-Taxol ) or vinblastine (SNU387 R-VBL )"
     . SPARSER::COLLECTION)
    ("Apicidin" . SPARSER::DRUG) ("PP4" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("Lys9" . SPARSER::PROTEIN)
    ("Lys 9" . SPARSER::PROTEIN) ("CREB3" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("histone deacetylase-3" . SPARSER::PROTEIN)
    ("miR-221 and HER2" . SPARSER::COLLECTION)
    ("HER2 and miR-221" . SPARSER::COLLECTION)
    ("the monoclonal HER2 antibody" . SPARSER::ANTIBODY)
    ("a pathological type" . TYPE) ("key miRNA" . SPARSER::PROTEIN)
    ("posttranscriptional gene" . SPARSER::GENE)
    ("the well-documented tumor suppressor PTEN" . SPARSER::PROTEIN)
    ("pcDNA3.1-PTEN-mut" . SPARSER::COLLECTION)
    ("PTEN ( xref A) and mRNA ( xref B)" . SPARSER::COLLECTION)
    ("pre-miR-221 or a scramble pre-miRNA" . SPARSER::COLLECTION)
    ("conservative 22-25 nucleotide RNA molecules" . SPARSER::MOLECULE)
    ("tumoricidal drugs" . SPARSER::DRUG)
    ("a transmembrane receptor tyrosine kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMB" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("pcDNA3.1" . SPARSER::PROTEIN) ("pre-miRNA" . SPARSER::RNA)
    ("MiR-221" . SPARSER::PROTEIN) ("HDAC5 or HDAC6" . SPARSER::COLLECTION)
    ("AVASTIN" . SPARSER::DRUG)
    ("an angiogenic marker protein" . SPARSER::PROTEIN)
    ("HDAC3-Flag" . SPARSER::COLLECTION)
    ("PAI-1, and VEGF" . SPARSER::COLLECTION)
    ("YY1, Snail, or AP-1" . SPARSER::COLLECTION)
    ("YY1, Snail, and AP-1" . SPARSER::COLLECTION)
    ("Hepatocyte growth factor and inducible nitric oxide synthase"
     . SPARSER::COLLECTION)
    ("celastrol and taxol" . SPARSER::COLLECTION)
    ("celastrol" . SPARSER::MOLECULE) ("PAI-1 and VEGF" . SPARSER::COLLECTION)
    ("VEGF and PAI-1" . SPARSER::COLLECTION)
    ("N-CoR/SMRT" . SPARSER::COLLECTION)
    ("VEGF and plasminogen activator inhibitor-1" . SPARSER::COLLECTION)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("miR-15b" . SPARSER::MOLECULE) ("VEGFR2" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("HIF-1- alpha" . SPARSER::PROTEIN) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("HIF1 alpha" . SPARSER::PROTEIN) ("N-CoR" . SPARSER::PROTEIN)
    ("Histone deacetylase-3" . SPARSER::PROTEIN) ("HM13-" . SPARSER::PROTEIN)
    ("ESI-035-BCL-XL" . SPARSER::PROTEIN-PAIR)
    ("HES3-HM13, and HES3-ID1" . SPARSER::COLLECTION)
    ("HM13 or ID1" . SPARSER::COLLECTION)
    ("the antiapoptotic BCL-XL and the proapoptotic BCL-XS"
     . SPARSER::COLLECTION)
    ("the proapoptotic BCL-XS" . SPARSER::PROTEIN)
    ("the antiapoptotic BCL-XL" . SPARSER::PROTEIN)
    ("HM13, ID1, or BCL-XL" . SPARSER::COLLECTION)
    ("variant (CNV)" . SPARSER::VARIANT) ("BCL-XL protein" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("Beclin-1" . SPARSER::PROTEIN)
    ("BCL-XS" . SPARSER::PROTEIN) ("HM13" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN) ("BCL2L1" . SPARSER::PROTEIN)
    ("MDM4 and USP2a" . SPARSER::COLLECTION)
    ("PI3K, AKT, and mTOR" . SPARSER::COLLECTION)
    ("AKT or mTOR" . SPARSER::COLLECTION)
    ("EEF1A/PI3K/AKT/mTOR-MDM4" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("pAKT and pRPS" . SPARSER::COLLECTION)
    ("pRPS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K, mTORC1, and mTORC2" . SPARSER::COLLECTION)
    ("MDM4 and p21" . SPARSER::COLLECTION)
    ("pAKT and p21" . SPARSER::COLLECTION)
    ("EEF1A2 and p21" . SPARSER::COLLECTION)
    ("pAKT and USP2a" . SPARSER::COLLECTION)
    ("EEF1A2 and MDM4" . SPARSER::COLLECTION)
    ("EEF1A2 and USP2a" . SPARSER::COLLECTION)
    ("EEF1A2 and pAKT" . SPARSER::COLLECTION)
    ("EEF1A2, pAKT, USP2 and MDM4" . SPARSER::COLLECTION)
    ("EEF1A2, pAKT, USP2a, and MDM4" . SPARSER::COLLECTION)
    ("EEF1A2-PI3K-AKT-mTOR-MDM4" . SPARSER::COLLECTION)
    ("pAKT and MDM4" . SPARSER::COLLECTION)
    ("AKT, USP2a, and MDM4" . SPARSER::COLLECTION)
    ("EEF1A2-AKT-MDM4" . SPARSER::COLLECTION)
    ("AKT, pAKT, and MDM4" . SPARSER::COLLECTION)
    ("serine, threonine, and tyrosine" . SPARSER::COLLECTION)
    ("AKT and MDM4" . SPARSER::COLLECTION)
    ("MDM4 and AKT" . SPARSER::COLLECTION)
    ("ubiquitinase" . SPARSER::UBIQUITINASE)
    ("LY294002 and cycloheximide" . SPARSER::COLLECTION)
    ("LY294002 or cycloheximide" . SPARSER::COLLECTION)
    ("AKT and RPS6K" . SPARSER::COLLECTION)
    ("regulatory associated protein" . SPARSER::PROTEIN)
    ("RICTOR" . SPARSER::PROTEIN) ("RAPTOR" . SPARSER::PROTEIN)
    ("PI3K-, mTORC1-, and mTORC2-multikinase" . SPARSER::COLLECTION)
    ("AKT1 and/or AKT2 isoforms ( xref , xref )" . SPARSER::COLLECTION)
    ("p53 and MDM4" . SPARSER::COLLECTION)
    ("p21 and PUMA" . SPARSER::COLLECTION)
    ("MDM4 and p53" . SPARSER::COLLECTION)
    ("the v-akt murine thymoma viral oncogene homolog (AKT) kinase"
     . SPARSER::KINASE)
    ("v" . SPARSER::PROTEIN) ("Ataxia" . SPARSER::PROTEIN)
    ("MDM4, MDMX, or HDMX" . SPARSER::COLLECTION) ("HDMX" . SPARSER::PROTEIN)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("EEF1A2/PI3K/AKT/mTOR/MDM4" . SPARSER::COLLECTION)
    ("EEF1A2/PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("AKT, and MDM4" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("v-akt" . SPARSER::COLLECTION)
    ("akt" . SPARSER::PROTEIN) ("EEF1A" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("USP2" . SPARSER::PROTEIN)
    ("PI103" . SPARSER::DRUG) ("RPS6" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("BCL2 binding component 3" . SPARSER::PROTEIN)
    ("Checkpoint Kinase 2" . SPARSER::PROTEIN)
    ("Mouse Double Minute 4" . SPARSER::PROTEIN)
    ("homolog 2" . SPARSER::PROTEIN) ("1A2" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN) ("LSD" . SPARSER::DRUG)
    ("SiRNA" . SPARSER::PROTEIN)
    ("specifically target human PTEN" . SPARSER::PROTEIN)
    ("Akt and glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::COLLECTION)
    ("phenylmethanesulfonyl fluoride (PMSF)" . SPARSER::MOLECULE)
    ("PMSF" . SPARSER::MOLECULE) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE)
    ("5 μL annexin V and 5 μL propidium iodide" . SPARSER::COLLECTION)
    ("ice-cold PBS" . SPARSER::PROTEIN)
    ("100 μL fresh culture media" . SPARSER::PROTEIN)
    ("streptomycin" . SPARSER::DRUG) ("Reagents" . SPARSER::MOLECULE)
    ("genes and drugs" . SPARSER::COLLECTION)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION)
    ("PTEN and Akt" . SPARSER::COLLECTION) ("DMSO-only" . SPARSER::MOLECULE)
    ("annexin V- and propidine" . SPARSER::COLLECTION)
    ("annexin V-" . SPARSER::PROTEIN) ("functional PTEN" . SPARSER::PROTEIN)
    ("flavonol" . SPARSER::MOLECULE)
    ("phosphatase and the tensin homolog" . SPARSER::COLLECTION)
    ("/PI3K/Akt" . SPARSER::COLLECTION) ("Kaempferol" . SPARSER::DRUG)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("tensin homolog" . SPARSER::PROTEIN)
    ("PI3Kβ and ≤1+" . SPARSER::COLLECTION)
    ("set 1 and TMA" . SPARSER::COLLECTION)
    ("EGFR, KRAS, p53, or LKB1" . SPARSER::COLLECTION)
    ("PIK3CA or AKT1" . SPARSER::COLLECTION)
    ("PIK3CB and PTEN" . SPARSER::COLLECTION)
    ("conversely PI3K inhibitors" . SPARSER::INHIBITOR)
    ("these histologic subtypes" . SPARSER::PROTEIN)
    ("adenocarcinoma histologic subtypes" . SPARSER::PROTEIN)
    ("cytoplasmic PI3Kβ and cytoplasmic PTEN ( xref )" . SPARSER::COLLECTION)
    ("higher cytoplasmic PI3Kβ and lower cytoplasmic PTEN (those samples that fall to the right-hand side of the diagonal line in xref )"
     . SPARSER::COLLECTION)
    ("the Tristar NSCLC TMA" . SPARSER::MOLECULE)
    ("both histologic subtypes" . SPARSER::PROTEIN)
    ("cytoplasmic PI3Kβ and nuclear PTEN ( xref )" . SPARSER::COLLECTION)
    ("higher PI3Kβ and lower PTEN (those samples to the right-hand side of the diagonal line in xref )"
     . SPARSER::COLLECTION)
    ("high PI3Kβ and low PTEN" . SPARSER::COLLECTION)
    ("relatively high PI3Kβ and relatively low PTEN protein"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and G protein–coupled receptor"
     . SPARSER::COLLECTION)
    ("PIK3CA and PIK3CB" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and G protein–coupled" . SPARSER::COLLECTION)
    ("CDKN2A and RB1 , NFE2L2 and KEAP1 , and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("RB1 , NFE2L2 and KEAP1 , and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("KEAP1 , and phosphatidylinositol-3" . SPARSER::COLLECTION)
    ("two major histologic types" . TYPE)
    ("PI3Kβ and PTEN" . SPARSER::COLLECTION) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("PTEN1" . SPARSER::PROTEIN) ("PTEN 1" . SPARSER::PROTEIN)
    ("CEP3" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Du145" . SPARSER::PROTEIN)
    ("G protein–coupled receptor" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN) ("p110γ" . SPARSER::PROTEIN)
    ("DDR2" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("PI3Kβ" . SPARSER::PROTEIN)
    ("EMP" . SPARSER::PROTEIN) ("RGR, TJG, DFN, and EWT" . SPARSER::COLLECTION)
    ("RGR" . SPARSER::PROTEIN) ("EpCAM" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("IF" . SPARSER::PROTEIN) ("Chloramphenicol" . SPARSER::DRUG)
    ("Bromodeoxyuridine" . SPARSER::DRUG)
    ("a sustained mesenchymal state" . SPARSER::BIO-STATE)
    ("MYB and Snail2" . SPARSER::COLLECTION)
    ("promoter and intron" . SPARSER::COLLECTION)
    ("dysfunctional EMT or MET" . SPARSER::COLLECTION)
    ("multiple developmental malformations" . SPARSER::PROTEIN)
    ("EMT or MET" . SPARSER::COLLECTION) ("MYB-KLF4" . SPARSER::COLLECTION)
    ("EMT, or MET" . SPARSER::COLLECTION)
    ("the flanking proximal promoter and exon" . SPARSER::COLLECTION)
    ("the flanking proximal promoter" . SPARSER::PROMOTER)
    ("the downstream proximal promoter and exon" . SPARSER::COLLECTION)
    ("the downstream proximal promoter" . SPARSER::PROMOTER)
    ("exon1, or intron" . SPARSER::COLLECTION)
    ("its proximal promoter" . SPARSER::PROMOTER)
    ("exogenous ZEB1" . SPARSER::PROTEIN)
    ("pcDNA3.1-ZEB1" . SPARSER::PROTEIN-PAIR)
    ("VIM and SNAI1" . SPARSER::COLLECTION) ("EGF-EMT" . SPARSER::COLLECTION)
    ("MYB mRNA (Figure  xref A, i) and protein (Figure  xref A, ii)"
     . SPARSER::COLLECTION)
    ("mesenchymal state" . SPARSER::BIO-STATE)
    ("CDH1 and cytokeratin" . SPARSER::COLLECTION)
    ("EGF, VIM and ZEB1" . SPARSER::COLLECTION)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("ZEB1/MYB relation" . SPARSER::COLLECTION)
    ("ZEB1/MYB" . SPARSER::COLLECTION) ("anoikis" . SPARSER::PROTEIN)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("CDH4, CDH13, ZEB2, SNAI1, SNAI2, TWIST1, MMP9, MMP13, and MMP14"
     . SPARSER::COLLECTION)
    ("MYB protein (Figure  xref B) and mRNA (Additional file xref D)"
     . SPARSER::COLLECTION)
    ("CDH1 and CD24" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("SNAI1, SNAI2, and ZEB1" . SPARSER::COLLECTION)
    ("EMT-MET" . SPARSER::COLLECTION) ("MYB and CDH1" . SPARSER::COLLECTION)
    ("ZEB1 and MYB" . SPARSER::COLLECTION)
    ("p21 and p73" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("MYB and Ets-1" . SPARSER::COLLECTION)
    ("Crumbs3, HUGL2, and Pals1" . SPARSER::COLLECTION)
    ("Pals1" . SPARSER::PROTEIN)
    ("FoxC2, Goosecoid, KLF8 and Id1" . SPARSER::COLLECTION)
    ("MYB-ZEB1" . SPARSER::COLLECTION) ("MYBsh-LA" . SPARSER::COLLECTION)
    ("MYB and ZEB1" . SPARSER::COLLECTION) ("LA" . SPARSER::PROTEIN)
    ("ZEB1-MYB" . SPARSER::COLLECTION)
    ("cytometry, and sulforhodamine B" . SPARSER::COLLECTION)
    ("MYB, ZEB1, and CDH1" . SPARSER::COLLECTION) ("MYB" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("CDH5" . SPARSER::PROTEIN)
    ("Snail 1" . SPARSER::PROTEIN) ("Snail2" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("CDH13" . SPARSER::PROTEIN)
    ("CDH4" . SPARSER::PROTEIN) ("Pax-2" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("per 2 " . SPARSER::PROTEIN)
    ("P200" . SPARSER::PROTEIN) ("HUGL2" . SPARSER::PROTEIN)
    ("Crumbs3" . SPARSER::PROTEIN) ("plakophilin3" . SPARSER::PROTEIN)
    ("Id1" . SPARSER::PROTEIN) ("FoxC2" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("ZEB2" . SPARSER::PROTEIN) ("homeobox 1" . SPARSER::PROTEIN)
    ("sulforhodamine B" . SPARSER::MOLECULE)
    ("LF and LW" . SPARSER::COLLECTION) ("WX and JYL" . SPARSER::COLLECTION)
    ("WX" . SPARSER::PROTEIN) ("Absolute neutrophil" . SPARSER::PROTEIN)
    ("Lactic dehydrogenase" . SPARSER::PROTEIN)
    ("the high β2-MG group and the low β2-MG group" . SPARSER::COLLECTION)
    ("TFS" . SPARSER::PROTEIN)
    ("T-cell large granular lymphocytic leukemia" . SPARSER::PROTEIN)
    ("β2-microglobulin" . SPARSER::PROTEIN)
    ("distinct miRNAs" . SPARSER::PROTEIN)
    ("lipids[ xref ] and expression of hepatic circadian genes[ xref ]"
     . SPARSER::COLLECTION)
    ("hepatic circadian genes" . SPARSER::GENE)
    ("cyclin D1 and CDK6" . SPARSER::COLLECTION)
    ("cyclin D1 , CDK6 , and E2F3" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE) ("=-1.04" . SPARSER::COLLECTION)
    ("=-1.21" . SPARSER::COLLECTION) ("exp" . SPARSER::PROTEIN)
    ("cel" . SPARSER::PROTEIN) ("GSK-3b" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN)
    ("cyclin G1" . SPARSER::PROTEIN) ("miR-21" . SPARSER::PROTEIN)
    ("- 2" . SPARSER::PROTEIN) ("let- 7" . SPARSER::RNA)
    ("naturally occurring molecules" . SPARSER::MOLECULE)
    ("occurring molecules" . SPARSER::MOLECULE) ("biologics" . SPARSER::DRUG)
    ("14-3-3ζ, AID, PKA-Cα and Ung" . SPARSER::COLLECTION)
    ("γ-H2AX, 53BP1 and DNA-PKcs" . SPARSER::COLLECTION)
    ("Mre11/Rad50/Nbs1" . SPARSER::COLLECTION)
    ("14-3-3 and RPA1" . SPARSER::COLLECTION)
    ("RPA–AID–14-3-3" . SPARSER::COLLECTION)
    ("AID, Ung, Msh2 and Msh6" . SPARSER::COLLECTION)
    ("14-3-3–AID" . SPARSER::COLLECTION)
    ("14-3-3 possibly bridge AID and Ung" . SPARSER::COLLECTION)
    ("AID and Ung" . SPARSER::COLLECTION)
    ("AID–14-3-3–Ung" . SPARSER::COLLECTION)
    ("foci and AID" . SPARSER::COLLECTION) ("-CCR5" . SPARSER::COLLECTION)
    ("secondary lymphoid" . SPARSER::PROTEIN)
    ("14-3-3ζ and AID" . SPARSER::COLLECTION)
    ("14-3-3 or AID and Vpr" . SPARSER::COLLECTION)
    ("AID and Vpr" . SPARSER::COLLECTION) ("14-3-3ζ" . SPARSER::PROTEIN)
    ("AID and chromatin" . SPARSER::COLLECTION)
    ("14-3-3γ and AID" . SPARSER::COLLECTION)
    ("the entire 96–amino acid viral protein" . SPARSER::PROTEIN)
    ("GFP-Vpr" . SPARSER::COLLECTION) ("LPS and mIL-4" . SPARSER::COLLECTION)
    ("pTAC-GFP-Vpr" . SPARSER::COLLECTION) ("pTAC-GFP" . SPARSER::COLLECTION)
    ("the HIV-1 accessory protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("foci or RPA" . SPARSER::COLLECTION)
    ("agonistic anti–hCD40 mAb" . SPARSER::DRUG)
    ("AID–containing nuclear foci or RPA–containing nuclear foci ( xref )"
     . SPARSER::COLLECTION)
    ("14-3-3 and RPA" . SPARSER::COLLECTION)
    ("14-3-3, AID and RPA" . SPARSER::COLLECTION)
    ("14-3-3 and AID or RPA" . SPARSER::COLLECTION)
    ("AID or RPA" . SPARSER::COLLECTION)
    ("14-3-3, AID or RPA" . SPARSER::COLLECTION)
    ("an agonistic anti–hCD40 mAb" . SPARSER::DRUG)
    ("IgG and IgE" . SPARSER::COLLECTION)
    ("IgG, IgA and IgE" . SPARSER::COLLECTION)
    ("14-3-3ζ–AID" . SPARSER::PROTEIN-PAIR)
    ("AID and RPA" . SPARSER::COLLECTION)
    ("GST–14-3-3γ–precipitated proteins" . SPARSER::PROTEIN)
    ("GST-14-3-3γ" . SPARSER::COLLECTION) ("14-3-3γ" . SPARSER::PROTEIN)
    ("GST–14-3-3γ" . SPARSER::COLLECTION) ("mIL" . SPARSER::PROTEIN)
    ("Ung or Ung" . SPARSER::COLLECTION) ("Ung" . SPARSER::PROTEIN)
    ("Flag–Ung" . SPARSER::COLLECTION) ("14-3-3 and Ung" . SPARSER::COLLECTION)
    ("14-3-3 and PKA-Cα and PKA-RIα or RPA1" . SPARSER::COLLECTION)
    ("PKA and Ung" . SPARSER::COLLECTION)
    ("AID and 14-3-3" . SPARSER::COLLECTION)
    ("AID C-terminal point mutants (Flag–AIDR190A–EYFP1–154, Flag–AIDF193A–EYFP1–154, Flag–AIDL196A–EYFP1–154) or AID S38A mutant (Flag–AIDS38A–EYFP1–154)"
     . SPARSER::COLLECTION)
    ("Flag–AID" . SPARSER::COLLECTION)
    ("the N-terminal 154 amino acids (EYFP1–154) and the C-terminal 84 amino acids (EYFP155–238) xref"
     . SPARSER::COLLECTION)
    ("atopic IgE antibodies" . SPARSER::ANTIBODY)
    ("viral protein" . SPARSER::PROTEIN)
    ("14-3-3, AID, PKA or Ung" . SPARSER::COLLECTION)
    ("AID, PKA and Ung" . SPARSER::COLLECTION)
    ("AID mutants or Ung mutants" . SPARSER::COLLECTION)
    ("AID and protein" . SPARSER::COLLECTION)
    ("AID and PKA" . SPARSER::COLLECTION) ("14-3-3-" . SPARSER::PROTEIN)
    ("acS" . SPARSER::PROTEIN)
    ("AID and other CSR-related genes" . SPARSER::COLLECTION)
    ("TLR4 and BCR" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("Toll-like receptors (TLRs) and B cell receptor (BCR)"
     . SPARSER::COLLECTION)
    ("receptor (BCR)" . SPARSER::RECEPTOR)
    ("trimeric CD154" . SPARSER::PROTEIN)
    ("IgG, IgE or IgA" . SPARSER::COLLECTION) ("dCs" . SPARSER::MOLECULE)
    ("deoxycytosines" . SPARSER::MOLECULE) ("Aicda" . SPARSER::PROTEIN)
    ("diverse biological effector" . SPARSER::EFFECTOR)
    ("IgG, IgE and IgA" . SPARSER::COLLECTION)
    ("autoantibody" . SPARSER::PROTEIN)
    ("PKA and/or Ung" . SPARSER::COLLECTION)
    ("AID, PKA and/or Ung" . SPARSER::COLLECTION)
    ("AID, PKA-Cα and Ung" . SPARSER::COLLECTION)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("14-3-3 and AID" . SPARSER::COLLECTION)
    ("AID and replication protein A (RPA)" . SPARSER::COLLECTION)
    ("scaffolds" . SPARSER::SCAFFOLD) ("-AGCT-3" . SPARSER::COLLECTION)
    ("antibody biological effector" . SPARSER::EFFECTOR)
    ("IgH" . SPARSER::PROTEIN) ("DC-SIGN" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Msh6" . SPARSER::PROTEIN) ("Msh2" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("hIL-4" . SPARSER::PROTEIN)
    ("hCD40" . SPARSER::PROTEIN) ("NaVO 3" . SPARSER::MOLECULE)
    ("Cγ1" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("1- C" . SPARSER::PROTEIN) ("RPA1" . SPARSER::PROTEIN)
    ("6 B" . SPARSER::PROTEIN) ("interleukin-4" . SPARSER::PROTEIN)
    ("CD154" . SPARSER::PROTEIN) ("Igα" . SPARSER::PROTEIN)
    ("PKA-C" . SPARSER::PROTEIN) ("S–S" . SPARSER::PROTEIN)
    ("EphA2, Wnt7A, and SOX4" . SPARSER::COLLECTION)
    ("SPP1, SMAD4 and PTEN" . SPARSER::COLLECTION)
    ("TCF/β-catenin" . SPARSER::COLLECTION)
    ("SOX2, SOX9, and SOX11" . SPARSER::COLLECTION)
    ("SOX2 and Nanog" . SPARSER::COLLECTION)
    ("Oct4 and Nanog" . SPARSER::COLLECTION) ("Trop2" . SPARSER::PROTEIN)
    ("growth factors and other cell-cycle control proteins"
     . SPARSER::COLLECTION)
    ("cyclin D1 and the AR" . SPARSER::COLLECTION)
    ("the AR and other nuclear receptors ( xref , xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("SUV" . SPARSER::PROTEIN) ("NeuT-PEC" . SPARSER::PROTEIN-PAIR)
    ("PEC" . SPARSER::PROTEIN)
    ("EphA2, Dkk1, SOX4 and Nanog" . SPARSER::COLLECTION)
    ("an amino terminal Flag-tagged cyclin D1" . SPARSER::PROTEIN)
    ("Tetracycline" . SPARSER::DRUG) ("cyclin D1 or DHT" . SPARSER::COLLECTION)
    ("Cyclin D1 and androgen receptor" . SPARSER::COLLECTION)
    ("TGFβ/BMT-Smad" . SPARSER::COLLECTION) ("BMT" . SPARSER::PROTEIN)
    ("Snail ( xref ) and N-Cadherin ( xref )" . SPARSER::COLLECTION)
    ("DKK" . SPARSER::PROTEIN) ("receptors and genes" . SPARSER::COLLECTION)
    ("Wnt7A" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("only 186 genes" . SPARSER::GENE) ("c-Myc-PEC" . SPARSER::COLLECTION)
    ("c-Myc and NeuT" . SPARSER::COLLECTION)
    ("CK5 and CK8" . SPARSER::COLLECTION) ("Hematoxylin" . SPARSER::MOLECULE)
    ("siRNA and cyclin D1" . SPARSER::COLLECTION)
    ("TGFβ, growth factors, and hypoxia" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin D2" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("TGFβ/BMP-SMAD" . SPARSER::COLLECTION)
    ("cyclin D1 or a fragment" . SPARSER::COLLECTION)
    ("androgen receptor ( AR )" . SPARSER::PROTEIN)
    ("Pten , c-Myc, and Ras" . SPARSER::COLLECTION)
    ("TMPRSS2-ERG" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("TGFβ/BMP-SMAD4" . SPARSER::COLLECTION) ("BMP" . SPARSER::PROTEIN)
    ("SOX11" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("CD49f" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("P/CAF" . SPARSER::PROTEIN) ("HP1α" . SPARSER::PROTEIN)
    ("Dkk1" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("Sox4" . SPARSER::PROTEIN) ("SOX4" . SPARSER::PROTEIN)
    ("Wnt7" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ZEB1" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("NRF1" . SPARSER::PROTEIN)
    ("the proteasome inhibitor bortezomib and the NF- κ B inhibitor CAPE"
     . SPARSER::COLLECTION)
    ("HDACi-" . SPARSER::MOLECULE)
    ("p53 , MDM2 and MDM4" . SPARSER::COLLECTION)
    ("inefficiently destabilises p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetylated p53 and the intrinsic p53 inhibitor MDM2 (mRNA and protein)"
     . SPARSER::COLLECTION)
    ("p53, acetylated p53 and the intrinsic p53 inhibitor MDM2 (mRNA and protein)"
     . SPARSER::COLLECTION)
    ("MDM2, p21 and PIG3" . SPARSER::COLLECTION)
    ("particular SIRT1" . SPARSER::PROTEIN)
    ("promoter or tumour" . SPARSER::COLLECTION)
    ("the partially p53-dependent agent entinostat" . SPARSER::DRUG)
    ("functional p53 and intact caspases" . SPARSER::COLLECTION)
    ("intact caspases" . SPARSER::PROTEIN)
    ("the particular HDACi" . SPARSER::MOLECULE) ("obatoclax" . SPARSER::DRUG)
    ("Obatoclax" . SPARSER::DRUG) ("vorinostat and CAPE" . SPARSER::COLLECTION)
    ("vorinostat and bortezomib" . SPARSER::COLLECTION)
    ("extent bortezomib's" . SPARSER::DRUG) ("Bortezomib" . SPARSER::DRUG)
    ("CAPE" . SPARSER::PROTEIN)
    ("Vorinostat and entinostat" . SPARSER::COLLECTION)
    ("BCL2 and MCL1" . SPARSER::COLLECTION)
    ("HDACi and tenovin-1 in p53+ cells" . SPARSER::COLLECTION)
    ("vorinostat, entinostat and apicidin" . SPARSER::COLLECTION)
    ("MDM2 and MDM4" . SPARSER::COLLECTION)
    ("p53 and HDACi" . SPARSER::COLLECTION)
    ("MDM2, MDM4 and p21" . SPARSER::COLLECTION)
    ("HDACi and tenovin-1" . SPARSER::COLLECTION)
    ("pifithrin-" . SPARSER::DRUG) ("pifithrin" . SPARSER::DRUG)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("vorinostat and entinostat" . SPARSER::COLLECTION)
    ("entinostat and etoposide" . SPARSER::COLLECTION)
    ("apicidin-" . SPARSER::DRUG) ("vorinostat-" . SPARSER::DRUG)
    ("the cytostatic drug etoposide" . SPARSER::DRUG)
    ("vorinostat, entinostat, apicidin and VPA" . SPARSER::COLLECTION)
    ("vorinostat, apicidin and VPA" . SPARSER::COLLECTION)
    ("the topoisomerase II inhibitor etoposide" . SPARSER::DRUG)
    ("apicidin and VPA" . SPARSER::COLLECTION)
    ("the cyclic tetrapeptide apicidin and the short-chain fatty acid valproic acid (VPA)"
     . SPARSER::COLLECTION)
    ("valproic acid (VPA)" . SPARSER::MOLECULE)
    ("the hydroxamic acid vorinostat" . SPARSER::DRUG)
    ("tetrapeptide" . SPARSER::MOLECULE) ("benzamide" . SPARSER::DRUG)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anthracyclines or alkylating agents ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("several commonly used chemotherapeutic drugs" . SPARSER::DRUG)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("NAD + instead of Zn 2+" . SPARSER::COLLECTION)
    ("‘HDACi'" . SPARSER::MOLECULE) ("five phylogenetic classes" . CLASS)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("vorinostat (also known as suberoylanilide hydroxamic acid, SAHA) and romidepsin (also known as FK228 and depsipeptide)"
     . SPARSER::COLLECTION)
    ("FK228 and depsipeptide" . SPARSER::COLLECTION)
    ("panobinostat, belinostat and entinostat" . SPARSER::COLLECTION)
    ("belinostat" . SPARSER::DRUG) ("depsipeptide" . SPARSER::DRUG)
    ("romidepsin" . SPARSER::DRUG) ("tenovin-1" . SPARSER::COLLECTION)
    ("TRAIL and bortezomib" . SPARSER::COLLECTION)
    ("four structurally distinct HDACi, vorinostat, entinostat, apicidin and valproic acid"
     . SPARSER::COLLECTION)
    ("HDACi, vorinostat, entinostat, apicidin and valproic acid"
     . SPARSER::COLLECTION)
    ("apicidin" . SPARSER::DRUG) ("entinostat" . SPARSER::DRUG)
    ("SIRT2" . SPARSER::PROTEIN) ("PIG3" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("β -2-microglobulin" . SPARSER::PROTEIN) ("DiOC 6" . SPARSER::DRUG)
    ("Valproic acid" . SPARSER::MOLECULE) ("z-VAD-fmk" . SPARSER::DRUG)
    ("short-chain fatty acid" . SPARSER::MOLECULE) ("MS-275" . SPARSER::DRUG)
    ("HDAC11" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("FK228" . SPARSER::DRUG)
    ("Skp2 or co-inhibition" . SPARSER::COLLECTION)
    ("Akt–Skp2" . SPARSER::COLLECTION) ("ATM–Akt" . SPARSER::COLLECTION)
    ("ORC1 or Cdc6" . SPARSER::COLLECTION)
    ("ATM-complemented" . SPARSER::COLLECTION) ("–Cdt1" . SPARSER::COLLECTION)
    ("Akti" . SPARSER::PROTEIN) ("Akt and Skp2" . SPARSER::COLLECTION)
    ("ATM and Akt" . SPARSER::COLLECTION) ("Akt-SCF" . SPARSER::COLLECTION)
    ("Skp1 and Cul1" . SPARSER::COLLECTION)
    ("Cyclin D1 and p21 WAF1" . SPARSER::COLLECTION)
    ("SCF Skp2 and Cul4-DDB1 Cdt2" . SPARSER::COLLECTION)
    ("2 ubiquitin ligases, SCF Skp2 and Cul4-DDB1 Cdt2" . SPARSER::COLLECTION)
    ("Cdh1" . SPARSER::PROTEIN) ("Cdh" . SPARSER::PROTEIN)
    ("Cul1 and Skp1" . SPARSER::COLLECTION) ("Cul4-DDB1" . SPARSER::COLLECTION)
    ("IR-" . SPARSER::PROTEIN)
    ("Cdk-SCF Skp2 and PCNA-Cul4-DDB1 Cdt2 ubiquitin ligases"
     . SPARSER::COLLECTION)
    ("Cdk-SCF" . SPARSER::COLLECTION) ("ATM and NBS1" . SPARSER::COLLECTION)
    ("PCNA-Cul4-DDB1" . SPARSER::COLLECTION) ("ATM-Chk2" . SPARSER::COLLECTION)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("Cdt1 and p27 Kip1" . SPARSER::COLLECTION)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("Cdc6, ORC1, cyclin D1, and p21 WAF1" . SPARSER::COLLECTION)
    ("ATM (referred to as T98G-ATMRi2) or luciferase" . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN) ("Cdc6, Cdt1, and MCM2–7" . SPARSER::COLLECTION)
    ("Mre11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("ATM-Akt-SCF" . SPARSER::COLLECTION) ("Cul1" . SPARSER::PROTEIN)
    ("VE-821" . SPARSER::DRUG) ("KU-55933" . SPARSER::DRUG)
    ("AT1" . SPARSER::PROTEIN) ("Cdt2" . SPARSER::PROTEIN)
    ("Cul4" . SPARSER::PROTEIN) ("pre-RC" . SPARSER::BIO-COMPLEX)
    ("ORC1" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("Interleukin-6/JAK/STAT3" . SPARSER::COLLECTION)
    ("subsequent Akt/mTOR" . SPARSER::COLLECTION)
    ("STAT3 and Akt" . SPARSER::COLLECTION)
    ("STAT3, Akt and ERK" . SPARSER::COLLECTION)
    ("proteins (SOCS)" . SPARSER::PROTEIN)
    ("STAT3 and EGFR" . SPARSER::COLLECTION) ("gefinitib" . SPARSER::DRUG)
    ("ERK and P38" . SPARSER::COLLECTION) ("STAT3-Akt" . SPARSER::COLLECTION)
    ("esp" . SPARSER::PROTEIN) ("PI3K and JNK" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("PI3K and c-Jun" . SPARSER::COLLECTION)
    ("STAT3 and RAF/MEK/ERK mitogen-activated protein kinase (MAPK) [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("Akt, STAT3 and RAF/MEK/ERK mitogen-activated protein kinase (MAPK) [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("STAT3, Akt and EGFR" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS3" . SPARSER::COLLECTION)
    ("EGFR and STAT3" . SPARSER::COLLECTION)
    ("Signal transducer and activator of transcription-3" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AC and NC" . SPARSER::COLLECTION) ("Carcinoembryonic" . SPARSER::PROTEIN)
    ("Radical" . SPARSER::MOLECULE)
    ("any demonstrable well-differentiated liposarcoma component"
     . SPARSER::COMPONENT)
    ("DOD" . SPARSER::PROTEIN)
    ("cytokeratin, CD34, S100, actin, calretinin, and CD117"
     . SPARSER::COLLECTION)
    ("Bcl-2, EMA, and CD99" . SPARSER::COLLECTION) ("EMA" . SPARSER::PROTEIN)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("antigen (CEA)" . SPARSER::PROTEIN) ("CEA" . SPARSER::PROTEIN)
    ("carcinoembryonic" . SPARSER::PROTEIN) ("HBsAg" . SPARSER::DRUG)
    ("dL" . SPARSER::MOLECULE)
    ("a well-differentiated liposarcoma component" . SPARSER::COMPONENT)
    ("ifosfamide" . SPARSER::DRUG) ("CD99" . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::PROTEIN) ("TP53 and/or PIK3CA" . SPARSER::COLLECTION)
    ("A considerable fraction" . SPARSER::COMPONENT)
    ("gefitinib, and erlotinib" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("S3b" . SPARSER::PROTEIN)
    ("S3a" . SPARSER::PROTEIN)
    ("an approximately 0.3% fraction" . SPARSER::COMPONENT)
    ("the possible 506 types" . TYPE) ("507 possible types" . TYPE)
    ("an Ion Torrent PGM" . SPARSER::PROTEIN)
    ("approximately 5,000 molecules" . SPARSER::MOLECULE)
    ("mutated alleles" . SPARSER::ALLELE) ("PGM" . SPARSER::PROTEIN)
    ("Ion" . SPARSER::MOLECULE) ("APC and KRAS" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE) ("5–2" . SPARSER::PROTEIN)
    ("Single-pass" . SPARSER::PROTEIN-FAMILY)
    ("p53 or TS" . SPARSER::COLLECTION)
    ("TP53 and MSI-H" . SPARSER::COLLECTION)
    ("p53 and its downstream target p21 WAF1" . SPARSER::COLLECTION)
    ("p21 WAF1" . SPARSER::PROTEIN) ("p53-p21 WAF1" . SPARSER::COLLECTION)
    ("pre- and postoperative radiotherapy" . SPARSER::COLLECTION)
    ("colon cancer and an immunophenotype" . SPARSER::COLLECTION)
    ("TS or p53" . SPARSER::COLLECTION) ("methotrexate" . SPARSER::DRUG)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("TS+" . SPARSER::PROTEIN)
    ("TS + " . SPARSER::PROTEIN) ("TS +" . SPARSER::PROTEIN)
    ("p53-TS +" . SPARSER::PROTEIN-PAIR)
    ("TS, p53, and p21 WAF1" . SPARSER::COLLECTION)
    ("anti-TS (Fig.  xref ) and anti-p21 (Fig.  xref ) antibodies"
     . SPARSER::COLLECTION)
    ("the anti-p53 (Fig.  xref and xref ), anti-TS (Fig.  xref ) and anti-p21 (Fig.  xref ) antibodies"
     . SPARSER::COLLECTION)
    ("the anti-p53" . SPARSER::ANTIBODY)
    ("TS, p53 and p21 WAF1" . SPARSER::COLLECTION) ("TS-" . SPARSER::PROTEIN)
    ("TS, p21 WAF1 and p53" . SPARSER::COLLECTION)
    ("/p53" . SPARSER::COLLECTION)
    ("thymidylate synthase (TS)" . SPARSER::PROTEIN)
    ("p53 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("PMS2" . SPARSER::PROTEIN)
    ("5FU" . SPARSER::DRUG) ("thymidylate synthase" . SPARSER::PROTEIN)
    ("PARP-1 proteins as well as the protein’s" . SPARSER::COLLECTION)
    ("PARP-1 proteins as well as the protein" . SPARSER::COLLECTION)
    ("lysozyme" . SPARSER::PROTEIN)
    ("arsenic bound peptide" . SPARSER::PEPTIDE) ("PARPzf" . SPARSER::PROTEIN)
    ("toxic metal ions" . SPARSER::MOLECULE)
    ("TPEN, or arsenite" . SPARSER::COLLECTION)
    ("apo-PARPzf" . SPARSER::PROTEIN-PAIR) ("apo" . SPARSER::PROTEIN)
    ("the correct conformation" . SPARSER::BIO-CONFORMATION)
    ("both arsenite and zinc" . SPARSER::COLLECTION)
    ("free arsenite or zinc" . SPARSER::COLLECTION)
    ("arsenite or TPEN" . SPARSER::COLLECTION) ("Arsenite" . SPARSER::DRUG)
    ("arsenite and TPEN" . SPARSER::COLLECTION)
    ("TPEN and arsenite" . SPARSER::COLLECTION)
    ("TPEN or arsenite" . SPARSER::COLLECTION)
    ("a membrane-permeable zinc chelator" . SPARSER::MOLECULE)
    ("Fpg" . SPARSER::PROTEIN-FAMILY)
    ("Both arsenite and zinc chelator TPEN" . SPARSER::COLLECTION)
    ("UVR" . SPARSER::PROTEIN-FAMILY) ("thiolate" . SPARSER::MOLECULE)
    ("thiolates" . SPARSER::MOLECULE)
    ("-DNA glycosylase (FPG)" . SPARSER::COLLECTION)
    ("group A (XPA)" . SPARSER::PROTEIN)
    ("-DNA glycosylase" . SPARSER::COLLECTION)
    ("FPG" . SPARSER::PROTEIN-FAMILY) ("ICP-AES" . SPARSER::COLLECTION)
    ("AES" . SPARSER::PROTEIN) ("ICP" . SPARSER::PROTEIN)
    ("the membrane-permeable zinc chelator TPEN" . SPARSER::DRUG)
    ("TPEN" . SPARSER::DRUG) ("arsenite" . SPARSER::DRUG)
    ("SbCl 3" . SPARSER::MOLECULE) ("NaAsO 2" . SPARSER::DRUG)
    ("sodium hydroxide" . SPARSER::MOLECULE)
    ("sodium arsenite" . SPARSER::DRUG)
    ("N,N,N’,N’-tetrakis (2-pyridylmethyl) ethylenediamine" . SPARSER::DRUG)
    ("Sodium arsenite" . SPARSER::DRUG)
    ("Zinc finger protein" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("group A" . SPARSER::PROTEIN) ("LZ" . SPARSER::PROTEIN)
    ("metallopeptidase" . SPARSER::PROTEIN)
    ("MMP9 [ xref ] and uPA [ xref ]" . SPARSER::COLLECTION)
    ("TIPE" . SPARSER::PROTEIN-FAMILY) ("MMP9 and uPA" . SPARSER::COLLECTION)
    ("TIPE2 or mutant" . SPARSER::COLLECTION) ("RGL" . SPARSER::PROTEIN)
    ("AFP" . SPARSER::PROTEIN) ("an active complex" . SPARSER::BIO-COMPLEX)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 9 (MMP9) and urokinase plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("a novel immune negative molecule and an inhibitor of the oncogenic Ras in mice"
     . SPARSER::COLLECTION)
    ("Alpha-fetoprotein" . SPARSER::PROTEIN)
    ("Reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RGL1" . SPARSER::PROTEIN) ("u-PA" . SPARSER::PROTEIN)
    ("PRK5" . SPARSER::PROTEIN) ("Plexin-B1" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("Ras 3 " . SPARSER::PROTEIN)
    ("TNFAIP8L3" . SPARSER::PROTEIN) ("TIPE3" . SPARSER::PROTEIN)
    ("TNFAIP8L1" . SPARSER::PROTEIN) ("A-D" . SPARSER::PROTEIN)
    ("B-D" . SPARSER::PROTEIN) ("TNFAIP8L2" . SPARSER::PROTEIN)
    ("TNFAIP8" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 9" . SPARSER::PROTEIN)
    ("TIPE2" . SPARSER::PROTEIN)
    ("p53, MYC, Chk1, ROS, and Stat3" . SPARSER::COLLECTION)
    ("MYC and mutant" . SPARSER::COLLECTION)
    ("cellular antioxidants" . SPARSER::DRUG)
    ("glutathione, thioredoxin, and NADPH" . SPARSER::COLLECTION)
    ("interleukins and PAI1" . SPARSER::COLLECTION)
    ("p53 or p16" . SPARSER::COLLECTION) ("MYC and Skp2" . SPARSER::COLLECTION)
    ("BiP, Grp94, calnexin, and calreticulin" . SPARSER::COLLECTION)
    ("calreticulin" . SPARSER::PROTEIN) ("calnexin" . SPARSER::PROTEIN)
    ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BiP and CHOP" . SPARSER::COLLECTION) ("ER and PDI" . SPARSER::COLLECTION)
    ("wildtype p53 and its target p21" . SPARSER::COLLECTION)
    ("PPIB" . SPARSER::PROTEIN) ("temozolomide" . SPARSER::DRUG)
    ("p53, and Skp2" . SPARSER::COLLECTION)
    ("Stat3 and Erk" . SPARSER::COLLECTION) ("BiP" . SPARSER::PROTEIN)
    ("CHOP" . SPARSER::PROTEIN)
    ("disulfide isomerase (PDI)" . SPARSER::PROTEIN) ("PDI" . SPARSER::PROTEIN)
    ("p53 and its transcriptional target p21" . SPARSER::COLLECTION)
    ("etoposide or daunorubicin" . SPARSER::COLLECTION)
    ("NRF2 and p53" . SPARSER::COLLECTION)
    ("p53 and Chk1" . SPARSER::COLLECTION)
    ("Jak2 and phospho-Stat3" . SPARSER::COLLECTION)
    ("Cyclophilin" . SPARSER::PROTEIN) ("OSM or AICAR" . SPARSER::COLLECTION)
    ("p27/Kip1" . SPARSER::COLLECTION)
    ("DUSP5 and Sprouty2" . SPARSER::COLLECTION)
    ("Sprouty, RasGap120, and DUSP" . SPARSER::COLLECTION)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RasGap" . SPARSER::PROTEIN)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("IL-11, IL-6, IL-8, PLAU and SERPINE1" . SPARSER::COLLECTION)
    ("PLAU" . SPARSER::PROTEIN) ("approximately 130 genes" . SPARSER::GENE)
    ("OSM" . SPARSER::PROTEIN) ("annexin-V/PI" . SPARSER::COLLECTION)
    ("lentiviral-delivered shRNA" . SPARSER::PROTEIN)
    ("prolactin" . SPARSER::PROTEIN)
    ("peptidyl-prolyl" . SPARSER::PROTEIN-PAIR)
    ("Cyclophilins" . SPARSER::PROTEIN)
    ("immediately targetable molecule" . SPARSER::MOLECULE)
    ("isomerase" . SPARSER::ISOMERASE) ("CypB" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("disulfide isomerase" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sprouty2" . SPARSER::PROTEIN)
    ("DUSP5" . SPARSER::PROTEIN) ("IL-11" . SPARSER::PROTEIN)
    ("UCP2" . SPARSER::PROTEIN) ("uncoupling protein-2" . SPARSER::PROTEIN)
    ("Oncostatin-M" . SPARSER::PROTEIN) ("cyclosporin A" . SPARSER::MOLECULE)
    ("annexin-V" . SPARSER::PROTEIN) ("WP1066" . SPARSER::DRUG)
    ("Cyclophilin B" . SPARSER::PROTEIN) ("Cyclosporin A" . SPARSER::MOLECULE)
    ("another major tumor suppressor protein" . SPARSER::PROTEIN)
    ("neither USP7 nor USP10" . SPARSER::COLLECTION)
    ("USP7 (HAUSP) and USP10" . SPARSER::COLLECTION)
    ("a PTEN deubiquitinase and a tumor-suppressing protein"
     . SPARSER::COLLECTION)
    ("PTEN and USP13" . SPARSER::COLLECTION)
    ("PTEN and phospho-AKT" . SPARSER::COLLECTION)
    ("HSP90 or co-transfected" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("GST-GFP" . SPARSER::COLLECTION) ("GST-USP13" . SPARSER::COLLECTION)
    ("Cyclin A2 and PLK1" . SPARSER::COLLECTION)
    ("APC-CDH1" . SPARSER::COLLECTION)
    ("DUBs, USP7, USP8, USP10 or USP39" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-FOXO1/3" . SPARSER::COLLECTION)
    ("AKT and FOXO" . SPARSER::COLLECTION)
    ("USP13 and PTEN" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-FOXO" . SPARSER::COLLECTION)
    ("AKT and FOXO1/3" . SPARSER::COLLECTION)
    ("DUBs, USP10, USP13, USP7, USP8, USP39 and USP4" . SPARSER::COLLECTION)
    ("PTEN-associated DUBs" . SPARSER::PROTEIN)
    ("a possible PTEN deubiquitinase and a putative tumor suppressor"
     . SPARSER::COLLECTION)
    ("a possible PTEN deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("USP7, USP10 or USP13" . SPARSER::COLLECTION)
    ("these five PTEN-associated DUBs" . SPARSER::PROTEIN)
    ("DUBs, USP7, USP8, USP10, USP13 or USP39" . SPARSER::COLLECTION)
    ("MYC-PTEN" . SPARSER::COLLECTION)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("ubiquitin-protein" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("DUBs" . SPARSER::PROTEIN) ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("USP4" . SPARSER::PROTEIN) ("USP39" . SPARSER::PROTEIN)
    ("USP8" . SPARSER::PROTEIN) ("MYC-tagged" . SPARSER::PROTEIN)
    ("NEDD4-1" . SPARSER::PROTEIN) ("USP13" . SPARSER::PROTEIN)
    ("pre-clinical testing dual mTORC1/mTORC2 inhibitors" . SPARSER::INHIBITOR)
    ("PPARγ and TGF-β1" . SPARSER::COLLECTION)
    ("Nox4, growth factors, BMPRII, PPARγ and mTORC2" . SPARSER::COLLECTION)
    ("BMPRII and PPARγ" . SPARSER::COLLECTION) ("BMPRII" . SPARSER::PROTEIN)
    ("PI3K/PTEN" . SPARSER::COLLECTION)
    ("mTORC2 and Akt" . SPARSER::COLLECTION)
    ("experimental PH" . SPARSER::PROTEIN)
    ("monocrotaline" . SPARSER::MOLECULE) ("Raf-ERK1/2" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION) ("SMC" . SPARSER::PROTEIN)
    ("mTORC2 and Nox4" . SPARSER::COLLECTION)
    ("P-ACC and Bim" . SPARSER::COLLECTION)
    ("Nox4 and mTORC2" . SPARSER::COLLECTION)
    ("AMPK or siRNA" . SPARSER::COLLECTION)
    ("Bim and Bcl2" . SPARSER::COLLECTION)
    ("AMPK and Bim" . SPARSER::COLLECTION)
    ("mTORC1-specific P-S6K1" . SPARSER::PROTEIN)
    ("P-ACC and P-AMPK" . SPARSER::COLLECTION)
    ("AMPK and AMPK" . SPARSER::COLLECTION)
    ("reduced cellular ATP and HIF1α levels" . SPARSER::COLLECTION)
    ("pulmonary vasculature" . SPARSER::PROTEIN)
    ("functionally distinct mTORC2" . SPARSER::PROTEIN)
    ("chronic hypoxia" . SPARSER::PROTEIN)
    ("protein, nucleotide and lipid" . SPARSER::COLLECTION)
    ("Akt and Raf" . SPARSER::COLLECTION)
    ("Akt and mTORC1" . SPARSER::COLLECTION)
    ("idiopathic PAH (IPAH)" . SPARSER::PROTEIN)
    ("mTORC1 (mTOR-raptor) and mTORC2 (mTOR-rictor)" . SPARSER::COLLECTION)
    ("distinct mTOR" . SPARSER::PROTEIN) ("mTOR-raptor" . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN)
    ("pathophysiological components" . SPARSER::COMPONENT)
    ("P-ACC" . SPARSER::PROTEIN) ("P-S6" . SPARSER::PROTEIN)
    ("P-S" . SPARSER::PROTEIN) ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("Nox4" . SPARSER::PROTEIN) ("kinase (JNK)" . SPARSER::KINASE)
    ("FOXO1 and FOXO4" . SPARSER::COLLECTION)
    ("IGF-1 and IGF-1" . SPARSER::COLLECTION)
    ("the normal zone-specific chondrocytes" . SPARSER::PROTEIN)
    ("FoxO3 and FoxO4" . SPARSER::COLLECTION)
    ("FOXOs, FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FOXO1 (which cross-react with FOXO4) or antibodies"
     . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("chondrocytes, FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FoxO1- and FoxO3-positive" . SPARSER::COLLECTION)
    ("FoxO1-" . SPARSER::PROTEIN) ("FoxOs" . SPARSER::PROTEIN-FAMILY)
    ("FoxO1 and FoxO3" . SPARSER::COLLECTION)
    ("only FOXO3 protein" . SPARSER::PROTEIN)
    ("hematoxylin, FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3, and FOXO4" . SPARSER::COLLECTION)
    ("ULK1, Beclin1, and LC3" . SPARSER::COLLECTION)
    ("molecules and organelles" . SPARSER::COLLECTION)
    ("cultured chondrocytes, IL-1β and TNF-α suppressed FOXO1"
     . SPARSER::PROTEIN)
    ("chondrocytes, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("FoxO3" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("FOXO1A" . SPARSER::PROTEIN)
    ("PDGF-AA" . SPARSER::PROTEIN) ("BMP-7" . SPARSER::PROTEIN)
    ("tert-Butyl hydroperoxide" . SPARSER::MOLECULE)
    ("Safranin O" . SPARSER::DRUG) ("Beclin1" . SPARSER::PROTEIN)
    ("ULK1" . SPARSER::PROTEIN) ("t-BHP" . SPARSER::MOLECULE)
    ("class O" . SPARSER::PROTEIN)
    ("a growth suppressive protein" . SPARSER::PROTEIN)
    ("RSK1 or RSK2" . SPARSER::COLLECTION)
    ("ERK-RSK-KIBRA" . SPARSER::COLLECTION) ("RAS-MAPK" . SPARSER::COLLECTION)
    ("Jub/WTIP" . SPARSER::COLLECTION) ("WTIP" . SPARSER::PROTEIN)
    ("Jub" . SPARSER::PROTEIN) ("EGFR-RAS-ERK" . SPARSER::COLLECTION)
    ("mitogens" . SPARSER::MITOGEN) ("WWC2 and/or WWC3" . SPARSER::COLLECTION)
    ("WWC2 and WWC3" . SPARSER::COLLECTION)
    ("either KIBRA3A (S542A/S544A/S548A) or KIBRA2A (T929A/S947A)"
     . SPARSER::COLLECTION)
    ("ERK and RSK" . SPARSER::COLLECTION)
    ("KIBRA and ERK1/2" . SPARSER::COLLECTION)
    ("transfected KIBRA and endogenous RSK2" . SPARSER::COLLECTION)
    ("ectopic RSK1 or its kinase inactive mutant" . SPARSER::COLLECTION)
    ("ERK-RSK" . SPARSER::COLLECTION)
    ("RSK1 ( xref ) and RSK2 ( xref )" . SPARSER::COLLECTION)
    ("The p90 ribosomal kinases (RSK)" . SPARSER::KINASE)
    ("CDK1 and ERK1/2" . SPARSER::COLLECTION)
    ("GST-KIBRA" . SPARSER::COLLECTION)
    ("relevant serine" . SPARSER::AMINO-ACID)
    ("ERK1 ( xref ) or ERK2 ( xref )" . SPARSER::COLLECTION)
    ("ERK1/2 and CDK1" . SPARSER::COLLECTION) ("PPCS" . SPARSER::PROTEIN)
    ("ERK1 ( xref ) and ERK2 ( xref ) kinases" . SPARSER::COLLECTION)
    ("MEK1/2 and subsequent ERK1/2 kinases ( xref )" . SPARSER::COLLECTION)
    ("U0126 and PD0325901" . SPARSER::COLLECTION)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("U0126 or PD0325901" . SPARSER::COLLECTION)
    ("phospho-protein and runs" . SPARSER::COLLECTION)
    ("MEK-ERK-RSK" . SPARSER::COLLECTION)
    ("the 90 kDa ribosomal S6 kinase (RSK) family" . SPARSER::PROTEIN-FAMILY)
    ("-extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("the polarity protein PALS1-associated tight junction (PATJ) and synaptopodin [ xref ]"
     . SPARSER::COLLECTION)
    ("the polarity protein PALS1-associated tight junction (PATJ)"
     . SPARSER::PROTEIN)
    ("synaptopodin" . SPARSER::PROTEIN) ("PATJ" . SPARSER::PROTEIN)
    ("cognition-associated protein" . SPARSER::PROTEIN)
    ("ERK1/2 and RSK1/2" . SPARSER::COLLECTION) ("-RSK" . SPARSER::COLLECTION)
    ("RSK" . SPARSER::PROTEIN)
    ("a memory performance-associated protein" . SPARSER::PROTEIN)
    ("KIBRA" . SPARSER::PROTEIN) ("Ajuba LIM protein" . SPARSER::PROTEIN)
    ("WWC3" . SPARSER::PROTEIN) ("WWC2" . SPARSER::PROTEIN)
    ("WWC family" . SPARSER::PROTEIN-FAMILY) ("NF2" . SPARSER::PROTEIN)
    ("Lats2" . SPARSER::PROTEIN) ("Anti-β" . SPARSER::PROTEIN)
    ("BI-D1870" . SPARSER::MOLECULE)
    ("cyclin dependent kinase 1" . SPARSER::PROTEIN)
    ("discoidin domain receptor tyrosine kinase 1" . SPARSER::PROTEIN)
    ("PALS1" . SPARSER::PROTEIN) ("WWC1" . SPARSER::PROTEIN)
    ("WW and C2 domain containing 1" . SPARSER::PROTEIN)
    ("RSK2" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("S6 kinases" . SPARSER::PROTEIN-FAMILY) ("p90" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("Iqgap1 or GFP" . SPARSER::COLLECTION) ("Tech" . SPARSER::PROTEIN)
    ("Nick" . SPARSER::PROTEIN) ("TdT" . SPARSER::PROTEIN)
    ("LCA" . SPARSER::PROTEIN) ("Bsep" . SPARSER::PROTEIN)
    ("Lats1 and Mst1/2" . SPARSER::COLLECTION)
    ("A major barrier" . SPARSER::PROTEIN)
    ("adenoviral IQGAP1" . SPARSER::PROTEIN) ("Iqgap2" . SPARSER::PROTEIN)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("E-cadherin ( xref ) and PP2A ( xref )" . SPARSER::COLLECTION)
    ("a key scaffolding protein" . SPARSER::PROTEIN)
    ("instead total ERK and EGFR" . SPARSER::COLLECTION)
    ("ERK or JNK" . SPARSER::COLLECTION) ("ERK and EGFR" . SPARSER::COLLECTION)
    ("proteins and cyclins" . SPARSER::COLLECTION)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mst1 and Lats 1" . SPARSER::COLLECTION)
    ("the functional adaptor proteins salvador (sav1) and Mob1 (data not shown)"
     . SPARSER::COLLECTION)
    ("sav1" . SPARSER::PROTEIN) ("salvador" . SPARSER::PROTEIN)
    ("Mst1, Lats1, and phospho-Lats1/2" . SPARSER::COLLECTION)
    ("Mst1" . SPARSER::PROTEIN) ("DDC" . SPARSER::PROTEIN)
    ("CDCA" . SPARSER::MOLECULE) ("SHP and BSEP" . SPARSER::COLLECTION)
    ("BSEP" . SPARSER::PROTEIN)
    ("Cyclin D1, and Osteopontin" . SPARSER::COLLECTION)
    ("Osteopontin" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("OC2-1D11" . SPARSER::COLLECTION) ("spontaneous HCC" . SPARSER::PROTEIN)
    ("α-catenin ( xref ) and the apical adaptor proteins"
     . SPARSER::COLLECTION)
    ("the apical adaptor proteins" . SPARSER::PROTEIN)
    ("atypical cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Merlin" . SPARSER::PROTEIN) ("Kibra" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TAZ" . SPARSER::PROTEIN)
    ("Sav" . SPARSER::PROTEIN) ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fxr" . SPARSER::PROTEIN)
    ("Farnesoid X Receptor (FXR)" . SPARSER::PROTEIN)
    ("Heterodimer" . SPARSER::HETERODIMER) ("detergents" . SPARSER::MOLECULE)
    ("signaling molecules and play important roles in liver regeneration ( xref )"
     . SPARSER::COLLECTION)
    ("lipids and lipid" . SPARSER::COLLECTION) ("Iqgap1" . SPARSER::PROTEIN)
    ("the scaffold protein Iqgap1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Iqgap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FXR and SHP" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("FXR" . SPARSER::PROTEIN) ("LATS1" . SPARSER::PROTEIN)
    ("p-YAP" . SPARSER::PROTEIN) ("bile salt export pump" . SPARSER::PROTEIN)
    ("PFIC2" . SPARSER::PROTEIN)
    ("progressive familial intrahepatic cholestasis 2" . SPARSER::PROTEIN)
    ("lats1" . SPARSER::PROTEIN)
    ("IQ motif containing GTPase activating protein1" . SPARSER::PROTEIN)
    ("TGR5" . SPARSER::PROTEIN) ("Lats 1" . SPARSER::PROTEIN)
    ("Mob1" . SPARSER::PROTEIN) ("chenodeoxycholic acid" . SPARSER::MOLECULE)
    ("GW4064" . SPARSER::DRUG) ("SPP1" . SPARSER::PROTEIN)
    ("Connective Tissue Growth Factor" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("OC2" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN) ("α-catenin" . SPARSER::PROTEIN)
    ("Mob1A" . SPARSER::PROTEIN) ("Lats1" . SPARSER::PROTEIN)
    ("Farnesoid X Receptor" . SPARSER::PROTEIN)
    ("oncogenes or inactivated tumour suppressor genes" . SPARSER::COLLECTION)
    ("PDACs" . SPARSER::MOLECULE) ("a degradative enzyme" . SPARSER::ENZYME)
    ("nanoparticle albumin-linked paclitaxel (nab-paclitaxel) and gemcitabine"
     . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("nanoparticle" . SPARSER::MOLECULE)
    ("KPC" . SPARSER::PROTEIN) ("Olaparib" . SPARSER::DRUG)
    ("Tp53 or other checkpoint genes" . SPARSER::COLLECTION)
    ("the acinar type" . TYPE) ("Tr/F11" . SPARSER::COLLECTION)
    ("more extensive genome" . SPARSER::PROTEIN) ("lacZ" . SPARSER::PROTEIN)
    ("Tp53 and Brca2" . SPARSER::COLLECTION)
    ("the structural mutant Tp53 R172H ( xref ) or the contact mutant Tp53 R270H ( xref )"
     . SPARSER::COLLECTION)
    ("Somewhat different Tp53 alleles" . SPARSER::ALLELE)
    ("conditional alleles" . SPARSER::ALLELE) ("Tp53" . SPARSER::PROTEIN)
    ("the conditional Brca2  F11 allele" . SPARSER::ALLELE)
    ("Tr and Brca2" . SPARSER::COLLECTION) ("Brca2" . SPARSER::PROTEIN)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PDX1-CRE" . SPARSER::COLLECTION)
    ("a conditional gene-targeted allele" . SPARSER::ALLELE)
    ("-CRE" . SPARSER::COLLECTION) ("PDX1" . SPARSER::PROTEIN)
    ("HCC-origin inflammatory cytokines" . SPARSER::PROTEIN)
    ("PI3K or ERK" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("CXCL5 and IL-8" . SPARSER::COLLECTION)
    ("CXCL5 and/or CXCL8" . SPARSER::COLLECTION)
    ("epithelial-derived neutrophil-activating peptide" . SPARSER::PEPTIDE)
    ("Src/EGFR/STAT5" . SPARSER::COLLECTION)
    ("CXCL8 and CXCL5" . SPARSER::COLLECTION)
    ("ras/raf/MEK/MAPK" . SPARSER::COLLECTION)
    ("ERK-PI3K-Akt" . SPARSER::COLLECTION)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGF and EGFR" . SPARSER::COLLECTION)
    ("a 170 kD transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("disulphide" . SPARSER::MOLECULE)
    ("Inflammatory cytokines and their receptors" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("extraneous CXCL5" . SPARSER::PROTEIN)
    ("BEZ235 or SHBM1009" . SPARSER::COLLECTION)
    ("U0126 or BEZ-235" . SPARSER::COLLECTION)
    ("BEZ235 or SHBM1009 ( P  < 0.05 or less, Fig.  xref A and B)"
     . SPARSER::COLLECTION)
    ("EFG" . SPARSER::PROTEIN)
    ("phosphorylated Akt and total Akt" . SPARSER::COLLECTION)
    ("phosphorylated ERK1/2 and total ERK1/2" . SPARSER::COLLECTION)
    ("phosphorylated Akt and total AKT" . SPARSER::COLLECTION)
    ("ERK1/2 (B) or Akt (C)" . SPARSER::COLLECTION)
    ("Erlotinib, or U0126" . SPARSER::COLLECTION)
    ("BEZ235 or SHBM1009 ( P  < 0.05 or less respectively)"
     . SPARSER::COLLECTION)
    ("BEZ235 and EGF" . SPARSER::COLLECTION)
    ("CXCL5 or CXCL8" . SPARSER::COLLECTION)
    ("CXCL5, XCR1 and CXCL8" . SPARSER::COLLECTION)
    ("CXCL12, CCL11 and CCR3" . SPARSER::COLLECTION)
    ("-kinase-extracellular signal-regulated kinases" . SPARSER::COLLECTION)
    ("EGF-EGFR-phosphoinositide 3" . SPARSER::COLLECTION)
    ("interleukin (IL)" . SPARSER::PROTEIN)
    ("IL-6 and IL-1" . SPARSER::COLLECTION) ("sorafinib" . SPARSER::DRUG)
    ("-epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("CXCR2 and EGFR" . SPARSER::COLLECTION)
    ("CXCL5 and CXCL8" . SPARSER::COLLECTION)
    ("EGF-EGFR" . SPARSER::COLLECTION) ("chemo-attractants" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("Sb225002" . SPARSER::DRUG) ("CCR3" . SPARSER::PROTEIN)
    ("CCL11" . SPARSER::PROTEIN) ("XCR1" . SPARSER::PROTEIN)
    ("SB225002" . SPARSER::DRUG) ("ENA-78" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN) ("CXCR2" . SPARSER::PROTEIN)
    ("BEZ-235" . SPARSER::DRUG) ("CXCL8" . SPARSER::PROTEIN)
    ("CXCL5" . SPARSER::PROTEIN) ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("Pisa" . SPARSER::PROTEIN) ("RET/PTC3" . SPARSER::COLLECTION)
    ("Iodine" . SPARSER::MOLECULE) ("THY" . SPARSER::MOLECULE)
    ("Prism" . SPARSER::PROTEIN) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("Reagent" . SPARSER::MOLECULE) ("TRI" . SPARSER::PROTEIN)
    ("cytometry (FC)" . SPARSER::PROTEIN) ("FC" . SPARSER::PROTEIN)
    ("haematoxylin" . SPARSER::MOLECULE) ("wax" . SPARSER::MOLECULE)
    ("serological biomarkers" . SPARSER::MOLECULE)
    ("Oxidant" . SPARSER::PROTEIN) ("PTC3" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("the tandem-purified RNP" . SPARSER::PROTEIN)
    ("ORF1p, PCNA, and UPF1" . SPARSER::COLLECTION)
    ("ORF1p/ORF2p/UPF1" . SPARSER::COLLECTION)
    ("at least three distinct types" . TYPE)
    ("Distinct RNPs" . SPARSER::PROTEIN)
    ("PARP1, RUVBL1 and RUVBL2" . SPARSER::COLLECTION)
    ("PCNA and TOP1" . SPARSER::COLLECTION)
    ("RUVBL1 and RUVBL2" . SPARSER::COLLECTION)
    ("PURA, PURB, MEPCE, and PCNA" . SPARSER::COLLECTION)
    ("polymerases and ligases" . SPARSER::COLLECTION)
    ("ORF2p and PCNA" . SPARSER::COLLECTION)
    ("EN-mutant or RT-mutant" . SPARSER::COLLECTION)
    ("UPF1, UPF2, and UPF3a" . SPARSER::COLLECTION)
    ("UPF1, UPF2 and UPF3a" . SPARSER::COLLECTION)
    ("ORF2p/UPF1" . SPARSER::COLLECTION)
    ("L1 bicistronic mRNA" . SPARSER::PROTEIN)
    ("mRNAs, and RNA" . SPARSER::COLLECTION)
    ("premature termination codons" . SPARSER::PROTEIN)
    ("ORF1 or ORF2" . SPARSER::COLLECTION)
    ("protein/RNP" . SPARSER::COLLECTION)
    ("these three distinct RNP" . SPARSER::PROTEIN)
    ("ORF1p and UPF1" . SPARSER::COLLECTION)
    ("PCNA and ORF2p" . SPARSER::COLLECTION)
    ("PARP1, RUVBL1, and RUVBL2" . SPARSER::COLLECTION)
    ("ORF2p-PCNA" . SPARSER::COLLECTION) ("/PCNA" . SPARSER::COLLECTION)
    ("ORF2p/PCNA" . SPARSER::COLLECTION)
    ("a canonical PCNA" . SPARSER::PROTEIN)
    ("UPF2 and UPF3a" . SPARSER::COLLECTION) ("UPF3a" . SPARSER::PROTEIN)
    ("mRNA and polypeptides" . SPARSER::COLLECTION)
    ("UPF1 and ORF2p" . SPARSER::COLLECTION)
    ("both ORF1p protein and L1 RNA" . SPARSER::COLLECTION)
    ("many cellular mRNAs" . SPARSER::PROTEIN)
    ("bicistronic mRNAs" . SPARSER::PROTEIN)
    ("premature nonsense codons" . SPARSER::PROTEIN)
    ("bicistronic L1 mRNA" . SPARSER::PROTEIN)
    ("UPF1 and PCNA" . SPARSER::COLLECTION)
    ("PABPC1, PABPC4, MOV10, UPF1, and ZCCHC3" . SPARSER::COLLECTION)
    ("PARP1, PURA, PURB, RUVBL2, NAP1, TOP1 and ZCCHC3" . SPARSER::COLLECTION)
    ("PURB" . SPARSER::PROTEIN) ("PURA" . SPARSER::PROTEIN)
    ("autoantigen" . SPARSER::DRUG) ("TRE" . SPARSER::PROTEIN)
    ("foci and greater" . SPARSER::COLLECTION)
    ("ORF1:ORF2p" . SPARSER::BIO-COMPLEX)
    ("ORF1p:ORF2p" . SPARSER::BIO-COMPLEX)
    ("approximately every ∼45 nucleotides" . SPARSER::NUCLEOTIDE)
    ("nucleotides and trimers" . SPARSER::COLLECTION)
    ("trimer" . SPARSER::TRIMER) ("trimers" . SPARSER::TRIMER)
    ("Interestingly Alu RNA" . SPARSER::RNA)
    ("Alu and ORF2" . SPARSER::COLLECTION) ("Alu" . SPARSER::PROTEIN)
    ("snRNAs" . SPARSER::RNA)
    ("both tagged ORF1p (pLD288) and ORF2p (pLD401)" . SPARSER::COLLECTION)
    ("RNase" . SPARSER::PROTEIN) ("pMT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("linkers" . SPARSER::LINKER) ("ORF1p and ORF2p" . SPARSER::COLLECTION)
    ("Multi" . SPARSER::PROTEIN) ("ORF1p" . SPARSER::PROTEIN)
    ("Doxycycline" . SPARSER::DRUG) ("ORF1p-Flag" . SPARSER::COLLECTION)
    ("40 fold more RNA and 5–10 fold more ORF1p" . SPARSER::COLLECTION)
    ("the polymerase-associated sliding clamp" . SPARSER::PROTEIN-FAMILY)
    ("ORF1 and ORF2" . SPARSER::COLLECTION) ("snRNA" . SPARSER::RNA)
    ("traditional matrices" . SPARSER::PROTEIN-FAMILY)
    ("Fractions" . SPARSER::COMPONENT) ("TPRT" . SPARSER::PROTEIN)
    ("endonuclease (EN)" . SPARSER::PROTEIN)
    ("a homotrimeric protein" . SPARSER::PROTEIN)
    ("proteins, ORF1p and ORF2p" . SPARSER::COLLECTION)
    ("about 90 retrotransposition-competent L1s" . SPARSER::PROTEIN)
    ("L1s or LINE-1s" . SPARSER::COLLECTION) ("at least three types" . TYPE)
    ("PABPC1 and MOV10" . SPARSER::COLLECTION) ("RNPs" . SPARSER::PROTEIN)
    ("endonuclease activity" . SPARSER::PROTEIN) ("RUVBL1" . SPARSER::PROTEIN)
    ("UPF3" . SPARSER::PROTEIN) ("UPF2" . SPARSER::PROTEIN)
    ("ARHGEF18" . SPARSER::PROTEIN) ("MAP3K14" . SPARSER::PROTEIN)
    ("PABPC4" . SPARSER::PROTEIN) ("IPO7" . SPARSER::PROTEIN)
    ("HAX1" . SPARSER::PROTEIN) ("ZCCHC3" . SPARSER::PROTEIN)
    ("TOP1" . SPARSER::PROTEIN) ("NAP1" . SPARSER::PROTEIN)
    ("RUVBL2" . SPARSER::PROTEIN) ("TROVE2" . SPARSER::PROTEIN)
    ("ORF2" . SPARSER::PROTEIN) ("ORF1" . SPARSER::PROTEIN)
    ("L1s" . SPARSER::PROTEIN)
    ("Long INterspersed Element-1" . SPARSER::PROTEIN)
    ("ORF2p" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("UPF1" . SPARSER::PROTEIN) ("MOV10" . SPARSER::PROTEIN)
    ("PABPC1" . SPARSER::PROTEIN) ("p38 or JNK" . SPARSER::COLLECTION)
    ("comparatively less reactive hydrogen superoxide" . SPARSER::MOLECULE)
    ("overnight intermittent hypoxia" . SPARSER::PROTEIN)
    ("DUSP1 and MnSOD" . SPARSER::COLLECTION)
    ("myocardial ischemia" . SPARSER::PROTEIN)
    ("intermittent hypoxia (IH)" . SPARSER::PROTEIN)
    ("JNK, p38 and ERK" . SPARSER::COLLECTION)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("an immediate-early gene" . SPARSER::GENE) ("CPAP" . SPARSER::PROTEIN)
    ("Intermittent hypoxia" . SPARSER::PROTEIN) ("OSA" . SPARSER::PROTEIN)
    ("intermittent hypoxia" . SPARSER::PROTEIN)
    ("IFN gamma" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("E-selectin" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EG7" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP1" . SPARSER::PROTEIN)
    ("Dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("a homozygous BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1- and BRCA2" . SPARSER::COLLECTION) ("FANCJ" . SPARSER::PROTEIN)
    ("UV radiation-damaged DNA" . SPARSER::DNA)
    ("whole-genome and whole exome" . SPARSER::COLLECTION)
    ("a genomic biomarker" . SPARSER::MOLECULE)
    ("FLOH and NtAI" . SPARSER::COLLECTION) ("FLOH" . SPARSER::PROTEIN)
    ("BRCA1 and RAD51C" . SPARSER::COLLECTION)
    ("BRCA1 or RAD51C" . SPARSER::COLLECTION)
    ("BRCA1 (n = 31) and RAD51C (n = 8)" . SPARSER::COLLECTION)
    ("genome or exome" . SPARSER::COLLECTION)
    ("estrogen receptor and HER2" . SPARSER::COLLECTION)
    ("erbB-2/neu" . SPARSER::COLLECTION)
    ("Reliable biomarkers" . SPARSER::MOLECULE)
    ("ovarian cancer genomes" . SPARSER::PROTEIN) ("RAD51C" . SPARSER::PROTEIN)
    ("erbB-2" . SPARSER::PROTEIN) ("bosentan" . SPARSER::DRUG)
    ("c-Jun and JNK" . SPARSER::COLLECTION)
    ("MAPK, JNK, PKC and PI3K" . SPARSER::COLLECTION)
    ("Jun and C/EBPβ" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("Hg" . SPARSER::MOLECULE) ("receptor and c-Jun" . SPARSER::COLLECTION)
    ("Receptor and c-Jun" . SPARSER::COLLECTION) ("Retinas" . SPARSER::DRUG)
    ("C/EBPβ and c-Jun" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE)
    ("further address AP-1’s" . SPARSER::PROTEIN)
    ("mutated promoter" . SPARSER::PROMOTER)
    ("further address AP-1" . SPARSER::PROTEIN)
    ("AP-1 and C/EBPβ" . SPARSER::COLLECTION)
    ("basic leucine zipper transcription factor family"
     . SPARSER::PROTEIN-FAMILY)
    ("basic leucine zipper proteins" . SPARSER::PROTEIN)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("Fos, Maf and JDP" . SPARSER::COLLECTION) ("JDP" . SPARSER::PROTEIN)
    ("ATF" . SPARSER::PROTEIN) ("c-Jun and ATF-3" . SPARSER::COLLECTION)
    ("CCAAT" . SPARSER::PROTEIN)
    ("retina and optic nerve head xref" . SPARSER::COLLECTION)
    ("the predominant receptor" . SPARSER::RECEPTOR)
    ("A (ET A ) receptors and endothelin B (ET B ) receptors"
     . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("rhodopsin" . SPARSER::PROTEIN)
    ("a 21 amino acid vasoactive peptide" . SPARSER::PEPTIDE)
    ("the optic disc" . SPARSER::BIO-COMPLEX) ("disc" . SPARSER::BIO-COMPLEX)
    ("c-Jun and C/EBPβ" . SPARSER::COLLECTION)
    ("c-Jun or C/EBPβ" . SPARSER::COLLECTION)
    ("Cyclophilin A" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("ET-1-" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("Jab1" . SPARSER::PROTEIN) ("ATF-3" . SPARSER::PROTEIN)
    ("ET-1" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("open angle" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("Akt or Erk" . SPARSER::COLLECTION) ("K-RasG12" . SPARSER::PROTEIN)
    ("ERK, PI3K, AKT or mTOR" . SPARSER::COLLECTION)
    ("K-Ras12" . SPARSER::PROTEIN) ("LSL-K-RasG12" . SPARSER::PROTEIN-PAIR)
    ("LSL-K-Ras" . SPARSER::COLLECTION) ("aLSL-K-ras" . SPARSER::COLLECTION)
    ("sftpc" . SPARSER::PROTEIN) ("TetO" . SPARSER::PROTEIN)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("Akt and Pdk1" . SPARSER::COLLECTION)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("JNK, ERK or AKT" . SPARSER::COLLECTION)
    ("PI3K-Pdk1" . SPARSER::COLLECTION) ("/CD73" . SPARSER::COLLECTION)
    ("/CD45" . SPARSER::COLLECTION) ("/CD34" . SPARSER::COLLECTION)
    ("/CD31" . SPARSER::COLLECTION) ("/E-Cadherin" . SPARSER::COLLECTION)
    ("Pdk1" . SPARSER::PROTEIN) ("RasG" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("CC-10" . SPARSER::PROTEIN)
    ("SP-C" . SPARSER::PROTEIN) ("E-Cad" . SPARSER::PROTEIN)
    ("pPdk1" . SPARSER::PROTEIN) ("PI3Kinase" . SPARSER::PROTEIN)
    ("Inhibitor 1" . SPARSER::PROTEIN) ("sox9" . SPARSER::PROTEIN)
    ("RasG12V" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("E-Cadherin" . SPARSER::PROTEIN)
    ("SAN" . SPARSER::PROTEIN) ("Prof" . SPARSER::PROTEIN)
    ("The ancestral codon" . SPARSER::PROTEIN) ("ACG" . SPARSER::PROTEIN)
    ("GTA" . SPARSER::PROTEIN) ("variants and 179" . SPARSER::COLLECTION)
    ("mature mRNA" . SPARSER::PROTEIN) ("FGF10 and FGF7" . SPARSER::COLLECTION)
    ("FGF7 or FGF10" . SPARSER::COLLECTION)
    ("the epithelial-associated isoform FGFR2-b" . SPARSER::COLLECTION)
    ("FGFR2-b" . SPARSER::COLLECTION) ("heterozygous MCF7" . SPARSER::PROTEIN)
    ("CCND1 (Cyclin D1) and the Greb1 (growth regulation by oestrogen in breast cancer 1) promoter"
     . SPARSER::COLLECTION)
    ("Greb1" . SPARSER::PROTEIN)
    ("binding transcriptionally inactive chromatin" . SPARSER::PROTEIN)
    ("oestradiol" . SPARSER::MOLECULE) ("FOXA1 and ERα" . SPARSER::COLLECTION)
    ("Oct1/Runx2" . SPARSER::COLLECTION)
    ("allele and its surrounding sequence" . SPARSER::COLLECTION)
    ("exogenous Runx2" . SPARSER::PROTEIN)
    ("Tamoxifen, an ER antagonist, and the expression of ERα"
     . SPARSER::COLLECTION)
    ("PS2 and c-Myb" . SPARSER::COLLECTION)
    ("Het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mRNAs and pmaxGFP" . SPARSER::COLLECTION)
    ("the disease-associated allele" . SPARSER::ALLELE)
    ("three possible genotypes" . SPARSER::PROTEIN) ("ZFN" . SPARSER::PROTEIN)
    ("the pro-apoptotic gene BIM" . SPARSER::PROTEIN)
    ("efficient genome" . SPARSER::PROTEIN) ("transgene" . SPARSER::PROTEIN)
    ("Runx2/Oct1" . SPARSER::COLLECTION) ("Nuclease" . SPARSER::PROTEIN)
    ("ERα and FGFR" . SPARSER::COLLECTION) ("FoxA1" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("Cel-1" . SPARSER::PROTEIN)
    ("Messenger RNAs" . SPARSER::RNA) ("FGF10" . SPARSER::PROTEIN)
    ("FGF7" . SPARSER::PROTEIN) ("PS2" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("FOXO1 or FOX03" . SPARSER::COLLECTION)
    ("keratin-1, keratin-10 and involucrin" . SPARSER::COLLECTION)
    ("involucrin and keratin-1" . SPARSER::COLLECTION)
    ("cysteine, serine and threonine" . SPARSER::COLLECTION)
    ("an epithelial barrier" . SPARSER::PROTEIN)
    ("FOXO1 or FOX3" . SPARSER::COLLECTION)
    ("keratinocytes and BID and TRADD" . SPARSER::COLLECTION)
    ("keratin 1 and keratin 10" . SPARSER::COLLECTION)
    ("FOXO1 and FOX3" . SPARSER::COLLECTION)
    ("FOXO1/FOXO3" . SPARSER::COLLECTION)
    ("keratin-14 and involucrin" . SPARSER::COLLECTION)
    ("involucrin and keratin-14" . SPARSER::COLLECTION)
    ("siRNA and FOXO3" . SPARSER::COLLECTION)
    ("mRNA and a 2" . SPARSER::COLLECTION)
    ("TLR-2 or TLR-4" . SPARSER::COLLECTION)
    ("TLR-4 and TLR-2" . SPARSER::COLLECTION) ("Leupeptin" . SPARSER::DRUG)
    ("leupeptin" . SPARSER::DRUG)
    ("the gingival epithelial barrier" . SPARSER::PROTEIN)
    ("fluorescent labeled dextran" . SPARSER::DEXTRAN)
    ("TLR-2 and TLR-4" . SPARSER::COLLECTION)
    ("FOXO1 or FOXO3" . SPARSER::COLLECTION)
    ("BID and TRADD" . SPARSER::COLLECTION) ("TRADD" . SPARSER::PROTEIN)
    ("BID" . SPARSER::PROTEIN) ("involucrin" . SPARSER::PROTEIN)
    ("TLR-2" . SPARSER::PROTEIN) ("fluorescent dextran" . SPARSER::DEXTRAN)
    ("dextran" . SPARSER::DEXTRAN) ("keratin 10" . SPARSER::PROTEIN)
    ("keratin 1" . SPARSER::PROTEIN) ("integrin beta-3" . SPARSER::PROTEIN)
    ("beta-1" . SPARSER::PROTEIN) ("Integrin beta-1" . SPARSER::PROTEIN)
    ("keratin-14" . SPARSER::PROTEIN) ("keratin-10" . SPARSER::PROTEIN)
    ("ribosomal protein L32" . SPARSER::PROTEIN) ("H2O2" . SPARSER::DRUG)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("beta -3" . SPARSER::PROTEIN) ("integrin beta -1" . SPARSER::PROTEIN)
    ("TLR-4" . SPARSER::PROTEIN) ("integrin beta-1" . SPARSER::PROTEIN)
    ("keratin-1" . SPARSER::PROTEIN) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("relatively much weaker" . SPARSER::PROTEIN)
    ("selumetinib" . SPARSER::DRUG) ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("non-expressing" . SPARSER::PROTEIN)
    ("dabrafenib and trametinib" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG)
    ("the ATP competitive BRAFi vemurafenib (PLX4032) and the allosteric MEKi’s AZD6244 and GSK1120212"
     . SPARSER::COLLECTION)
    ("the ATP competitive BRAFi vemurafenib" . SPARSER::DRUG)
    ("AZD6244 and GSK1120212" . SPARSER::COLLECTION)
    ("MK2206 and GSK2141795" . SPARSER::COLLECTION)
    ("BRAF or MEK" . SPARSER::COLLECTION)
    ("PTEN-non-expressing" . SPARSER::PROTEIN-PAIR)
    ("p-GSK3β" . SPARSER::COLLECTION) ("AKTi" . SPARSER::PROTEIN)
    ("BRAF-" . SPARSER::PROTEIN) ("exogenous AKT1 Q79K" . SPARSER::PROTEIN)
    ("p-AKT1" . SPARSER::COLLECTION) ("FLAG-AKT1" . SPARSER::COLLECTION)
    ("AKT1 and AKT3" . SPARSER::COLLECTION) ("PHD-GFP" . SPARSER::COLLECTION)
    ("sunitinib and gefitnib" . SPARSER::COLLECTION)
    ("gefitnib" . SPARSER::DRUG) ("p-CRAF" . SPARSER::COLLECTION)
    ("RTK/PDGFRβ" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("two key receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGFRβ and EGFR" . SPARSER::COLLECTION)
    ("PIK3CA , AKT1 and AKT3" . SPARSER::COLLECTION)
    ("PI3K/PTEN/AKT" . SPARSER::COLLECTION)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("AKT1 (Q79K) kown" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("GSK2118436" . SPARSER::DRUG) ("GSK1120212" . SPARSER::DRUG)
    ("PLX4032" . SPARSER::DRUG) ("GSK795" . SPARSER::DRUG)
    ("GSK2141795" . SPARSER::DRUG) ("PI3K inhibitor BKM120" . SPARSER::DRUG)
    ("MK2206" . SPARSER::DRUG) ("FR180204" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("PHLPP1" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("PDGFRβ" . SPARSER::PROTEIN)
    ("PAK1 and/or PAK2" . SPARSER::COLLECTION)
    ("BCR-ABL-STAT5" . SPARSER::COLLECTION)
    ("Raf and MAPK" . SPARSER::COLLECTION)
    ("Rac or Cdc42" . SPARSER::COLLECTION)
    ("STAT5 and group I" . SPARSER::COLLECTION)
    ("importin-α5" . SPARSER::PROTEIN-PAIR)
    ("JAKs and STATs" . SPARSER::COLLECTION)
    ("imatinib (2 μ M ) and the kinetics of STAT5 S725" . SPARSER::COLLECTION)
    ("STAT5, PAK1, PAK2 and Rac1" . SPARSER::COLLECTION)
    ("PAK1 and PAK2" . SPARSER::COLLECTION)
    ("kinases, mammalian target of rapamycin, glycogen synthase kinase-3β and PIM1—that"
     . SPARSER::COLLECTION)
    ("IPA-3 and PF-3758309" . SPARSER::COLLECTION)
    ("a phospho-mimetic variant" . SPARSER::VARIANT)
    ("PKA, PKB and PKC" . SPARSER::COLLECTION)
    ("kinases, PAKs and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("Mitogen-activated protein kinases (MAPKs) and cyclin-dependent kinases (CDKs)"
     . SPARSER::COLLECTION)
    ("at least one STAT5 molecule" . SPARSER::MOLECULE)
    ("the corresponding phospho-mimetic mutants" . SPARSER::MUTANT)
    ("Lamin B and α-tubulin" . SPARSER::COLLECTION)
    ("The phospho-mimetic variants (S→D) STAT5 S725D" . SPARSER::PROTEIN)
    ("STAT5 S779A and STAT5 SASA proteins" . SPARSER::COLLECTION)
    ("the STAT5 S779A and STAT5 SASA proteins" . SPARSER::COLLECTION)
    ("-YFP" . SPARSER::COLLECTION)
    ("the STAT5 S725A and the STAT5 wt" . SPARSER::COLLECTION)
    ("STAT5 S725A or STAT5 S779A" . SPARSER::COLLECTION)
    ("PB" . SPARSER::PROTEIN)
    ("STAT5 S725A and STAT5 S779A (a diagram of the STAT5 mutants is provided in xref )"
     . SPARSER::COLLECTION)
    ("lymphoid, myeloid and erythroid" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stat5b" . SPARSER::PROTEIN) ("CDK8" . SPARSER::PROTEIN)
    ("PF-3758309" . SPARSER::DRUG) ("18 h" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("IPA-3" . SPARSER::MOLECULE)
    ("PIM1" . SPARSER::PROTEIN) ("TDZD-8" . SPARSER::DRUG)
    ("KN-93" . SPARSER::MOLECULE) ("B-6" . SPARSER::PROTEIN)
    ("HSC70" . SPARSER::PROTEIN) ("interferon-β" . SPARSER::DRUG)
    ("p160" . SPARSER::PROTEIN) ("v-ABL" . SPARSER::PROTEIN)
    ("p185" . SPARSER::PROTEIN) ("a/b" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("Mx-1" . SPARSER::PROTEIN)
    ("p210" . SPARSER::PROTEIN) ("group I" . SPARSER::PROTEIN)
    ("Jun/Fos" . SPARSER::COLLECTION) ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase, Akt, and cyclin D1"
     . SPARSER::COLLECTION)
    ("noise-driven PINs" . SPARSER::PROTEIN)
    ("NFkB and c-Jun" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("A18C/63C and P102C/63C" . SPARSER::COLLECTION)
    ("cardiolipin and PAGE4" . SPARSER::COLLECTION)
    ("mitochondrial-associated PAGE4" . SPARSER::PROTEIN)
    ("the double cysteine mutants (with very low labeling efficiency so that nearly all molecules only contain one Alexa 555 randomly distributed between the cysteine) A18C/63C (0.257 without c-Jun, 0.250 with c-Jun) and P102C/63C (0.244 without c-Jun, 0.250 with c-Jun)"
     . SPARSER::COLLECTION)
    ("A18C/63C" . SPARSER::PROTEIN)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("a distinct conformational state" . SPARSER::BIO-STATE)
    ("the typical run" . SPARSER::PROTEIN-FAMILY)
    ("c-Jun/PAGE4" . SPARSER::COLLECTION)
    ("c-Jun and PAGE4" . SPARSER::COLLECTION)
    ("a bona fide transcription factor" . SPARSER::PROTEIN)
    ("MEKK and PAGE4" . SPARSER::COLLECTION) ("JNKK" . SPARSER::PROTEIN)
    ("MAPKKK" . SPARSER::PROTEIN) ("nV5-PAGE4" . SPARSER::COLLECTION)
    ("GAL4-c-Jun" . SPARSER::COLLECTION) ("MEKK" . SPARSER::PROTEIN)
    ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("c-Jun and AP-1" . SPARSER::COLLECTION) ("gal" . SPARSER::PROTEIN)
    ("Ade" . SPARSER::PROTEIN) ("sigma" . SPARSER::PROTEIN-FAMILY)
    ("liposomes" . SPARSER::PROTEIN) ("Ia" . SPARSER::MOLECULE)
    ("polypeptides" . SPARSER::PEPTIDE) ("Cysteine" . SPARSER::AMINO-ACID)
    ("dimeric PAGE4 form" . SPARSER::FORM)
    ("globular proteins" . SPARSER::PROTEIN)
    ("ovalbumin (MW43 kD; elution 15.6 ml) and ribonuclease"
     . SPARSER::COLLECTION)
    ("ribonuclease" . SPARSER::PROTEIN) ("ovalbumin" . SPARSER::PROTEIN)
    ("dynamic light" . SPARSER::PROTEIN)
    ("several other cancer-associated genes" . SPARSER::GENE)
    ("PIN" . SPARSER::PROTEIN) ("PINs" . SPARSER::PROTEIN)
    ("lack rigid 3D" . SPARSER::PROTEIN-FAMILY) ("IDPs" . SPARSER::PROTEIN)
    ("protein (IDP)" . SPARSER::PROTEIN) ("IDP" . SPARSER::PROTEIN)
    ("PIA" . SPARSER::PROTEIN)
    ("a developmentally-regulated gene" . SPARSER::GENE)
    ("Prostate-associated gene 4" . SPARSER::PROTEIN)
    ("PAGE4/c-Jun" . SPARSER::COLLECTION)
    ("a CTA and a proto-oncogene" . SPARSER::COLLECTION)
    ("cardiolipin" . SPARSER::MOLECULE)
    ("PAGE4 and c-Jun" . SPARSER::COLLECTION)
    ("Prostate-associated Gene 4" . SPARSER::PROTEIN)
    ("Antigen (CTA)" . SPARSER::PROTEIN) ("CTA" . SPARSER::PROTEIN)
    ("Antigen" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("BPH-1" . SPARSER::PROTEIN) ("Mir-221" . SPARSER::PROTEIN)
    ("aa1" . SPARSER::PROTEIN) ("43 kD" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("ZNF394" . SPARSER::PROTEIN)
    ("nV5" . SPARSER::PROTEIN) ("P102" . SPARSER::PROTEIN)
    ("proto-oncogene c-Jun" . SPARSER::PROTEIN) ("gene 4" . SPARSER::PROTEIN)
    ("PAGE4" . SPARSER::PROTEIN) ("Gene 4" . SPARSER::PROTEIN)
    ("NVP-BEZ235 or everolimus" . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("pAKT and mTOR" . SPARSER::COLLECTION)
    ("RAD001 or LY294002" . SPARSER::COLLECTION)
    ("weekly LY294002 SQ" . SPARSER::MOLECULE)
    ("weekly DMSO SQ" . SPARSER::MOLECULE)
    ("MEK inhibitor PD0325901 (50 nM) or RAD001 (50 nM)" . SPARSER::COLLECTION)
    ("RAD001 and LY294002" . SPARSER::COLLECTION)
    ("MAPK/MEK" . SPARSER::COLLECTION)
    ("PD0325901 and RAD001" . SPARSER::COLLECTION)
    ("AKT or p70S6" . SPARSER::COLLECTION)
    ("LY294002, RAD001 and PD0325901" . SPARSER::COLLECTION)
    ("RAD001 (50 nM) and/or PD0325901 (50 nM)" . SPARSER::COLLECTION)
    ("AKT, p70S6K, and ERK1/2" . SPARSER::COLLECTION)
    ("IGF/IGF1-R" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("AKT or MAPK" . SPARSER::COLLECTION)
    ("pAKT and pERK" . SPARSER::COLLECTION)
    ("PD98059 or PD0325901" . SPARSER::COLLECTION)
    ("a MAPK/ERK inhibitor and/or PI3K inhibitor" . SPARSER::COLLECTION)
    ("PKB/AKT" . SPARSER::COLLECTION)
    ("proteins and phosphatidylinositol 3-kinases" . SPARSER::COLLECTION)
    ("an orally bioavailable mTOR inhibitor" . SPARSER::INHIBITOR)
    ("-rapamycin" . SPARSER::DRUG) ("SQ" . SPARSER::MOLECULE)
    ("NVP-AEW541" . SPARSER::DRUG) ("Group D" . SPARSER::PROTEIN)
    ("Group C" . SPARSER::PROTEIN) ("Group B" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("IGF1-R" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("potentially efficacious therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("S1P 1 and S1P 3" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("PKC and PI3K" . SPARSER::COLLECTION) ("emetine" . SPARSER::DRUG)
    ("Bcl-2 and Bcl-X" . SPARSER::COLLECTION)
    ("GF109203X and LY294002" . SPARSER::COLLECTION)
    ("proteins and proteasomal" . SPARSER::COLLECTION)
    ("MAP/ERK" . SPARSER::COLLECTION)
    ("caspase-3 and Bim" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("dihydrosphingosine" . SPARSER::DRUG) ("SK" . SPARSER::PROTEIN)
    ("Bmf and PUMA" . SPARSER::COLLECTION)
    ("pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("mycS" . SPARSER::PROTEIN) ("Receptors" . SPARSER::RECEPTOR)
    ("protein/ERK" . SPARSER::COLLECTION)
    ("Bcl-2-associated X Protein" . SPARSER::PROTEIN)
    ("multi-domain pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("/Bcl-2-associated death promoter" . SPARSER::COLLECTION)
    ("Noxa" . SPARSER::PROTEIN) ("IL-6 and S1P 1" . SPARSER::COLLECTION)
    ("-sphingosine-1-phosphate" . SPARSER::DRUG)
    ("ceramide" . SPARSER::MOLECULE) ("sphingomyelin" . SPARSER::MOLECULE)
    ("PI3K/PKB" . SPARSER::COLLECTION) ("PI3K and PKC" . SPARSER::COLLECTION)
    ("pro-apoptotic BH3-only protein Bim" . SPARSER::PROTEIN)
    ("S1PRs" . SPARSER::PROTEIN-FAMILY) ("S1PR" . SPARSER::PROTEIN-FAMILY)
    ("S1P 3" . SPARSER::PROTEIN) ("anti-angiogenic" . SPARSER::DRUG)
    ("Raf-1" . SPARSER::PROTEIN) ("Mcl-1 protein" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("GF109203X" . SPARSER::DRUG)
    ("DEVD-CHO" . SPARSER::DRUG) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("FOXO3A" . SPARSER::PROTEIN)
    ("Bcl-2-associated death promoter" . SPARSER::PROTEIN)
    ("Bcl-2-modifying factor" . SPARSER::PROTEIN) ("Bcl-X" . SPARSER::PROTEIN)
    ("Bcl-2-like protein 1" . SPARSER::PROTEIN)
    ("Bcl-2 homologous antagonist/killer" . SPARSER::PROTEIN)
    ("G-proteins" . SPARSER::PROTEIN) ("SK2" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("FTY720" . SPARSER::DRUG)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S1P 1" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("a significantly higher RR" . SPARSER::MOLECULE)
    ("the Western Washington State" . SPARSER::BIO-STATE)
    ("BRAF, MSI and PTEN" . SPARSER::COLLECTION)
    ("two major Scandinavian cohorts" . SPARSER::MOLECULE)
    ("PETCAC-3" . SPARSER::COLLECTION) ("DCR" . SPARSER::PROTEIN)
    ("the retrospective cohort" . SPARSER::MOLECULE)
    ("ITT" . SPARSER::MOLECULE)
    ("irinotecan and cetuximab" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("a naturally occurring quinolone alkaloid" . SPARSER::MOLECULE)
    ("occurring quinolone alkaloid" . SPARSER::MOLECULE)
    ("quinolone" . SPARSER::MOLECULE) ("Irinotecan" . SPARSER::DRUG)
    ("avastin" . SPARSER::DRUG)
    ("fluoropyrimidines and related pro-drugs" . SPARSER::COLLECTION)
    ("fluoropyrimidines" . SPARSER::DRUG)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("both archival tumor tissue and plasma cell-free DNA" . SPARSER::DNA)
    ("SORT1 or TCF21" . SPARSER::COLLECTION)
    ("causative alleles" . SPARSER::ALLELE)
    ("HDAC9 (for all IS/CAD) and SORT1 (for LAS/CAD)" . SPARSER::COLLECTION)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("robustly associated variants" . SPARSER::VARIANT)
    ("RAI1-PEMT-RASD1" . SPARSER::COLLECTION) ("EDNRA" . SPARSER::PROTEIN)
    ("PEMT" . SPARSER::PROTEIN) ("LAS and vice versa" . SPARSER::COLLECTION)
    ("LAS" . SPARSER::PROTEIN) ("WDR12" . SPARSER::PROTEIN)
    ("PHACTR1" . SPARSER::PROTEIN) ("von Willebrand factor" . SPARSER::PROTEIN)
    ("LDL-C" . SPARSER::PROTEIN) ("TCF21" . SPARSER::PROTEIN)
    ("SORT1" . SPARSER::PROTEIN) ("NT5C2" . SPARSER::PROTEIN)
    ("RASD1" . SPARSER::PROTEIN) ("RAI1" . SPARSER::PROTEIN)
    ("HDAC9" . SPARSER::PROTEIN) ("SH2B3" . SPARSER::PROTEIN)
    ("MH" . SPARSER::MOLECULE) ("YK" . SPARSER::MOLECULE)
    ("GABA" . SPARSER::MOLECULE)
    ("an efficacious treatment target" . SPARSER::TARGET-PROTEIN)
    ("GAD1/β-catenin/MMP7" . SPARSER::COLLECTION)
    ("the ECM substrates and degradation of basement membrane proteins [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("GAD1/β-catenin" . SPARSER::COLLECTION)
    ("MMP7 , cyclinD1 , and c-myc" . SPARSER::COLLECTION)
    ("a common ancestral gene" . SPARSER::GENE)
    ("GAD1 and GAD2" . SPARSER::COLLECTION) ("casein" . SPARSER::PROTEIN)
    ("HSC-2, and HSC-3" . SPARSER::COLLECTION)
    ("HO-1-N-1" . SPARSER::COLLECTION) ("KOSC-2" . SPARSER::COLLECTION)
    ("HO-1-u-1" . SPARSER::COLLECTION) ("HSC-3" . SPARSER::PROTEIN)
    ("HSC-2" . SPARSER::PROTEIN)
    ("fibronectin, vitronectin, laminin, and elastin" . SPARSER::COLLECTION)
    ("vitronectin" . SPARSER::PROTEIN)
    ("protein, and glycogen synthase" . SPARSER::COLLECTION)
    ("the principal inhibitory neurotransmitter" . SPARSER::MOLECULE)
    ("β-catenin and MMP7" . SPARSER::COLLECTION)
    ("the shRNA and specific GAD1 inhibitor" . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("Matrix metalloproteinase-7" . SPARSER::PROTEIN)
    ("Gamma-aminobutyric acid" . SPARSER::MOLECULE) ("GAD2" . SPARSER::PROTEIN)
    ("N-1" . SPARSER::PROTEIN) ("LRP 5/6" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("GABA)" . SPARSER::PROTEIN)
    ("GAD1" . SPARSER::PROTEIN)
    ("Glutamate decarboxylase 1" . SPARSER::PROTEIN)
    ("PGCs and LMNs" . SPARSER::COLLECTION) ("sentinel" . SPARSER::DRUG)
    ("the same histologic subtypes" . SPARSER::PROTEIN)
    ("PGCs and their corresponding LMNs" . SPARSER::COLLECTION)
    ("PGC and LNM" . SPARSER::COLLECTION) ("FISH " . SPARSER::PROTEIN)
    ("IHC + FISH" . SPARSER::PROTEIN) ("PGC" . SPARSER::PROTEIN)
    ("PGCs and their LNMs" . SPARSER::COLLECTION) ("LMNs" . SPARSER::PROTEIN)
    ("PGCs" . SPARSER::PROTEIN) ("Chromosome 17" . SPARSER::PROTEIN)
    ("NENs and the region-specific antibodies" . SPARSER::COLLECTION)
    ("PC  1" . SPARSER::PROTEIN) ("PC1 and PC2" . SPARSER::COLLECTION)
    ("more malignant NENs" . SPARSER::PROTEIN)
    ("mRNA and proteins/peptides" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("Pancreastatin" . SPARSER::PROTEIN) ("CgA and 5-HT" . SPARSER::COLLECTION)
    ("CgA and/or its peptide" . SPARSER::COLLECTION)
    ("CgA and its peptide" . SPARSER::COLLECTION)
    ("the predominant 75-80 kDa CgA protein" . SPARSER::PROTEIN)
    ("a relevant regulator" . SPARSER::REGULATOR)
    ("fragments, mRNA and protein" . SPARSER::COLLECTION)
    ("I/II and vasostatin" . SPARSER::COLLECTION)
    ("western blot and ELISA use antibodies" . SPARSER::ANTIBODY)
    ("CgA and its fragments" . SPARSER::COLLECTION)
    ("small intestinal NENs" . SPARSER::PROTEIN)
    ("AKT or prohormone" . SPARSER::COLLECTION)
    ("CgA and this processing enzyme" . SPARSER::COLLECTION)
    ("post-translational effectors" . SPARSER::EFFECTOR)
    ("STS" . SPARSER::PROTEIN) ("SI-NENs" . SPARSER::COLLECTION)
    ("SI" . SPARSER::PROTEIN) ("SI-NEN" . SPARSER::COLLECTION)
    ("NEN" . SPARSER::PROTEIN) ("NENs" . SPARSER::PROTEIN)
    ("the fibrinolytic enzyme" . SPARSER::ENZYME)
    ("PC1-3" . SPARSER::COLLECTION) ("PC1" . SPARSER::PROTEIN)
    ("catestatin" . SPARSER::PROTEIN) ("pancreastatin" . SPARSER::PROTEIN)
    ("GEP-NENs" . SPARSER::COLLECTION) ("GEP" . SPARSER::PROTEIN)
    ("the principal component" . SPARSER::COMPONENT)
    ("secretory proteins" . SPARSER::PROTEIN)
    ("hydrophilic acidic protein" . SPARSER::PROTEIN)
    ("CgA" . SPARSER::PROTEIN) ("prohormone" . SPARSER::MOLECULE)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("A mRNA (PCR) and protein (ELISA/western blot)" . SPARSER::COLLECTION)
    ("mRNA (PCR)" . SPARSER::PROTEIN) ("chromogranin" . SPARSER::PROTEIN)
    ("Chromogranin" . SPARSER::PROTEIN) ("PC2" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("Lys-Arg" . SPARSER::MOLECULE)
    ("Arg-Val" . SPARSER::MOLECULE) ("ALG9" . SPARSER::PROTEIN)
    ("PCSK1" . SPARSER::PROTEIN) ("Messenger RNA" . SPARSER::RNA)
    ("tryptophan hydroxylase1" . SPARSER::PROTEIN)
    ("prohormone convertase 1" . SPARSER::PROTEIN) ("5-HT" . SPARSER::PROTEIN)
    ("RAD001" . SPARSER::DRUG) ("IL6 and IL8" . SPARSER::COLLECTION)
    ("several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("AU-Rich unstable mRNAs" . SPARSER::PROTEIN)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("HuR and beta-catenin" . SPARSER::COLLECTION)
    ("beta-catenin and cytoplasmic mRNA" . SPARSER::COLLECTION)
    ("CA9 and IL6" . SPARSER::COLLECTION)
    ("CA9, SNAI2 and IL6" . SPARSER::COLLECTION)
    ("hypoxia and its mediator HIF-1alpha" . SPARSER::COLLECTION)
    ("the stem cell regulator SNAI2 and the hypoxia survival CA9 gene"
     . SPARSER::COLLECTION)
    ("beta-catenin/HuR" . SPARSER::COLLECTION)
    ("the pivotal breast cancer stem cells growth factor Interleukin 6"
     . SPARSER::PROTEIN)
    ("hypoxic luminal and normoxic basal-like cells" . SPARSER::COLLECTION)
    ("hypoxic luminal" . SPARSER::DRUG) ("-S5B" . SPARSER::COLLECTION)
    ("density gradient-separated cytosolic fractions" . SPARSER::COMPONENT)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("immuno" . SPARSER::PROTEIN)
    ("CA9 or SNAI2" . SPARSER::COLLECTION) ("HuR/mRNA" . SPARSER::COLLECTION)
    ("ER-alpha and E-cadherin" . SPARSER::COLLECTION)
    ("SNAI2-shRNA" . SPARSER::COLLECTION)
    ("beta-catenin and HIF1-alpha" . SPARSER::COLLECTION)
    ("HIF-1alpha transcriptional co-factor" . SPARSER::MOLECULE)
    ("beta-catenin/TCF" . SPARSER::COLLECTION) ("shBeta" . SPARSER::PROTEIN)
    ("MCF7-shBeta" . SPARSER::COLLECTION)
    ("keratin 18 (KRT18) and e-cadherin (CDH1)" . SPARSER::COLLECTION)
    ("carbonic anhydrase 9 (CA9) and SNAI2 ( xref )" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine Interleukin 6" . SPARSER::PROTEIN)
    ("beta-catenin beta-catenin" . SPARSER::PROTEIN)
    ("tumor mammary gland stem/progenitor cells state" . SPARSER::BIO-STATE)
    ("carbonic anhydrase 9 (CA9) and SNAI2" . SPARSER::COLLECTION)
    ("beta-catenin and HIF-1alpha" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("SNAI2 and CA9" . SPARSER::COLLECTION)
    ("CA9 and SNAI2" . SPARSER::COLLECTION) ("beta catenin" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("HIF-1-alpha" . SPARSER::PROTEIN) ("precursor mRNA" . SPARSER::RNA)
    ("S5B" . SPARSER::PROTEIN) ("Pol2" . SPARSER::PROTEIN)
    ("e-cadherin" . SPARSER::PROTEIN) ("keratin 18" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("Beta-tubulin" . SPARSER::PROTEIN)
    ("Mix 1" . SPARSER::PROTEIN) ("DNAse-1" . SPARSER::PROTEIN)
    ("beta-glucuronidase" . SPARSER::PROTEIN)
    ("Thymidine Kinase" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("HIF1alpha" . SPARSER::PROTEIN)
    ("Carbonic anhydrase-9" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("(Beta" . SPARSER::PROTEIN) ("pN 2" . SPARSER::PROTEIN)
    ("Interleukin 6" . SPARSER::PROTEIN) ("HIF1-alpha" . SPARSER::PROTEIN)
    ("carbonic anhydrase 9" . SPARSER::PROTEIN)
    ("HIF-1alpha" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("CA9" . SPARSER::PROTEIN)
    ("Bcl-2 and Survivin" . SPARSER::COLLECTION)
    ("Etoposide and paclitaxel" . SPARSER::COLLECTION)
    ("phytochemicals" . SPARSER::DRUG) ("paclitaxel" . SPARSER::DRUG)
    ("natural product-derived substances" . SPARSER::SUBSTANCE)
    ("EGFR or gp130" . SPARSER::COLLECTION)
    ("IL-6, EGF, and EGFR" . SPARSER::COLLECTION)
    ("JAK2, or Src" . SPARSER::COLLECTION) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("IL-6/gp130" . SPARSER::COLLECTION)
    ("Cyclin D 1 , c-Myc, Survivin, and Bcl-2" . SPARSER::COLLECTION)
    ("CAR or inhibiting NF-κB [ xref , xref ]" . SPARSER::COLLECTION)
    ("Yin" . SPARSER::PROTEIN) ("coumarin" . SPARSER::DRUG)
    ("DU145-Luc" . SPARSER::COLLECTION) ("M67-Luc" . SPARSER::COLLECTION)
    ("JAK2 or Src" . SPARSER::COLLECTION)
    ("Cyclin D 1 , c-Myc, Survivin, Bcl-2, and Socs3" . SPARSER::COLLECTION)
    ("STAT3 and PC-3" . SPARSER::COLLECTION)
    ("CREB-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 and p27" . SPARSER::COLLECTION) ("Cyclin/Cdk" . SPARSER::COLLECTION)
    ("PC-3 and RWPE-3" . SPARSER::COLLECTION)
    ("DU145 and PC-3" . SPARSER::COLLECTION)
    ("CAR and NF-κB" . SPARSER::COLLECTION)
    ("receptor (CAR)" . SPARSER::RECEPTOR) ("CAR" . SPARSER::PROTEIN)
    ("androstane" . SPARSER::MOLECULE)
    ("Cyclin D 1 , c-Myc, and p21" . SPARSER::COLLECTION)
    ("Bcl-2, Mcl-1, and Survivin" . SPARSER::COLLECTION)
    ("JAK2 and Src" . SPARSER::COLLECTION) ("docetaxel" . SPARSER::DRUG)
    ("janus kinase 2 (JAK2) or Src" . SPARSER::COLLECTION)
    ("cyclin D 1 , c-Myc, survivin, Bcl-2, and Socs3" . SPARSER::COLLECTION)
    ("Socs3" . SPARSER::PROTEIN) ("scoparone" . SPARSER::DRUG)
    ("Chinese herbal medicine" . SPARSER::DRUG) ("Scoparone" . SPARSER::DRUG)
    ("RPLP0" . SPARSER::PROTEIN) ("M67" . SPARSER::PROTEIN)
    ("Cyclin D 1" . SPARSER::PROTEIN) ("janus kinase 2" . SPARSER::PROTEIN)
    ("cyclin D 1" . SPARSER::PROTEIN) ("Scott" . SPARSER::PROTEIN)
    ("Genomes" . SPARSER::PROTEIN) ("constitutional DNA" . SPARSER::DNA)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("RAS , EGFR , or PIK3CA" . SPARSER::COLLECTION)
    ("cystic component" . SPARSER::COMPONENT) ("PNI" . SPARSER::PROTEIN)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("SMO , SHH , or GLI" . SPARSER::COLLECTION) ("GLI" . SPARSER::PROTEIN)
    ("SMO" . SPARSER::PROTEIN) ("YB-1-sncRNA" . SPARSER::PROTEIN-PAIR)
    ("miRNA and sncRNA" . SPARSER::COLLECTION)
    ("tRNAs and snoRNAs" . SPARSER::COLLECTION)
    ("fragments and YB-1" . SPARSER::COLLECTION)
    ("tRNAs, or fragments" . SPARSER::COLLECTION) ("tRNAs" . SPARSER::PROTEIN)
    ("longer non-coding RNAs" . SPARSER::RNA)
    ("C/D Box snoRNAs or their precursors" . SPARSER::COLLECTION)
    ("YB-1, U33 and U34" . SPARSER::COLLECTION)
    ("YB-1:mRNA" . SPARSER::BIO-COMPLEX) ("SnoRNAs" . SPARSER::RNA)
    ("rRNA" . SPARSER::PROTEIN) ("YB-1 and snoRNAs" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN) ("the repressive RISC" . SPARSER::PROTEIN)
    ("their mature forms" . SPARSER::FORM)
    ("YB-1 and the cold shock protein LIN28" . SPARSER::COLLECTION)
    ("YB-1 and these miRNAs" . SPARSER::COLLECTION)
    ("Let-7 and miR-30c" . SPARSER::COLLECTION)
    ("regulator or ‘hub’" . SPARSER::COLLECTION)
    ("families, and miR-30c" . SPARSER::COLLECTION)
    ("protein or RNA" . SPARSER::COLLECTION)
    ("only six miRNAs" . SPARSER::PROTEIN)
    ("AGO2 (EIF2C2) and hnRNPA1" . SPARSER::COLLECTION)
    ("specific miRNAs and other sncRNAs" . SPARSER::COLLECTION)
    ("ACA" . SPARSER::PROTEIN)
    ("A previously annotated miRNA" . SPARSER::PROTEIN)
    ("HBII" . SPARSER::PROTEIN)
    ("U34 (SNORD34) and SNORD68" . SPARSER::COLLECTION)
    ("small nucleolar (sno)RNAs" . SPARSER::RNA) ("hsa" . SPARSER::PROTEIN)
    ("actually not canonical miRNAs" . SPARSER::PROTEIN)
    ("unquantifiable RNA binding" . SPARSER::PROTEIN)
    ("AKT1 , TP53 , and E2F1" . SPARSER::COLLECTION)
    ("18S ribosomal RNA" . SPARSER::RNA)
    ("successfully IP YB-1 protein" . SPARSER::PROTEIN)
    ("spike" . SPARSER::PROTEIN) ("siYB-1" . SPARSER::COLLECTION)
    ("receptor and p53" . SPARSER::COLLECTION)
    ("mature miRNA" . SPARSER::PROTEIN) ("mature miRNAs" . SPARSER::PROTEIN)
    ("DICER1 and HNRNPA1" . SPARSER::COLLECTION)
    ("miRNAs and other small noncoding (snc)RNAs" . SPARSER::COLLECTION)
    ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("LIN28 and YB-1" . SPARSER::COLLECTION)
    ("another well-conserved RNA-binding protein" . SPARSER::PROTEIN)
    ("YB-1 and miRNAs" . SPARSER::COLLECTION)
    ("YB-1 and LIN28" . SPARSER::COLLECTION)
    ("YB-1 and microRNAs" . SPARSER::COLLECTION)
    ("microRNAs and Breast" . SPARSER::COLLECTION)
    ("a multifunctional cold-shock domain protein" . SPARSER::PROTEIN)
    ("snoRNAs" . SPARSER::RNA)
    ("ribosomal RNAs and small nucleolar RNAs" . SPARSER::COLLECTION)
    ("RNAs and small nucleolar RNAs" . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA) ("RNA-immunoprecipitation" . SPARSER::RNA)
    ("YB-1 and sncRNAs" . SPARSER::COLLECTION)
    ("The nucleic acid-binding protein YB-1" . SPARSER::PROTEIN)
    ("Bis–Tris" . SPARSER::MOLECULE) ("Protein Kinase R" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("hnRNPA1" . SPARSER::PROTEIN)
    ("U34" . SPARSER::PROTEIN) ("U29" . SPARSER::PROTEIN)
    ("EIF2C2" . SPARSER::PROTEIN) ("YBX1" . SPARSER::PROTEIN)
    ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("small nucleolar RNAs" . SPARSER::RNA) ("LIN28" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("aggressive SCCs" . SPARSER::PROTEIN)
    ("mesenchymal proteins, N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("proteins, N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("hydrate" . SPARSER::MOLECULE) ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and Akt" . SPARSER::COLLECTION)
    ("ERK and MAPK" . SPARSER::COLLECTION)
    ("this xenograft cutaneous SCCs" . SPARSER::PROTEIN)
    ("various chemopreventive drugs" . SPARSER::DRUG)
    ("a suicidal inhibitor" . SPARSER::INHIBITOR)
    ("COX and ODC" . SPARSER::COLLECTION)
    ("DFMO, or diclofenac" . SPARSER::COLLECTION)
    ("fibronectin and EMT-associated transcription factors slug"
     . SPARSER::COLLECTION)
    ("EMT-associated transcription factors slug" . SPARSER::PROTEIN)
    ("cyclin D1, and anti-apoptotic" . SPARSER::COLLECTION)
    ("p-Akt/p-ERK" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN) ("DFMO or diclofenac" . SPARSER::COLLECTION)
    ("DFMO (p = 0.05) or diclofenac (p = 0.03)" . SPARSER::COLLECTION)
    ("both ODC (p = 0.01) and COX-2 (p = 0.008)" . SPARSER::COLLECTION)
    ("PGE 2 and polyamines" . SPARSER::COLLECTION)
    ("polyamines" . SPARSER::MOLECULE)
    ("proliferating cell nuclear antigen (PCNA) and cyclin D1 (p = 0.001)"
     . SPARSER::COLLECTION)
    ("diclofenac  " . SPARSER::DRUG) ("DFMO  " . SPARSER::DRUG)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("DFMO and sulindac" . SPARSER::COLLECTION) ("sulindac" . SPARSER::DRUG)
    ("celecoxib" . SPARSER::DRUG) ("polyamine" . SPARSER::MOLECULE)
    ("ODC/COX" . SPARSER::COLLECTION)
    ("PCNA and cyclin D1" . SPARSER::COLLECTION)
    ("DFMO and diclofenac" . SPARSER::COLLECTION)
    ("diclofenac" . SPARSER::DRUG) ("DFMO" . SPARSER::DRUG)
    ("their respective small molecule inhibitors" . SPARSER::INHIBITOR)
    ("ODC and COX-2" . SPARSER::COLLECTION) ("ODC" . SPARSER::PROTEIN)
    ("group III" . SPARSER::PROTEIN) ("Group I" . SPARSER::PROTEIN)
    ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("the two polymorphic variants" . SPARSER::VARIANT)
    ("allele, OR=0.96" . SPARSER::COLLECTION)
    ("several histological subtypes" . SPARSER::PROTEIN)
    ("histological types" . TYPE) ("Pro/Arg" . SPARSER::COLLECTION)
    ("Pro/Pro" . SPARSER::COLLECTION) ("ApoE" . SPARSER::PROTEIN)
    ("SE" . SPARSER::PROTEIN) ("Nrf2 and eNOS" . SPARSER::COLLECTION)
    ("PI3K/Akt/Nrf2" . SPARSER::COLLECTION)
    ("ER and Nrf2" . SPARSER::COLLECTION) ("shikonin" . SPARSER::DRUG)
    ("ERβ and antioxidant" . SPARSER::COLLECTION)
    ("ERβ and Nrf2" . SPARSER::COLLECTION)
    ("antioxidative stress enzymes" . SPARSER::ENZYME)
    ("NOS and antioxidant" . SPARSER::COLLECTION)
    ("strong ERβ and weak ERα" . SPARSER::COLLECTION)
    ("weak ERα" . SPARSER::PROTEIN) ("strong ERβ" . SPARSER::PROTEIN)
    ("daidzein and equol" . SPARSER::COLLECTION) ("quinine" . SPARSER::DRUG)
    ("genistein (2 g/kg) significantly increased hepatic NQO1 mRNA"
     . SPARSER::PROTEIN)
    ("isoflavones and Nrf2" . SPARSER::COLLECTION)
    ("caffeic acid phenethyl ester, quercetin, resveratrol and puerarin"
     . SPARSER::COLLECTION)
    ("ester, quercetin, resveratrol and puerarin" . SPARSER::COLLECTION)
    ("puerarin" . SPARSER::DRUG)
    ("antioxidant and anti-cancer" . SPARSER::COLLECTION)
    ("daidzein and genistein" . SPARSER::COLLECTION)
    ("oridonin" . SPARSER::DRUG) ("vasodilator" . SPARSER::PROTEIN)
    ("Nrf2-siRNA" . SPARSER::COLLECTION)
    ("DPN or the specific ERα activator" . SPARSER::COLLECTION)
    ("PHTPP" . SPARSER::MOLECULE)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("Two classic ERs" . SPARSER::PROTEIN)
    ("equol and daidzein" . SPARSER::COLLECTION)
    ("weak Nrf2" . SPARSER::PROTEIN)
    ("LY294002 and ICI182,780" . SPARSER::COLLECTION)
    ("Akt and ER" . SPARSER::COLLECTION)
    ("Nrf2, HO-1, or NQO1" . SPARSER::COLLECTION)
    ("LY294002 or ICI182,780" . SPARSER::COLLECTION)
    ("specific inhibitors of the PI3K/Akt (LY294002) and ER (ICI182, 780) pathways"
     . SPARSER::COLLECTION)
    ("protein, and HO-1 and NQO1" . SPARSER::COLLECTION)
    ("Nrf2 and NOQ1" . SPARSER::COLLECTION)
    ("Nrf2 and ARE-genes" . SPARSER::COLLECTION)
    ("ARE-genes" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("a cardioprotective antioxidant enzyme" . SPARSER::ENZYME)
    ("Heme" . SPARSER::PROTEIN) ("racemic equol" . SPARSER::MOLECULE)
    ("eNOS and AMPK" . SPARSER::COLLECTION)
    ("isoflavones, and S-" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("HDL" . SPARSER::PROTEIN) ("LDL" . SPARSER::PROTEIN)
    ("equol or daidzein" . SPARSER::COLLECTION)
    ("Only S- (-)equol" . SPARSER::MOLECULE)
    ("a racemic mixture" . SPARSER::MOLECULE)
    ("S- (-)equol and R- (+)equol" . SPARSER::MOLECULE)
    ("equol and R-" . SPARSER::COLLECTION) ("Equol" . SPARSER::MOLECULE)
    ("H 2 O 2 or tBHP" . SPARSER::COLLECTION) ("tBHP" . SPARSER::MOLECULE)
    ("antagonist (PHTPP)" . SPARSER::MOLECULE)
    ("ICI182,780 and LY294002" . SPARSER::COLLECTION)
    ("Nrf2, HO-1, and NQO1" . SPARSER::COLLECTION)
    ("HO-1, and NQO1" . SPARSER::COLLECTION) ("HA-Nrf2" . SPARSER::COLLECTION)
    ("S- (-)equol (10–250 nM) increases nuclear factor-erythroid 2-related factor 2"
     . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE) ("nicotinamide" . SPARSER::PROTEIN)
    ("hy" . SPARSER::MOLECULE) ("pGL 4" . SPARSER::PROTEIN)
    ("t -BHP" . SPARSER::MOLECULE)
    ("tert -butyl hydroperoxide" . SPARSER::MOLECULE)
    ("ICI182780" . SPARSER::DRUG) ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("GPR30" . SPARSER::PROTEIN)
    ("estrogen-related receptor beta" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("ICI182, 780" . SPARSER::DRUG)
    ("Nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("TERT or other nearby genes" . SPARSER::COLLECTION)
    ("A allele or AA and AA/AG genotypes" . SPARSER::COLLECTION)
    ("AA and AA/AG genotypes" . SPARSER::COLLECTION)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION)
    ("The homozygous AA alleles" . SPARSER::ALLELE) ("Ding" . SPARSER::PROTEIN)
    ("the histological type" . TYPE) ("genotypes" . SPARSER::PROTEIN)
    ("Males" . SPARSER::MOLECULE)
    ("telomerase reverse transcriptase ( TERT ) and cleft lip and palate trans-membrane 1-like ( CLPTM1L )"
     . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nicotinic acetylcholine receptor" . SPARSER::PROTEIN)
    ("two main histological types" . TYPE) ("ADC" . SPARSER::PROTEIN)
    ("SQC" . SPARSER::PROTEIN) ("allele or GG" . SPARSER::COLLECTION)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("CLPTM1L" . SPARSER::PROTEIN)
    ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("mahanine and the disruption of AR signaling" . SPARSER::COLLECTION)
    ("mitotic kinase CDK1" . SPARSER::PROTEIN)
    ("phytochemical" . SPARSER::DRUG)
    ("drugs, MDV3100 and abiraterone" . SPARSER::COLLECTION)
    ("AR, or drugs" . SPARSER::COLLECTION)
    ("a highly attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("CDK1-AF" . SPARSER::COLLECTION) ("mitotic protein" . SPARSER::PROTEIN)
    ("CDK1 and CDK9" . SPARSER::COLLECTION)
    ("androgen and other growth factors" . SPARSER::COLLECTION)
    ("DHT and mahanine" . SPARSER::COLLECTION)
    ("MG132 (5µM) and mahanine (20µM)" . SPARSER::COLLECTION)
    ("CHX" . SPARSER::PROTEIN) ("AR and ARv7" . SPARSER::COLLECTION)
    ("aggressive forms" . SPARSER::FORM)
    ("LNCaP and LNCaP" . SPARSER::COLLECTION)
    ("forskolin and IL6" . SPARSER::COLLECTION)
    ("forskolin or IL6" . SPARSER::COLLECTION)
    ("forskolin (50µM) or IL6 (50ng/ml)" . SPARSER::COLLECTION)
    ("forskolin" . SPARSER::PROTEIN) ("Gal4" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("ARR3-TK-luciferase" . SPARSER::COLLECTION)
    ("DHT-" . SPARSER::PROTEIN) ("ARR3-TK-luc" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("CDK1 and AR" . SPARSER::COLLECTION)
    ("EGF and IL-6" . SPARSER::COLLECTION)
    ("a steroidal receptor" . SPARSER::RECEPTOR)
    ("mitotic kinase" . SPARSER::KINASE) ("mahanine" . SPARSER::DRUG)
    ("alkaloid" . SPARSER::MOLECULE) ("Mahanine" . SPARSER::DRUG)
    ("MDV3100" . SPARSER::DRUG) ("SGK1" . SPARSER::PROTEIN)
    ("ARR3" . SPARSER::PROTEIN) ("ARv7" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG)
    ("DNA, RNA and protein" . SPARSER::COLLECTION)
    ("SIRT1–AROS" . SPARSER::COLLECTION)
    ("activator or perhaps" . SPARSER::COLLECTION)
    ("SIRT1, AROS and p53" . SPARSER::COLLECTION) ("DBC1" . SPARSER::PROTEIN)
    ("SIRT1 and active" . SPARSER::COLLECTION)
    ("etoposide and trichostatin" . SPARSER::COLLECTION)
    ("both total and acetylated p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AROS, and SIRT1" . SPARSER::COLLECTION)
    ("AROS or SIRT1" . SPARSER::COLLECTION)
    ("AROS and SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 or AROS" . SPARSER::COLLECTION)
    ("the relevant siRNAs" . SPARSER::PROTEIN)
    ("SIRT1 and Lamin" . SPARSER::COLLECTION)
    ("SIRT1/AROS" . SPARSER::COLLECTION)
    ("SIRT1 and AROS" . SPARSER::COLLECTION)
    ("mature small ribosomal subunits" . SPARSER::PROTEIN)
    ("small ribosomal subunits" . SPARSER::PROTEIN)
    ("the first reported post-translational regulator" . SPARSER::REGULATOR)
    ("active regulator" . SPARSER::REGULATOR)
    ("N-Myc and c-Myc" . SPARSER::COLLECTION) ("coenzyme" . SPARSER::MOLECULE)
    ("c-Myc and N-Myc" . SPARSER::COLLECTION)
    ("the transcription factors p53 [ xref , xref ] and the FOXOs [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("the transcriptional repressor pRb [ xref ] and the signalling phosphatase PTEN [ xref ]"
     . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN) ("AROS" . SPARSER::PROTEIN)
    ("LDH-B" . SPARSER::PROTEIN) ("acetyl-transferase" . SPARSER::PROTEIN)
    ("S1 b" . SPARSER::PROTEIN) ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("RPS19BP1" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Active regulator of SIRT1" . SPARSER::PROTEIN)
    ("XPC-Rad23" . SPARSER::COLLECTION) ("XPV" . SPARSER::PROTEIN)
    ("CSB" . SPARSER::PROTEIN) ("Rad23 and XPC" . SPARSER::COLLECTION)
    ("TFIIH" . SPARSER::PROTEIN) ("a key p53 regulator" . SPARSER::PROTEIN)
    ("p53-MDM2" . SPARSER::COLLECTION) ("p53 and XPC" . SPARSER::COLLECTION)
    ("p53 and its transcription target" . SPARSER::COLLECTION)
    ("MDM2-XPC-Rad23" . SPARSER::COLLECTION) ("XPC-MDM2" . SPARSER::COLLECTION)
    ("p53-Rad23" . SPARSER::COLLECTION)
    ("Given Rad23’s" . SPARSER::PROTEIN-FAMILY)
    ("UBA/UBL" . SPARSER::COLLECTION) ("UBL" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN)
    ("the N-terminal fragment (aa 1–301) nor the C-terminal fragment (aa 291–491)"
     . SPARSER::COLLECTION)
    ("intact MDM2" . SPARSER::PROTEIN) ("-MDM2" . SPARSER::COLLECTION)
    ("Flag-XPC" . SPARSER::COLLECTION)
    ("the XPC allele and its two partners" . SPARSER::COLLECTION)
    ("Rad23 and MDM2" . SPARSER::COLLECTION)
    ("stop-codon" . SPARSER::PROTEIN-PAIR) ("Myc-p53" . SPARSER::COLLECTION)
    ("MDM2 and XPC" . SPARSER::COLLECTION) ("MDM2-XPC" . SPARSER::COLLECTION)
    ("Pirh2 and XPC" . SPARSER::COLLECTION)
    ("XPC and MDM2" . SPARSER::COLLECTION)
    ("XPC and Myc-tagged" . SPARSER::COLLECTION)
    ("MDM2 or Pirh2" . SPARSER::COLLECTION)
    ("two major E3s" . SPARSER::MOLECULE)
    ("MDM2 and Pirh2" . SPARSER::COLLECTION)
    ("Ub-protein" . SPARSER::COLLECTION) ("Proteasomal" . SPARSER::PROTEIN)
    ("XPA" . SPARSER::PROTEIN)
    ("xeroderma pigmentosum (XP)" . SPARSER::PROTEIN) ("Ddi" . SPARSER::DRUG)
    ("MDM2-p53" . SPARSER::COLLECTION)
    ("XPC W690S pathogenic mutant" . SPARSER::MUTANT)
    ("bringing ubiquitylated p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XPC" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("UBE4B" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("Pirh2" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN) ("Dsk2" . SPARSER::PROTEIN)
    ("Rad23" . SPARSER::PROTEIN-FAMILY)
    ("GT, JPP, HF, DH, YZ, MK and JMP" . SPARSER::COLLECTION)
    ("GT, JPP, MK and JMP" . SPARSER::COLLECTION)
    ("HF, DH, YZ and MK" . SPARSER::COLLECTION) ("DH" . SPARSER::PROTEIN)
    ("GT, JPP and JMP" . SPARSER::COLLECTION) ("JMP" . SPARSER::PROTEIN)
    ("Bovine serum albumin" . SPARSER::PROTEIN) ("Sterol" . SPARSER::PROTEIN)
    ("phenylindole" . SPARSER::MOLECULE) ("ACR" . SPARSER::PROTEIN)
    ("TGF-β/SMAD3" . SPARSER::COLLECTION)
    ("normal chondrocytes" . SPARSER::PROTEIN)
    ("chondrocytes and Baugé" . SPARSER::COLLECTION)
    ("IGFBP-5 [ xref ] and SMAD3 [ xref ]" . SPARSER::COLLECTION)
    ("Tec" . SPARSER::PROTEIN) ("Sox9 [ xref ] and Sox9" . SPARSER::COLLECTION)
    ("NFAT5 and NFAT3" . SPARSER::COLLECTION)
    ("an indirect regulator" . SPARSER::REGULATOR) ("NFATs" . SPARSER::PROTEIN)
    ("NFAT3 (activator) and SMAD3 (inhibitor)" . SPARSER::COLLECTION)
    ("functional NFAT3 (GGAAA)" . SPARSER::PROTEIN)
    ("NFAT3 or SMAD3" . SPARSER::COLLECTION)
    ("some intronic miRNAs" . SPARSER::PROTEIN)
    ("intronic miRNAs" . SPARSER::PROTEIN)
    ("WWP2 and TGF-β" . SPARSER::COLLECTION)
    ("human normal chondrocytes" . SPARSER::PROTEIN)
    ("TGF-β and ionomycin" . SPARSER::COLLECTION)
    ("ionomycin and TGF-β" . SPARSER::COLLECTION)
    ("NFAT (GGAAA at position -234 bp) and SMAD3 (CAGA at position -209 bp and -195 bp, and TTGGTGTTGG at -120 bp)"
     . SPARSER::COLLECTION)
    ("GGAAA" . SPARSER::PROTEIN) ("NFAT and SMAD3" . SPARSER::COLLECTION)
    ("NFAT3 and NFAT5" . SPARSER::COLLECTION)
    ("ionomycin, NaCl and TGF-β" . SPARSER::COLLECTION)
    ("NFAT3, NFAT5 and SMAD3" . SPARSER::COLLECTION)
    ("Ionomycin and TGF-β" . SPARSER::COLLECTION)
    ("ionomycin and NaCl" . SPARSER::COLLECTION)
    ("ionomycin or TGF-β" . SPARSER::COLLECTION)
    ("SMAD3, NFAT3 and NFAT5" . SPARSER::COLLECTION)
    ("ionomycin and NFAT5" . SPARSER::COLLECTION)
    ("NFAT1, NFAT2, NFAT4 or MAZ" . SPARSER::COLLECTION)
    ("NFAT (GGAAA) and SMAD3 (CAGA, TTGGTGTTGG)" . SPARSER::COLLECTION)
    ("NMP4 (CAAAAA), MAZ (GAGAGA), NFAT (GGAAA) and SMAD3 (CAGA, TTGGTGTTGG)"
     . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GenBank:NC" . SPARSER::BIO-COMPLEX)
    ("Intronic miRNAs" . SPARSER::PROTEIN)
    ("the protein tyrosine kinase or focal adhesion kinase ( PTK2/FAK ) gene"
     . SPARSER::COLLECTION)
    ("two unrelated intronic miRNAs" . SPARSER::PROTEIN)
    ("PTK2/FAK" . SPARSER::COLLECTION)
    ("the longest variant" . SPARSER::VARIANT) ("ATG" . SPARSER::DRUG)
    ("variants or isoforms" . SPARSER::COLLECTION)
    ("mRNAs and miRNAs" . SPARSER::COLLECTION) ("-3p" . SPARSER::COLLECTION)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN) ("disintegrin" . SPARSER::PROTEIN)
    ("NFAT3 and SMAD3" . SPARSER::COLLECTION)
    ("NFAT3 ( P ≤0.01) and SMAD3 ( P ≤0.05) differentially"
     . SPARSER::COLLECTION)
    ("MAZ" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("Mothers against decapentaplegic homolog 3" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("Bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("IGFBP-5" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("S3 B" . SPARSER::PROTEIN)
    ("SREBF2" . SPARSER::PROTEIN) ("S3 A" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("MAP1A" . SPARSER::PROTEIN) ("NFATc3" . SPARSER::PROTEIN)
    ("NFAT4" . SPARSER::PROTEIN) ("NFAT1" . SPARSER::PROTEIN)
    ("SIS3" . SPARSER::MOLECULE)
    ("nuclear receptor-interacting protein 1" . SPARSER::PROTEIN)
    ("dynamin 1" . SPARSER::PROTEIN) ("IGFBP5" . SPARSER::PROTEIN)
    ("ADAMTS-5" . SPARSER::PROTEIN) ("MMP-13" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-13" . SPARSER::PROTEIN)
    ("histone deacetylase 4" . SPARSER::PROTEIN) ("NFAT5" . SPARSER::PROTEIN)
    ("NFAT3" . SPARSER::PROTEIN)
    ("mothers against decapentaplegic homolog 3" . SPARSER::PROTEIN)
    ("NMP4" . SPARSER::PROTEIN) ("WWP2" . SPARSER::PROTEIN)
    ("WW domain containing E3 ubiquitin protein ligase 2" . SPARSER::PROTEIN)
    ("MAD" . SPARSER::PROTEIN) ("cis-" . SPARSER::PROTEIN)
    ("both miR-10b and -151a" . SPARSER::COLLECTION)
    ("target and KLF4" . SPARSER::COLLECTION)
    ("CDKN1A and CDKN2A" . SPARSER::COLLECTION)
    ("In fact all these miRs" . SPARSER::PROTEIN)
    ("p63 or p73" . SPARSER::COLLECTION)
    ("p53 and the related p63 and p73 proteins" . SPARSER::COLLECTION)
    ("p53 and miR-151a" . SPARSER::COLLECTION)
    ("FAK and miR-151a" . SPARSER::COLLECTION) ("pri" . SPARSER::PROTEIN)
    ("using western blot" . SPARSER::PROTEIN)
    ("PVT1, pre-miR-1204 and pre-miR-1206" . SPARSER::COLLECTION)
    ("mature miR-10b and -23b" . SPARSER::COLLECTION)
    ("miR-10b and -23b" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN) ("DXR" . SPARSER::PROTEIN)
    ("endogenous miR-associated promoters" . SPARSER::PROMOTER)
    ("P21, MDM2, BAX and PUMA" . SPARSER::COLLECTION)
    ("LOF" . SPARSER::PROTEIN) ("LOF-p53" . SPARSER::PROTEIN-PAIR)
    ("p53 or p63 and p73" . SPARSER::COLLECTION)
    ("galactose" . SPARSER::MOLECULE)
    ("miR-34a and −1204" . SPARSER::COLLECTION)
    ("p63 β and p73β" . SPARSER::COLLECTION) ("p73β" . SPARSER::PROTEIN)
    ("p63 β" . SPARSER::PROTEIN) ("TA-p63β and TA-p73β" . SPARSER::COLLECTION)
    ("TA-p73β" . SPARSER::PROTEIN-PAIR) ("TA-p63β" . SPARSER::PROTEIN-PAIR)
    ("p63 and p73" . SPARSER::COLLECTION) ("pri-miR" . SPARSER::PROTEIN-PAIR)
    ("miR-10b, -23b and -151a" . SPARSER::COLLECTION)
    ("noncanonical response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("p85 alpha (the regulatory subunit of the phosphatidylinositol-3 kinase, PI3K) and CDC42 (Cell division cycle 42, a Rho family GTPase)"
     . SPARSER::COLLECTION)
    ("a target miR and target mRNAs" . SPARSER::COLLECTION)
    ("glucose as well as lipid metabolism" . SPARSER::COLLECTION)
    ("a tetrameric (dimer of dimers) sequence-specific transcription factor"
     . SPARSER::PROTEIN)
    ("a prominent tumor suppressor gene" . SPARSER::PROTEIN)
    ("the mature miRs" . SPARSER::PROTEIN)
    ("mature miR-10b" . SPARSER::MOLECULE)
    ("modest doxorubicin-" . SPARSER::PROTEIN)
    ("doxorubicin-" . SPARSER::PROTEIN) ("Nutlin" . SPARSER::DRUG)
    ("doxorubicin-treated MCF7 cells and HCT116 p53 +/+" . SPARSER::PROTEIN)
    ("Immuno" . SPARSER::PROTEIN) ("p53, p63β and p73β" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("RNAs and microRNAs" . SPARSER::COLLECTION)
    ("miR-106a" . SPARSER::MOLECULE) ("or 2 " . SPARSER::MOLECULE)
    ("PhosphoGlycerate Kinase 1" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("LEU2" . SPARSER::PROTEIN) ("TRP1" . SPARSER::PROTEIN)
    ("GAL1" . SPARSER::PROTEIN) ("CYC1" . SPARSER::PROTEIN)
    ("miR -10b" . SPARSER::MOLECULE) ("p53-related protein" . SPARSER::PROTEIN)
    ("miR-125b" . SPARSER::MOLECULE)
    ("Cell division cycle 42" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("p85 alpha" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("PVT1" . SPARSER::PROTEIN) ("miR-10b" . SPARSER::MOLECULE)
    ("technically less complex" . SPARSER::BIO-COMPLEX)
    ("‘light’" . SPARSER::PROTEIN)
    ("worse PS (p<0.001) and slightly greater median pack-years"
     . SPARSER::COLLECTION)
    ("PY" . SPARSER::MOLECULE) ("complex, and reader" . SPARSER::COLLECTION)
    ("cigarette" . SPARSER::DRUG) ("- 1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("ALK and ERBB2" . SPARSER::COLLECTION)
    ("RASA1, DOK2, EGFR, and KRAS" . SPARSER::COLLECTION)
    ("DOK2/SHC1" . SPARSER::COLLECTION) ("RASGEFs" . SPARSER::PROTEIN)
    ("EGFR-RAS" . SPARSER::COLLECTION)
    ("at least part of DOK2’s" . SPARSER::COMPONENT)
    ("andC/KRAS" . SPARSER::COLLECTION) ("BothC/Kras" . SPARSER::COLLECTION)
    ("Kras-" . SPARSER::PROTEIN) ("fromC/EGFR" . SPARSER::COLLECTION)
    ("/Dok2" . SPARSER::COLLECTION) ("theC/EGFR" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN) ("Cohorts" . SPARSER::MOLECULE)
    ("doxycycline-inducible bitransgenic EGFR" . SPARSER::PROTEIN)
    ("EGFR or EGFR" . SPARSER::COLLECTION)
    ("the EGF receptor complex and DOK2-mediated recruitment of RASA1"
     . SPARSER::COLLECTION)
    ("EGFR L858R and RASA1" . SPARSER::COLLECTION)
    ("DOK2 and wild-type EGFR and RASA1 ( xref )" . SPARSER::COLLECTION)
    ("EGFR and RASA1" . SPARSER::COLLECTION)
    ("DOK2 and EGFR" . SPARSER::COLLECTION)
    ("RAS and ERK" . SPARSER::COLLECTION)
    ("DOK2 and KRAS" . SPARSER::COLLECTION) ("KRAS-" . SPARSER::PROTEIN)
    ("SRC, AKT, and ERK" . SPARSER::COLLECTION)
    ("DOK1 and DOK2" . SPARSER::COLLECTION)
    ("RASA1/RASGAP" . SPARSER::COLLECTION) ("RASGAP" . SPARSER::PROTEIN)
    ("DOK1, DOK2, and DOK3" . SPARSER::COLLECTION)
    ("AKT, SRC, and RAS" . SPARSER::COLLECTION) ("DOK" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("Dok2" . SPARSER::PROTEIN) ("RAS-GTP" . SPARSER::PROTEIN)
    ("RAS-binding" . SPARSER::PROTEIN) ("MAP-kinase" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("DOK3" . SPARSER::PROTEIN)
    ("DOK1" . SPARSER::PROTEIN) ("DOK2" . SPARSER::PROTEIN)
    ("antiangiogenic genes" . SPARSER::GENE) ("b" . SPARSER::PROTEIN)
    ("miRNAs and their targets" . SPARSER::COLLECTION)
    ("new light" . SPARSER::PROTEIN)
    ("miR-181a, miR-29b and miRNA" . SPARSER::COLLECTION)
    ("pGL-CASP3" . SPARSER::COLLECTION) ("pGL" . SPARSER::PROTEIN)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("enzymes, Drosha and Dicer" . SPARSER::COLLECTION)
    ("Drosha and Dicer" . SPARSER::COLLECTION)
    ("Bax and CASP3" . SPARSER::COLLECTION)
    ("cysteine-aspartic acid" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Let-7" . SPARSER::RNA)
    ("miR-29b" . SPARSER::MOLECULE) ("miR-181a" . SPARSER::MOLECULE)
    ("miR-126" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("Hsa-let-7" . SPARSER::RNA) ("Hsa-Let-7" . SPARSER::RNA)
    ("caspase-6" . SPARSER::PROTEIN) ("caspase-10" . SPARSER::PROTEIN)
    ("MiR-21" . SPARSER::PROTEIN) ("Ox-LDL" . SPARSER::PROTEIN)
    ("hsa-let-7" . SPARSER::RNA) ("CASP3" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("LOX-1" . SPARSER::PROTEIN)
    ("ox-LDL" . SPARSER::PROTEIN)
    ("docosahexaenoic acid (DHA)" . SPARSER::MOLECULE)
    ("DHA" . SPARSER::MOLECULE) ("creatine" . SPARSER::PROTEIN)
    ("selegiline and rasagiline" . SPARSER::COLLECTION)
    ("rasagiline" . SPARSER::DRUG) ("selegiline" . SPARSER::DRUG)
    ("ropinirole and pramipexole" . SPARSER::COLLECTION)
    ("ropinirole" . SPARSER::DRUG)
    ("hydrogen peroxide, dopamine and L-dopa" . SPARSER::COLLECTION)
    ("pramipexole" . SPARSER::DRUG)
    ("a peripheral decarboxylase inhibitor" . SPARSER::INHIBITOR)
    ("Levodopa" . SPARSER::DRUG) ("DOPA" . SPARSER::MOLECULE)
    ("ELL" . SPARSER::PROTEIN) ("decarboxylase" . SPARSER::PROTEIN)
    ("currently used drugs" . SPARSER::DRUG)
    ("even kinase dead mutant" . SPARSER::MUTANT)
    ("rotenone or paraquat" . SPARSER::COLLECTION)
    ("LRRK2 and dynamin-like protein" . SPARSER::COLLECTION)
    ("DJ-1-ASK1" . SPARSER::COLLECTION)
    ("SNpc and striatum" . SPARSER::COLLECTION)
    ("ASK-1/Trx1" . SPARSER::COLLECTION)
    ("ASK1 and Trx1" . SPARSER::COLLECTION)
    ("Daxx/Apoptosis Signal Regulating Kinase 1" . SPARSER::COLLECTION)
    ("Daxx" . SPARSER::PROTEIN) ("Trx1" . SPARSER::PROTEIN)
    ("Trx" . SPARSER::PROTEIN)
    ("an oxidative-stress-induced chaperone inducer" . SPARSER::MOLECULE)
    ("exogenous glutathione" . SPARSER::DRUG)
    ("H 2 O 2 and paraquat" . SPARSER::COLLECTION)
    ("paraquat or rotenone" . SPARSER::COLLECTION)
    ("orthologs, DJ-1alpha and DJ-1beta" . SPARSER::COLLECTION)
    ("dopamine and tyrosine" . SPARSER::COLLECTION)
    ("H 2 O 2 , 6-OHDA, rotenone or MPTP" . SPARSER::COLLECTION)
    ("an evolutionarily conserved neuroprotective protein" . SPARSER::PROTEIN)
    ("PINK1 and muscle specific" . SPARSER::COLLECTION)
    ("A39S mutant DJ-1 and P399L mutant PINK1 [ xref ]" . SPARSER::COLLECTION)
    ("DJ-1 and PINK1" . SPARSER::COLLECTION)
    ("a neuroprotective protein" . SPARSER::PROTEIN)
    ("PINK1 and parkin" . SPARSER::COLLECTION)
    ("PINK1/parkin" . SPARSER::COLLECTION)
    ("glutathione reductase and glutathione-S-transferase"
     . SPARSER::COLLECTION)
    ("larger mitochondria" . SPARSER::PROTEIN)
    ("MPP + and hydrogen peroxide" . SPARSER::COLLECTION)
    ("swollen mitochondria" . SPARSER::PROTEIN)
    ("dopamine or 6-OHDA" . SPARSER::COLLECTION)
    ("autoso-mal" . SPARSER::COLLECTION) ("mal" . SPARSER::PROTEIN)
    ("feed forward state" . SPARSER::BIO-STATE)
    ("prion" . SPARSER::PROTEIN-FAMILY)
    ("the alpha-synuclein mRNA and the IRE" . SPARSER::COLLECTION)
    ("IRE" . SPARSER::PROTEIN) ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("alpha-synuclein and dopamine" . SPARSER::COLLECTION)
    ("nitrated" . SPARSER::MOLECULE)
    ("oligomeric alpha-synuclein" . SPARSER::PROTEIN)
    ("TNF-alpha, IL6 and IL-1beta" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("mutant alpha-synuclein release proinflammatory cytokines"
     . SPARSER::PROTEIN)
    ("TNF-alpha and IL1-alpha" . SPARSER::COLLECTION)
    ("PGC1α-target genes and consequently disturbing mitochondrial morphology and function [ xref ]"
     . SPARSER::COLLECTION)
    ("functional mitochondria" . SPARSER::PROTEIN)
    ("increased calcium and ROS levels" . SPARSER::COLLECTION)
    ("transporter and greater" . SPARSER::COLLECTION)
    ("in turn increases ROS" . SPARSER::PROTEIN)
    ("MPTP and other mitochondrial toxins" . SPARSER::COLLECTION)
    ("other mitochondrial toxins" . SPARSER::MOLECULE)
    ("malonate" . SPARSER::DRUG)
    ("mutant or wild-type alpha-synuclein" . SPARSER::COLLECTION)
    ("MPTP and 6-OHDA" . SPARSER::COLLECTION)
    ("the pesticides rotenone [ xref ] or dichlorvos [ xref ]"
     . SPARSER::COLLECTION)
    ("dichlorvos" . SPARSER::MOLECULE)
    ("alpha-synuclein, parkin, DJ-1, PINK-1 and Leucine-rich repeat"
     . SPARSER::COLLECTION)
    ("PROTEINS" . SPARSER::PROTEIN) ("pesticide" . SPARSER::MOLECULE)
    ("Sera" . SPARSER::PROTEIN) ("pesticides" . SPARSER::MOLECULE)
    ("Toxins" . SPARSER::MOLECULE)
    ("the mitochondrial genome" . SPARSER::PROTEIN)
    ("pathogenic proteins" . SPARSER::PROTEIN)
    ("environmental toxin" . SPARSER::MOLECULE)
    ("RANTES/chemokine" . SPARSER::COLLECTION)
    ("carrageenan" . SPARSER::MOLECULE)
    ("a more general pro-inflammatory state" . SPARSER::BIO-STATE)
    ("antigen (HLA)" . SPARSER::PROTEIN)
    ("proteins, lipids and DNA" . SPARSER::COLLECTION)
    ("MPTP, rotenone or 6-OHDA" . SPARSER::COLLECTION)
    ("superoxide and nitric oxide" . SPARSER::COLLECTION)
    ("Microglia" . SPARSER::PROTEIN)
    ("mitochondrial Complex I" . SPARSER::PROTEIN)
    ("defective mitochondria" . SPARSER::PROTEIN)
    ("parkin and ubiquitin" . SPARSER::COLLECTION)
    ("vital cellular components" . SPARSER::COMPONENT)
    ("UBIQUITIN" . SPARSER::PROTEIN)
    ("platelets and skeletal muscle" . SPARSER::COLLECTION)
    ("ubisemiquinone" . SPARSER::DRUG)
    ("succinate-coenzyme Q" . SPARSER::PROTEIN-PAIR)
    ("oxidoreductase" . SPARSER::PROTEIN) ("ubiquinone" . SPARSER::DRUG)
    ("thiol or amine" . SPARSER::COLLECTION) ("amine" . SPARSER::MOLECULE)
    ("free reactive iron" . SPARSER::MOLECULE)
    ("hydroperoxides" . SPARSER::MOLECULE) ("Lipid" . SPARSER::LIPID)
    ("Lipids" . SPARSER::LIPID) ("iron and MPTP" . SPARSER::COLLECTION)
    ("GSH and GSSG" . SPARSER::COLLECTION)
    ("hemoglobin and cytochrome c" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE) ("ferritin" . SPARSER::PROTEIN)
    ("ferric iron (Fe 3+ ) and ferrous iron (Fe 2+ )" . SPARSER::COLLECTION)
    ("ferrous iron" . SPARSER::MOLECULE) ("ferric iron" . SPARSER::MOLECULE)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("an essential cofactor" . SPARSER::MOLECULE)
    ("nitrosylated iron regulated protein" . SPARSER::PROTEIN)
    ("IRP" . SPARSER::PROTEIN) ("Iron" . SPARSER::MOLECULE)
    ("oxidant" . SPARSER::PROTEIN) ("thioredoxin" . SPARSER::PROTEIN)
    ("NAD + or NADP +" . SPARSER::COLLECTION)
    ("NADH and NADPH" . SPARSER::COLLECTION) ("IDH" . SPARSER::PROTEIN)
    ("isocitrate" . SPARSER::PROTEIN) ("thiols and GSH" . SPARSER::COLLECTION)
    ("thiols" . SPARSER::MOLECULE) ("disulfides" . SPARSER::MOLECULE)
    ("tripeptide" . SPARSER::MOLECULE) ("disulfide (GSSG)" . SPARSER::MOLECULE)
    ("dopamine metabolites as well as proteins and lipids [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("catecholamine" . SPARSER::MOLECULE) ("polymer" . SPARSER::MOLECULE)
    ("transporters (DAT)" . SPARSER::PROTEIN) ("DAT" . SPARSER::PROTEIN)
    ("dopa" . SPARSER::MOLECULE)
    ("superoxide and depletion of cellular NADPH" . SPARSER::COLLECTION)
    ("cellular NADPH" . SPARSER::PROTEIN)
    ("an ammonium molecule and H 2 O 2" . SPARSER::COLLECTION)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("the predominant enzyme" . SPARSER::ENZYME)
    ("MAO-A and MAO-B" . SPARSER::COLLECTION) ("catechol" . SPARSER::PROTEIN)
    ("oxygen or enzymes such as tyrosinase [ xref ]" . SPARSER::COLLECTION)
    ("tyrosinase" . SPARSER::PROTEIN) ("quinones" . SPARSER::MOLECULE)
    ("NOX" . SPARSER::PROTEIN)
    ("HNE and malondialdehyde" . SPARSER::COLLECTION)
    ("malondialdehyde" . SPARSER::MOLECULE)
    ("defensive enzymes" . SPARSER::ENZYME)
    ("chaperones and antioxidant" . SPARSER::COLLECTION)
    ("iNOS and nNOS" . SPARSER::COLLECTION)
    ("Peroxynitrite" . SPARSER::MOLECULE)
    ("nNOS or iNOS" . SPARSER::COLLECTION) ("neuronal NOS" . SPARSER::PROTEIN)
    ("endothelial NOS" . SPARSER::PROTEIN)
    ("synthase (NOS)" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("nNOS" . SPARSER::PROTEIN)
    ("the highly reactive hydroxyl radical" . SPARSER::MOLECULE)
    ("hydroxyl radical ( • OH) and hydrogen peroxide (H 2 O 2 )"
     . SPARSER::COLLECTION)
    ("nitric oxide synthase (NOS) or NADPH" . SPARSER::COLLECTION)
    ("a perilous state" . SPARSER::BIO-STATE) ("paraquat" . SPARSER::MOLECULE)
    ("soluble proteins" . SPARSER::PROTEIN) ("HNE" . SPARSER::PROTEIN)
    ("the various neuronal types" . TYPE) ("SNpc" . SPARSER::PROTEIN)
    ("which damages key cellular pathogenetic proteins" . SPARSER::PROTEIN)
    ("DJ-1, PINK1, parkin, alpha-synuclein and LRRK2" . SPARSER::COLLECTION)
    ("iron" . SPARSER::MOLECULE) ("Coenzyme Q10" . SPARSER::DRUG)
    ("vitamin C" . SPARSER::MOLECULE) ("PRDX3" . SPARSER::PROTEIN)
    ("peroxiredoxin 3" . SPARSER::PROTEIN) ("ASK-1" . SPARSER::PROTEIN)
    ("Apoptosis Signal Regulating Kinase 1" . SPARSER::PROTEIN)
    ("thioredoxin-1" . SPARSER::PROTEIN) ("muscle specific" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("S-nitrosoglutathione" . SPARSER::MOLECULE)
    ("nuclear factor erythroid 2-related factor" . SPARSER::PROTEIN)
    ("CD36" . SPARSER::PROTEIN) ("IL-1beta" . SPARSER::PROTEIN)
    ("IL1-alpha" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("PLD2" . SPARSER::PROTEIN) ("Leucine-rich repeat" . SPARSER::PROTEIN)
    ("PINK-1" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::DRUG)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("UCH-L1" . SPARSER::PROTEIN) ("MPP +" . SPARSER::MOLECULE)
    ("coenzyme Q" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN) ("iron-sulfur" . SPARSER::MOLECULE)
    ("a chain" . SPARSER::PROTEIN) ("NADP +" . SPARSER::MOLECULE)
    ("alpha-ketoglutarate" . SPARSER::DRUG) ("Grx1" . SPARSER::PROTEIN)
    ("glutaredoxin 1" . SPARSER::PROTEIN)
    ("alpha-Synuclein" . SPARSER::PROTEIN) ("VMAT2" . SPARSER::PROTEIN)
    ("vesicular monoamine transporter" . SPARSER::PROTEIN)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("MAO-B" . SPARSER::PROTEIN)
    ("MAO-A" . SPARSER::PROTEIN) ("S-nitrosothiols" . SPARSER::MOLECULE)
    ("inducible NOS" . SPARSER::PROTEIN)
    ("Superoxide anion" . SPARSER::MOLECULE)
    ("hydroxyl radical" . SPARSER::MOLECULE)
    ("superoxide anion" . SPARSER::MOLECULE) ("6-OHDA" . SPARSER::MOLECULE)
    ("6-hydroxydopamine" . SPARSER::DRUG)
    ("a potential and novel therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ERK and DLP1" . SPARSER::COLLECTION)
    ("protein or lipid" . SPARSER::COLLECTION)
    ("Mfn2 or DLP1" . SPARSER::COLLECTION) ("ERK-DLP1" . SPARSER::COLLECTION)
    ("ERK-DLP-1" . SPARSER::COLLECTION)
    ("pharmaceutical inhibitors" . SPARSER::INHIBITOR)
    ("mitochondrial fission/fusion" . SPARSER::PROTEIN)
    ("Fission/fusion" . SPARSER::PROTEIN)
    ("DLP1 and Mfn2" . SPARSER::COLLECTION)
    ("extracellular receptor kinase (ERK) and p38 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("kinase (ERK)" . SPARSER::KINASE) ("Probucol" . SPARSER::DRUG)
    ("lipid and protein" . SPARSER::COLLECTION)
    ("increased mitochondrial ROS" . SPARSER::PROTEIN)
    ("fraction and cytosol" . SPARSER::COLLECTION)
    ("Fission/Fusion" . SPARSER::PROTEIN)
    ("mitochondrial ROS" . SPARSER::PROTEIN) ("Mitosox" . SPARSER::DRUG)
    ("intact mitochondria" . SPARSER::PROTEIN)
    ("fission/fusion" . SPARSER::PROTEIN)
    ("respiratory chain key enzyme" . SPARSER::ENZYME)
    ("HD" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("amyloid beta peptide (Aβ) and neurofibrillary tangles with tau hyperphosphorylation"
     . SPARSER::COLLECTION)
    ("tau" . SPARSER::PROTEIN) ("ERK-fission/fusion" . SPARSER::PROTEIN-PAIR)
    ("siRNA-DLP1" . SPARSER::COLLECTION)
    ("dynamin-like protein (DLP1) and mitofusin 2 (Mfn2)"
     . SPARSER::COLLECTION)
    ("Light Chain" . SPARSER::PROTEIN) ("DLP-1" . SPARSER::PROTEIN)
    ("Hsp60" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("Mitotracker Red" . SPARSER::MOLECULE)
    ("ubiquinol-cytochrome c reductase" . SPARSER::PROTEIN)
    ("ubiquinone reductase" . SPARSER::PROTEIN) ("mM −1" . SPARSER::PROTEIN)
    ("min −1" . SPARSER::PROTEIN) ("PD98058" . SPARSER::DRUG)
    ("Mfn1" . SPARSER::PROTEIN) ("mitofusin 1" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("amyloid beta" . SPARSER::PROTEIN)
    ("Mfn2" . SPARSER::PROTEIN) ("mitofusin 2" . SPARSER::PROTEIN)
    ("DLP1" . SPARSER::PROTEIN) ("dynamin-like protein" . SPARSER::PROTEIN)
    ("inflammatory cytokines and ONOO" . SPARSER::COLLECTION)
    ("cytokines and ONOO" . SPARSER::COLLECTION)
    ("Hsp27 and HG" . SPARSER::COLLECTION)
    ("cytokine and HG" . SPARSER::COLLECTION)
    ("TEMPOL and L-NAME" . SPARSER::COLLECTION) ("TEMPOL" . SPARSER::DRUG)
    ("NONOate" . SPARSER::MOLECULE) ("nitrite" . SPARSER::MOLECULE)
    ("HG and cytokines" . SPARSER::COLLECTION) ("STZ-mouse" . SPARSER::DRUG)
    ("STZ" . SPARSER::DRUG) ("glucose or HG" . SPARSER::COLLECTION)
    ("individual pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α, IL-1β or IFN-γ" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines and high glucose" . SPARSER::COLLECTION)
    ("chaperone, anti-apoptotic and anti-inflammatory" . SPARSER::COLLECTION)
    ("kynurenines" . SPARSER::MOLECULE) ("electrons" . SPARSER::MOLECULE)
    ("ICAM-1 and vascular endothelial growth factor-A" . SPARSER::COLLECTION)
    ("diabetic retina" . SPARSER::DRUG)
    ("monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("interleukin-1β (IL-1β) and interferon-γ (IFN-γ)" . SPARSER::COLLECTION)
    ("Several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("interferon-γ" . SPARSER::PROTEIN) ("local ischemia" . SPARSER::PROTEIN)
    ("exogenous peroxynitrite" . SPARSER::MOLECULE)
    ("peroxynitrite" . SPARSER::MOLECULE) ("NOS" . SPARSER::PROTEIN)
    ("tryptophan (MT)" . SPARSER::MOLECULE)
    ("kynurenine and ROS" . SPARSER::COLLECTION) ("IDO" . SPARSER::PROTEIN)
    ("mixtures (CM)" . SPARSER::MOLECULE) ("mixtures" . SPARSER::MOLECULE)
    ("the diabetic retina" . SPARSER::DRUG) ("Hsp25" . SPARSER::PROTEIN)
    ("L-tryptophan" . SPARSER::MOLECULE) ("CM-H" . SPARSER::MOLECULE)
    ("indoleamine 2, 3-dioxygenase" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("SIN-1" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor-A" . SPARSER::PROTEIN)
    ("caspase-1" . SPARSER::PROTEIN) ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("L-NAME" . SPARSER::MOLECULE)
    ("indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("HSF-1" . SPARSER::PROTEIN) ("MPG" . SPARSER::PROTEIN)
    ("LM" . SPARSER::MOLECULE) ("ZR" . SPARSER::PROTEIN)
    ("ZR-ATMi and ZR-ctr" . SPARSER::COLLECTION)
    ("ZR-ctr" . SPARSER::COLLECTION) ("ZR-ATMi" . SPARSER::COLLECTION)
    ("iniparib or its solvent" . SPARSER::COLLECTION)
    ("olaparib or its solvent (DMSO)" . SPARSER::COLLECTION)
    ("solvent (DMSO)" . SPARSER::MOLECULE) ("WST-1" . SPARSER::COLLECTION)
    ("ATMi" . SPARSER::PROTEIN) ("IR and doxorubicin" . SPARSER::COLLECTION)
    ("MCF7-ATMi" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("MCF7-ctr" . SPARSER::COLLECTION) ("ctr" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 , and TP53" . SPARSER::COLLECTION)
    ("olaparib (a competitive PARP-1/2 inhibitor) and iniparib (a molecule originally described as a covalent PARP-1 inhibitor)"
     . SPARSER::COLLECTION)
    ("olaparib and iniparib" . SPARSER::COLLECTION)
    ("iniparib" . SPARSER::DRUG)
    ("breast cancer 1 (BRCA1) and BRCA2" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("SAR240550" . SPARSER::DRUG) ("KU 55933" . SPARSER::DRUG)
    ("gag-pol" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rap1 and LFA-1" . SPARSER::COLLECTION)
    ("Rac1 and Rap1" . SPARSER::COLLECTION)
    ("CXCR4 (binding SDF1α) and CCR7 (binding CCL21)" . SPARSER::COLLECTION)
    ("PBCs" . SPARSER::PROTEIN) ("ERM and phospho-ERM" . SPARSER::COLLECTION)
    ("CXCL12, or SDF-1α" . SPARSER::COLLECTION)
    ("either CCR7 or its ligands" . SPARSER::COLLECTION)
    ("CCL21 and CCL19" . SPARSER::COLLECTION)
    ("CXCR4 and CCR7" . SPARSER::COLLECTION)
    ("PKCδ and PKCβ" . SPARSER::COLLECTION)
    ("specifically ERM proteins" . SPARSER::PROTEIN)
    ("extracellular chemokine" . SPARSER::PROTEIN)
    ("p-ERM" . SPARSER::COLLECTION) ("pERM" . SPARSER::PROTEIN)
    ("Ezrin-radixin-moesin" . SPARSER::COLLECTION) ("Ezrin" . SPARSER::PROTEIN)
    ("CFSE or CMTMR" . SPARSER::COLLECTION) ("CMTMR" . SPARSER::DRUG)
    ("CCL21-CCR7" . SPARSER::COLLECTION)
    ("the fluorescent dye CFSE" . SPARSER::DRUG)
    ("which holds chemokines and adhesion ligands" . SPARSER::COLLECTION)
    ("which holds chemokines" . SPARSER::PROTEIN)
    ("fluorescent vital dyes CFSE or PKH26" . SPARSER::COLLECTION)
    ("CFSE or PKH26" . SPARSER::COLLECTION) ("CFSE" . SPARSER::DRUG)
    ("chemotactic cues" . SPARSER::PROTEIN-FAMILY)
    ("PMA and ionomycin" . SPARSER::COLLECTION)
    ("PKCδ and PKCβI" . SPARSER::COLLECTION)
    ("tubulin and PKCθ" . SPARSER::COLLECTION)
    ("PKCβ and PKCθ" . SPARSER::COLLECTION)
    ("NF-κB, NFAT, and AP-1" . SPARSER::COLLECTION)
    ("GTPases and myosin" . SPARSER::COLLECTION)
    ("cytoskeletal and adhesive components" . SPARSER::COMPONENT)
    ("CD43, CD44, and ICAM" . SPARSER::COLLECTION)
    ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("ezrin-radixin-moesin (ERM)" . SPARSER::COLLECTION)
    ("CD43 and ERM" . SPARSER::COLLECTION)
    ("many extracellular receptors and cytoskeletal regulators"
     . SPARSER::COLLECTION)
    ("cytoskeletal regulators" . SPARSER::REGULATOR)
    ("m 2  " . SPARSER::MOLECULE) ("ddH 2" . SPARSER::PROTEIN)
    ("NH4Cl" . SPARSER::MOLECULE) ("S11" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("DOCK2" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("CCL19" . SPARSER::PROTEIN) ("PKH26" . SPARSER::DRUG)
    ("alpha tubulin" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("CCL21" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("Akt, Erk, and Ampk" . SPARSER::COLLECTION)
    ("Ampk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF-1R- 3" . SPARSER::COLLECTION)
    ("AnnexinV and PI" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("IGF/Akt" . SPARSER::COLLECTION) ("IGF-1R-3" . SPARSER::COLLECTION)
    ("an miR-223 inhibitor and withdrawal of bFGF" . SPARSER::COLLECTION)
    ("Nanog and Oct-4" . SPARSER::COLLECTION) ("h" . SPARSER::PROTEIN)
    ("RNAs approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("bFGF and IGF" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("Oct-4 and Nanog" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG)
    ("IGF-1R/Akt" . SPARSER::COLLECTION)
    ("exogenous miR-223 and miR-223 inhibitor" . SPARSER::INHIBITOR)
    ("fibroblast growth factor (FGF) and the insulin-like growth factor receptor (IGF-1R)"
     . SPARSER::COLLECTION)
    ("G 2 /M" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM, ATR, DNAPK, mTOR, JNK1, and CSNK1A1L" . SPARSER::COLLECTION)
    ("DNAPK" . SPARSER::PROTEIN) ("lapatinib and BYL719" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("EGFR, HER2, and HER3" . SPARSER::COLLECTION)
    ("mammary fat" . SPARSER::PROTEIN)
    ("the more dramatic cytotoxic" . SPARSER::PROTEIN)
    ("PIK3CA and PIK3CA" . SPARSER::COLLECTION)
    ("genomic PIK3CA" . SPARSER::PROTEIN)
    ("the strong EF1a promoter" . SPARSER::PROMOTER)
    ("EF1a" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("HER2 ( xref ) and HER3 ( xref )" . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION)
    ("proteins or phospho-proteins" . SPARSER::COLLECTION)
    ("the dual EGFR/HER2 kinase inhibitor lapatinib" . SPARSER::DRUG)
    ("EGFR, HER2 and HER3" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K inhibitor BYL719 and lapatinib" . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("CSNK1A1" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("BYL719" . SPARSER::DRUG) ("PI3K inhibitor BYL719" . SPARSER::DRUG)
    ("protein and Bcl-2" . SPARSER::COLLECTION)
    ("VEGF, Zeb1 and Snail" . SPARSER::COLLECTION)
    ("DDB2 and the bcl-2 promoter" . SPARSER::COLLECTION)
    ("HDAC1 and DDB1" . SPARSER::COLLECTION)
    ("FLAG-DDB2" . SPARSER::COLLECTION) ("FLAG-DDB1" . SPARSER::COLLECTION)
    ("FLAG-tagged DDB1 and FLAG-tagged DDB2" . SPARSER::COLLECTION)
    ("GST affinity -purified GST" . SPARSER::PROTEIN)
    ("GST-HDAC1" . SPARSER::COLLECTION)
    ("HDAC1 and DDB1 or DDB2" . SPARSER::COLLECTION)
    ("DDB1 or DDB2" . SPARSER::COLLECTION)
    ("DDB2 or DDB1" . SPARSER::COLLECTION)
    ("HDAC1 and DDB" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN)
    ("CRE and Sp1" . SPARSER::COLLECTION)
    ("neither E2F1 nor Sp1" . SPARSER::COLLECTION)
    ("only 2 nucleotides" . SPARSER::NUCLEOTIDE) ("BCPM" . SPARSER::PROTEIN)
    ("BCP" . SPARSER::PROTEIN) ("the proximal promoter" . SPARSER::PROMOTER)
    ("-AGCCTGCAGCCT-3" . SPARSER::COLLECTION)
    ("-response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("MnSOD" . SPARSER::PROTEIN) ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("occurring mutant" . SPARSER::MUTANT)
    ("negligible endogenous DDB2" . SPARSER::PROTEIN)
    ("DDB2 and Bcl-2" . SPARSER::COLLECTION)
    ("the associated DDB1" . SPARSER::PROTEIN)
    ("DDB2 and DDB1" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("DDB1-DDB2-Cul4A" . SPARSER::COLLECTION) ("GGR" . SPARSER::PROTEIN)
    ("DDB1 (p127) and DDB2 (p48)" . SPARSER::COLLECTION)
    ("transcription factors C/EBPα (CCAAT/enhancer binding protein α) and A-Myb ( xref , xref )"
     . SPARSER::COLLECTION)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("E2F1 and Sp1" . SPARSER::COLLECTION) ("DDB" . SPARSER::DRUG)
    ("DDB1 and DDB2" . SPARSER::COLLECTION)
    ("DDB1 and HDAC1" . SPARSER::COLLECTION) ("Target cell" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("p48" . SPARSER::PROTEIN)
    ("A-Myb" . SPARSER::PROTEIN) ("c-AMP" . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN) ("a 3-h" . SPARSER::PROTEIN-PAIR)
    ("mTOR and mTOR" . SPARSER::COLLECTION)
    ("tor2 temperature-sensitive mutants" . SPARSER::MUTANT)
    ("Rps6" . SPARSER::PROTEIN) ("Rps" . SPARSER::PROTEIN)
    ("Gad8 and Tor1" . SPARSER::COLLECTION)
    ("Tor1 and Gad8" . SPARSER::COLLECTION)
    ("psk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the ksg1.208 temperature-sensitive mutant" . SPARSER::MUTANT)
    ("the essential Ksg1 kinase" . SPARSER::KINASE) ("KCl" . SPARSER::MOLECULE)
    ("lox" . SPARSER::PROTEIN) ("Rheb and TSC1/2" . SPARSER::COLLECTION)
    ("Gad8, and Gad8" . SPARSER::COLLECTION)
    ("TSC1–TSC2" . SPARSER::COLLECTION)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TOR complex 1 (TORC1) and TOR complex 2 (TORC2)" . SPARSER::COLLECTION)
    ("TOR kinases form at least two different complexes"
     . SPARSER::BIO-COMPLEX)
    ("Nitrogen" . SPARSER::MOLECULE) ("TOR" . SPARSER::PROTEIN)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE) ("PF-4708671" . SPARSER::DRUG)
    ("p -nitrophenyl" . SPARSER::MOLECULE)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Anti–" . SPARSER::ANTIBODY) ("P-S6K" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("pREP1" . SPARSER::PROTEIN)
    ("Glutamic acid" . SPARSER::AMINO-ACID) ("ura4" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein S6" . SPARSER::PROTEIN) ("Ryh1" . SPARSER::PROTEIN)
    ("ksg1" . SPARSER::PROTEIN) ("Ksg1" . SPARSER::PROTEIN)
    ("1 D" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("Tor2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("Tor1" . SPARSER::PROTEIN) ("Gad8" . SPARSER::PROTEIN)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("aflibercept" . SPARSER::DRUG) ("the 34 evaluable pts" . SPARSER::PROTEIN)
    ("IIIB" . SPARSER::DRUG)
    ("14 evaluable KRAS mutant pts" . SPARSER::PROTEIN)
    ("18 evaluable KRAS wild-type pts" . SPARSER::PROTEIN)
    ("A pathologic CR" . SPARSER::PROTEIN)
    ("34 evaluable pts" . SPARSER::PROTEIN)
    ("A 2 pts (11.7%) and c" . SPARSER::COLLECTION)
    ("the 40 treated pts" . SPARSER::PROTEIN) ("pts" . SPARSER::PROTEIN)
    ("BEV" . SPARSER::DRUG) ("genotype" . SPARSER::PROTEIN)
    ("CPT-11 and OXP" . SPARSER::COLLECTION) ("OXP" . SPARSER::DRUG)
    ("all three most active chemotherapeutic drugs" . SPARSER::DRUG)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("OS 9" . SPARSER::PROTEIN)
    ("CPT-11" . SPARSER::DRUG) ("MN" . SPARSER::PROTEIN)
    ("CRL4 and other cullin-based ubiquitin ligases" . SPARSER::COLLECTION)
    ("Vpx and Vif" . SPARSER::COLLECTION)
    ("SAMHD1 and APOBEC3G" . SPARSER::COLLECTION)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DN CUL4A and DN UBC12 (Figure  xref D)" . SPARSER::COLLECTION)
    ("the exogenous protein" . SPARSER::PROTEIN)
    ("Here both exogenous UNG2–2HA" . SPARSER::COLLECTION)
    ("Here both DN UBC12 and DN CUL4A" . SPARSER::COLLECTION)
    ("Here both DN UBC12" . SPARSER::PROTEIN)
    ("exogenous UNG2–2HA" . SPARSER::COLLECTION)
    ("UNG2—2HA" . SPARSER::COLLECTION) ("UNG2–2HA" . SPARSER::COLLECTION)
    ("APOBEC3G-HA" . SPARSER::COLLECTION) ("pNL" . SPARSER::PROTEIN)
    ("Dominant negative (DN) NEDD8 E2 ligase UBC12" . SPARSER::PROTEIN)
    ("Primary human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("antiserum" . SPARSER::PROTEIN)
    ("exogenously-produced FLAG–CUL4A" . SPARSER::COLLECTION)
    ("FLAG–CUL4A" . SPARSER::COLLECTION)
    ("functional APOBEC3G" . SPARSER::PROTEIN)
    ("Vpr or Vpx" . SPARSER::COLLECTION) ("MDMs" . SPARSER::PROTEIN)
    ("Vpr and Vpx" . SPARSER::COLLECTION)
    ("a strong therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("either MLN4924
[ xref ] or a dominant negative form of the NEDD8-conjugating enzyme UBC12 (UBE2M)"
     . SPARSER::COLLECTION)
    ("enzymes, UBC12 or UBE2F" . SPARSER::COLLECTION)
    ("thioester" . SPARSER::MOLECULE)
    ("the viral Vif protein" . SPARSER::PROTEIN)
    ("CUL5-Elongin" . SPARSER::COLLECTION) ("Elongin" . SPARSER::PROTEIN)
    ("dGTP" . SPARSER::DGTP) ("the essential parts" . SPARSER::COMPONENT)
    ("SAMHD1 and Vpx" . SPARSER::COLLECTION) ("sulfamate" . SPARSER::MOLECULE)
    ("APOBEC3G and SAMHD1" . SPARSER::COLLECTION)
    ("the antiviral protein APOBEC3G" . SPARSER::PROTEIN)
    ("the antiviral protein SAMHD1" . SPARSER::PROTEIN)
    ("HIV and SIV defeat antiviral proteins" . SPARSER::PROTEIN)
    ("CRLs" . SPARSER::PROTEIN) ("Monoclonal Antibody" . SPARSER::DRUG)
    ("G–protein" . SPARSER::PROTEIN) ("Cullin4" . SPARSER::PROTEIN)
    ("—2" . SPARSER::PROTEIN) ("UBE2M" . SPARSER::PROTEIN)
    ("CUL1" . SPARSER::PROTEIN) ("UBC12" . SPARSER::PROTEIN)
    ("ATP dependent" . SPARSER::PROTEIN) ("CUL4A" . SPARSER::PROTEIN)
    ("cullin4A" . SPARSER::PROTEIN) ("NAE1" . SPARSER::PROTEIN)
    ("cullin5" . SPARSER::PROTEIN) ("SAMHD1" . SPARSER::PROTEIN)
    ("cullin4" . SPARSER::PROTEIN)
    ("methyltransferase or trichostatin" . SPARSER::COLLECTION)
    ("the Notch ligand delta and a downstream target" . SPARSER::COLLECTION)
    ("NOTCH3 and Asef" . SPARSER::COLLECTION)
    ("miR-1 and NOTCH3 or Asef" . SPARSER::COLLECTION)
    ("NOTCH3 or Asef" . SPARSER::COLLECTION) ("miR-1-1" . SPARSER::COLLECTION)
    ("APCs and NOTCH3" . SPARSER::COLLECTION)
    ("endothelial DLL4" . SPARSER::PROTEIN)
    ("Endothelial DLL4" . SPARSER::PROTEIN)
    ("NOTCH3-Asef" . SPARSER::COLLECTION)
    ("N3ICD or Asef" . SPARSER::COLLECTION) ("Mut-3" . SPARSER::COLLECTION)
    ("Hes1 and HEY1" . SPARSER::COLLECTION)
    ("protein and Asef" . SPARSER::COLLECTION) ("N3ICD" . SPARSER::PROTEIN)
    ("directly target NOTCH 3" . SPARSER::PROTEIN)
    ("N3ICD-CSL" . SPARSER::PROTEIN-PAIR)
    ("CSL-1, -2 and -3" . SPARSER::COLLECTION)
    ("-2 and -3" . SPARSER::COLLECTION) ("Mut-1" . SPARSER::COLLECTION)
    ("Asef-b" . SPARSER::PROTEIN-PAIR) ("GSI" . SPARSER::PROTEIN)
    ("the colorectal tumor cell lines DLD-1" . SPARSER::PROTEIN)
    ("-NOTCH3-Asef" . SPARSER::COLLECTION)
    ("the ubiquitous DNA-binding protein CSL" . SPARSER::PROTEIN)
    ("Hes1, HEY1 and HEY2" . SPARSER::COLLECTION)
    ("CBF-1/RBP-Jκ" . SPARSER::COLLECTION) ("CSL" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN)
    ("heterodimeric transmembrane receptors" . SPARSER::RECEPTOR)
    ("Jagged1 and Jagged2" . SPARSER::COLLECTION)
    ("DLL-1, DLL3 and DLL4" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("bFGF, VEGF and HGF" . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("Asef and Asef2" . SPARSER::COLLECTION)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("miR-1-NOTCH3-Asef" . SPARSER::COLLECTION)
    ("the Cdc42- and Rac1-specific guanine nucleotide exchange factor Asef"
     . SPARSER::COLLECTION)
    ("Cdc42-" . SPARSER::PROTEIN) ("Asef" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("TAGLN2" . SPARSER::PROTEIN)
    ("Hes-1" . SPARSER::PROTEIN) ("NOTCH 3" . SPARSER::PROTEIN)
    ("CSL-1" . SPARSER::PROTEIN) ("P-1" . SPARSER::PROTEIN)
    ("P-2" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("Notch4" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("γ–secretase" . SPARSER::PROTEIN) ("HEY1" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("RBP-Jκ" . SPARSER::PROTEIN)
    ("CBF-1" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("DLL4" . SPARSER::PROTEIN) ("DLL-1" . SPARSER::PROTEIN)
    ("Jagged2" . SPARSER::PROTEIN) ("Jagged1" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("NOTCH1" . SPARSER::PROTEIN)
    ("Asef2" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("β–catenin" . SPARSER::PROTEIN) ("miR-1" . SPARSER::PROTEIN)
    ("The previously reported truncated MEIS1 isoform" . SPARSER::ISOFORM)
    ("consecutive cohort and both" . SPARSER::COLLECTION)
    ("consecutive cohort" . SPARSER::MOLECULE) ("TS" . SPARSER::PROTEIN)
    ("keratin-positive epithelial tumor fractions and vimentin-positive stromal fractions"
     . SPARSER::COLLECTION)
    ("the consecutive cohort" . SPARSER::MOLECULE)
    ("a consecutive cohort" . SPARSER::MOLECULE) ("MSP" . SPARSER::PROTEIN)
    ("200 unique genes" . SPARSER::GENE) ("KRAS and p53" . SPARSER::COLLECTION)
    ("MSS" . SPARSER::PROTEIN) ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("tumor suppressor genes and/or activating mutations in proto-oncogenes"
     . SPARSER::COLLECTION)
    ("which misses exon" . SPARSER::PROTEIN)
    ("tumor-associated genes" . SPARSER::GENE)
    ("genes and oncogenes" . SPARSER::COLLECTION) ("1 µL" . SPARSER::PROTEIN)
    ("1-2 µ" . SPARSER::PROTEIN) ("SW480" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("Mitogen Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEIS1" . SPARSER::PROTEIN)
    ("the isogenic cell line HCT116 p21 -/-" . SPARSER::PROTEIN)
    ("p21 and cyclin-dependent kinase 6" . SPARSER::COLLECTION)
    ("FBI-1 and c-Myc" . SPARSER::COLLECTION)
    ("TSG101/p21" . SPARSER::COLLECTION) ("TSG101 (FL)" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("p21-luciferase" . SPARSER::COLLECTION)
    ("PR or CC" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("TSG101-co-repressor" . SPARSER::PROTEIN-PAIR)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("ectopically-expressed TSG101" . SPARSER::PROTEIN)
    ("p21 promoter-driven luciferase" . SPARSER::PROTEIN)
    ("TSG101 and p21 protein" . SPARSER::COLLECTION)
    ("p21-Luc" . SPARSER::COLLECTION)
    ("pcDNA-SRα/HA-TSG101" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("HA-TSG101" . SPARSER::PROTEIN-PAIR) ("pcDNA-SRα" . SPARSER::PROTEIN-PAIR)
    ("Luciferase" . SPARSER::PROTEIN) ("TAL" . SPARSER::MOLECULE)
    ("the centrally-located PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSAP" . SPARSER::PROTEIN)
    ("ESCRT endocytic trafficking complexes" . SPARSER::BIO-COMPLEX)
    ("UEV" . SPARSER::PROTEIN-FAMILY) ("p21 CIP1/WAF1" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("FBI-1" . SPARSER::PROTEIN) ("DMAP1" . SPARSER::PROTEIN)
    ("D-10" . SPARSER::PROTEIN) ("C-2" . SPARSER::PROTEIN)
    ("SRα" . SPARSER::PROTEIN) ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TSG101" . SPARSER::PROTEIN) ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("dopamine transporters and the dopamine" . SPARSER::COLLECTION)
    ("dopamine receptors, dopamine transporters and the dopamine"
     . SPARSER::COLLECTION)
    ("Catechol" . SPARSER::PROTEIN)
    ("epinephrine and norepinephrine" . SPARSER::COLLECTION)
    ("pargyline" . SPARSER::DRUG) ("MAOA and MAOB" . SPARSER::COLLECTION)
    ("MAOB" . SPARSER::PROTEIN) ("MAOA and AKAP12" . SPARSER::COLLECTION)
    ("the respective mature miRs" . SPARSER::PROTEIN)
    ("miR-142-regulated genes" . SPARSER::GENE)
    ("neuronal genes" . SPARSER::GENE) ("key neuronal genes" . SPARSER::GENE)
    ("ARNTL or BMAL1" . SPARSER::COLLECTION) ("ARNTL" . SPARSER::PROTEIN)
    ("Clock" . SPARSER::PROTEIN) ("cocaine" . SPARSER::DRUG)
    ("the two functional mature forms" . SPARSER::FORM)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("a severe form" . SPARSER::FORM) ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MiRs" . SPARSER::PROTEIN) ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("RISC" . SPARSER::PROTEIN) ("MiR" . SPARSER::PROTEIN)
    ("MAOA" . SPARSER::PROTEIN) ("oxidase (MAO)" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("NHLH2" . SPARSER::PROTEIN)
    ("AKAP12" . SPARSER::PROTEIN) ("Monoamine Oxidase A" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("MAP2" . SPARSER::PROTEIN)
    ("BMAL1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("DRD1" . SPARSER::PROTEIN) ("Sirtuin1" . SPARSER::PROTEIN)
    ("RPS" . SPARSER::PROTEIN) ("BAX/p53" . SPARSER::COLLECTION)
    ("whose RPS7" . SPARSER::PROTEIN)
    ("family (MMP)" . SPARSER::PROTEIN-FAMILY)
    ("ERK 1/2, MEK1/2 and JNK1/2" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xl" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("cip" . SPARSER::PROTEIN) ("annexin" . SPARSER::PROTEIN)
    ("Cdk4 and cyclin B1" . SPARSER::COLLECTION)
    ("an essential suppressor" . SPARSER::SUPPRESSOR)
    ("p21 Cip1/Waf1" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("p53/MDM2" . SPARSER::COLLECTION)
    ("RPL36a" . SPARSER::PROTEIN) ("ribosomal proteins L26" . SPARSER::PROTEIN)
    ("ERK1/2, MEK1/2, and P38" . SPARSER::COLLECTION)
    ("RPL37" . SPARSER::PROTEIN) ("Cdk 4" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("carbon monoxide" . SPARSER::MOLECULE) ("pP38" . SPARSER::PROTEIN)
    ("Bcl-XS" . SPARSER::PROTEIN) ("MMP13" . SPARSER::PROTEIN)
    ("waf1" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("RPL36" . SPARSER::PROTEIN) ("ribosomal protein L15" . SPARSER::PROTEIN)
    ("RPL19" . SPARSER::PROTEIN) ("L26" . SPARSER::PROTEIN)
    ("RPS19" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHK1 and RAD51" . SPARSER::COLLECTION)
    ("cytarabine or DNR co-treatments" . SPARSER::COLLECTION)
    ("VPA and cytarabine or clofarabine" . SPARSER::COLLECTION)
    ("cytarabine or clofarabine" . SPARSER::COLLECTION)
    ("clofarabine" . SPARSER::DRUG)
    ("BRCA1, CHK1 , and RAD51" . SPARSER::COLLECTION)
    ("cytarabine " . SPARSER::MOLECULE)
    ("RAD51 and CHK1" . SPARSER::COLLECTION) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("RAD51-shRNA" . SPARSER::COLLECTION) ("CHK1-" . SPARSER::PROTEIN)
    ("CHK1-shRNA" . SPARSER::COLLECTION)
    ("BRCA1 and CHK1" . SPARSER::COLLECTION)
    ("NTC-shRNA" . SPARSER::COLLECTION) ("-shRNA" . SPARSER::COLLECTION)
    ("NTC" . SPARSER::PROTEIN) ("cytarabine or DNR" . SPARSER::COLLECTION)
    ("cytarabine- or DNR-induced DNA DSBs" . SPARSER::COLLECTION)
    ("cytarabine and panobinostat" . SPARSER::COLLECTION)
    ("Cytarabine-" . SPARSER::MOLECULE)
    ("Cytarabine or DNR" . SPARSER::COLLECTION)
    ("Cytarabine" . SPARSER::MOLECULE)
    ("MRE11, RAD50, 53BP1, ATM, ATR, Ku70, and CHK2" . SPARSER::COLLECTION)
    ("caspase 3 and PARP" . SPARSER::COLLECTION)
    ("BRCA1 , CHK1 , and RAD51" . SPARSER::COLLECTION)
    ("BRCA1 and RAD51" . SPARSER::COLLECTION) ("HDACI" . SPARSER::MOLECULE)
    ("HDACIs and shRNA" . SPARSER::COLLECTION)
    ("valproic acid (VPA) and cytarabine" . SPARSER::COLLECTION)
    ("VPA" . SPARSER::PROTEIN) ("HDACIs" . SPARSER::MOLECULE)
    ("cytarabine (ara-C) and anthracycline [e.g., daunorubicin (DNR)]"
     . SPARSER::COLLECTION)
    ("cytarabine and daunorubicin" . SPARSER::COLLECTION)
    ("panobinostat and cytarabine" . SPARSER::COLLECTION)
    ("cytarabine or panobinostat" . SPARSER::COLLECTION)
    ("BRCA1, CHK1, or RAD51" . SPARSER::COLLECTION)
    ("cytarabine- or DNR-induced DNA double-strand" . SPARSER::COLLECTION)
    ("cytarabine-" . SPARSER::MOLECULE)
    ("BRCA1, CHK1, and RAD51" . SPARSER::COLLECTION)
    ("Panobinostat" . SPARSER::DRUG)
    ("panobinostat and cytarabine or daunorubicin (DNR)" . SPARSER::COLLECTION)
    ("panobinostat and cytarabine or daunorubicin" . SPARSER::COLLECTION)
    ("cytarabine or daunorubicin" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("panobinostat" . SPARSER::DRUG)
    ("histone 4" . SPARSER::PROTEIN) ("RPL13" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE)
    ("Histone deacetylase" . SPARSER::PROTEIN) ("ara-C" . SPARSER::DRUG)
    ("IL2" . SPARSER::PROTEIN) ("oligomers and gapmers" . SPARSER::COLLECTION)
    ("codon or aptamers" . SPARSER::COLLECTION)
    ("enzyme and mRNA" . SPARSER::COLLECTION)
    ("exogenous RNase H enzyme" . SPARSER::ENZYME)
    ("Oligomers" . SPARSER::PROTEIN)
    ("full-length p53 protein and its N-truncated ΔNp53 isoform"
     . SPARSER::COLLECTION)
    ("oligonucleotides or their GAP variants and the level"
     . SPARSER::COLLECTION)
    ("their GAP variants and the level" . SPARSER::COLLECTION)
    ("RNases" . SPARSER::PROTEIN)
    ("a commercially available enzyme" . SPARSER::ENZYME)
    ("at least six deoxyribonucleotides" . SPARSER::MOLECULE)
    ("LNA/PS" . SPARSER::COLLECTION)
    ("deoxyribonucleotides" . SPARSER::MOLECULE)
    ("the full-length reporter protein and 39 amino acids"
     . SPARSER::COLLECTION)
    ("p53 and/or ΔNp53" . SPARSER::COLLECTION)
    ("Oligonucleotides" . SPARSER::MOLECULE) ("Antisense" . SPARSER::PROTEIN)
    ("Codons" . SPARSER::PROTEIN) ("DMS" . SPARSER::DRUG)
    ("-proximal part" . SPARSER::COMPONENT) ("ribozymes" . SPARSER::RNA)
    ("Oligomer" . SPARSER::MOLECULE)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("which lacks 39 amino acids" . SPARSER::AMINO-ACID)
    ("Mdm2/Hdm2" . SPARSER::COLLECTION) ("p53 and ΔNp53" . SPARSER::COLLECTION)
    ("LNA" . SPARSER::PROTEIN)
    ("p53 protein and its ΔNp53 isoform" . SPARSER::COLLECTION)
    ("M 2" . SPARSER::MOLECULE) ("Pb 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("or 2 µ" . SPARSER::MOLECULE) ("Mg 2+" . SPARSER::MOLECULE)
    ("SP6" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("JAK1 and Akt1" . SPARSER::COLLECTION)
    ("JAK/PI3K/Akt" . SPARSER::COLLECTION)
    ("JAK2 (AG490) and JAK3 (Janex-1)" . SPARSER::COLLECTION)
    ("Activator" . SPARSER::ACTIVATOR) ("Akt3/PKBγ" . SPARSER::COLLECTION)
    ("Akt1/PKBα" . SPARSER::COLLECTION) ("IKB" . SPARSER::PROTEIN)
    ("p44/p42 MAPK" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines/chemokines" . SPARSER::COLLECTION)
    ("IFN-γ, IL-8 and TNF-α" . SPARSER::COLLECTION)
    ("a more severe form" . SPARSER::FORM)
    ("Tat-mediated CCL5" . SPARSER::PROTEIN)
    ("protein level wherein JAK2 and JAK3 specific inhibitors"
     . SPARSER::INHIBITOR)
    ("JAK2 and JAK3" . SPARSER::COLLECTION)
    ("JAK 2 (AG 490) and JAK 3 (Janex-1)" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and JAK3" . SPARSER::COLLECTION)
    ("Akt2 and Akt3" . SPARSER::COLLECTION)
    ("Akt1/Akt2/Akt3" . SPARSER::COLLECTION)
    ("C/EBPα, C/EBPγ and AP-1" . SPARSER::COLLECTION)
    ("MAPK and JNK" . SPARSER::COLLECTION)
    ("p50 (NF-κB1) and p65 (RelA)" . SPARSER::COLLECTION)
    ("CCL5/GFAP" . SPARSER::COLLECTION) ("strong GFAP" . SPARSER::PROTEIN)
    ("MAPKs and Janus" . SPARSER::COLLECTION) ("p38/JNK" . SPARSER::COLLECTION)
    ("CC-chemokine" . SPARSER::COLLECTION) ("CCLs" . SPARSER::DRUG)
    ("Chemokine" . SPARSER::PROTEIN) ("interleukins" . SPARSER::PROTEIN)
    ("excitatory neurotransmitters" . SPARSER::MOLECULE)
    ("neurotoxic substances" . SPARSER::SUBSTANCE)
    ("substances" . SPARSER::SUBSTANCE) ("the viral RNA" . SPARSER::RNA)
    ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("AP-1, C/EBPα and C/EBPγ" . SPARSER::COLLECTION)
    ("the respective genes" . SPARSER::GENE)
    ("AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting"
     . SPARSER::COLLECTION)
    ("pharmacological inhibitors and siRNA" . SPARSER::COLLECTION)
    ("PKBγ" . SPARSER::PROTEIN) ("PKBα" . SPARSER::PROTEIN)
    ("phospho-kinases" . SPARSER::PROTEIN) ("IKK2" . SPARSER::PROTEIN)
    ("p42 MAPK" . SPARSER::PROTEIN) ("JAK 3" . SPARSER::PROTEIN)
    ("AG 490" . SPARSER::DRUG) ("JAK 2" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("Phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Activator protein-1" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("C-C chemokine receptor type 5" . SPARSER::PROTEIN)
    ("N-methyl-D-aspartate" . SPARSER::MOLECULE) ("C/EBPα" . SPARSER::PROTEIN)
    ("functional BRCA1" . SPARSER::PROTEIN)
    ("PARP inhibitors and radiation xref" . SPARSER::COLLECTION)
    ("PARP-inhibitor and radiation sensitivity" . SPARSER::COLLECTION)
    ("14,500 well-characterised human genes" . SPARSER::GENE)
    ("pyrimidine" . SPARSER::DRUG)
    ("the 180,985 expressed heterozygous variants" . SPARSER::VARIANT)
    ("those heterozygous variants" . SPARSER::VARIANT)
    ("AI" . SPARSER::PROTEIN) ("a further 184,740 small RNA" . SPARSER::RNA)
    ("CpGs" . SPARSER::PROTEIN) ("somatic CpG" . SPARSER::PROTEIN)
    ("Tobacco" . SPARSER::DRUG)
    ("genome and transcriptome" . SPARSER::COLLECTION)
    ("the main histological subtypes" . SPARSER::PROTEIN)
    ("TP53 and BRCA2" . SPARSER::COLLECTION) ("DNA-repair" . SPARSER::DNA)
    ("both the whole genome and whole transcriptome (coding and non-coding)"
     . SPARSER::COLLECTION)
    ("v19" . SPARSER::PROTEIN) ("TTF-1" . SPARSER::PROTEIN)
    ("multi" . SPARSER::PROTEIN)
    ("microglia/macrophages" . SPARSER::COLLECTION)
    ("macrophage/microglia" . SPARSER::COLLECTION)
    ("NF-κB, STAT3 and p38 MAPK" . SPARSER::COLLECTION)
    ("gp130/cytokine" . SPARSER::COLLECTION)
    ("inducibly decrease NF-κB p65 protein" . SPARSER::PROTEIN)
    ("AZD1480 or WA" . SPARSER::COLLECTION)
    ("AZD1480 and WA" . SPARSER::COLLECTION)
    ("AZD1480 or both" . SPARSER::COLLECTION)
    ("kinase, IKKα/β, and NF-κB" . SPARSER::COLLECTION)
    ("NEMO/IKKβ" . SPARSER::COLLECTION)
    ("intratumoral NF-κB" . SPARSER::PROTEIN)
    ("p65 and IκBα" . SPARSER::COLLECTION)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("both tumor cell NF-κB and global STAT3" . SPARSER::COLLECTION)
    ("global STAT3" . SPARSER::PROTEIN)
    ("food and AZD1480" . SPARSER::COLLECTION)
    ("no antibodies (No IgG), isotype control or gp130-specific neutralizing antibodies (α-gp130)"
     . SPARSER::COLLECTION)
    ("JAK/gp130" . SPARSER::COLLECTION) ("sh-p65" . SPARSER::COLLECTION)
    ("sh" . SPARSER::PROTEIN-FAMILY)
    ("a new wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-6 and SOCS3" . SPARSER::COLLECTION)
    ("soluble chromatin" . SPARSER::PROTEIN)
    ("p65 or STAT3" . SPARSER::COLLECTION) ("Promoters" . SPARSER::PROMOTER)
    ("IL-6 and soluble IL-6 receptor (sIL-6R)" . SPARSER::COLLECTION)
    ("soluble IL-6 receptor" . SPARSER::PROTEIN)
    ("a classical activator" . SPARSER::ACTIVATOR)
    ("p-p65" . SPARSER::COLLECTION)
    ("a pro-inflammatory cytokine and potent activator" . SPARSER::COLLECTION)
    ("a pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("IL-6 and LIF" . SPARSER::COLLECTION)
    ("IKKα, IKKβ and NEMO" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION) ("NF-κB/p52" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("SOCS3, VEGF, c-Myc and IL-6" . SPARSER::COLLECTION)
    ("Mes" . SPARSER::MOLECULE) ("the most commonly occurring type" . TYPE)
    ("occurring type" . TYPE) ("NF-κB and/or STAT3" . SPARSER::COLLECTION)
    ("TNF-α and IL-6" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION) ("IL−6" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("P65" . SPARSER::PROTEIN) ("AZD1480" . SPARSER::DRUG)
    ("IKKβ" . SPARSER::PROTEIN)
    ("PD-related proteins and the candidate Parkin-binding proteins"
     . SPARSER::COLLECTION)
    ("associated variants" . SPARSER::VARIANT)
    ("E3 ubiquitin ligases and their substrates" . SPARSER::COLLECTION)
    ("HSPD1 and CLPX" . SPARSER::COLLECTION)
    ("Parkin and several proteins" . SPARSER::COLLECTION)
    ("Bax and the mitochondrial pro-apoptotic protein ARTS"
     . SPARSER::COLLECTION)
    ("the mitochondrial pro-apoptotic protein ARTS" . SPARSER::PROTEIN)
    ("ARTS" . SPARSER::PROTEIN)
    ("TOMM70A, DAP3 and OPA1" . SPARSER::COLLECTION)
    ("CCT3, CLPX1, HSPD1, PRKCSH and BAG2" . SPARSER::COLLECTION)
    ("HSPD1, CASP14, H1F0, DAP3, AIFM1, GSDMA, SET, OPA1, and BAG2"
     . SPARSER::COLLECTION)
    ("SET" . SPARSER::PROTEIN) ("GSDMA" . SPARSER::PROTEIN)
    ("the candidate proteins and the PD-related proteins"
     . SPARSER::COLLECTION)
    ("proteins, and protein" . SPARSER::COLLECTION)
    ("only three candidate proteins" . SPARSER::PROTEIN)
    ("the Western Blot" . SPARSER::PROTEIN)
    ("LRPPRC and TOMM70A" . SPARSER::COLLECTION) ("YWHAE" . SPARSER::PROTEIN)
    ("HNRNPF" . SPARSER::PROTEIN) ("TUBB" . SPARSER::PROTEIN)
    ("Parkin/PINK1" . SPARSER::COLLECTION) ("LMNA" . SPARSER::PROTEIN)
    ("only MonogenicPD proteins" . SPARSER::PROTEIN)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("TriC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prefoldin" . SPARSER::PROTEIN-FAMILY) ("LEA" . SPARSER::PROTEIN)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("DAPPLE" . SPARSER::PROTEIN) ("calmodulin" . SPARSER::PROTEIN)
    ("the candidate Parkin-binding proteins, which interacts with two other MonogenicPD proteins (UCHL1, SNCA) in HNet"
     . SPARSER::PROTEIN)
    ("Calmodulin" . SPARSER::PROTEIN)
    ("CLPX, PRKCSH, DAP3 and CALU" . SPARSER::COLLECTION)
    ("CALU" . SPARSER::PROTEIN) ("PRKCSH" . SPARSER::PROTEIN)
    ("CLPX" . SPARSER::PROTEIN) ("LRPPRC" . SPARSER::PROTEIN)
    ("SNCA" . SPARSER::PROTEIN)
    ("a form of parkinsonism with dementia and juvenile disease onset xref"
     . SPARSER::COLLECTION)
    ("UCHL1 and FBXO7" . SPARSER::COLLECTION)
    ("UCHL1, FBXO7, and ATP13A2" . SPARSER::COLLECTION)
    ("Parkin and MonogenicPD" . SPARSER::COLLECTION)
    ("monogenic forms" . SPARSER::FORM)
    ("Parkin, PINK1, and proteins" . SPARSER::COLLECTION)
    ("203 unique peptides" . SPARSER::PEPTIDE) ("Mito" . SPARSER::DRUG)
    ("the candidate Parkin-binding proteins and the proteins"
     . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION)
    ("Parkin and PINK1 and genes" . SPARSER::COLLECTION)
    ("PINK1 and genes" . SPARSER::COLLECTION)
    ("PINK1/Parkin" . SPARSER::COLLECTION)
    ("Parkin and PINK1" . SPARSER::COLLECTION)
    ("the candidate proteins and the proteins" . SPARSER::COLLECTION)
    ("approximately 1–2" . SPARSER::PROTEIN) ("MAP1S" . SPARSER::PROTEIN)
    ("CCT3" . SPARSER::PROTEIN) ("BAG2" . SPARSER::PROTEIN)
    ("OPA1" . SPARSER::PROTEIN) ("AIFM1" . SPARSER::PROTEIN)
    ("H1F0" . SPARSER::PROTEIN) ("CASP14" . SPARSER::PROTEIN)
    ("HSPD1" . SPARSER::PROTEIN) ("HSP90AB1" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("EEF1A2" . SPARSER::PROTEIN)
    ("RPS27A" . SPARSER::PROTEIN) ("SLC25A4" . SPARSER::PROTEIN)
    ("TUBA4A" . SPARSER::PROTEIN) ("TUBA1C" . SPARSER::PROTEIN)
    ("ND1" . SPARSER::PROTEIN) ("Pre-mRNA" . SPARSER::RNA)
    ("Alpha-synuclein" . SPARSER::PROTEIN) ("CALM1" . SPARSER::PROTEIN)
    ("DAP3" . SPARSER::PROTEIN) ("TOMM70A" . SPARSER::PROTEIN)
    ("PARK7" . SPARSER::PROTEIN) ("HSPA8" . SPARSER::PROTEIN)
    ("DNAJA1" . SPARSER::PROTEIN) ("ATP13A2" . SPARSER::PROTEIN)
    ("FBXO7" . SPARSER::PROTEIN) ("UCHL1" . SPARSER::PROTEIN)
    ("cell division cycle 37" . SPARSER::PROTEIN) ("PARK2" . SPARSER::PROTEIN)
    ("genes or polymorphisms" . SPARSER::COLLECTION)
    ("cryptic" . SPARSER::PROTEIN) ("thromboxane" . SPARSER::MOLECULE)
    ("COX-2 and ITGA2" . SPARSER::COLLECTION)
    ("a strong genetic component" . SPARSER::COMPONENT)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("thromboxane A2" . SPARSER::MOLECULE) ("ITGA2" . SPARSER::PROTEIN)
    ("ITGA2B" . SPARSER::PROTEIN)
    ("steroidogenic AKR1C3 and constitutively active AR variants"
     . SPARSER::COLLECTION)
    ("Cyp17" . SPARSER::PROTEIN) ("androgen and AR" . SPARSER::COLLECTION)
    ("adrenal-derived androgens" . SPARSER::DRUG)
    ("SRD5A2 and HSD17B6" . SPARSER::COLLECTION)
    ("CYP11A1, CYP17A1 and HSD3B2" . SPARSER::COLLECTION)
    ("AKR1C2 and HSD17B10" . SPARSER::COLLECTION)
    ("androstanediol" . SPARSER::MOLECULE)
    ("which bypasses testosterone" . SPARSER::MOLECULE)
    ("adrenal-derived androstenedione" . SPARSER::PROTEIN)
    ("AKR1C3 and SRD5A1" . SPARSER::COLLECTION)
    ("homogeneous AKR1C3" . SPARSER::PROTEIN)
    ("AKR1C3 and constitutively active AR variants" . SPARSER::COLLECTION)
    ("AKR1C3 and AR-V" . SPARSER::COLLECTION)
    ("approximately 80 kDa" . SPARSER::PROTEIN)
    ("approximate 110 kDa" . SPARSER::PROTEIN) ("log-rank " . SPARSER::PROTEIN)
    ("rank " . SPARSER::PROTEIN)
    ("DHEA and androstenedione" . SPARSER::COLLECTION)
    ("androstenediol" . SPARSER::DRUG) ("adrenals" . SPARSER::DRUG)
    ("androstenedione" . SPARSER::PROTEIN) ("DHEA" . SPARSER::DRUG)
    ("AKR1C2 and UGT2B15" . SPARSER::COLLECTION)
    ("PC and PC" . SPARSER::COLLECTION)
    ("AKR1C3 and AKR1C2" . SPARSER::COLLECTION)
    ("CYP17A1, HSD3B2, SRD5A1 and SRD5A2" . SPARSER::COLLECTION)
    ("CYP17A1 and HSD3B2" . SPARSER::COLLECTION)
    ("CYP11A1, CYP17A1, and HSD3B2" . SPARSER::COLLECTION)
    ("HSD3B2" . SPARSER::PROTEIN)
    ("weak circulating androgens" . SPARSER::DRUG)
    ("testosterone and DHT" . SPARSER::COLLECTION)
    ("AR-V7 and AR-V567es" . SPARSER::COLLECTION) ("LBD" . SPARSER::PROTEIN)
    ("PC (CRPC)" . SPARSER::PROTEIN) ("AKR1C3 and AR-Vs" . SPARSER::COLLECTION)
    ("SRD5A1, AKR1C2, AKR1C3, and HSD17B10" . SPARSER::COLLECTION)
    ("CYP11A1, CYP17A1, HSD3B2, SRD5A2, and HSD17B6" . SPARSER::COLLECTION)
    ("HSD" . SPARSER::PROTEIN) ("steroidogenic" . SPARSER::PROTEIN)
    ("Steroidogenic" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG) ("PGJ2" . SPARSER::MOLECULE)
    ("FP receptor" . SPARSER::PROTEIN) ("UGT2B15" . SPARSER::PROTEIN)
    ("RPL13A" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("HSD17B6" . SPARSER::PROTEIN) ("SRD5A2" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN) ("CYP11A1" . SPARSER::PROTEIN)
    ("HSD17B10" . SPARSER::PROTEIN) ("AKR1C3" . SPARSER::PROTEIN)
    ("AKR1C2" . SPARSER::PROTEIN) ("SRD5A1" . SPARSER::PROTEIN)
    ("either valine (V) or phenylalanine (F)" . SPARSER::COLLECTION)
    ("H/R or R/H" . SPARSER::COLLECTION)
    ("either arginine (R) or histidine (H)" . SPARSER::COLLECTION)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("only 1 DLT" . SPARSER::PROTEIN)
    ("leucovorin, or capecitabine" . SPARSER::COLLECTION)
    ("oxaliplatin, leucovorin, 5-fluorouracil, bevacizumab, capecitabine, and irinotecan"
     . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG) ("leucovorin" . SPARSER::DRUG)
    ("FcγRIIA or IIIA" . SPARSER::COLLECTION) ("Biomarker" . SPARSER::MOLECULE)
    ("ALP" . SPARSER::PROTEIN) ("aminotransferase" . SPARSER::PROTEIN)
    ("bilirubin" . SPARSER::MOLECULE) ("AEs" . SPARSER::PROTEIN)
    ("lenalidomide or cetuximab" . SPARSER::COLLECTION)
    ("cetuximab and lenalidomide" . SPARSER::COLLECTION)
    ("DLT" . SPARSER::PROTEIN) ("arm and lenalidomide" . SPARSER::COLLECTION)
    ("SER" . SPARSER::AMINO-ACID) ("ARG" . SPARSER::PROTEIN)
    ("ALA" . SPARSER::AMINO-ACID) ("CYS" . SPARSER::AMINO-ACID)
    ("VAL" . SPARSER::AMINO-ACID) ("ASP" . SPARSER::PROTEIN) ("Types" . TYPE)
    ("lenalidomide and panitumumab" . SPARSER::COLLECTION)
    ("Revlimid" . SPARSER::DRUG) ("Lenalidomide" . SPARSER::DRUG)
    ("many therapeutic mAbs" . SPARSER::DRUG) ("Fc" . SPARSER::PROTEIN)
    ("capecitabine" . SPARSER::DRUG) ("perifosine" . SPARSER::PROTEIN)
    ("regorafenib" . SPARSER::DRUG) ("oxaliplatin-" . SPARSER::DRUG)
    ("fluoropyrimidine-" . SPARSER::DRUG) ("fluoropyrimidine" . SPARSER::DRUG)
    ("Anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Erbitux" . SPARSER::DRUG) ("mAbs" . SPARSER::DRUG)
    ("oral lenalidomide (starting dose 25 mg/day) and intravenous cetuximab (400 mg/m 2 followed by weekly 250 mg/m 2 )"
     . SPARSER::COLLECTION)
    ("intravenous cetuximab" . SPARSER::DRUG) ("IIb" . SPARSER::DRUG)
    ("lenalidomide and cetuximab" . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG) ("FcγRIIIA" . SPARSER::PROTEIN)
    ("H/R" . SPARSER::PROTEIN) ("CDw32" . SPARSER::PROTEIN)
    ("FcγRII" . SPARSER::PROTEIN) ("CD64" . SPARSER::PROTEIN)
    ("FcγRIIA" . SPARSER::PROTEIN) ("FcγRs" . SPARSER::PROTEIN-FAMILY)
    ("FcγR" . SPARSER::PROTEIN-FAMILY) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("Ki-ras" . SPARSER::PROTEIN) ("tryptophan" . SPARSER::AMINO-ACID)
    ("HDAC and NCoR" . SPARSER::COLLECTION)
    ("most AR target genes and cell proliferation" . SPARSER::COLLECTION)
    ("pro-proliferative genes" . SPARSER::GENE)
    ("growth suppressive AR target genes" . SPARSER::GENE)
    ("NKX3.1 and p27" . SPARSER::COLLECTION)
    ("tumor suppressors and differentiation genes" . SPARSER::COLLECTION)
    ("p44/MEP50" . SPARSER::COLLECTION)
    ("directly co-occupies androgen response elements"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Transcriptional cofactors" . SPARSER::PROTEIN)
    ("the NKX3.1 AREI and the HUS1 ARE" . SPARSER::COLLECTION)
    ("AREI" . SPARSER::PROTEIN) ("NKX3.1 and HUS1" . SPARSER::COLLECTION)
    ("both the primary and secondary ARE"
     . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("NKX3.1, KRT18, and HUS1" . SPARSER::COLLECTION)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("NKX3.1, KRT18, HUS1, and JAG1" . SPARSER::COLLECTION)
    ("CCNA2 and CDC6" . SPARSER::COLLECTION)
    ("NKX3.1, PMEPA1, HUS1, and KRT18" . SPARSER::COLLECTION)
    ("NLSTBLR1 and LNCaP" . SPARSER::COLLECTION)
    ("exemplary androgen-regulated genes" . SPARSER::GENE)
    ("Cyclin A2 and CDC6" . SPARSER::COLLECTION)
    ("siRNA in LNCaP pBabe control cells ( xref ) and LNCaP NLSTBLR1 containing cells ( xref )"
     . SPARSER::COLLECTION)
    ("pBabe" . SPARSER::PROTEIN) ("LNCaP-NLSTBLR1" . SPARSER::COLLECTION)
    ("LNCaP-pBabe" . SPARSER::PROTEIN-PAIR) ("NLSTBLR1" . SPARSER::PROTEIN)
    ("GFP-TBLR1" . SPARSER::COLLECTION)
    ("GFP-NLSTBLR1" . SPARSER::PROTEIN-PAIR)
    ("wildtype TBLR1 and the mutant" . SPARSER::COLLECTION)
    ("a parallel western blot" . SPARSER::PROTEIN)
    ("Rottlerin" . SPARSER::DRUG) ("TBLR1 and AR" . SPARSER::COLLECTION)
    ("AR and TBLR1" . SPARSER::COLLECTION)
    ("androgen or AR" . SPARSER::COLLECTION)
    ("RAR, PPARgamma, and NFkappaB" . SPARSER::COLLECTION)
    ("NFkappaB" . SPARSER::PROTEIN) ("PPARgamma" . SPARSER::PROTEIN)
    ("pro-proliferative AR target genes" . SPARSER::GENE)
    ("NHR" . SPARSER::PROTEIN) ("NCoR and SMRT" . SPARSER::COLLECTION)
    ("receptor (RAR)" . SPARSER::RECEPTOR)
    ("receptor (TR)" . SPARSER::RECEPTOR) ("RAR" . SPARSER::PROTEIN)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and other nuclear hormone receptors (NHR) ( xref )"
     . SPARSER::COLLECTION)
    ("receptors (NHR)" . SPARSER::RECEPTOR)
    ("TBL1X, and GPS2, IR10, and HDAC3" . SPARSER::COLLECTION)
    ("GPS2, IR10, and HDAC3" . SPARSER::COLLECTION)
    ("receptor (SMRT)" . SPARSER::RECEPTOR)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("retinoic acid and thyroid" . SPARSER::COLLECTION)
    ("Transducin" . SPARSER::PROTEIN) ("p44/Mep50/WDR77" . SPARSER::COLLECTION)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("coactivators or corepressors" . SPARSER::COLLECTION)
    ("Androgen Receptor (AR)" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("BCL-3" . SPARSER::PROTEIN) ("MEP50" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("BMPR1B" . SPARSER::PROTEIN)
    ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("set 1" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("HUS1" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("Retinoic acid" . SPARSER::MOLECULE) ("β-gal" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("IR10" . SPARSER::PROTEIN)
    ("GPS2" . SPARSER::PROTEIN) ("TBL1X" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("WDR77" . SPARSER::PROTEIN)
    ("Mep50" . SPARSER::PROTEIN) ("ARA70" . SPARSER::PROTEIN)
    ("KRT18" . SPARSER::PROTEIN) ("TBLR1" . SPARSER::PROTEIN)
    ("Androgen Receptor" . SPARSER::PROTEIN)
    ("MLN0128 and rapamycin" . SPARSER::COLLECTION)
    ("S6K1 and PI3K" . SPARSER::COLLECTION)
    ("rapamycin, temsirolimus and everolimus" . SPARSER::COLLECTION)
    ("4EBP1 and p-S6K1" . SPARSER::COLLECTION)
    ("perhaps other dual inhibitors" . SPARSER::INHIBITOR)
    ("MLN0128-treated TSGs" . SPARSER::PROTEIN)
    ("4EBP1, HIF1α, MTA1 and c-Myc" . SPARSER::COLLECTION)
    ("p-4EBP1" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("both temsirolimus ( p = 0.009) and MLN0128 ( p < 0.0001)"
     . SPARSER::COLLECTION)
    ("SGR" . SPARSER::PROTEIN) ("VHL" . SPARSER::PROTEIN)
    ("CAIX, CD10, CD117 and CD7" . SPARSER::COLLECTION)
    ("CD117 ( xref – xref ) and CK7" . SPARSER::COLLECTION)
    ("weak patchy CK7" . SPARSER::PROTEIN) ("patchy CD10" . SPARSER::PROTEIN)
    ("case 3 showed modest CAIX" . SPARSER::PROTEIN)
    ("membranous CAIX" . SPARSER::PROTEIN) ("CAIX" . SPARSER::PROTEIN)
    ("sunitinib" . SPARSER::DRUG)
    ("MLN0128 and temsirolimus" . SPARSER::COLLECTION)
    ("MLN0128 or temsirolimus" . SPARSER::COLLECTION)
    ("invasive PCa" . SPARSER::PROTEIN)
    ("YB1, MTA1, vimentin and CD44" . SPARSER::COLLECTION)
    ("4EBP1 and S6k1" . SPARSER::COLLECTION) ("everolimus" . SPARSER::DRUG)
    ("dual mTOR inhibitors" . SPARSER::INHIBITOR)
    ("4EBP1, p-S6K1, HIF1α and MTA1" . SPARSER::COLLECTION)
    ("Temsirolimus" . SPARSER::DRUG) ("MRI" . SPARSER::PROTEIN)
    ("TSGs" . SPARSER::PROTEIN)
    ("temsirolimus and MLN0128" . SPARSER::COLLECTION)
    ("TSG" . SPARSER::PROTEIN)
    ("the only first-generation mTOR inhibitor" . SPARSER::INHIBITOR)
    ("temsirolimus" . SPARSER::DRUG) ("pS6K" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6K1" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD7" . SPARSER::PROTEIN) ("RAG2" . SPARSER::PROTEIN)
    ("S6k1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("YB1" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN) ("p-S6K" . SPARSER::PROTEIN)
    ("MLN0128" . SPARSER::DRUG)
    ("MEK1 or its presumed target ERK" . SPARSER::COLLECTION)
    ("these mutated forms" . SPARSER::FORM) ("SF3B1" . SPARSER::PROTEIN)
    ("the longest protein" . SPARSER::PROTEIN)
    ("TP53, U2AF1, ARID1A and TTN" . SPARSER::COLLECTION)
    ("BRAF and MAP2K1" . SPARSER::COLLECTION)
    ("MEK1 and its effector ERK" . SPARSER::COLLECTION)
    ("the dual specificity kinase MEK1" . SPARSER::PROTEIN)
    ("MAP2K1, U2AF1, ARID1A, TP53 , and TTN" . SPARSER::COLLECTION)
    ("U2AF1" . SPARSER::PROTEIN) ("TTN" . SPARSER::PROTEIN)
    ("cladribine or pentostatin" . SPARSER::COLLECTION)
    ("cladribine" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Polynucleotide Kinase" . SPARSER::PROTEIN) ("SF3" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX) ("CD103" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("IGHV4-34" . SPARSER::PROTEIN)
    ("Wei-feng WANG and Zhi-hua ZHOU" . SPARSER::COLLECTION)
    ("QIN and Jing-kang" . SPARSER::COLLECTION)
    ("WANG and Jun-chao" . SPARSER::COLLECTION)
    ("Zhi-hua" . SPARSER::COLLECTION) ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("QIN" . SPARSER::PROTEIN) ("hua" . SPARSER::PROTEIN)
    ("WANG" . SPARSER::PROTEIN) ("Yan" . SPARSER::PROTEIN)
    ("the entire genome" . SPARSER::PROTEIN)
    ("and β-globin" . SPARSER::COLLECTION) ("globin" . SPARSER::PROTEIN)
    ("IIIb" . SPARSER::DRUG) ("pAKT(+) and the group" . SPARSER::COLLECTION)
    ("p110α and pAKT" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("homologous genes" . SPARSER::GENE) ("tuberin" . SPARSER::PROTEIN)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("p110α, p110β, and p110δ" . SPARSER::COLLECTION) ("Class" . CLASS)
    ("IA and IB" . SPARSER::COLLECTION) ("IA" . SPARSER::MOLECULE)
    ("PIKs" . SPARSER::BIO-COMPLEX) ("kinase (PIK)" . SPARSER::KINASE)
    ("PIK" . SPARSER::BIO-COMPLEX) ("the 20th exon" . SPARSER::PROTEIN)
    ("the 9th exon" . SPARSER::PROTEIN)
    ("P110α and pAKT" . SPARSER::COLLECTION) ("α-globin" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("x-Gal" . SPARSER::MOLECULE)
    ("FKHR-L1" . SPARSER::PROTEIN) ("caspase 9" . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("p85β" . SPARSER::PROTEIN) ("PI4Ks" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("P110α" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("Tiam" . SPARSER::PROTEIN-FAMILY) ("Zeb1" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("ERK-MAPK" . SPARSER::COLLECTION)
    ("Raf/ERK1/2" . SPARSER::COLLECTION)
    ("RASSF1A and adenomatous polyposis coli (APC)" . SPARSER::COLLECTION)
    ("Dlg" . SPARSER::PROTEIN) ("discs" . SPARSER::BIO-COMPLEX)
    ("KIF2C, KIF2A, and KIF2B" . SPARSER::COLLECTION)
    ("KIF2C or both using siRNA" . SPARSER::COLLECTION)
    ("residual KIF2A and KIF2C" . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("polymers" . SPARSER::MOLECULE)
    ("actin and α-tubulin" . SPARSER::COLLECTION)
    ("KIF2C or KIF2A" . SPARSER::COLLECTION)
    ("growth factor and nutrient" . SPARSER::COLLECTION)
    ("human telomerase reverse transcriptase (hTERT) and CDK4"
     . SPARSER::COLLECTION)
    ("KIF2C and KIF2A" . SPARSER::COLLECTION)
    ("KIF2A or KIF2C" . SPARSER::COLLECTION)
    ("KIF2A and KIF2C" . SPARSER::COLLECTION)
    ("mitotic centromere-associated kinesin (MCAK)" . SPARSER::PROTEIN)
    ("MCAK" . SPARSER::PROTEIN)
    ("essential signaling components" . SPARSER::COMPONENT)
    ("matrigel" . SPARSER::PROTEIN)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-Ras/ERK1/2" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("L-arginine" . SPARSER::MOLECULE)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H-Ras" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("KIF2" . SPARSER::PROTEIN)
    ("KIF2B" . SPARSER::PROTEIN) ("kinesin family" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin" . SPARSER::PROTEIN)
    ("kinesin-13" . SPARSER::PROTEIN) ("lethal factor" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN) ("KIF2A" . SPARSER::PROTEIN)
    ("KIF2C" . SPARSER::PROTEIN) ("NO 2 and MET" . SPARSER::COLLECTION)
    ("CG and GG" . SPARSER::COLLECTION)
    ("pyrene and MET" . SPARSER::COLLECTION) ("dams" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("NO 2" . SPARSER::MOLECULE)
    ("RUNX1-ETO" . SPARSER::COLLECTION)
    ("aberrant transcription factor" . SPARSER::PROTEIN)
    ("only flow cytometry" . SPARSER::PROTEIN)
    ("western blot and flow cytometry" . SPARSER::PROTEIN)
    ("REH and UoCB6" . SPARSER::COLLECTION)
    ("daunorubicin and asparaginase" . SPARSER::COLLECTION)
    ("daunorubicin, asparaginase and vincristine" . SPARSER::COLLECTION)
    ("asparaginase" . SPARSER::PROTEIN) ("daunorubicin" . SPARSER::DRUG)
    ("MDM2 and the pro-apoptotic BAX and PUMA proteins" . SPARSER::COLLECTION)
    ("the pro-apoptotic BAX and PUMA proteins" . SPARSER::PROTEIN)
    ("the anti-V5 antibody or the negative control antibody (mIgG)"
     . SPARSER::COLLECTION)
    ("RHD" . SPARSER::PROTEIN) ("REH and AT2" . SPARSER::COLLECTION)
    ("TARGETS" . SPARSER::TARGET-PROTEIN) ("REH" . SPARSER::PROTEIN)
    ("differentially regulated genes" . SPARSER::GENE)
    ("approximately 25% ETV6/RUNX1" . SPARSER::COLLECTION)
    ("DNA-damaging and p53-activating chemotherapeutic drugs" . SPARSER::DRUG)
    ("pro-apoptotic BAX and PUMA" . SPARSER::COLLECTION)
    ("BAX and PUMA" . SPARSER::COLLECTION) ("MDM2/p53" . SPARSER::COLLECTION)
    ("the predominant negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("ETV6/RUNX1" . SPARSER::COLLECTION) ("MAD2L1" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("p53 regulator" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN) ("AT2" . SPARSER::PROTEIN)
    ("hdm2" . SPARSER::PROTEIN) ("pro-B" . SPARSER::DRUG)
    ("Nutlin-3" . SPARSER::DRUG) ("RUNX1" . SPARSER::PROTEIN)
    ("ETV6" . SPARSER::PROTEIN)
    ("P53 and its downstream targets" . SPARSER::COLLECTION)
    ("AURKA-HDM2" . SPARSER::COLLECTION)
    ("P53 and its downstream transcriptional targets" . SPARSER::COLLECTION)
    ("P53 and P21 protein" . SPARSER::COLLECTION)
    ("an investigational HDM2 specific inhibitor" . SPARSER::INHIBITOR)
    ("HDM2/P53" . SPARSER::COLLECTION) ("AURKA/HDM2" . SPARSER::COLLECTION)
    ("immuno-protein" . SPARSER::PROTEIN-PAIR)
    ("AURKA/P53" . SPARSER::COLLECTION)
    ("HDM2 and AURKA" . SPARSER::COLLECTION)
    ("PUMA, NOXA, P21 and BAX" . SPARSER::COLLECTION)
    ("NOXA" . SPARSER::PROTEIN) ("HDM2 and P53" . SPARSER::COLLECTION)
    ("exogenous AURKA protein" . SPARSER::PROTEIN)
    ("P53 and its downstream target P21" . SPARSER::COLLECTION)
    ("AURKA or HDM2" . SPARSER::COLLECTION)
    ("inhibitor (AKTI)" . SPARSER::INHIBITOR) ("AKTI" . SPARSER::PROTEIN)
    ("P53 and P21" . SPARSER::COLLECTION)
    ("an investigational AURKA specific inhibitor" . SPARSER::INHIBITOR)
    ("HDM2, P53, and P21" . SPARSER::COLLECTION)
    ("P53, P21, and BAX" . SPARSER::COLLECTION)
    ("P53 and its downstream targets (P21 and BAX)" . SPARSER::COLLECTION)
    ("P21 and BAX" . SPARSER::COLLECTION) ("BAX" . SPARSER::PROTEIN)
    ("P53 and P73" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Taxol and Cisplatin" . SPARSER::COLLECTION)
    ("Docetaxel, Cisplatin and 5-Fluorouracil" . SPARSER::COLLECTION)
    ("Docetaxel" . SPARSER::DRUG) ("DCF" . SPARSER::PROTEIN)
    ("an investigational small molecule specific inhibitor"
     . SPARSER::INHIBITOR)
    ("alisertib" . SPARSER::DRUG) ("AURKA and HDM2" . SPARSER::COLLECTION)
    ("P21 protein" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("Kinase activity" . SPARSER::PROTEIN) ("Nutlin3A" . SPARSER::DRUG)
    ("RF-1" . SPARSER::PROTEIN) ("Double Minute 2" . SPARSER::PROTEIN)
    ("Aurora Kinase A" . SPARSER::PROTEIN)
    ("BLM and other substrate" . SPARSER::COLLECTION)
    ("ankyrin" . SPARSER::PROTEIN)
    ("a BLM-associated protein" . SPARSER::PROTEIN)
    ("The residual TopBP1" . SPARSER::PROTEIN)
    ("BLM and probably other substrates" . SPARSER::COLLECTION)
    ("probably other substrates" . SPARSER::SUBSTRATE)
    ("CHK1 and RPA" . SPARSER::COLLECTION)
    ("MIB1 and TopBP1" . SPARSER::COLLECTION)
    ("TopBP1 and MIB1" . SPARSER::COLLECTION)
    ("TopBP1 and E3" . SPARSER::COLLECTION) ("BLM/MIB1" . SPARSER::COLLECTION)
    ("wild-type BLM and a K63A mutant" . SPARSER::COLLECTION)
    ("BLM and GST" . SPARSER::COLLECTION) ("MBP" . SPARSER::PROTEIN)
    ("GST-MIB1" . SPARSER::COLLECTION) ("MIB1/BLM" . SPARSER::COLLECTION)
    ("BLM-associated proteins" . SPARSER::PROTEIN) ("Ligase" . SPARSER::LIGASE)
    ("SCE or BLM" . SPARSER::COLLECTION) ("hydroxyurea" . SPARSER::DRUG)
    ("NEK11, CDC7 and CDK2" . SPARSER::COLLECTION)
    ("p-BLM" . SPARSER::COLLECTION) ("GST-TopBP1-BRCT5" . SPARSER::COLLECTION)
    ("BRCT5" . SPARSER::PROTEIN) ("BLM/TopBP1" . SPARSER::COLLECTION)
    ("BLM and TopBP1" . SPARSER::COLLECTION)
    ("TopBP1-BRCT5" . SPARSER::PROTEIN-PAIR)
    ("TOP3A and RMI1" . SPARSER::COLLECTION)
    ("TopBP1 and BLM" . SPARSER::COLLECTION) ("SFB-BLM" . SPARSER::COLLECTION)
    ("GST-TopBP1" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("TopBP1/BLM" . SPARSER::COLLECTION) ("SFB" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("the major TopBP1-associated protein" . SPARSER::PROTEIN)
    ("a major TopBP1-associated protein" . SPARSER::PROTEIN)
    ("streptavidin" . SPARSER::PROTEIN) ("ATR-ATRIP" . SPARSER::COLLECTION)
    ("ATRIP" . SPARSER::PROTEIN) ("53BP1 and ATM" . SPARSER::COLLECTION)
    ("Treslin/ticrr" . SPARSER::COLLECTION) ("ticrr" . SPARSER::PROTEIN)
    ("Treslin" . SPARSER::PROTEIN) ("AAD" . SPARSER::MOLECULE)
    ("phosphopeptide" . SPARSER::PROTEIN)
    ("an un-degradable BLM mutant" . SPARSER::MUTANT)
    ("SCE" . SPARSER::PROTEIN)
    ("TopBP1 and Bloom syndrome helicase (BLM)" . SPARSER::COLLECTION)
    ("helicase (BLM)" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("RMI1" . SPARSER::PROTEIN) ("TOP3A" . SPARSER::PROTEIN)
    ("Glutathione-S-transferase" . SPARSER::PROTEIN)
    ("RNAse A" . SPARSER::PROTEIN) ("NEK11" . SPARSER::PROTEIN)
    ("UBCH5c" . SPARSER::PROTEIN) ("S-protein" . SPARSER::PROTEIN)
    ("anti–β" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|) ("MIB1" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN)
    ("brainstem (54%) and non-brainstem (45%) pediatric GGs"
     . SPARSER::COLLECTION)
    ("our pediatric brainstem GG cohort" . SPARSER::MOLECULE)
    ("pediatric brainstem GGs withBRAF V600E" . SPARSER::PROTEIN)
    ("parietal and occipital lobes" . SPARSER::PROTEIN)
    ("the frontal lobe" . SPARSER::PROTEIN)
    ("the temporal lobe" . SPARSER::PROTEIN) ("GGs" . SPARSER::PROTEIN)
    ("GG" . SPARSER::PROTEIN) ("brainstem" . SPARSER::PROTEIN)
    ("brainstem GG" . SPARSER::PROTEIN) ("definitive BRAF" . SPARSER::PROTEIN)
    ("occasional examples" . SPARSER::EXAMPLE) ("vinblastine" . SPARSER::DRUG)
    ("vincristine" . SPARSER::DRUG)
    ("Pediatric brainstem PA" . SPARSER::PROTEIN)
    ("vemurafinib" . SPARSER::DRUG)
    ("prepronociceptin (PNOC)" . SPARSER::PROTEIN) ("PNOC" . SPARSER::PROTEIN)
    ("prepronociceptin" . SPARSER::PROTEIN) ("neuropeptide" . SPARSER::PROTEIN)
    ("PLX4720" . SPARSER::DRUG) ("neuron-specific enolase" . SPARSER::PROTEIN)
    ("H3F3A" . SPARSER::PROTEIN) ("MV" . SPARSER::PROTEIN)
    ("Cystathionine" . SPARSER::MOLECULE)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("the chemotherapeutic agents etoposide" . SPARSER::DRUG)
    ("Ets-1, Nrf2, and HIF-1α" . SPARSER::COLLECTION)
    ("xCT and glutathione peroxidase" . SPARSER::COLLECTION)
    ("Ets-1 and GPX-1" . SPARSER::COLLECTION)
    ("xCT and GPX-1" . SPARSER::COLLECTION)
    ("HIF-1α, xCT, GPX-1, and GPX-2" . SPARSER::COLLECTION)
    ("HIF-1α and GPX-2" . SPARSER::COLLECTION)
    ("HIF-1α, xCT, and GPX-2" . SPARSER::COLLECTION)
    ("HIF-1α, xCT, and GPX-1" . SPARSER::COLLECTION)
    ("GPX-1" . SPARSER::COLLECTION) ("Total cellular GSH" . SPARSER::DRUG)
    ("Sulfasalazine" . SPARSER::DRUG) ("cystathionine" . SPARSER::MOLECULE)
    ("PPG" . SPARSER::PROTEIN) ("xCT" . SPARSER::PROTEIN)
    ("Quantitative total GSH" . SPARSER::DRUG) ("-H 2 DCFDA" . SPARSER::DRUG)
    ("GSH, and GPX" . SPARSER::COLLECTION)
    ("GSH and GPX" . SPARSER::COLLECTION)
    ("intracellular cysteine" . SPARSER::AMINO-ACID)
    ("cystine" . SPARSER::MOLECULE) ("antiporter" . SPARSER::PROTEIN)
    ("GSH and glutathione peroxidase" . SPARSER::COLLECTION)
    ("glutathione (GSH)" . SPARSER::DRUG) ("thiol" . SPARSER::MOLECULE)
    ("v-ets" . SPARSER::COLLECTION) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and Akt" . SPARSER::COLLECTION)
    ("Cisplatin and other platinum drugs" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG)
    ("a largely incurable state" . SPARSER::BIO-STATE)
    ("sulfasalazine" . SPARSER::DRUG) ("GPX" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("Glutathione peroxidase" . SPARSER::PROTEIN)
    ("L-glutamate" . SPARSER::MOLECULE) ("GPX2" . SPARSER::PROTEIN)
    ("GPX1" . SPARSER::PROTEIN) ("Glucose oxidase" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("Ets1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN)
    ("transporter activity" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN) ("Ets-1" . SPARSER::PROTEIN)
    ("cytometry and NFAT" . SPARSER::COLLECTION) ("KS" . SPARSER::PROTEIN)
    ("KP" . SPARSER::PROTEIN) ("EO" . SPARSER::PROTEIN)
    ("The latter proteins" . SPARSER::PROTEIN)
    ("the viral protein" . SPARSER::PROTEIN)
    ("mutants or variants" . SPARSER::COLLECTION)
    ("CD4/CD8" . SPARSER::COLLECTION)
    ("the positional homology" . SPARSER::PROTEIN)
    ("P104A/P107A" . SPARSER::PROTEIN)
    ("newly developed mutants" . SPARSER::MUTANT) ("TRG" . SPARSER::PROTEIN)
    ("CD4, CD8β or MHC-I" . SPARSER::COLLECTION)
    ("CD4 and MHC-I" . SPARSER::COLLECTION)
    ("peripheral CD4 + T-cell" . SPARSER::PROTEIN)
    ("CD3 and CXCR4" . SPARSER::COLLECTION)
    ("CD3 or CXCR4" . SPARSER::COLLECTION)
    ("highly diverse primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("PAK2 and CD3" . SPARSER::COLLECTION)
    ("CD4, CD28 and MHC-I" . SPARSER::COLLECTION)
    ("two previously described SIVmac Nef deletion mutants" . SPARSER::MUTANT)
    ("SIVmac" . SPARSER::PROTEIN)
    ("their positional homology" . SPARSER::PROTEIN)
    ("other lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("CD3 or CD4" . SPARSER::COLLECTION)
    ("AU1-tagged SF2 Nef proteins" . SPARSER::PROTEIN)
    ("CD4 and CD3" . SPARSER::COLLECTION) ("TGRs" . SPARSER::PROTEIN)
    ("the relevant human proteins" . SPARSER::PROTEIN)
    ("The latter protein" . SPARSER::PROTEIN)
    ("valine-glycine-phenylalanine" . SPARSER::COLLECTION)
    ("VGF" . SPARSER::PROTEIN) ("valine" . SPARSER::AMINO-ACID)
    ("TGR" . SPARSER::PROTEIN) ("CD4 and CD8β" . SPARSER::COLLECTION)
    ("a single bicistronic mRNA" . SPARSER::PROTEIN)
    ("eGFP" . SPARSER::PROTEIN)
    ("other primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("CXCR4 and CD28" . SPARSER::COLLECTION)
    ("CD4, CD8β, CD28, MHC-I and CXCR4" . SPARSER::COLLECTION)
    ("The accessory viral protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("previously described mutants" . SPARSER::MUTANT)
    ("highly divergent lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("all primate lentiviral genomes" . SPARSER::PROTEIN)
    ("Enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("IL-7" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("SDF1" . SPARSER::PROTEIN) ("P107" . SPARSER::PROTEIN)
    ("TGR 1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("noticeable upregulated PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNMs" . SPARSER::MOLECULE) ("HER-2 and EGFR" . SPARSER::COLLECTION)
    ("HER-2 or EGFR" . SPARSER::COLLECTION)
    ("targets and biomarkers" . SPARSER::COLLECTION)
    ("cancer biomarkers and therapeutic targets" . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("a targetable molecule" . SPARSER::MOLECULE)
    ("PAK1/HER-2/EGFR" . SPARSER::COLLECTION)
    ("PAK1 and PCNA" . SPARSER::COLLECTION)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("Protein and RNA" . SPARSER::COLLECTION)
    ("PAK1 and HER-2" . SPARSER::COLLECTION)
    ("HER-2, PI3K, SRC, MAP2K4, MEK2 and NCK" . SPARSER::COLLECTION)
    ("EGFR and HER-2" . SPARSER::COLLECTION) ("NCK" . SPARSER::PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN)
    ("Rho, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("the evolutionary conserved family" . SPARSER::PROTEIN-FAMILY)
    ("targets and anti-cancer" . SPARSER::COLLECTION)
    ("an oncogene and drugable protein kinase" . SPARSER::COLLECTION)
    ("drugable protein kinase" . SPARSER::KINASE) ("T1–2" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("MAP2K4" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN)
    ("HIF2α, PHD3 and MYC" . SPARSER::COLLECTION)
    ("OCT4, NANOG and SOX2" . SPARSER::COLLECTION)
    ("PAX6 , FLRT3 and MSX2" . SPARSER::COLLECTION)
    ("GATA4, GATA6, CDX2 or CGA" . SPARSER::COLLECTION)
    ("GATA4 and GATA6" . SPARSER::COLLECTION)
    ("CDX2 and CGA" . SPARSER::COLLECTION) ("CGA" . SPARSER::PROTEIN)
    ("lentiviral sh-RNAs" . SPARSER::RNA) ("MYC/MAX" . SPARSER::COLLECTION)
    ("MAX" . SPARSER::PROTEIN) ("OCT4 , SOX2 or NANOG" . SPARSER::COLLECTION)
    ("PHD1 and PHD3" . SPARSER::COLLECTION) ("PHDs" . SPARSER::PROTEIN)
    ("clearly more efficient regulator" . SPARSER::REGULATOR)
    ("Hif" . SPARSER::PROTEIN-FAMILY)
    ("a decreased pluripotent state" . SPARSER::BIO-STATE)
    ("OCT4, SOX2 and NANOG" . SPARSER::COLLECTION)
    ("HIF1α and HIF2α" . SPARSER::COLLECTION)
    ("chemical hypoxia mimetic CoCl 2" . SPARSER::MOLECULE)
    ("hypoxia and normoxia" . SPARSER::COLLECTION) ("Blot" . SPARSER::PROTEIN)
    ("OCT4 and NANOG" . SPARSER::COLLECTION)
    ("OCT4 , NANOG and SOX2" . SPARSER::COLLECTION)
    ("A2B5 and SSEA-1" . SPARSER::COLLECTION)
    ("EGLN3 (PHD3) and GLUT1" . SPARSER::COLLECTION)
    ("PHD2 and PHD3" . SPARSER::COLLECTION)
    ("ambient oxygen" . SPARSER::MOLECULE)
    ("normoxia (21% O 2 ) and hypoxia (4% O 2 )" . SPARSER::COLLECTION)
    ("the pluripotent state" . SPARSER::BIO-STATE)
    ("a pleiotropic transcription factor" . SPARSER::PROTEIN)
    ("cellular oxygen" . SPARSER::MOLECULE) ("PHD1–3" . SPARSER::COLLECTION)
    ("prolyl" . SPARSER::PROTEIN) ("pVHL" . SPARSER::PROTEIN)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("HIFs" . SPARSER::PROTEIN)
    ("enhanced pluripotent state" . SPARSER::BIO-STATE)
    ("continuous hypoxia" . SPARSER::PROTEIN) ("SSEA" . SPARSER::PROTEIN)
    ("regulated kinase 1" . SPARSER::PROTEIN) ("GATA6" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("sh-RNAs" . SPARSER::RNA)
    ("NF-KappaB" . SPARSER::PROTEIN) ("HIF-2α" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("FLRT3" . SPARSER::PROTEIN)
    ("MSX2" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("LEFTY2" . SPARSER::PROTEIN) ("HEY2" . SPARSER::PROTEIN)
    ("INSIG2" . SPARSER::PROTEIN) ("DEC1" . SPARSER::PROTEIN)
    ("BHLHE40" . SPARSER::PROTEIN) ("PFKFB4" . SPARSER::PROTEIN)
    ("SSEA-1" . SPARSER::PROTEIN) ("A2B5" . SPARSER::DRUG)
    ("TRA-1" . SPARSER::PROTEIN) ("TRA-2" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN) ("EGLN3" . SPARSER::PROTEIN)
    ("PHD3" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("l-glutamine" . SPARSER::MOLECULE) ("PHD1" . SPARSER::PROTEIN)
    ("Von Hippel-Lindau" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("PI3K-AKT and MAPK" . SPARSER::COLLECTION)
    ("heregulin and anisomycin" . SPARSER::COLLECTION)
    ("anisomycin" . SPARSER::DRUG)
    ("high PUMA (either ≥150 H-Score or ≥100 H-Score) or low PUMA (either <150 H-Score or <100 H-Score)"
     . SPARSER::COLLECTION)
    ("TM-PUMA protein" . SPARSER::COLLECTION)
    ("PUMA or TM-PUMA" . SPARSER::COLLECTION)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("a triple mutant PUMA" . SPARSER::PROTEIN)
    ("Phenylalanine" . SPARSER::AMINO-ACID) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("pulldown" . SPARSER::PROTEIN)
    ("commercially available purified recombinant PUMA and HER2 proteins"
     . SPARSER::PROTEIN)
    ("p-HER2" . SPARSER::COLLECTION) ("ME and NME" . SPARSER::COLLECTION)
    ("α-tubulin and COX IV" . SPARSER::COLLECTION) ("ME" . SPARSER::PROTEIN)
    ("PUMA and HER2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("lapatinib" . SPARSER::DRUG) ("obvious ligands" . SPARSER::LIGAND)
    ("HER2 and Bad or Bmf" . SPARSER::COLLECTION)
    ("Bad or Bmf" . SPARSER::COLLECTION) ("Bmf" . SPARSER::PROTEIN)
    ("pro-apoptotic proteins Bax/Bak" . SPARSER::COLLECTION)
    ("Bax/Bak" . SPARSER::COLLECTION) ("MOMP" . SPARSER::PROTEIN)
    ("PI3K-AKT and ERK1/2" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-xL, Mcl-1, and Bcl-2" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN) ("HER2-PUMA" . SPARSER::COLLECTION)
    ("HER2 and PUMA" . SPARSER::COLLECTION) ("TM-PUMA" . SPARSER::COLLECTION)
    ("HER2 and p53" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("IKK1" . SPARSER::PROTEIN)
    ("kinase-1" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("s 5a" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("PUMA protein" . SPARSER::PROTEIN)
    ("MMP9 and MMP2" . SPARSER::COLLECTION) ("Shi" . SPARSER::PROTEIN)
    ("Antagonists" . SPARSER::MOLECULE) ("NES" . SPARSER::PROTEIN)
    ("-Luc" . SPARSER::COLLECTION) ("pcmv-MDM2" . SPARSER::COLLECTION)
    ("MDM2 and MMP9" . SPARSER::COLLECTION) ("collagenase" . SPARSER::PROTEIN)
    ("endopeptidases" . SPARSER::PROTEIN) ("MDM2-siRNA" . SPARSER::COLLECTION)
    ("MDM2, or MDM2" . SPARSER::COLLECTION)
    ("MMP9 and MDM2" . SPARSER::COLLECTION) ("KLF8" . SPARSER::PROTEIN)
    ("beta-arrestin" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("GAL4, p53, and VP16" . SPARSER::COLLECTION)
    ("methylated promoters" . SPARSER::PROMOTER)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("miRNA or siRNA" . SPARSER::COLLECTION)
    ("mRNA, and perhaps" . SPARSER::COLLECTION)
    ("β-tubulin (cytosolic) and RARα (nuclear)" . SPARSER::COLLECTION)
    ("LNCaP and CWR-22Rv1" . SPARSER::COLLECTION)
    ("p21 proteins ( xref ) and mRNAs ( xref )" . SPARSER::COLLECTION)
    ("survivin and p21" . SPARSER::COLLECTION) ("RV" . SPARSER::MOLECULE)
    ("mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("sGCα1 mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("p53, and Mdm2" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("Mdm2 and EP300" . SPARSER::COLLECTION)
    ("p27/kip-1" . SPARSER::COLLECTION) ("ions" . SPARSER::MOLECULE)
    ("ZNF" . SPARSER::PROTEIN) ("p53 and PTEN" . SPARSER::COLLECTION)
    ("PI3-AKT" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("p53 and p300 or CBP" . SPARSER::COLLECTION)
    ("p300 or CBP" . SPARSER::COLLECTION) ("p21/CIP1" . SPARSER::COLLECTION)
    ("sGC" . SPARSER::PROTEIN) ("VP16" . SPARSER::DRUG)
    ("GAL4" . SPARSER::PROTEIN) ("UHRF1" . SPARSER::PROTEIN)
    ("B-p" . SPARSER::PROTEIN) ("Nutlin-3A" . SPARSER::DRUG)
    ("Nutlin 3A" . SPARSER::DRUG) ("β-tubulin" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("RARα" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("ZNF307" . SPARSER::PROTEIN) ("ZNF668" . SPARSER::PROTEIN)
    ("ZNF306" . SPARSER::PROTEIN) ("ZKSCAN3" . SPARSER::PROTEIN)
    ("kip-1" . SPARSER::PROTEIN) ("ZNF23" . SPARSER::PROTEIN)
    ("C 2 H 2" . SPARSER::MOLECULE) ("GUCY1A3" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("NKX3.1" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("Zinc Finger" . SPARSER::PROTEIN)
    ("intraglomerular Th1/Th2 transcription factors T-bet/GATA3"
     . SPARSER::COLLECTION)
    ("this special type" . TYPE)
    ("PTC ( P = 0.052) and glomerulitis ( P < 0.001)" . SPARSER::COLLECTION)
    ("I/II" . SPARSER::PROTEIN) ("prednisolone" . SPARSER::DRUG)
    ("MMF" . SPARSER::DRUG)
    ("panel-reactive antibodies (PRA)" . SPARSER::ANTIBODY)
    ("PRA" . SPARSER::PROTEIN)
    ("intraglomerular T-bet/GATA3" . SPARSER::COLLECTION)
    ("intraglomerular T-bet" . SPARSER::PROTEIN)
    ("new strong immunosuppressants" . SPARSER::DRUG)
    ("immunosuppressants" . SPARSER::DRUG)
    ("antibodies and glomerulitis" . SPARSER::COLLECTION)
    ("HLA-I/II" . SPARSER::COLLECTION)
    ("Both intraglomerular T-bet-" . SPARSER::PROTEIN)
    ("T-bet-" . SPARSER::PROTEIN) ("T-bet and GATA3" . SPARSER::COLLECTION)
    ("intraglomerular T-bet or GATA3" . SPARSER::COLLECTION)
    ("T-bet or GATA3" . SPARSER::COLLECTION)
    ("T-bet/GATA3" . SPARSER::COLLECTION)
    ("mycophenolate mofetil" . SPARSER::DRUG) ("T-bet" . SPARSER::PROTEIN)
    ("Nrf2/Jdp2/MafK" . SPARSER::COLLECTION)
    ("JDP2–MafK" . SPARSER::COLLECTION)
    ("genes and enzymes" . SPARSER::COLLECTION)
    ("Jdp2 and MafK" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("previously identified Nrf2 target genes" . SPARSER::GENE)
    ("such a tripartite complex" . SPARSER::BIO-COMPLEX)
    ("MafK, Nrf2 and Jdp2" . SPARSER::COLLECTION)
    ("promoter and TPA" . SPARSER::COLLECTION)
    ("Jdp2, MafK and Nrf2" . SPARSER::COLLECTION)
    ("HO-1 or NQO1" . SPARSER::COLLECTION)
    ("NQO1 and HO-1" . SPARSER::COLLECTION)
    ("Nrf2 or MafK" . SPARSER::COLLECTION)
    ("proteins–Nrf2" . SPARSER::COLLECTION)
    ("ROS and 8-oxo-dGuo" . SPARSER::COLLECTION)
    ("MafK, Jdp2 and Nrf2" . SPARSER::COLLECTION)
    ("Jdp2 and Nrf2" . SPARSER::COLLECTION)
    ("MEFs, MafK and Nrf2" . SPARSER::COLLECTION) ("Txnrd1" . SPARSER::PROTEIN)
    ("Gclm" . SPARSER::PROTEIN) ("Gclc" . SPARSER::PROTEIN)
    ("the Nrf2-responsive gene family and the JDP2 target gene family"
     . SPARSER::COLLECTION)
    ("a triple complex" . SPARSER::BIO-COMPLEX)
    ("JDP2-Nrf2" . SPARSER::COLLECTION) ("MafK-Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and MafK, Nrf2 and JDP2, and JDP2 and MafK" . SPARSER::COLLECTION)
    ("MafK, Nrf2 and JDP2, and JDP2 and MafK" . SPARSER::COLLECTION)
    ("JDP2, and JDP2 and MafK" . SPARSER::COLLECTION)
    ("the respective antibodies" . SPARSER::ANTIBODY)
    ("Nrf2, JDP2 and MafK" . SPARSER::COLLECTION)
    ("Nrf2 (lane 3) or MafK (lane 4)" . SPARSER::COLLECTION)
    ("JDP2 (lane 2), Nrf2 (lane 3) or MafK (lane 4)" . SPARSER::COLLECTION)
    ("Nrf2, MafK and JDP2" . SPARSER::COLLECTION)
    ("-TGACTCAGC-3" . SPARSER::COLLECTION)
    ("JDP2 ( xref ; lanes 1 and 4–6) or JDP2/MafK (lanes 10–15)"
     . SPARSER::COLLECTION)
    ("JDP2/MafK" . SPARSER::COLLECTION) ("JDP2 or MafK" . SPARSER::COLLECTION)
    ("JDP2 and MafK" . SPARSER::COLLECTION)
    ("JDP2 and Nrf2" . SPARSER::COLLECTION)
    ("JDP2 or Nrf2" . SPARSER::COLLECTION) ("GST–Nrf2" . SPARSER::COLLECTION)
    ("GST–MafK" . SPARSER::COLLECTION) ("MafK or Nrf2" . SPARSER::COLLECTION)
    ("MafK and Nrf2" . SPARSER::COLLECTION)
    ("IVT–protein" . SPARSER::COLLECTION) ("GST–protein" . SPARSER::COLLECTION)
    ("JDP2, MafK and Nrf2" . SPARSER::COLLECTION) ("ZIP" . SPARSER::PROTEIN)
    ("-fused" . SPARSER::COLLECTION) ("TPA and SFN" . SPARSER::COLLECTION)
    ("the respective endogenous protein" . SPARSER::PROTEIN)
    ("nonspecific siRNA" . SPARSER::PROTEIN)
    ("KD or Jdp2" . SPARSER::COLLECTION)
    ("Nrf2 and Jdp2" . SPARSER::COLLECTION)
    ("Nrf2 or Jdp2" . SPARSER::COLLECTION)
    ("MEFs and Jdp2" . SPARSER::COLLECTION)
    ("the key transcription factor" . SPARSER::PROTEIN)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("the key components involved in controlling ROS level"
     . SPARSER::COMPONENT)
    ("protein and NAD(P)H" . SPARSER::COLLECTION)
    ("MEFs, and TPA" . SPARSER::COLLECTION)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("tBHQ" . SPARSER::DRUG)
    ("SFN" . SPARSER::PROTEIN) ("sulforaphane" . SPARSER::DRUG)
    ("Antioxidant" . SPARSER::PROTEIN) ("GSSG" . SPARSER::DRUG)
    ("GSH" . SPARSER::DRUG) ("TPA" . SPARSER::DRUG)
    ("Jdp2 KO and WT MEFs ( xref )" . SPARSER::COLLECTION)
    ("the stress-induced AP-1 protein family" . SPARSER::PROTEIN-FAMILY)
    ("ROS and electrophiles" . SPARSER::COLLECTION)
    ("a basic zipper region (bZIP) repressor protein" . SPARSER::PROTEIN)
    ("AP-1 and CRE" . SPARSER::COLLECTION)
    ("cyclin A2 and p53" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("MafG, MafK or MafF" . SPARSER::COLLECTION) ("MafF" . SPARSER::PROTEIN)
    ("MafG" . SPARSER::PROTEIN) ("–electrophile" . SPARSER::MOLECULE)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("electrophile" . SPARSER::MOLECULE) ("electrophiles" . SPARSER::MOLECULE)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("jagged 1 and NAD(P)H" . SPARSER::COLLECTION)
    ("oxygenase-1" . SPARSER::COLLECTION) ("quinone" . SPARSER::MOLECULE)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("oxidative stress-inducing reagents" . SPARSER::MOLECULE)
    ("Jdp2" . SPARSER::PROTEIN) ("Nrf2 and MafK" . SPARSER::COLLECTION)
    ("Nrf2–MafK" . SPARSER::COLLECTION) ("MafK" . SPARSER::PROTEIN)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TOPRO-3" . SPARSER::MOLECULE)
    ("pGL4" . SPARSER::PROTEIN) ("H 2 DCFDA" . SPARSER::DRUG)
    ("C-16" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("NQO2" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("thioredoxin reductase 1, cytoplasmic" . SPARSER::PROTEIN)
    ("Jag1" . SPARSER::PROTEIN)
    ("glutamate–cysteine ligase catalytic subunit" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("jagged 1" . SPARSER::PROTEIN)
    ("glutamate–cysteine ligase" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("JDP2" . SPARSER::PROTEIN)
    ("Jun dimerization protein 2" . SPARSER::PROTEIN)
    ("TES" . SPARSER::PROTEIN) ("GT" . SPARSER::PROTEIN)
    ("LT" . SPARSER::PROTEIN) ("PN" . SPARSER::PROTEIN)
    ("an HIV-1 accessory protein" . SPARSER::PROTEIN)
    ("the HIV-1 accessory protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral reverse transcriptase, integrase and protease"
     . SPARSER::COLLECTION)
    ("reverse transcriptase, integrase and protease" . SPARSER::COLLECTION)
    ("Zap70" . SPARSER::PROTEIN) ("Hck, c-Src or Lyn" . SPARSER::COLLECTION)
    ("Zap-70 or Syk" . SPARSER::COLLECTION)
    ("Hck and Zap-70" . SPARSER::COLLECTION)
    ("the HIV-1 accessory protein" . SPARSER::PROTEIN)
    ("a unique antagonist" . SPARSER::MOLECULE)
    ("U87MG/CD4/CXCR4" . SPARSER::COLLECTION) ("DLC" . SPARSER::PROTEIN)
    ("Dasatinib" . SPARSER::DRUG) ("melt" . SPARSER::DRUG)
    ("Zap-70 or Hck" . SPARSER::COLLECTION)
    ("Hck and p85" . SPARSER::COLLECTION) ("associated Hck" . SPARSER::PROTEIN)
    ("Syk/Zap-70" . SPARSER::COLLECTION)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("resazurin" . SPARSER::DRUG) ("an intact viral nef gene" . SPARSER::GENE)
    ("CD4 and CXCR4" . SPARSER::COLLECTION) ("Nef:Hck" . SPARSER::PROTEIN)
    ("a potent inhibitor of Hck and other SFKs [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("pyrrolopyrimidine" . SPARSER::DRUG)
    ("Nef:Hck-YEEI" . SPARSER::COLLECTION)
    ("Hck and Lyn" . SPARSER::COLLECTION)
    ("Tyr-Glu-Glu-Ile" . SPARSER::COLLECTION)
    ("Hck, Lyn, and c-Src" . SPARSER::COLLECTION)
    ("Hck-YEEI" . SPARSER::COLLECTION) ("YEEI" . SPARSER::PROTEIN)
    ("antiretroviral drugs" . SPARSER::DRUG)
    ("powerful adjuvants" . SPARSER::DRUG)
    ("The active Nef:Hck complex" . SPARSER::BIO-COMPLEX)
    ("hck" . SPARSER::PROTEIN) ("Hck, Lyn or c-Src" . SPARSER::COLLECTION)
    ("the HIV-1 Nef accessory protein" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN)
    ("Hck and other Src-family tyrosine kinases" . SPARSER::COLLECTION)
    ("a viral accessory protein" . SPARSER::PROTEIN)
    ("ClN 4" . SPARSER::PROTEIN) ("p40" . SPARSER::PROTEIN)
    ("p55" . SPARSER::PROTEIN) ("Gag proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein-G" . SPARSER::PROTEIN) ("Gag protein" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("Gal1" . SPARSER::PROTEIN)
    ("pYC2" . SPARSER::PROTEIN) ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("non-selective" . SPARSER::PROTEIN) ("PACS-2" . SPARSER::PROTEIN)
    ("clathrin adaptor protein" . SPARSER::PROTEIN)
    ("Zap-70" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("A-419259" . SPARSER::DRUG)
    ("P 72" . SPARSER::PROTEIN) ("IB" . SPARSER::DRUG)
    ("Reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("enzyme, p110α and p85α" . SPARSER::COLLECTION)
    ("inhibitors or inhibitors" . SPARSER::COLLECTION)
    ("EGFR, AKT3, PTEN and WEE1" . SPARSER::COLLECTION)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("ERα, PR, and ERBB2" . SPARSER::COLLECTION)
    ("HR- and ERBB2+" . SPARSER::COLLECTION)
    ("PIK3CA , PIK3R1 or AKT1" . SPARSER::COLLECTION)
    ("PIK3R1 and PTEN" . SPARSER::COLLECTION)
    ("P70S6K and AKT1" . SPARSER::COLLECTION)
    ("only one AKT1" . SPARSER::PROTEIN)
    ("hormone and ERBB2" . SPARSER::COLLECTION)
    ("PIK3CA and/or PIK3R1" . SPARSER::COLLECTION)
    ("PIK3CA/PIK3R1" . SPARSER::COLLECTION) ("ERBB2-" . SPARSER::PROTEIN)
    ("both exon 9 and exon 20" . SPARSER::COLLECTION)
    ("PTEN and p85" . SPARSER::COLLECTION)
    ("EGFR , PDK1 , PTEN , AKT1 , AKT2, AKT3, GOLPH3 , P70S6K , and WEE1"
     . SPARSER::COLLECTION)
    ("PIK3CA , PIK3R1 and AKT1" . SPARSER::COLLECTION)
    ("the two genes encoding PI3K subunits and their role in PI3K pathway deregulation and patient survival"
     . SPARSER::COLLECTION)
    ("P70S6K as well as other targets such as GSK3, WEE1 or BAD"
     . SPARSER::COLLECTION)
    ("GSK3, WEE1 or BAD" . SPARSER::COLLECTION)
    ("PIK3CA, PIK3R1 and AKT1" . SPARSER::COLLECTION)
    ("PIK3CA and PIK3R1 genes and additional PI3K pathway-associated genes"
     . SPARSER::COLLECTION)
    ("additional PI3K pathway-associated genes" . SPARSER::GENE)
    ("PIK3CA and PIK3R1" . SPARSER::COLLECTION)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("regulatory subunit 1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chi 2" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("PIK3R3" . SPARSER::PROTEIN) ("PIK3R2" . SPARSER::PROTEIN)
    ("PIK3CG" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("PIK3CB" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("P70S6K" . SPARSER::PROTEIN) ("WEE1" . SPARSER::PROTEIN)
    ("GOLPH3" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN)
    ("MKK, DKL, KDL, HSL, SWK and ENL" . SPARSER::COLLECTION)
    ("ENL" . SPARSER::PROTEIN) ("HSL" . SPARSER::PROTEIN)
    ("JCH" . SPARSER::PROTEIN) ("PNA" . SPARSER::PROTEIN)
    ("iodine" . SPARSER::MOLECULE)
    ("RAS/RAF/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("loco" . SPARSER::PROTEIN)
    ("the low-risk well-differentiated PTC group" . SPARSER::MOLECULE)
    ("T4a" . SPARSER::PROTEIN) ("allele and ppxx" . SPARSER::COLLECTION)
    ("PvuII allelic variants" . SPARSER::VARIANT)
    ("PP or pp" . SPARSER::COLLECTION) ("PP or Pp" . SPARSER::COLLECTION)
    ("ESR1 variants and spontaneous abortion" . SPARSER::COLLECTION)
    ("the fetal genome" . SPARSER::PROTEIN) ("ESR" . SPARSER::PROTEIN)
    ("PP, pp , and Pp" . SPARSER::COLLECTION)
    ("PP, pp , and PpI" . SPARSER::COLLECTION) ("fetuses" . SPARSER::PROTEIN)
    ("human fetal genome" . SPARSER::PROTEIN)
    ("an extremely polymorphic gene" . SPARSER::GENE)
    ("numerous polymorphic variants" . SPARSER::VARIANT)
    ("an unintentional end of pregnancy" . SPARSER::PROTEIN)
    ("ER α and ER β" . SPARSER::COLLECTION)
    ("ESR1 and ESR2" . SPARSER::COLLECTION)
    ("placental estrogen" . SPARSER::MOLECULE)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("group B" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN)
    ("human healthy retina" . SPARSER::DRUG)
    ("retinal VEGF" . SPARSER::PROTEIN)
    ("VEGF-A, Otx2, p53, and p63 and Otx1 and Otx3" . SPARSER::COLLECTION)
    ("p63 and Otx1 and Otx3" . SPARSER::COLLECTION)
    ("intravitreal ranibizumab" . SPARSER::DRUG)
    ("ranibizumab" . SPARSER::DRUG) ("very severe PVR" . SPARSER::PROTEIN)
    ("Otx1, Otx2, and Otx3" . SPARSER::COLLECTION)
    ("the internal part" . SPARSER::COMPONENT)
    ("more severe PVR" . SPARSER::PROTEIN)
    ("VEGF-A, Otx2, p5, and p63" . SPARSER::COLLECTION)
    ("a very severe PVR" . SPARSER::PROTEIN)
    ("VEGF-A and p53 family" . SPARSER::COLLECTION)
    ("VEGF-A, Otx1, Otx2, Otx3, p53, and p63" . SPARSER::COLLECTION)
    ("perinatal" . SPARSER::PROTEIN) ("fish" . SPARSER::PROTEIN)
    ("Otx2, p53, and p63" . SPARSER::COLLECTION)
    ("VEGF-A, p53, and p63" . SPARSER::COLLECTION)
    ("VEGF-A, Otx2, and p63" . SPARSER::COLLECTION)
    ("VEGF-A, Otx2, and p53" . SPARSER::COLLECTION)
    ("the rostral part" . SPARSER::COMPONENT) ("OTX" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("VEGF-A, Otx2, p53, p63 and Otx1 and Otx3" . SPARSER::COLLECTION)
    ("p53 family, and VEGF-A" . SPARSER::COLLECTION)
    ("VEGF-A, Otx2, p53, and p63" . SPARSER::COLLECTION)
    ("Otx1 and Otx3" . SPARSER::COLLECTION)
    ("VEGF-A, Otx2, Otx3, p53, and p63" . SPARSER::COLLECTION)
    ("VEGF-A, Otx1, Otx2, Otx3, and p53 family" . SPARSER::COLLECTION)
    ("PVR" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("beta-actin" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("Otx3" . SPARSER::PROTEIN) ("Otx2" . SPARSER::PROTEIN)
    ("Otx1" . SPARSER::PROTEIN)
    ("a universal negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("the related proteins Lyn and IgM-BCR ( xref )" . SPARSER::COLLECTION)
    ("both Lck and the TCR/CD4 complex" . SPARSER::COLLECTION)
    ("IgM-BCR" . SPARSER::COLLECTION)
    ("BCR and Fc-epsilon" . SPARSER::COLLECTION)
    ("Fc-epsilon" . SPARSER::PROTEIN-PAIR) ("epsilon" . SPARSER::PROTEIN)
    ("BCR" . SPARSER::PROTEIN) ("LIME or Dok1" . SPARSER::COLLECTION)
    ("Dok1" . SPARSER::PROTEIN) ("Dok" . SPARSER::PROTEIN)
    ("LIME" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("PAG and Csk" . SPARSER::COLLECTION) ("PAG-Csk" . SPARSER::COLLECTION)
    ("subsequently releases Csk" . SPARSER::PROTEIN)
    ("directly binding Lck/Fyn" . SPARSER::COLLECTION)
    ("Erk1/Erk2" . SPARSER::COLLECTION) ("Lck and Fyn" . SPARSER::COLLECTION)
    ("Pyk2, cyclin-dependent kinases, Fyn, and Lck" . SPARSER::COLLECTION)
    ("both FAK and its related kinase" . SPARSER::COLLECTION)
    ("Lck/Fyn" . SPARSER::COLLECTION) ("Csk and Lck" . SPARSER::COLLECTION)
    ("Lck and Csk" . SPARSER::COLLECTION)
    ("FAK, Csk, and Lck" . SPARSER::COLLECTION) ("hyper" . SPARSER::PROTEIN)
    ("Lck and its inhibitor Csk" . SPARSER::COLLECTION)
    ("Csk and CD3" . SPARSER::COLLECTION)
    ("CD3 and/or CD4" . SPARSER::COLLECTION)
    ("FAK and Lck" . SPARSER::COLLECTION) ("FAK and Csk" . SPARSER::COLLECTION)
    ("the stimulatory anti-CD3 and anti-CD4 antibodies" . SPARSER::ANTIBODY)
    ("anti-CD3 and anti-CD4" . SPARSER::COLLECTION)
    ("membrane-associated Csk" . SPARSER::PROTEIN)
    ("fluorochromes" . SPARSER::MOLECULE)
    ("approximately 5-fold more IL-2 and approximately 2-fold more IFN-γ"
     . SPARSER::COLLECTION)
    ("approximately 2-fold more IFN-γ" . SPARSER::PROTEIN)
    ("approximately 5-fold more IL-2" . SPARSER::PROTEIN)
    ("the Luc- or FAK-specific miRNAs" . SPARSER::COLLECTION)
    ("Luc-" . SPARSER::PROTEIN)
    ("many proximal signaling molecules" . SPARSER::MOLECULE)
    ("PLC-γ1 and Pyk2" . SPARSER::COLLECTION)
    ("LAT, PLC-γ1, and SLP-76" . SPARSER::COLLECTION)
    ("LAT, SLP-76, and PLC-γ1" . SPARSER::COLLECTION)
    ("Luc and Fak" . SPARSER::COLLECTION)
    ("the stimulatory anti-TCR antibody" . SPARSER::ANTIBODY)
    ("Lck, LAT, SLP-76, PLC-γ1, or Csk" . SPARSER::COLLECTION)
    ("agonistic anti-TCR antibody" . SPARSER::ANTIBODY)
    ("the Luc or FAK-specific miRNAs" . SPARSER::COLLECTION)
    ("Lck, Csk, SLP-76, LAT, Grb2, and PLC-γ1" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("Actin" . SPARSER::PROTEIN)
    ("detergent-insoluble membrane lipid" . SPARSER::LIPID)
    ("detergent" . SPARSER::MOLECULE) ("Cbp" . SPARSER::PROTEIN)
    ("PAG" . SPARSER::PROTEIN) ("glycosphingolipid" . SPARSER::MOLECULE)
    ("PLC-γ1 and PI3K" . SPARSER::COLLECTION) ("ITAMs" . SPARSER::PROTEIN)
    ("Lck and/or Fyn" . SPARSER::COLLECTION) ("Csk" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1-4" . SPARSER::PROTEIN)
    ("Proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("PF-573228" . SPARSER::DRUG) ("CD247" . SPARSER::PROTEIN)
    ("PAG/Cbp" . SPARSER::PROTEIN) ("Csk-binding protein" . SPARSER::PROTEIN)
    ("PLC-γ1" . SPARSER::PROTEIN) ("AK" . SPARSER::PROTEIN)
    ("p38δ and AP-1" . SPARSER::COLLECTION)
    ("only p38α and p38β isoforms" . SPARSER::ISOFORM)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("p38γ and p38δ" . SPARSER::COLLECTION)
    ("p38α, p38β, p38γ and p38δ" . SPARSER::COLLECTION)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt-2 and Akt-3" . SPARSER::COLLECTION)
    ("IL-6 and TNF-α" . SPARSER::COLLECTION)
    ("Akt-2 (ser-474, thr-309) and Akt-3 (ser-472, thr-305)"
     . SPARSER::COLLECTION)
    ("Akt-1 (ser-473, thr-308), Akt-2 (ser-474, thr-309) and Akt-3 (ser-472, thr-305)"
     . SPARSER::COLLECTION)
    ("thr" . SPARSER::AMINO-ACID) ("JNK/MAPK" . SPARSER::COLLECTION)
    ("CREB (cAMP response element-binding protein), AP-1 (activator protein 1), C/EBP (CCAAT/enhancer binding protein) and IRF (interferon regulatory factor)"
     . SPARSER::COLLECTION)
    ("EBP" . SPARSER::PROTEIN)
    ("p50- and p65-specific siRNA" . SPARSER::COLLECTION)
    ("p50-" . SPARSER::PROTEIN)
    ("a ubiquitous transcription factor" . SPARSER::PROTEIN)
    ("a proinflammatory chemokine" . SPARSER::PROTEIN)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and ROS" . SPARSER::COLLECTION)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION) ("UV light" . SPARSER::PROTEIN)
    ("ethidium" . SPARSER::MOLECULE)
    ("targeted Akt-2 (3.83 ± 0.64-fold; 1,742.8 ± 82.6 pg/ml) and Akt-3 (3.54 ± 0.53-fold; 1,408.2 ± 150.8 pg/ml)"
     . SPARSER::COLLECTION)
    ("Akt-1, Akt-2 and Akt-3" . SPARSER::COLLECTION)
    ("mRNA and 48 h" . SPARSER::COLLECTION)
    ("either SP600125 (13.89 ± 0.85-fold, 2,919.9 ± 111.5 pg/ml) or SB203580 (22.89 ± 2.09-fold, 4,233.6 ± 433.3 pg/ml)"
     . SPARSER::COLLECTION)
    ("SP600125-JNK" . SPARSER::COLLECTION)
    ("p50 siRNA (540.42 ± 41.39 pg/ml) and p65 siRNA (864.32 ± 77.43 pg/ml)"
     . SPARSER::COLLECTION)
    ("both p50 siRNA (2.4 ± 0.43-fold) and p65 siRNA (3.49 ± 0.61-fold)"
     . SPARSER::COLLECTION)
    ("CCL5 and GFAP" . SPARSER::COLLECTION)
    ("GFAP- and CCL5-specific antibodies" . SPARSER::COLLECTION)
    ("GFAP-" . SPARSER::PROTEIN)
    ("a multifunctional chemokine" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages (MDM)" . SPARSER::PROTEIN)
    ("a 96-amino-acid protein" . SPARSER::PROTEIN)
    ("IL-6, IL-8 and CCL5" . SPARSER::COLLECTION)
    ("perivascular macrophages and astrocytes" . SPARSER::COLLECTION)
    ("macrophages and astrocytes" . SPARSER::COLLECTION)
    ("RANTES/CCL5" . SPARSER::COLLECTION) ("RANTES" . SPARSER::PROTEIN)
    ("neurotoxins" . SPARSER::PROTEIN) ("barrier (BBB)" . SPARSER::PROTEIN)
    ("Astrocytes" . SPARSER::PROTEIN) ("the more severe forms" . SPARSER::FORM)
    ("the perivascular macrophages and microglia" . SPARSER::COLLECTION)
    ("macrophages and microglia" . SPARSER::COLLECTION)
    ("microglia" . SPARSER::PROTEIN) ("p50 and p65" . SPARSER::COLLECTION)
    ("MAPK, Akt-2 and Akt-3, and AP-1 transcription factor"
     . SPARSER::COLLECTION)
    ("Akt-3, and AP-1 transcription factor" . SPARSER::COLLECTION)
    ("NF-κB (SC514) and PI3K/Akt (LY294002) inhibitor" . SPARSER::COLLECTION)
    ("using specific chemical inhibitors and siRNAs" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("p38 MAP kinases" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKK-2" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("D-F" . SPARSER::PROTEIN) ("G-I" . SPARSER::PROTEIN)
    ("HD2" . SPARSER::PROTEIN) ("P230" . SPARSER::PROTEIN)
    ("Akt-1" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKK-β" . SPARSER::PROTEIN) ("gp120" . SPARSER::DRUG)
    ("TGF-beta" . SPARSER::PROTEIN) ("quinolinic acid" . SPARSER::MOLECULE)
    ("Akt-3" . SPARSER::PROTEIN) ("Akt-2" . SPARSER::PROTEIN)
    ("mitochondrial glutathione" . SPARSER::DRUG)
    ("methyltransferases and histone" . SPARSER::COLLECTION)
    ("SAM and SAH" . SPARSER::COLLECTION) ("TNF or LPS" . SPARSER::COLLECTION)
    ("rolipram" . SPARSER::DRUG)
    ("SAH and enzymes that interact with these metabolites"
     . SPARSER::COLLECTION)
    ("the immediate upstream metabolite" . SPARSER::MOLECULE)
    ("A20, IκB-α and IL-8" . SPARSER::COLLECTION)
    ("A20 and IκB-α" . SPARSER::COLLECTION)
    ("a western blot" . SPARSER::PROTEIN)
    ("p65 and IκB-α" . SPARSER::COLLECTION)
    ("at least five different enzymes" . SPARSER::ENZYME)
    ("cytosolic IκB-α and nuclear p65" . SPARSER::COLLECTION)
    ("IκB-α, A20 and IL-8" . SPARSER::COLLECTION)
    ("IL-8 and A20" . SPARSER::COLLECTION)
    ("NFκB-luciferase" . SPARSER::COLLECTION)
    ("Ado or Hcy" . SPARSER::COLLECTION)
    ("the classical TNF sensitizer actinomycin D" . SPARSER::MOLECULE)
    ("Ado and Hcy" . SPARSER::COLLECTION)
    ("adenosine (Ado) and homocysteine (Hcy)" . SPARSER::COLLECTION)
    ("Hcy" . SPARSER::MOLECULE) ("Ado" . SPARSER::PROTEIN)
    ("active transcriptional complexes" . SPARSER::BIO-COMPLEX)
    ("adenosine and homocysteine" . SPARSER::COLLECTION)
    ("actinomycin D and cycloheximide" . SPARSER::COLLECTION)
    ("S-adenosylmethionine (SAM) and an increase in S-adenosylhomocysteine (SAH)"
     . SPARSER::COLLECTION)
    ("IkB" . SPARSER::PROTEIN) ("homocysteine" . SPARSER::MOLECULE)
    ("S-adenosylhomocysteine (SAH)" . SPARSER::MOLECULE)
    ("SAH" . SPARSER::MOLECULE) ("SAM" . SPARSER::MOLECULE)
    ("Hepatocytes" . SPARSER::PROTEIN)
    ("partby inflammatory cytokines" . SPARSER::PROTEIN)
    ("PDE4B" . SPARSER::PROTEIN) ("RIP-1" . SPARSER::PROTEIN)
    ("TNFAIP3" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("SAH hydrolase" . SPARSER::PROTEIN) ("IκB" . SPARSER::PROTEIN)
    ("A-12" . SPARSER::PROTEIN) ("andβ" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("IκB-α" . SPARSER::PROTEIN) ("S-adenosylhomocysteine" . SPARSER::MOLECULE)
    ("S-adenosylmethionine" . SPARSER::DRUG)
    ("p120GAP as well as NF1" . SPARSER::COLLECTION)
    ("KRas and wt" . SPARSER::COLLECTION)
    ("GEF and/or GAP" . SPARSER::COLLECTION)
    ("the most predominant forms" . SPARSER::FORM)
    ("SOS and p120GAP" . SPARSER::COLLECTION)
    ("GEFs and GAPs" . SPARSER::COLLECTION)
    ("wt HRas and G12V mutant" . SPARSER::COLLECTION)
    ("wt HRas and G13V HRas mutant (see below)" . SPARSER::COLLECTION)
    ("GAPs, p120GAP and NF1" . SPARSER::COLLECTION)
    ("SOS, RasGRF, and RasGRP" . SPARSER::COLLECTION)
    ("SOS" . SPARSER::PROTEIN) ("GNE and GTP" . SPARSER::COLLECTION)
    ("the faster Ras GNE" . SPARSER::PROTEIN)
    ("k  −2 and k  +6" . SPARSER::COLLECTION)
    ("a smaller k  −1 and a larger k  −2 ( xref )" . SPARSER::COLLECTION)
    ("a larger k  −2" . SPARSER::PROTEIN)
    ("a smaller k  −1" . SPARSER::PROTEIN)
    ("the intrinsic GNE" . SPARSER::PROTEIN)
    ("k  −1 and k  −2" . SPARSER::COLLECTION)
    ("Cdc25 and/or p120GAP" . SPARSER::COLLECTION)
    ("Cdc25 and p120GAP" . SPARSER::COLLECTION)
    ("GEF and GAP" . SPARSER::COLLECTION)
    ("Ras and its regulators" . SPARSER::COLLECTION)
    ("the listed Costello syndrome-relevant HRas mutants" . SPARSER::MUTANT)
    ("NRas and KRas" . SPARSER::COLLECTION)
    ("NKCD and SAK" . SPARSER::COLLECTION)
    ("GDP and GTP" . SPARSER::COLLECTION) ("GNE" . SPARSER::PROTEIN)
    ("RasGRP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RasGRF" . SPARSER::PROTEIN-FAMILY) ("GEFs" . SPARSER::PROTEIN)
    ("NRas" . SPARSER::PROTEIN) ("NKCD/SAK" . SPARSER::COLLECTION)
    ("HRas" . SPARSER::PROTEIN) ("SAK" . SPARSER::PROTEIN)
    ("NKCD" . SPARSER::PROTEIN) ("k  −7" . SPARSER::PROTEIN)
    ("k  −5" . SPARSER::PROTEIN) ("k  −4" . SPARSER::PROTEIN)
    ("k  −3" . SPARSER::PROTEIN) ("k  +" . SPARSER::MOLECULE)
    ("k  −2" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("k  −1" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("Mono-Q" . SPARSER::DRUG) ("mental retardation" . SPARSER::PROTEIN)
    ("neurofibromin1" . SPARSER::PROTEIN)
    ("Son of Sevenless" . SPARSER::PROTEIN) ("Ras family" . SPARSER::PROTEIN)
    ("p120GAP" . SPARSER::PROTEIN) ("Sunitinib" . SPARSER::DRUG)
    ("HRAS" . SPARSER::PROTEIN) ("SDHD" . SPARSER::PROTEIN)
    ("SDHC" . SPARSER::PROTEIN) ("SDHB" . SPARSER::PROTEIN)
    ("SDHA" . SPARSER::PROTEIN) ("group and KIT" . SPARSER::COLLECTION)
    ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor receptor alpha (PDGFRA)"
     . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor receptor alpha"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("a viral oncogene" . SPARSER::ONCOGENE)
    ("v-KIT" . SPARSER::COLLECTION) ("Cajal" . SPARSER::PROTEIN)
    ("KIT-exon" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("DOG-1" . SPARSER::PROTEIN)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("145 kD" . SPARSER::PROTEIN)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("possible effectors" . SPARSER::EFFECTOR)
    ("mangiferin and aspalathin" . SPARSER::COLLECTION)
    ("unique drug" . SPARSER::DRUG) ("Aspalathin" . SPARSER::DRUG)
    ("luteolin and apigenin" . SPARSER::COLLECTION)
    ("glycoside" . SPARSER::MOLECULE) ("apigenin" . SPARSER::DRUG)
    ("glucosidases" . SPARSER::PROTEIN) ("glycosides" . SPARSER::MOLECULE)
    ("-rutinoside" . SPARSER::MOLECULE) ("flavone" . SPARSER::DRUG)
    ("liquiritigenin and ERB-041" . SPARSER::COLLECTION)
    ("ERβ homodimers and ERα/ERβ heterodimers" . SPARSER::COLLECTION)
    ("ERα/ERβ" . SPARSER::COLLECTION)
    ("genistein and enterodiol" . SPARSER::COLLECTION)
    ("the agonist and antagonist activity of Cyclopia" . SPARSER::COLLECTION)
    ("ERE-promoter" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ER regulated genes" . SPARSER::GENE)
    ("ERβ agonists and ERα antagonists in COS-1 cells" . SPARSER::COLLECTION)
    ("ERα, and MF101" . SPARSER::COLLECTION) ("liquiritigenin" . SPARSER::DRUG)
    ("SERMs and ER" . SPARSER::COLLECTION) ("BPA" . SPARSER::PROTEIN)
    ("Bisphenol" . SPARSER::MOLECULE) ("xenoestrogen" . SPARSER::MOLECULE)
    ("an ERα agonist and an ERβ antagonist" . SPARSER::COLLECTION)
    ("antagonist and ERβ" . SPARSER::COLLECTION)
    ("bazedoxifene" . SPARSER::DRUG) ("SERMS" . SPARSER::DRUG)
    ("E 2 and genistein" . SPARSER::COLLECTION)
    ("antiestrogens" . SPARSER::DRUG)
    ("Genistein ( xref ) and enterodiol ( xref )" . SPARSER::COLLECTION)
    ("Estrogen" . SPARSER::MOLECULE)
    ("E 2 , the polyphenols, and P104" . SPARSER::COLLECTION)
    ("agonist and SM6Met" . SPARSER::COLLECTION)
    ("residual E 2" . SPARSER::MOLECULE) ("E 2 and P104" . SPARSER::COLLECTION)
    ("luteolin, enterodiol, and coumestrol" . SPARSER::COLLECTION)
    ("a pro-inflammatory transcription factor" . SPARSER::PROTEIN)
    ("genistein, luteolin, and coumestrol" . SPARSER::COLLECTION)
    ("Enterodiol" . SPARSER::MOLECULE)
    ("the pre- and post-menopausal levels of E 2" . SPARSER::COLLECTION)
    ("pre-" . SPARSER::DNA-RESPONSE-ELEMENT) ("coumestrol" . SPARSER::MOLECULE)
    ("enterodiol" . SPARSER::MOLECULE)
    ("either ERα ( xref ) or ERβ ( xref )" . SPARSER::COLLECTION)
    ("COS" . SPARSER::MOLECULE) ("Methanol" . SPARSER::MOLECULE)
    ("rutinoside" . SPARSER::MOLECULE) ("Luteolin" . SPARSER::DRUG)
    ("mangiferin and isomangiferin" . SPARSER::COLLECTION)
    ("xanthones, mangiferin and isomangiferin" . SPARSER::COLLECTION)
    ("-hexoside" . SPARSER::MOLECULE) ("hexoside" . SPARSER::MOLECULE)
    ("benzophenones" . SPARSER::DRUG) ("aspalathin" . SPARSER::DRUG)
    ("glucoside" . SPARSER::MOLECULE) ("phloretin" . SPARSER::DRUG)
    ("hesperidin" . SPARSER::MOLECULE) ("flavanones" . SPARSER::DRUG)
    ("vicenin" . SPARSER::DRUG) ("scolymoside" . SPARSER::DRUG)
    ("flavones" . SPARSER::DRUG) ("isomangiferin" . SPARSER::DRUG)
    ("mangiferin" . SPARSER::DRUG) ("xanthones" . SPARSER::DRUG)
    ("antagonists and ERβ" . SPARSER::COLLECTION) ("BUS" . SPARSER::DRUG)
    ("methanol" . SPARSER::MOLECULE)
    ("luteolin, eriodictyol, naringenin, and formononetin"
     . SPARSER::COLLECTION)
    ("formononetin" . SPARSER::DRUG) ("naringenin" . SPARSER::DRUG)
    ("eriodictyol" . SPARSER::DRUG) ("luteolin" . SPARSER::DRUG)
    ("caffeine" . SPARSER::MOLECULE) ("natural SERMs" . SPARSER::DRUG)
    ("Phytoestrogens" . SPARSER::MOLECULE)
    ("diarylpropionitrile (DPN)" . SPARSER::DRUG) ("DPN" . SPARSER::MOLECULE)
    ("diarylpropionitrile" . SPARSER::DRUG) ("MPP" . SPARSER::PROTEIN)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("SERMs, raloxifene and tamoxifen" . SPARSER::COLLECTION)
    ("raloxifene" . SPARSER::PROTEIN) ("Estrogens" . SPARSER::MOLECULE)
    ("hot" . SPARSER::PROTEIN) ("Phytoestrogen" . SPARSER::MOLECULE)
    ("pGL2" . SPARSER::PROTEIN) ("17β-Estradiol" . SPARSER::PROTEIN)
    ("SirT1" . SPARSER::PROTEIN) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("histology type and chemotherapy agent" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("Ras-MAPK" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN) ("SIRT1 " . SPARSER::PROTEIN)
    ("SIRT 3" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("SIRT 1" . SPARSER::PROTEIN) ("Sirtuin 1" . SPARSER::PROTEIN)
    ("DR and diabetic CAD risk [ xref - xref ]" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("DR and diabetic CAD" . SPARSER::COLLECTION)
    ("DR or diabetic CAD risk" . SPARSER::COLLECTION)
    ("DR (REM OR 1.09, 95% CI 0.97, 1.22) or diabetic CAD risk (REM OR 1.07, 95% CI 0.81, 1.42)"
     . SPARSER::COLLECTION)
    ("etc ." . SPARSER::PROTEIN) ("HGF or c-Met" . SPARSER::COLLECTION)
    ("HGF/c-Met" . SPARSER::COLLECTION)
    ("adverse prognostic biomarker" . SPARSER::MOLECULE)
    ("HR and 95%CI" . SPARSER::COLLECTION)
    ("antibody and MET" . SPARSER::COLLECTION)
    ("IHC and housekeeping genes" . SPARSER::GENE)
    ("performing Southern blot" . SPARSER::PROTEIN)
    ("FISH[ xref ], Southern blot[ xref ], and silver in-situ hybridization(SISH)[ xref ]"
     . SPARSER::COLLECTION)
    ("c-Met/HGF" . SPARSER::COLLECTION)
    ("This receptor and its hepatocyte growth factor (HGF) ligand"
     . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potentially safer target" . SPARSER::TARGET-PROTEIN)
    ("injured retinal vasculature" . SPARSER::PROTEIN)
    ("the retinal vasculature" . SPARSER::PROTEIN)
    ("diabetic origin form" . SPARSER::FORM)
    ("PI(3)K-AKT" . SPARSER::COLLECTION) ("phosphatidyl" . SPARSER::MOLECULE)
    ("PAI-1 and TGF-β1" . SPARSER::COLLECTION)
    ("significantly more PAI-1" . SPARSER::PROTEIN)
    ("TGF-β1/PAI-1" . SPARSER::COLLECTION)
    ("TGF-β1, TGF-βR1, TGF-βR2, PAI-1 and tPA" . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN) ("a unique diabetic cohort" . SPARSER::MOLECULE)
    ("a unique cohort" . SPARSER::MOLECULE) ("retinas" . SPARSER::DRUG)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("Plasmin" . SPARSER::PROTEIN)
    ("urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (t-PA)"
     . SPARSER::COLLECTION)
    ("serine proteinases, urokinase plasminogen activator (uPA) and tissue-type plasminogen activator (t-PA)"
     . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("cGMP" . SPARSER::PROTEIN)
    ("shRNA or PAI-1" . SPARSER::COLLECTION)
    ("TGF-β1 and PAI-1" . SPARSER::COLLECTION)
    ("PI3 Kinase" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inositol 3-kinase" . SPARSER::PROTEIN) ("TGF-βR" . SPARSER::PROTEIN)
    ("LRP-1" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 1" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN) ("TGF- β1" . SPARSER::PROTEIN)
    ("YAP1 and rs1820453" . SPARSER::COLLECTION)
    ("the DNA-damage" . SPARSER::DNA) ("P73-" . SPARSER::PROTEIN)
    ("Estrogen Receptor (ER)" . SPARSER::PROTEIN)
    ("frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("gene and breast" . SPARSER::COLLECTION) ("RASSF1A" . SPARSER::PROTEIN)
    ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ASPP2" . SPARSER::PROTEIN)
    ("protein-2" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("Yes-associated protein 1" . SPARSER::PROTEIN)
    ("yes-associated protein 1" . SPARSER::PROTEIN)
    ("The pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("ABL" . SPARSER::PROTEIN)
    ("the local healthy control reference group" . SPARSER::MOLECULE)
    ("the ancestral allele" . SPARSER::ALLELE) ("ATT" . SPARSER::PROTEIN)
    ("Ile" . SPARSER::AMINO-ACID) ("EL" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("a deregulated chimeric tyrosine kinase" . SPARSER::PROTEIN)
    ("Bim" . SPARSER::PROTEIN) ("imatinib" . SPARSER::DRUG)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("BIM" . SPARSER::PROTEIN)
    ("BCR-ABL fusion gene" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ammonium chloride" . SPARSER::MOLECULE) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("TSA and 5-Aza" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC) inhibitor trichostatin (TSA) and methyltransferase inhibitor 5-Azacytidine (5-Aza)"
     . SPARSER::COLLECTION)
    ("trichostatin (TSA) and methyltransferase inhibitor 5-Azacytidine (5-Aza)"
     . SPARSER::COLLECTION)
    ("Azacytidine" . SPARSER::DRUG) ("bacterial toxins" . SPARSER::MOLECULE)
    ("TcdB" . SPARSER::DRUG) ("toxin" . SPARSER::MOLECULE)
    ("HAT and HDAC" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("a more condensed chromatin state and transcriptional gene silencing"
     . SPARSER::COLLECTION)
    ("relaxed chromatin state and gene-transcription activation"
     . SPARSER::COLLECTION)
    ("HATs" . SPARSER::PROTEIN) ("acetyltransferases" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("RhoA and RhoC" . SPARSER::COLLECTION)
    ("RhoC" . SPARSER::PROTEIN) ("FCM" . SPARSER::MOLECULE)
    ("RhoB siRNA or Control siRNA" . SPARSER::COLLECTION)
    ("yet not Control siRNA" . SPARSER::PROTEIN)
    ("various histological types" . TYPE)
    ("different histological types" . TYPE)
    ("RhoB and other GTPases" . SPARSER::COLLECTION)
    ("growth factors and protein-tyrosine" . SPARSER::COLLECTION)
    ("triphosphatase (GTP)" . SPARSER::PROTEIN)
    ("trichostatin (TSA)" . SPARSER::MOLECULE) ("azacytidine" . SPARSER::DRUG)
    ("trichostatin" . SPARSER::MOLECULE) ("RhoB" . SPARSER::PROTEIN)
    ("peptides and TCRs" . SPARSER::COLLECTION)
    ("“neo-antigens" . SPARSER::COLLECTION)
    ("HLA-A*2402 and HLA-A" . SPARSER::COLLECTION) ("CTL" . SPARSER::PROTEIN)
    ("NCI-H1975-A2 and PC9/ZD" . SPARSER::COLLECTION)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("T790M-5" . SPARSER::PROTEIN)
    ("peptide T790M-5" . SPARSER::PROTEIN) ("mAb" . SPARSER::DRUG)
    ("antigen" . SPARSER::PROTEIN)
    ("the EGFR-T790M-derived HLA-A2-binding peptides" . SPARSER::PEPTIDE)
    ("the EGFR-T790M-derived peptides" . SPARSER::PEPTIDE)
    ("mutated amino acid" . SPARSER::AMINO-ACID)
    ("tumor-associated proteins or peptides" . SPARSER::COLLECTION)
    ("proteins or peptides" . SPARSER::COLLECTION)
    ("antigens" . SPARSER::PROTEIN) ("delE" . SPARSER::PROTEIN)
    ("neo-antigens" . SPARSER::COLLECTION) ("methionine" . SPARSER::MOLECULE)
    ("HLA-A*2402" . SPARSER::PROTEIN) ("IgG2a" . SPARSER::PROTEIN)
    ("M-5" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene- and locus-level" . SPARSER::COLLECTION) ("gene-" . SPARSER::GENE)
    ("PCa and these genes" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, PTK2 and RAF1" . SPARSER::COLLECTION)
    ("protein (RKIP)" . SPARSER::PROTEIN) ("RKIP" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NEP" . SPARSER::PROTEIN)
    ("EGFR/HER2" . SPARSER::COLLECTION)
    ("specific anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("heterodimeric HER" . SPARSER::PROTEIN)
    ("HER/ERBB/EGFR" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("combining all the genes" . SPARSER::GENE)
    ("the relevant proteins" . SPARSER::PROTEIN)
    ("tran-eQTL" . SPARSER::COLLECTION) ("tran" . SPARSER::PROTEIN-FAMILY)
    ("eQTL" . SPARSER::PROTEIN) ("MAP2K1 (YRI)" . SPARSER::PROTEIN)
    ("ERBB2 (YRI)" . SPARSER::PROTEIN) ("IGF1 (CEU)" . SPARSER::PROTEIN)
    ("ASN and CEU" . SPARSER::COLLECTION) ("PDGFB" . SPARSER::PROTEIN)
    ("cis-eQTL" . SPARSER::COLLECTION)
    ("EGFR (in the pathway) and MKRN2" . SPARSER::COLLECTION)
    ("ASN, CEU, and YRI" . SPARSER::COLLECTION) ("ASN" . SPARSER::AMINO-ACID)
    ("iHs" . SPARSER::MOLECULE) ("Almost all the genes" . SPARSER::GENE)
    ("ARTP" . SPARSER::PROTEIN) ("genes and SNPs" . SPARSER::COLLECTION)
    ("RTKs-ERK" . SPARSER::COLLECTION) ("genes and SNP" . SPARSER::COLLECTION)
    ("RTK-ERK" . SPARSER::COLLECTION)
    ("genes and networks" . SPARSER::COLLECTION)
    ("p38-MAPK" . SPARSER::COLLECTION)
    ("zoledronic acid (ZOL)" . SPARSER::DRUG)
    ("bcl-2 and bad" . SPARSER::COLLECTION)
    ("proteins, and caspase" . SPARSER::COLLECTION)
    ("Ras/Erk" . SPARSER::COLLECTION) ("bad" . SPARSER::PROTEIN)
    ("FTI" . SPARSER::DRUG) ("ZOL" . SPARSER::DRUG)
    ("Raf, MEK, and extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("EGFR, ERBB2, PTK2, and RAF1" . SPARSER::COLLECTION)
    ("RTK/ERK" . SPARSER::COLLECTION)
    ("neutral endopeptidase" . SPARSER::PROTEIN)
    ("focal adhesion-associated protein" . SPARSER::PROTEIN)
    ("ERBB1" . SPARSER::PROTEIN) ("MKRN2" . SPARSER::PROTEIN)
    ("FLT1" . SPARSER::PROTEIN) ("CCND3" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("zoledronic acid" . SPARSER::DRUG) ("MAPK3" . SPARSER::PROTEIN)
    ("PTK2" . SPARSER::PROTEIN) ("protein and NgBR" . SPARSER::COLLECTION)
    ("ER-NgBR-survivin" . SPARSER::COLLECTION)
    ("ER and survivin" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("ER-alpha and NgBR" . SPARSER::COLLECTION)
    ("staurosporine and tunicamycin" . SPARSER::COLLECTION)
    ("CHO" . SPARSER::PROTEIN) ("Nogo-B/ASY" . SPARSER::COLLECTION)
    ("ASY" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("HER2 and any molecular subtypes" . SPARSER::COLLECTION)
    ("ER, PR, HER2 and any molecular subtypes" . SPARSER::COLLECTION)
    ("NgBR, Nogo-B and survivin" . SPARSER::COLLECTION)
    ("NogoB-NgBR" . SPARSER::COLLECTION) ("Nogo-A/B" . SPARSER::PROTEIN-PAIR)
    ("NgR and LiNGO1" . SPARSER::COLLECTION) ("NgR" . SPARSER::PROTEIN)
    ("reticulon" . SPARSER::PROTEIN) ("Nogo" . SPARSER::PROTEIN)
    ("NgBR and survivin" . SPARSER::COLLECTION)
    ("NgBR and Nogo-B" . SPARSER::COLLECTION)
    ("Nogo-B and NgBR" . SPARSER::COLLECTION) ("NgBR" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("ER-alpha" . SPARSER::PROTEIN)
    ("D–F" . SPARSER::PROTEIN) ("Beta-actin" . SPARSER::PROTEIN)
    ("Na3VO4" . SPARSER::MOLECULE) ("CK5" . SPARSER::PROTEIN)
    ("LiNGO1" . SPARSER::PROTEIN) ("RTN4" . SPARSER::PROTEIN)
    ("Nogo-B" . SPARSER::PROTEIN)
    ("both p53 and Bax/Bcl-2 proteins" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-2" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX) ("nanorods" . SPARSER::MOLECULE)
    ("ZnO" . SPARSER::MOLECULE) ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("p53-siRNA" . SPARSER::COLLECTION) ("Cytometry" . SPARSER::PROTEIN)
    ("Bcl-2/Bax" . SPARSER::COLLECTION) ("Bcl-2 and p53" . SPARSER::COLLECTION)
    ("Bcl-2, MDM2 and p21WAF1" . SPARSER::COLLECTION)
    ("MDM2 and GADD45α" . SPARSER::COLLECTION)
    ("p21WAF/CIP1" . SPARSER::COLLECTION) ("WAF" . SPARSER::PROTEIN)
    ("types and levels" . SPARSER::COLLECTION)
    ("p53 and Bcl-2" . SPARSER::COLLECTION) ("HK-1" . SPARSER::PROTEIN)
    ("Pifithrin" . SPARSER::DRUG) ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("VX-680" . SPARSER::DRUG) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("C 40" . SPARSER::PROTEIN) ("Pifithrin-alpha" . SPARSER::DRUG)
    ("WAF1" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("insC" . SPARSER::PROTEIN) ("P300/CBP" . SPARSER::COLLECTION)
    ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("protein-RAD51" . SPARSER::COLLECTION)
    ("MRE11, RAD50, and NBS1" . SPARSER::COLLECTION)
    ("exon and part" . SPARSER::COLLECTION)
    ("a eukaryotic homologue" . SPARSER::PROTEIN)
    ("ECA, BRCC5, MRMV2, HRAD51, RAD51A, HsRad51, and HsT16930"
     . SPARSER::COLLECTION)
    ("HsT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECA" . SPARSER::PROTEIN)
    ("environmental mutagens" . SPARSER::MOLECULE)
    ("mutagens" . SPARSER::MOLECULE) ("gene and summary" . SPARSER::COLLECTION)
    ("The most dangerous and lethal types" . TYPE)
    ("catalase, glutathione reductase, and glutathione peroxidase"
     . SPARSER::COLLECTION)
    ("atypical sporadic FECD" . SPARSER::PROTEIN)
    ("early-onset FECD and most typical late-onset form" . SPARSER::COLLECTION)
    ("most typical late-onset form" . SPARSER::FORM)
    ("FECD" . SPARSER::PROTEIN) ("HsRad51" . SPARSER::PROTEIN)
    ("RAD51A" . SPARSER::PROTEIN) ("HRAD51" . SPARSER::PROTEIN)
    ("MRMV2" . SPARSER::PROTEIN) ("homolog (S. cerevisiae)" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN)
    ("type VIII" . SPARSER::PROTEIN) ("p32" . SPARSER::PROTEIN)
    ("COL8A2" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("superoxide dismutase 1" . SPARSER::PROTEIN) ("SOD1" . SPARSER::PROTEIN)
    ("visual system homeobox 1" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE) ("PI3K and MAP kinase" . SPARSER::COLLECTION)
    ("an endogenous antimicrobial peptide" . SPARSER::PEPTIDE)
    ("PI3K and ERK" . SPARSER::COLLECTION)
    ("ERK and MEK" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::PROTEIN)
    ("PI3K p85 and/or p110 dimers" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN) ("p85/p110" . SPARSER::COLLECTION)
    ("HSP20 and PI3K" . SPARSER::COLLECTION)
    ("subunit and PI3K" . SPARSER::COLLECTION)
    ("HSP20 and PTEN" . SPARSER::COLLECTION)
    ("HSP20 and AKT" . SPARSER::COLLECTION)
    ("14-3-3 and actin" . SPARSER::COLLECTION)
    ("PI3K and HSP20" . SPARSER::COLLECTION)
    ("p110β and HSP20" . SPARSER::COLLECTION)
    ("p110α and PI3K" . SPARSER::COLLECTION)
    ("p85 and PI3K" . SPARSER::COLLECTION)
    ("PI3K or PTEN" . SPARSER::COLLECTION)
    ("TGFα/epidermal growth factor" . SPARSER::COLLECTION)
    ("AKT, ERK or MEK" . SPARSER::COLLECTION)
    ("ERK and/or MEK" . SPARSER::COLLECTION)
    ("AKT, ERK and/or MEK" . SPARSER::COLLECTION)
    ("AKT or ERK" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("p110α and p110β" . SPARSER::COLLECTION)
    ("thrombin or botrocetin" . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN)
    ("HSP27 (HSPB1), αB-crystallin (HSPB5) and HSP20 (HSPB6)"
     . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN-FAMILY)
    ("HSPC (HSP90) and HSPH (HSP110)" . SPARSER::COLLECTION)
    ("HSPC" . SPARSER::PROTEIN) ("HSPA" . SPARSER::PROTEIN-FAMILY)
    ("AKT and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("PR-39" . SPARSER::PROTEIN) ("CAL101" . SPARSER::DRUG)
    ("14-3-3" . SPARSER::PROTEIN) ("PI3" . SPARSER::PROTEIN)
    ("L27A" . SPARSER::PROTEIN) ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("p110δ" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("HSPB5" . SPARSER::PROTEIN) ("HSPB1" . SPARSER::PROTEIN)
    ("HSP110" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("HSPB6" . SPARSER::PROTEIN) ("HSP20" . SPARSER::PROTEIN)
    ("the polymorphic alleles" . SPARSER::ALLELE)
    ("a possible low-penetrant susceptibility allele" . SPARSER::ALLELE)
    ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("polymorphic variants" . SPARSER::VARIANT) ("cyclinD1" . SPARSER::PROTEIN)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("a potential early pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("very few predictive biomarkers" . SPARSER::MOLECULE)
    ("MTD" . SPARSER::PROTEIN)
    ("a phosphomimetic (S194D) RalA mutant" . SPARSER::MUTANT)
    ("phosphorylation-deficient and phosphomimetic mutants and endogenous RalA-depleted PDAC cells"
     . SPARSER::COLLECTION)
    ("an attractive druggable target" . SPARSER::TARGET-PROTEIN)
    ("an early pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("a possible early biomarker" . SPARSER::MOLECULE)
    ("a S194 phosphomimetic mutant" . SPARSER::MUTANT)
    ("a RalA S194 phosphomimetic mutant" . SPARSER::MUTANT)
    ("Panc" . SPARSER::PROTEIN) ("nestin" . SPARSER::PROTEIN)
    ("PKA and ATP" . SPARSER::COLLECTION) ("GST-RalA" . SPARSER::COLLECTION)
    ("PKA" . SPARSER::PROTEIN) ("Brdu" . SPARSER::DRUG)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("RalA and RalB" . SPARSER::COLLECTION) ("RalB" . SPARSER::PROTEIN)
    ("Gemcitabine" . SPARSER::DRUG)
    ("an effective pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("a possible early predictive biomarker" . SPARSER::MOLECULE)
    ("PDX" . SPARSER::PROTEIN) ("RalGEF-Ral" . SPARSER::COLLECTION)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RalGEF" . SPARSER::PROTEIN)
    ("MLN8054" . SPARSER::DRUG) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("cAMP-dependent" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("MLN8237" . SPARSER::DRUG) ("K-Ras" . SPARSER::PROTEIN)
    ("SREBPs, NF-Y, SP-1, or VDR" . SPARSER::COLLECTION)
    ("VDR" . SPARSER::PROTEIN) ("SREBPs" . SPARSER::PROTEIN-FAMILY)
    ("integrin and receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("integrins, EGFR, and MET" . SPARSER::COLLECTION)
    ("GNL" . SPARSER::PROTEIN) ("Dicer and mutant" . SPARSER::COLLECTION)
    ("HGF and EGF" . SPARSER::COLLECTION)
    ("both TAp63 and endogenous mutant p53" . SPARSER::COLLECTION)
    ("TAp63 and Dicer" . SPARSER::COLLECTION) ("MDA" . SPARSER::DRUG)
    ("Partial" . SPARSER::PROTEIN) ("these mature miRs" . SPARSER::PROTEIN)
    ("Dicer and/or TAp63" . SPARSER::COLLECTION)
    ("integrin, MET, and EGFR" . SPARSER::COLLECTION)
    ("integrins and growth factor" . SPARSER::COLLECTION)
    ("enhancers" . SPARSER::PROTEIN) ("TA" . SPARSER::PROTEIN)
    ("p53, p63, and p73" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors ( xref )" . SPARSER::COLLECTION)
    ("mature miRs" . SPARSER::PROTEIN) ("-miRs" . SPARSER::COLLECTION)
    ("Drosha" . SPARSER::PROTEIN)
    ("p53, TAp63, and Dicer" . SPARSER::COLLECTION) ("miRs" . SPARSER::PROTEIN)
    ("Dicer" . SPARSER::PROTEIN) ("SP-1" . SPARSER::PROTEIN)
    ("NF-Y" . SPARSER::PROTEIN) ("AGO2" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("HGF receptor" . SPARSER::PROTEIN)
    ("CCA-3" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("Rab coupling protein" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAp63" . SPARSER::PROTEIN)
    ("integrin and vinculin" . SPARSER::COLLECTION)
    ("oligomeric complexes" . SPARSER::BIO-COMPLEX)
    ("Src, ERK1/2, and lipoxygenase" . SPARSER::COLLECTION)
    ("a highly conserved cytoskeletal protein" . SPARSER::PROTEIN)
    ("focal complexes" . SPARSER::BIO-COMPLEX)
    ("kinase, and actin" . SPARSER::COLLECTION)
    ("at least 24 proteins" . SPARSER::PROTEIN) ("-HETE" . SPARSER::MOLECULE)
    ("HETE" . SPARSER::MOLECULE)
    ("more cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("transverse actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("esters" . SPARSER::MOLECULE)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("regulating cytoskeletal proteins" . SPARSER::PROTEIN)
    ("vinculin, paxillin, talin and α-actinin" . SPARSER::COLLECTION)
    ("β1 integrin and the key structural proteins, α-actinin and talin"
     . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("proteins, α-actinin and talin" . SPARSER::COLLECTION)
    ("-polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("Neither talin nor phospho-p38" . SPARSER::COLLECTION)
    ("vinculin-GST" . SPARSER::COLLECTION)
    ("vinculin-talin" . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX)
    ("vinculin and p38" . SPARSER::COLLECTION)
    ("vinculin and p38 MAPK" . SPARSER::COLLECTION)
    ("kinase and phospho-p38" . SPARSER::COLLECTION) ("MAK" . SPARSER::PROTEIN)
    ("phospho-p38 and vinculin" . SPARSER::COLLECTION)
    ("α-actinin, F-actin, and phosphotyrosine" . SPARSER::COLLECTION)
    ("α-actinin and phosphotyrosine" . SPARSER::COLLECTION)
    ("phosphotyrosine and F-actin" . SPARSER::COLLECTION)
    ("cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("vinculin and talin" . SPARSER::COLLECTION)
    ("arachidonic acid-treated cells displayed increased talin"
     . SPARSER::PROTEIN)
    ("untreated cells expressed talin" . SPARSER::PROTEIN)
    ("arachidonic acid-treated cells showed many more vinculin-containing foci"
     . SPARSER::PROTEIN)
    ("at least two signaling proteins" . SPARSER::PROTEIN)
    ("Talin" . SPARSER::PROTEIN) ("vinculin-" . SPARSER::PROTEIN)
    ("arachidonic acid–treated cells displayed strong vinculin ( xref ) and β 1 integrin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vinculin ( xref ) and fairly diffuse β 1 integrin" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN) ("Vinculin" . SPARSER::PROTEIN)
    ("spindly" . SPARSER::PROTEIN)
    ("short cortical filaments" . SPARSER::PROTEIN-FAMILY)
    ("an Alexa Fluor 660-labeled phalloidin" . SPARSER::MOLECULE)
    ("a cytoskeletal protein" . SPARSER::PROTEIN)
    ("collagen IV substrates" . SPARSER::SUBSTRATE)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("MAP kinase, actin, α-actinin, talin and vinculin" . SPARSER::COLLECTION)
    ("talin" . SPARSER::PROTEIN) ("MAP" . SPARSER::PROTEIN)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Integrins" . SPARSER::PROTEIN)
    ("heterodimeric transmembrane surface glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("arachidonic acid-treated cells contained vinculin" . SPARSER::PROTEIN)
    ("GST-vinculin" . SPARSER::COLLECTION)
    ("the phospho-(active) form" . SPARSER::FORM)
    ("vinculin and phospho-p38" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN)
    ("short cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("cap-binding protein" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("α-Actinin" . SPARSER::PROTEIN)
    ("Filamentous actin" . SPARSER::BIO-COMPLEX)
    ("Type IV collagen" . SPARSER::PROTEIN) ("α-actinin" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("MAPKAPK2" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("a reasonable biomarker" . SPARSER::MOLECULE)
    ("DNA and cut" . SPARSER::COLLECTION)
    ("the distinctive genomic biomarkers" . SPARSER::MOLECULE)
    ("previously identified germline variants" . SPARSER::VARIANT)
    ("53BP1, RAD51, PTEN and USP11" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA 2" . SPARSER::COLLECTION)
    ("Several genomic biomarkers" . SPARSER::MOLECULE)
    ("the probable germline variants" . SPARSER::VARIANT)
    ("variants (SNV)" . SPARSER::VARIANT)
    ("polyubiquitinate" . SPARSER::PROTEIN)
    ("γ-H2AX and 53BP1" . SPARSER::COLLECTION)
    ("53BP1 and RAD51" . SPARSER::COLLECTION)
    ("γ-H2AX and the IC 50" . SPARSER::COLLECTION)
    ("AZD2281 and BSI-201" . SPARSER::COLLECTION) ("TE-1" . SPARSER::PROTEIN)
    ("SCCs" . SPARSER::PROTEIN) ("CDDP" . SPARSER::DRUG)
    ("ESD" . SPARSER::PROTEIN) ("USP11" . SPARSER::PROTEIN)
    ("BRCA 2" . SPARSER::PROTEIN) ("Histone H2A.X" . SPARSER::PROTEIN)
    ("BSI-201" . SPARSER::DRUG) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("AZD2281" . SPARSER::DRUG)
    ("IL-2 and similar cytokines" . SPARSER::COLLECTION)
    ("Jak1 and Jak3" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("IL-2 and TNFa" . SPARSER::COLLECTION) ("TNFa" . SPARSER::PROTEIN)
    ("NPM/-ALK" . SPARSER::COLLECTION)
    ("IL-2 and functionally similar cytokines" . SPARSER::COLLECTION)
    ("IL-2 and other cytokines" . SPARSER::COLLECTION)
    ("ALK- and ALK+TCL" . SPARSER::COLLECTION)
    ("IL-2 and NPM/ALK" . SPARSER::COLLECTION)
    ("SOCS3 and Irf-4" . SPARSER::COLLECTION)
    ("STAT5, STAT3, and ERK" . SPARSER::COLLECTION)
    ("small molecule inhibitors and siRNA technology" . SPARSER::COLLECTION)
    ("Egr-1, Fosl-1, SOCS3 and Irf-4" . SPARSER::COLLECTION)
    ("STAT5a and STAT5b" . SPARSER::COLLECTION)
    ("particular STAT5" . SPARSER::PROTEIN) ("NPM-ALK" . SPARSER::COLLECTION)
    ("Jak3 as well as two different inhibitors" . SPARSER::COLLECTION)
    ("IL-2 and Sudhl-1" . SPARSER::COLLECTION)
    ("IL-2 and ALK" . SPARSER::COLLECTION)
    ("IL-2- and NPM/ALK-" . SPARSER::COLLECTION) ("ALK-" . SPARSER::PROTEIN)
    ("IL-2-" . SPARSER::PROTEIN) ("MDM2 and JNK" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("the ALK gene and several different partners" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN) ("IL-2 or ALK" . SPARSER::COLLECTION)
    ("CD25, SOCS3, and Irf-4" . SPARSER::COLLECTION)
    ("STAT5 and STAT3" . SPARSER::COLLECTION)
    ("Egr-1 and Fosl-1" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION)
    ("Egr-1, Fosl-1, SOCS3, and Irf-4" . SPARSER::COLLECTION)
    ("Irf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Jak/STAT" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPM/ALK" . SPARSER::COLLECTION)
    ("ALK-TCL" . SPARSER::COLLECTION) ("the key cytokine" . SPARSER::PROTEIN)
    ("/ALK" . SPARSER::COLLECTION) ("TCL" . SPARSER::PROTEIN)
    ("NPM" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("Jak-STAT" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("Jak3" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("sCD25" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("Fosl-1" . SPARSER::PROTEIN) ("Egr-1" . SPARSER::PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("IL-2/IL-4/IL-21" . SPARSER::COLLECTION)
    ("CD40LG (hyper-IgM syndrome; xref ) or ICOS (common variable immunodeficiency; xref )"
     . SPARSER::COLLECTION)
    ("XLP" . SPARSER::PROTEIN) ("stimulatory cytokines" . SPARSER::PROTEIN)
    ("STAT3 or IL21R" . SPARSER::COLLECTION)
    ("serum IgM and lack serum IgG and IgA ( xref )" . SPARSER::COLLECTION)
    ("IL2RG or JAK3" . SPARSER::COLLECTION)
    ("IL-4R and IL-21R" . SPARSER::COLLECTION)
    ("IL-4, IL-10, BAFF, and APRIL" . SPARSER::COLLECTION)
    ("IL-21/IL-21R" . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION)
    ("IL-4 or IL-10" . SPARSER::COLLECTION) ("Cytokines" . SPARSER::PROTEIN)
    ("protective Ig" . SPARSER::MOLECULE)
    ("a functional IL-21R" . SPARSER::PROTEIN)
    ("AICDA (IL-4 and IL-10) and XBP1 (IL-4)" . SPARSER::COLLECTION)
    ("AICDA , PRDM1 , and XBP1" . SPARSER::COLLECTION)
    ("IgD and IgM" . SPARSER::COLLECTION)
    ("IL-21 and a putative alternate receptor" . SPARSER::COLLECTION)
    ("a putative alternate receptor" . SPARSER::RECEPTOR)
    ("substantially more XBP1" . SPARSER::PROTEIN)
    ("IL-21 ( xref , left) and IL-10 ( xref , left)" . SPARSER::COLLECTION)
    ("IL-21 or IL-10" . SPARSER::COLLECTION)
    ("the residual wild-type STAT3 dimers" . SPARSER::DIMER)
    ("memory B cells IL-21" . SPARSER::PROTEIN)
    ("IL-21 and IL-10" . SPARSER::COLLECTION)
    ("PRDM1 , XBP1 , and IRF4" . SPARSER::COLLECTION)
    ("PAX5 , PRDM1 , XBP1 , and IRF4" . SPARSER::COLLECTION)
    ("PRDM1 and XBP1" . SPARSER::COLLECTION)
    ("Blimp-1 and XBP-1" . SPARSER::COLLECTION)
    ("XBP-1 and IRF4" . SPARSER::COLLECTION)
    ("STAT1 or STAT3" . SPARSER::COLLECTION)
    ("BAFF and APRIL" . SPARSER::COLLECTION) ("APRIL" . SPARSER::PROTEIN)
    ("BAFF" . SPARSER::PROTEIN) ("CD40L and IL-21" . SPARSER::COLLECTION)
    ("CD40L/IL-21" . SPARSER::COLLECTION)
    ("IL-10 or IL-21" . SPARSER::COLLECTION)
    ("CD40L/CpG" . SPARSER::COLLECTION) ("mature IgE" . SPARSER::PROTEIN)
    ("CD40L/IL-4" . SPARSER::COLLECTION) ("IgG and IgA" . SPARSER::COLLECTION)
    ("IL-21, and Ig" . SPARSER::COLLECTION)
    ("STAT4 or STAT6" . SPARSER::COLLECTION)
    ("IgM and IgD" . SPARSER::COLLECTION) ("IgG or IgA" . SPARSER::COLLECTION)
    ("IgD" . SPARSER::PROTEIN)
    ("CD80, CD86, CD95, and TACI" . SPARSER::COLLECTION)
    ("CD24, CD80, CD95, and TACI" . SPARSER::COLLECTION)
    ("memory B cells lack CD27" . SPARSER::PROTEIN)
    ("AICDA" . SPARSER::PROTEIN)
    ("PRDM1 (Blimp-1 [B lymphocyte induced maturation protein-1]) and XBP1 ( X-box binding protein 1 )"
     . SPARSER::COLLECTION)
    ("functional STAT3" . SPARSER::PROTEIN)
    ("CD80 and CD86" . SPARSER::COLLECTION)
    ("CD21, CD27, and TACI" . SPARSER::COLLECTION) ("TACI" . SPARSER::PROTEIN)
    ("B cell–intrinsic genes ( CD19 / CD81 , CD40 , IKBKG , DOCK8 , and IL2RG ) or genes"
     . SPARSER::COLLECTION)
    ("B cell–intrinsic genes" . SPARSER::GENE)
    ("CD81 , CD40 , IKBKG , DOCK8 , and IL2RG" . SPARSER::COLLECTION)
    ("CD40LG , ICOS , and SH2D1A" . SPARSER::COLLECTION)
    ("Ig" . SPARSER::MOLECULE) ("SAP" . SPARSER::PROTEIN)
    ("ICOS" . SPARSER::PROTEIN) ("IKBKG" . SPARSER::PROTEIN)
    ("Abs" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("IL-21R/STAT3" . SPARSER::COLLECTION)
    ("IgM, IgG, and IgA" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("IL-10–" . SPARSER::PROTEIN)
    ("STAT1, STAT3, and STAT5" . SPARSER::COLLECTION)
    ("Long-lived antibody" . SPARSER::PROTEIN) ("PCs" . SPARSER::PROTEIN)
    ("IL-10 and IL-21" . SPARSER::COLLECTION) ("K-19" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("IgG4" . SPARSER::PROTEIN)
    ("IgG3" . SPARSER::BIO-COMPLEX) ("IgG2" . SPARSER::BIO-COMPLEX)
    ("CXCR5" . SPARSER::PROTEIN) ("IL-4R" . SPARSER::PROTEIN)
    ("IL-10R" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("IL-21 receptor" . SPARSER::PROTEIN) ("CD43" . SPARSER::PROTEIN)
    ("X-box binding protein 1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("Blimp-1" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("IL10R" . SPARSER::PROTEIN)
    ("CD27" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN) ("SH2D1A" . SPARSER::PROTEIN)
    ("CD40LG" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("DOCK8" . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("IL21" . SPARSER::PROTEIN)
    ("IL-21R" . SPARSER::PROTEIN)
    ("transcriptionally repressive chromatin" . SPARSER::PROTEIN)
    ("repressive chromatin state" . SPARSER::BIO-STATE)
    ("p97/VCP" . SPARSER::COLLECTION) ("VCP" . SPARSER::PROTEIN)
    ("BRCA1/Rap80" . SPARSER::COLLECTION) ("FK" . SPARSER::MOLECULE)
    ("polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("polycomb" . SPARSER::PROTEIN) ("NuRD" . SPARSER::PROTEIN)
    ("the cellular LSD1" . SPARSER::PROTEIN)
    ("RNF168 or RNF8" . SPARSER::COLLECTION) ("H2A-Ub" . SPARSER::COLLECTION)
    ("MDC1 and pH2A" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN) ("NuRD–CHD4" . SPARSER::COLLECTION)
    ("using lentiviral-mediated shRNA" . SPARSER::PROTEIN)
    ("53BP1 and MDC1" . SPARSER::COLLECTION)
    ("the first 171 amino acids of LSD1 (NΔ-LSD1)" . SPARSER::PROTEIN)
    ("Δ-LSD1" . SPARSER::COLLECTION) ("Flag-LSD1" . SPARSER::COLLECTION)
    ("LSD1 and RNF168" . SPARSER::COLLECTION)
    ("LSD1 and the other damage-associated E3 ligase RNF8"
     . SPARSER::COLLECTION)
    ("the other damage-associated E3 ligase RNF8" . SPARSER::PROTEIN)
    ("Flag–RNF168" . SPARSER::COLLECTION)
    ("the tagged RNF168 and its associated proteins" . SPARSER::COLLECTION)
    ("LSD1 and 53BP1" . SPARSER::COLLECTION) ("IRIF" . SPARSER::PROTEIN)
    ("whose foci" . SPARSER::PROTEIN) ("very distinct foci" . SPARSER::PROTEIN)
    ("foci (IRIF)" . SPARSER::PROTEIN) ("GFP-RNF168" . SPARSER::COLLECTION)
    ("KAP1 and CHD4" . SPARSER::COLLECTION)
    ("KU55933 or DMSO" . SPARSER::COLLECTION) ("HA-LSD1" . SPARSER::COLLECTION)
    ("ATM or ataxia" . SPARSER::COLLECTION) ("visible H3K4" . SPARSER::PROTEIN)
    ("proteins, Cdt1 and geminin" . SPARSER::COLLECTION)
    ("ligases" . SPARSER::LIGASE) ("geminin" . SPARSER::PROTEIN)
    ("LSD1 and H3K4" . SPARSER::COLLECTION)
    ("I-PpoI–induced DSBs recruited LSD1" . SPARSER::PROTEIN)
    ("ribosomal DNA" . SPARSER::DNA) ("rDNA" . SPARSER::PROTEIN)
    ("PpoI" . SPARSER::PROTEIN)
    ("the histone H3K9/K36 demethylase JMJD2A nor the H3K27 demethylase JMJD3"
     . SPARSER::COLLECTION)
    ("two LSD1-associated proteins, CoREST and BHC80" . SPARSER::COLLECTION)
    ("proteins, CoREST and BHC80" . SPARSER::COLLECTION)
    ("CoREST" . SPARSER::PROTEIN) ("HR and crossovers" . SPARSER::COLLECTION)
    ("BRCA1 and Rap80" . SPARSER::COLLECTION)
    ("androgen and estrogen" . SPARSER::COLLECTION)
    ("lysine and arginine" . SPARSER::COLLECTION)
    ("the associated enzymes" . SPARSER::ENZYME)
    ("H2A/H2A" . SPARSER::COLLECTION)
    ("BRCA1 hypomorphic alleles" . SPARSER::ALLELE)
    ("irradiation-induced foci" . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("MRE11–RAD50–NBS1" . SPARSER::COLLECTION)
    ("the DDR and place LSD1" . SPARSER::COLLECTION)
    ("foci, 53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("LSD1/KDM1A" . SPARSER::COLLECTION) ("hCdt1" . SPARSER::PROTEIN)
    ("L3MBTL1" . SPARSER::PROTEIN) ("p97" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("PRDM9" . SPARSER::PROTEIN) ("SPR-5" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("CHD4" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("KU55933" . SPARSER::DRUG)
    ("green fluorescent" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K5" . SPARSER::PROTEIN)
    ("JMJD3" . SPARSER::PROTEIN) ("JMJD2A" . SPARSER::PROTEIN)
    ("BHC80" . SPARSER::PROTEIN) ("Rap80" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tip60" . SPARSER::PROTEIN) ("XRCC4" . SPARSER::PROTEIN)
    ("RNF8" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("KDM1A" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("RNF168" . SPARSER::PROTEIN)
    ("avidin-biotin" . SPARSER::PROTEIN-PAIR)
    ("hematoxylin" . SPARSER::MOLECULE) ("avidin" . SPARSER::PROTEIN)
    ("biotinylated secondary antibody" . SPARSER::PROTEIN)
    ("5% bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("paraformaldehyde" . SPARSER::DRUG)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("peroxidase (HRP)" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("MBL" . SPARSER::PROTEIN) ("SIGMA" . SPARSER::PROTEIN-FAMILY)
    ("pAdxsi-GFP" . SPARSER::PROTEIN-PAIR) ("EagI" . SPARSER::PROTEIN)
    ("pGEM" . SPARSER::MOLECULE)
    ("-AGGGTAGAGTGGATGGTCAGT-3" . SPARSER::COLLECTION)
    ("-ACCTGCCTGCCTTTGCCTAA-3" . SPARSER::COLLECTION)
    ("cleaved apoptotic-related proteins" . SPARSER::PROTEIN)
    ("Caspases" . SPARSER::PROTEIN)
    ("apoptotic-related proteins" . SPARSER::PROTEIN)
    ("Propofol" . SPARSER::DRUG)
    ("N -acetylcysteine (NAC) and probucol therapy" . SPARSER::COLLECTION)
    ("probucol" . SPARSER::DRUG)
    ("cytokines and growth factor" . SPARSER::COLLECTION)
    ("Ischemia" . SPARSER::PROTEIN)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("monocyte chemoattractant protein-1 (MCP-1) and monocyte colony-stimulating factor (MCSF)"
     . SPARSER::COLLECTION)
    ("Platelet activating factor (PAF), monocyte chemoattractant protein-1 (MCP-1) and monocyte colony-stimulating factor (MCSF)"
     . SPARSER::COLLECTION)
    ("colony-stimulating factor (MCSF)" . SPARSER::PROTEIN)
    ("activating factor (PAF)" . SPARSER::PROTEIN) ("MCSF" . SPARSER::PROTEIN)
    ("PAF" . SPARSER::PROTEIN-FAMILY) ("excessive ROS" . SPARSER::PROTEIN)
    ("H 2 O 2 and superoxide anions" . SPARSER::COLLECTION)
    ("the vascular barrier" . SPARSER::PROTEIN)
    ("an important biological barrier" . SPARSER::PROTEIN)
    ("complex, ECs injury and loss" . SPARSER::COLLECTION)
    ("eNOS and phospho-Akt" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("the H 2 O 2 group and the Adv-GFP group" . SPARSER::COLLECTION)
    ("protein, caspase-7, and PARP" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION) ("Adv-GFP" . SPARSER::COLLECTION)
    ("IH" . SPARSER::MOLECULE) ("Akt/eNOS" . SPARSER::COLLECTION)
    ("phospho-Akt and eNOS" . SPARSER::COLLECTION)
    ("Akt, phospho-Akt and eNOS" . SPARSER::COLLECTION)
    ("iodide and Hoechst" . SPARSER::COLLECTION)
    ("caspase-7 and PARP" . SPARSER::COLLECTION) ("eNOS" . SPARSER::PROTEIN)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("N -acetylcysteine" . SPARSER::DRUG) ("I/R" . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("activating factor" . SPARSER::PROTEIN)
    ("superoxide anions" . SPARSER::MOLECULE) ("CCK-8" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("Substrates" . SPARSER::SUBSTRATE)
    ("MKK" . SPARSER::PROTEIN-FAMILY) ("GN-CSF" . SPARSER::COLLECTION)
    ("CSF" . SPARSER::PROTEIN) ("stromal p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TM" . SPARSER::PROTEIN) ("EdU" . SPARSER::DRUG)
    ("pro-angiogenic mediators" . SPARSER::PROTEIN)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("-thymidine" . SPARSER::COLLECTION) ("thymidine" . SPARSER::PROTEIN)
    ("p-p38 and CD31" . SPARSER::COLLECTION) ("podoplanin" . SPARSER::PROTEIN)
    ("p53 and EGFR or pEGFR" . SPARSER::COLLECTION)
    ("EGFR or pEGFR" . SPARSER::COLLECTION)
    ("EGFR and COX2" . SPARSER::COLLECTION) ("AKT-mTOR" . SPARSER::COLLECTION)
    ("phospho-ERK and phospho-JNK" . SPARSER::COLLECTION)
    ("Phosphorylated ERK1/2 (p-ERK1/2) and JNK (p-JNK)" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("Examples" . SPARSER::EXAMPLE)
    ("the extracellular signal-regulated protein kinases (ERK1 and ERK2), c-Jun N-terminal kinases (JNK1, JNK2, JNK3), and p38 MAPKs (p38α, p38β, p38γ, p38δ)"
     . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("ink4A" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL1β" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("p-MK2" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("PECAM1" . SPARSER::PROTEIN)
    ("LYVE1" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("Interleukin-1β" . SPARSER::PROTEIN)
    ("p38δ" . SPARSER::PROTEIN) ("p38γ" . SPARSER::PROTEIN)
    ("JNK3" . SPARSER::PROTEIN) ("JNK2" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB-203580" . SPARSER::DRUG)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("MSH2-MSH3" . SPARSER::COLLECTION) ("MSH2-MSH6" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("mismatch repair
protein"
     . SPARSER::PROTEIN)
    ("CX31" . SPARSER::PROTEIN) ("BH2" . SPARSER::MOLECULE)
    ("MSH3" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("SMAD4 and clathrin and caveolin-1" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (MMP9)"
     . SPARSER::COLLECTION)
    ("clathrin/caveolin-1" . SPARSER::COLLECTION)
    ("caveolin-1 and clathrin" . SPARSER::COLLECTION)
    ("SMAD4 and clathrin or caveolin-1" . SPARSER::COLLECTION)
    ("clathrin or caveolin-1" . SPARSER::COLLECTION)
    ("GFP-SMAD4" . SPARSER::COLLECTION)
    ("proteins and ion channel" . SPARSER::COLLECTION)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("a heteromeric signaling complex" . SPARSER::BIO-COMPLEX)
    ("receptor (TGFBRII)" . SPARSER::RECEPTOR) ("TGFBRI" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("clathrin and caveolin-1" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN) ("LAMC2" . SPARSER::PROTEIN)
    ("gamma 2" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("SB431542" . SPARSER::DRUG)
    ("Clathrin heavy chain" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("R-SMAD" . SPARSER::PROTEIN-FAMILY) ("SMAD2" . SPARSER::PROTEIN)
    ("receptor-activated SMAD" . SPARSER::PROTEIN-FAMILY)
    ("receptor type" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("proteins and ER" . SPARSER::COLLECTION) ("TUDCA" . SPARSER::DRUG)
    ("siRNA or 10058-F4" . SPARSER::COLLECTION)
    ("Tunicamycin" . SPARSER::MOLECULE)
    ("NME1 and COPS2" . SPARSER::COLLECTION)
    ("anti-SIRT7 and anti-Myc" . SPARSER::COLLECTION)
    ("SIRT7 and Myc" . SPARSER::COLLECTION)
    ("Flag-SIRT7" . SPARSER::COLLECTION)
    ("Myc and SIRT7" . SPARSER::COLLECTION)
    ("ribosomal components" . SPARSER::COMPONENT)
    ("specifically target SIRT7" . SPARSER::PROTEIN)
    ("tunicamycin and thapsigargin" . SPARSER::COLLECTION)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("adeno-associated virus 8 (AAV8)-mediated gene" . SPARSER::GENE)
    ("VLDL" . SPARSER::PROTEIN) ("VLDL-TG" . SPARSER::COLLECTION)
    ("TG" . SPARSER::PROTEIN) ("lipoprotein" . SPARSER::PROTEIN)
    ("KO" . SPARSER::PROTEIN) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("cirrhosis" . SPARSER::PROTEIN) ("ribosomal proteins" . SPARSER::PROTEIN)
    ("XBP-1" . SPARSER::PROTEIN) ("Sirt7" . SPARSER::PROTEIN)
    ("IF2" . SPARSER::PROTEIN) ("COPS2" . SPARSER::PROTEIN)
    ("NME1" . SPARSER::PROTEIN) ("ELK4" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("Erdj4" . SPARSER::PROTEIN)
    ("XBP1s" . SPARSER::PROTEIN) ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("K18" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("Seahorse" . SPARSER::PROTEIN)
    ("blood glucose and cholesterol" . SPARSER::COLLECTION)
    ("TSC2 and Raptor" . SPARSER::COLLECTION)
    ("AMPK, ACC and Raptor" . SPARSER::COLLECTION)
    ("the tumor suppressor TSC2 and the mTORC1 subunit Raptor"
     . SPARSER::COLLECTION)
    ("Raptor" . SPARSER::PROTEIN) ("KSR2-AMPK" . SPARSER::COLLECTION)
    ("anorectic POMC-derived peptides" . SPARSER::PEPTIDE)
    ("POMC" . SPARSER::PROTEIN)
    ("the anorectic hormone leptin ( xref ) and the orexigenic hormone ghrelin ( xref )"
     . SPARSER::COLLECTION)
    ("the orexigenic hormone ghrelin" . SPARSER::PROTEIN)
    ("the anorectic hormone leptin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ghrelin" . SPARSER::PROTEIN)
    ("fatty acid and glucose" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN) ("Leptin" . SPARSER::PROTEIN)
    ("mediating leptin’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("leptin and melanocortin" . SPARSER::COLLECTION)
    ("SNS" . SPARSER::PROTEIN)
    ("other highly penetrant genetic forms" . SPARSER::FORM)
    ("the antidiabetic drug metformin" . SPARSER::DRUG)
    ("BSA, or BSA" . SPARSER::COLLECTION)
    ("fatty acyl-CoA molecules" . SPARSER::MOLECULE)
    ("AMPK and human KSR2" . SPARSER::COLLECTION)
    ("Glucose" . SPARSER::PROTEIN) ("Male" . SPARSER::MOLECULE)
    ("triglycerides, and adiponectin" . SPARSER::COLLECTION)
    ("triglycerides" . SPARSER::MOLECULE)
    ("norepinephrine, epinephrine, and dopamine" . SPARSER::COLLECTION)
    ("epinephrine" . SPARSER::DRUG) ("LF" . SPARSER::PROTEIN)
    ("KSR2 and B-Raf and MEK" . SPARSER::COLLECTION)
    ("B-Raf and MEK" . SPARSER::COLLECTION)
    ("MEK and B-Raf" . SPARSER::COLLECTION) ("KSR2-MEK" . SPARSER::COLLECTION)
    ("DFG" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("KSR2 and MEK" . SPARSER::COLLECTION) ("APE" . SPARSER::PROTEIN)
    ("a completely nonfunctional KSR2 molecule" . SPARSER::MOLECULE)
    ("B-Raf, and MEK" . SPARSER::COLLECTION)
    ("associated MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a nonfunctional form" . SPARSER::FORM)
    ("the KSR2-associated MEK and ERK" . SPARSER::COLLECTION)
    ("ERK and B-Raf" . SPARSER::COLLECTION)
    ("B-Raf, MEK, and ERK" . SPARSER::COLLECTION)
    ("B-Raf, MEK, or ERK" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("Five nonsynonymous variants" . SPARSER::VARIANT)
    ("heterozygous form" . SPARSER::FORM) ("p " . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN) ("almost all KSR2 variants" . SPARSER::VARIANT)
    ("KSR2 and AMPK" . SPARSER::COLLECTION) ("KSR2-MEK1" . SPARSER::COLLECTION)
    ("KSR" . SPARSER::PROTEIN) ("Raf, MEK, and ERK" . SPARSER::COLLECTION)
    ("KSR1 and KSR2" . SPARSER::COLLECTION)
    ("Ras-Raf-MEK" . SPARSER::COLLECTION)
    ("the commonly prescribed antidiabetic drug" . SPARSER::DRUG)
    ("Raf-MEK-ERK" . SPARSER::COLLECTION) ("–2 " . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("anti-ERK" . SPARSER::PROTEIN)
    ("Erk1" . SPARSER::PROTEIN) ("CA3" . SPARSER::PROTEIN)
    ("Fatty Acid" . SPARSER::MOLECULE) ("C-peptide" . SPARSER::MOLECULE)
    ("m 2" . SPARSER::MOLECULE) ("B-Raf" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN) ("KSR1" . SPARSER::PROTEIN)
    ("Membrane-bound" . SPARSER::PROTEIN)
    ("Ksr2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KSR2" . SPARSER::PROTEIN)
    ("Kinase suppressor of Ras 2" . SPARSER::PROTEIN)
    ("kinases
and lipid"
     . SPARSER::COLLECTION)
    ("PIP4K2A and one allele" . SPARSER::COLLECTION)
    ("PIP4K2A or PIP4K2B" . SPARSER::COLLECTION)
    ("p53 and PI5P4Ks" . SPARSER::COLLECTION)
    ("glucose and ROS" . SPARSER::COLLECTION) ("TIGAR" . SPARSER::PROTEIN)
    ("pentose" . SPARSER::MOLECULE) ("NADPH" . SPARSER::PROTEIN)
    ("PIP4K2B and both alleles" . SPARSER::COLLECTION)
    ("only one allele" . SPARSER::ALLELE)
    ("PIP4K2A and/or PIP4K2B alleles" . SPARSER::COLLECTION)
    ("flx" . SPARSER::PROTEIN) ("cre" . SPARSER::PROTEIN)
    ("neomycin" . SPARSER::DRUG) ("Southern blot" . SPARSER::PROTEIN)
    ("lack both alleles of p53 and the
observation"
     . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG) ("NAC" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("IIB" . SPARSER::PROTEIN) ("polyphosphate" . SPARSER::MOLECULE)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("PIP4K2B and PIP4K2A" . SPARSER::COLLECTION)
    ("only two alleles" . SPARSER::ALLELE)
    ("PIP4K2B and PIP4K2C" . SPARSER::COLLECTION)
    ("significantly higher PIP4K2A mRNA" . SPARSER::PROTEIN)
    ("RPPA" . SPARSER::PROTEIN) ("PIP4K2B and TP53" . SPARSER::COLLECTION)
    ("ERBB2 and PIP4K2B" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("HER2/Neu" . SPARSER::COLLECTION) ("HER-2/Neu" . SPARSER::COLLECTION)
    ("Neu" . SPARSER::PROTEIN)
    ("PIP4K2B and/or PIP4K2A genes" . SPARSER::COLLECTION)
    ("PIP4K2A and PIP4K2B" . SPARSER::COLLECTION)
    ("high-fat" . SPARSER::PROTEIN) ("PIP" . SPARSER::PROTEIN)
    ("protein
kinase B or PKB"
     . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("PH" . SPARSER::PROTEIN)
    ("kinases, phosphatases, and
phospholipases"
     . SPARSER::COLLECTION)
    ("phospholipases" . SPARSER::PROTEIN)
    ("Phosphoinositide" . SPARSER::PROTEIN)
    ("phosphatidylinositol (PI)" . SPARSER::MOLECULE)
    ("TP53 and PIP4K2B" . SPARSER::COLLECTION) ("pMD2" . SPARSER::MOLECULE)
    ("a 37" . SPARSER::PROTEIN) ("GDC0941" . SPARSER::DRUG)
    ("N-acetylcysteine" . SPARSER::DRUG) ("GDC-0941" . SPARSER::DRUG)
    ("β-galactosidase" . SPARSER::PROTEIN)
    ("type
1"
     . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN) ("PIP4K2C" . SPARSER::PROTEIN)
    ("kinase
activity"
     . SPARSER::PROTEIN)
    ("P 4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIP5Ks" . SPARSER::PROTEIN)
    ("PI-5" . SPARSER::PROTEIN) ("PIP5K1A" . SPARSER::PROTEIN)
    ("P 5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-4-phosphate" . SPARSER::MOLECULE)
    ("PI-4" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("protein
kinase B"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PI-3" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("PIP4K2A" . SPARSER::PROTEIN) ("PIP4K2B" . SPARSER::PROTEIN)
    ("and
β"
     . SPARSER::PROTEIN)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("all TRAIL-receptor-specific antibodies" . SPARSER::ANTIBODY)
    ("PS" . SPARSER::PROTEIN) ("EB" . SPARSER::PROTEIN-FAMILY)
    ("TMG" . SPARSER::PROTEIN) ("RK" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("mIgG" . SPARSER::PROTEIN)
    ("DR" . SPARSER::MOLECULE) ("other chemotherapeutic drugs" . SPARSER::DRUG)
    ("TRAIL-R1, TRAIL-R2 and TRAIL-R4" . SPARSER::COLLECTION)
    ("a larger cohort" . SPARSER::MOLECULE) ("lexatumumab" . SPARSER::DRUG)
    ("many chemotherapeutic drugs" . SPARSER::DRUG)
    ("tumor type and clinical setting (adjuvant, curative and palliative treatment)"
     . SPARSER::COLLECTION)
    ("TRAIL-R2-" . SPARSER::PROTEIN) ("TRAIL-R1-" . SPARSER::PROTEIN)
    ("receptors, caspase-8, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Cohort" . SPARSER::MOLECULE)
    ("TRAIL-R4 and nuclear caspase-8" . SPARSER::COLLECTION)
    ("TRAIL-R1, TRAIL-R2, TRAIL-R4 and nuclear caspase-8"
     . SPARSER::COLLECTION)
    ("TRAIL receptors and the apoptosis regulatory proteins caspase-8, Bcl-xL and Mcl-1"
     . SPARSER::COLLECTION)
    ("Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("a soluble receptor" . SPARSER::RECEPTOR)
    ("osteoprotegerin" . SPARSER::PROTEIN)
    ("receptors, TRAIL-R3 and TRAIL-R4" . SPARSER::COLLECTION)
    ("TRAIL-R1 and/or TRAIL-R2" . SPARSER::COLLECTION)
    ("FADD and cytoplasmic caspase-8" . SPARSER::COLLECTION)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("sorafenib" . SPARSER::DRUG)
    ("Sorafenib" . SPARSER::DRUG)
    ("TRAIL-R3, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("TRAIL-R2 and TRAIL-R4" . SPARSER::COLLECTION)
    ("TRAIL-R2 and –R4" . SPARSER::COLLECTION)
    ("TRAIL-R4, caspase-8, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("caspase-8, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("TRAIL-R1 and TRAIL-R2" . SPARSER::COLLECTION)
    ("TRAIL receptor 1 (TRAIL-R1) and TRAIL-R2" . SPARSER::COLLECTION)
    ("the TRAIL death receptors, TRAIL receptor 1 (TRAIL-R1) and TRAIL-R2"
     . SPARSER::COLLECTION)
    ("TRAIL-R3 and TRAIL-R4" . SPARSER::COLLECTION)
    ("TRAIL" . SPARSER::PROTEIN) ("TRAIL-receptor 3" . SPARSER::PROTEIN)
    ("TRAIL-receptor 2" . SPARSER::PROTEIN)
    ("TRAIL-receptor 1" . SPARSER::PROTEIN)
    ("TNF-related apoptosis inducing ligand" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PARP2" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("A-C" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("IgG 1 " . SPARSER::BIO-COMPLEX) ("C-15" . SPARSER::PROTEIN)
    ("TR4" . SPARSER::PROTEIN) ("TR3" . SPARSER::PROTEIN)
    ("TR2" . SPARSER::PROTEIN) ("TR1" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("DR4" . SPARSER::PROTEIN) ("Death Receptor 4" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("TRAIL-R4" . SPARSER::PROTEIN)
    ("TRAIL-R3" . SPARSER::PROTEIN) ("TRAIL-R2" . SPARSER::PROTEIN)
    ("TRAIL-R1" . SPARSER::PROTEIN) ("TRAIL receptor 1" . SPARSER::PROTEIN)
    ("TNF-related apoptosis-inducing ligand" . SPARSER::PROTEIN)
    ("LPS and Pam3csk4" . SPARSER::COLLECTION) ("csk" . SPARSER::PROTEIN)
    ("PLK" . SPARSER::PROTEIN) ("TIRAP and MyD88" . SPARSER::COLLECTION)
    ("TLR2 or TLR4" . SPARSER::COLLECTION)
    ("TLRs or their signal adaptor protein" . SPARSER::COLLECTION)
    ("TLRs and their adaptor proteins" . SPARSER::COLLECTION)
    ("PLK1, low levels of PLK2 and PLK3, and moderate level of PLK4"
     . SPARSER::COLLECTION)
    ("TLR2- and TLR4-induced TNF-α" . SPARSER::COLLECTION)
    ("ERK, p38, and p65" . SPARSER::COLLECTION)
    ("ERK and p65" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("MAPKs and NF-κB" . SPARSER::COLLECTION)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("TLR2 and TLR4" . SPARSER::COLLECTION)
    ("TLR2 , TLR4 , and MyD88" . SPARSER::COLLECTION)
    ("a receptor or its signal adaptor protein" . SPARSER::COLLECTION)
    ("TLR2, TLR4, and MyD88" . SPARSER::COLLECTION)
    ("TNF-α and IL-8" . SPARSER::COLLECTION) ("GW" . SPARSER::PROTEIN)
    ("PLK2 and PLK3 , and LPS" . SPARSER::COLLECTION)
    ("PLK3 , and LPS" . SPARSER::COLLECTION)
    ("Only 10 μM GW843682X" . SPARSER::DRUG)
    ("LPS or Pam3CSK4" . SPARSER::COLLECTION)
    ("LPS and Pam3CSK4" . SPARSER::COLLECTION)
    ("PLK1, PLK2, PLK3, or PLK4" . SPARSER::COLLECTION)
    ("PLK1, PLK2, PLK3 , or PLK4" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("PLK2 and PLK3" . SPARSER::COLLECTION)
    ("PLK2 and PLK4" . SPARSER::COLLECTION)
    ("ABCA1-activated protein kinase" . SPARSER::COLLECTION)
    ("glycogen synthase and other substrates [ xref ]" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("TLR-TRIF" . SPARSER::COLLECTION) ("TLR-MyD88" . SPARSER::COLLECTION)
    ("IFN-β (TRIF)" . SPARSER::PROTEIN) ("TLR3 and TLR4" . SPARSER::COLLECTION)
    ("NF-κB and interferon regulatory factor 3" . SPARSER::COLLECTION)
    ("TRIF" . SPARSER::PROTEIN) ("IL-1R-associated kinases" . SPARSER::KINASE)
    ("TIR-associated protein (TIRAP)" . SPARSER::PROTEIN)
    ("TNFR" . SPARSER::PROTEIN) ("IRAKs" . SPARSER::PROTEIN)
    ("TIRAP" . SPARSER::PROTEIN) ("TIR" . SPARSER::PROTEIN-FAMILY)
    ("TLR2-" . SPARSER::PROTEIN) ("ERK, p38 and NF-κB" . SPARSER::COLLECTION)
    ("ERK and NF-κB" . SPARSER::COLLECTION)
    ("PLK1, and PLK1" . SPARSER::COLLECTION) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("IL-1β and IL-8" . SPARSER::COLLECTION)
    ("PLK1 and PLK3" . SPARSER::COLLECTION) ("CSK" . SPARSER::PROTEIN)
    ("Pam" . SPARSER::PROTEIN)
    ("PLK1, PLK2, PLK3 and PLK4" . SPARSER::COLLECTION)
    ("THP-1" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("PLKs" . SPARSER::PROTEIN) ("1 - 2" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("BAY 11-7082" . SPARSER::DRUG)
    ("SB203580" . SPARSER::DRUG) ("SP600125" . SPARSER::PROTEIN)
    ("ABCA1" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("TRAF3" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("IL-1R" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("GW843682X" . SPARSER::DRUG) ("PLK3" . SPARSER::PROTEIN)
    ("PLK2" . SPARSER::PROTEIN) ("PLK1" . SPARSER::PROTEIN)
    ("Polo-like" . SPARSER::PROTEIN)
    ("a phosphatidic acid phosphatase" . SPARSER::PHOSPHATASE)
    ("PKC-" . SPARSER::PROTEIN) ("Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("RalA" . SPARSER::PROTEIN) ("RalGDS" . SPARSER::PROTEIN)
    ("family, or DAGK" . SPARSER::COLLECTION)
    ("cellular PA" . SPARSER::PROTEIN) ("Ren" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("Arf and Rho" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins, PKC-ζ, RAB11FIP1, PLC-β, SOS and mTOR" . SPARSER::COLLECTION)
    ("PLC" . SPARSER::PROTEIN) ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("Torin-1, or rapamycin" . SPARSER::COLLECTION)
    ("Lipin 1 and mTOR" . SPARSER::COLLECTION)
    ("mTOR-associated FKBP38" . SPARSER::PROTEIN)
    ("S6K, 4E-BP1 and AKT" . SPARSER::COLLECTION)
    ("FKBP38 and mTOR" . SPARSER::COLLECTION)
    ("PA and the cellular inhibitor" . SPARSER::COLLECTION)
    ("LPAAT-" . SPARSER::PROTEIN)
    ("S6K, 4E-BP1, and AKT" . SPARSER::COLLECTION)
    ("siRNA and KRas" . SPARSER::COLLECTION)
    ("LP-1 and LP-2" . SPARSER::COLLECTION) ("KRas" . SPARSER::PROTEIN)
    ("LP-1 and LP-4" . SPARSER::COLLECTION)
    ("protein, LP-1, LP-2 and LP-4" . SPARSER::COLLECTION)
    ("LP-1" . SPARSER::PROTEIN) ("4E-BP1, S6K, and AKT" . SPARSER::COLLECTION)
    ("AKT, mTOR, and S6K" . SPARSER::COLLECTION)
    ("Ras and Raf" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("PLD- and DAGK-produced PA" . SPARSER::COLLECTION)
    ("PLD-" . SPARSER::PROTEIN) ("adipocytes" . SPARSER::PROTEIN)
    ("4E-BP1 and S6K" . SPARSER::COLLECTION)
    ("PLD and DAGK" . SPARSER::COLLECTION)
    ("PLD and DAG" . SPARSER::COLLECTION)
    ("CGL1, or Berardinelli-Seip" . SPARSER::COLLECTION)
    ("CGL" . SPARSER::PROTEIN) ("acyltransferase" . SPARSER::PROTEIN)
    ("lysophospholipid" . SPARSER::MOLECULE)
    ("phospholipase D (PLD)" . SPARSER::PROTEIN)
    ("PA and choline" . SPARSER::COLLECTION) ("LPA" . SPARSER::LPA)
    ("DAG" . SPARSER::DAG) ("diacylglycerol" . SPARSER::PROTEIN)
    ("DAGK" . SPARSER::PROTEIN) ("PLD" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("S6 Ribosomal Kinase" . SPARSER::KINASE)
    ("4E-BP1, and AKT" . SPARSER::COLLECTION)
    ("glycerolipid" . SPARSER::MOLECULE)
    ("4E-BP1, S6K and Akt" . SPARSER::COLLECTION)
    ("mTORC1-" . SPARSER::PROTEIN)
    ("Raf, PKC-ζ and mTOR" . SPARSER::COLLECTION) ("PA" . SPARSER::PROTEIN)
    ("LPAAT" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("PI5" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4-phosphate 5-kinase" . SPARSER::PROTEIN)
    ("RAB11FIP1" . SPARSER::PROTEIN) ("co-factor" . SPARSER::MOLECULE)
    ("Torin-1" . SPARSER::DRUG)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sn -2" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("lysophosphatidic acid acyltransferase" . SPARSER::PROTEIN)
    ("diacylglycerol kinase" . SPARSER::PROTEIN)
    ("phospholipase D" . SPARSER::PROTEIN) ("Lipin 1" . SPARSER::PROTEIN)
    ("FKBP38" . SPARSER::PROTEIN)
    ("Lysophosphatidic acid acyltransferase" . SPARSER::PROTEIN)
    ("FGG" . SPARSER::PROTEIN) ("ploidy" . SPARSER::PROTEIN)
    ("FGFR1 and MET" . SPARSER::COLLECTION) ("only 21 genes" . SPARSER::GENE)
    ("copy-neutral allelic imbalance fractions" . SPARSER::COMPONENT)
    ("GAP-ploidy" . SPARSER::PROTEIN-PAIR) ("MYCL" . SPARSER::PROTEIN)
    ("p22" . SPARSER::PROTEIN) ("FGA" . SPARSER::PROTEIN)
    ("CNA" . SPARSER::PROTEIN) ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("CDK4 , ERBB2 , ID1 , RB1 , CDKN2A and PTEN" . SPARSER::COLLECTION)
    ("NKX2-1/TITF1" . SPARSER::COLLECTION)
    ("recurrent CNAs" . SPARSER::PROTEIN) ("CNAs" . SPARSER::PROTEIN)
    ("subtypes, magnoid and squamoid" . SPARSER::COLLECTION)
    ("surfactant" . SPARSER::PROTEIN)
    ("ALK , RET , and ROS1" . SPARSER::COLLECTION)
    ("the most frequent histological type" . TYPE)
    ("TXNRD1" . SPARSER::PROTEIN) ("GGA2" . SPARSER::PROTEIN)
    ("CLDN10" . SPARSER::PROTEIN) ("CAMTA1" . SPARSER::PROTEIN)
    ("TNFRSF10B" . SPARSER::PROTEIN)
    ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("WHSC1L1" . SPARSER::PROTEIN)
    ("DUSP4" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("p34" . SPARSER::PROTEIN) ("ID1" . SPARSER::PROTEIN)
    ("TITF1" . SPARSER::PROTEIN) ("NKX2-1" . SPARSER::PROTEIN)
    ("ROS1" . SPARSER::PROTEIN)
    ("PCNA, BRCA1, P53 and ATM" . SPARSER::COLLECTION)
    ("hMLH1 and PCNA" . SPARSER::COLLECTION)
    ("hMLH1 and hMSH2" . SPARSER::COLLECTION)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("Ki67 or PCNA" . SPARSER::COLLECTION)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("PCNA or Ki67" . SPARSER::COLLECTION)
    ("hMSH2 or hMLH1" . SPARSER::COLLECTION)
    ("HMSH2, hMLH1, PCNA and Ki67" . SPARSER::COLLECTION)
    ("proteins, hMSH2, hMLH1, PCNA and Ki67" . SPARSER::COLLECTION)
    ("hMSH2, hMLH1, PCNA and Ki67" . SPARSER::COLLECTION)
    ("hMLH1, hMSH2, PCNA and Ki67" . SPARSER::COLLECTION)
    ("KRAS, BRAF, APC, P53, and TGF-β" . SPARSER::COLLECTION)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("hMLH1 or hMSH2" . SPARSER::COLLECTION)
    ("EGFR, KRAS, BRAF, PI3K and AKT" . SPARSER::COLLECTION)
    ("especially epidermal growth factor receptor tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("the predominant form" . SPARSER::FORM)
    ("hMLH1, hMSH2 and PCNA" . SPARSER::COLLECTION)
    ("hMLH1 and the adenocarcinoma subtype" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("melting" . SPARSER::DRUG)
    ("hMSH2 and hMLH1" . SPARSER::COLLECTION)
    ("PCNA and Ki67" . SPARSER::COLLECTION)
    ("HMSH2 and hMLH1" . SPARSER::COLLECTION) ("Mismatch" . SPARSER::PROTEIN)
    ("a 15 µ" . SPARSER::PROTEIN) ("K-2" . SPARSER::PROTEIN)
    ("hMSH2" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("HMSH2" . SPARSER::PROTEIN) ("Dai" . SPARSER::PROTEIN)
    ("histological type or anatomical location ( xref )" . SPARSER::COLLECTION)
    ("histological type" . TYPE) ("Histological Type" . TYPE) ("Type" . TYPE)
    ("type and ethnicity" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("Ray" . SPARSER::PROTEIN) ("cross-complementing" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("polymerase beta" . SPARSER::PROTEIN)
    ("a useful predictive biomarker" . SPARSER::MOLECULE)
    ("oxaliplatin or irinotecan" . SPARSER::COLLECTION)
    ("NCCN" . SPARSER::MOLECULE) ("levamisole" . SPARSER::MOLECULE)
    ("patients received standard 5-FU" . SPARSER::PROTEIN)
    ("Mixture" . SPARSER::MOLECULE)
    ("Cetuximab and Panitumumab" . SPARSER::COLLECTION)
    ("Panitumumab" . SPARSER::DRUG)
    ("specific genes and its inference" . SPARSER::COLLECTION)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a predictive biomarker" . SPARSER::MOLECULE) ("mCRC" . SPARSER::PROTEIN)
    ("ras  " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ras " . SPARSER::HUMAN-PROTEIN-FAMILY) ("N-ras" . SPARSER::PROTEIN)
    ("K- ras" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("Allele" . SPARSER::ALLELE) ("tobacco or alcohol" . SPARSER::COLLECTION)
    ("SSBs, and LIGIII" . SPARSER::COLLECTION) ("SSBs" . SPARSER::PROTEIN)
    ("tobacco" . SPARSER::DRUG)
    ("XRCC1 Arg399Gln variants and HNSCC risk" . SPARSER::COLLECTION)
    ("Arg/Gln" . SPARSER::COLLECTION) ("Arg/Arg" . SPARSER::COLLECTION)
    ("Gln/Gln" . SPARSER::COLLECTION)
    ("scaffolding protein" . SPARSER::PROTEIN) ("G-A" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN)
    ("Poly [ADP-ribose] polymerase 1" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("X-ray repair" . SPARSER::PROTEIN)
    ("autoantibodies" . SPARSER::PROTEIN) ("HF" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR)
    ("transforming growth factor-beta (TGF-β) and activin type 1 receptor kinases"
     . SPARSER::COLLECTION)
    ("activin" . SPARSER::PROTEIN) ("CCP" . SPARSER::PROTEIN)
    ("intima-media" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("HLA-DRB1" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("Ras/ERK-MAPK" . SPARSER::COLLECTION)
    ("the lentiviral shRNA-GLIPR-2" . SPARSER::COLLECTION)
    ("shRNA-GLIPR-2" . SPARSER::COLLECTION)
    ("GLIPR-2, vimentin and α-SMA" . SPARSER::COLLECTION)
    ("E-cadherin, vimentin and α-SMA" . SPARSER::COLLECTION)
    ("MAPK/ERK1/2" . SPARSER::COLLECTION)
    ("vimentin and α-SMA" . SPARSER::COLLECTION)
    ("GLIPR-2 and GLIPR-2" . SPARSER::COLLECTION)
    ("GAPR-1 and C9orf19" . SPARSER::COLLECTION)
    ("type2 and EMT" . SPARSER::COLLECTION)
    ("actin and vimentin" . SPARSER::COLLECTION)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("p- ERK1" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("α-SMA" . SPARSER::PROTEIN)
    ("PD98059" . SPARSER::MOLECULE) ("penicillin G" . SPARSER::MOLECULE)
    ("HK-2" . SPARSER::PROTEIN) ("C9orf19" . SPARSER::PROTEIN)
    ("GAPR-1" . SPARSER::PROTEIN) ("type2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 3" . SPARSER::PROTEIN) ("PR-1" . SPARSER::PROTEIN)
    ("GLIPR-2" . SPARSER::PROTEIN) ("n-3 and n-6" . SPARSER::COLLECTION)
    ("PUFAs" . SPARSER::MOLECULE) ("n-3 PUFA and risk" . SPARSER::COLLECTION)
    ("GCKR" . SPARSER::PROTEIN) ("related traits" . SPARSER::PROTEIN)
    ("gene and environment" . SPARSER::COLLECTION)
    ("CDKAL1 , HHEX , IGF2BP2 , TCF7L2 and SLC30A8" . SPARSER::COLLECTION)
    ("HHEX" . SPARSER::PROTEIN) ("Variants" . SPARSER::VARIANT)
    ("fat, MUFA, and smoking" . SPARSER::COLLECTION)
    ("MUFA" . SPARSER::MOLECULE) ("PUFA and PUFA" . SPARSER::COLLECTION)
    ("HOMA" . SPARSER::PROTEIN) ("dietary PUFA" . SPARSER::MOLECULE)
    ("dietary n-3" . SPARSER::PROTEIN) ("Traits" . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid (PUFA)" . SPARSER::MOLECULE)
    ("HOMA-IR" . SPARSER::COLLECTION) ("PUFA" . SPARSER::MOLECULE)
    ("IR" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("macronutrients" . SPARSER::MOLECULE) ("GCTA" . SPARSER::PROTEIN)
    ("MTNR1B" . SPARSER::PROTEIN) ("FAT3" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN) ("NFKB1" . SPARSER::PROTEIN)
    ("PLIN1" . SPARSER::PROTEIN) ("SLC30A8" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("IGF2BP2" . SPARSER::PROTEIN)
    ("CDKAL1" . SPARSER::PROTEIN) ("E-23" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("E-5" . SPARSER::PROTEIN)
    ("n-3" . SPARSER::PROTEIN) ("E-6" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("β-cell" . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("n-6" . SPARSER::PROTEIN) ("toxins" . SPARSER::MOLECULE)
    ("Chen" . SPARSER::PROTEIN)
    ("radiation-induced eIF2α kinase" . SPARSER::KINASE)
    ("tunicamycin" . SPARSER::MOLECULE) ("Saccharomyces" . SPARSER::PROTEIN)
    ("salubrinal and Vorinostat" . SPARSER::COLLECTION)
    ("Vorinostat" . SPARSER::DRUG)
    ("the phosphomimetic eIF2α S51D" . SPARSER::PROTEIN)
    ("/CD 24" . SPARSER::COLLECTION) ("ESA" . SPARSER::PROTEIN)
    ("eIF2α S51A and eIF2α S51D" . SPARSER::COLLECTION)
    ("the phosphomimetic variant" . SPARSER::VARIANT)
    ("the phosphomimetic eIF2α S51D variant" . SPARSER::VARIANT)
    ("rapamycin and irradiation" . SPARSER::COLLECTION)
    ("HDACi" . SPARSER::MOLECULE) ("TSC" . SPARSER::PROTEIN)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("doxorubicin or histone deacetylase" . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("MEF" . SPARSER::PROTEIN)
    ("kinase (PERK)" . SPARSER::KINASE) ("PERK" . SPARSER::PROTEIN)
    ("Salubrinal" . SPARSER::DRUG)
    ("the constitutive repressor of eIF2α phosphorylation (CreP) or the stress-induced growth arrest and DNA damage inducible protein (GADD34)"
     . SPARSER::COLLECTION)
    ("the stress-induced growth arrest and DNA damage inducible protein"
     . SPARSER::PROTEIN)
    ("its competitive inhibitor" . SPARSER::INHIBITOR)
    ("an active eIF2·GTP complex" . SPARSER::BIO-COMPLEX)
    ("codon and GTP" . SPARSER::COLLECTION) ("GDP" . SPARSER::NUCLEOTIDE)
    ("eIF2" . SPARSER::PROTEIN) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("mTORC" . SPARSER::PROTEIN) ("binding mTOR's" . SPARSER::PROTEIN)
    ("immunosuppressant" . SPARSER::DRUG) ("The mTOR's" . SPARSER::PROTEIN)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION) ("making eIF2α" . SPARSER::PROTEIN)
    ("the catalytic competitive inhibitor" . SPARSER::INHIBITOR)
    ("vorinostat" . SPARSER::DRUG)
    ("the phosphomimetic eIF2α variant" . SPARSER::VARIANT)
    ("salubrinal" . SPARSER::DRUG) ("eIF2α" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN) ("KU-0063794" . SPARSER::DRUG)
    ("CD 24" . SPARSER::PROTEIN) ("LT1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN) ("GADD34" . SPARSER::PROTEIN)
    ("PP1c" . SPARSER::PROTEIN) ("α at" . SPARSER::PROTEIN)
    ("mTORC2" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("FK506 binding protein 12" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("Ku-0063794" . SPARSER::DRUG)
    ("I-SceI" . SPARSER::PROTEIN) ("GSK" . SPARSER::PROTEIN)
    ("Plk2 or Plk3" . SPARSER::COLLECTION)
    ("Plk2 and Plk3" . SPARSER::COLLECTION)
    ("RTK/RAS/PI3K" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("INK4A/ARF" . SPARSER::COLLECTION) ("p53 and Plk1" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR) ("BBB" . SPARSER::PROTEIN)
    ("the mitotically-enriched fraction" . SPARSER::COMPONENT)
    ("SOX9 and the astrocyte differentiation marker GFAP ( xref )"
     . SPARSER::COLLECTION)
    ("the neural stem cell self-renewal factors SOX2, SOX9 and the astrocyte differentiation marker GFAP ( xref )"
     . SPARSER::COLLECTION)
    ("the neural stem cell self-renewal factors SOX2" . SPARSER::PROTEIN)
    ("812 proteins and their associated phosphorylated forms"
     . SPARSER::COLLECTION)
    ("their associated phosphorylated forms" . SPARSER::FORM)
    ("Imatinib" . SPARSER::DRUG)
    ("a lesser extent c-Kit and several other kinases" . SPARSER::COLLECTION)
    ("Cell-permeable chemical inhibitors" . SPARSER::INHIBITOR)
    ("CENP-A, CENP, or p21" . SPARSER::COLLECTION)
    ("an ATP-competitive" . SPARSER::ATP) ("PDGFRs" . SPARSER::PROTEIN)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho-histone" . SPARSER::PROTEIN) ("bright" . SPARSER::PROTEIN)
    ("Cdk/Crk" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("Crk" . SPARSER::PROTEIN)
    ("kinases, cyclin dependent kinases, and protein A" . SPARSER::COLLECTION)
    ("EMD" . SPARSER::PROTEIN) ("‘mesenchymal’ subtypes" . SPARSER::PROTEIN)
    ("this critical mitotic kinase" . SPARSER::KINASE)
    ("the pre-eminent class" . CLASS) ("Neural basal media" . SPARSER::PROTEIN)
    ("EGF and FGF-2" . SPARSER::COLLECTION) ("RB/CDK" . SPARSER::COLLECTION)
    ("RTK/PI3K" . SPARSER::COLLECTION)
    ("a conditional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BI" . SPARSER::PROTEIN) ("Antibody" . SPARSER::PROTEIN)
    ("GNS" . SPARSER::PROTEIN) ("Plk3" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("GSK461364" . SPARSER::DRUG)
    ("SOX9" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("CENP-A" . SPARSER::PROTEIN)
    ("Tyrosine Kinase" . SPARSER::PROTEIN) ("PDGF Receptor" . SPARSER::PROTEIN)
    ("Sox9" . SPARSER::PROTEIN) ("Plk2" . SPARSER::PROTEIN)
    ("α Tubulin" . SPARSER::PROTEIN) ("alpha-tubulin" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY) ("BI2536" . SPARSER::DRUG)
    ("GSK 461364" . SPARSER::DRUG) ("BI 2536" . SPARSER::DRUG)
    ("Plk1" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("only polymorphic variants" . SPARSER::VARIANT)
    ("ID 1, ID3 and ID" . SPARSER::COLLECTION)
    ("a premature termination codon" . SPARSER::PROTEIN)
    ("growth factor, and survivin" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("S10 and S46" . SPARSER::COLLECTION) ("and β" . SPARSER::PROTEIN)
    ("a premature stop codon" . SPARSER::PROTEIN)
    ("Intronic ID 17 variant" . SPARSER::VARIANT)
    ("ID 2 and E-cadherin" . SPARSER::COLLECTION)
    ("a 36-year-old young Caucasian male" . SPARSER::MOLECULE)
    ("5 distinct GCs" . SPARSER::PROTEIN) ("ID 2 and ID" . SPARSER::COLLECTION)
    ("GCs " . SPARSER::PROTEIN) ("sporadic GC" . SPARSER::PROTEIN)
    ("and β-catenin" . SPARSER::COLLECTION)
    ("converse ID 17 intronic variant" . SPARSER::VARIANT)
    ("agarose" . SPARSER::MOLECULE) ("intronic ID" . SPARSER::PROTEIN)
    ("Polymorphic and silent variants" . SPARSER::VARIANT)
    ("the mature E-cadherin" . SPARSER::PROTEIN)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("E-cadherin and N-cadherin" . SPARSER::COLLECTION)
    ("the mature protein" . SPARSER::PROTEIN)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("alanine-threonine" . SPARSER::COLLECTION) ("EC" . SPARSER::PROTEIN)
    ("the immature and mature (after the N-terminal cleavage) proteins"
     . SPARSER::PROTEIN)
    ("GC or AMAG" . SPARSER::COLLECTION)
    ("a homozygous state" . SPARSER::BIO-STATE)
    ("heterozygous state" . SPARSER::BIO-STATE)
    ("ID 4 and ID" . SPARSER::COLLECTION) ("WA" . SPARSER::MOLECULE)
    ("hereditary diffuse GC" . SPARSER::PROTEIN)
    ("consecutive random GC" . SPARSER::PROTEIN)
    ("prostatic" . SPARSER::PROTEIN)
    ("FIGC or intestinal GCs" . SPARSER::COLLECTION)
    ("intestinal GCs" . SPARSER::PROTEIN) ("FIGC" . SPARSER::PROTEIN)
    ("hereditary diffuse GC (HDGC)" . SPARSER::PROTEIN)
    ("GC (HDGC)" . SPARSER::PROTEIN) ("HDGC" . SPARSER::PROTEIN)
    ("intestinal type and diffuse type" . SPARSER::COLLECTION)
    ("intestinal type" . TYPE) ("of 45 or younger" . SPARSER::COLLECTION)
    ("GCs" . SPARSER::PROTEIN) ("U7" . SPARSER::PROTEIN)
    ("K1" . SPARSER::PROTEIN) ("A 2 µ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ID3" . SPARSER::PROTEIN) ("c- myc" . SPARSER::PROTEIN)
    ("ID 2" . SPARSER::PROTEIN) ("S46" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("ID4" . SPARSER::PROTEIN)
    ("ID 4" . SPARSER::PROTEIN) ("ID 3" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("protein 3" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("emphysema" . SPARSER::PROTEIN) ("antioxidants" . SPARSER::DRUG)
    ("kappaB" . SPARSER::PROTEIN) ("transducers" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN) ("superoxide" . SPARSER::MOLECULE)
    ("catalase" . SPARSER::PROTEIN) ("Redox" . SPARSER::PROTEIN)
    ("their own toxic metabolites" . SPARSER::PROTEIN)
    ("MIG" . SPARSER::PROTEIN)
    ("enzymes and antimicrobial peptides" . SPARSER::COLLECTION)
    ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("defensins" . SPARSER::PROTEIN) ("PAMPs" . SPARSER::PROTEIN)
    ("Neutrophils and macrophages" . SPARSER::COLLECTION)
    ("aims" . SPARSER::PROTEIN)
    ("several cytoprotective genes" . SPARSER::GENE)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("NADP" . SPARSER::MOLECULE) ("glutathione" . SPARSER::DRUG)
    ("Nfr2" . SPARSER::PROTEIN)
    ("a basic Leucine Zipper (bZIP) transcription factor" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("Leucine" . SPARSER::AMINO-ACID)
    ("extracellular surrounding biological substrates" . SPARSER::SUBSTRATE)
    ("ROS and proteases" . SPARSER::COLLECTION)
    ("protease enzymes and other pro-inflammatory mediators"
     . SPARSER::COLLECTION)
    ("other pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("macrophages and CD4" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("PCM" . SPARSER::PROTEIN)
    ("Neutrophils" . SPARSER::PROTEIN) ("keap1" . SPARSER::PROTEIN)
    ("pro-oxidant" . SPARSER::MOLECULE)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("CXCR3" . SPARSER::PROTEIN)
    ("CXCL-9" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("nuclear factor erythroid-2" . SPARSER::PROTEIN)
    ("Th-1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("glycemic state" . SPARSER::BIO-STATE)
    ("GM-CSF and STAT5Pytr" . SPARSER::COLLECTION)
    ("dexamethasone and IL-4" . SPARSER::COLLECTION)
    ("diabetic monocytes" . SPARSER::PROTEIN)
    ("STAT-STAT" . SPARSER::COLLECTION)
    ("IL-10- and IL-4-" . SPARSER::COLLECTION) ("IL-4-" . SPARSER::PROTEIN)
    ("IL-10-" . SPARSER::PROTEIN)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("IL-4 and IL-10" . SPARSER::COLLECTION)
    ("at least 2 genes" . SPARSER::GENE) ("Genome" . SPARSER::PROTEIN)
    ("IL-4 and dexamethasone" . SPARSER::COLLECTION)
    ("-PTGS2" . SPARSER::COLLECTION) ("dexamethasone" . SPARSER::PROTEIN)
    ("Dexamethasone" . SPARSER::PROTEIN) ("IL10-PTGS2" . SPARSER::COLLECTION)
    ("Exogenous GM-CSF" . SPARSER::PROTEIN)
    ("CSF2 and PGTS2" . SPARSER::COLLECTION)
    ("GM-CSF, and IL-4" . SPARSER::COLLECTION)
    ("STAT5/STAT6" . SPARSER::COLLECTION)
    ("GM-CSF or IL-2" . SPARSER::COLLECTION)
    ("CSF2 or PTGS2" . SPARSER::COLLECTION) ("COX2/PGS2" . SPARSER::COLLECTION)
    ("significantly higher activated STAT5" . SPARSER::PROTEIN)
    ("Monocytes" . SPARSER::PROTEIN) ("IL10 and PTGS2" . SPARSER::COLLECTION)
    ("readily analyzable using modification specific antibodies"
     . SPARSER::ANTIBODY)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("glass or endotoxin" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE) ("glass" . SPARSER::MOLECULE)
    ("proteins, STAT5A and STAT5B" . SPARSER::COLLECTION)
    ("Excessive PGE2" . SPARSER::DRUG)
    ("the pro-inflammatory prostanoid prostaglandin E2" . SPARSER::MOLECULE)
    ("monocytes and nonobese" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("macrophages, and myeloid" . SPARSER::COLLECTION)
    ("Macrophage" . SPARSER::PROTEIN) ("Myeloid" . SPARSER::PROTEIN)
    ("SMRT/NCoR" . SPARSER::COLLECTION) ("CBP/P300" . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("acetylase" . SPARSER::PROTEIN) ("CSF2 and PTGS2" . SPARSER::COLLECTION)
    ("PGS2/COX2" . SPARSER::COLLECTION)
    ("synthase 2/cyclooxygenase 2" . SPARSER::COLLECTION)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("Histone" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("sodium bicarbonate" . SPARSER::DRUG) ("IL-4" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("Type 1" . SPARSER::PROTEIN)
    ("Colony Stimulating Factor" . SPARSER::PROTEIN)
    ("RNA Polymerase II" . SPARSER::PROTEIN) ("P300" . SPARSER::PROTEIN)
    ("PGS2" . SPARSER::PROTEIN) ("cyclooxygenase 2" . SPARSER::PROTEIN)
    ("GM-CSF" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony stimulating factor" . SPARSER::PROTEIN)
    ("CSF2" . SPARSER::PROTEIN)
    ("trypsin inhibitor and trypsin" . SPARSER::COLLECTION)
    ("trypsin" . SPARSER::PROTEIN)
    ("three colorectal carcinoma samples EGFR" . SPARSER::PROTEIN)
    ("bisphosphonate" . SPARSER::MOLECULE)
    ("phosphatidylinositol" . SPARSER::MOLECULE) ("EGFR-" . SPARSER::PROTEIN)
    ("CRCs" . SPARSER::PROTEIN) ("anti-EGFR-" . SPARSER::PROTEIN)
    ("EGFR or TATI/SPINK1" . SPARSER::COLLECTION)
    ("EGFR/TATI" . SPARSER::COLLECTION) ("EGFR−/TATI+" . SPARSER::COLLECTION)
    ("TATI+" . SPARSER::PROTEIN) ("EGFR−TATI+" . SPARSER::PROTEIN-PAIR)
    ("A–B" . SPARSER::PROTEIN) ("EGFR and TATI" . SPARSER::COLLECTION)
    ("inhibitor (TATI)" . SPARSER::INHIBITOR)
    ("pancreatic secretory trypsin inhibitor (PSTI)" . SPARSER::PROTEIN)
    ("PSTI" . SPARSER::PROTEIN) ("EGF, and epigen" . SPARSER::COLLECTION)
    ("epigen" . SPARSER::PROTEIN) ("heparin" . SPARSER::PROTEIN)
    ("betacellulin" . SPARSER::PROTEIN) ("epiregulin" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::DRUG) ("amphiregulin" . SPARSER::PROTEIN)
    ("EGF" . SPARSER::PROTEIN) ("triphosphatase" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE)
    ("The monoclonal antibodies cetuximab and panitumumab"
     . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("local CRC" . SPARSER::PROTEIN) ("EGFR−" . SPARSER::PROTEIN)
    ("TATI−" . SPARSER::PROTEIN) ("EGFR and TATI/SPINK1" . SPARSER::COLLECTION)
    ("TATI/SPINK1" . SPARSER::COLLECTION)
    ("tumor-associated trypsinogen inhibitor TATI" . SPARSER::PROTEIN)
    ("TATI" . SPARSER::PROTEIN) ("alpha polypeptide" . SPARSER::PROTEIN)
    ("C–D" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("SPINK1" . SPARSER::PROTEIN) ("SPINK 1" . SPARSER::PROTEIN)
    ("type1" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("RAD52-MUS81" . SPARSER::COLLECTION)
    ("MUS81 and GEN1" . SPARSER::COLLECTION)
    ("RAD52 and CHK1" . SPARSER::COLLECTION)
    ("BLM, SLX4 or GEN1" . SPARSER::COLLECTION)
    ("defective RAD51" . SPARSER::PROTEIN) ("BIR" . SPARSER::PROTEIN)
    ("SUMO" . SPARSER::PROTEIN)
    ("a phosphomimetic RAD51-T309D mutant" . SPARSER::MUTANT)
    ("an unphosphorylatable RAD51-T309A mutant" . SPARSER::MUTANT)
    ("recombinase" . SPARSER::PROTEIN)
    ("exonucleases and endonucleases" . SPARSER::COLLECTION)
    ("replisomes" . SPARSER::BIO-COMPLEX)
    ("the functional homolog of" . SPARSER::PROTEIN)
    ("CHK1 or RAD51" . SPARSER::COLLECTION)
    ("another structure-specific endonuclease" . SPARSER::PROTEIN)
    ("TIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATR, RAD9 or TOPBP1" . SPARSER::COLLECTION)
    ("Ctrl, MUS81 or RAD52" . SPARSER::COLLECTION)
    ("RAD51, RAD52 and MUS81" . SPARSER::COLLECTION)
    ("chromatin-associated RAD51" . SPARSER::PROTEIN)
    ("the phosphomimetic RAD51-T309D mutant" . SPARSER::MUTANT)
    ("GEN1 or SLX4" . SPARSER::COLLECTION)
    ("RAD52/MUS81" . SPARSER::COLLECTION)
    ("SLX4, GEN1 or BLM" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("only IdU-positive replication foci" . SPARSER::PROTEIN)
    ("IdU" . SPARSER::DRUG) ("RAD51 and RAD52" . SPARSER::COLLECTION)
    ("rid" . SPARSER::DRUG) ("-flap" . SPARSER::COLLECTION)
    ("flap" . SPARSER::PROTEIN) ("nuclease and RAD52" . SPARSER::COLLECTION)
    ("nuclease" . SPARSER::PROTEIN)
    ("Myc-tagged MUS81 and GST-tagged EME1 ( xref )" . SPARSER::COLLECTION)
    ("RAD52 or RAD51" . SPARSER::COLLECTION)
    ("MUS81/EME1" . SPARSER::COLLECTION)
    ("MUS81 and RAD52" . SPARSER::COLLECTION)
    ("chromatin-associated RAD52" . SPARSER::PROTEIN)
    ("MUS81 and RAD51" . SPARSER::COLLECTION)
    ("SLX4 or GEN1" . SPARSER::COLLECTION)
    ("MUS81 or RAD52" . SPARSER::COLLECTION)
    ("MUS81/RAD52" . SPARSER::COLLECTION)
    ("wild-type RAD51 or the phosphorylation-defective RAD51-T309A mutant ( xref )"
     . SPARSER::COLLECTION)
    ("the phosphorylation-defective RAD51-T309A mutant" . SPARSER::MUTANT)
    ("alkaline" . SPARSER::PROTEIN) ("UCN-01 or HU" . SPARSER::COLLECTION)
    ("ATR or RAD9" . SPARSER::COLLECTION)
    ("ATR, RAD9 or TIPIN" . SPARSER::COLLECTION)
    ("the DNA damage checkpoint kinase CHK2 or the replication fork protection factor TIPIN"
     . SPARSER::COLLECTION)
    ("Ctrl or MUS81" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("ATR and CHK1" . SPARSER::COLLECTION)
    ("UCN-01 or ETP-46464" . SPARSER::COLLECTION)
    ("ATR, CHK1 or TIPIN" . SPARSER::COLLECTION)
    ("intense γH2AX" . SPARSER::PROTEIN) ("ATR or CHK1" . SPARSER::COLLECTION)
    ("TIPIN or CHK2" . SPARSER::COLLECTION)
    ("MUS81, TIPIN or CHK2" . SPARSER::COLLECTION) ("TIPIN" . SPARSER::PROTEIN)
    ("CHK1 or ATR" . SPARSER::COLLECTION)
    ("RAD9 or TOPBP1" . SPARSER::COLLECTION) ("hTERT" . SPARSER::PROTEIN)
    ("RecQ" . SPARSER::PROTEIN-FAMILY) ("WRN" . SPARSER::PROTEIN)
    ("RAD51 or RAD52" . SPARSER::COLLECTION)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("a structure-specific endonuclease" . SPARSER::PROTEIN)
    ("exonucleases" . SPARSER::PROTEIN) ("replisome" . SPARSER::PROTEIN)
    ("RAD52 or MUS81" . SPARSER::COLLECTION)
    ("RAD52 and MUS81" . SPARSER::COLLECTION)
    ("the structure-specific endonuclease MUS81" . SPARSER::PROTEIN)
    ("cm −1" . SPARSER::PROTEIN) ("M −1" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("Lamin B1" . SPARSER::PROTEIN)
    ("H3 histone" . SPARSER::PROTEIN) ("Mus81" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("rad51" . SPARSER::PROTEIN)
    ("Rad53" . SPARSER::PROTEIN) ("P 32" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("GEN1" . SPARSER::PROTEIN)
    ("SLX4" . SPARSER::PROTEIN) ("Bromo-deoxyuridine" . SPARSER::DRUG)
    ("UCN-01" . SPARSER::DRUG) ("ETP-46464" . SPARSER::DRUG)
    ("TOPBP1" . SPARSER::PROTEIN) ("RAD9" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("EME1" . SPARSER::PROTEIN)
    ("RAD52" . SPARSER::PROTEIN) ("MUS81" . SPARSER::PROTEIN)
    ("E6 and p53DD" . SPARSER::COLLECTION)
    ("γ-H2AX, 53BP1, Brca1 and Chk2" . SPARSER::COLLECTION)
    ("pATM" . SPARSER::PROTEIN) ("LCR" . SPARSER::PROTEIN)
    ("the respective E1 and E2 genes" . SPARSER::GENE)
    ("BPV-1" . SPARSER::COLLECTION)
    ("replicated viral genomes" . SPARSER::PROTEIN) ("HP" . SPARSER::PROTEIN)
    ("the papillomaviral E1 and E2 proteins" . SPARSER::PROTEIN)
    ("extrachromosomal HPV31 E6STOP genomes" . SPARSER::PROTEIN)
    ("other viral genes" . SPARSER::GENE)
    ("DNA and the ability of E6 mutants to inhibit p53 K382 acetylation"
     . SPARSER::COLLECTION)
    ("HPV16 extrachromosomal genomes" . SPARSER::PROTEIN)
    ("E6I128T" . SPARSER::PROTEIN)
    ("two other mutant genomes HPV16 E6I128T and HPV16 E6Δ146–151"
     . SPARSER::COLLECTION)
    ("genomes HPV16 E6I128T" . SPARSER::PROTEIN)
    ("barely detectable viral genomes" . SPARSER::PROTEIN)
    ("0.5 nM actinomycin D or 5 nM actinomycin D" . SPARSER::COLLECTION)
    ("the respective genome" . SPARSER::PROTEIN)
    ("viral genomes" . SPARSER::PROTEIN)
    ("the viral genomes" . SPARSER::PROTEIN)
    ("the HPV16 E6I128T extrachromosomal genome" . SPARSER::PROTEIN)
    ("E6AP and p53" . SPARSER::COLLECTION)
    ("E6AP and increases telomerase activity" . SPARSER::COLLECTION)
    ("the HPV16 E6*I and E6*II mutant viral genomes" . SPARSER::PROTEIN)
    ("detectable circular viral genomes" . SPARSER::PROTEIN)
    ("non-unit length viral DNA" . SPARSER::DNA)
    ("circular viral DNA genomes" . SPARSER::PROTEIN)
    ("extrachromosomal HPV16 genomes" . SPARSER::PROTEIN)
    ("antibiotic" . SPARSER::DRUG) ("31 E6 null genomes" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN)
    ("an extrachromosomal genome" . SPARSER::PROTEIN)
    ("the ubiquitin ligase E6AP and the tumor suppressor p53"
     . SPARSER::COLLECTION)
    ("a tripartite complex" . SPARSER::BIO-COMPLEX)
    ("approximately 150 amino acids" . SPARSER::AMINO-ACID)
    ("viral and cellular genes" . SPARSER::GENE)
    ("Additional viral genes" . SPARSER::GENE)
    ("50–200 extrachromosomal genomes" . SPARSER::PROTEIN)
    ("bovine papillomavirus type 1 (BPV1) as well as HPV6b"
     . SPARSER::COLLECTION)
    ("bovine papillomavirus type 1" . SPARSER::PROTEIN)
    ("two papillomaviral genes" . SPARSER::GENE)
    ("E1 and E2" . SPARSER::COLLECTION)
    ("an 8 kB circular double-stranded DNA" . SPARSER::DNA)
    ("its viral genome" . SPARSER::PROTEIN)
    ("the viral genome" . SPARSER::PROTEIN)
    ("the viral gene E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral circular genome" . SPARSER::PROTEIN)
    ("genome" . SPARSER::PROTEIN) ("genomes" . SPARSER::PROTEIN)
    ("SAT" . SPARSER::PROTEIN) ("interferon-induced" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("interferon induced" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("E6AP" . SPARSER::PROTEIN)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the characteristic DNA" . SPARSER::DNA)
    ("INM and ONM" . SPARSER::COLLECTION) ("Lamin" . SPARSER::PROTEIN)
    ("the initial cellular trigger" . SPARSER::PROTEIN)
    ("PKC and cdk" . SPARSER::COLLECTION) ("Dextran" . SPARSER::DEXTRAN)
    ("protein and chromatin" . SPARSER::COLLECTION)
    ("PKCα and cdk-1/2" . SPARSER::COLLECTION)
    ("Thapsigargin" . SPARSER::MOLECULE) ("chelator" . SPARSER::MOLECULE)
    ("untypical Ca ++ -independent PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Roscovitine" . SPARSER::DRUG)
    ("cdk-2 and AAV2" . SPARSER::COLLECTION)
    ("PKC and cdk-2" . SPARSER::COLLECTION)
    ("the soluble cytoplasmic fractions" . SPARSER::COMPONENT)
    ("cdk-2 and iii" . SPARSER::COLLECTION)
    ("PKC, cdk and caspase-3" . SPARSER::COLLECTION)
    ("pro-, meta- and anaphase" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKC, cdk-1/2 and caspase-3" . SPARSER::COLLECTION)
    ("zDEVD-fmk" . SPARSER::COLLECTION) ("fmk" . SPARSER::PROTEIN)
    ("roscovitine" . SPARSER::DRUG) ("EM" . SPARSER::PROTEIN)
    ("DNA or uptake" . SPARSER::COLLECTION) ("Electron" . SPARSER::MOLECULE)
    ("the membrane impermeable PI" . SPARSER::PROTEIN)
    ("Nup358 and Nup153" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN) ("smaller molecules" . SPARSER::MOLECULE)
    ("receptor (LBR)" . SPARSER::RECEPTOR) ("LBR" . SPARSER::PROTEIN)
    ("NRK" . SPARSER::PROTEIN) ("iodixanol" . SPARSER::DRUG)
    ("anti" . SPARSER::PROTEIN) ("PV and NEBD" . SPARSER::COLLECTION)
    ("DAPI" . SPARSER::DRUG) ("iodide (PI)" . SPARSER::PROTEIN)
    ("soluble cytosolic proteins" . SPARSER::PROTEIN)
    ("soluble cytoplasmic proteins" . SPARSER::PROTEIN)
    ("Digitonin" . SPARSER::MOLECULE) ("digitonin" . SPARSER::MOLECULE)
    ("canine PV" . SPARSER::PROTEIN) ("capsids" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN)
    ("The larger protein" . SPARSER::PROTEIN)
    ("autonomous PV" . SPARSER::PROTEIN) ("cdks and PKC" . SPARSER::COLLECTION)
    ("PKCδ and cdks" . SPARSER::COLLECTION)
    ("lamins and lamin-associated proteins" . SPARSER::COLLECTION)
    ("lamin-associated proteins" . SPARSER::PROTEIN)
    ("both peripheral and integral membrane proteins" . SPARSER::PROTEIN)
    ("lamin" . SPARSER::PROTEIN) ("lamins" . SPARSER::PROTEIN-FAMILY)
    ("INM and the chromatin" . SPARSER::COLLECTION) ("INM" . SPARSER::PROTEIN)
    ("receptor-RanGTP" . SPARSER::COLLECTION) ("RanGTP" . SPARSER::PROTEIN)
    ("soluble transport receptors" . SPARSER::RECEPTOR)
    ("karyopherin" . SPARSER::PROTEIN)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macromolecules" . SPARSER::MOLECULE) ("NPCs" . SPARSER::MOLECULE)
    ("nucleoporins" . SPARSER::PROTEIN) ("NPC" . SPARSER::MOLECULE)
    ("macromolecule" . SPARSER::MOLECULE)
    ("key mitotic enzymes" . SPARSER::ENZYME) ("ZVAD-fmk" . SPARSER::DRUG)
    ("c-PLA 2" . SPARSER::PROTEIN) ("α- tubulin" . SPARSER::PROTEIN)
    ("TAT-1" . SPARSER::PROTEIN) ("NO 3" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("cyclin A2" . SPARSER::PROTEIN)
    ("LY333531" . SPARSER::DRUG) ("PKCβ" . SPARSER::PROTEIN)
    ("PKCγ" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("Cdk-2" . SPARSER::PROTEIN) ("Cdk-1" . SPARSER::PROTEIN)
    ("zVAD-fmk" . SPARSER::DRUG) ("cdk-1" . SPARSER::PROTEIN)
    ("Tx-100" . SPARSER::DRUG) ("nuclear pores" . SPARSER::BIO-COMPLEX)
    ("p62" . SPARSER::PROTEIN) ("Nup214" . SPARSER::PROTEIN)
    ("Nup153" . SPARSER::PROTEIN) ("Nup62" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("PLA 2" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("PKC α" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("cdk-2" . SPARSER::PROTEIN) ("the canonical DRE" . SPARSER::PROTEIN)
    ("showed no significant ligand- or species-specific differences"
     . SPARSER::COLLECTION)
    ("kynurenine" . SPARSER::MOLECULE) ("ligand-" . SPARSER::LIGAND)
    ("DREs" . SPARSER::PROTEIN) ("classical AhR agonists" . SPARSER::AGONIST)
    ("-GGGCGGG-3" . SPARSER::COLLECTION) ("PON1 and Bax" . SPARSER::COLLECTION)
    ("quercetin or DMBA-DHD" . SPARSER::COLLECTION)
    ("these receptors and their associated proteins" . SPARSER::COLLECTION)
    ("their associated proteins" . SPARSER::PROTEIN)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("XRE-PON1" . SPARSER::COLLECTION) ("TCDD or 3MC" . SPARSER::COLLECTION)
    ("XRE-PON" . SPARSER::COLLECTION) ("PON" . SPARSER::PROTEIN)
    ("XRE" . SPARSER::PROTEIN) ("PON1-luciferase" . SPARSER::COLLECTION)
    ("DRE3 or PON1" . SPARSER::COLLECTION)
    ("a heterologous promoter" . SPARSER::PROMOTER)
    ("YFP-AhR" . SPARSER::COLLECTION)
    ("a competitive ligand" . SPARSER::LIGAND)
    ("a basal transcription factor" . SPARSER::PROTEIN)
    ("DRE3 or Bax or mutant" . SPARSER::COLLECTION)
    ("DRE3, Bax, or mutant" . SPARSER::COLLECTION)
    ("TCDD or DMBA-DHD" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("the AhR and/or the AhR:ARNT complex" . SPARSER::COLLECTION)
    ("protein:PON1" . SPARSER::BIO-COMPLEX)
    ("protein:DRE3" . SPARSER::BIO-COMPLEX)
    ("TCDD- or DMBA-DHD-induced" . SPARSER::COLLECTION)
    ("Bax or mutant" . SPARSER::COLLECTION)
    ("protein-DRE3" . SPARSER::COLLECTION)
    ("DMSO, TCDD or DMBADHD" . SPARSER::COLLECTION)
    ("DRE3, Bax or mutant" . SPARSER::COLLECTION)
    ("quercetin-" . SPARSER::MOLECULE) ("TCDD-" . SPARSER::PROTEIN)
    ("AhR:ARNT:DNA" . SPARSER::COLLECTION) ("DRE3" . SPARSER::PROTEIN)
    ("AhR:ARNT:DRE3" . SPARSER::BIO-COMPLEX)
    ("quercetin and TCDD" . SPARSER::COLLECTION)
    ("PON1 or Bax" . SPARSER::COLLECTION) ("DRE" . SPARSER::PROTEIN)
    ("ligand:AhR:ARNT:DRE" . SPARSER::COLLECTION)
    ("AhR and ARNT" . SPARSER::COLLECTION)
    ("the murine Bax and human PON1 genes" . SPARSER::COLLECTION)
    ("Bax or PON1" . SPARSER::COLLECTION) ("-GCGTG-3" . SPARSER::COLLECTION)
    ("DHD" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("PAH" . SPARSER::PROTEIN) ("AhR:ARNT" . SPARSER::BIO-COMPLEX)
    ("the Ah receptor nuclear translocator (ARNT) protein and the resulting ligand:AhR:ARNT heterodimer"
     . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("ligand:AhR:ARNT" . SPARSER::COLLECTION) ("ARNT" . SPARSER::PROTEIN)
    ("labile and only transient AhR activators [ xref ]" . SPARSER::COLLECTION)
    ("labile" . SPARSER::PROTEIN) ("methylcholanthrene" . SPARSER::MOLECULE)
    ("pyrene" . SPARSER::PROTEIN) ("TCDD" . SPARSER::PROTEIN)
    ("a unique ligand-dependent transcription factor" . SPARSER::PROTEIN)
    ("Bax and PON1" . SPARSER::COLLECTION)
    ("the murine Bax and human paraoxonase 1 (PON1) genes"
     . SPARSER::COLLECTION)
    ("structurally diverse chemicals" . SPARSER::MOLECULE)
    ("dioxin" . SPARSER::MOLECULE) ("AhR" . SPARSER::PROTEIN)
    ("PCB 126" . SPARSER::DRUG) ("SREBP2" . SPARSER::PROTEIN)
    ("sterol regulatory element binding protein 2" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("a 2s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("Ah receptor" . SPARSER::PROTEIN) ("PON1" . SPARSER::PROTEIN)
    ("paraoxonase 1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("transglutaminase-2 (TG2) and FlnA" . SPARSER::COLLECTION)
    ("serotonin" . SPARSER::MOLECULE) ("FlnA–Ras" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factors and GTPase-activating"
     . SPARSER::COLLECTION)
    ("p120RasGAP/p190RhoGAP" . SPARSER::COLLECTION)
    ("FlnA–FilGAP" . SPARSER::COLLECTION) ("Rac–GAP" . SPARSER::COLLECTION)
    ("Rac1–GAP" . SPARSER::COLLECTION) ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("FlnA–actin" . SPARSER::COLLECTION) ("FlnA/actin" . SPARSER::COLLECTION)
    ("filamin" . SPARSER::PROTEIN-FAMILY) ("exogenous FlnA" . SPARSER::PROTEIN)
    ("FlnAs" . SPARSER::PROTEIN) ("RhoA and Rac1" . SPARSER::COLLECTION)
    ("RhoA–Rac1" . SPARSER::COLLECTION) ("RhoA–ROCK" . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN)
    ("ARHGAP22 and a closely related Rac1-specific GAP protein"
     . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1 and ROCK" . SPARSER::COLLECTION)
    ("NSC23766 and Y27632" . SPARSER::COLLECTION)
    ("RhoA-Rac1" . SPARSER::PROTEIN-PAIR)
    ("dt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dCI" . SPARSER::MOLECULE)
    ("GST–Cdc42/Rac Interactive Binding (GST–Crib) fusion proteins"
     . SPARSER::PROTEIN)
    ("GST–Cdc42/Rac" . SPARSER::COLLECTION) ("GST–RTK" . SPARSER::COLLECTION)
    ("Crib" . SPARSER::DRUG) ("FlnA–KO" . SPARSER::PROTEIN-PAIR)
    ("filamins" . SPARSER::PROTEIN-FAMILY)
    ("FlnA/β-actin" . SPARSER::COLLECTION)
    ("GTPases, RhoA and Rac1" . SPARSER::COLLECTION)
    ("subdomains" . SPARSER::PROTEIN) ("MNS" . SPARSER::PROTEIN)
    ("FLNA" . SPARSER::PROTEIN) ("vimentin and PKCε" . SPARSER::COLLECTION)
    ("the 3rd Igl" . SPARSER::PROTEIN)
    ("small GTPases and their regulators" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("Filamin’s" . SPARSER::PROTEIN-FAMILY)
    ("three highly related homologous proteins" . SPARSER::PROTEIN)
    ("around signaling molecules" . SPARSER::MOLECULE)
    ("FilGAP" . SPARSER::PROTEIN) ("Igl" . SPARSER::PROTEIN)
    ("which anchors various transmembrane proteins" . SPARSER::PROTEIN)
    ("a ubiquitous actin binding protein" . SPARSER::PROTEIN)
    ("anchors" . SPARSER::ANCHOR) ("FlnA" . SPARSER::PROTEIN)
    ("Filamin" . SPARSER::PROTEIN-FAMILY)
    ("transglutaminase-2" . SPARSER::PROTEIN) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("p120RasGAP" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN) ("1–4" . SPARSER::PROTEIN)
    ("Igl 1" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("ARHGAP22" . SPARSER::PROTEIN) ("GTPase Activating" . SPARSER::PROTEIN)
    ("2–4" . SPARSER::PROTEIN) ("NSC23766" . SPARSER::DRUG)
    ("X-linked" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("R-Ras" . SPARSER::PROTEIN) ("non-muscle" . SPARSER::PROTEIN)
    ("(beta" . SPARSER::PROTEIN) ("alpha)" . SPARSER::PROTEIN)
    ("rational drug" . SPARSER::DRUG)
    ("a nonspecific phosphodiesterase inhibitor" . SPARSER::INHIBITOR)
    ("Pentoxifylline (PTX)" . SPARSER::DRUG) ("xanthine" . SPARSER::MOLECULE)
    ("Pentoxifylline" . SPARSER::DRUG)
    ("NF-KB and STAT3" . SPARSER::COLLECTION) ("MCL" . SPARSER::PROTEIN)
    ("platinum (IV)" . SPARSER::MOLECULE)
    ("CPA-1 and CPA-7" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("MAPK and PI3K/Akt [ xref ]" . SPARSER::COLLECTION)
    ("purine" . SPARSER::DRUG)
    ("the most widely used chemotherapeutic drugs" . SPARSER::DRUG)
    ("cisplatin, carboplatin, and oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("carboplatin" . SPARSER::DRUG)
    ("Platinum" . SPARSER::MOLECULE) ("AC" . SPARSER::PROTEIN)
    ("Pacritinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("JAK1 and JAK2" . SPARSER::COLLECTION) ("Ruxolitinib" . SPARSER::DRUG)
    ("JAK1, JAK2, JAK3, and TYK2" . SPARSER::COLLECTION)
    ("tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tyrphostins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bromo" . SPARSER::MOLECULE) ("oxime" . SPARSER::MOLECULE)
    ("Mcl-1 and survivin" . SPARSER::COLLECTION)
    ("Nam and coworkers" . SPARSER::COLLECTION) ("cSrc" . SPARSER::PROTEIN)
    ("Nam" . SPARSER::PROTEIN-FAMILY) ("indirubin" . SPARSER::DRUG)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("a Chinese herbal medicine" . SPARSER::DRUG) ("Indirubin" . SPARSER::DRUG)
    ("homoserine" . SPARSER::MOLECULE)
    ("STAT3 and STAT1" . SPARSER::COLLECTION)
    ("cyclopentenone" . SPARSER::DRUG) ("Fas/CD95" . SPARSER::COLLECTION)
    ("STAT3/p53/p21" . SPARSER::COLLECTION)
    ("JAK2, Src, Akt, Erk, or JNK" . SPARSER::COLLECTION)
    ("gemcitabine" . SPARSER::DRUG)
    ("phosphotyrosine of constitutively activated STAT3 in many human cancer cell"
     . SPARSER::PROTEIN)
    ("cucurbitacin" . SPARSER::MOLECULE) ("Cucurbitacin" . SPARSER::MOLECULE)
    ("STAT3 and STAT5" . SPARSER::COLLECTION) ("bortezomib" . SPARSER::DRUG)
    ("flavopiridol" . SPARSER::DRUG) ("PKC and Erk-1" . SPARSER::COLLECTION)
    ("Flavopiridol" . SPARSER::DRUG) ("Src and STAT3" . SPARSER::COLLECTION)
    ("a naturally occurring polyphenolic phytoalexin" . SPARSER::MOLECULE)
    ("phytoalexin" . SPARSER::MOLECULE) ("Curcumin" . SPARSER::DRUG)
    ("STAT3 or other inhibitors" . SPARSER::COLLECTION)
    ("SDF-1/CXCL12" . SPARSER::COLLECTION)
    ("IL6, IL10, and VEGF" . SPARSER::COLLECTION)
    ("STAT3 and HIF1 α" . SPARSER::COLLECTION)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("The most potent angiogenic molecule" . SPARSER::MOLECULE)
    ("IL6 and TNF α" . SPARSER::COLLECTION) ("stathmin" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("MMP-9 and MMP-1" . SPARSER::COLLECTION) ("LIF" . SPARSER::PROTEIN)
    ("p53, which is considered to be the most common inhibitor of cellular proliferation as well as inducer"
     . SPARSER::COLLECTION)
    ("Mcl" . SPARSER::PROTEIN) ("BclxL" . SPARSER::PROTEIN)
    ("cyclin D1 and cMyc" . SPARSER::COLLECTION)
    ("cMyc and cyclin D1" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("STP" . SPARSER::PROTEIN) ("RET/PTC" . SPARSER::COLLECTION)
    ("RET" . SPARSER::PROTEIN) ("TRK" . SPARSER::PROTEIN)
    ("kinases, oncogenes, and viruses" . SPARSER::COLLECTION)
    ("PIAS1 and PIAS3" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("PIASx and PIASy" . SPARSER::COLLECTION)
    ("PIAS1, PIAS3 and PIASx" . SPARSER::COLLECTION)
    ("STAT1, STAT3, and STAT4" . SPARSER::COLLECTION)
    ("PIASx" . SPARSER::PROTEIN)
    ("transcriptional corepressors or coactivators" . SPARSER::COLLECTION)
    ("corepressors or coactivators" . SPARSER::COLLECTION)
    ("PIAS1, PIAS3, PIASy, PIASxa, and PIASxb" . SPARSER::COLLECTION)
    ("PIASy" . SPARSER::PROTEIN) ("PIAS" . SPARSER::PROTEIN-FAMILY)
    ("tyrosine and serine" . SPARSER::COLLECTION)
    ("both phosphotyrosine and phosphoserine/phosphothreonine"
     . SPARSER::COLLECTION)
    ("phosphoserine/phosphothreonine" . SPARSER::COLLECTION)
    ("JAK3 and STAT3" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("The classical PTPs" . SPARSER::PROTEIN)
    ("CD45 and nontransmembrane" . SPARSER::COLLECTION)
    ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("classical protein tyrosine phosphatases (PTPs), dual-specificity phosphatases, and low molecular weight phosphatases [ xref ]"
     . SPARSER::COLLECTION)
    ("classical protein tyrosine phosphatases" . SPARSER::PHOSPHATASE)
    ("PTPs" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("PKC δ , mTOR, and NLK" . SPARSER::COLLECTION) ("NLK" . SPARSER::PROTEIN)
    ("Src and abl" . SPARSER::COLLECTION) ("abl" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGFR)" . SPARSER::PROTEIN)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR) ("VEGFR" . SPARSER::PROTEIN)
    ("a valid molecular target" . SPARSER::TARGET-PROTEIN)
    ("active STAT dimer" . SPARSER::DIMER)
    ("homotypic dimers" . SPARSER::DIMER)
    ("STAT1 and STAT4" . SPARSER::COLLECTION)
    ("chromosome 17, and STAT3, STAT5a, and STAT5b" . SPARSER::COLLECTION)
    ("STAT3, STAT5a, and STAT5b" . SPARSER::COLLECTION)
    ("STAT4, STAT5a, STAT5b, and STAT6" . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN) ("NF-KB" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IS3" . SPARSER::PROTEIN) ("CPA-1" . SPARSER::PROTEIN)
    ("BMS-911543" . SPARSER::DRUG) ("JAK2 inhibitor AZD1480" . SPARSER::DRUG)
    ("SAR302503" . SPARSER::DRUG) ("TYK2" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("interleukin 2" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("Mcl-1" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("STA1" . SPARSER::PROTEIN)
    ("cucurbitacin I" . SPARSER::DRUG) ("JSI-124" . SPARSER::DRUG)
    ("Erk-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pp60" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("FLLL32" . SPARSER::DRUG) ("CXCL12" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("HIF1 α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN) ("oncoprotein 18" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN) ("cIAP2" . SPARSER::PROTEIN)
    ("pim-1" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("SOCS2" . SPARSER::PROTEIN) ("SOCS7" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN) ("PIAS3" . SPARSER::PROTEIN)
    ("PIAS1" . SPARSER::PROTEIN) ("DAM1" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("TC-PTP" . SPARSER::PROTEIN) ("PTP1B" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("SHP1" . SPARSER::PROTEIN)
    ("PKC δ" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("colony stimulating factor-1" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("NH2" . SPARSER::MOLECULE)
    ("phosphotyrosine interaction" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("STAT4" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("heterogeneous disordered monomer conformations"
     . SPARSER::BIO-CONFORMATION)
    ("glutamine" . SPARSER::AMINO-ACID) ("soluble forms" . SPARSER::FORM)
    ("rather soluble forms" . SPARSER::FORM)
    ("canonical hsp40·hsp70·Htt client complexes" . SPARSER::BIO-COMPLEX)
    ("delivering substrates" . SPARSER::SUBSTRATE)
    ("pathogenic Httex1" . SPARSER::PROTEIN)
    ("hsp40 and hsp40·hsp70" . SPARSER::COLLECTION)
    ("a monomeric state" . SPARSER::BIO-STATE)
    ("Httex1 and hsp70" . SPARSER::COLLECTION) ("oligomer" . SPARSER::MOLECULE)
    ("pathogenic Htt" . SPARSER::PROTEIN) ("three basic classes" . CLASS)
    ("the Httex1 oligomeric state" . SPARSER::BIO-STATE)
    ("Chaperone" . SPARSER::PROTEIN) ("DNAJB1 and hsp70" . SPARSER::COLLECTION)
    ("small diffusible oligomers form" . SPARSER::FORM)
    ("which targets proteins" . SPARSER::PROTEIN)
    ("a heterogeneous mixture" . SPARSER::MOLECULE)
    ("SVA" . SPARSER::PROTEIN-FAMILY)
    ("monomers and aggregates" . SPARSER::COLLECTION)
    ("a fluorescent protein" . SPARSER::PROTEIN) ("Httex1" . SPARSER::PROTEIN)
    ("glutamines" . SPARSER::AMINO-ACID)
    ("conformation and aggregation" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insoluble protein" . SPARSER::PROTEIN)
    ("notably small oligomeric forms" . SPARSER::FORM)
    ("peptide and protein" . SPARSER::COLLECTION)
    ("amyloid" . SPARSER::PROTEIN)
    ("protein quality control chaperones hsp40 (DNAJB1) and hsp70 (HSPA1A)"
     . SPARSER::COLLECTION)
    ("state and flow" . SPARSER::COLLECTION) ("Htt" . SPARSER::PROTEIN)
    ("polyglutamine" . SPARSER::MOLECULE)
    ("hsp40 and hsp70" . SPARSER::COLLECTION) ("huntingtin" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("Hsp40" . SPARSER::PROTEIN) ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNAJB1" . SPARSER::PROTEIN) ("hsp70" . SPARSER::PROTEIN)
    ("hsp40" . SPARSER::PROTEIN) ("MEK and ERK" . SPARSER::COLLECTION)
    ("MAP3K8/COT" . SPARSER::COLLECTION) ("COT" . SPARSER::PROTEIN)
    ("NRAS" . SPARSER::PROTEIN) ("vermurafenib" . SPARSER::DRUG)
    ("type and intraindividual concordance" . SPARSER::COLLECTION)
    ("Zelboraf" . SPARSER::DRUG)
    ("vemurafenib or dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("BRAF" . SPARSER::PROTEIN) ("MAP3K8" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN)
    ("therapeutics, or vaccine" . SPARSER::COLLECTION)
    ("exonuclease" . SPARSER::PROTEIN) ("CPSF6/CypA" . SPARSER::COLLECTION)
    ("CPSF6/cyclophilins" . SPARSER::COLLECTION) ("Cyp" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN) ("SmBz-CsA" . SPARSER::COLLECTION)
    ("CsA" . SPARSER::PROTEIN) ("cyclophilin" . SPARSER::PROTEIN)
    ("NEMO (IKK)" . SPARSER::PROTEIN) ("IKK" . SPARSER::PROTEIN)
    ("NEMO" . SPARSER::PROTEIN) ("genes (STING)" . SPARSER::GENE)
    ("STING" . SPARSER::PROTEIN) ("cGAS" . SPARSER::PROTEIN)
    ("Vpx" . SPARSER::PROTEIN) ("VLP" . SPARSER::PROTEIN)
    ("P90A" . SPARSER::PROTEIN) ("CypA and nuclear pore" . SPARSER::COLLECTION)
    ("VSV" . SPARSER::PROTEIN)
    ("the IFNAR2 nor isotype control antibody" . SPARSER::COLLECTION)
    ("IP10, IFIT1 and CCL8" . SPARSER::COLLECTION)
    ("macrophages (MDM)" . SPARSER::PROTEIN)
    ("alternate cofactors" . SPARSER::PROTEIN)
    ("Nup358 and TNPO3" . SPARSER::COLLECTION)
    ("CPSF6 and cyclophilins" . SPARSER::COLLECTION)
    ("cyclosporine" . SPARSER::DRUG) ("PAMP" . SPARSER::PROTEIN)
    ("IFN-receptor" . SPARSER::DRUG)
    ("cofactors Cleavage and Polyadenylation Specificity Factor subunit 6 (CPSF6) and cyclophilins (Nup358 and CypA)"
     . SPARSER::COLLECTION)
    ("an antiviral state" . SPARSER::BIO-STATE)
    ("Nup358 and CypA" . SPARSER::COLLECTION)
    ("NFκB and IRF3" . SPARSER::COLLECTION) ("MDM" . SPARSER::PROTEIN)
    ("CypA" . SPARSER::PROTEIN) ("cyclophilins" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("pdb 1" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("NF- κ B" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("IgG2A" . SPARSER::PROTEIN)
    ("beta galactosidase" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M-CSF" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("TREX1" . SPARSER::PROTEIN) ("cyclic GMP-AMP synthase" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX) ("CCL8" . SPARSER::PROTEIN)
    ("IFIT1" . SPARSER::PROTEIN) ("IFNAR2" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("TNPO3" . SPARSER::PROTEIN) ("Nup358" . SPARSER::PROTEIN)
    ("CPSF6" . SPARSER::PROTEIN) ("subunit 6" . SPARSER::PROTEIN)
    ("P90" . SPARSER::PROTEIN) ("CtIP-P21" . SPARSER::COLLECTION)
    ("P53–P21" . SPARSER::COLLECTION) ("CtIP and BRCA1" . SPARSER::COLLECTION)
    ("a positive transcriptional inducer" . SPARSER::PROTEIN)
    ("both endogenous CtIP and ectopically expressed CtIP"
     . SPARSER::COLLECTION)
    ("CtIP or BRCA1" . SPARSER::COLLECTION) ("HA-BRCA1" . SPARSER::COLLECTION)
    ("further deletion mutants" . SPARSER::MUTANT)
    ("CtIP(300–604) or CtIP(600–897)" . SPARSER::COLLECTION)
    ("FLAG-CtIP" . SPARSER::COLLECTION) ("HA-CtIP" . SPARSER::COLLECTION)
    ("The heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("CtIP, BRCA1, and ZBRK1" . SPARSER::COLLECTION)
    ("Sp1/Sp3" . SPARSER::COLLECTION) ("CDK2 and CDK1" . SPARSER::COLLECTION)
    ("CtIP, BRCA1, and E2" . SPARSER::COLLECTION)
    ("this heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("The serine-327-phosphorylated CtIP" . SPARSER::PROTEIN)
    ("zinc finger and BRCA1" . SPARSER::COLLECTION)
    ("ANG1 , bFGF , HMGA2 , LIMK1 , and RFC1" . SPARSER::COLLECTION)
    ("CtBP" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("camptothecin" . SPARSER::DRUG) ("C 20" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("AP4" . SPARSER::PROTEIN) ("Sp3" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("Chk1" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("RFC1" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("ANG1" . SPARSER::PROTEIN)
    ("ZBRK1" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("CtBP-interacting protein" . SPARSER::PROTEIN)
    ("Cyclin and SIX proteins" . SPARSER::COLLECTION)
    ("Val" . SPARSER::AMINO-ACID) ("pdb" . SPARSER::MOLECULE)
    ("the pro-mitotic EYA2 molecule" . SPARSER::MOLECULE)
    ("active complexes" . SPARSER::BIO-COMPLEX)
    ("CyclinD/CDK6" . SPARSER::COLLECTION) ("CyclinD" . SPARSER::PROTEIN)
    ("functional SIX1" . SPARSER::PROTEIN)
    ("CDK6, CDK6D224Y and CDK6NFG" . SPARSER::COLLECTION)
    ("EYA2 and the CDK6 cell cycle kinase" . SPARSER::COLLECTION)
    ("Cyclin D1, p27, and c-myc" . SPARSER::COLLECTION)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("CDK6 , and SIX1" . SPARSER::COLLECTION)
    ("MG132 and Lactacystin" . SPARSER::COLLECTION)
    ("CDK6 and tubulin" . SPARSER::COLLECTION)
    ("EYA2 or EYA2 and CDK6" . SPARSER::COLLECTION)
    ("Lactacystin" . SPARSER::DRUG) ("some longer Ub" . SPARSER::PROTEIN)
    ("Ub" . SPARSER::PROTEIN)
    ("elongation and mono-ubiquitin" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID)
    ("CDK6 or CDK6NFG" . SPARSER::COLLECTION)
    ("EYA2/CDK6" . SPARSER::COLLECTION) ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("CDK6 or mutant" . SPARSER::COLLECTION) ("CDK6D224Y" . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN-FAMILY) ("SDS" . SPARSER::PROTEIN)
    ("a transcriptionally active complex" . SPARSER::BIO-COMPLEX)
    ("CDK6 or CDK6" . SPARSER::COLLECTION)
    ("rabbit IgG or polyclonal CDK6 antibody" . SPARSER::COLLECTION)
    ("slightly more EYA2 protein" . SPARSER::PROTEIN)
    ("a monoclonal CDK6 antibody" . SPARSER::ANTIBODY)
    ("monoclonal CDK6 antibody" . SPARSER::ANTIBODY)
    ("CDK6 or CDK6D224Y" . SPARSER::COLLECTION)
    ("antibody or IgG" . SPARSER::COLLECTION)
    ("EYA2 and CDK6" . SPARSER::COLLECTION)
    ("conjugated anti-CDK6 antibody or rabbit IgG" . SPARSER::COLLECTION)
    ("which causes malformations" . SPARSER::PROTEIN)
    ("EYA1 and EYA2" . SPARSER::COLLECTION)
    ("malformations" . SPARSER::PROTEIN) ("BOR" . SPARSER::PROTEIN)
    ("FLAG-EYA2" . SPARSER::COLLECTION) ("KIP" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN) ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdk4 and cdk6" . SPARSER::COLLECTION)
    ("CDK6 and EYA2" . SPARSER::COLLECTION) ("cdh" . SPARSER::PROTEIN)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("phosphatases and form" . SPARSER::COLLECTION)
    ("bipartite" . SPARSER::PROTEIN)
    ("Runx1, Fbxo7, and Hsp90/Cdc37" . SPARSER::COLLECTION)
    ("Fbxo7" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("osteoclasts" . SPARSER::PROTEIN) ("cdks" . SPARSER::PROTEIN)
    ("EYA" . SPARSER::PROTEIN)
    ("a D-Cyclin-activated kinase" . SPARSER::KINASE)
    ("C-21" . SPARSER::PROTEIN) ("a 15 " . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("SIX1" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("Eya1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("Drosophila)" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("EYA1" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN) ("cdk6" . SPARSER::PROTEIN)
    ("EYA2" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("facilitated proper DDR" . SPARSER::PROTEIN) ("CBP" . SPARSER::PROTEIN)
    ("bromodomain" . SPARSER::PROTEIN) ("Mdm2-p53" . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION) ("ATM" . SPARSER::PROTEIN)
    ("Lysine" . SPARSER::AMINO-ACID) ("S4 and S5" . SPARSER::COLLECTION)
    ("anchor" . SPARSER::ANCHOR) ("p53 and MDC1-tBRCT" . SPARSER::COLLECTION)
    ("the sterical conformations" . SPARSER::BIO-CONFORMATION)
    ("endogenous MDC1 and the unmodified p53 CTD peptide or the peptide"
     . SPARSER::COLLECTION)
    ("the unmodified p53 CTD peptide or the peptide" . SPARSER::COLLECTION)
    ("pull-down unmodified p53 CTD peptide and a peptide"
     . SPARSER::COLLECTION)
    ("GST-tBRCT" . SPARSER::COLLECTION) ("Peptides" . SPARSER::PEPTIDE)
    ("p53 CTD peptides containing Ac-K382 and pS392 or peptides containing either Ac-K382 or pS392"
     . SPARSER::COLLECTION)
    ("Tet and CTD peptides" . SPARSER::COLLECTION)
    ("the Tet and CTD (none modification) peptides" . SPARSER::COLLECTION)
    ("p53 and His-tBRCT" . SPARSER::COLLECTION)
    ("GST-p53" . SPARSER::COLLECTION)
    ("p53 or fragments" . SPARSER::COLLECTION)
    ("antibodies and p53" . SPARSER::COLLECTION)
    ("anti-MDC1-tBRCT" . SPARSER::COLLECTION)
    ("hardly co-IP p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tBRCT-MDC1" . SPARSER::COLLECTION) ("tBRCT" . SPARSER::PROTEIN)
    ("GST (p53-GST) and the tBRCT" . SPARSER::COLLECTION)
    ("MDC1-FHA" . SPARSER::COLLECTION) ("MDC1-tBRCT" . SPARSER::COLLECTION)
    ("p53-GST" . SPARSER::COLLECTION) ("NCS" . SPARSER::PROTEIN)
    ("neocarzinostatin" . SPARSER::PROTEIN)
    ("Rad51 [ xref , xref ] and 53BP1 [ xref , xref ]" . SPARSER::COLLECTION)
    ("MDC1 and p53" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("the most severe form" . SPARSER::FORM)
    ("G2/M and intra-S phase" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION) ("Tet" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE)
    ("histones and other proteins" . SPARSER::COLLECTION)
    ("p53-MDC1" . SPARSER::COLLECTION) ("p53 and MDC1" . SPARSER::COLLECTION)
    ("SO 4" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("γH2AX" . SPARSER::PROTEIN) ("triton X-100" . SPARSER::MOLECULE)
    ("D-1" . SPARSER::PROTEIN) ("cm -1" . SPARSER::PROTEIN)
    ("M -1" . SPARSER::PROTEIN)
    ("Phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("T-antigen" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("ph-p" . SPARSER::PROTEIN) ("Ac-K" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("phospho-protein" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("MDC1" . SPARSER::PROTEIN)
    ("a valuable prognostic biomarker" . SPARSER::MOLECULE)
    ("growth factors and their cognate receptors" . SPARSER::COLLECTION)
    ("FOXO1, FOXO3a, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("oncogenes and inactivation of tumor suppressor genes"
     . SPARSER::COLLECTION)
    ("FOXO3a mRNA (p = 0.03) and protein (p = 0.019)" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("forkhead" . SPARSER::PROTEIN) ("FOXO6" . SPARSER::PROTEIN)
    ("FOXO4" . SPARSER::PROTEIN) ("dopamine (DA)" . SPARSER::DRUG)
    ("DA" . SPARSER::MOLECULE) ("One possible solution" . SPARSER::MOLECULE)
    ("many behavioural traits" . SPARSER::PROTEIN)
    ("particular behavioural traits" . SPARSER::PROTEIN)
    ("DAT1 and COMT" . SPARSER::COLLECTION)
    ("the homozygous A2/A2" . SPARSER::COLLECTION)
    ("the heterozygous type" . TYPE)
    ("Guo and colleagues xref" . SPARSER::COLLECTION)
    ("traits" . SPARSER::PROTEIN)
    ("the AR gene and three dopaminergic genes ( DAT1 , DRD2 , and COMT )"
     . SPARSER::COLLECTION)
    ("three dopaminergic genes" . SPARSER::GENE)
    ("DAT1 , DRD2 , and COMT" . SPARSER::COLLECTION)
    ("certain genes and aggressive behaviour" . SPARSER::COLLECTION)
    ("Guo and co-authors xref" . SPARSER::COLLECTION)
    ("DRD2 and DAT1" . SPARSER::COLLECTION) ("A2/A2" . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE) ("DAT1 and DRD2" . SPARSER::COLLECTION)
    ("striatum" . SPARSER::PROTEIN) ("Dopamine" . SPARSER::DRUG)
    ("catabolism" . SPARSER::PROTEIN) ("DRD4 and DRD2" . SPARSER::COLLECTION)
    ("alcohol" . SPARSER::DRUG) ("dopamine" . SPARSER::PROTEIN)
    ("gene ( AR )" . SPARSER::GENE) ("DAT1-COMT" . SPARSER::COLLECTION)
    ("DAT1-DRD2" . SPARSER::COLLECTION)
    ("AR , DAT1 , DRD2 , and COMT" . SPARSER::COLLECTION)
    ("COMT" . SPARSER::PROTEIN)
    ("catechol-O-methyltransferase" . SPARSER::PROTEIN)
    ("dopamine transporter" . SPARSER::PROTEIN) ("DRD4" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("DRD2" . SPARSER::PROTEIN)
    ("DAT1" . SPARSER::PROTEIN) ("NR" . SPARSER::PROTEIN)
    ("naturally occurring STAT3 mutants" . SPARSER::MUTANT)
    ("occurring STAT3 mutants" . SPARSER::MUTANT)
    ("inactive heterodimers" . SPARSER::HETERODIMER)
    ("several dominant-negative STAT3 point mutants" . SPARSER::MUTANT)
    ("active STAT3 homodimers" . SPARSER::HOMODIMER)
    ("weak and instable STAT1 dimers" . SPARSER::DIMER)
    ("non-functional weak heterodimers" . SPARSER::HETERODIMER)
    ("preformed homodimers as well as heterodimers" . SPARSER::COLLECTION)
    ("the monomeric STAT3 deletion mutants" . SPARSER::MUTANT)
    ("STAT3-YFP" . SPARSER::COLLECTION)
    ("STAT3-ΔN only forms dimers" . SPARSER::DIMER)
    ("STAT3-" . SPARSER::PROTEIN)
    ("the fluorescent proteins" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG)
    ("the classical JAK/STAT signaling pathway tyrosine" . SPARSER::AMINO-ACID)
    ("IL-6 and sIL-6Rα" . SPARSER::COLLECTION) ("sIL" . SPARSER::PROTEIN)
    ("STAT3-YF-YFP" . SPARSER::PROTEIN)
    ("a fluorescent STAT3-YF-YFP fusion protein" . SPARSER::PROTEIN)
    ("the dominant-negative STAT3-YF mutant" . SPARSER::MUTANT)
    ("HEK-STAT3-YF-YFP" . SPARSER::COLLECTION) ("HEK" . SPARSER::PROTEIN)
    ("Other known dominant-negative forms" . SPARSER::FORM)
    ("cellular STAT3" . SPARSER::PROTEIN)
    ("a classical feedback inhibitor" . SPARSER::INHIBITOR)
    ("the associated Janus kinases" . SPARSER::PROTEIN)
    ("Ligand" . SPARSER::LIGAND)
    ("classical JAK/STAT signaling STAT proteins" . SPARSER::PROTEIN)
    ("naturally occuring dominant-negative STAT3 mutants" . SPARSER::MUTANT)
    ("gp130-receptors" . SPARSER::COLLECTION)
    ("STAT3-CFP" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN)
    ("STAT3-YF-YFP forms homodimers as well as heterodimers"
     . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN)
    ("a dominant-negative STAT3 mutant" . SPARSER::MUTANT)
    ("YF" . SPARSER::MOLECULE) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("m67" . SPARSER::PROTEIN) ("P40)" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("gp80" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("liganded" . SPARSER::MOLECULE)
    ("AP-1 and Forkhead" . SPARSER::COLLECTION)
    ("ERE- and AP-1-like" . SPARSER::COLLECTION)
    ("Forkhead" . SPARSER::PROTEIN) ("AP-1 or Sp-1" . SPARSER::COLLECTION)
    ("ERα-ERβ" . SPARSER::COLLECTION) ("ERE-" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERβ-chromatin" . SPARSER::COLLECTION)
    ("an essential part" . SPARSER::COMPONENT)
    ("the repressive E2F7" . SPARSER::PROTEIN) ("E2F7" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("driving genes" . SPARSER::GENE)
    ("ERα, CCNA2 and c-Myc" . SPARSER::COLLECTION)
    ("ERα or ERβ" . SPARSER::COLLECTION) ("repressor" . SPARSER::REPRESSOR)
    ("cisplatin" . SPARSER::DRUG)
    ("Apoptosis-associated genes" . SPARSER::GENE)
    ("ERα and ERβ" . SPARSER::COLLECTION)
    ("tamoxifen or ICI" . SPARSER::COLLECTION)
    ("CCNA2 and BCL2" . SPARSER::COLLECTION)
    ("pS2, CCNA2 and BCL2" . SPARSER::COLLECTION) ("ERα-" . SPARSER::PROTEIN)
    ("the anti-apoptotic BCL2 and the proliferative MYC" . SPARSER::COLLECTION)
    ("the proliferative MYC" . SPARSER::PROTEIN)
    ("/ER β" . SPARSER::COLLECTION)
    ("TGFB2, SLC3A2, B4GALT1 and CCNA2" . SPARSER::COLLECTION)
    ("T47D-ERβ, and genes" . SPARSER::COLLECTION)
    ("IGF1R, THBS1, KLF10, AEN, CAV1 and PLOD2" . SPARSER::COLLECTION)
    ("AEN" . SPARSER::PROTEIN) ("only 77 genes" . SPARSER::GENE)
    ("TGFB2, PIK3R1 and GATA3" . SPARSER::COLLECTION)
    ("GRO" . SPARSER::PROTEIN)
    ("AP-1, E2F, c-Myc, TGFβ, NFκB and FoxO4" . SPARSER::COLLECTION)
    ("ERα, and NFY" . SPARSER::COLLECTION)
    ("APOD, ANXA1 , and SYNPO" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION) ("SYNPO" . SPARSER::PROTEIN)
    ("APOD" . SPARSER::PROTEIN)
    ("AP-1, FoxO4, SMADs, and NFκB" . SPARSER::COLLECTION)
    ("SMADs" . SPARSER::PROTEIN) ("E2F and AP-1" . SPARSER::COLLECTION)
    ("Smad3, FoxJ2 and FoxO4" . SPARSER::COLLECTION)
    ("c-Myc, NFY and Sp1" . SPARSER::COLLECTION) ("FoxJ2" . SPARSER::PROTEIN)
    ("TGFB2 and DKK1" . SPARSER::COLLECTION)
    ("the Wnt inhibitor DKK1 (Dickkopf 1) and TGFB2 (Transforming growth factor beta 2)"
     . SPARSER::COLLECTION)
    ("AHR (Aryl hydrocarbon receptor), the Wnt inhibitor DKK1 (Dickkopf 1) and TGFB2 (Transforming growth factor beta 2)"
     . SPARSER::COLLECTION)
    ("AHR" . SPARSER::PROTEIN) ("ERβ and ERα" . SPARSER::COLLECTION)
    ("ERβ, and siRNA" . SPARSER::COLLECTION) ("MCF7-ERβ" . SPARSER::COLLECTION)
    ("blasticidin" . SPARSER::MOLECULE) ("functional ERβ" . SPARSER::PROTEIN)
    ("ERα and estrogen" . SPARSER::COLLECTION)
    ("the predominant ER" . SPARSER::PROTEIN)
    ("tamoxifen, or estrogen" . SPARSER::COLLECTION)
    ("SPINK4" . SPARSER::PROTEIN) ("Sp-1" . SPARSER::PROTEIN)
    ("Cathepsin D" . SPARSER::PROTEIN) ("Claudin 1" . SPARSER::PROTEIN)
    ("CLDN1" . SPARSER::PROTEIN) ("Apolipoprotein D" . SPARSER::PROTEIN)
    ("member 5" . SPARSER::PROTEIN) ("subfamily K" . SPARSER::PROTEIN)
    ("Potassium channel" . SPARSER::PROTEIN) ("KCNK5" . SPARSER::PROTEIN)
    ("PLOD2" . SPARSER::PROTEIN) ("CAV1" . SPARSER::PROTEIN)
    ("KLF10" . SPARSER::PROTEIN) ("THBS1" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("B4GALT1" . SPARSER::PROTEIN)
    ("SLC3A2" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("IGFBP4" . SPARSER::PROTEIN) ("MYBL1" . SPARSER::PROTEIN)
    ("ANXA1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("FoxO4" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p85" . SPARSER::PROTEIN) ("PIK3R1" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN)
    ("Transforming growth factor beta 2" . SPARSER::PROTEIN)
    ("TGFB2" . SPARSER::PROTEIN) ("Dickkopf 1" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN)
    ("Aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("ERβ 1" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("Acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("AKT, ILK, and NF-κB" . SPARSER::COLLECTION)
    ("the exogenous recombinant IGFBP2" . SPARSER::PROTEIN)
    ("intrinsic IGFBP2" . SPARSER::PROTEIN) ("Normal HSCs" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acute leukemia" . SPARSER::PROTEIN) ("LSP" . SPARSER::PROTEIN)
    ("EMB" . SPARSER::PROTEIN) ("A-B" . SPARSER::PROTEIN)
    ("IGFBP2-" . SPARSER::PROTEIN) ("SCs" . SPARSER::PROTEIN)
    ("ERK and STAT6" . SPARSER::COLLECTION) ("Mac-1" . SPARSER::PROTEIN)
    ("normal HSCs" . SPARSER::PROTEIN) ("AML1-ETO" . SPARSER::COLLECTION)
    ("shRNA and shRNA" . SPARSER::COLLECTION)
    ("the extrinsic IGFBP2" . SPARSER::PROTEIN)
    ("IGFBP2 mRNA (Figure  xref A) and IGFBP2 protein (Figure  xref B)"
     . SPARSER::COLLECTION)
    ("the acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("PML-RARA" . SPARSER::COLLECTION) ("RARA" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN) ("APL" . SPARSER::PROTEIN)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("kinase (ILK)" . SPARSER::KINASE)
    ("ILK" . SPARSER::PROTEIN) ("IGFs" . SPARSER::PROTEIN)
    ("at least six circulating proteins" . SPARSER::PROTEIN)
    ("IGF-1 and IGF-2" . SPARSER::COLLECTION)
    ("the most common acute leukemia" . SPARSER::PROTEIN)
    ("immature myeloid" . SPARSER::PROTEIN)
    ("AKT and other signaling molecules" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("ITGB4" . SPARSER::PROTEIN)
    ("CX3CR1" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("H-I" . SPARSER::PROTEIN) ("C-D" . SPARSER::PROTEIN)
    ("NB4" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("B-ALL" . SPARSER::PROTEIN)
    ("IGF-2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("IGFBP2" . SPARSER::PROTEIN)
    ("Pre" . SPARSER::DNA-RESPONSE-ELEMENT) ("FB" . SPARSER::PROTEIN)
    ("ELC" . SPARSER::PROTEIN) ("ACL" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("Polymerase" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN) ("EDTA" . SPARSER::MOLECULE)
    ("CISH" . SPARSER::PROTEIN)
    ("other less common homologous recombination genes" . SPARSER::GENE)
    ("ER/PR" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("ER, PR and HER2" . SPARSER::COLLECTION) ("lobular type" . TYPE)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("active and catalytically inactive" . SPARSER::COLLECTION)
    ("anthracycline" . SPARSER::MOLECULE) ("von" . SPARSER::PROTEIN)
    ("the largest cohort" . SPARSER::MOLECULE) ("RFS" . SPARSER::PROTEIN)
    ("ER and PR" . SPARSER::COLLECTION)
    ("53BP1 and PAI-1" . SPARSER::COLLECTION) ("Prot" . SPARSER::PROTEIN)
    ("mgP" . SPARSER::PROTEIN) ("Bisulphite" . SPARSER::MOLECULE)
    ("BRCA1/53BP1/PARP-1" . SPARSER::COLLECTION)
    ("PARP-1/BRCA1/53BP1" . SPARSER::COLLECTION)
    ("cis-platinum and PARP" . SPARSER::COLLECTION)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION) ("ductal type" . TYPE)
    ("p  " . SPARSER::PROTEIN) ("BRCA1-" . SPARSER::PROTEIN)
    ("BRCA-" . SPARSER::PROTEIN-FAMILY) ("olaparib" . SPARSER::DRUG)
    ("functional BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("SSB" . SPARSER::PROTEIN)
    ("uPA and PAI-1" . SPARSER::COLLECTION)
    ("receptor and HER2" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("ADP-Ribose" . SPARSER::MOLECULE)
    ("Plasminogen activator" . SPARSER::PROTEIN)
    ("Breast cancer type 1 susceptibility protein" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("pT1" . SPARSER::PROTEIN) ("TP53BP1" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN) ("cis-platinum" . SPARSER::DRUG)
    ("P53 binding protein 1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("53BP1" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("pericentric heterochromatin" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("cardiac polypyrimidine tract binding protein (PTB)" . SPARSER::PROTEIN)
    ("PTB" . SPARSER::PROTEIN) ("HDAC1, HDAC2, or HDAC3" . SPARSER::COLLECTION)
    ("Mut-Luc" . SPARSER::PROTEIN-PAIR) ("Mut" . SPARSER::PROTEIN)
    ("an online promoter" . SPARSER::PROMOTER) ("ErbB2" . SPARSER::PROTEIN)
    ("Stat3-PTPN13" . SPARSER::COLLECTION)
    ("FAP1, PTPL1, PTPLE, PTPBAS, and PTP1E" . SPARSER::COLLECTION)
    ("PTPBAS" . SPARSER::PROTEIN) ("PTPLE" . SPARSER::PROTEIN)
    ("PTP" . SPARSER::PROTEIN) ("cardiac muscle" . SPARSER::PROTEIN)
    ("cellular FLICE-like inhibitory protein" . SPARSER::PROTEIN)
    ("polypyrimidine tract binding protein" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("Mgcl 2" . SPARSER::MOLECULE) ("PGL3" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("Interleukin-6" . SPARSER::PROTEIN)
    ("PTP1" . SPARSER::PROTEIN) ("PTPL1" . SPARSER::PROTEIN)
    ("FAP1" . SPARSER::PROTEIN) ("PTPN13" . SPARSER::PROTEIN)
    ("MIBG and phenformin" . SPARSER::COLLECTION)
    ("anti-MYC/MYCN" . SPARSER::COLLECTION) ("demethylase" . SPARSER::PROTEIN)
    ("functional AMPK" . SPARSER::PROTEIN)
    ("pre" . SPARSER::DNA-RESPONSE-ELEMENT) ("biguanides" . SPARSER::MOLECULE)
    ("metformin, and phenformin" . SPARSER::COLLECTION)
    ("another mitochondrial inhibitor and anti-diabetic drug"
     . SPARSER::COLLECTION)
    ("that metformin and MIBG function" . SPARSER::COLLECTION)
    ("favorable NB genes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("the tumor growth suppressive gene" . SPARSER::GENE)
    ("EGR1, EPHA2, GADD45B, NRG1, PERP and SEL1L" . SPARSER::COLLECTION)
    ("NB (EFNB2, EFNB3, EPHB6, NTRK1, CD44 and MIZ-1) and tumor suppressor genes [early growth response 1 (EGR1), EPH receptor A2 (EPHA2), growth arrest and DNA-damage-inducible, beta (GADD45B), neuregulin 1 (NRG1), TP53 apoptosis effector (PERP) and sel-1 suppressor of lin-12-like (C. elegans) (SEL1L)]"
     . SPARSER::COLLECTION)
    ("EFNB2, EFNB3, EPHB6, NTRK1, CD44 and MIZ-1" . SPARSER::COLLECTION)
    ("known favorable NB genes" . SPARSER::GENE)
    ("unfavorable NB" . SPARSER::PROTEIN)
    ("favorable NB genes" . SPARSER::GENE)
    ("several favorable NB genes" . SPARSER::GENE)
    ("p-trifluoromethoxyphenylhydrazone (FCCP)" . SPARSER::PROTEIN-PAIR)
    ("p-trifluoromethoxyphenylhydrazone" . SPARSER::PROTEIN-PAIR)
    ("transporters or NET" . SPARSER::COLLECTION)
    ("norepinephrine" . SPARSER::DRUG)
    ("Unfavorable NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("norepinephrine transporter (NET)" . SPARSER::PROTEIN)
    ("Phenformin" . SPARSER::DRUG)
    ("NB [(ephrin ( EFN ) B2, EFNB3, EPH receptor B6 ( EPHB6 ) , neurotrophic tyrosine kinase, receptor, type 1 ( NTRK1 ) , CD44 and Myc-interacting zinc finger protein ( MIZ-1 )] and tumor suppressor genes [(early growth response 1 ( EGR1 ) , EPH receptor A2 ( EPHA2 ) , growth arrest and DNA-damage-inducible, beta ( GADD45B ) , neuregulin 1 ( NRG1 ) , TP53 apoptosis effector ( PERP ) and sel-1 suppressor of lin-12-like ( C. elegans ) ( SEL1L )]"
     . SPARSER::COLLECTION)
    ("PERP" . SPARSER::PROTEIN) ("EPH" . SPARSER::PROTEIN)
    ("ephrin" . SPARSER::PROTEIN) ("MIBG and metformin" . SPARSER::COLLECTION)
    ("Metformin and phenformin" . SPARSER::COLLECTION)
    ("Metformin" . SPARSER::DRUG) ("NB" . SPARSER::PROTEIN)
    ("MIBG" . SPARSER::DRUG) ("metformin and phenformin" . SPARSER::COLLECTION)
    ("phenformin" . SPARSER::DRUG) ("metaiodobenzylguanidine" . SPARSER::DRUG)
    ("REDD1" . SPARSER::PROTEIN) ("Complex I" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG)
    ("sel-1 suppressor of lin-12-like (C. elegans)" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN) ("sex Determining Region Y" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("transcription factor 4" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("norepinephrine transporter" . SPARSER::PROTEIN)
    ("sel-1 suppressor of lin-12-like ( C. elegans )" . SPARSER::PROTEIN)
    ("neuregulin 1" . SPARSER::PROTEIN) ("GADD45B" . SPARSER::PROTEIN)
    ("growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN) ("NTRK1" . SPARSER::PROTEIN)
    ("typical druggable targets" . SPARSER::TARGET-PROTEIN)
    ("active and important" . SPARSER::COLLECTION)
    ("small-molecule TKI and monoclonal antibodies" . SPARSER::COLLECTION)
    ("FLT3 and PKC" . SPARSER::COLLECTION) ("Components" . SPARSER::COMPONENT)
    ("the proximal signaling interactome" . SPARSER::PROTEIN)
    ("midostaurin or lestaurtinib" . SPARSER::COLLECTION)
    ("erlotinib and midostaurin or erlotinib and lestaurtinib"
     . SPARSER::COLLECTION)
    ("midostaurin or erlotinib and lestaurtinib" . SPARSER::COLLECTION)
    ("erlotinib and lestaurtinib" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("Erlotinib or midostaurin" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG)
    ("erlotinib and midostaurin" . SPARSER::COLLECTION)
    ("using immobilized midostaurin and protein lysates from either PC9 or PC9GR cells"
     . SPARSER::COLLECTION)
    ("re-identified midostaurin (PKC412) and lestaurtinib (CEP-701)"
     . SPARSER::COLLECTION)
    ("specifically binding EGFR T790M gatekeeper allele" . SPARSER::ALLELE)
    ("vulnerable proteins" . SPARSER::PROTEIN)
    ("SHC1 and GRB2" . SPARSER::COLLECTION) ("Bank" . SPARSER::PROTEIN)
    ("GRP78,CDC37, P85B, PK3CA, P55G, and CDK9" . SPARSER::COLLECTION)
    ("Chemical" . SPARSER::MOLECULE) ("shRNA and siRNA" . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION)
    ("EGFR or tyrosine" . SPARSER::COLLECTION) ("Dbl" . SPARSER::PROTEIN)
    ("GRP78 and CDC37" . SPARSER::COLLECTION)
    ("MEK or PI3K" . SPARSER::COLLECTION) ("GRB2/SHC1" . SPARSER::COLLECTION)
    ("EGFR, GRB2, and SHC1" . SPARSER::COLLECTION)
    ("new oncoproteins" . SPARSER::PROTEIN)
    ("client proteins" . SPARSER::PROTEIN) ("oncoproteins" . SPARSER::PROTEIN)
    ("EGFR and downstream pERK and pAKT" . SPARSER::COLLECTION)
    ("pERK and pAKT" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("chaperoning aberrant RTK" . SPARSER::PROTEIN)
    ("HSP90 and HSP90" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION)
    ("CDK9, CD11A, CD11B, and A-RAF" . SPARSER::COLLECTION)
    ("EGFR, GRB2, SHC1, and MK12" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("SHC1, GRB2, MK12, and ARHG5" . SPARSER::COLLECTION)
    ("MAPK/Rho" . SPARSER::COLLECTION)
    ("EGFR, GRB2, SHC1, and GRP78" . SPARSER::COLLECTION)
    ("CD11A, CD11B, CDK9, and ARAF" . SPARSER::COLLECTION)
    ("pulldowns" . SPARSER::PROTEIN) ("GLO" . SPARSER::PROTEIN)
    ("ERB" . SPARSER::PROTEIN)
    ("EGFR, A-Raf, CDK4, and IKKα" . SPARSER::COLLECTION)
    ("EGFR, GRB2, HS90A and HS90B, CDC37, ERRFI, and UBS3B"
     . SPARSER::COLLECTION)
    ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("EGFR or ERBB2" . SPARSER::COLLECTION)
    ("GRB2 and ERFFI" . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, GRB2, ARHG5, PTPN12, AP2A1 and AP2M1, ERFFI, and UBS3B"
     . SPARSER::COLLECTION)
    ("AP2M1, ERFFI, and UBS3B" . SPARSER::COLLECTION)
    ("EGFR, ARHG5, UBS3B, ERRFI, and SHC1" . SPARSER::COLLECTION)
    ("MINT" . SPARSER::PROTEIN) ("35 unique proteins" . SPARSER::PROTEIN)
    ("186 unique proteins" . SPARSER::PROTEIN)
    ("368 unique phosphotyrosine phosphopeptides" . SPARSER::PROTEIN)
    ("erlotinib or DMSO" . SPARSER::COLLECTION)
    ("Phosphopeptide" . SPARSER::PROTEIN)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("GRP78 (found in lung cancer cell lines and in both mutant and wild-type EGFR complexes in AALE) and CDC37 (found in lung cancer cell lines but not in AALE)"
     . SPARSER::COLLECTION)
    ("an important heterodimeric protein" . SPARSER::PROTEIN)
    ("linking EGFR" . SPARSER::PROTEIN)
    ("GRB2, SHC1, ERRFI, and UBS3B" . SPARSER::COLLECTION)
    ("GRB2, SHC1, ERRFI, UBS3B, ERBB2, GRP78, AP2M1, and CDC37"
     . SPARSER::COLLECTION)
    ("unique protein" . SPARSER::PROTEIN)
    ("disease-relevant EGFR isoforms" . SPARSER::ISOFORM)
    ("catenin and cadherin" . SPARSER::COLLECTION)
    ("PTPRD and PTPRF" . SPARSER::COLLECTION) ("PTPRF" . SPARSER::PROTEIN)
    ("PTPRD" . SPARSER::PROTEIN) ("phosphatases" . SPARSER::PHOSPHATASE)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("adherin" . SPARSER::PROTEIN)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VP" . SPARSER::PROTEIN)
    ("transporter" . SPARSER::PROTEIN) ("EGFR pulldowns" . SPARSER::PROTEIN)
    ("ERRFI and UBS3B" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR or exon" . SPARSER::COLLECTION) ("Strep-HA" . SPARSER::COLLECTION)
    ("co-purified EGFR and the adaptor proteins GRB2 and SHC1"
     . SPARSER::COLLECTION)
    ("GRB2 and SHC1" . SPARSER::COLLECTION)
    ("ERBB3 in the PC9 cells and 38 putative interacting proteins in the HCC827 cells ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("PI3K (PK3CA, PK3CB, P85A, P85B, and P55G) and multiple heat-shock proteins"
     . SPARSER::COLLECTION)
    ("CB" . SPARSER::PROTEIN) ("possibly other chaperones" . SPARSER::PROTEIN)
    ("chaperone and HSP90 co-chaperone" . SPARSER::COLLECTION)
    ("EGFR and ERBB3" . SPARSER::COLLECTION)
    ("chaperones or co-chaperones" . SPARSER::COLLECTION)
    ("GRP78, HS90A, HS90B, and CDC37" . SPARSER::COLLECTION)
    ("AP2M1, AP2A1, AP2A2, and AP2B1" . SPARSER::COLLECTION)
    ("TBA" . SPARSER::PROTEIN) ("tubulin" . SPARSER::PROTEIN)
    ("EGFR and PDGFR" . SPARSER::COLLECTION)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("RTKs" . SPARSER::PROTEIN)
    ("MIG-6, and UBS3B" . SPARSER::COLLECTION) ("ERRFI" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN)
    ("EGFR in the PC9 cells and 10 putative interacting proteins in the HCC827 cells ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("mutant EGFR or other bait proteins" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("pertinent proteins" . SPARSER::PROTEIN) ("Exon" . SPARSER::PROTEIN)
    ("TAP" . SPARSER::PROTEIN) ("Interactomes" . SPARSER::PROTEIN)
    ("interactomes" . SPARSER::PROTEIN) ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("State" . SPARSER::BIO-STATE)
    ("complexes and networks" . SPARSER::COLLECTION)
    ("MEK/PI3K" . SPARSER::COLLECTION)
    ("downstream extracellular signal-regulated kinase (ERK), phosphoinositide 3-kinase (PI3K)/Akt, and STAT signaling"
     . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("midostaurin and lestaurtinib" . SPARSER::COLLECTION)
    ("lestaurtinib" . SPARSER::DRUG) ("midostaurin" . SPARSER::DRUG)
    ("GLU" . SPARSER::AMINO-ACID) ("ARHG" . SPARSER::PROTEIN)
    ("ARAF" . SPARSER::PROTEIN) ("MK" . SPARSER::PROTEIN)
    ("interactome" . SPARSER::PROTEIN) ("EGFR interactome" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION) ("Caspase-3" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("PDPK1" . SPARSER::PROTEIN) ("AMPK1" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN) ("CEP-701" . SPARSER::DRUG)
    ("PKC412" . SPARSER::DRUG) ("CI-1033" . SPARSER::DRUG)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("PDGFRα" . SPARSER::PROTEIN)
    ("derived growth factor receptor-alpha" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("A-RAF" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("A-Raf" . SPARSER::PROTEIN) ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Pyk2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PTP-PEST" . SPARSER::PROTEIN) ("PTPN12" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vacuolar protein sorting-associated protein 13A" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN) ("adaptor protein" . SPARSER::PROTEIN)
    ("P55" . SPARSER::PROTEIN) ("P85" . SPARSER::PROTEIN)
    ("PK3" . SPARSER::PROTEIN) ("HSP90 co-chaperone" . SPARSER::PROTEIN)
    ("AP2B1" . SPARSER::PROTEIN) ("AP2A2" . SPARSER::PROTEIN)
    ("AP2A1" . SPARSER::PROTEIN) ("AP2M1" . SPARSER::PROTEIN)
    ("CDC37" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("STS-1" . SPARSER::PROTEIN) ("MIG-6" . SPARSER::PROTEIN)
    ("ERBB receptor feedback inhibitor 1" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("heat-shock protein 90" . SPARSER::PROTEIN) ("CD11A" . SPARSER::PROTEIN)
    ("CD11B" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("A ‘" . SPARSER::PROTEIN)
    ("viral nucleoprotein" . SPARSER::PROTEIN)
    ("viral ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("nucleoprotein" . SPARSER::PROTEIN) ("TLR4-MyD88" . SPARSER::COLLECTION)
    ("STAT1 Y701F and the Y701F/S727A double mutant ( xref )"
     . SPARSER::COLLECTION)
    ("IRF" . SPARSER::PROTEIN) ("type I and type II" . SPARSER::COLLECTION)
    ("a dominant-negative MKK6 mutant" . SPARSER::MUTANT)
    ("IRFs" . SPARSER::PROTEIN) ("IRF3 and NF-κB" . SPARSER::COLLECTION)
    ("chemotactic cytokines" . SPARSER::PROTEIN)
    ("nearly all HPAIV-induced genes" . SPARSER::GENE)
    ("Global mRNA" . SPARSER::PROTEIN)
    ("IRF3, NF-κB, AP1, and NFATC4" . SPARSER::COLLECTION)
    ("HPAI" . SPARSER::DRUG)
    ("highly virulent H5N1 variants" . SPARSER::VARIANT)
    ("dsRNA" . SPARSER::RNA)
    ("20 mg/kg SB 202190 hydrochloride or vehicle 3" . SPARSER::COLLECTION)
    ("SB 202190 hydrochloride or vehicle" . SPARSER::COLLECTION)
    ("OAS1 and IP-10" . SPARSER::COLLECTION)
    ("water-soluble SB 202190 hydrochloride" . SPARSER::MOLECULE)
    ("hydrochloride" . SPARSER::MOLECULE)
    ("the dominant-negative STAT1 Y701F mutant" . SPARSER::MUTANT)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a dominant-negative STAT1 (Y701F) or STAT1 (Y701F/S727A) double mutant"
     . SPARSER::COLLECTION)
    ("a dominant-negative STAT1" . SPARSER::PROTEIN)
    ("SB 202190 or DMSO" . SPARSER::COLLECTION)
    ("viral proteins PB2" . SPARSER::PROTEIN)
    ("dominant-negative STAT1" . SPARSER::PROTEIN)
    ("response elements (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("STAT2 and IRF9" . SPARSER::COLLECTION)
    ("the dominant-negative MKK6 mutant" . SPARSER::MUTANT)
    ("GBP1 and VCAM1" . SPARSER::COLLECTION)
    ("MxA and IP10" . SPARSER::COLLECTION) ("MxA" . SPARSER::PROTEIN)
    ("IFN- or other STAT-activating cytokine-stimulated gene expression"
     . SPARSER::COLLECTION)
    ("IFN-" . SPARSER::DRUG) ("MX1 or OAS1" . SPARSER::COLLECTION)
    ("No viral genomic RNA or mRNA" . SPARSER::COLLECTION)
    ("No viral genomic RNA" . SPARSER::RNA) ("viral genes" . SPARSER::GENE)
    ("SB 202190-" . SPARSER::DRUG)
    ("DMSO- or SB 202190-pretreated HUVEC" . SPARSER::COLLECTION)
    ("DMSO-" . SPARSER::MOLECULE)
    ("a dominant-negative mitogen-activated protein kinase kinase 6 mutant"
     . SPARSER::MUTANT)
    ("viral RNA-induced type I IFN" . SPARSER::DRUG)
    ("IFNβ or IFN" . SPARSER::COLLECTION) ("JAK/STAT" . SPARSER::COLLECTION)
    ("NF-κB ( xref ) and IRF3 ( xref )" . SPARSER::COLLECTION)
    ("enhanceosome" . SPARSER::PROTEIN) ("IFNβ and ISGs" . SPARSER::COLLECTION)
    ("Viral RNA" . SPARSER::RNA)
    ("p38α ( MAPK14 ) and p38β ( MAPK11 )" . SPARSER::COLLECTION)
    ("IFNβ and ISG" . SPARSER::COLLECTION)
    ("viral ribonucleoproteins" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("the viral NS1 protein" . SPARSER::PROTEIN)
    ("inhibitor, or left" . SPARSER::COLLECTION)
    ("Viral polymerase protein PB2" . SPARSER::PROTEIN)
    ("two highly pathogenic subtypes" . SPARSER::PROTEIN)
    ("diverse MAPKs" . SPARSER::PROTEIN)
    ("nearly all (94%) HPAIV-induced genes" . SPARSER::GENE)
    ("primary human monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1β, TNF-α, and IL-6" . SPARSER::COLLECTION)
    ("IRF3, NF-κB, and AP1" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("transcriptional regulators HMGA1 (high-mobility group protein HMG-I/HMG-Y) and NFATC4 (nuclear factor of activated T-cells, cytoplasmic 4)"
     . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("IFNβ and other cytokines" . SPARSER::COLLECTION)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("MyD88" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("early endosome antigen 1" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCL5" . SPARSER::PROTEIN)
    ("CXCL9" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("IRF9" . SPARSER::PROTEIN)
    ("MAP Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VCAM1" . SPARSER::PROTEIN)
    ("GBP1" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("IP10" . SPARSER::PROTEIN) ("OAS1" . SPARSER::PROTEIN)
    ("MX1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 6" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN)
    ("interferon regulatory factor 7" . SPARSER::PROTEIN)
    ("phospholipase A 2" . SPARSER::PROTEIN) ("ATF-2" . SPARSER::PROTEIN)
    ("retinoic acid inducible gene I" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("PB2" . SPARSER::PROTEIN) ("C-14" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("MAPK11" . SPARSER::PROTEIN) ("MAPK14" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("SB 203580" . SPARSER::DRUG)
    ("IL-1β" . SPARSER::PROTEIN) ("activator protein 1" . SPARSER::PROTEIN)
    ("interferon regulatory factor 3" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN) ("NFATC4" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("STAT1" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("SB 202190" . SPARSER::DRUG) ("proteins and Vif" . SPARSER::COLLECTION)
    ("ADX" . SPARSER::PROTEIN) ("ART" . SPARSER::PROTEIN)
    ("the integrated proviral DNA" . SPARSER::DNA) ("NOD" . SPARSER::PROTEIN)
    ("proviral DNA" . SPARSER::DNA) ("NOG" . SPARSER::PROTEIN)
    ("coreceptor" . SPARSER::PROTEIN) ("env" . SPARSER::PROTEIN)
    ("A3F and A3G" . SPARSER::COLLECTION) ("SS" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("RNA binding, and forms" . SPARSER::COLLECTION)
    ("the assembled multimeric complexes" . SPARSER::BIO-COMPLEX)
    ("gapped ssDNA substrates as well as tail-DNA" . SPARSER::COLLECTION)
    ("AFM" . SPARSER::PROTEIN) ("the homodimeric forms" . SPARSER::FORM)
    ("the oligomeric forms" . SPARSER::FORM)
    ("homotetramers" . SPARSER::HOMOTETRAMER)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::MOLECULE) ("integrase" . SPARSER::PROTEIN)
    ("the viral DNA" . SPARSER::DNA) ("viral DNA" . SPARSER::DNA)
    ("viral RNA or cDNA" . SPARSER::COLLECTION)
    ("apurinic-apyrimidinic endonucleases" . SPARSER::PROTEIN)
    ("DNA glycosylase (UDG)" . SPARSER::PROTEIN)
    ("endonucleases" . SPARSER::PROTEIN) ("RNA and DNA" . SPARSER::COLLECTION)
    ("Hypermutated proviral DNAs" . SPARSER::DNA)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RDD" . SPARSER::PROTEIN-FAMILY)
    ("VII and A3DE" . SPARSER::COLLECTION) ("-CC" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN) ("CC" . SPARSER::PROTEIN)
    ("the viral minus-strand DNA" . SPARSER::DNA)
    ("A3A, A3B, and A3C" . SPARSER::COLLECTION)
    ("essential cellular cofactors" . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("TLR2" . SPARSER::PROTEIN)
    ("also known as Fas-associated death domain (FADD) interleukin-1β-converting enzyme (FLICE)-like inhibitory protein"
     . SPARSER::PROTEIN)
    ("interleukin-1β-converting enzyme" . SPARSER::COLLECTION)
    ("SLB" . SPARSER::PROTEIN) ("cFLIP" . SPARSER::PROTEIN)
    ("FLICE" . SPARSER::PROTEIN) ("FADD" . SPARSER::PROTEIN)
    ("FLIP" . SPARSER::PROTEIN) ("Vif and A3G" . SPARSER::COLLECTION)
    ("AID and A3G" . SPARSER::COLLECTION)
    ("kinases and A3G" . SPARSER::COLLECTION)
    ("Serine/threonine" . SPARSER::COLLECTION)
    ("Prostaglandin" . SPARSER::PROTEIN)
    ("NFATc2 and IRF-4" . SPARSER::COLLECTION) ("IFN" . SPARSER::DRUG)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an overwhelming antiviral state and curbs propagation"
     . SPARSER::COLLECTION)
    ("an overwhelming antiviral state" . SPARSER::BIO-STATE)
    ("interferon" . SPARSER::PROTEIN)
    ("CUL5, RBX, EloB, EloC, and CBF-β" . SPARSER::COLLECTION)
    ("cullins" . SPARSER::PROTEIN-FAMILY) ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("RBX" . SPARSER::PROTEIN) ("Nedd8" . SPARSER::PROTEIN)
    ("CUL5-Vif" . SPARSER::COLLECTION) ("Vif and RUNX" . SPARSER::COLLECTION)
    ("binding factor-β (CBF-β) normally forms functional heterodimers"
     . SPARSER::HETERODIMER)
    ("heterodimers" . SPARSER::HETERODIMER) ("IFNs" . SPARSER::DRUG)
    ("EloC and a RING-box subunit 2 (RBX2) and CBF-β" . SPARSER::COLLECTION)
    ("a RING-box subunit 2 (RBX2) and CBF-β" . SPARSER::COLLECTION)
    ("EloB" . SPARSER::PROTEIN)
    ("cellular ribonucleoprotein (RNP)" . SPARSER::PROTEIN)
    ("RNP" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("non-viral RNAs and none" . SPARSER::COLLECTION)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("inhibitors that inhibit Vif's" . SPARSER::INHIBITOR)
    ("proteins or Vif" . SPARSER::COLLECTION) ("CBF" . SPARSER::PROTEIN)
    ("Alanine" . SPARSER::AMINO-ACID) ("-CX" . SPARSER::COLLECTION)
    ("CX" . SPARSER::PROTEIN-FAMILY) ("EloC" . SPARSER::PROTEIN)
    ("elongin" . SPARSER::PROTEIN) ("A3F" . SPARSER::PROTEIN)
    ("heterogeneous conformational states" . SPARSER::BIO-STATE)
    ("Vif, and Vif" . SPARSER::COLLECTION) ("DPD" . SPARSER::PROTEIN)
    ("Mapping" . SPARSER::PROTEIN) ("A3F-Vif" . SPARSER::PROTEIN-PAIR)
    ("Vif-A3" . SPARSER::COLLECTION) ("A3-Vif" . SPARSER::COLLECTION)
    ("A2 and A3F-CTD" . SPARSER::COLLECTION) ("TadA" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::PROTEIN) ("-1, -2 and +1" . SPARSER::COLLECTION)
    ("A3A and A3G" . SPARSER::COLLECTION) ("dinucleotide" . SPARSER::MOLECULE)
    ("Vif and A3F" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("extensive salt" . SPARSER::MOLECULE) ("monomers" . SPARSER::MONOMER)
    ("tetramer" . SPARSER::TETRAMER) ("homodimers" . SPARSER::HOMODIMER)
    ("rod" . SPARSER::PROTEIN) ("RNA or ssDNA" . SPARSER::COLLECTION)
    ("A2, A3A, A3C, and A3F-CTD" . SPARSER::COLLECTION)
    ("a soluble mutant" . SPARSER::MUTANT)
    ("CD1 and CD2" . SPARSER::COLLECTION) ("cysteines" . SPARSER::AMINO-ACID)
    ("histidine" . SPARSER::AMINO-ACID) ("PCX" . SPARSER::PROTEIN)
    ("CD1" . SPARSER::PROTEIN) ("two distinct mRNAs" . SPARSER::PROTEIN)
    ("codons" . SPARSER::PROTEIN) ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uridines" . SPARSER::DRUG) ("cytidines" . SPARSER::MOLECULE)
    ("catalytic polypeptide (APOBEC) family" . SPARSER::PROTEIN-FAMILY)
    ("APOBEC3" . SPARSER::PROTEIN) ("Vif-APOBEC3" . SPARSER::PROTEIN-PAIR)
    ("the viral protein Vif" . SPARSER::PROTEIN) ("Vif" . SPARSER::PROTEIN)
    ("VII" . SPARSER::PROTEIN) ("APOBEC" . SPARSER::BIO-COMPLEX)
    ("CCR5" . SPARSER::PROTEIN) ("γC" . SPARSER::PROTEIN)
    ("Rag2" . SPARSER::PROTEIN) ("C -3" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EBP-β" . SPARSER::PROTEIN)
    ("PIN1" . SPARSER::PROTEIN) ("SP3" . SPARSER::PROTEIN)
    ("MT-4" . SPARSER::PROTEIN) ("MT-2" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN) ("TRIM5" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("IRF-4" . SPARSER::PROTEIN)
    ("NFATc2" . SPARSER::PROTEIN) ("NFATc1" . SPARSER::PROTEIN)
    ("TRIM5α" . SPARSER::PROTEIN) ("TLR-3" . SPARSER::PROTEIN)
    ("Toll-like receptor-3" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("UBE2F" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("ubiquitin-like protein NEDD8" . SPARSER::PROTEIN)
    ("C-E" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("RBX2" . SPARSER::PROTEIN) ("subunit 2" . SPARSER::PROTEIN)
    ("SRP19" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("NL4" . SPARSER::PROTEIN) ("CUL5" . SPARSER::PROTEIN)
    ("cullin 5" . SPARSER::PROTEIN) ("CX 3" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aspartic acid" . SPARSER::AMINO-ACID)
    ("adenosine deaminase" . SPARSER::PROTEIN) ("G-2" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("K3" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("2-4" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN)
    ("virion infectivity factor" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pre-mRNA" . SPARSER::RNA)
    ("APOBEC4" . SPARSER::PROTEIN) ("A3A" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("APOBEC2" . SPARSER::PROTEIN)
    ("APOBEC1" . SPARSER::PROTEIN) ("apolipoprotein B" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("APOBEC3F" . SPARSER::PROTEIN)
    ("3D-CRT" . SPARSER::COLLECTION) ("CRT" . SPARSER::PROTEIN)
    ("NF-κB and nodal" . SPARSER::COLLECTION)
    ("ML-IAP (BIRC7 or livin) and ILP-2 (BIRC8)" . SPARSER::COLLECTION)
    ("BIRC7 or livin" . SPARSER::COLLECTION)
    ("Apollon/Bruce" . SPARSER::COLLECTION) ("c-IAP1" . SPARSER::COLLECTION)
    ("livin" . SPARSER::PROTEIN) ("Apollon" . SPARSER::PROTEIN)
    ("survivin" . SPARSER::PROTEIN) ("NAIP" . SPARSER::PROTEIN)
    ("genes or proteins" . SPARSER::COLLECTION)
    ("IAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("available biomarkers" . SPARSER::MOLECULE)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("the major histologic form" . SPARSER::FORM) ("TNM" . SPARSER::MOLECULE)
    ("XIAP and NF-κB" . SPARSER::COLLECTION)
    ("X-chromosome-linked IAP (XIAP) and nuclear factor-κB (NF-κB)"
     . SPARSER::COLLECTION)
    ("IAP (XIAP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ILP-2" . SPARSER::PROTEIN)
    ("BIRC7" . SPARSER::PROTEIN) ("ML-IAP" . SPARSER::PROTEIN)
    ("BIRC6" . SPARSER::PROTEIN) ("BIRC5" . SPARSER::PROTEIN)
    ("BIRC4" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("c-IAP2" . SPARSER::PROTEIN) ("BIRC2" . SPARSER::PROTEIN)
    ("IAP1" . SPARSER::PROTEIN) ("BIRC1" . SPARSER::PROTEIN)
    ("Lck and other kinases" . SPARSER::COLLECTION)
    ("reagents or dose" . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("PHA/PMA" . SPARSER::COLLECTION)
    ("a naturally occurring N-terminally" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("Fas and FasL" . SPARSER::COLLECTION)
    ("Fas and TNF-α" . SPARSER::COLLECTION)
    ("PAK and PI3Ks" . SPARSER::COLLECTION) ("Bad" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("programmed death-1 surface protein" . SPARSER::PROTEIN)
    ("p38/MAPK" . SPARSER::COLLECTION)
    ("Fas and Fas ligand" . SPARSER::COLLECTION) ("Fas" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN)
    ("several viral proteins" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("sera" . SPARSER::PROTEIN)
    ("DCs" . SPARSER::MOLECULE)
    ("intercellular adhesion molecule ICAM-1 and the coactivation molecule CD23"
     . SPARSER::COLLECTION)
    ("intercellular adhesion molecule ICAM-1" . SPARSER::PROTEIN)
    ("the soluble forms" . SPARSER::FORM)
    ("CC-chemokines" . SPARSER::PROTEIN-PAIR) ("chemotaxis" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN) ("APCs" . SPARSER::PROTEIN)
    ("CD3 and CD28" . SPARSER::COLLECTION) ("WASp" . SPARSER::PROTEIN)
    ("actin [ xref ] and Nef-PAK2" . SPARSER::COLLECTION)
    ("Rac and Cdc42, and Vavl" . SPARSER::COLLECTION)
    ("Cdc42, and Vavl" . SPARSER::COLLECTION)
    ("signalosome" . SPARSER::PROTEIN) ("Cdc42–Racl" . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("a Nef-associated kinase (NAK)" . SPARSER::KINASE)
    ("Cdc42 and Racl" . SPARSER::COLLECTION) ("Racl" . SPARSER::PROTEIN)
    ("NAK" . SPARSER::PROTEIN) ("P21-associated kinases" . SPARSER::KINASE)
    ("Cdc42 and Rac" . SPARSER::COLLECTION) ("PAKs" . SPARSER::PROTEIN-FAMILY)
    ("LAT and SLP-76" . SPARSER::COLLECTION)
    ("its immediate downstream target" . SPARSER::TARGET-PROTEIN)
    ("CD4-Lck" . SPARSER::COLLECTION) ("Hck and Fyn" . SPARSER::COLLECTION)
    ("transmembrane protein LAT and adapter protein SLP-76"
     . SPARSER::COLLECTION)
    ("Neri" . SPARSER::PROTEIN) ("Lck and PKC-θ" . SPARSER::COLLECTION)
    ("NF-κB or AP-1" . SPARSER::COLLECTION)
    ("one ankyrin repeat-containing subunit (p50 or p52) and one trans-activation domain-containing subunit (p65/ RelA, RelB or c-Rel)"
     . SPARSER::COLLECTION)
    ("p50 or p52" . SPARSER::COLLECTION)
    ("RelA, RelB or c-Rel" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN) ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("JNK" . SPARSER::PROTEIN) ("cFos and cJun" . SPARSER::COLLECTION)
    ("cJun" . SPARSER::PROTEIN) ("cFos" . SPARSER::PROTEIN)
    ("Vav" . SPARSER::PROTEIN) ("NFAT-driven luciferase" . SPARSER::PROTEIN)
    ("NFAT and IL-2" . SPARSER::COLLECTION) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("NFAT promoter-driven luciferase" . SPARSER::PROTEIN)
    ("Wang" . SPARSER::PROTEIN)
    ("the Calm-dependent serine/threonine phosphatase Calcineurin"
     . SPARSER::PROTEIN)
    ("inositol" . SPARSER::PROTEIN)
    ("NFAT, AP-1, and NF-κB" . SPARSER::COLLECTION)
    ("CD3/CD28" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("phorbol" . SPARSER::DRUG) ("Jurkat" . SPARSER::PROTEIN)
    ("NFAT, AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("Calcineurin" . SPARSER::PROTEIN) ("MAPKs" . SPARSER::PROTEIN)
    ("AP-1" . SPARSER::PROTEIN) ("p56-Lck and ZAP-70" . SPARSER::COLLECTION)
    ("LAT" . SPARSER::PROTEIN) ("/CD3 complex" . SPARSER::COLLECTION)
    ("protein-sorting complexes and actin network components [ xref ]"
     . SPARSER::COLLECTION)
    ("intracellular kinases" . SPARSER::KINASE)
    ("CD4 and HLA-I" . SPARSER::COLLECTION)
    ("the viral entry receptor CD4" . SPARSER::PROTEIN)
    ("HLA" . SPARSER::PROTEIN)
    ("a multifunctional viral protein" . SPARSER::PROTEIN)
    ("anti-CD28" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("Bcl-XL" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("serine/ threonine protein kinase" . SPARSER::PROTEIN)
    ("CD95" . SPARSER::PROTEIN) ("membrane-bound" . SPARSER::PROTEIN)
    ("IL-15" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("FAK2" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("C chain" . SPARSER::PROTEIN)
    ("I-κBα" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("I-κB" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("IP 3 R" . SPARSER::PROTEIN) ("IP 3" . SPARSER::IP3)
    ("NFAT2" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN) ("SLP-76" . SPARSER::PROTEIN)
    ("ZAP-70" . SPARSER::PROTEIN) ("p56-Lck" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("CD3 complex" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("AMPK and PGC-1α" . SPARSER::COLLECTION)
    ("GATA-4 and Upstream Stimulatory Factor-1" . SPARSER::COLLECTION)
    ("Bruce" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("compound C or siRNAs" . SPARSER::COLLECTION)
    ("the antidiabetic drugs metformin and rosiglitazone"
     . SPARSER::COLLECTION)
    ("metformin and rosiglitazone" . SPARSER::COLLECTION)
    ("rosiglitazone" . SPARSER::DRUG) ("metformin" . SPARSER::DRUG)
    ("AICAR" . SPARSER::PROTEIN)
    ("glucose and fatty acids" . SPARSER::COLLECTION)
    ("etc" . SPARSER::PROTEIN) ("analogs" . SPARSER::ANALOG)
    ("our two most efficacious siRNAs" . SPARSER::PROTEIN)
    ("AMPK or PGC-1α" . SPARSER::COLLECTION)
    ("AMPK and/or PGC-1α" . SPARSER::COLLECTION)
    ("significantly more mitochondria" . SPARSER::PROTEIN)
    ("AR-AMPK-PGC-1α" . SPARSER::COLLECTION)
    ("-derivative" . SPARSER::DERIVATIVE) ("derivative" . SPARSER::DERIVATIVE)
    ("the dorsolateral lobes" . SPARSER::PROTEIN)
    ("Pb-Myc" . SPARSER::COLLECTION) ("Pb-Cre" . SPARSER::COLLECTION)
    ("Cre" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("Androgen" . SPARSER::PROTEIN)
    ("palmitate ( xref ) and oleate ( xref )" . SPARSER::COLLECTION)
    ("both the saturated fatty acid palmitate and the monounsaturated fatty acid oleate"
     . SPARSER::COLLECTION)
    ("oleate" . SPARSER::MOLECULE) ("palmitate" . SPARSER::PROTEIN)
    ("palmitoyltransferase" . SPARSER::PROTEIN) ("etomoxir" . SPARSER::DRUG)
    ("citrate" . SPARSER::PROTEIN)
    ("rotenone and antimycin" . SPARSER::COLLECTION)
    ("antimycin" . SPARSER::DRUG) ("Given AMPK's" . SPARSER::PROTEIN)
    ("what effects androgens" . SPARSER::DRUG)
    ("Given AMPK" . SPARSER::PROTEIN) ("Androgens" . SPARSER::DRUG)
    ("radical" . SPARSER::MOLECULE) ("p-AMPK" . SPARSER::COLLECTION)
    ("TMA" . SPARSER::MOLECULE)
    ("the predominant catalytic subunit" . SPARSER::PROTEIN)
    ("given AMPK's" . SPARSER::PROTEIN) ("given AMPK" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("CaMKK" . SPARSER::PROTEIN)
    ("sugars" . SPARSER::MOLECULE) ("tracers" . SPARSER::MOLECULE)
    ("AMPK-PGC-1α" . SPARSER::COLLECTION)
    ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("testosterone" . SPARSER::MOLECULE)
    ("glucose and fatty acid" . SPARSER::COLLECTION)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("-AMP-activated" . SPARSER::COLLECTION) ("ARR2" . SPARSER::PROTEIN)
    ("A-1" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("Pgc1 α" . SPARSER::PROTEIN) ("PPARGC1A" . SPARSER::PROTEIN)
    ("Upstream Stimulatory Factor-1" . SPARSER::PROTEIN)
    ("GATA-4" . SPARSER::PROTEIN) ("STO-609" . SPARSER::DRUG)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("PGC-1" . SPARSER::PROTEIN) ("c-T" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN)
    ("monounsaturated fatty acid" . SPARSER::MOLECULE)
    ("AMPKα1" . SPARSER::PROTEIN) ("compound C" . SPARSER::MOLECULE)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("AMPKα 1" . SPARSER::PROTEIN)
    ("protein kinase kinase" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("AMP-activated" . SPARSER::PROTEIN) ("paralogs" . SPARSER::PROTEIN)
    ("SCF" . SPARSER::PROTEIN) ("the frog ortholog p9" . SPARSER::PROTEIN)
    ("Skp2" . SPARSER::PROTEIN) ("phosCdc6-Cks1" . SPARSER::COLLECTION)
    ("Wee1-Cdk1" . SPARSER::COLLECTION)
    ("Cdk and its own regulators ( xref )" . SPARSER::COLLECTION)
    ("Swe1/Wee1" . SPARSER::COLLECTION)
    ("Swe1 and its phosphorylation state" . SPARSER::COLLECTION)
    ("serines" . SPARSER::AMINO-ACID) ("threonines" . SPARSER::AMINO-ACID)
    ("orthologs" . SPARSER::PROTEIN) ("Cdk1-Wee1" . SPARSER::COLLECTION)
    ("Swe1" . SPARSER::PROTEIN) ("Cdk or other kinases" . SPARSER::COLLECTION)
    ("a phosphate-binding pocket mutant or the consensus-binding mutants"
     . SPARSER::COLLECTION)
    ("max" . SPARSER::PROTEIN)
    ("a generic single-site substrate" . SPARSER::SUBSTRATE)
    ("phosCdc6" . SPARSER::PROTEIN) ("sidechains" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("guanidinium" . SPARSER::MOLECULE)
    ("sidechain" . SPARSER::PROTEIN) ("sidechain-Cks1" . SPARSER::PROTEIN-PAIR)
    ("phi" . SPARSER::PROTEIN) ("van" . SPARSER::PROTEIN)
    ("Cks1-phosCdc6" . SPARSER::COLLECTION)
    ("a proline (T9P) or a lysine (T9K)" . SPARSER::COLLECTION)
    ("pY" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("Cks1 and phosCdc6" . SPARSER::COLLECTION)
    ("phosphothreonine and proline" . SPARSER::COLLECTION)
    ("−1" . SPARSER::PROTEIN) ("−3, +2, and +3" . SPARSER::COLLECTION)
    ("TP" . SPARSER::PROTEIN) ("aspartate" . SPARSER::PROTEIN)
    ("disulfide" . SPARSER::MOLECULE)
    ("phosphoserine and phosphotyrosine" . SPARSER::COLLECTION)
    ("dot-blot and ITC" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("mers" . SPARSER::PROTEIN) ("PVDF" . SPARSER::DRUG)
    ("BSA" . SPARSER::PROTEIN) ("phosphopeptides" . SPARSER::PROTEIN)
    ("dot-blot" . SPARSER::PROTEIN) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("phosphopeptide-Cks" . SPARSER::PROTEIN-PAIR)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("Skp" . SPARSER::PROTEIN)
    ("the mitotic regulators Wee1 and Cdc25" . SPARSER::COLLECTION)
    ("Wee1 and Cdc25" . SPARSER::COLLECTION)
    ("subunit, and Cks" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("substrates and regulators" . SPARSER::COLLECTION)
    ("the mitotic regulator Wee1" . SPARSER::PROTEIN)
    ("putative Cks-directed Cdk substrates and binding partners"
     . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cks" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pT7" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("Cdc6" . SPARSER::PROTEIN)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("Cks1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("Sic1" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wee1" . SPARSER::PROTEIN) ("adjuvants" . SPARSER::DRUG)
    ("SERMs and SERDs" . SPARSER::COLLECTION) ("SERDs" . SPARSER::DRUG)
    ("fulvestrant or tamoxifen" . SPARSER::COLLECTION)
    ("LBDs" . SPARSER::PROTEIN) ("classical ER target genes" . SPARSER::GENE)
    ("these two metastatic tumor cohorts and the primary tumors"
     . SPARSER::COLLECTION)
    ("the substituent glycine" . SPARSER::AMINO-ACID)
    ("glycine" . SPARSER::AMINO-ACID) ("acceptor" . SPARSER::MOLECULE)
    ("acceptors" . SPARSER::MOLECULE)
    ("the 3 coactivator-bound ER variants" . SPARSER::VARIANT)
    ("cofactor" . SPARSER::MOLECULE)
    ("the starting agonist conformation and the final conformation"
     . SPARSER::COLLECTION)
    ("coactivator-bound ER D538G" . SPARSER::PROTEIN)
    ("The pure antiestrogen" . SPARSER::DRUG) ("Bazedoxifene" . SPARSER::DRUG)
    ("4-hydroxytamoxifen (4-OHT) or fulvestrant" . SPARSER::COLLECTION)
    ("tamoxifen or fulvestrant" . SPARSER::COLLECTION)
    ("estrogen and doxycycline" . SPARSER::COLLECTION)
    ("doxycycline and 1% sucrose" . SPARSER::COLLECTION)
    ("doxycycline" . SPARSER::DRUG) ("tetracycline" . SPARSER::DRUG)
    ("an ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("ER and AIB1" . SPARSER::COLLECTION) ("corepressors" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID)
    ("Ser463Pro/Asp538Gly and Asp538Gly mutants" . SPARSER::COLLECTION)
    ("GREB1, MYC, PGR and TFF1" . SPARSER::COLLECTION)
    ("GREB1, MYC, PGR, TFF1, XBP and CTSD" . SPARSER::COLLECTION)
    ("HA-ER" . SPARSER::COLLECTION) ("CTSD" . SPARSER::PROTEIN)
    ("HA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("WT receptor (5X basal WT levels) and the Ser463Pro mutant (3X basal Ser463Pro levels)"
     . SPARSER::COLLECTION)
    ("Ser463Pro/Asp538Gly" . SPARSER::PROTEIN) ("pRL-TK" . SPARSER::COLLECTION)
    ("Renilla-luciferase" . SPARSER::COLLECTION) ("TK" . SPARSER::PROTEIN)
    ("pRL" . SPARSER::PROTEIN)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Medicine" . SPARSER::DRUG) ("ER−" . SPARSER::PROTEIN)
    ("PIK3CA and GATA3" . SPARSER::COLLECTION)
    ("ESR1 , RPTOR and ERBB3" . SPARSER::COLLECTION)
    ("RPTOR" . SPARSER::PROTEIN)
    ("TP53 , PIK3CA and GATA3" . SPARSER::COLLECTION)
    ("Mets" . SPARSER::PROTEIN) ("SERD" . SPARSER::DRUG)
    ("GnRH" . SPARSER::PROTEIN) ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("Pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("These included highly recurrent mutations p" . SPARSER::PROTEIN)
    ("TIF-2" . SPARSER::PROTEIN) ("AIB-1" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("Phospho-Serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("ICI 182780" . SPARSER::DRUG) ("4–Hydroxytamoxifen" . SPARSER::DRUG)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("glycine)" . SPARSER::PROTEIN)
    ("N–C" . SPARSER::PROTEIN) ("nitrogen atom" . SPARSER::MOLECULE)
    ("H12" . SPARSER::PROTEIN) ("TIF2" . SPARSER::PROTEIN)
    ("4OHT" . SPARSER::DRUG) ("4-OHT" . SPARSER::DRUG)
    ("SNX2112" . SPARSER::DRUG) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("AF-2" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("p21/p27/p57" . SPARSER::COLLECTION)
    ("somatic variants and whole-genomes" . SPARSER::COLLECTION)
    ("CDKN1B and CDKN2C" . SPARSER::COLLECTION) ("menin" . SPARSER::PROTEIN)
    ("CDKN2A and related genes" . SPARSER::COLLECTION)
    ("Cdk4/Cdk6" . SPARSER::COLLECTION) ("Cdk2 and Cdk4" . SPARSER::COLLECTION)
    ("PIK3CA and EGFR" . SPARSER::COLLECTION)
    ("genes or promoter regions" . SPARSER::COLLECTION)
    ("mapping" . SPARSER::PROTEIN) ("STOP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdkn1b" . SPARSER::PROTEIN)
    ("haploinsufficient tumor suppressors" . SPARSER::SUPPRESSOR)
    ("FBXW7, PTEN, DICER1 and CREBBP" . SPARSER::COLLECTION)
    ("CREBBP" . SPARSER::PROTEIN)
    ("a haploinsufficient tumor suppressor gene" . SPARSER::PROTEIN)
    ("only one gene" . SPARSER::GENE)
    ("SRC, FYN, KDR and IDH1" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("FYN" . SPARSER::PROTEIN) ("ATRX and COL1A1" . SPARSER::COLLECTION)
    ("arm" . SPARSER::PROTEIN)
    ("DAXX, ATRX, PTEN and TSC2" . SPARSER::COLLECTION)
    ("Well-differentiated NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SI-NET" . SPARSER::COLLECTION) ("NET" . SPARSER::PROTEIN)
    ("SI-NETs" . SPARSER::COLLECTION) ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p57" . SPARSER::PROTEIN) ("CDKN2C" . SPARSER::PROTEIN)
    ("MEN-1" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("BCL10" . SPARSER::PROTEIN)
    ("DICER1" . SPARSER::PROTEIN) ("FBXW7" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("larger cohorts" . SPARSER::MOLECULE)
    ("the mutated ESR1 variants" . SPARSER::VARIANT)
    ("this tumor type and such patients" . SPARSER::COLLECTION)
    ("GNRHR" . SPARSER::PROTEIN) ("FGFR" . SPARSER::PROTEIN)
    ("mTOR and phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("4-hydroxytamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("4-hydroxytamoxifen, fulvestrant and endoxifen" . SPARSER::COLLECTION)
    ("endoxifen" . SPARSER::DRUG) ("-luciferase" . SPARSER::COLLECTION)
    ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT) ("anastrozole" . SPARSER::DRUG)
    ("FGFR2-AFF3" . SPARSER::COLLECTION)
    ("ARID2, ARID1A and SMARCA4" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("letrozole and exemestane" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("letrozole" . SPARSER::DRUG)
    ("tamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("Drugs" . SPARSER::DRUG)
    ("‘actionable’ therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("refs" . SPARSER::PROTEIN) ("Gly" . SPARSER::AMINO-ACID)
    ("Asn" . SPARSER::AMINO-ACID)
    ("ligand-binding domain (LBD)" . SPARSER::MOLECULE)
    ("anti-estrogens and estrogen" . SPARSER::COLLECTION)
    ("18 h" . SPARSER::PROTEIN) ("Y chromosome" . SPARSER::PROTEIN)
    ("bcl2" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("gonadotropin-releasing hormone receptor" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SRC1" . SPARSER::PROTEIN)
    ("β-estradiol" . SPARSER::MOLECULE) ("steroid hormone" . SPARSER::MOLECULE)
    ("AFF3" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("ARID2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOTCH2" . SPARSER::PROTEIN) ("FGFR2" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("anti-estrogens" . SPARSER::DRUG)
    ("ESR1" . SPARSER::PROTEIN) ("ER-a" . SPARSER::PROTEIN)
    ("UCP1 and PRDM16" . SPARSER::COLLECTION)
    ("lipogenic genes" . SPARSER::GENE)
    ("receptors, RARβ and PPARα" . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE) ("SIRT1-FGF21" . SPARSER::COLLECTION)
    ("PRDM16 and Cidea" . SPARSER::COLLECTION)
    ("other white adipose genes" . SPARSER::GENE) ("leptin" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN)
    ("DIO2, Cidea, and Cox7a1" . SPARSER::COLLECTION)
    ("Cidea" . SPARSER::PROTEIN) ("thermogenic genes" . SPARSER::GENE)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("RQ" . SPARSER::MOLECULE)
    ("VO" . SPARSER::MOLECULE) ("PM" . SPARSER::PROTEIN)
    ("more visible fat" . SPARSER::PROTEIN)
    ("SREBP1c and FAS" . SPARSER::COLLECTION)
    ("ketogenic genes" . SPARSER::GENE)
    ("HMGCS2 and HMGCL" . SPARSER::COLLECTION)
    ("Plasma triglyceride and cholesterol levels" . SPARSER::COLLECTION)
    ("in vivo adenoviral gene" . SPARSER::GENE)
    ("a competitive antagonist" . SPARSER::MOLECULE)
    ("FGF21 and fatty acid" . SPARSER::COLLECTION)
    ("resveratrol (10 M) and SRT1720 (5 M)" . SPARSER::COLLECTION)
    ("SREBP-1c, FAS, and stearoyl-CoA" . SPARSER::COLLECTION)
    ("a key lipogenic transcription factor" . SPARSER::PROTEIN)
    ("sterol" . SPARSER::PROTEIN) ("FAS" . SPARSER::PROTEIN)
    ("lyase (HMGCL)" . SPARSER::PROTEIN) ("HMGCL" . SPARSER::PROTEIN)
    ("lyase" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("FGF21 and β-oxidation" . SPARSER::COLLECTION)
    ("dehydrogenase (MCAD)" . SPARSER::PROTEIN) ("MCAD" . SPARSER::PROTEIN)
    ("SIRT1 and FGF21" . SPARSER::COLLECTION)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("redox" . SPARSER::PROTEIN) ("lipids" . SPARSER::LIPID)
    ("triglyceride" . SPARSER::MOLECULE) ("defective FGF21" . SPARSER::PROTEIN)
    ("brown fat-like genes" . SPARSER::GENE) ("hepatocytes" . SPARSER::PROTEIN)
    ("klotho" . SPARSER::PROTEIN)
    ("the hepatocyte-derived hormone" . SPARSER::MOLECULE)
    ("Polyphenolic SIRT1 activators" . SPARSER::ACTIVATOR)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("AMPK, SREBP-1, and PGC-1α" . SPARSER::COLLECTION)
    ("AMPK" . SPARSER::PROTEIN) ("SIRT1 or FGF21" . SPARSER::COLLECTION)
    ("fat" . SPARSER::PROTEIN) ("Resveratrol or SRT1720" . SPARSER::COLLECTION)
    ("Resveratrol" . SPARSER::PROTEIN)
    ("pharmacologic activators" . SPARSER::ACTIVATOR)
    ("resveratrol or SRT1720" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR)
    ("Sirt1 (SIRT1 LKO mice) and their wild-type littermates (controls)"
     . SPARSER::COLLECTION)
    ("Sirt1" . SPARSER::PROTEIN) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glucose" . SPARSER::PROTEIN)
    ("The hepatocyte-derived hormone fibroblast growth factor 21"
     . SPARSER::PROTEIN)
    ("AIMS" . SPARSER::PROTEIN) ("RARβ" . SPARSER::PROTEIN)
    ("CPT-1" . SPARSER::PROTEIN) ("DIO2" . SPARSER::PROTEIN)
    ("PRDM16" . SPARSER::PROTEIN) ("UCP1" . SPARSER::PROTEIN)
    ("SREBP1c" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("SCD1" . SPARSER::PROTEIN) ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("SREBP-1c" . SPARSER::PROTEIN)
    ("element binding protein" . SPARSER::PROTEIN)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("BDH1" . SPARSER::PROTEIN)
    ("HMG-CoA" . SPARSER::DRUG) ("HMGCS2" . SPARSER::PROTEIN)
    ("synthase 2" . SPARSER::PROTEIN) ("ACAT1" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("acyl-CoA" . SPARSER::MOLECULE)
    ("CPT1" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("SRT1720" . SPARSER::DRUG) ("SIRT1" . SPARSER::PROTEIN)
    ("FGF21" . SPARSER::PROTEIN)
    ("fibroblast growth factor 21" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("Tris" . SPARSER::MOLECULE)
    ("tetramethylrhodamine" . SPARSER::MOLECULE)
    ("conotoxin" . SPARSER::PROTEIN)
    ("mitochondrial uniporter" . SPARSER::PROTEIN)
    ("bovine serum albumin" . SPARSER::PROTEIN)
    ("-tetraacetic acid acetoxymethyl ester" . SPARSER::MOLECULE)
    ("ester" . SPARSER::MOLECULE) ("ethane" . SPARSER::MOLECULE)
    ("bis" . SPARSER::PROTEIN) ("hypoxia or ischemia" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3" . SPARSER::COLLECTION)
    ("ER-mitochondria" . SPARSER::COLLECTION)
    ("mPTP and NCXmito" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("staurosporine" . SPARSER::DRUG)
    ("chelators" . SPARSER::MOLECULE) ("ionophores" . SPARSER::MOLECULE)
    ("Ionomycin" . SPARSER::DRUG)
    ("ionomycin or an L-VDCC agonist" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("FCCP" . SPARSER::MOLECULE)
    ("Nrf1" . SPARSER::PROTEIN) ("new mitochondria" . SPARSER::PROTEIN)
    ("VDAC and the mitofusins" . SPARSER::COLLECTION)
    ("Miro" . SPARSER::PROTEIN) ("mitochondrial proteases" . SPARSER::PROTEIN)
    ("LC3 and COX IV" . SPARSER::COLLECTION)
    ("calcium and/or c-Fos signaling" . SPARSER::COLLECTION)
    ("c-Fos/PINK1" . SPARSER::COLLECTION)
    ("CREB, c-Jun, FOXO3a and NFκB" . SPARSER::COLLECTION)
    ("p-c-Fos" . SPARSER::COLLECTION) ("EGTA" . SPARSER::MOLECULE)
    ("ionomycin" . SPARSER::DRUG) ("ionophore" . SPARSER::MOLECULE)
    ("rotenone" . SPARSER::PROTEIN) ("VDCC" . SPARSER::PROTEIN)
    ("CTX" . SPARSER::PROTEIN) ("MG-132 and Baf" . SPARSER::COLLECTION)
    ("AAG" . SPARSER::PROTEIN) ("CCCP and Baf" . SPARSER::COLLECTION)
    ("COX IV and LC3-II" . SPARSER::COLLECTION)
    ("MG-132 and bafilomycin A1" . SPARSER::COLLECTION)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chaperone" . SPARSER::PROTEIN)
    ("PINK1 and co-staining" . SPARSER::COLLECTION) ("PI" . SPARSER::PROTEIN)
    ("Cytotoxic" . SPARSER::PROTEIN) ("mCherry-LC3B" . SPARSER::COLLECTION)
    ("puncta" . SPARSER::PROTEIN) ("mCherry" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("the autophagic protein LC3" . SPARSER::PROTEIN)
    ("proteins, COX IV and prohibitin 1" . SPARSER::COLLECTION)
    ("PINK1 or parkin" . SPARSER::COLLECTION) ("SD" . SPARSER::PROTEIN)
    ("CS" . SPARSER::PROTEIN) ("NCX2 and NCX3" . SPARSER::COLLECTION)
    ("Isoforms" . SPARSER::ISOFORM) ("mPTP" . SPARSER::PROTEIN)
    ("the mitochondrial uniporter" . SPARSER::PROTEIN)
    ("mCU" . SPARSER::PROTEIN) ("uniporter" . SPARSER::PROTEIN)
    ("FBJ murine osteosarcoma viral oncogene homolog)" . SPARSER::PROTEIN)
    ("AMP" . SPARSER::AMP) ("calretinin and calbindin" . SPARSER::COLLECTION)
    ("calbindin" . SPARSER::PROTEIN) ("calretinin" . SPARSER::PROTEIN)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("neurotransmitter" . SPARSER::MOLECULE) ("Calcium" . SPARSER::CALCIUM)
    ("parkin" . SPARSER::PROTEIN)
    ("VDAC and the mitofusins ( xref )" . SPARSER::COLLECTION)
    ("VDAC" . SPARSER::PROTEIN)
    ("old and damaged mitochondria" . SPARSER::PROTEIN)
    ("Drosophila" . SPARSER::PROTEIN) ("MPTP" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("neurotoxin" . SPARSER::PROTEIN)
    ("55 kDa (ΔN-PINK1) and 45 kDa (ΔN 2 -PINK1)" . SPARSER::COLLECTION)
    ("-PINK1" . SPARSER::COLLECTION) ("rhomboid" . SPARSER::PROTEIN-FAMILY)
    ("presenilin" . SPARSER::PROTEIN) ("PARL" . SPARSER::PROTEIN)
    ("approximately 63 kDa" . SPARSER::PROTEIN)
    ("Parkin, DJ-1, LRRK2 and α-synuclein" . SPARSER::COLLECTION)
    ("Parkin" . SPARSER::PROTEIN) ("BAPTA" . SPARSER::MOLECULE)
    ("CCCP" . SPARSER::MOLECULE) ("G-P" . SPARSER::PROTEIN)
    ("P-E" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN) ("DAP-1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("E–H" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("LC3" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("K25" . SPARSER::PROTEIN) ("-2 " . SPARSER::PROTEIN)
    ("Fluo-3 " . SPARSER::MOLECULE) ("Lamin A/C" . SPARSER::PROTEIN)
    ("F-10" . SPARSER::PROTEIN) ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-tubulin" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("prohibitin 1" . SPARSER::PROTEIN) ("COX IV" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("citrate synthase" . SPARSER::PROTEIN)
    ("Citrate synthase" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("bafilomycin A1" . SPARSER::DRUG) ("voltage-dependent" . SPARSER::PROTEIN)
    ("NCX3" . SPARSER::PROTEIN) ("NCX2" . SPARSER::PROTEIN)
    ("Na +" . SPARSER::MOLECULE) ("homolog)" . SPARSER::PROTEIN)
    ("Ca 2 +" . SPARSER::CALCIUM-ION) ("MG-132" . SPARSER::DRUG)
    ("Ca 2 + /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("LRRK2" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("chelating agent" . SPARSER::MOLECULE)
    ("PINK1" . SPARSER::PROTEIN) ("STAT3 and cytokines" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("proximal signaling molecules Lyn and Syk" . SPARSER::COLLECTION)
    ("Lyn and Syk" . SPARSER::COLLECTION)
    ("Akt, and ERK" . SPARSER::COLLECTION) ("Syk" . SPARSER::PROTEIN)
    ("mouse anti-IgE" . SPARSER::ANTIBODY) ("DNP" . SPARSER::DRUG)
    ("Steward" . SPARSER::MOLECULE) ("mut-" . SPARSER::PROTEIN)
    ("Tryptase" . SPARSER::PROTEIN) ("f-Met-Leu-Phe" . SPARSER::COLLECTION)
    ("Leu" . SPARSER::AMINO-ACID) ("Subcutaneous morphine" . SPARSER::MOLECULE)
    ("morphine" . SPARSER::MOLECULE) ("histamine" . SPARSER::PROTEIN)
    ("peanut-specific IgE" . SPARSER::PROTEIN)
    ("milk-specific IgE" . SPARSER::PROTEIN)
    ("the atopic control group" . SPARSER::MOLECULE)
    ("shed mechanistic light" . SPARSER::PROTEIN)
    ("genes and pathways" . SPARSER::COLLECTION) ("RI" . SPARSER::MOLECULE)
    ("mast cell" . SPARSER::PROTEIN) ("allergen" . SPARSER::MOLECULE)
    ("Morphine" . SPARSER::MOLECULE) ("food" . SPARSER::MOLECULE)
    ("hyper-IgE" . SPARSER::PROTEIN-PAIR) ("IgE" . SPARSER::PROTEIN)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("IL-21" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN)
    ("β-hexosaminidase" . SPARSER::PROTEIN)
    ("l -glutamine" . SPARSER::MOLECULE) ("CD117" . SPARSER::PROTEIN)
    ("MAR-1" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("CD16" . SPARSER::PROTEIN) ("IgG 1" . SPARSER::BIO-COMPLEX)
    ("Stat 3" . SPARSER::PROTEIN) ("Stat3" . SPARSER::PROTEIN)
    ("CD123" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("extracelluar signaling ERK/MAPK" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("Snail and Twist1" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) and Wnt ( xref )"
     . SPARSER::COLLECTION)
    ("N-cadherin and fibrinogen" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN) ("MAPK and Akt" . SPARSER::COLLECTION)
    ("receptors and ER" . SPARSER::COLLECTION)
    ("MAPK and PR" . SPARSER::COLLECTION)
    ("PRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (PRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("functional ERα" . SPARSER::PROTEIN) ("E 2 and PP2" . SPARSER::COLLECTION)
    ("inducers, Twist1 and Snail" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE) ("kinases/Akt" . SPARSER::COLLECTION)
    ("ER and c-Src" . SPARSER::COLLECTION) ("SERMs" . SPARSER::DRUG)
    ("own E 2" . SPARSER::MOLECULE) ("the pure antiestrogen" . SPARSER::DRUG)
    ("own estrogen" . SPARSER::MOLECULE) ("aromatase" . SPARSER::PROTEIN)
    ("Twist1 and Snail" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("the pure antiestrogen ICI182,780" . SPARSER::DRUG)
    ("PP2 and E 2" . SPARSER::COLLECTION) ("antiestrogen" . SPARSER::DRUG)
    ("either E 2 , a c-Src inhibitor PP2, or the combination"
     . SPARSER::COLLECTION)
    ("Zeb-1" . SPARSER::PROTEIN) ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Src kinase" . SPARSER::PROTEIN)
    ("insulin like growth factor-1" . SPARSER::PROTEIN)
    ("RU486" . SPARSER::DRUG) ("pS2" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("dual-luciferase" . SPARSER::PROTEIN) ("HEMA 3" . SPARSER::PROTEIN)
    ("PP 2" . SPARSER::DRUG) ("ERβ" . SPARSER::PROTEIN)
    ("AG1024" . SPARSER::DRUG) ("ICI 182,780" . SPARSER::DRUG)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Twist1" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("ICI182,780" . SPARSER::DRUG) ("E 2" . SPARSER::MOLECULE)
    ("CGH" . SPARSER::PROTEIN) ("FW" . SPARSER::MOLECULE)
    ("the substrates of MDM2 and the presence of MDM2 in both TP53 wild-type and mutated carcinoma cells"
     . SPARSER::COLLECTION)
    ("p53 and IGF-1R" . SPARSER::COLLECTION)
    ("erlotinib or tarceva" . SPARSER::COLLECTION) ("tarceva" . SPARSER::DRUG)
    ("this dual inhibitor" . SPARSER::INHIBITOR)
    ("a dual IGF-1R/insulin receptor kinase inhibitor" . SPARSER::INHIBITOR)
    ("IGF-1R/insulin receptor" . SPARSER::COLLECTION)
    ("PQIP" . SPARSER::MOLECULE) ("IGF-I/IGF-II" . SPARSER::COLLECTION)
    ("IGF-1R, AKT, and ERK" . SPARSER::COLLECTION)
    ("XIAP (Figure  xref A) and caspase-9, caspase-3, PARP, and DFF45"
     . SPARSER::COLLECTION)
    ("caspase-9, caspase-3, PARP, and DFF45" . SPARSER::COLLECTION)
    ("which releases XIAP" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein (XIAP)" . SPARSER::PROTEIN)
    ("SMAC/DIABLO" . SPARSER::COLLECTION) ("DIABLO" . SPARSER::PROTEIN)
    ("SMAC" . SPARSER::PROTEIN)
    ("caspase-3, DFF45, and PARP" . SPARSER::COLLECTION)
    ("AKT/ERK" . SPARSER::COLLECTION) ("IGF-1R and p53" . SPARSER::COLLECTION)
    ("APC , TP53 , PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN) ("APC" . SPARSER::PROTEIN)
    ("AKT and ERK" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("picropodophyllin" . SPARSER::DRUG)
    ("insulin receptor and IGF-1R" . SPARSER::COLLECTION)
    ("Monoclonal antibodies and kinase inhibitors" . SPARSER::INHIBITOR)
    ("antibodies and kinase" . SPARSER::COLLECTION)
    ("monoclonal antibodies and small molecule IGF-1R inhibitors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("IGF-IGF-1R" . SPARSER::COLLECTION)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("/AKT" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("AKT and ERK and caspase" . SPARSER::COLLECTION)
    ("ERK and caspase" . SPARSER::COLLECTION) ("BAD" . SPARSER::PROTEIN)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("IGF-1R, AKT and ERK" . SPARSER::COLLECTION)
    ("AKT and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("caspase" . SPARSER::PROTEIN) ("Picropodophyllin (PPP)" . SPARSER::DRUG)
    ("Picropodophyllin" . SPARSER::DRUG)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN)
    ("second mitochondria-derived activator of caspase" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("TP5" . SPARSER::PROTEIN) ("MDM2 protein" . SPARSER::PROTEIN)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("Triton x-100" . SPARSER::MOLECULE)
    ("IRS-1" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("DFF45" . SPARSER::PROTEIN)
    ("DNA fragmentation factor-45" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF-1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("both Akt [ xref ] and MAPK [ xref ]" . SPARSER::COLLECTION)
    ("rapamycin" . SPARSER::DRUG) ("Fyn and c-Src" . SPARSER::COLLECTION)
    ("shRNAs" . SPARSER::RNA) ("α5β1 or α4β1" . SPARSER::COLLECTION)
    ("Kinase (FAK)" . SPARSER::KINASE) ("Kinase" . SPARSER::KINASE)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("AKT/mTOR/eIF4E" . SPARSER::COLLECTION)
    ("eIF4E and the eIF4F" . SPARSER::COLLECTION)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("each polysomal fraction" . SPARSER::COMPONENT)
    ("light polysomes (fraction 4 through 8; poorly translated mRNAs) and heave polysomes (fraction 9 through 12; efficiently well-translated mRNAs)"
     . SPARSER::COLLECTION)
    ("untranslated complex (fraction 1 through 3), light polysomes (fraction 4 through 8; poorly translated mRNAs) and heave polysomes (fraction 9 through 12; efficiently well-translated mRNAs)"
     . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("DMSO or PP2" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("polysome" . SPARSER::BIO-COMPLEX)
    ("S6 ribosomal protein (on Ser235/236) and 4E-BP1 (on Ser65)"
     . SPARSER::COLLECTION)
    ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("AKT and SGK" . SPARSER::COLLECTION) ("SGK" . SPARSER::PROTEIN)
    ("TORC1 and TORC2" . SPARSER::COLLECTION)
    ("PP2 or shRNA" . SPARSER::COLLECTION) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("weak mRNAs" . SPARSER::PROTEIN) ("Ras/ERK" . SPARSER::COLLECTION)
    ("ATK/mTOR" . SPARSER::COLLECTION) ("ATK" . SPARSER::PROTEIN)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("PI3-K/Akt" . SPARSER::COLLECTION)
    ("these weak mRNAs" . SPARSER::PROTEIN)
    ("cellular mRNAs" . SPARSER::PROTEIN) ("helicase" . SPARSER::PROTEIN)
    ("nutrient and oxygen" . SPARSER::COLLECTION)
    ("oxygen" . SPARSER::MOLECULE) ("nutrient" . SPARSER::MOLECULE)
    ("eIF" . SPARSER::PROTEIN) ("VEGF" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("p-S6" . SPARSER::PROTEIN)
    ("C-11" . SPARSER::PROTEIN) ("Sin1" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("SHP2" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("4E-BP" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("SL" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("YL" . SPARSER::PROTEIN) ("translational medicine" . SPARSER::DRUG)
    ("medicine" . SPARSER::DRUG) ("Slug" . SPARSER::PROTEIN)
    ("miR-124-3p" . SPARSER::PROTEIN)
    ("miR-124-3p-Rho" . SPARSER::PROTEIN-PAIR)
    ("fibronectin, N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("potential diagnostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("bank" . SPARSER::PROTEIN) ("all histological types" . TYPE)
    ("MicroRNA" . SPARSER::RNA)
    ("primary HCCs and miR-124-3p" . SPARSER::COLLECTION)
    ("HCCs and miR-124-3p" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("NF-κB and Phospho-NF-κB" . SPARSER::COLLECTION)
    ("c-Met, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("a possible novel target" . SPARSER::TARGET-PROTEIN)
    ("pT-ROCK1 " . SPARSER::COLLECTION) ("pT" . SPARSER::PROTEIN)
    ("pT-ROCK1" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("Rho/ROCK" . SPARSER::COLLECTION)
    ("miR-124-3p directly targets ROCK1" . SPARSER::PROTEIN)
    ("NC or miR-124-3p" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("NC" . SPARSER::PROTEIN) ("SV" . SPARSER::MOLECULE)
    ("an effective therapeutic biomarker" . SPARSER::MOLECULE)
    ("a diagnostic biomarker" . SPARSER::MOLECULE)
    ("CDK6 and ITGB1" . SPARSER::COLLECTION) ("HCC" . SPARSER::PROTEIN)
    ("CIS" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("antisense" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("BCa" . SPARSER::PROTEIN) ("predictive biomarker" . SPARSER::MOLECULE)
    ("ROCK1, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("peroxidase and DAB" . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN)
    ("cytometry and Colony-forming" . SPARSER::COLLECTION)
    ("a therapeutic biomarker" . SPARSER::MOLECULE)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROCK1 " . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("U6" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("ITGB1" . SPARSER::PROTEIN)
    ("messenger RNAs" . SPARSER::RNA) ("c-Met" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("dUMP" . SPARSER::DUMP) ("genomic uracil" . SPARSER::DRUG)
    ("UNG1/UNG2" . SPARSER::COLLECTION)
    ("adeno-associated virus type 2" . SPARSER::PROTEIN)
    ("UNG2 and the CRL4 (DCAF1) complex" . SPARSER::COLLECTION)
    ("the Vpr-CUL4-E3 ligase complex and its subsequent targeting to the proteasome ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("UNG2 and SMUG1" . SPARSER::COLLECTION) ("aldehyde" . SPARSER::MOLECULE)
    ("protein and uracil–DNA glycosylase" . SPARSER::COLLECTION)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("Uracil" . SPARSER::DRUG) ("UNG1 and SMUG1" . SPARSER::COLLECTION)
    ("the irrelevant siRNA" . SPARSER::PROTEIN)
    ("isotype-matched irrelevant monoclonal antibodies" . SPARSER::ANTIBODY)
    ("UNG2/UNG1" . SPARSER::COLLECTION) ("UGI" . SPARSER::INHIBITOR)
    ("UNG1, UNG2 and SMUG1" . SPARSER::COLLECTION)
    ("PEG-U9" . SPARSER::COLLECTION) ("PEG" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN)
    ("actively degrading cellular UNG2" . SPARSER::PROTEIN)
    ("DCAF1, DDB1 and CUL4" . SPARSER::COLLECTION)
    ("virion-associated UNG2" . SPARSER::PROTEIN)
    ("inhibitor (UGI)" . SPARSER::INHIBITOR)
    ("yeast two-hybrid screening identified UNG2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated and Rad3-related" . SPARSER::COLLECTION)
    ("CHK1 and H2AX" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("p300/CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TFIIB" . SPARSER::PROTEIN)
    ("SP1" . SPARSER::PROTEIN) ("viral proteins" . SPARSER::PROTEIN)
    ("-2 and IL-6" . SPARSER::COLLECTION) ("IL" . SPARSER::PROTEIN)
    ("interleukin" . SPARSER::PROTEIN) ("SHM" . SPARSER::DRUG)
    ("AID" . SPARSER::PROTEIN) ("SMUG1 and TDG" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen and replication protein A"
     . SPARSER::COLLECTION)
    ("foci" . SPARSER::PROTEIN)
    ("the thymine–DNA glycosylase (TDG) and the methyl-binding domain protein"
     . SPARSER::COLLECTION)
    ("thymine–DNA glycosylase (TDG)" . SPARSER::PROTEIN)
    ("thymine" . SPARSER::MOLECULE) ("TDG" . SPARSER::PROTEIN)
    ("pyrimidines" . SPARSER::DRUG) ("UDG" . SPARSER::PROTEIN)
    ("promoters and alternative splicing" . SPARSER::COLLECTION)
    ("the same unique UNG gene" . SPARSER::GENE)
    ("mitochondria" . SPARSER::PROTEIN) ("UNG" . SPARSER::PROTEIN)
    ("DNA polymerase and DNA" . SPARSER::COLLECTION)
    ("ligase" . SPARSER::LIGASE) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nick" . SPARSER::PROTEIN) ("deoxyribose" . SPARSER::MOLECULE)
    ("Cytosine" . SPARSER::NUCLEOBASE) ("chemicals" . SPARSER::MOLECULE)
    ("dUTP" . SPARSER::MOLECULE) ("Vpr-UNG2" . SPARSER::COLLECTION)
    ("DDB1-CUL4" . SPARSER::COLLECTION) ("uracil" . SPARSER::DRUG)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BCR-ABL" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("CRL4" . SPARSER::PROTEIN)
    ("U9" . SPARSER::PROTEIN) ("Uracil–DNA glycosylase" . SPARSER::PROTEIN)
    ("DCAF1" . SPARSER::PROTEIN) ("APOBEC-3G" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("15 kD" . SPARSER::PROTEIN)
    ("virion-associated protein" . SPARSER::PROTEIN)
    ("hyper-IgM syndrome" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("MBD4" . SPARSER::PROTEIN) ("thymine–DNA glycosylase" . SPARSER::PROTEIN)
    ("SMUG1" . SPARSER::PROTEIN) ("UNG1" . SPARSER::PROTEIN)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("CUL4" . SPARSER::PROTEIN) ("DDB1" . SPARSER::PROTEIN)
    ("UNG2" . SPARSER::PROTEIN) ("DNA glycosylase" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN)
    ("RFP and anti-androgens" . SPARSER::COLLECTION)
    ("AR and PI3K" . SPARSER::COLLECTION) ("Pten" . SPARSER::PROTEIN)
    ("Bcl-xL, Survivin, and c-Myc" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN) ("ABCB1 and ABCG2" . SPARSER::COLLECTION)
    ("a chimeric soluble IL-6 receptor fusion protein" . SPARSER::PROTEIN)
    ("AR and pSTAT3" . SPARSER::COLLECTION)
    ("MSI-1, Sox2 and CD44" . SPARSER::COLLECTION)
    ("mirror primary PC" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("RFP or IL-6" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl" . SPARSER::COLLECTION)
    ("anti-androgen, bicalutamide, and IL-6" . SPARSER::COLLECTION)
    ("bicalutamide" . SPARSER::DRUG) ("Sox2 and MSI-1" . SPARSER::COLLECTION)
    ("MSI-1 and Sox2" . SPARSER::COLLECTION)
    ("MSI-1 and Nanog" . SPARSER::COLLECTION)
    ("MSI-1, Sox2, CD44, and Nanog" . SPARSER::COLLECTION)
    ("RFP or anti-IL-6" . SPARSER::COLLECTION)
    ("a soluble fusion protein" . SPARSER::PROTEIN)
    ("gp130 and IL-6Rα" . SPARSER::COLLECTION)
    ("CD44 or Sox2" . SPARSER::COLLECTION)
    ("CD44, Musashi-1, and Nanog" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN) ("Sox2 and integrin" . SPARSER::COLLECTION)
    ("/Sox2" . SPARSER::COLLECTION) ("/MSI" . SPARSER::COLLECTION)
    ("MSI" . SPARSER::PROTEIN) ("Musashi-1 and Sox2" . SPARSER::COLLECTION)
    ("Musashi-1, Sox2, and CD44" . SPARSER::COLLECTION)
    ("STAT3 and AR" . SPARSER::COLLECTION)
    ("Ras and Myc" . SPARSER::COLLECTION) ("vasculature" . SPARSER::PROTEIN)
    ("AR or STAT3" . SPARSER::COLLECTION) ("Rag" . SPARSER::PROTEIN)
    ("TRAMP" . SPARSER::PROTEIN) ("soluble IL-6" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("RFP" . SPARSER::PROTEIN)
    ("IL-6/gp130/STAT3" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION) ("/CD24" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION) ("dimers" . SPARSER::DIMER)
    ("receptor-associated Janus Kinases" . SPARSER::PROTEIN)
    ("JAKs" . SPARSER::PROTEIN) ("Kinases" . SPARSER::KINASE)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("receptors and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("EGFR, PDGFR and SRC" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("PDGFR" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("abiraterone" . SPARSER::DRUG)
    ("PC" . SPARSER::PROTEIN) ("AR and STAT3" . SPARSER::COLLECTION)
    ("soluble IL-6 receptor fusion protein or silencing STAT3"
     . SPARSER::COLLECTION)
    ("soluble IL-6 receptor fusion protein" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("Musashi-1" . SPARSER::PROTEIN) ("TC2" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("L-Glutamine" . SPARSER::MOLECULE)
    ("Sox2" . SPARSER::PROTEIN) ("Sox-2" . SPARSER::PROTEIN)
    ("MSI-1" . SPARSER::PROTEIN) ("Caspase3" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("TC1" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("SATB1 mRNA or total SATB1 protein" . SPARSER::COLLECTION)
    ("SATB1 mRNA and total SATB1 protein" . SPARSER::COLLECTION)
    ("HDAC1 or PCAF" . SPARSER::COLLECTION)
    ("phospho-SATB1 and HDAC1" . SPARSER::COLLECTION)
    ("Han" . SPARSER::PROTEIN) ("MARs" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("phospholemman" . SPARSER::PROTEIN)
    ("mRNA and phospho-SATB1" . SPARSER::COLLECTION)
    ("-2 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-3 or MMP-7" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("U87- and SU3-pEGFP-N1-SATB1" . SPARSER::COLLECTION)
    ("U87-" . SPARSER::PROTEIN) ("U87 and SU3" . SPARSER::COLLECTION)
    ("pEGFP-N1-SATB1" . SPARSER::COLLECTION)
    ("MTT and Matrigel" . SPARSER::COLLECTION)
    ("SATB1 and phospho-SATB1" . SPARSER::COLLECTION)
    ("MGMT" . SPARSER::PROTEIN) ("methylguanine" . SPARSER::MOLECULE)
    ("PKC and phospho-SATB1" . SPARSER::COLLECTION)
    ("LCM" . SPARSER::PROTEIN-FAMILY) ("HDAC1 and PCAF" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN)
    ("a global chromatin organizer and gene regulator" . SPARSER::REGULATOR)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("G418" . SPARSER::MOLECULE)
    ("protein A" . SPARSER::PROTEIN) ("Delta-" . SPARSER::PROTEIN)
    ("TBC1D1" . SPARSER::PROTEIN)
    ("TBC1 domain family member 1" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("HR 2" . SPARSER::PROTEIN) ("protein kinase-C" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("SATB1" . SPARSER::PROTEIN)
    ("Special AT-rich sequence-binding protein 1" . SPARSER::PROTEIN)
    ("homologous molecules" . SPARSER::MOLECULE)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("PI3K and ERK1/2" . SPARSER::COLLECTION)
    ("PI3-K and ERK1/2" . SPARSER::COLLECTION)
    ("resolvins and COX-2-derived prostaglandins" . SPARSER::COLLECTION)
    ("enzyme and COX-2" . SPARSER::COLLECTION) ("enteric" . SPARSER::PROTEIN)
    ("extravascular lung water" . SPARSER::MOLECULE)
    ("intravenous β -agonists" . SPARSER::AGONIST)
    ("-agonists" . SPARSER::AGONIST) ("salbutamol" . SPARSER::DRUG)
    ("agonists" . SPARSER::AGONIST) ("ALI" . SPARSER::PROTEIN)
    ("PI3K/AkT" . SPARSER::COLLECTION) ("AkT" . SPARSER::PROTEIN)
    ("group and LPS" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("p-AKT, a downstream molecule of PI3K, and the phosphorylation of ERK1/2"
     . SPARSER::COLLECTION)
    ("LY294002, and LPS" . SPARSER::COLLECTION)
    ("LY294002 and UO126" . SPARSER::COLLECTION)
    ("UO126, LY294002, and UO126" . SPARSER::COLLECTION)
    ("ERK1/2 and PI3K/AKT" . SPARSER::COLLECTION)
    ("group and resolvin" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("MCP-1 and IL-8" . SPARSER::COLLECTION)
    ("interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1)"
     . SPARSER::COLLECTION)
    ("some proinflammatory chemokines" . SPARSER::PROTEIN)
    ("chemokines" . SPARSER::PROTEIN) ("PGE 2 and PGD 2" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN) ("Resolvin" . SPARSER::MOLECULE)
    ("E series resolvins (RvE) and D series resolvins (RvD)"
     . SPARSER::COLLECTION)
    ("EPA" . SPARSER::PROTEIN)
    ("mediators and modulators" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("metabolites" . SPARSER::MOLECULE)
    ("LPS, TNF- α , or IL-1 β" . SPARSER::COLLECTION)
    ("cyclooxygenase" . SPARSER::PROTEIN)
    ("the damaged alveolar blood/air barrier" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor, bFGF, and keratinocyte growth factor"
     . SPARSER::COLLECTION)
    ("KGF" . SPARSER::PROTEIN) ("bFGF" . SPARSER::PROTEIN)
    ("PGs" . SPARSER::MOLECULE) ("resolvin" . SPARSER::MOLECULE)
    ("LPS" . SPARSER::PROTEIN) ("resolvins" . SPARSER::MOLECULE)
    ("ERK-1" . SPARSER::PROTEIN) ("ERK-2" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("P44" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("P42" . SPARSER::PROTEIN)
    ("PI3-K" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("HFL-1" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("LY294002" . SPARSER::MOLECULE) ("UO126" . SPARSER::DRUG)
    ("docosahexaenoic acid" . SPARSER::MOLECULE) ("IL-1 β" . SPARSER::PROTEIN)
    ("TNF- α" . SPARSER::PROTEIN) ("COX-3" . SPARSER::PROTEIN)
    ("cyclooxygenase-1" . SPARSER::PROTEIN)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("ERK2" . SPARSER::PROTEIN) ("PGD 2" . SPARSER::PROTEIN)
    ("PGE 2" . SPARSER::DRUG)
    ("RPS7, RPS14, RPL26 and RPL11" . SPARSER::COLLECTION)
    ("RP and HDM2" . SPARSER::COLLECTION)
    ("RPS14 and RPL11" . SPARSER::COLLECTION)
    ("RPL11 ( xref , xref ) and RPS14 ( xref )" . SPARSER::COLLECTION)
    ("RPS14 ( xref , xref ) and RPL26 ( xref , xref )" . SPARSER::COLLECTION)
    ("RPS7 ( xref ), RPS14 ( xref , xref ) and RPL26 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("the RP-HDM2-p53 ternary complex" . SPARSER::BIO-COMPLEX)
    ("Treacher" . SPARSER::PROTEIN)
    ("finally makes p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both exogenous and endogenous RPL6" . SPARSER::PROTEIN)
    ("p53 and mdm2" . SPARSER::COLLECTION)
    ("HDM2 or mutant" . SPARSER::COLLECTION)
    ("RPL6-shRNA" . SPARSER::COLLECTION) ("HDM2-RPL6" . SPARSER::COLLECTION)
    ("MTT" . SPARSER::MOLECULE) ("RPL6-associated proteins" . SPARSER::PROTEIN)
    ("HA-p53" . SPARSER::COLLECTION) ("pCMV-HDM2" . SPARSER::COLLECTION)
    ("RPL6, HDM2 and p53" . SPARSER::COLLECTION)
    ("the functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPL6 and RPL11" . SPARSER::COLLECTION)
    ("p21 and HDM2" . SPARSER::COLLECTION)
    ("a well-studied important regulator" . SPARSER::REGULATOR)
    ("pCMV-p53" . SPARSER::COLLECTION)
    ("full-length RPL6 and several HDM2 truncation mutants ( xref E)"
     . SPARSER::COLLECTION)
    ("RPL6 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("RPL6 and p53" . SPARSER::COLLECTION)
    ("HDM2 and RPL6" . SPARSER::COLLECTION) ("Myc-HDM2" . SPARSER::COLLECTION)
    ("Flag-RPL6" . SPARSER::COLLECTION) ("RP–MDM2" . SPARSER::COLLECTION)
    ("RPL5 and RPL11" . SPARSER::COLLECTION) ("RP–HDM2" . SPARSER::COLLECTION)
    ("RPS7 ( xref , xref ) and RPS14 ( xref , xref )" . SPARSER::COLLECTION)
    ("reagent" . SPARSER::MOLECULE) ("ActD" . SPARSER::MOLECULE)
    ("the associated macrocytic anemia" . SPARSER::PROTEIN)
    ("ribosome and human" . SPARSER::COLLECTION)
    ("RP-HDM2-p53" . SPARSER::COLLECTION) ("RPs" . SPARSER::PROTEIN)
    ("erythroid" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("Ribosome" . SPARSER::BIO-COMPLEX) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("HDM2 and p53" . SPARSER::COLLECTION)
    ("RPL6 and HDM2" . SPARSER::COLLECTION)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("HDM2-p53" . SPARSER::COLLECTION) ("Cyclin E" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("RPS3" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("MDM4" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("MG132" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("RPS7" . SPARSER::PROTEIN)
    ("RPL26" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("RNA polymerase I" . SPARSER::PROTEIN)
    ("macrocytic anemia" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN)
    ("Diamond–Blackfan anemia" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("actinomycin D" . SPARSER::MOLECULE) ("RPL6" . SPARSER::PROTEIN)
    ("ribosomal protein L6" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("PKCι, Ect2 and MMP10" . SPARSER::COLLECTION)
    ("PKCι and Ect2" . SPARSER::COLLECTION)
    ("PKCι-Par6-Ect2-Mek-Erk" . SPARSER::COLLECTION)
    ("murine ovarian TICs" . SPARSER::PROTEIN)
    ("LSL-Kras" . SPARSER::COLLECTION) ("LSL" . SPARSER::PROTEIN)
    ("ALDH1, CD44 and MMP10" . SPARSER::COLLECTION)
    ("stem cell marker genes and the ability" . SPARSER::COLLECTION)
    ("PKCι-Ect2-Mek-Erk" . SPARSER::COLLECTION) ("pERK" . SPARSER::PROTEIN)
    ("pErk" . SPARSER::PROTEIN) ("FLAG-Par6" . SPARSER::COLLECTION)
    ("PKCι and Par6" . SPARSER::COLLECTION)
    ("PKCι-Par6-Ect2" . SPARSER::COLLECTION)
    ("PKCι-Par6-Ect2–Mek-Erk-MMP10" . SPARSER::COLLECTION)
    ("PRKCI, ECT2 and MMP10" . SPARSER::COLLECTION)
    ("the atypical PKC" . SPARSER::PROTEIN)
    ("PKCι and PKCζ" . SPARSER::COLLECTION) ("PKC" . SPARSER::PROTEIN)
    ("Ect2 and MMP10" . SPARSER::COLLECTION)
    ("PKCι-Par6-Ect2-Mek-Erk-MMP10" . SPARSER::COLLECTION)
    ("Mek and Erk" . SPARSER::COLLECTION) ("PKCι-Par6" . SPARSER::COLLECTION)
    ("GEF" . SPARSER::GEF) ("ID" . SPARSER::PROTEIN)
    ("exogenous PKCι" . SPARSER::PROTEIN)
    ("the ovarian TICs" . SPARSER::PROTEIN) ("KD" . SPARSER::PROTEIN)
    ("Ovarian TICs" . SPARSER::PROTEIN)
    ("ALDH1 and CD44" . SPARSER::COLLECTION) ("Prom1" . SPARSER::PROTEIN)
    ("NANOG" . SPARSER::PROTEIN) ("auranofin (ANF)" . SPARSER::DRUG)
    ("ANF" . SPARSER::PROTEIN) ("PB1" . SPARSER::PROTEIN)
    ("aurothiomalate and aurothioglucose" . SPARSER::COLLECTION)
    ("aurothioglucose" . SPARSER::DRUG) ("aurothiomalate" . SPARSER::MOLECULE)
    ("a transcriptional target and downstream effector" . SPARSER::COLLECTION)
    ("stromelysin" . SPARSER::PROTEIN)
    ("Rac1, Pak, Mek, and Erk" . SPARSER::COLLECTION)
    ("its binding partners Par6 and the Rho family guanine nucleotide exchange factor"
     . SPARSER::COLLECTION)
    ("PDAC" . SPARSER::MOLECULE)
    ("survive conventional platinum-" . SPARSER::MOLECULE)
    ("platinum-" . SPARSER::MOLECULE) ("taxane" . SPARSER::DRUG)
    ("platinum" . SPARSER::MOLECULE) ("deadly ovarian TICs" . SPARSER::PROTEIN)
    ("auranofin" . SPARSER::DRUG) ("PRKCI and ECT2" . SPARSER::COLLECTION)
    ("PKCι-Ect2" . SPARSER::COLLECTION) ("PRKCI" . SPARSER::PROTEIN)
    ("Mek-Erk" . SPARSER::COLLECTION) ("Ect2" . SPARSER::PROTEIN)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ovarian TICs" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("cis-platin" . SPARSER::DRUG) ("PKCζ" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("B-27" . SPARSER::PROTEIN) ("N-2" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("D-glucose" . SPARSER::MOLECULE)
    ("MMP10" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECT2" . SPARSER::PROTEIN)
    ("PKCι" . SPARSER::PROTEIN) ("ETS" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT) ("formalin" . SPARSER::MOLECULE)
    ("WNT " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the entire cohort" . SPARSER::MOLECULE)
    ("PTCH1/CDKN2A/CDKN2B/PTEN" . SPARSER::COLLECTION)
    ("MYCN/GLI2/CDK6/YAP1/PPM1D" . SPARSER::COLLECTION)
    ("TERT and TP53" . SPARSER::COLLECTION)
    ("distinct prognostic patient cohorts" . SPARSER::MOLECULE)
    ("WNT and SHH" . SPARSER::COLLECTION)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("a clinically well-annotated medulloblastoma cohort" . SPARSER::MOLECULE)
    ("ATRX/DAXX" . SPARSER::COLLECTION) ("DAXX" . SPARSER::PROTEIN)
    ("ATRX" . SPARSER::PROTEIN) ("SCNA" . SPARSER::PROTEIN)
    ("pediatric cohorts" . SPARSER::MOLECULE)
    ("SHH and WNT" . SPARSER::COLLECTION) ("Group" . SPARSER::MOLECULE)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SHH" . SPARSER::PROTEIN)
    ("TERT" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("PPM1D" . SPARSER::PROTEIN) ("YAP1" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("1B" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("G-3" . SPARSER::PROTEIN)
    ("C-3" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("MYC, MYCN, AKT and p53" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("calpain" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("Calpain" . SPARSER::PROTEIN) ("calpains" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("racemate" . SPARSER::MOLECULE) ("KDM7A/JHDM1D" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("GDF15, DDIT3 and EGR1" . SPARSER::COLLECTION)
    ("ATF3, ATF4, ATF5, ATF6, DDIT3, DDIT4, DNAJC3, EDEME1, HSPA5, GDF15, HERPUD1, NDRG1, and XBP1"
     . SPARSER::COLLECTION)
    ("mesenchymal signature genes" . SPARSER::GENE)
    ("EZH2, NOTCH3, DLL3 and TWIST1" . SPARSER::COLLECTION)
    ("CDKN1A, CDKN2B, EGR1, and SEL1L" . SPARSER::COLLECTION)
    ("MKI67, PCNA, CCNE1, CCNE2, CDK1, CDK2, CDC6, CDC7, CHEK1, CHEK2, FOXM1, MCM2, MCM4, MCM7, MCM8, MSH2, MSH6, AURKB, BUB1, PLK4, E2F1, and E2F2"
     . SPARSER::COLLECTION)
    ("E2F2" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("IPA" . SPARSER::MOLECULE)
    ("the neuroblastoma growth suppressive gene" . SPARSER::GENE)
    ("CDKN1A, EGR1, NRG1 and SEL1L" . SPARSER::COLLECTION)
    ("MIZ-1" . SPARSER::PROTEIN)
    ("favorable neuroblastoma genes (EPHB6, CD44) and growth suppressive genes (EGR1, NRG1, SEL1L, EPHA2)"
     . SPARSER::COLLECTION)
    ("growth suppressive genes" . SPARSER::GENE)
    ("favorable neuroblastoma genes" . SPARSER::GENE)
    ("MYCN or MYC" . SPARSER::COLLECTION) ("NSAID" . SPARSER::PROTEIN)
    ("Diclofenac and Celecoxib" . SPARSER::COLLECTION)
    ("Celecoxib" . SPARSER::DRUG) ("Diclofenac" . SPARSER::DRUG)
    ("NSAIDs" . SPARSER::DRUG) ("MYCN/MYC" . SPARSER::COLLECTION)
    ("MYC/MYCN" . SPARSER::COLLECTION)
    ("favorable neuroblastoma genes and genes" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("MYC and MYCN" . SPARSER::COLLECTION)
    ("deacetylases and proteasomes" . SPARSER::COLLECTION)
    ("proteasomes" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN) ("COXs" . SPARSER::PROTEIN)
    ("termed favorable neuroblastoma genes" . SPARSER::GENE)
    ("TP53-" . SPARSER::PROTEIN)
    ("some favorable neuroblastoma genes ( EPHB6, CD44 ) and genes"
     . SPARSER::COLLECTION)
    ("some favorable neuroblastoma genes" . SPARSER::GENE)
    ("EGR1, EPHA2, NRG1 and SEL1L" . SPARSER::COLLECTION)
    ("p53 proteins and the favorable neuroblastoma genes"
     . SPARSER::COLLECTION)
    ("the MYCN, MYC, AKT, p53 proteins and the favorable neuroblastoma genes"
     . SPARSER::COLLECTION)
    ("the favorable neuroblastoma genes" . SPARSER::GENE)
    ("MYCN and MYC" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("caspase 12" . SPARSER::PROTEIN) ("JHDM1D" . SPARSER::PROTEIN)
    ("KDM7A" . SPARSER::PROTEIN) ("KDM6B" . SPARSER::PROTEIN)
    ("KDM5A" . SPARSER::PROTEIN) ("KDM4A" . SPARSER::PROTEIN)
    ("KDM3A" . SPARSER::PROTEIN) ("XBP1" . SPARSER::PROTEIN)
    ("NDRG1" . SPARSER::PROTEIN) ("HERPUD1" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("HSPA5" . SPARSER::PROTEIN)
    ("DNAJC3" . SPARSER::PROTEIN) ("DDIT4" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("ATF5" . SPARSER::PROTEIN) ("ATF4" . SPARSER::PROTEIN)
    ("ATF3" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("DLL3" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("PLK4" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("MCM8" . SPARSER::PROTEIN) ("MCM7" . SPARSER::PROTEIN)
    ("MCM4" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("CHEK1" . SPARSER::PROTEIN) ("CDC7" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("EFNB3" . SPARSER::PROTEIN)
    ("EFNB2" . SPARSER::PROTEIN) ("p75 NTR" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pH 3" . SPARSER::MOLECULE)
    ("P40" . SPARSER::PROTEIN) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proto-oncogene" . SPARSER::PROTEIN) ("SEL1L" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("EPHA2" . SPARSER::PROTEIN)
    ("EGR1" . SPARSER::PROTEIN) ("EPHB6" . SPARSER::PROTEIN)
    ("the lentivious AR shRNA" . SPARSER::PROTEIN)
    ("Sec23A" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("FGF8 ( xref ) as well as TMPRSS2 ( xref )" . SPARSER::COLLECTION)
    ("prostate-specific antigen (PSA) ( xref ), Cdk1 and Cdk2 ( xref ), PMEPA1 ( xref ), FGF8 ( xref ) as well as TMPRSS2 ( xref )"
     . SPARSER::COLLECTION)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("Cdk1 and Cdk2" . SPARSER::COLLECTION)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3A and DNMT3B" . SPARSER::COLLECTION)
    ("GDS" . SPARSER::PROTEIN) ("Rv" . SPARSER::MOLECULE)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("PC-3 and DU145" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("neo" . SPARSER::PROTEIN) ("BSP" . SPARSER::PROTEIN)
    ("bisulfite" . SPARSER::MOLECULE)
    ("androgen receptor and DNA" . SPARSER::COLLECTION)
    ("usually cause gene" . SPARSER::GENE)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("DNMT" . SPARSER::PROTEIN)
    ("DNMTs" . SPARSER::PROTEIN) ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("Aza" . SPARSER::DRUG)
    ("Dnmt1" . SPARSER::PROTEIN) ("Sec23" . SPARSER::PROTEIN-FAMILY)
    ("TMPRSS2" . SPARSER::PROTEIN) ("FGF8" . SPARSER::PROTEIN)
    ("PMEPA1" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("DU 145" . SPARSER::PROTEIN)
    ("DNMT3B" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN)
    ("Methyltransferase Activity" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("C4-2" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("serial DNA" . SPARSER::DNA) ("JAK2 and ABL1" . SPARSER::COLLECTION)
    ("The latter gene" . SPARSER::GENE)
    ("target, and SPI1" . SPARSER::COLLECTION)
    ("the most appropriate GC" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("JAK2 , ABL1 , and B2M and GUSB" . SPARSER::COLLECTION)
    ("polymerase" . SPARSER::PROTEIN) ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Leukemia" . SPARSER::PROTEIN) ("leukocytes" . SPARSER::PROTEIN)
    ("RNA or DNA" . SPARSER::COLLECTION)
    ("ABL1 , GUSB , and JAK2" . SPARSER::COLLECTION)
    ("ABL1 , B2M , GUSB , and JAK2" . SPARSER::COLLECTION)
    ("available RNA" . SPARSER::RNA) ("B2M and GUSB" . SPARSER::COLLECTION)
    ("PMF " . SPARSER::PROTEIN) ("PV " . SPARSER::PROTEIN)
    ("EAC" . SPARSER::PROTEIN) ("ABL1 and JAK2WT" . SPARSER::COLLECTION)
    ("PLT" . SPARSER::PROTEIN) ("PV and PMF" . SPARSER::COLLECTION)
    ("DNA or RNA" . SPARSER::COLLECTION) ("PMFs" . SPARSER::PROTEIN)
    ("gene (CG)" . SPARSER::GENE)
    ("housekeeping gene (HKG)" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN)
    ("ABL1 or β2 microglobulin" . SPARSER::COLLECTION)
    ("GUSB" . SPARSER::PROTEIN) ("platelets" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("PMF" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("SPI1" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("β2 microglobulin" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("PWD, JLF and JVG" . SPARSER::COLLECTION)
    ("JFK" . SPARSER::PROTEIN) ("PWD" . SPARSER::PROTEIN)
    ("FasL and PD1" . SPARSER::COLLECTION) ("Ras-Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FasL" . SPARSER::PROTEIN)
    ("P72/P75" . SPARSER::COLLECTION) ("codon" . SPARSER::PROTEIN)
    ("alanine codon (GCT)" . SPARSER::PROTEIN) ("cytosine" . SPARSER::MOLECULE)
    ("guanine" . SPARSER::PROTEIN)
    ("two key prolines in Nef’s" . SPARSER::AMINO-ACID)
    ("prolines" . SPARSER::AMINO-ACID)
    ("13.4 dpi (n = 4, p = 0.0106) and LAINef fs ∆-13" . SPARSER::COLLECTION)
    ("dpi" . SPARSER::PROTEIN) ("adenosine" . SPARSER::PROTEIN)
    ("CD4 and MHCI" . SPARSER::COLLECTION) ("MHCI" . SPARSER::PROTEIN)
    ("MHC" . SPARSER::PROTEIN) ("amino acids (SRPGKTC)" . SPARSER::AMINO-ACID)
    ("amino acids (SRPG)" . SPARSER::AMINO-ACID) ("SRPG" . SPARSER::PROTEIN)
    ("adenines" . SPARSER::NUCLEOBASE) ("run" . SPARSER::PROTEIN-FAMILY)
    ("viral RNA" . SPARSER::RNA) ("endonuclease" . SPARSER::PROTEIN)
    ("XhoI" . SPARSER::PROTEIN-FAMILY)
    ("correct defective genes" . SPARSER::GENE)
    ("vif and pol" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("vif" . SPARSER::PROTEIN) ("Hck" . SPARSER::PROTEIN)
    ("P72A/P75A" . SPARSER::PROTEIN) ("BLT" . SPARSER::PROTEIN)
    ("The HIV-1 accessory protein" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("SK3" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("SK1" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD34" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN) ("anti-viral" . SPARSER::DRUG)
    ("IL-2" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p24" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("activated protein kinase" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN) ("P75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P72" . SPARSER::PROTEIN) ("DT, GS and DWN" . SPARSER::COLLECTION)
    ("DT" . SPARSER::PROTEIN) ("pathological states" . SPARSER::BIO-STATE)
    ("the parent gene" . SPARSER::GENE)
    ("the parent gene SERPINA6" . SPARSER::PROTEIN)
    ("likely only one serpin gene" . SPARSER::GENE)
    ("fungi" . SPARSER::PROTEIN) ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("most extracellular serpins [ xref , xref ] and each inhibitory serpin"
     . SPARSER::COLLECTION)
    ("most extracellular serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these proximal genes" . SPARSER::GENE)
    ("The polymeric form" . SPARSER::FORM)
    ("form and back" . SPARSER::COLLECTION)
    ("cofactors and/or glycosaminoglycans" . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE)
    ("both the serpin and the target" . SPARSER::COLLECTION)
    ("delta" . SPARSER::PROTEIN)
    ("the protease's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polypeptide" . SPARSER::PEPTIDE) ("‘A’ referencing" . SPARSER::PROTEIN)
    ("antitrypsin" . SPARSER::PROTEIN)
    ("new serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("‘serpin’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("peptidase" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspases and cathespins" . SPARSER::COLLECTION)
    ("cysteine" . SPARSER::AMINO-ACID) ("proteases" . SPARSER::PROTEIN)
    ("RCL" . SPARSER::PROTEIN)
    ("Approximately 1,500 serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chymotrypsin" . SPARSER::PROTEIN)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("monomeric proteins" . SPARSER::PROTEIN)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("human SERPIN genes and some" . SPARSER::COLLECTION)
    ("multiple paralogous genes" . SPARSER::GENE) ("SERPIN" . SPARSER::PROTEIN)
    ("Serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Serpins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chaperones" . SPARSER::PROTEIN) ("J–P" . SPARSER::PROTEIN)
    ("SERPINI2" . SPARSER::PROTEIN) ("SERPINI1" . SPARSER::PROTEIN)
    ("HSP47" . SPARSER::PROTEIN) ("SERPINH1" . SPARSER::PROTEIN)
    ("SERPING1" . SPARSER::PROTEIN) ("Serpinf1" . SPARSER::PROTEIN)
    ("SERPINF2" . SPARSER::PROTEIN) ("neurotrophic factor" . SPARSER::PROTEIN)
    ("pigment epithelium-derived factor" . SPARSER::PROTEIN)
    ("SERPINF1" . SPARSER::PROTEIN) ("Serpine 1" . SPARSER::PROTEIN)
    ("PAI1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("SERPINE1" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("heparin cofactor II" . SPARSER::PROTEIN) ("SERPIND1" . SPARSER::PROTEIN)
    ("SERPINC1" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("SERPINB9" . SPARSER::PROTEIN) ("PI8" . SPARSER::PROTEIN)
    ("SERPINB8" . SPARSER::PROTEIN) ("PI6" . SPARSER::PROTEIN)
    ("SERPINB6" . SPARSER::PROTEIN)
    ("squamous cell carcinoma antigen 1" . SPARSER::PROTEIN)
    ("cathepsin L" . SPARSER::PROTEIN) ("PAI2" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 2" . SPARSER::PROTEIN)
    ("B13" . SPARSER::PROTEIN) ("SERPINB2" . SPARSER::PROTEIN)
    ("SERPINB4" . SPARSER::PROTEIN) ("SERPINB13" . SPARSER::PROTEIN)
    ("SERPINB5" . SPARSER::DRUG) ("SERPINB3" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("SERPINB1" . SPARSER::PROTEIN)
    ("thyroxine-binding globulin" . SPARSER::PROTEIN)
    ("corticosteroid-binding globulin" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::PROTEIN) ("SERPINA5" . SPARSER::PROTEIN)
    ("PI4" . SPARSER::PROTEIN) ("SERPINA4" . SPARSER::PROTEIN)
    ("cathepsin G" . SPARSER::PROTEIN) ("SERPINA3" . SPARSER::PROTEIN)
    ("SERPINA2" . SPARSER::PROTEIN) ("neutrophil elastase" . SPARSER::PROTEIN)
    ("SERPINE2" . SPARSER::PROTEIN) ("SERPINA6" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("A’" . SPARSER::PROTEIN)
    ("SERPINA1" . SPARSER::PROTEIN) ("A–I" . SPARSER::PROTEIN)
    ("A–P" . SPARSER::PROTEIN) ("serine proteinase" . SPARSER::PROTEIN)
    ("serpin family" . SPARSER::PROTEIN) ("KL" . SPARSER::PROTEIN)
    ("BG" . SPARSER::PROTEIN) ("AF" . SPARSER::PROTEIN)
    ("AGA" . SPARSER::PROTEIN) ("our western blot" . SPARSER::PROTEIN)
    ("RIN" . SPARSER::PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("low EGFR and vice versa" . SPARSER::COLLECTION)
    ("EGFR and COX" . SPARSER::COLLECTION)
    ("EGFR or vice versa" . SPARSER::COLLECTION) ("versa" . SPARSER::PROTEIN)
    ("EGFR and Kras" . SPARSER::COLLECTION)
    ("only one homogenous COX-2 protein" . SPARSER::PROTEIN)
    ("mature COX-2 protein" . SPARSER::PROTEIN)
    ("around 64 kDa" . SPARSER::PROTEIN)
    ("glycosylation mature COX-2" . SPARSER::PROTEIN)
    ("COX-1 and COX-2" . SPARSER::COLLECTION) ("indomethacin" . SPARSER::DRUG)
    ("prostanoids" . SPARSER::MOLECULE)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and COX-1" . SPARSER::COLLECTION)
    ("either total COX-2 (~66 + 74 kDa) or the 74 kDa protein"
     . SPARSER::COLLECTION)
    ("mRNA and EGFR" . SPARSER::COLLECTION) ("COX-EGFR" . SPARSER::COLLECTION)
    ("COX-1 and EGFR" . SPARSER::COLLECTION)
    ("COX-1, COX-2, and EGFR" . SPARSER::COLLECTION)
    ("EGFR and COX-2" . SPARSER::COLLECTION) ("CRC" . SPARSER::PROTEIN)
    ("COX-2 and EGFR" . SPARSER::COLLECTION)
    ("protein and COX-2" . SPARSER::COLLECTION)
    ("COX-1, COX-2 and EGFR" . SPARSER::COLLECTION)
    ("COX and EGFR" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("Cyclooxygenase" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclooxygenase-1" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("R-1" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("PTGS1" . SPARSER::PROTEIN)
    ("COX1" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("tween 20" . SPARSER::MOLECULE) ("P-40" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("HDAC8 and
possibly other HDACs"
     . SPARSER::COLLECTION)
    ("possibly other HDACs" . SPARSER::PROTEIN)
    ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("a cleavable substrate" . SPARSER::SUBSTRATE)
    ("Fluor" . SPARSER::MOLECULE)
    ("the wild-type HDAC8 and
these mutants"
     . SPARSER::COLLECTION)
    ("MAL" . SPARSER::PROTEIN) ("Boc" . SPARSER::PROTEIN)
    ("–1" . SPARSER::PROTEIN) ("Lys33Glu/Asp87–89Arg" . SPARSER::PROTEIN)
    ("Salt" . SPARSER::MOLECULE) ("Mutants" . SPARSER::MUTANT)
    ("substrate and product" . SPARSER::COLLECTION)
    ("the perturbed form (HDAC8:SAHA) and the
free form"
     . SPARSER::COLLECTION)
    ("the
triple Asp"
     . SPARSER::AMINO-ACID)
    ("its aromatic cap
group"
     . SPARSER::MOLECULE)
    ("hydroxamate" . SPARSER::MOLECULE) ("Complex" . SPARSER::BIO-COMPLEX)
    ("regulators
and inhibitors"
     . SPARSER::COLLECTION)
    ("the microkinetic states" . SPARSER::BIO-STATE)
    ("the subsequent f3 state" . SPARSER::BIO-STATE)
    ("three consecutive states" . SPARSER::BIO-STATE)
    ("the triple Asp" . SPARSER::AMINO-ACID) ("light" . SPARSER::PROTEIN)
    ("explicit solvent" . SPARSER::MOLECULE)
    ("HDAC3 and HDAC8" . SPARSER::COLLECTION)
    ("the distal part" . SPARSER::COMPONENT) ("ion" . SPARSER::MOLECULE)
    ("Lys" . SPARSER::AMINO-ACID) ("PDB" . SPARSER::MOLECULE)
    ("The distal part" . SPARSER::COMPONENT) ("parts" . SPARSER::COMPONENT)
    ("electron" . SPARSER::MOLECULE) ("HDACs and HDAC8" . SPARSER::COLLECTION)
    ("inhibitors and substrates" . SPARSER::COLLECTION)
    ("the classical class
I HDACs"
     . SPARSER::PROTEIN)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("at least 11 classical
zinc-dependent
isoforms"
     . SPARSER::ISOFORM)
    ("classes" . CLASS) ("HDAC" . SPARSER::PROTEIN) ("SAHA" . SPARSER::DRUG)
    ("histones" . SPARSER::PROTEIN) ("HDACs" . SPARSER::PROTEIN)
    ("DNA or bromodomains" . SPARSER::COLLECTION) ("ray" . SPARSER::PROTEIN)
    ("a key hydrolase" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("type IX" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("–2" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("de-" . SPARSER::MOLECULE) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("M –1" . SPARSER::PROTEIN) ("1–L" . SPARSER::PROTEIN)
    ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC3" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("HDAC8" . SPARSER::PROTEIN) ("histone deacetylase 8" . SPARSER::PROTEIN)
    ("western blot" . SPARSER::PROTEIN) ("DNA-dsb" . SPARSER::DNA)
    ("BRCA1 , BRCA2 , RAD51 and RAD50" . SPARSER::COLLECTION)
    ("severe hypoxia" . SPARSER::PROTEIN)
    ("p53- and HIF-1 α" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hypoxia" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG) ("WB" . SPARSER::PROTEIN)
    ("PHD" . SPARSER::PROTEIN) ("BRCA1 and MLH1" . SPARSER::COLLECTION)
    ("MLH1 , MSH2, and MSH6" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , RAD51, and RAD50" . SPARSER::COLLECTION)
    ("NER" . SPARSER::PROTEIN) ("ajuba" . SPARSER::PROTEIN)
    ("JUB" . SPARSER::PROTEIN) ("AURKB" . SPARSER::PROTEIN)
    ("AURKA" . SPARSER::PROTEIN)
    ("PGK1 , PFKFB3 , HK2 , and ALDOA" . SPARSER::COLLECTION)
    ("ALDOA" . SPARSER::PROTEIN) ("FOS" . SPARSER::PROTEIN)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDC6 , CCND1 , CCNE2 , and CDK2" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("DDR" . SPARSER::PROTEIN) ("hypoxia- and low pH" . SPARSER::COLLECTION)
    ("hypoxia-" . SPARSER::PROTEIN) ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("MLH1" . SPARSER::PROTEIN)
    ("HIF-1 β and HIF-1" . SPARSER::COLLECTION) ("monomer" . SPARSER::MONOMER)
    ("Intratumoral hypoxia" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("hypoxia and BRCA" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("dimethyloxalylglycine (DMOG)" . SPARSER::DRUG)
    ("a cell-permeable inhibitor of both proline and asparaginyl hydroxylases"
     . SPARSER::COLLECTION)
    ("a cell-permeable inhibitor" . SPARSER::INHIBITOR)
    ("normoxia" . SPARSER::PROTEIN) ("asparaginyl" . SPARSER::PROTEIN)
    ("DMOG" . SPARSER::DRUG) ("dimethyloxalylglycine" . SPARSER::DRUG)
    ("mismatch" . SPARSER::PROTEIN) ("hypoxia" . SPARSER::PROTEIN)
    ("BRCA2 protein" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("TPX2" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("PFKFB3" . SPARSER::PROTEIN) ("PGK1" . SPARSER::PROTEIN)
    ("SLC2A1" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("CCNB2" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDKN1A" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("CDC6" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("HIF-1a" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("HIF-1" . SPARSER::PROTEIN) ("HIF-1 β" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("HIF-1 α" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("only one mutant allele" . SPARSER::ALLELE)
    ("neither the gene nor the protein expression" . SPARSER::COLLECTION)
    ("mixture" . SPARSER::MOLECULE)
    ("antibodies and IHC" . SPARSER::COLLECTION)
    ("p53 and TP53" . SPARSER::COLLECTION)
    ("PTCs and FTC" . SPARSER::COLLECTION) ("FTC and FA" . SPARSER::COLLECTION)
    ("FA" . SPARSER::PROTEIN) ("Our group and others" . SPARSER::COLLECTION)
    ("PTCs" . SPARSER::PROTEIN) ("an aggressive form" . SPARSER::FORM)
    ("p53 and CD8+" . SPARSER::COLLECTION)
    ("CD68 and tumor-infiltrating lymphocytes (TIL) subsets"
     . SPARSER::COLLECTION)
    ("tumor-associated macrophages (TAM)" . SPARSER::PROTEIN)
    ("CD3, CD4, CD8, and CD20" . SPARSER::COLLECTION)
    ("DTC" . SPARSER::MOLECULE) ("MDM2" . SPARSER::PROTEIN)
    ("tumor antigen" . SPARSER::DRUG) ("2–4 " . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("TP53" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("CD68" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("Mer" . SPARSER::PROTEIN) ("Ron" . SPARSER::PROTEIN)
    ("Ros" . SPARSER::PROTEIN) ("Fes" . SPARSER::PROTEIN)
    ("Axl" . SPARSER::PROTEIN) ("Lck" . SPARSER::PROTEIN)
    ("Abl" . SPARSER::PROTEIN) ("TrkB" . SPARSER::PROTEIN)
    ("TrkA" . SPARSER::PROTEIN)
    ("Crizotinib and Tivantinib" . SPARSER::COLLECTION)
    ("c-MET and AKT" . SPARSER::COLLECTION)
    ("ERK and 4E-BP1" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("AKT and STAT3" . SPARSER::COLLECTION) ("p-MET" . SPARSER::COLLECTION)
    ("Iodide" . SPARSER::PROTEIN) ("Propidium" . SPARSER::MOLECULE)
    ("either Tivantinib (1 μM) or Crizotinib (10 μM)" . SPARSER::COLLECTION)
    ("Tivantinib or Crizotinib" . SPARSER::COLLECTION)
    ("Thyroid" . SPARSER::PROTEIN) ("TPC-1" . SPARSER::PROTEIN)
    ("PTC" . SPARSER::PROTEIN) ("ATC" . SPARSER::DRUG)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE)
    ("c-MET and Anaplastic Lymphoma Kinase (ALK)" . SPARSER::COLLECTION)
    ("a potent ATP competitive inhibitor" . SPARSER::INHIBITOR)
    ("c-MET and Anaplastic Lymphoma Kinase" . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("IκBα/NF-κB" . SPARSER::COLLECTION)
    ("PIK3/AKT" . SPARSER::COLLECTION) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("HGF/c-MET" . SPARSER::COLLECTION)
    ("HGF" . SPARSER::PROTEIN)
    ("Tivantinib and Crizotinib" . SPARSER::COLLECTION)
    ("Crizotinib" . SPARSER::DRUG) ("Tivantinib" . SPARSER::DRUG)
    ("Tie2" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("CO2" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE)
    ("Anaplastic Lymphoma Kinase" . SPARSER::PROTEIN)
    ("PF-2341066" . SPARSER::DRUG) ("IκBα" . SPARSER::PROTEIN)
    ("PIK3" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("PI3K-Akt, MAP kinase and JAK-STAT" . SPARSER::COLLECTION)
    ("the EtOH-soluble fraction" . SPARSER::COMPONENT)
    ("a water-soluble form" . SPARSER::FORM) ("water" . SPARSER::MOLECULE)
    ("RAS-MAP kinase" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cytokine" . SPARSER::PROTEIN)
    ("HL60" . SPARSER::PROTEIN) ("phosphomimetic RB" . SPARSER::PROTEIN)
    ("pure nimbolide" . SPARSER::DRUG)
    ("U87 and U87EGFRvIII" . SPARSER::COLLECTION) ("PARP" . SPARSER::PROTEIN)
    ("oncogenes" . SPARSER::ONCOGENE)
    ("TMZ, PI3K and mTOR" . SPARSER::COLLECTION)
    ("a clear grasp" . SPARSER::PROTEIN) ("grasp" . SPARSER::PROTEIN)
    ("GBB" . SPARSER::PROTEIN) ("Rank" . SPARSER::PROTEIN)
    ("DsRed" . SPARSER::PROTEIN) ("lentiviral luciferase" . SPARSER::PROTEIN)
    ("DMSO or nimbolide" . SPARSER::COLLECTION)
    ("Many preclinical drugs" . SPARSER::DRUG) ("barrier" . SPARSER::PROTEIN)
    ("EtOH or Azt" . SPARSER::COLLECTION)
    ("nimbolide or DMSO" . SPARSER::COLLECTION)
    ("Azt or EtoH" . SPARSER::COLLECTION) ("EtoH" . SPARSER::MOLECULE)
    ("Akt, Erk1/2, STAT3 and RB" . SPARSER::COLLECTION)
    ("95% EtOH (1% final) or PBS (control)" . SPARSER::COLLECTION)
    ("PBS" . SPARSER::PROTEIN)
    ("an RB phosphomimetic mutant" . SPARSER::MUTANT)
    ("Azt and nimbolide" . SPARSER::COLLECTION)
    ("EtOH or DMSO" . SPARSER::COLLECTION) ("GST-RB" . SPARSER::COLLECTION)
    ("DMSO" . SPARSER::MOLECULE) ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK3β and Cyclin D1" . SPARSER::COLLECTION)
    ("proteasomal" . SPARSER::PROTEIN) ("CDKs" . SPARSER::PROTEIN)
    ("Caspase" . SPARSER::PROTEIN) ("Akt and RB" . SPARSER::COLLECTION)
    ("Azt and its principal cytotoxic component nimbolide"
     . SPARSER::COLLECTION)
    ("its principal cytotoxic component nimbolide" . SPARSER::DRUG)
    ("monolayers" . SPARSER::PROTEIN) ("normal astrocytes" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN)
    ("an EtOH-soluble fraction" . SPARSER::COMPONENT)
    ("EGFR or EGFRvIII" . SPARSER::COLLECTION)
    ("mTORC1/C2 inhibitor PP242 and the PI3K/mTOR dual kinase inhibitor BEZ235"
     . SPARSER::COLLECTION)
    ("Etoposide, Camptothecin, another alkylating agent Mitomycin C, mTORC1 inhibitor Rapamycin, mTORC1/C2 inhibitor PP242 and the PI3K/mTOR dual kinase inhibitor BEZ235"
     . SPARSER::COLLECTION)
    ("the PI3K/mTOR dual kinase inhibitor BEZ235" . SPARSER::DRUG)
    ("Rapamycin" . SPARSER::DRUG) ("Camptothecin" . SPARSER::DRUG)
    ("topoisomerase" . SPARSER::PROTEIN) ("TMZ" . SPARSER::DRUG)
    ("Temozolomide" . SPARSER::DRUG) ("EtOH" . SPARSER::MOLECULE)
    ("solvent" . SPARSER::MOLECULE) ("log-rank" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("t" . SPARSER::PROTEIN)
    ("amide" . SPARSER::MOLECULE) ("DMBA" . SPARSER::MOLECULE)
    ("anthracene" . SPARSER::DRUG) ("caspases" . SPARSER::PROTEIN)
    ("ROS" . SPARSER::PROTEIN) ("leukemia" . SPARSER::PROTEIN)
    ("ketone" . SPARSER::MOLECULE)
    ("the principal cytotoxic component" . SPARSER::COMPONENT)
    ("macrophages" . SPARSER::PROTEIN) ("Trabectedin" . SPARSER::DRUG)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("curcumin and resveratrol" . SPARSER::COLLECTION)
    ("Bax" . SPARSER::PROTEIN) ("resveratrol" . SPARSER::PROTEIN)
    ("curcumin" . SPARSER::DRUG) ("isothiocyanates" . SPARSER::MOLECULE)
    ("Phytochemicals" . SPARSER::DRUG) ("MEK-Erk1/2" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and PTEN" . SPARSER::COLLECTION)
    ("INK4a/ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("Nimbolide" . SPARSER::DRUG)
    ("mTOR or other cell cycle regulators" . SPARSER::COLLECTION)
    ("Akt, Erk1/2 and STAT3" . SPARSER::COLLECTION)
    ("CDK4/CDK6" . SPARSER::COLLECTION) ("EGFRvIII" . SPARSER::PROTEIN)
    ("that nimbolide or an ethanol soluble fraction" . SPARSER::COLLECTION)
    ("an ethanol soluble fraction" . SPARSER::COMPONENT)
    ("Azt" . SPARSER::DRUG) ("ethanol" . SPARSER::PROTEIN)
    ("triterpenoid" . SPARSER::MOLECULE) ("nimbolide" . SPARSER::DRUG)
    ("CDKN2A" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("or 2" . SPARSER::MOLECULE)
    ("GSK3β" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PARP3" . SPARSER::PROTEIN) ("S-G2" . SPARSER::PROTEIN)
    ("5-2" . SPARSER::PROTEIN) ("BEZ235" . SPARSER::DRUG)
    ("PP242" . SPARSER::DRUG) ("mTORC1" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG) ("alkylating agent" . SPARSER::MOLECULE)
    ("Caspase 3" . SPARSER::PROTEIN) ("CDK4/6" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("P21" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("4EBP1" . SPARSER::PROTEIN) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pS6" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("U87" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("Integrin" . SPARSER::PROTEIN)
    ("Rho GTPase-activating protein" . SPARSER::COLLECTION)
    ("RhoGAP" . SPARSER::PROTEIN) ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("WASP/N-WASP" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("Cdc42/Rac" . SPARSER::COLLECTION)
    ("Rho, Rac, and Cdc42" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPases" . SPARSER::GTPASE)
    ("nearly all examined proteins" . SPARSER::PROTEIN)
    ("retina and myelin" . SPARSER::COLLECTION) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("Wnt/TCF" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("ShRNA" . SPARSER::PROTEIN)
    ("nearly all tested proteins" . SPARSER::PROTEIN)
    ("β1-integrin and β-catenin" . SPARSER::COLLECTION)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1/cdc42" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("myelin" . SPARSER::PROTEIN) ("retina" . SPARSER::DRUG)
    ("Substrate" . SPARSER::SUBSTRATE) ("laminin" . SPARSER::PROTEIN)
    ("FITC–phalloidin" . SPARSER::MOLECULE) ("phalloidin" . SPARSER::MOLECULE)
    ("ROCK1/ROCK2" . SPARSER::COLLECTION)
    ("ROCK1 (Fig.  xref ) and ROCK2 (Fig.  xref )" . SPARSER::COLLECTION)
    ("ROCK1 and seq2 and seq4" . SPARSER::COLLECTION)
    ("HG" . SPARSER::MOLECULE) ("the mesenchymal type" . TYPE)
    ("integrins and matrix" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a half LIM domains protein (FHL2) and estrogen receptor (ER) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("cofilin" . SPARSER::PROTEIN) ("kinase (LIMK)" . SPARSER::KINASE)
    ("LIMK" . SPARSER::PROTEIN) ("GTPase" . SPARSER::GTPASE)
    ("differentially" . SPARSER::PROTEIN)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("p190A" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("rac1" . SPARSER::PROTEIN) ("N-WASP" . SPARSER::PROTEIN)
    ("Cdc42" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("pERK1/2" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("6.3 " . SPARSER::PROTEIN) ("ROCK1 protein" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("FHL2" . SPARSER::PROTEIN) ("myosin phosphatase" . SPARSER::PROTEIN)
    ("myosin-binding subunit" . SPARSER::PROTEIN)
    ("member A" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("MSA-P and MSA-C" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN) ("p12" . SPARSER::PROTEIN)
    ("hemizygous genes" . SPARSER::GENE) ("ataxia-" . SPARSER::PROTEIN)
    ("MIM" . SPARSER::PROTEIN) ("sibs" . SPARSER::DRUG)
    ("epilepsy" . SPARSER::PROTEIN) ("met" . SPARSER::AMINO-ACID)
    ("Trk" . SPARSER::PROTEIN) ("neurotrophin" . SPARSER::PROTEIN)
    ("SHC-transforming protein" . SPARSER::COLLECTION)
    ("SHC" . SPARSER::PROTEIN)
    ("fragile X mental retardation 1 and leucine-rich kinase 2 genes"
     . SPARSER::COLLECTION)
    ("hydrolase-1" . SPARSER::COLLECTION) ("leucine" . SPARSER::AMINO-ACID)
    ("hydrolase" . SPARSER::PROTEIN) ("ubiquitin" . SPARSER::PROTEIN)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("fibrillar α-synuclein" . SPARSER::PROTEIN)
    ("cerebellar ataxia" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("allele" . SPARSER::ALLELE) ("DNAs" . SPARSER::DNA)
    ("glial" . SPARSER::PROTEIN) ("COQ2" . SPARSER::PROTEIN)
    ("fragile X mental retardation 1" . SPARSER::PROTEIN)
    ("dopamine beta-hydroxylase" . SPARSER::PROTEIN)
    ("apolipoprotein E" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN)
    ("α-synuclein" . SPARSER::PROTEIN) ("MSA-P" . SPARSER::PROTEIN)
    ("SHC2" . SPARSER::PROTEIN) ("transforming protein" . SPARSER::PROTEIN)
    ("alpha-synuclein" . SPARSER::PROTEIN)
    ("at least part" . SPARSER::COMPONENT) ("elegans" . SPARSER::PROTEIN)
    ("macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("interactors" . SPARSER::PROTEIN)
    ("G3BP1 and another core SG component" . SPARSER::COLLECTION)
    ("the protein's" . SPARSER::PROTEIN) ("ribosylase" . SPARSER::PROTEIN)
    ("G3BP1 and SIRT6" . SPARSER::COLLECTION)
    ("a robust and physiologic SIRT6-interacting protein" . SPARSER::PROTEIN)
    ("DNAse and RNAse" . SPARSER::COLLECTION) ("NaCl" . SPARSER::PROTEIN)
    ("RNAse" . SPARSER::PROTEIN) ("DNAse" . SPARSER::PROTEIN)
    ("G3BP1, Caprin-1, or USP10" . SPARSER::COLLECTION)
    ("Caprin-1 and USP10" . SPARSER::COLLECTION)
    ("USP10 and caprin-1" . SPARSER::COLLECTION)
    ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("SIRT6 and G3BP1" . SPARSER::COLLECTION)
    ("multiple SIRT6-associated complexes" . SPARSER::BIO-COMPLEX)
    ("the SIRT6-associated proteins" . SPARSER::PROTEIN)
    ("GO" . SPARSER::PROTEIN)
    ("previously uncharacterized SIRT6" . SPARSER::PROTEIN)
    ("HYRC" . SPARSER::PROTEIN) ("IPs" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("multi-protein" . SPARSER::COLLECTION) ("KDa" . SPARSER::PROTEIN)
    ("fractions" . SPARSER::COMPONENT) ("SIRT6-FLAG" . SPARSER::COLLECTION)
    ("SIRT6-G3BP1" . SPARSER::COLLECTION)
    ("multiple macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("80+ previously unknown SIRT6-interacting proteins" . SPARSER::PROTEIN)
    ("CtIP and acetyltransferase" . SPARSER::COLLECTION)
    ("Parp-1" . SPARSER::PROTEIN) ("Parp" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("acetyltransferase" . SPARSER::PROTEIN)
    ("CtIP" . SPARSER::PROTEIN) ("lysines" . SPARSER::AMINO-ACID)
    ("NAD" . SPARSER::MOLECULE) ("enzymes" . SPARSER::ENZYME)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("elongation" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("Tween20" . SPARSER::MOLECULE) ("beta-tubulin" . SPARSER::PROTEIN)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("beta-2" . SPARSER::PROTEIN)
    ("EIF3" . SPARSER::BIO-COMPLEX) ("RNA binding" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("Caprin-1" . SPARSER::PROTEIN)
    ("caprin-1" . SPARSER::PROTEIN) ("USP10" . SPARSER::PROTEIN)
    ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPase Activating Protein" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("G3BP1" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("BAF155 and CDK6" . SPARSER::COLLECTION)
    ("BAF250A/BAF155/BAF170" . SPARSER::COLLECTION)
    ("BAF250A and BAF155" . SPARSER::COLLECTION)
    ("BAF170 and BAF155" . SPARSER::COLLECTION)
    ("E2F ( xref ) and E2F" . SPARSER::COLLECTION)
    ("MYC ( xref , xref ) and CCND1 ( xref )" . SPARSER::COLLECTION)
    ("p21 and CCNA1" . SPARSER::COLLECTION)
    ("BAF250A and BAF47" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("deacetylases and chromatin" . SPARSER::COLLECTION)
    ("Acetyl" . SPARSER::MOLECULE) ("octamer" . SPARSER::PROTEIN)
    ("methylases" . SPARSER::PROTEIN) ("acetyl" . SPARSER::MOLECULE)
    ("Nucleosome" . SPARSER::BIO-COMPLEX)
    ("PD 0332991 and Anastrozole" . SPARSER::COLLECTION)
    ("Letrozole and CDK 4/6" . SPARSER::COLLECTION)
    ("Hormone" . SPARSER::MOLECULE) ("Letrozole" . SPARSER::DRUG)
    ("Anastrozole" . SPARSER::DRUG) ("NCT" . SPARSER::PROTEIN)
    ("Paclitaxel" . SPARSER::DRUG) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an endoplasmatic reticulum-bound receptor" . SPARSER::RECEPTOR)
    ("derivatives" . SPARSER::DERIVATIVE) ("BCRP/ABCG2" . SPARSER::COLLECTION)
    ("BCRP" . SPARSER::PROTEIN) ("MYC and p53" . SPARSER::COLLECTION)
    ("MYC" . SPARSER::PROTEIN) ("BAF53A and BAF57" . SPARSER::COLLECTION)
    ("FUL and BAF170" . SPARSER::COLLECTION) ("weaker" . SPARSER::PROTEIN)
    ("BRG1, BAF250A and BAF47" . SPARSER::COLLECTION)
    ("BAF250A, BAF155 and BAF47" . SPARSER::COLLECTION)
    ("BGR" . SPARSER::PROTEIN)
    ("deacetylases and the hSWI/SNF chromatin" . SPARSER::COLLECTION)
    ("subunit" . SPARSER::FRAGMENT) ("Acetylases" . SPARSER::PROTEIN)
    ("ATPase" . SPARSER::PROTEIN) ("CCND1 and CCNE1" . SPARSER::COLLECTION)
    ("the indirect downstream effector" . SPARSER::EFFECTOR)
    ("effector" . SPARSER::EFFECTOR) ("transfectants" . SPARSER::PROTEIN)
    ("TRA" . SPARSER::PROTEIN) ("FTC" . SPARSER::DRUG)
    ("GREB1 and RERG" . SPARSER::COLLECTION)
    ("BCAR1 and ABCG2" . SPARSER::COLLECTION)
    ("TSA (inhibitor of class I and II mammalian histone deacetylases) and AZA (cytidine analogue that inhibits methyltransferases, thereby hypomethylating the DNA)"
     . SPARSER::COLLECTION)
    ("cytidine" . SPARSER::MOLECULE) ("deacetylases" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN)
    ("GREB1, BCAR3 and ERBB2" . SPARSER::COLLECTION)
    ("BCAR1, ABCG2 and CDK6" . SPARSER::COLLECTION)
    ("ABCG2 and ERBB2" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("RERG , GREB1 and GPER" . SPARSER::COLLECTION)
    ("ERs and PGR" . SPARSER::COLLECTION) ("AZA and TSA" . SPARSER::COLLECTION)
    ("TSA" . SPARSER::PROTEIN) ("AZA" . SPARSER::DRUG)
    ("ERs" . SPARSER::PROTEIN)
    ("ER β and its target progesterone receptor (PGR)" . SPARSER::COLLECTION)
    ("ER α , ER β and its target progesterone receptor (PGR)"
     . SPARSER::COLLECTION)
    ("progesterone receptor (PGR)" . SPARSER::PROTEIN)
    ("PGR" . SPARSER::PROTEIN) ("Gene" . SPARSER::GENE)
    ("functional ER" . SPARSER::PROTEIN)
    ("a pure anti-oestrogen" . SPARSER::DRUG) ("faslodex" . SPARSER::DRUG)
    ("CpG" . SPARSER::PROTEIN) ("tamoxifen (TAM)" . SPARSER::DRUG)
    ("gold" . SPARSER::MOLECULE) ("SERM" . SPARSER::DRUG)
    ("TAM" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("antagonists" . SPARSER::MOLECULE) ("stimulant" . SPARSER::DRUG)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SWI" . SPARSER::PROTEIN)
    ("BAF250A, BAF170 and BAF155" . SPARSER::COLLECTION)
    ("BRG1, BAF170 and BAF47" . SPARSER::COLLECTION)
    ("hSWI/SNF" . SPARSER::COLLECTION) ("subunits" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN) ("chromatin" . SPARSER::PROTEIN)
    ("Sucrose" . SPARSER::MOLECULE) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("GPER and CDK6" . SPARSER::COLLECTION) ("histone" . SPARSER::PROTEIN)
    ("ER and ER-related genes ( GREB1 , RERG ) or genes" . SPARSER::COLLECTION)
    ("ER-related genes ( GREB1 , RERG ) or genes" . SPARSER::COLLECTION)
    ("RERG" . SPARSER::PROTEIN) ("GPER" . SPARSER::PROTEIN)
    ("Fulvestrant" . SPARSER::DRUG)
    ("selected resistance-associated genes" . SPARSER::GENE)
    ("FR" . SPARSER::PROTEIN) ("FUL" . SPARSER::DRUG)
    ("fulvestrant (FUL)" . SPARSER::DRUG) ("fulvestrant" . SPARSER::DRUG)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("anti-oestrogens" . SPARSER::DRUG)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("CDK 4/6" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("PD 0332991" . SPARSER::DRUG)
    ("Cyclin Dependent Kinase 4" . SPARSER::PROTEIN)
    ("PD-0332991" . SPARSER::DRUG) ("hormone-sensitive" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("CCNA1" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("BCAR3" . SPARSER::PROTEIN) ("BAF53A" . SPARSER::PROTEIN)
    ("ACTL6A" . SPARSER::PROTEIN) ("BAF57" . SPARSER::PROTEIN)
    ("SmarcE1" . SPARSER::PROTEIN) ("SNF5" . SPARSER::PROTEIN)
    ("SmarcA4" . SPARSER::PROTEIN) ("ARID1A" . SPARSER::PROTEIN)
    ("BAF 155" . SPARSER::PROTEIN) ("SmarcC1" . SPARSER::PROTEIN)
    ("SmarcC2" . SPARSER::PROTEIN) ("CDK 6" . SPARSER::PROTEIN)
    ("β -tubulin" . SPARSER::PROTEIN) ("α -tubulin" . SPARSER::PROTEIN)
    ("C-22" . SPARSER::PROTEIN) ("CDK 4" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("PD0332991" . SPARSER::DRUG)
    ("L -glutamine" . SPARSER::MOLECULE) ("F-12" . SPARSER::PROTEIN)
    ("ER β" . SPARSER::PROTEIN) ("ER α" . SPARSER::PROTEIN)
    ("BAF47" . SPARSER::PROTEIN) ("BAF155" . SPARSER::PROTEIN)
    ("BAF170" . SPARSER::PROTEIN) ("BAF250A" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("BCAR 3" . SPARSER::PROTEIN) ("BCAR1" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("anti-oestrogen" . SPARSER::DRUG)
    ("isoform" . SPARSER::ISOFORM) ("Fasudil" . SPARSER::DRUG)
    ("molecule" . SPARSER::MOLECULE) ("substrate" . SPARSER::SUBSTRATE)
    ("variety" . SPARSER::VARIETY) ("homodimer" . SPARSER::HOMODIMER)
    ("heterodimer" . SPARSER::HETERODIMER) ("dimer" . SPARSER::DIMER)
    ("microtubules" . SPARSER::PROTEIN) ("nocodazole" . SPARSER::DRUG)
    ("MEFs" . SPARSER::PROTEIN) ("PPase" . SPARSER::PROTEIN)
    ("flag-ROCKI" . SPARSER::COLLECTION) ("flag" . SPARSER::PROTEIN-FAMILY)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("the ROCKI −/− and ROCKII −/− mice" . SPARSER::COLLECTION)
    ("RhoE" . SPARSER::PROTEIN) ("ROCKs" . SPARSER::PROTEIN-FAMILY)
    ("filaments and myosin" . SPARSER::COLLECTION)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("myosin light chain (MLC)" . SPARSER::PROTEIN)
    ("LIMK1 and LIMK2" . SPARSER::COLLECTION)
    ("proteins, and etc." . SPARSER::COLLECTION)
    ("ezrin-radixin-moesin" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("moesin" . SPARSER::PROTEIN) ("radixin" . SPARSER::PROTEIN)
    ("ezrin" . SPARSER::PROTEIN) ("substrates" . SPARSER::SUBSTRATE)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("actin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("serine" . SPARSER::AMINO-ACID)
    ("ROCKI (also called ROKβ) and ROCKII (also known as Rho kinase and ROKα)"
     . SPARSER::COLLECTION)
    ("Rho-associated protein kinase (ROCK), ROCKI (also called ROKβ) and ROCKII (also known as Rho kinase and ROKα)"
     . SPARSER::COLLECTION)
    ("Rho kinase and ROKα" . SPARSER::COLLECTION) ("GTP" . SPARSER::NUCLEOTIDE)
    ("ROCKI and phospho-S1366" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY) ("Active" . SPARSER::ACTIVE)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("pSer" . SPARSER::PROTEIN)
    ("reagents" . SPARSER::MOLECULE)
    ("Rho-associated protein kinase (ROCK)" . SPARSER::KINASE)
    ("kinase (ROCK)" . SPARSER::KINASE)
    ("ROCKI and ROCKII" . SPARSER::COLLECTION) ("ROCKII" . SPARSER::PROTEIN)
    ("ROCKI" . SPARSER::PROTEIN) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("isoforms" . SPARSER::ISOFORM)
    ("GEF-H1" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("MgCl 2" . SPARSER::MOLECULE)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("NP-40" . SPARSER::DRUG)
    ("S19" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("α-adducin" . SPARSER::PROTEIN)
    ("LIMK2" . SPARSER::PROTEIN) ("LIMK1" . SPARSER::PROTEIN)
    ("MYPT1" . SPARSER::PROTEIN) ("myosin binding subunit" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("ROKα" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN)
    ("PI3K inhibitors and mTOR inhibitors" . SPARSER::COLLECTION)
    ("CK20 or CDX2" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tim" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nodal" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA)
    ("92 previously untreated AAs" . SPARSER::MOLECULE)
    ("adenomatous component" . SPARSER::COMPONENT)
    ("CK20 and CDX2" . SPARSER::COLLECTION) ("adjuvant" . SPARSER::DRUG)
    ("seven" . SPARSER::PROTEIN)
    ("irinotecan, and 5-fluorouracil" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("Cetuximab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("Kras" . SPARSER::PROTEIN)
    ("AKT/mammalian target of Rapamycin" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("phosphotidylinositol-3" . SPARSER::COLLECTION)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("lipid" . SPARSER::LIPID)
    ("thyroid" . SPARSER::PROTEIN)
    ("ampullary adenomas and low-grade AA" . SPARSER::MOLECULE)
    ("DPC4/SMAD4" . SPARSER::COLLECTION) ("AAs" . SPARSER::MOLECULE)
    ("male" . SPARSER::MOLECULE)
    ("previously untreated AA" . SPARSER::MOLECULE) ("AA" . SPARSER::MOLECULE)
    ("PI3K-AKT" . SPARSER::PROTEIN) ("CDX2" . SPARSER::PROTEIN)
    ("CK20" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("cytokeratin 7" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("mammalian target of Rapamycin" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PIP2)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("SMAD4" . SPARSER::PROTEIN) ("DPC4" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("TN-" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("synergizes" . SPARSER::PROTEIN) ("miRNAs" . SPARSER::PROTEIN)
    ("E2F-regulated lncRNAs" . SPARSER::RNA) ("tip" . SPARSER::PROTEIN)
    ("endogenous E2F1 or endogenous E2F3 and endogenous E2F1"
     . SPARSER::COLLECTION)
    ("endogenous E2F3 and endogenous E2F1" . SPARSER::COLLECTION)
    ("a viral protein" . SPARSER::PROTEIN) ("miR" . SPARSER::PROTEIN)
    ("microRNAs" . SPARSER::RNA) ("regulator" . SPARSER::REGULATOR)
    ("the chemotherapeutic drug etoposide" . SPARSER::DRUG)
    ("etoposide" . SPARSER::PROTEIN) ("two distinct siRNA" . SPARSER::PROTEIN)
    ("FBS" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("two distinct siRNAs" . SPARSER::PROTEIN)
    ("oncoprotein" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("conditional E2F1" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("E2F1 and E2F3" . SPARSER::COLLECTION)
    ("conditional E2F3" . SPARSER::PROTEIN) ("OHT" . SPARSER::DRUG)
    ("inducer" . SPARSER::MOLECULE) ("a somatic map" . SPARSER::PROTEIN)
    ("lincRNA" . SPARSER::RNA)
    ("8,196 long intergenic non-coding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA) ("RNA" . SPARSER::RNA)
    ("ER-E2F1" . SPARSER::COLLECTION)
    ("either E2F1 or a DNA" . SPARSER::COLLECTION)
    ("Inhibitor" . SPARSER::INHIBITOR)
    ("an oncogene or a tumor suppressor [ xref ]" . SPARSER::COLLECTION)
    ("RB/E2F" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("promoters" . SPARSER::PROMOTER)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("cis" . SPARSER::PROTEIN)
    ("scaffold" . SPARSER::SCAFFOLD) ("ncRNA" . SPARSER::RNA) ("class" . CLASS)
    ("the chemotherapeutic drug Etoposide" . SPARSER::DRUG)
    ("Etoposide" . SPARSER::PROTEIN) ("E2F1 and ERIC" . SPARSER::COLLECTION)
    ("E2F1 or E2F3" . SPARSER::COLLECTION)
    ("E2F3 or endogenous E2Fs" . SPARSER::COLLECTION)
    ("exogenous E2F1, E2F3 or endogenous E2Fs" . SPARSER::COLLECTION)
    ("exogenous E2F1" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("The pivotal transcription factor E2F1" . SPARSER::PROTEIN)
    ("RB" . SPARSER::PROTEIN) ("unique long non-coding RNAs" . SPARSER::RNA)
    ("lncRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("β-Actin" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("U20" . SPARSER::PROTEIN)
    ("2F1" . SPARSER::PROTEIN) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCNE1" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN) ("Gab2" . SPARSER::PROTEIN)
    ("E2" . SPARSER::MOLECULE) ("miR-16" . SPARSER::PROTEIN)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("caspase 3" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("chr8" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("E2F3" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("lysosomal" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("Western blot" . SPARSER::PROTEIN) ("baicalin" . SPARSER::DRUG)
    ("MMP-2 and MMP-12" . SPARSER::COLLECTION) ("calcium" . SPARSER::CALCIUM)
    ("STAT2 and STAT6" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("Src, STAT5a/b and p38α" . SPARSER::COLLECTION)
    ("EGFR, p38α, Src, Lyn, STAT2, STAT6, STAT5a/b and c-Jun"
     . SPARSER::COLLECTION)
    ("Lyn or Fyn" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("CAS" . SPARSER::PROTEIN) ("STAT" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("Fyn" . SPARSER::PROTEIN)
    ("kinases" . SPARSER::KINASE)
    ("gefitinib or the MET inhibitor SU11274" . SPARSER::COLLECTION)
    ("gefitinib and PHA-665752" . SPARSER::COLLECTION)
    ("EGFR or MET" . SPARSER::COLLECTION) ("MET-TKI" . SPARSER::COLLECTION)
    ("receptors" . SPARSER::RECEPTOR) ("MET and EGFR" . SPARSER::COLLECTION)
    ("PD168393 or BIBW2992" . SPARSER::COLLECTION)
    ("N-cadherin, vimentin and negative regulators" . SPARSER::COLLECTION)
    ("β-catenin, SLUG and SNAIL" . SPARSER::COLLECTION)
    ("SLUG and SNAIL" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("Src, STAT5a/b or p38α" . SPARSER::COLLECTION)
    ("dasatinib and the combination" . SPARSER::COLLECTION)
    ("U0126 or NVP-BEZ235" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("mTOR" . SPARSER::PROTEIN)
    ("dasatinib" . SPARSER::DRUG) ("EGFR and MET" . SPARSER::COLLECTION)
    ("PD168393 and BIBW2992" . SPARSER::COLLECTION)
    ("Cys" . SPARSER::AMINO-ACID) ("afatinib" . SPARSER::DRUG)
    ("EGFR and Src" . SPARSER::COLLECTION) ("ATP" . SPARSER::ATP)
    ("target" . SPARSER::TARGET-PROTEIN) ("siRNA-EGFR" . SPARSER::COLLECTION)
    ("siRNA-" . SPARSER::PROTEIN) ("siRNAs" . SPARSER::PROTEIN)
    ("p38, STAT5 and Src" . SPARSER::COLLECTION)
    ("Lyn, STAT2, STAT6, STAT5a/b and c-Jun" . SPARSER::COLLECTION)
    ("Lyn" . SPARSER::PROTEIN) ("Ser/Thr" . SPARSER::COLLECTION)
    ("Ser" . SPARSER::AMINO-ACID)
    ("MET, Akt and ERK 1/2" . SPARSER::COLLECTION)
    ("EGFR, and Src" . SPARSER::COLLECTION)
    ("gelatinolytic MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("MMPs" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("Gefitinib" . SPARSER::DRUG)
    ("GR" . SPARSER::PROTEIN) ("irreversible TKIs" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("TKI" . SPARSER::PROTEIN) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("exon" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG)
    ("traditional chemotherapeutic drugs" . SPARSER::DRUG)
    ("drugs" . SPARSER::DRUG) ("Src, STAT5 and p38" . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("gefitinib" . SPARSER::DRUG) ("MET" . SPARSER::PROTEIN)
    ("-mutant" . SPARSER::MUTANT) ("TKIs" . SPARSER::PROTEIN)
    ("MMP-12" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("TGF-β1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("Claudin-1" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("β-catenin" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("phospho-kinase" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src kinase" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("p38α" . SPARSER::PROTEIN)
    ("Phospho-kinase" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-ERK1" . SPARSER::PROTEIN)
    ("p70S6" . SPARSER::PROTEIN) ("p-Src" . SPARSER::PROTEIN)
    ("R-250" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("BIBW2992" . SPARSER::DRUG) ("PD168393" . SPARSER::DRUG)
    ("SU11274" . SPARSER::DRUG) ("U0126" . SPARSER::DRUG)
    ("NVP-BEZ235" . SPARSER::DRUG) ("ZD1839" . SPARSER::DRUG)
    ("CO 2" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT5" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("cofactors" . SPARSER::PROTEIN)
    ("daidzein, quercetin, and equol" . SPARSER::COLLECTION)
    ("equol" . SPARSER::MOLECULE) ("quercetin" . SPARSER::MOLECULE)
    ("phytoestrogens" . SPARSER::DRUG) ("variants" . SPARSER::VARIANT)
    ("alleles" . SPARSER::ALLELE) ("endocrine" . SPARSER::PROTEIN)
    ("Flutamide" . SPARSER::DRUG) ("hydroxyflutamide" . SPARSER::DRUG)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("promiscuously mutant ARs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factors and proteins" . SPARSER::COLLECTION)
    ("the promiscuously mutant AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A Western blot" . SPARSER::PROTEIN) ("Proteins" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("tyrosine" . SPARSER::AMINO-ACID) ("luciferase" . SPARSER::PROTEIN)
    ("PSA protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("promoter" . SPARSER::PROMOTER) ("Promoter" . SPARSER::PROMOTER)
    ("AR protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("mRNA and Protein" . SPARSER::COLLECTION) ("Protein" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN)
    ("promiscuously mutant AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the rabbit polyclonal anti-AR" . SPARSER::ANTIBODY)
    ("flutamide" . SPARSER::DRUG) ("bisphenol" . SPARSER::MOLECULE)
    ("estrogen" . SPARSER::MOLECULE)
    ("the promiscuously mutant AR receptor" . SPARSER::RECEPTOR)
    ("PBSA" . SPARSER::DRUG) ("DHT" . SPARSER::PROTEIN)
    ("the mutant AR and the WT-AR" . SPARSER::COLLECTION)
    ("genistein or 1 nmol/L" . SPARSER::COLLECTION) ("Casodex" . SPARSER::DRUG)
    ("antagonist" . SPARSER::MOLECULE) ("Mutant" . SPARSER::MUTANT)
    ("dehydrogenase" . SPARSER::PROTEIN) ("lactate" . SPARSER::LACTATE)
    ("cytometry" . SPARSER::PROTEIN)
    ("genistein or androgen" . SPARSER::COLLECTION) ("trypan" . SPARSER::DRUG)
    ("WT AR (LAPC-4 cells) or T877A mutant AR (LNCaP cells)"
     . SPARSER::COLLECTION)
    ("AR and PSA" . SPARSER::COLLECTION) ("ARs" . SPARSER::PROTEIN)
    ("estradiol" . SPARSER::PROTEIN) ("cytotoxic" . SPARSER::PROTEIN)
    ("ligands" . SPARSER::LIGAND) ("progesterone" . SPARSER::PROTEIN)
    ("threonine" . SPARSER::AMINO-ACID) ("The latter types" . TYPE)
    ("antiandrogens" . SPARSER::DRUG) ("progestins" . SPARSER::DRUG)
    ("estrogens" . SPARSER::MOLECULE) ("testicular androgens" . SPARSER::DRUG)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("coactivators" . SPARSER::PROTEIN) ("cytokines" . SPARSER::PROTEIN)
    ("androgens" . SPARSER::DRUG) ("most recurrent PCa" . SPARSER::PROTEIN)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSA" . SPARSER::PROTEIN) ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("antioxidant" . SPARSER::PROTEIN) ("Akt and MAPK" . SPARSER::COLLECTION)
    ("genes" . SPARSER::GENE) ("state" . SPARSER::BIO-STATE)
    ("the principal isoflavone" . SPARSER::MOLECULE)
    ("genistein and daidzein" . SPARSER::COLLECTION)
    ("glycitein" . SPARSER::DRUG) ("daidzein" . SPARSER::DRUG)
    ("isoflavone" . SPARSER::MOLECULE) ("isoflavones" . SPARSER::MOLECULE)
    ("States" . SPARSER::BIO-STATE) ("agonist" . SPARSER::AGONIST)
    ("PC-3" . SPARSER::PROTEIN) ("LNCaP" . SPARSER::PROTEIN)
    ("Genistein" . SPARSER::PROTEIN) ("Ala" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("phytoestrogen" . SPARSER::DRUG)
    ("genistein" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("chemical" . SPARSER::MOLECULE) ("PCa" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("anti-androgens" . SPARSER::DRUG) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G2/M" . SPARSER::PROTEIN) ("TIP3" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("nM 3" . SPARSER::DRUG)
    ("Dual–Luciferase" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3- phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG) ("N-20" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("g protein" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("C-AR" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("phenol red" . SPARSER::DRUG)
    ("17β-estradiol" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("androgen receptor" . SPARSER::PROTEIN)
    ("AG" . SPARSER::PROTEIN) ("complement" . SPARSER::PROTEIN)
    ("BKM120 and MK-2206" . SPARSER::COLLECTION)
    ("regulators" . SPARSER::REGULATOR)
    ("type and tumor" . SPARSER::COLLECTION) ("RR" . SPARSER::MOLECULE)
    ("inhibitors" . SPARSER::INHIBITOR) ("Aromatase" . SPARSER::PROTEIN)
    ("hormone" . SPARSER::MOLECULE) ("Taxol" . SPARSER::DRUG)
    ("Cyclophosphamide, Adriamycin, and Fluorouracil" . SPARSER::COLLECTION)
    ("Cyclophosphamide, Methotrexate, and Fluorouracil" . SPARSER::COLLECTION)
    ("Methotrexate" . SPARSER::DRUG) ("CMF" . SPARSER::PROTEIN)
    ("Fluorouracil" . SPARSER::DRUG) ("Adriamycin" . SPARSER::DRUG)
    ("Cyclophosphamide" . SPARSER::DRUG) ("cohort" . SPARSER::MOLECULE)
    ("ER, PR or HER2" . SPARSER::COLLECTION)
    ("CD44 or CD24" . SPARSER::COLLECTION)
    ("ER- and PR-" . SPARSER::COLLECTION)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("CD44 (Permanent Red, xref ) and CD24 (DAB brown, xref )"
     . SPARSER::COLLECTION)
    ("DAB" . SPARSER::MOLECULE) ("example" . SPARSER::EXAMPLE)
    ("CD24 and other Biomarkers" . SPARSER::COLLECTION)
    ("CD44, CD24 and other Biomarkers" . SPARSER::COLLECTION)
    ("Biomarkers" . SPARSER::MOLECULE) ("HER2-" . SPARSER::PROTEIN)
    ("types" . TYPE) ("HER-" . SPARSER::PROTEIN) ("HER" . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("representative CSC biomarkers" . SPARSER::MOLECULE)
    ("CD44/CD24" . SPARSER::COLLECTION) ("fraction" . SPARSER::COMPONENT)
    ("drug" . SPARSER::DRUG) ("component" . SPARSER::COMPONENT)
    ("a clinically relevant prognostic biomarker" . SPARSER::MOLECULE)
    ("IGF-I and IGFBP-3" . SPARSER::COLLECTION)
    ("activator" . SPARSER::ACTIVATOR)
    ("PTEN, pAkt, and FOXO1" . SPARSER::COLLECTION)
    ("AKT/PI3K" . SPARSER::COLLECTION) ("biomarker" . SPARSER::MOLECULE)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("inhibitor" . SPARSER::INHIBITOR) ("MAPK" . SPARSER::PROTEIN)
    ("particularly Insulin-like Growth Factor Binding Protein (IGFBP)-3"
     . SPARSER::PROTEIN)
    ("a systemic growth factor" . SPARSER::GROWTH-FACTOR)
    ("IGF" . SPARSER::PROTEIN) ("group" . SPARSER::MOLECULE)
    ("gene and protein" . SPARSER::COLLECTION) ("cohorts" . SPARSER::MOLECULE)
    ("subtypes and biomarkers" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("Tamoxifen" . SPARSER::MOLECULE)
    ("receptor-subtypes" . SPARSER::COLLECTION) ("Los" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("CD44-" . SPARSER::PROTEIN)
    ("high pAkt, decreased FOXO1, and high CD24+ expression"
     . SPARSER::COLLECTION)
    ("HR-" . SPARSER::PROTEIN) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("CD24-" . SPARSER::PROTEIN) ("HR" . SPARSER::PROTEIN)
    ("Receptor" . SPARSER::RECEPTOR) ("Formalin" . SPARSER::MOLECULE)
    ("the Insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP3)"
     . SPARSER::COLLECTION)
    ("CD44 and CD24" . SPARSER::COLLECTION)
    ("Akt, and FOXO1" . SPARSER::COLLECTION) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("subtypes" . SPARSER::PROTEIN) ("PTEN" . SPARSER::PROTEIN)
    ("targets" . SPARSER::TARGET-PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALDH1" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("MK-2206" . SPARSER::MOLECULE)
    ("BKM120" . SPARSER::DRUG) ("chromosome 17" . SPARSER::PROTEIN)
    ("cell membrane" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("IGF-I Receptor" . SPARSER::PROTEIN) ("IGFBP-3" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor Binding Protein" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("Insulin-like Growth Factor" . SPARSER::PROTEIN)
    ("HER2" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("IGF binding protein-3" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("FOXO1" . SPARSER::PROTEIN) ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD24" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("ER" . SPARSER::PROTEIN) ("Gln" . SPARSER::AMINO-ACID)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("Hsp70 and c-Raf" . SPARSER::COLLECTION)
    ("both collagen type I (gelatin) and type IV (Matrigel)"
     . SPARSER::COLLECTION)
    ("IV" . SPARSER::PROTEIN) ("Lox" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE)
    ("The consequent aldehydes" . SPARSER::MOLECULE)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("aldehydes" . SPARSER::MOLECULE)
    ("lysine and hydroxylysine" . SPARSER::COLLECTION)
    ("elastin and collagen" . SPARSER::COLLECTION)
    ("semialdehyde" . SPARSER::MOLECULE) ("lysine" . SPARSER::AMINO-ACID)
    ("c-Cbl and CD2" . SPARSER::COLLECTION)
    ("Altered oligomerization states or solution-phase" . SPARSER::COLLECTION)
    ("solution" . SPARSER::MOLECULE) ("states" . SPARSER::BIO-STATE)
    ("the computed electrostatic potential maps" . SPARSER::PROTEIN)
    ("nitrogen" . SPARSER::MOLECULE) ("n-Src" . SPARSER::COLLECTION)
    ("CD2AP and CIN85" . SPARSER::COLLECTION)
    ("SH3KBP1 and the ORF3 protein" . SPARSER::COLLECTION)
    ("EGFR and Met" . SPARSER::COLLECTION) ("receptor" . SPARSER::RECEPTOR)
    ("Met" . SPARSER::AMINO-ACID)
    ("Hip1R, SHIP1, and SH3KBP1-binding protein 1" . SPARSER::COLLECTION)
    ("Hip1R" . SPARSER::PROTEIN) ("proline-arginine" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID) ("CIN85/CD2AP" . SPARSER::COLLECTION)
    ("the atypical ligand" . SPARSER::LIGAND)
    ("suppressor" . SPARSER::SUPPRESSOR) ("ECM" . SPARSER::PROTEIN)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("media" . SPARSER::PROTEIN)
    ("siRNA" . SPARSER::PROTEIN) ("FITC" . SPARSER::MOLECULE)
    ("linker" . SPARSER::LINKER) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("Computed electrostatic potential maps" . SPARSER::PROTEIN)
    ("maps" . SPARSER::PROTEIN) ("part" . SPARSER::COMPONENT)
    ("-1" . SPARSER::PROTEIN) ("Glu" . SPARSER::AMINO-ACID)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("conformation" . SPARSER::BIO-CONFORMATION) ("tri" . SPARSER::PROTEIN)
    ("Asp" . SPARSER::AMINO-ACID) ("salt" . SPARSER::MOLECULE)
    ("forms" . SPARSER::FORM) ("Arg" . SPARSER::AMINO-ACID)
    ("Trp" . SPARSER::AMINO-ACID) ("Tyr" . SPARSER::AMINO-ACID)
    ("Phe" . SPARSER::AMINO-ACID) ("Pro" . SPARSER::AMINO-ACID)
    ("II" . SPARSER::PROTEIN) ("type" . TYPE)
    ("polyproline" . SPARSER::PROTEIN)
    ("peptide (RPRPAARHW)" . SPARSER::PEPTIDE) ("mer" . SPARSER::PROTEIN)
    ("c-Raf" . SPARSER::COLLECTION) ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alanines" . SPARSER::AMINO-ACID) ("variant" . SPARSER::VARIANT)
    ("HA-CIN85" . SPARSER::COLLECTION)
    ("progressive C-terminal deletion mutants" . SPARSER::MUTANT)
    ("LOX-PP/CIN85" . SPARSER::COLLECTION)
    ("sprouty2, Src, Ras or SHIP1" . SPARSER::COLLECTION)
    ("ASAP1/AMAP1" . SPARSER::COLLECTION) ("EGFR" . SPARSER::PROTEIN)
    ("an atypical ligand" . SPARSER::LIGAND)
    ("CIN85 and LOX-PP antibodies" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY)
    ("CIN85 or control mouse IgG ( xref )" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("antibody" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN) ("trastuzumab" . SPARSER::DRUG)
    ("MCF7" . SPARSER::PROTEIN)
    ("myc-His-tagged rLOX-PP and GST-CIN85 protein" . SPARSER::PROTEIN)
    ("GST-CIN85" . SPARSER::COLLECTION) ("rLOX-PP" . SPARSER::COLLECTION)
    ("His" . SPARSER::AMINO-ACID) ("myc" . SPARSER::PROTEIN)
    ("FLAG-CD2AP" . SPARSER::COLLECTION) ("GFP-CIN85" . SPARSER::COLLECTION)
    ("GST-LOX-PP" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("GFP" . SPARSER::PROTEIN) ("CIN85 and CD2AP" . SPARSER::COLLECTION)
    ("aa" . SPARSER::MOLECULE) ("peptides" . SPARSER::PEPTIDE)
    ("Q9y5k6" . SPARSER::PROTEIN) ("Q96b97" . SPARSER::PROTEIN)
    ("approximately 85 kDa" . SPARSER::PROTEIN)
    ("LOX-PP-GST" . SPARSER::COLLECTION) ("Sepharose" . SPARSER::MOLECULE)
    ("Glutathione" . SPARSER::DRUG) ("DNA" . SPARSER::DNA)
    ("GST" . SPARSER::PROTEIN)
    ("a novel LOX-PP-interacting protein" . SPARSER::PROTEIN)
    ("alanine" . SPARSER::AMINO-ACID) ("peptide" . SPARSER::PEPTIDE)
    ("Peptide" . SPARSER::PEPTIDE)
    ("phosphatidylinositol 3-kinase, and Ras" . SPARSER::COLLECTION)
    ("form" . SPARSER::FORM) ("carboxy" . SPARSER::MOLECULE)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("proline" . SPARSER::AMINO-ACID)
    ("homology" . SPARSER::PROTEIN) ("Src" . SPARSER::PROTEIN)
    ("family" . SPARSER::PROTEIN-FAMILY) ("kinase (FAK)" . SPARSER::KINASE)
    ("FAK" . SPARSER::PROTEIN) ("kinase" . SPARSER::KINASE)
    ("integrin" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("neu" . SPARSER::PROTEIN)
    ("a functional 32-kDa active enzyme (LOX) and an 18-kDa propeptide (LOX-PP)"
     . SPARSER::COLLECTION)
    ("enzyme (LOX)" . SPARSER::ENZYME) ("active" . SPARSER::ACTIVE)
    ("pro" . SPARSER::AMINO-ACID) ("inactive" . SPARSER::INACTIVE)
    ("oncogene" . SPARSER::ONCOGENE) ("rrg" . SPARSER::PROTEIN)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lysyl oxidase (LOX)" . SPARSER::PROTEIN)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("elastin" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::PROTEIN) ("enzyme" . SPARSER::ENZYME)
    ("oxidase" . SPARSER::PROTEIN) ("Matrigel" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT) ("map" . SPARSER::PROTEIN)
    ("mutants" . SPARSER::MUTANT) ("proteins" . SPARSER::PROTEIN)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("complex" . SPARSER::BIO-COMPLEX)
    ("ligand" . SPARSER::LIGAND) ("kDa" . SPARSER::PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("Cbl" . SPARSER::PROTEIN)
    ("LOX-PP" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("LOX" . SPARSER::PROTEIN) ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene" . SPARSER::GENE) ("alpha-" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("Hsp70" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("CD2" . SPARSER::PROTEIN) ("ORF3" . SPARSER::PROTEIN)
    ("SHKBP1" . SPARSER::PROTEIN)
    ("SH3KBP1-binding protein 1" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("Cbl-b" . SPARSER::PROTEIN) ("β-PIX" . SPARSER::PROTEIN)
    ("PP-II" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("sprouty2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytoplasmic adapter protein" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serum albumin" . SPARSER::PROTEIN) ("Rin3" . SPARSER::PROTEIN)
    ("U23" . SPARSER::PROTEIN) ("SH3KBP1" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("Protein-G" . SPARSER::PROTEIN)
    ("Protein A" . SPARSER::PROTEIN) ("light chain" . SPARSER::PROTEIN)
    ("NBP1" . SPARSER::PROTEIN) ("M2" . SPARSER::MOLECULE)
    ("β-actin" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("ASAP1" . SPARSER::PROTEIN)
    ("B-4" . SPARSER::PROTEIN) ("TX-100" . SPARSER::DRUG)
    ("Triton X-100" . SPARSER::MOLECULE)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("F12" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("PP-1" . SPARSER::PROTEIN) ("P113" . SPARSER::PROTEIN)
    ("BM-40" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("T-3" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD2AP" . SPARSER::PROTEIN) ("p130Cas" . SPARSER::PROTEIN)
    ("H- Ras" . SPARSER::PROTEIN) ("Lysyl oxidase" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("AMAP1" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("c-Cbl" . SPARSER::PROTEIN) ("CIN85" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN) ("precursor protein" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID) ("lysyl oxidase" . SPARSER::PROTEIN)))